geneId	geneSymbol	DSI	DPI	diseaseId	diseaseName	diseaseType	diseaseClass	diseaseSemanticType	score	EI	YearInitial	YearFinal	NofPmids	NofSnps	source
        1	A1BG	0.7	0.538	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2017	2017	   1	   0	CTD_human
        1	A1BG	0.7	0.538	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
        2	A2M	0.529	0.769	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.50	0.769	1998	2018	   3	   0	CTD_human
        2	A2M	0.529	0.769	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.31	1	2004	2019	   1	   0	CTD_human
        2	A2M	0.529	0.769	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
        2	A2M	0.529	0.769	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1998	2004	   3	   0	CTD_human
        2	A2M	0.529	0.769	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	1987	2000	   2	   0	PSYGENET
        2	A2M	0.529	0.769	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1987	2000	   2	   0	PSYGENET
        2	A2M	0.529	0.769	C0019202	Hepatolenticular Degeneration	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
        2	A2M	0.529	0.769	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
        2	A2M	0.529	0.769	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
        2	A2M	0.529	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
        2	A2M	0.529	0.769	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.32	1	1983	1989	   1	   0	CTD_human
        2	A2M	0.529	0.769	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2007	2009	   2	   0	CTD_human
        2	A2M	0.529	0.769	C0027726	Nephrotic Syndrome	group	C13;C12	Disease or Syndrome	0.51	1	1998	2001	   1	   0	CTD_human
        2	A2M	0.529	0.769	C0206669	Hepatocellular Adenoma	disease	C06;C04	Neoplastic Process	0.50	1	2004	2004	   1	   0	CTD_human
        2	A2M	0.529	0.769	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
        2	A2M	0.529	0.769	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.30	1	2007	2009	   2	   0	CTD_human
        2	A2M	0.529	0.769	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.31	1	1998	2016	   3	   0	CTD_human
        2	A2M	0.529	0.769	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.37	0.8	1998	2010	   3	   0	CTD_human
        2	A2M	0.529	0.769	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1998	2004	   3	   0	CTD_human
        2	A2M	0.529	0.769	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1998	2004	   3	   0	CTD_human
        2	A2M	0.529	0.769	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	1998	2004	   3	   0	CTD_human
        2	A2M	0.529	0.769	C1527352	Hepatic Form of Wilson Disease	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
        2	A2M	0.529	0.769	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
        2	A2M	0.529	0.769	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.51	1	2004	2004	   1	   0	CTD_human
        2	A2M	0.529	0.769	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2013	2013	   1	   0	CTD_human
        2	A2M	0.529	0.769	C3279661	alpha-2-Macroglobulin Deficiency	disease	C08	Disease or Syndrome	0.31	1	1989	1989	   0	   0	CTD_human
        9	NAT1	0.536	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2000	2000	   1	   0	PSYGENET
        9	NAT1	0.536	0.846	C0004403	Autosome Abnormalities	group	C23	Cell or Molecular Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
        9	NAT1	0.536	0.846	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.40	0.75	1995	2018	   1	   0	CTD_human
        9	NAT1	0.536	0.846	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.40	0.76	1995	2017	   1	   0	CTD_human
        9	NAT1	0.536	0.846	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	1	1995	2018	   1	   0	CTD_human
        9	NAT1	0.536	0.846	C0008625	Chromosome Aberrations	group	C23	Cell or Molecular Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
        9	NAT1	0.536	0.846	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2001	2001	   1	   0	CTD_human
        9	NAT1	0.536	0.846	C0027651	Neoplasms	group	C04	Neoplastic Process	0.40	1	1998	2019	   1	   0	CTD_human
        9	NAT1	0.536	0.846	C0028796	Dermatitis, Occupational	disease	C17;C24	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
        9	NAT1	0.536	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.32	1	2002	2005	   1	   0	CTD_human
        9	NAT1	0.536	0.846	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
        9	NAT1	0.536	0.846	C0086457	Industrial Dermatosis	disease	C17;C24	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
        9	NAT1	0.536	0.846	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
        9	NAT1	0.536	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.36	0.857	1999	2011	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.40	0.939	1995	2018	   5	   0	CTD_human
       10	NAT2	0.451	0.885	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.40	0.935	1995	2018	   5	   0	CTD_human
       10	NAT2	0.451	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.857	1996	2018	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.31	1	2011	2016	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0011999	Diastematomyelia	disease	C16;C10	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0013182	Drug Allergy	group	C20;C25	Pathologic Function	0.30	1	2010	2011	   3	   0	CTD_human
       10	NAT2	0.451	0.885	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2007	2007	   2	   0	CTD_human
       10	NAT2	0.451	0.885	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2002	2015	   4	   0	CTD_human
       10	NAT2	0.451	0.885	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.36	0.857	2000	2019	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0023530	Leukopenia	disease	C15	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0027794	Neural Tube Defects	group	C16;C10	Congenital Abnormality	0.31	1	2010	2010	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0027806	Neurenteric Cyst	disease	C16;C10	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0028796	Dermatitis, Occupational	disease	C17;C24	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.33	1	2002	2005	   4	   0	CTD_human
       10	NAT2	0.451	0.885	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2007	2007	   2	   0	CTD_human
       10	NAT2	0.451	0.885	C0080218	Tethered Cord Syndrome	disease	C16;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0086457	Industrial Dermatosis	disease	C17;C24	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0152234	Iniencephaly	disease	C16;C10	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0152426	Craniorachischisis	disease	C16;C10	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0266453	Exencephaly	disease	C16;C10	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0344479	Spinal Cord Myelodysplasia	disease	C16;C10	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.34	0.75	1995	2009	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.882	1998	2017	   4	   0	CTD_human
       10	NAT2	0.451	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.863	1996	2018	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0702169	Acrania	disease	C16;C10	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.40	1	2002	2019	   4	   0	CTD_human
       10	NAT2	0.451	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.33	1	2002	2015	   4	   0	CTD_human
       10	NAT2	0.451	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	2002	2018	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.31	1	2011	2016	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.39	0.9	1996	2017	   1	   0	CTD_human
       10	NAT2	0.451	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2002	2015	   4	   0	CTD_human
       10	NAT2	0.451	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2002	2015	   4	   0	CTD_human
       10	NAT2	0.451	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2002	2015	   4	   0	CTD_human
       10	NAT2	0.451	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
       12	SERPINA3	0.486	0.846	C0023794	Lipoidosis	disease	C16;C18	Disease or Syndrome	0.30	1	2005	2007	   3	   0	CTD_human
       12	SERPINA3	0.486	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
       12	SERPINA3	0.486	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.34	1	1998	2017	   1	   0	CTD_human
       13	AADAC	0.631	0.615	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
       15	AANAT	0.67	0.692	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
       15	AANAT	0.67	0.692	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	PSYGENET
       15	AANAT	0.67	0.692	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	PSYGENET
       15	AANAT	0.67	0.692	C0393770	Delayed Sleep Phase Syndrome	disease	C10;F03;C24	Disease or Syndrome	0.31	1	2003	2003	   1	   0	CTD_human
       15	AANAT	0.67	0.692	C0494410	Nonorganic Sleep Wake Cycle Disorders	disease	C10;F03;C24	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
       15	AANAT	0.67	0.692	C0751758	Advanced Sleep Phase Syndrome	disease	C10;F03;C24	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
       15	AANAT	0.67	0.692	C0751759	Non-24 Hour Sleep-Wake Disorder	disease	C10;F03;C24	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
       15	AANAT	0.67	0.692	C0751760	Shift-Work Sleep Disorder	disease	C10;F03;C24	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
       15	AANAT	0.67	0.692	C0877792	Sleep Disorders, Circadian Rhythm	group	C10;F03;C24	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
       16	AARS1	0.647	0.462	C2750090	Charcot-Marie-Tooth Disease, Axonal, Type 2n	disease	C16;C10	Disease or Syndrome	0.71	1	2010	2019	   5	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
       16	AARS1	0.647	0.462	C4225361	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29	disease		Disease or Syndrome	0.70	1	2015	2017	   2	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
       18	ABAT	0.628	0.538	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2005	2005	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0017168	Gastroesophageal reflux disease	disease	C06	Disease or Syndrome	0.31	1	2011	2011	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0023380	Lethargy	phenotype	C23;C10;F01	Sign or Symptom	0.40	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0026825	Flaccid Muscle Tone	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0026827	Muscle hypotonia	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0033922	Psychomotor Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0034933	Reflex, Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.41	1	1999	2018	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0151572	Reflex, Corneal, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0151888	Hyporeflexia	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0151889	Hyperreflexia	phenotype	C23;C10	Finding	0.40	1	1999	2010	   1	   3	CTD_human
       18	ABAT	0.628	0.538	C0234146	Absent reflex	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0234784	Reflex, Gag, Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0241772	Reflex, Deep Tendon, Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.50	1	1989	2012	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0277839	Hoffman's Reflex	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0277850	Reflex, Pendular	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0278211	Reflex, Corneal, Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0342708	Gamma aminobutyric acid transaminase deficiency	disease	C16;C18	Disease or Syndrome	0.70	1	1998	2019	   5	   8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       18	ABAT	0.628	0.538	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0424230	Motor retardation	phenotype	C23;C10;F01	Finding	0.40	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0424605	Developmental delay (disorder)	phenotype	F03	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
       18	ABAT	0.628	0.538	C0427201	Floppy Muscles	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0427202	Muscle Tone Atonic	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0522345	Reflex, Acoustic, Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.40	1	2016	2016	   1	   0	GENOMICS_ENGLAND
       18	ABAT	0.628	0.538	C0558845	Reflex, Ankle, Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0558846	Reflex, Triceps, Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0558847	Reflex, Biceps, Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0576612	Reflex, Anal, Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0743002	Abnormal Deep Tendon Reflex	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751330	Unilateral Hypotonia	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751456	Developmental Psychomotor Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751468	Bulbocavernosus Reflex, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751469	Bulbocavernousus Reflex Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751470	Palmo-Mental Reflex	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751471	Reflex, Anal, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751472	Reflex, Ankle, Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751473	Reflex, Ankle, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751474	Reflex, Biceps, Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751475	Reflex, Biceps, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751476	Reflex, Gag, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751477	Reflex, Knee, Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751478	Reflex, Knee, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751479	Reflex, Moro, Asymmetric	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751480	Reflex, Triceps, Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751481	Reflex, Triceps, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C2267233	Neonatal Hypotonia	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       19	ABCA1	0.467	0.846	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.40	0.992	2000	2020	   1	   0	CTD_human
       19	ABCA1	0.467	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.52	1	2012	2018	   1	   1	CTD_human;UNIPROT
       19	ABCA1	0.467	0.846	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
       19	ABCA1	0.467	0.846	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.55	1	2002	2017	   1	   0	CTD_human;GENOMICS_ENGLAND
       19	ABCA1	0.467	0.846	C0020445	Hypercholesterolemia, Familial	disease	C16;C18	Disease or Syndrome	0.33	1	2003	2019	   1	   0	CTD_human
       19	ABCA1	0.467	0.846	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
       19	ABCA1	0.467	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
       19	ABCA1	0.467	0.846	C0039292	Tangier Disease	disease	C16;C18;C10	Disease or Syndrome	1.00	0.991	1999	2019	  23	  24	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       19	ABCA1	0.467	0.846	C0342898	Apolipoprotein A-I deficiency	phenotype	C16;C18	Pathologic Function	0.30	1	2004	2012	   2	   0	ORPHANET
       19	ABCA1	0.467	0.846	C0473527	Hypoalphalipoproteinemias	disease	C16;C18	Disease or Syndrome	0.40	1	2002	2020	   0	   0	CTD_human
       19	ABCA1	0.467	0.846	C0745103	Hyperlipoproteinemia Type IIa	disease	C16;C18	Disease or Syndrome	0.52	1	2005	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
       19	ABCA1	0.467	0.846	C0751544	Tangier Disease Neuropathy	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1999	2007	   3	   0	CTD_human
       19	ABCA1	0.467	0.846	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
       19	ABCA1	0.467	0.846	C1704417	Hyperlipoproteinemia Type IIb	disease	C16;C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
       19	ABCA1	0.467	0.846	C1704429	Hypoalphalipoproteinemia, Familial	disease	C16;C18	Disease or Syndrome	0.80	0.972	1999	2017	   9	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       19	ABCA1	0.467	0.846	C2931838	Familial HDL deficiency	disease	C16;C18	Disease or Syndrome	0.40	1	1999	2017	   2	   0	CTD_human
       19	ABCA1	0.467	0.846	C3711531	Hdl Deficiency, Type 2	disease	C16;C18	Disease or Syndrome	0.30	1	1999	2001	   2	   0	CTD_human
       19	ABCA1	0.467	0.846	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
       21	ABCA3	0.592	0.615	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
       21	ABCA3	0.592	0.615	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
       21	ABCA3	0.592	0.615	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
       21	ABCA3	0.592	0.615	C0013990	Pathological accumulation of air in tissues	phenotype	C23	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
       21	ABCA3	0.592	0.615	C0020192	Hyaline Membrane Disease	disease	C16;C08	Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
       21	ABCA3	0.592	0.615	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
       21	ABCA3	0.592	0.615	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.42	1	2014	2016	   1	   0	CTD_human
       21	ABCA3	0.592	0.615	C0035220	Respiratory Distress Syndrome, Newborn	disease	C16;C08	Disease or Syndrome	0.40	1	2006	2018	   1	   0	ORPHANET
       21	ABCA3	0.592	0.615	C0085786	Hamman-Rich syndrome	disease	C23;C01;C08	Disease or Syndrome	0.40	1	2005	2014	   1	   2	ORPHANET
       21	ABCA3	0.592	0.615	C0852283	Respiratory Distress Syndrome	disease		Disease or Syndrome	0.40	1	2006	2018	   1	   0	ORPHANET
       21	ABCA3	0.592	0.615	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.32	1	2008	2017	   1	   0	ORPHANET
       21	ABCA3	0.592	0.615	C1861829	Cataract microcornea syndrome	disease	C11	Disease or Syndrome	0.31	1	2014	2014	   1	   0	GENOMICS_ENGLAND
       21	ABCA3	0.592	0.615	C1970456	Surfactant Metabolism Dysfunction, Pulmonary, 3	disease	C08	Disease or Syndrome	0.70	1	2004	2018	   4	   8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       21	ABCA3	0.592	0.615	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C0002896	Sideroblastic anemia	disease	C15	Disease or Syndrome	0.43	1	2001	2016	   2	   0	CTD_human
       22	ABCB7	0.678	0.385	C0004134	Ataxia	phenotype	C23;C10	Sign or Symptom	0.43	1	2000	2016	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C0240991	Ataxia, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C0278161	Ataxia, Motor	phenotype	C23;C10	Finding	0.30	1	2006	2006	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C0427190	Ataxia, Truncal	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C0520966	Abnormal coordination	phenotype	C23;C10	Finding	0.30	1	2006	2006	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C0750937	Ataxia, Appendicular	phenotype	C23;C10	Finding	0.30	1	2006	2006	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C0750940	Tremor, Rubral	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C1845028	ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	disease	C16;C10;C15	Disease or Syndrome	0.74	1	1999	2018	   6	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
       23	ABCF1	0.674	0.538	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
       23	ABCF1	0.674	0.538	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
       23	ABCF1	0.674	0.538	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
       23	ABCF1	0.674	0.538	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2012	2012	   1	   0	CTD_human
       23	ABCF1	0.674	0.538	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
       23	ABCF1	0.674	0.538	C1527304	Allergic Reaction	phenotype	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
       23	ABCF1	0.674	0.538	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
       24	ABCA4	0.493	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	1	2001	2019	   0	   1	UNIPROT
       24	ABCA4	0.493	0.769	C0008924	Cleft upper lip	disease	C16;C07	Congenital Abnormality	0.41	0.75	2010	2017	   1	  11	CTD_human
       24	ABCA4	0.493	0.769	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2012	2018	   1	   0	CTD_human
       24	ABCA4	0.493	0.769	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
       24	ABCA4	0.493	0.769	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.34	1	2000	2015	   0	   0	GENOMICS_ENGLAND
       24	ABCA4	0.493	0.769	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.70	0.974	1998	2019	   1	  19	CTD_human;GENOMICS_ENGLAND
       24	ABCA4	0.493	0.769	C0242383	Age related macular degeneration	disease	C11	Disease or Syndrome	0.70	0.957	1997	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
       24	ABCA4	0.493	0.769	C0271093	Stargardt's disease	phenotype		Disease or Syndrome	1.00	0.995	1997	2020	   1	  12	CTD_human;GENOMICS_ENGLAND;ORPHANET
       24	ABCA4	0.493	0.769	C0339539	Familial Exudative Vitreoretinopathy	disease		Congenital Abnormality	0.31	0	2018	2018	   1	   0	CTD_human
       24	ABCA4	0.493	0.769	C1855465	STARGARDT DISEASE 1 (disorder)	disease		Disease or Syndrome	1.00	0.978	1997	2020	  21	 306	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       24	ABCA4	0.493	0.769	C1858080	Retinal Dystrophy, Early Onset Severe	disease	C16;C11	Disease or Syndrome	0.60	1	1999	2018	   0	   2	GENOMICS_ENGLAND
       24	ABCA4	0.493	0.769	C1858806	CONE-ROD DYSTROPHY 3 (disorder)	disease	C16;C11	Disease or Syndrome	0.90	1	1998	2018	   3	  53	CTD_human;GENOMICS_ENGLAND;UNIPROT
       24	ABCA4	0.493	0.769	C1866422	RETINITIS PIGMENTOSA 19	disease	C16;C11	Disease or Syndrome	0.80	1	1999	2017	   0	  22	CTD_human;GENOMICS_ENGLAND
       24	ABCA4	0.493	0.769	C3489532	Cone-Rod Dystrophy 2	disease	C16;C11	Disease or Syndrome	0.40	1	1998	2017	   3	   0	ORPHANET
       24	ABCA4	0.493	0.769	C3495438	Macular Degeneration, Age-Related, 2	disease	C11	Disease or Syndrome	0.70	1	1997	2009	   2	  26	CTD_human;GENOMICS_ENGLAND;UNIPROT
       24	ABCA4	0.493	0.769	C4282180	Juvenile macular degeneration	disease		Disease or Syndrome	0.50	1	1999	2018	   0	   0	CTD_human
       25	ABL1	0.432	0.923	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0003706	Arachnodactyly	disease	C16;C05	Congenital Abnormality	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
       25	ABL1	0.432	0.923	C0005941	Bone Diseases, Developmental	group	C05	Disease or Syndrome	0.31	1	2017	2018	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1999	2018	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.32	1	1993	2017	   1	   0	ORPHANET
       25	ABL1	0.432	0.923	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2011	2013	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0015544	Failure to Thrive	disease	C23	Disease or Syndrome	0.40	1	2017	2017	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0018798	Congenital Heart Defects	group	C16;C14	Congenital Abnormality	0.31	1	2017	2017	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	0.958	1989	2019	   2	   0	CTD_human
       25	ABL1	0.432	0.923	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2002	2012	   2	   0	CTD_human
       25	ABL1	0.432	0.923	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.80	0.983	1982	2020	   3	  21	CGI;CTD_human;ORPHANET
       25	ABL1	0.432	0.923	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0025202	melanoma	disease	C04	Neoplastic Process	0.31	1	2015	2015	   0	   0	UNIPROT
       25	ABL1	0.432	0.923	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2009	2009	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.31	1	2001	2009	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0039075	Syndactyly	disease	C16;C05	Congenital Abnormality	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
       25	ABL1	0.432	0.923	C0151491	Congenital musculoskeletal anomalies	group	C16;C05	Congenital Abnormality	0.30	1	2017	2017	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0265610	Clinodactyly of fingers	disease	C16;C05	Congenital Abnormality	0.40	1	2017	2017	   1	   0	GENOMICS_ENGLAND
       25	ABL1	0.432	0.923	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0345958	Large cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30				   0	   0	UNIPROT
       25	ABL1	0.432	0.923	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2011	2013	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.40	0.9	1993	2019	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1999	2018	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C1292769	Precursor B-cell lymphoblastic leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	0.933	1996	2019	   1	   0	ORPHANET
       25	ABL1	0.432	0.923	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.33	1	2005	2018	   1	   0	CTD_human
       25	ABL1	0.432	0.923	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.60	0.96	1998	2019	   1	   0	CGI;ORPHANET
       25	ABL1	0.432	0.923	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.60	0.991	1987	2020	   2	   0	CGI;CTD_human
       25	ABL1	0.432	0.923	C4539857	CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME	disease		Disease or Syndrome	0.60	1	2017	2017	   1	   2	GENOMICS_ENGLAND;UNIPROT
       25	ABL1	0.432	0.923	C4551485	Clinodactyly	disease		Congenital Abnormality	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
       25	ABL1	0.432	0.923	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
       26	AOC1	0.628	0.769	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	1983	1983	   1	   0	CTD_human
       26	AOC1	0.628	0.769	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.31	1	1983	2018	   1	   0	CTD_human
       26	AOC1	0.628	0.769	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	1983	1983	   1	   0	CTD_human
       28	ABO	0.427	0.885	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	1988	1990	   2	   0	PSYGENET
       28	ABO	0.427	0.885	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.40	0.933	2010	2019	   1	   0	CTD_human
       28	ABO	0.427	0.885	C0010474	Curling Ulcer	disease	C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
       28	ABO	0.427	0.885	C0013295	Duodenal Ulcer	disease	C06	Disease or Syndrome	0.43	1	1979	2013	   1	   2	CTD_human
       28	ABO	0.427	0.885	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2009	2015	   2	   0	CTD_human
       28	ABO	0.427	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
       28	ABO	0.427	0.885	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.43	1	2009	2018	   1	   1	CTD_human
       28	ABO	0.427	0.885	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	1990	1990	   1	   0	PSYGENET
       28	ABO	0.427	0.885	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.50	0.96	2009	2018	   2	   1	CTD_human
       28	ABO	0.427	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.33	0.5	2007	2018	   1	   0	CTD_human
       28	ABO	0.427	0.885	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.34	1	1979	1994	   4	   0	PSYGENET
       28	ABO	0.427	0.885	C0751956	Acute Cerebrovascular Accidents	disease	C10;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
       28	ABO	0.427	0.885	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.50	0.9	2010	2019	   1	   2	CTD_human
       28	ABO	0.427	0.885	C4317009	Diverticular Diseases	group	C06	Disease or Syndrome	0.40	1	2018	2018	   1	   1	CTD_human
       28	ABO	0.427	0.885	C4505353	Diverticular Bleeding	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
       28	ABO	0.427	0.885	C4721610	Carcinoma, Ovarian Epithelial	disease	C04;C13;C19	Neoplastic Process	0.35	1	2012	2019	   1	   0	CTD_human
       29	ABR	0.65	0.5	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2010	2014	   1	   0	CTD_human
       29	ABR	0.65	0.5	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2014	2018	   1	   0	CTD_human
       31	ACACA	0.48	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2017	2020	   0	   1	UNIPROT
       31	ACACA	0.48	0.846	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.31	1	2016	2018	   1	   0	CTD_human
       31	ACACA	0.48	0.846	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.31	1	2016	2018	   1	   0	CTD_human
       31	ACACA	0.48	0.846	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
       31	ACACA	0.48	0.846	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
       31	ACACA	0.48	0.846	C0268603	Acetyl-CoA: carboxylase deficiency	disease	C16;C18	Disease or Syndrome	0.30				   0	   0	CTD_human
       31	ACACA	0.48	0.846	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
       31	ACACA	0.48	0.846	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
       31	ACACA	0.48	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.35	1	2011	2019	   1	   0	CTD_human
       32	ACACB	0.644	0.654	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.50	1	2006	2012	   1	   0	CTD_human
       32	ACACB	0.644	0.654	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.34	1	2006	2011	   1	   0	CTD_human
       32	ACACB	0.644	0.654	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
       32	ACACB	0.644	0.654	C1335302	Pancreatic Ductal Adenocarcinoma	disease	C06;C04;C19	Neoplastic Process	0.30				   0	   0	UNIPROT
       33	ACADL	0.736	0.462	C0220711	Long chain acyl-CoA dehydrogenase deficiency	disease	C16;C18	Disease or Syndrome	0.50	1	1983	2014	   5	   0	CLINGEN;ORPHANET
       34	ACADM	0.638	0.462	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.31	1	2017	2017	   0	   1	UNIPROT
       34	ACADM	0.638	0.462	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
       34	ACADM	0.638	0.462	C0035410	Rhabdomyolysis	phenotype	C05	Pathologic Function	0.30				   0	   0	GENOMICS_ENGLAND
       34	ACADM	0.638	0.462	C0038644	Sudden infant death syndrome	disease	C23	Disease or Syndrome	0.40	1	1986	2004	   0	   0	GENOMICS_ENGLAND
       34	ACADM	0.638	0.462	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
       34	ACADM	0.638	0.462	C0085605	Liver Failure	disease	C06	Disease or Syndrome	0.30	1	1997	1997	   1	   0	CTD_human
       34	ACADM	0.638	0.462	C0220710	Medium-chain acyl-coenzyme A dehydrogenase deficiency	disease	C16;C18	Disease or Syndrome	1.00	0.991	1983	2019	  24	 107	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
       34	ACADM	0.638	0.462	C0520459	Necrotizing Enterocolitis	disease	C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
       35	ACADS	0.663	0.538	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
       35	ACADS	0.663	0.538	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.31	1	2018	2019	   1	   0	CTD_human
       35	ACADS	0.663	0.538	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.31	1	2018	2019	   1	   0	CTD_human
       35	ACADS	0.663	0.538	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
       35	ACADS	0.663	0.538	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
       35	ACADS	0.663	0.538	C0342783	Deficiency of butyryl-CoA dehydrogenase	disease	C16;C18	Disease or Syndrome	1.00	1	1989	2018	  11	  41	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
       35	ACADS	0.663	0.538	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
       35	ACADS	0.663	0.538	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2019	2019	   1	   0	CTD_human
       36	ACADSB	0.691	0.5	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
       36	ACADSB	0.691	0.5	C1864912	2-Methylbutyryl-CoA Dehydrogenase Deficiency	disease	C16;C18	Disease or Syndrome	0.70	1	2000	2016	   8	   4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       37	ACADVL	0.653	0.654	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
       37	ACADVL	0.653	0.654	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
       37	ACADVL	0.653	0.654	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
       37	ACADVL	0.653	0.654	C0270984	Metabolic myopathy	group	C05;C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
       37	ACADVL	0.653	0.654	C0369183	Erythrocyte Mean Corpuscular Hemoglobin Test	phenotype		Laboratory Procedure	0.30	1	1999	1999	   1	   0	GENOMICS_ENGLAND
       37	ACADVL	0.653	0.654	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
       37	ACADVL	0.653	0.654	C1261502	Finding of Mean Corpuscular Hemoglobin	phenotype		Finding	0.30	1	1999	1999	   1	   0	GENOMICS_ENGLAND
       37	ACADVL	0.653	0.654	C3887523	Very long chain acyl-CoA dehydrogenase deficiency	disease	C16;C18;C05;C10;C15	Disease or Syndrome	1.00	0.989	1985	2020	  15	 116	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
       38	ACAT1	0.538	0.692	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.50	1	2010	2010	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.40	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C1536500	Deficiency of acetyl-CoA acetyltransferase	disease	C16;C18	Disease or Syndrome	0.80	1	1979	2019	  12	  29	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       38	ACAT1	0.538	0.692	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
       38	ACAT1	0.538	0.692	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       39	ACAT2	0.686	0.462	C0342735	Cytosolic acetoacetyl-CoA thiolase deficiency	disease	C16;C18	Disease or Syndrome	0.30				   0	   0	CTD_human
       40	ASIC2	0.653	0.538	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	CTD_human
       40	ASIC2	0.653	0.538	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
       41	ASIC1	0.653	0.615	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
       41	ASIC1	0.653	0.615	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
       41	ASIC1	0.653	0.615	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.40	0.985	1991	2020	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0002726	Amyloidosis	disease	C18	Disease or Syndrome	0.40	1	1996	2020	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0002871	Anemia	disease	C15	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.31	1	2018	2019	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.31	1	2018	2019	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.34	1	2002	2019	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.31	1	2008	2010	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.40	0.931	2002	2020	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0018273	Growth Disorders	group	C23	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0023186	Learning Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0025261	Memory Disorders	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.31	1	2008	2017	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0026650	Movement Disorders	group	C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0026850	Muscular Dystrophy	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.35	1	2000	2018	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.32	1	2018	2019	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2015	2018	   1	   0	PSYGENET
       43	ACHE	0.445	0.885	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.33	1	2010	2019	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0040822	Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0040827	Saturnine Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0149840	Senile Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.31	1	2010	2017	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0233794	Memory impairment	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.40	1	2005	2020	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0234370	Persistent Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0234371	Continuous Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0234372	Intermittent Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0234373	Fine Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0234374	Coarse Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0234375	Massive Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0234376	Action Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0234377	Passive Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0234378	Static Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0234379	Resting Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0234381	Darkness Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0235078	Tremor, Perioral	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0235081	Tremor, Limb	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0235082	Tremor, Muscle	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0235083	Nerve Tremors	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0235843	Tremor, Neonatal	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0236733	Amphetamine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0236804	Amphetamine Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0236807	Amphetamine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0266487	Etat Marbre	disease	C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2013	2013	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0353676	Organophosphorus Poisoning	disease	C25	Injury or Poisoning	0.30	1	1987	2013	   3	   0	CTD_human
       43	ACHE	0.445	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.32	1	2013	2018	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.34	1	2002	2019	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0700359	Organophosphate poisoning	disease	C25	Injury or Poisoning	0.30	1	1987	2013	   3	   0	CTD_human
       43	ACHE	0.445	0.885	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2013	2013	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0751262	Adult Learning Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0751263	Learning Disturbance	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0751265	Learning Disabilities	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0751292	Age-Related Memory Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0751293	Memory Disorder, Semantic	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0751294	Memory Disorder, Spatial	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0751295	Memory Loss	phenotype	C23;C10;F01	Sign or Symptom	0.31	1	2008	2017	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C0751564	Pill Rolling Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C0751565	Tremor, Semirhythmic	phenotype	C23;C10	Finding	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C1330966	Developmental Academic Disorder	phenotype	C23;C10;F03	Finding	0.30	1	2008	2008	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C1527384	Involuntary Quiver	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
       43	ACHE	0.445	0.885	C3494247	Organothiophosphonate Poisoning	disease	C25	Injury or Poisoning	0.30	1	1987	2013	   3	   0	CTD_human
       43	ACHE	0.445	0.885	C3494248	Organothiophosphate Poisoning	disease	C25	Injury or Poisoning	0.30	1	1987	2013	   3	   0	CTD_human
       43	ACHE	0.445	0.885	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.31	1	2010	2017	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2016	   2	   0	CTD_human
       43	ACHE	0.445	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
       47	ACLY	0.563	0.692	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
       47	ACLY	0.563	0.692	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
       47	ACLY	0.563	0.692	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
       47	ACLY	0.563	0.692	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
       47	ACLY	0.563	0.692	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
       47	ACLY	0.563	0.692	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
       47	ACLY	0.563	0.692	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
       47	ACLY	0.563	0.692	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2011	2015	   1	   0	CTD_human
       48	ACO1	0.628	0.577	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
       48	ACO1	0.628	0.577	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
       48	ACO1	0.628	0.577	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
       50	ACO2	0.619	0.654	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
       50	ACO2	0.619	0.654	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
       50	ACO2	0.619	0.654	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2005	2012	   1	   0	CTD_human
       50	ACO2	0.619	0.654	C3281192	INFANTILE CEREBELLAR-RETINAL DEGENERATION	disease		Disease or Syndrome	0.74	1	2012	2019	   2	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       50	ACO2	0.619	0.654	C4225384	OPTIC ATROPHY 9	disease		Disease or Syndrome	0.70	1	2012	2014	   2	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
       51	ACOX1	0.61	0.731	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2004	2004	   1	   0	CTD_human
       51	ACOX1	0.61	0.731	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.30	1	2004	2004	   1	   0	CTD_human
       51	ACOX1	0.61	0.731	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2004	2004	   1	   0	CTD_human
       51	ACOX1	0.61	0.731	C1849678	Peroxisomal ACYL-COA oxidase deficiency	disease	C16;C18;C10;C19	Disease or Syndrome	0.92	1	1994	2016	   7	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       51	ACOX1	0.61	0.731	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.35	1	2003	2018	   2	   0	CTD_human
       52	ACP1	0.566	0.731	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	1990	2017	   1	   0	PSYGENET
       52	ACP1	0.566	0.731	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2002	2002	   1	   0	PSYGENET
       52	ACP1	0.566	0.731	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2002	2002	   1	   0	PSYGENET
       53	ACP2	0.78	0.346	C0268410	Acid Phosphatase Deficiency	disease	C16;C18	Disease or Syndrome	0.30				   0	   0	CTD_human
       54	ACP5	0.561	0.731	C0020503	Hyperparathyroidism, Secondary	disease	C19	Disease or Syndrome	0.30	1	2011	2012	   2	   0	CTD_human
       54	ACP5	0.561	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
       54	ACP5	0.561	0.731	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
       54	ACP5	0.561	0.731	C0432222	Spondyloenchondrodysplasia	disease	C16;C05;C20	Disease or Syndrome	0.57	1	2011	2018	   2	   0	CTD_human;ORPHANET
       54	ACP5	0.561	0.731	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
       54	ACP5	0.561	0.731	C1842763	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION	disease	C16;C05;C20	Disease or Syndrome	0.72	1	1958	2018	   4	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
       54	ACP5	0.561	0.731	C3860213	Autoinflammatory disorder	disease		Disease or Syndrome	0.30	1	2011	2011	   1	   0	GENOMICS_ENGLAND
       55	ACP3	0.525	0.731	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
       55	ACP3	0.525	0.731	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
       55	ACP3	0.525	0.731	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
       55	ACP3	0.525	0.731	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
       55	ACP3	0.525	0.731	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
       58	ACTA1	0.54	0.769	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.40	1	2006	2013	   2	   0	GENOMICS_ENGLAND
       58	ACTA1	0.54	0.769	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.53	1	2001	2013	   4	   0	CLINGEN;GENOMICS_ENGLAND
       58	ACTA1	0.54	0.769	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       58	ACTA1	0.54	0.769	C0175709	Centronuclear myopathy	disease	C05;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
       58	ACTA1	0.54	0.769	C0206157	Myopathies, Nemaline	disease	C05;C10	Disease or Syndrome	0.40	0.976	1999	2019	   1	   0	GENOMICS_ENGLAND
       58	ACTA1	0.54	0.769	C0270969	Zebra body myopathy	disease	C05;C10	Disease or Syndrome	0.31	1	2015	2015	   1	   0	ORPHANET
       58	ACTA1	0.54	0.769	C0410180	Eichsfeld type congenital muscular dystrophy	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	ORPHANET
       58	ACTA1	0.54	0.769	C0410203	X-linked centronuclear myopathy	disease	C05;C10	Congenital Abnormality	0.30				   0	   0	CTD_human
       58	ACTA1	0.54	0.769	C0410207	Tubular Aggregate Myopathy	disease	C05;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
       58	ACTA1	0.54	0.769	C0546125	Nemaline Myopathy, Childhood Onset	disease	C05;C10	Disease or Syndrome	0.30				   0	   0	ORPHANET
       58	ACTA1	0.54	0.769	C0546264	Congenital Fiber Type Disproportion	disease	C05;C10	Congenital Abnormality	0.74	1	1999	2010	   5	   7	CTD_human;GENOMICS_ENGLAND;UNIPROT
       58	ACTA1	0.54	0.769	C0752282	Congenital Structural Myopathy	disease	C05;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
       58	ACTA1	0.54	0.769	C1834339	Myopathy, Actin, Congenital, with Excess of Thin Myofilaments	disease	C05;C10	Disease or Syndrome	0.60	1	2009	2011	   1	   1	GENOMICS_ENGLAND
       58	ACTA1	0.54	0.769	C1834558	Myopathy, Centronuclear, Autosomal Dominant	disease	C05;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
       58	ACTA1	0.54	0.769	C2750537	Myopathy, Actin, Congenital, With Cores	disease	C05;C10	Disease or Syndrome	0.60	1	2009	2011	   1	   2	GENOMICS_ENGLAND
       58	ACTA1	0.54	0.769	C3645536	Autosomal Recessive Centronuclear Myopathy	disease	C05;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
       58	ACTA1	0.54	0.769	C3661489	Autosomal Dominant Myotubular Myopathy	disease	C05;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
       58	ACTA1	0.54	0.769	C3711389	Actin-Accumulation Myopathy	disease	C05;C10	Disease or Syndrome	0.93	1	1988	2018	  16	  48	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       58	ACTA1	0.54	0.769	C4225181	MYOPATHY, SCAPULOHUMEROPERONEAL	disease		Disease or Syndrome	0.70	1	2015	2015	   1	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       58	ACTA1	0.54	0.769	C4551952	Myopathy, Centronuclear, 1	disease	C05;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
       59	ACTA2	0.508	0.846	C0005398	Cholestasis, Extrahepatic	disease	C06	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.31	1	2011	2019	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0015934	Fetal Growth Retardation	phenotype	C23;C16;C13	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0017668	Focal glomerulosclerosis	disease	C13;C12	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0019189	Hepatitis, Chronic	disease	C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0022116	Ischemia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2014	2018	   3	   0	CTD_human
       59	ACTA2	0.508	0.846	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2015	2016	   2	   0	CTD_human
       59	ACTA2	0.508	0.846	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0026654	Moyamoya Disease	disease	C10;C14	Disease or Syndrome	0.60	1	2009	2018	   2	   0	GENOMICS_ENGLAND;ORPHANET
       59	ACTA2	0.508	0.846	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.31	1	2013	2014	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0027719	Nephrosclerosis	disease	C13;C12	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.31	1	2018	2019	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0036421	Systemic Scleroderma	disease	C17	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0041956	Ureteral obstruction	phenotype	C13;C12	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0086432	Hyalinosis, Segmental Glomerular	disease	C13;C12	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2001	2001	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0149519	Chronic Persistent Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0162872	Aortic Aneurysm, Thoracic	disease	C14	Disease or Syndrome	0.43	1	2007	2018	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.32	1	2014	2018	   3	   0	CTD_human
       59	ACTA2	0.508	0.846	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0340630	Aortic Aneurysm, Thoracoabdominal	disease	C14	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0520463	Chronic active hepatitis	disease	C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0524611	Cryptogenic Chronic Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C1619692	Nephrogenic Fibrosing Dermopathy	disease	C23;C17	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C1876165	Copper-Overload Cirrhosis	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C2673186	Aortic Aneurysm, Familial Thoracic 6	disease	C23;C17;C14	Disease or Syndrome	0.70	1	2007	2017	   5	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
       59	ACTA2	0.508	0.846	C2931384	Moyamoya disease 1	disease	C10;C14	Disease or Syndrome	0.39	1	2009	2018	   2	   0	ORPHANET
       59	ACTA2	0.508	0.846	C3151201	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	disease		Disease or Syndrome	0.78	1	2007	2019	   3	   0	GENOMICS_ENGLAND;ORPHANET;UNIPROT
       59	ACTA2	0.508	0.846	C3279690	MOYAMOYA DISEASE 5	disease		Disease or Syndrome	0.70	1	2007	2016	   4	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
       59	ACTA2	0.508	0.846	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       59	ACTA2	0.508	0.846	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.60	1	2000	2016	   7	   0	CLINGEN;GENOMICS_ENGLAND
       59	ACTA2	0.508	0.846	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2015	   1	   0	PSYGENET
       60	ACTB	0.325	0.923	C0005818	Blood Platelet Disorders	group	C15	Disease or Syndrome	0.31	1	2012	2017	   1	   0	GENOMICS_ENGLAND
       60	ACTB	0.325	0.923	C0007097	Carcinoma	group	C04	Neoplastic Process	0.39	0.9	1991	2016	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0009363	Congenital ocular coloboma (disorder)	disease	C16;C11	Congenital Abnormality	0.31	1	2012	2017	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0013393	Dysostoses	disease	C05	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.32	1	2006	2018	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2005	2014	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0018784	Sensorineural Hearing Loss (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.40	1	2006	2006	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.31	1	2004	2013	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.32	1	2009	2019	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.39	1	2010	2020	   1	   0	PSYGENET
       60	ACTB	0.325	0.923	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.32	1	2004	2007	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	1	1999	2019	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0263579	Pigmented hairy epidermal nevus	disease	C16;C04;C17;C10	Neoplastic Process	0.31	1	2017	2017	   1	   0	ORPHANET
       60	ACTB	0.325	0.923	C0265541	Cranioschisis	disease	C16;C10	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0272183	Qualitative abnormality of granulocyte	disease	C15	Disease or Syndrome	0.31	1	1999	1999	   1	   0	GENOMICS_ENGLAND
       60	ACTB	0.325	0.923	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0393588	Dystonia, Paroxysmal	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0393610	Dystonia, Diurnal	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0497552	Congenital neurologic anomalies	group	C16;C10	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.32	1	2005	2014	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2009	2009	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0751093	Dystonia, Limb	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C1691779	Sensory hearing loss	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C1846331	Juvenile-onset dystonia	disease	C10	Disease or Syndrome	0.70	1	2002	2018	   2	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       60	ACTB	0.325	0.923	C1853623	Fryns-Aftimos Syndrome	disease	C23;C16;C05;C10;F03;F01	Disease or Syndrome	0.36	1	2012	2017	   2	   0	GENOMICS_ENGLAND
       60	ACTB	0.325	0.923	C1855722	Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation	disease	C23;C16;C11;C10;F03;F01	Disease or Syndrome	0.72	1	1989	2018	   6	  29	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       60	ACTB	0.325	0.923	C1858042	Becker Nevus Syndrome	disease	C04;C17	Disease or Syndrome	0.31	1	2017	2017	   1	   0	ORPHANET
       60	ACTB	0.325	0.923	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.972	1997	2020	   2	   0	CTD_human
       60	ACTB	0.325	0.923	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.50	1	2012	2015	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
       60	ACTB	0.325	0.923	C4554007	Uveoretinal Coloboma	disease	C16;C11	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
       70	ACTC1	0.61	0.538	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.65	1	2006	2019	   0	   3	CTD_human
       70	ACTC1	0.61	0.538	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.70	0.962	1999	2019	  12	   3	CLINGEN;GENOMICS_ENGLAND
       70	ACTC1	0.61	0.538	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
       70	ACTC1	0.61	0.538	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
       70	ACTC1	0.61	0.538	C0034951	Refractive Errors	group	C11	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
       70	ACTC1	0.61	0.538	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
       70	ACTC1	0.61	0.538	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
       70	ACTC1	0.61	0.538	C0340427	Familial dilated cardiomyopathy	disease	C14	Disease or Syndrome	0.31	1	1998	2000	   1	   0	ORPHANET
       70	ACTC1	0.61	0.538	C0344724	Ostium secundum atrial septal defect	disease	C16;C14	Congenital Abnormality	0.31	1	2008	2016	   1	   0	ORPHANET
       70	ACTC1	0.61	0.538	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.46	1	1999	2015	   0	   2	GENOMICS_ENGLAND
       70	ACTC1	0.61	0.538	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.37	1	1998	2019	   0	   0	CTD_human
       70	ACTC1	0.61	0.538	C1527310	Ametropia	disease	C11	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
       70	ACTC1	0.61	0.538	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
       70	ACTC1	0.61	0.538	C1960469	Left ventricular noncompaction	disease	C14	Disease or Syndrome	0.41	1	2008	2014	   1	   2	ORPHANET
       70	ACTC1	0.61	0.538	C2677506	Cardiomyopathy, Familial Hypertrophic, 11	disease	C16;C14	Disease or Syndrome	0.70	1	1998	2019	   7	   9	CTD_human;GENOMICS_ENGLAND;UNIPROT
       70	ACTC1	0.61	0.538	C2748552	Atrial Septal Defect 5	disease	C16;C14	Disease or Syndrome; Congenital Abnormality	0.70	1	1998	2019	   5	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
       70	ACTC1	0.61	0.538	C3150681	CARDIOMYOPATHY, DILATED, 1R	disease		Disease or Syndrome	0.80	1	1998	2019	   4	   4	GENOMICS_ENGLAND;UNIPROT
       70	ACTC1	0.61	0.538	C3150682	LEFT VENTRICULAR NONCOMPACTION 4	disease		Disease or Syndrome	0.60				   0	   1	GENOMICS_ENGLAND
       70	ACTC1	0.61	0.538	C4021133	Left ventricular noncompaction cardiomyopathy	disease	C23	Disease or Syndrome	0.32	1	2015	2018	   0	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0005745	Blepharoptosis	disease	C11	Disease or Syndrome	0.41	1	1996	2014	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0009363	Congenital ocular coloboma (disorder)	disease	C16;C11	Congenital Abnormality	0.41	1	2012	2017	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C0024433	Macrostomia	disease	C16;C07	Congenital Abnormality	0.40	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0033377	Ptosis	disease	C23	Disease or Syndrome	0.41	1	1996	2014	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0240583	Short upturned nose	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C0265541	Cranioschisis	disease	C16;C10	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0266551	Congenital coloboma of iris	disease	C16;C11	Congenital Abnormality	0.40	1	2017	2017	   1	   0	ORPHANET
       71	ACTG1	0.477	0.846	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0497552	Congenital neurologic anomalies	group	C16;C10	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C0857379	Abnormality of the pinna	phenotype		Finding	0.40	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C0948089	Acute Coronary Syndrome	disease	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.43	1	1996	2009	   1	   1	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C1843156	Progressive sensorineural hearing impairment	disease	C23;C10;C09	Disease or Syndrome	0.40	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C1844505	Pointed chin	phenotype		Finding	0.40	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C1849340	Long palpebral fissure	phenotype		Finding	0.40	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C1853623	Fryns-Aftimos Syndrome	disease	C23;C16;C05;C10;F03;F01	Disease or Syndrome	0.38	1	2012	2017	   0	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C1855722	Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation	disease	C23;C16;C11;C10;F03;F01	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
       71	ACTG1	0.477	0.846	C1858172	Deafness, Autosomal Dominant 20	disease	C23;C10;C09	Disease or Syndrome	0.70	1	1996	2014	   8	  10	CTD_human;GENOMICS_ENGLAND;UNIPROT
       71	ACTG1	0.477	0.846	C1865014	Long philtrum	phenotype		Finding	0.40	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C1865017	Thin upper lip vermilion	phenotype		Finding	0.40	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C1868571	Highly arched eyebrow	phenotype		Finding	0.40	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C1970280	Hearing loss begins with loss of high frequencies	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C1970281	Audiogram shows sloping configuration	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C1970282	Deafness, profound, by 6th decade	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C3279369	Microphthalmia (in some patients)	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C3281235	BARAITSER-WINTER SYNDROME 2	disease		Disease or Syndrome	0.70	1	1996	2016	   4	   9	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
       71	ACTG1	0.477	0.846	C3549665	Deafness (in some patients)	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C3711374	Nonsyndromic Deafness	disease	C23;C10;C09	Disease or Syndrome	0.33	1	2003	2018	  18	   0	CLINGEN
       71	ACTG1	0.477	0.846	C3808883	Short neck (in some patients)	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C4012410	Enlarged ventricles (in some patients)	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C4229649	Heart defect (in some patients)	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C4229650	Pterygium colli (in some patients)	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C4229651	Hypertelorism/telecanthus	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C4229652	Eye coloboma (in some patients)	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C4229653	Trigonocephaly/metopic ridge	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C4231117	Pectus (in some patients)	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C4231118	Kyphosis/scoliosis (in some patients)	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C4231120	Prominent nasal root on profile	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C4231121	Large, squared nose tip	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C4231123	Retrognathia (in some patients)	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C4231124	Prominent/full/wide cheeks	phenotype		Finding	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
       71	ACTG1	0.477	0.846	C4554007	Uveoretinal Coloboma	disease	C16;C11	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
       71	ACTG1	0.477	0.846	C4708599	Coloboma of choroid and retina	disease		Congenital Abnormality	0.30	1	2017	2017	   1	   0	ORPHANET
       72	ACTG2	0.505	0.808	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
       72	ACTG2	0.505	0.808	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
       72	ACTG2	0.505	0.808	C0042781	Visceral Myopathy	disease	C06	Disease or Syndrome	0.75	0.917	2012	2020	   5	  15	CTD_human;GENOMICS_ENGLAND;UNIPROT
       72	ACTG2	0.505	0.808	C0266833	Visceral Myopathy, Familial	disease	C06	Disease or Syndrome	0.52	1	2012	2015	   1	   0	CTD_human;ORPHANET
       72	ACTG2	0.505	0.808	C1608393	Megacystis microcolon intestinal hypoperistalsis syndrome	disease	C16;C06	Disease or Syndrome	0.66	1	2014	2017	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
       72	ACTG2	0.505	0.808	C1835084	Megaduodenum and-or Megacystis	disease	C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
       81	ACTN4	0.508	0.808	C0007097	Carcinoma	group	C04	Neoplastic Process	0.32	1	2002	2019	   1	   0	CTD_human
       81	ACTN4	0.508	0.808	C0017668	Focal glomerulosclerosis	disease	C13;C12	Disease or Syndrome	0.50	1	2003	2019	   0	   0	CTD_human
       81	ACTN4	0.508	0.808	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
       81	ACTN4	0.508	0.808	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
       81	ACTN4	0.508	0.808	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2002	2002	   1	   0	CTD_human
       81	ACTN4	0.508	0.808	C0086432	Hyalinosis, Segmental Glomerular	disease	C13;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
       81	ACTN4	0.508	0.808	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
       81	ACTN4	0.508	0.808	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
       81	ACTN4	0.508	0.808	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
       81	ACTN4	0.508	0.808	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
       81	ACTN4	0.508	0.808	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
       81	ACTN4	0.508	0.808	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
       81	ACTN4	0.508	0.808	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
       81	ACTN4	0.508	0.808	C1868672	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	disease	C13;C12	Disease or Syndrome	0.31	1	2000	2000	   1	   0	ORPHANET
       81	ACTN4	0.508	0.808	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
       81	ACTN4	0.508	0.808	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
       81	ACTN4	0.508	0.808	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
       81	ACTN4	0.508	0.808	C4551527	Focal segmental glomerulosclerosis 1	disease	C13;C12	Disease or Syndrome	0.80	1	2000	2015	   9	   8	GENOMICS_ENGLAND;UNIPROT
       86	ACTL6A	0.678	0.346	C0424605	Developmental delay (disorder)	phenotype	F03	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
       86	ACTL6A	0.678	0.346	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
       86	ACTL6A	0.678	0.346	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.31	1	2017	2017	   1	   0	GENOMICS_ENGLAND
       87	ACTN1	0.695	0.577	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
       87	ACTN1	0.695	0.577	C2751260	Macrothrombocytopenia	disease	C15	Disease or Syndrome	0.48	0.889	2013	2020	   0	   4	GENOMICS_ENGLAND
       87	ACTN1	0.695	0.577	C3554663	BLEEDING DISORDER, PLATELET-TYPE, 15	disease		Disease or Syndrome	0.70	1	2013	2015	   3	   7	CTD_human;GENOMICS_ENGLAND;UNIPROT
       87	ACTN1	0.695	0.577	C4304021	Autosomal dominant macrothrombocytopenia	disease	C16	Disease or Syndrome	0.32	1	2013	2016	   1	   0	ORPHANET
       88	ACTN2	0.686	0.462	C0340427	Familial dilated cardiomyopathy	disease	C14	Disease or Syndrome	0.30	1	2004	2014	   2	   0	ORPHANET
       88	ACTN2	0.686	0.462	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.31	1	2019	2019	   0	   0	GENOMICS_ENGLAND
       88	ACTN2	0.686	0.462	C2677338	Cardiomyopathy, Dilated, 1AA	disease	C14	Disease or Syndrome	0.70	1	2004	2016	   6	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
       90	ACVR1	0.535	0.731	C0004114	Astrocytoma	disease	C04	Neoplastic Process	0.32	1	2014	2014	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	0.75	2007	2018	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0009782	Connective Tissue Diseases	group	C17	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
       90	ACVR1	0.535	0.731	C0016037	Fibrodysplasia Ossificans Progressiva	disease	C05	Disease or Syndrome	1.00	1	2006	2020	   5	   9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       90	ACVR1	0.535	0.731	C0017638	Glioma	disease	C04	Neoplastic Process	0.50	1	2014	2014	   3	   0	CGI;CTD_human
       90	ACVR1	0.535	0.731	C0025202	melanoma	disease	C04	Neoplastic Process	0.31	1	2016	2016	   0	   0	UNIPROT
       90	ACVR1	0.535	0.731	C0027122	Myositis Ossificans	disease	C05	Disease or Syndrome	0.31	1	2007	2007	   0	   0	CTD_human
       90	ACVR1	0.535	0.731	C0085576	Iron-Refractory Iron Deficiency Anemia	disease	C18;C15	Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
       90	ACVR1	0.535	0.731	C0205768	Subependymal Giant Cell Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0242488	Acute Lung Injury	disease	C08	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2014	2014	   3	   0	CTD_human
       90	ACVR1	0.535	0.731	C0280783	Juvenile Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0280785	Diffuse Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0334579	Anaplastic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0334580	Protoplasmic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0334581	Gemistocytic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0334582	Fibrillary Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0334583	Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0338070	Childhood Cerebral Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0547065	Mixed oligoastrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.31	1	2014	2014	   3	   0	CTD_human
       90	ACVR1	0.535	0.731	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.33	0.75	2007	2018	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0750935	Cerebral Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C0750936	Intracranial Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C1704230	Grade I Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
       90	ACVR1	0.535	0.731	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
       92	ACVR2A	0.636	0.615	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
       92	ACVR2A	0.636	0.615	C0920269	Microsatellite Instability	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
       92	ACVR2A	0.636	0.615	C1721098	Replication Error Phenotype	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
       93	ACVR2B	0.601	0.615	C0037221	Situs Inversus	disease	C16	Congenital Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
       93	ACVR2B	0.601	0.615	C0175707	Asplenia Syndrome	disease	C16;C15;C14	Disease or Syndrome	0.50	1	1997	1999	   1	   0	CTD_human
       93	ACVR2B	0.601	0.615	C0265357	Polysplenia Syndrome	disease	C16;C15;C14	Congenital Abnormality	0.50	1	1997	1999	   1	   0	CTD_human
       93	ACVR2B	0.601	0.615	C0266642	Situs ambiguus	disease	C16;C15;C14	Congenital Abnormality	0.61	1	1999	2019	   1	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
       93	ACVR2B	0.601	0.615	C1167664	Situs ambiguous	disease		Congenital Abnormality	0.30				   0	   0	ORPHANET
       93	ACVR2B	0.601	0.615	C3151057	HETEROTAXY, VISCERAL, 4, AUTOSOMAL	disease		Disease or Syndrome	0.90	1	1997	1999	   1	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
       93	ACVR2B	0.601	0.615	C3178805	Heterotaxy Syndrome	disease	C16;C15;C14	Disease or Syndrome	0.70	1	1997	1999	   1	   0	CTD_human;GENOMICS_ENGLAND
       93	ACVR2B	0.601	0.615	C3178806	Right Atrial Isomerism	disease	C16;C15;C14	Congenital Abnormality	0.50	1	1997	1999	   1	   0	CTD_human
       93	ACVR2B	0.601	0.615	C3178807	Left Atrial Isomerism	disease	C16;C15;C14	Congenital Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
       93	ACVR2B	0.601	0.615	C4277690	Ciliopathies	disease	C16	Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
       94	ACVRL1	0.493	0.769	C0005779	Blood Coagulation Disorders	group	C15	Disease or Syndrome	0.31	1	2006	2006	   1	   0	GENOMICS_ENGLAND
       94	ACVRL1	0.493	0.769	C0014591	Epistaxis	phenotype	C23;C08;C09	Pathologic Function	0.40	1	2003	2003	   1	   1	GENOMICS_ENGLAND
       94	ACVRL1	0.493	0.769	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.51	1	2003	2016	   1	   0	CTD_human
       94	ACVRL1	0.493	0.769	C0039445	Hereditary hemorrhagic telangiectasia	disease	C16;C15;C14	Disease or Syndrome	0.60	1	1996	2019	   1	   0	CTD_human
       94	ACVRL1	0.493	0.769	C0039446	Telangiectasis	disease	C14	Finding	0.34	1	2002	2008	   1	   0	GENOMICS_ENGLAND
       94	ACVRL1	0.493	0.769	C0155675	Pulmonary Arteriovenous Fistulas	disease	C23;C16;C14	Disease or Syndrome	0.40	1	2003	2003	   1	   0	GENOMICS_ENGLAND
       94	ACVRL1	0.493	0.769	C0241790	Congenital pulmonary arteriovenous malformation	disease	C08	Congenital Abnormality	0.40	1	2003	2003	   1	   0	GENOMICS_ENGLAND
       94	ACVRL1	0.493	0.769	C0340543	Familial primary pulmonary hypertension	disease	C08	Disease or Syndrome	0.56	1	2010	2017	   6	   0	GENOMICS_ENGLAND;ORPHANET
       94	ACVRL1	0.493	0.769	C0520557	Arteriovenous malformation of liver	disease	C16;C14	Congenital Abnormality	0.40	1	2003	2003	   1	   0	GENOMICS_ENGLAND
       94	ACVRL1	0.493	0.769	C1150929	2-oxo-hept-3-ene-1,7-dioate hydratase activity	phenotype		Molecular Function	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
       94	ACVRL1	0.493	0.769	C1458140	Bleeding tendency	phenotype	C15	Pathologic Function	0.30	1	2006	2006	   1	   0	GENOMICS_ENGLAND
       94	ACVRL1	0.493	0.769	C1701939	Familial pulmonary arterial hypertension	disease		Disease or Syndrome	0.30	1	2012	2014	   5	   0	ORPHANET
       94	ACVRL1	0.493	0.769	C1832529	HEREDITARY HEMORRHAGIC TELANGIECTASIA-RELATED PULMONARY ARTERIAL HYPERTENSION	disease	C08;C14	Disease or Syndrome	0.40	1	1996	2015	  11	  27	CLINGEN
       94	ACVRL1	0.493	0.769	C1838163	OSLER-RENDU-WEBER SYNDROME 2	disease	C16;C15;C14	Disease or Syndrome	0.76	1	1996	2018	  23	  91	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
       94	ACVRL1	0.493	0.769	C1857690	Pulmonary arteriovenous malformation	disease	C16;C14	Anatomical Abnormality	0.40	1	2003	2003	   1	   0	GENOMICS_ENGLAND
       94	ACVRL1	0.493	0.769	C2973725	Pulmonary arterial hypertension	disease	C08;C14	Disease or Syndrome	0.50	0.909	2002	2019	   1	   2	GENOMICS_ENGLAND
       94	ACVRL1	0.493	0.769	C3203102	Idiopathic pulmonary arterial hypertension	disease	C08	Disease or Syndrome	0.50	0.971	2001	2020	   1	   0	GENOMICS_ENGLAND
       94	ACVRL1	0.493	0.769	C3850148	Vascular Remodeling	phenotype	C23	Organ or Tissue Function	0.30	1	2016	2016	   1	   0	CTD_human
       94	ACVRL1	0.493	0.769	C3852953	Pulmonary Arterial Remodeling	phenotype	C23	Organ or Tissue Function	0.30	1	2016	2016	   1	   0	CTD_human
       94	ACVRL1	0.493	0.769	C4551861	Telangiectasia, Hereditary Hemorrhagic, Type 1	disease	C16;C15;C14	Disease or Syndrome	0.42	1	2004	2014	   1	   4	CTD_human
       94	ACVRL1	0.493	0.769	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
       95	ACY1	0.653	0.577	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
       95	ACY1	0.653	0.577	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.31	1	2004	2011	   1	   0	CTD_human
       95	ACY1	0.653	0.577	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
       95	ACY1	0.653	0.577	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
       95	ACY1	0.653	0.577	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
       95	ACY1	0.653	0.577	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
       95	ACY1	0.653	0.577	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
       95	ACY1	0.653	0.577	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
       95	ACY1	0.653	0.577	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
       95	ACY1	0.653	0.577	C1835922	Aminoacylase 1 deficiency	disease	C16;C18	Disease or Syndrome	0.70	1	2005	2011	   4	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       95	ACY1	0.653	0.577	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
       98	ACYP2	0.659	0.577	C2750088	HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO	disease		Finding	0.30	1	2015	2015	   1	   0	CTD_human
      100	ADA	0.44	0.885	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2000	2013	   1	   0	CTD_human
      100	ADA	0.44	0.885	C0020452	Hyperemia	disease	C14	Disease or Syndrome	0.31	1	1989	2008	   2	   0	CTD_human
      100	ADA	0.44	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      100	ADA	0.44	0.885	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	1990	1990	   1	   0	CTD_human
      100	ADA	0.44	0.885	C0037928	Spinal Cord Diseases	group	C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      100	ADA	0.44	0.885	C0042484	Venous Engorgement	phenotype	C14	Pathologic Function	0.30	1	1989	1994	   2	   0	CTD_human
      100	ADA	0.44	0.885	C0085110	Severe Combined Immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.50	0.991	1974	2019	   1	   2	GENOMICS_ENGLAND
      100	ADA	0.44	0.885	C0178824	Reactive Hyperemia	phenotype	C14	Pathologic Function	0.30	1	1989	1994	   2	   0	CTD_human
      100	ADA	0.44	0.885	C0220744	Multiple gastrointestinal atresias (disorder)	disease	C16;C06	Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
      100	ADA	0.44	0.885	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.33	1	1990	2019	   1	   0	CTD_human
      100	ADA	0.44	0.885	C0268124	Adenosine deaminase deficiency	disease	C16;C18;C20	Disease or Syndrome	0.60	1	1976	2018	   0	   0	ORPHANET
      100	ADA	0.44	0.885	C0333233	Active Hyperemia	phenotype	C14	Pathologic Function	0.30	1	1989	1994	   2	   0	CTD_human
      100	ADA	0.44	0.885	C0392607	Severe combined immunodeficiency due to adenosine deaminase deficiency	disease	C16;C18;C20;C15	Disease or Syndrome	0.80	0.977	1980	2019	   0	   7	CTD_human;GENOMICS_ENGLAND;ORPHANET
      100	ADA	0.44	0.885	C0700216	Structural Clinical Interview for DSM-III	phenotype		Diagnostic Procedure	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      100	ADA	0.44	0.885	C1335302	Pancreatic Ductal Adenocarcinoma	disease	C06;C04;C19	Neoplastic Process	0.30				   0	   1	UNIPROT
      100	ADA	0.44	0.885	C1863236	SCID Due to ADA Deficiency, Early-Onset	disease		Disease or Syndrome	0.60	1	1984	2019	  12	  32	GENOMICS_ENGLAND;UNIPROT
      100	ADA	0.44	0.885	C1863239	Partial adenosine deaminase deficiency	disease	C16;C18;C20;C15	Disease or Syndrome	0.42	1	1986	1990	   0	   1	CTD_human
      100	ADA	0.44	0.885	C2700553	Omenn Syndrome	disease	C16;C18;C20	Disease or Syndrome	0.51	1	2011	2011	   0	   0	GENOMICS_ENGLAND;ORPHANET
      101	ADAM8	0.59	0.731	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
      101	ADAM8	0.59	0.731	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      101	ADAM8	0.59	0.731	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      101	ADAM8	0.59	0.731	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      101	ADAM8	0.59	0.731	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      101	ADAM8	0.59	0.731	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      102	ADAM10	0.489	0.846	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.70	0.986	2000	2019	   1	   1	CTD_human
      102	ADAM10	0.489	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1997	2020	   1	   0	CTD_human
      102	ADAM10	0.489	0.846	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.31	1	2018	2019	   1	   0	CTD_human
      102	ADAM10	0.489	0.846	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.31	0.5	2012	2019	   1	   0	CTD_human
      102	ADAM10	0.489	0.846	C0406811	Reticulate acropigmentation of Kitamura	disease	C16;C17	Disease or Syndrome	0.72	1	2013	2019	   1	   5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      102	ADAM10	0.489	0.846	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.32	1	2013	2019	   1	   0	CTD_human
      102	ADAM10	0.489	0.846	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      102	ADAM10	0.489	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1997	2020	   1	   0	CTD_human
      102	ADAM10	0.489	0.846	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      102	ADAM10	0.489	0.846	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      102	ADAM10	0.489	0.846	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      102	ADAM10	0.489	0.846	C1321872	Stage IV Skin Melanoma	disease	C04;C17	Neoplastic Process	0.30				   0	   1	UNIPROT
      102	ADAM10	0.489	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	0.5	2006	2017	   1	   0	CTD_human
      102	ADAM10	0.489	0.846	C3714534	dowling-degos disease	disease	C16;C17	Disease or Syndrome	0.31	1	2013	2013	   0	   0	CTD_human
      102	ADAM10	0.489	0.846	C3810041	ALZHEIMER DISEASE 18	disease		Disease or Syndrome	0.60	1	2009	2013	   2	   2	CTD_human;UNIPROT
      102	ADAM10	0.489	0.846	C4552092	Dowling-Degos disease 1	disease	C16;C17	Disease or Syndrome	0.30				   0	   0	CTD_human
      102	ADAM10	0.489	0.846	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      103	ADAR	0.501	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.54	1	2015	2019	   1	   1	CTD_human;UNIPROT
      103	ADAR	0.501	0.808	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.44	1	2006	2016	   3	   0	GENOMICS_ENGLAND
      103	ADAR	0.501	0.808	C0393591	AICARDI-GOUTIERES SYNDROME	disease	C16;C20;C10	Disease or Syndrome	0.80	1	2012	2020	   1	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
      103	ADAR	0.501	0.808	C0406775	Symmetrical dyschromatosis of extremities	disease	C23;C17	Congenital Abnormality	0.80	1	2003	2020	   5	  11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      103	ADAR	0.501	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.34	1	2015	2019	   1	   0	CTD_human
      103	ADAR	0.501	0.808	C0795996	STRIATONIGRAL DEGENERATION, INFANTILE (disorder)	disease	C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	ORPHANET
      103	ADAR	0.501	0.808	C0796126	AICARDI-GOUTIERES SYNDROME 1	disease	C16;C20;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      103	ADAR	0.501	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      103	ADAR	0.501	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      103	ADAR	0.501	0.808	C3489724	Aicardi-Goutieres Syndrome 2	disease	C16;C20;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      103	ADAR	0.501	0.808	C3489725	Pseudo-TORCH syndrome	disease	C16;C20;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      103	ADAR	0.501	0.808	C3539013	AICARDI-GOUTIERES SYNDROME 6	disease		Disease or Syndrome	0.60	1	2004	2016	   6	  13	GENOMICS_ENGLAND;UNIPROT
      103	ADAR	0.501	0.808	C3860213	Autoinflammatory disorder	disease		Disease or Syndrome	0.31	1	2012	2018	   1	   0	GENOMICS_ENGLAND
      103	ADAR	0.501	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      104	ADARB1	0.588	0.654	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	0.333	2004	2014	   3	   0	PSYGENET
      104	ADARB1	0.588	0.654	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      104	ADARB1	0.588	0.654	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
      104	ADARB1	0.588	0.654	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2012	2014	   2	   0	PSYGENET
      104	ADARB1	0.588	0.654	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      105	ADARB2	0.716	0.308	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      105	ADARB2	0.716	0.308	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      105	ADARB2	0.716	0.308	C0013170	Drug habituation	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      105	ADARB2	0.716	0.308	C0013222	Drug Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      105	ADARB2	0.716	0.308	C0029231	Organic Mental Disorders, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      105	ADARB2	0.716	0.308	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      105	ADARB2	0.716	0.308	C0038580	Substance Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      105	ADARB2	0.716	0.308	C0038586	Substance Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      105	ADARB2	0.716	0.308	C0236969	Substance-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      105	ADARB2	0.716	0.308	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      105	ADARB2	0.716	0.308	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      105	ADARB2	0.716	0.308	C4316881	Prescription Drug Abuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      107	ADCY1	0.659	0.462	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      107	ADCY1	0.659	0.462	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      107	ADCY1	0.659	0.462	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      107	ADCY1	0.659	0.462	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      107	ADCY1	0.659	0.462	C0751217	Hyperkinesia, Generalized	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      107	ADCY1	0.659	0.462	C1846647	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CLINGEN
      107	ADCY1	0.659	0.462	C1857809	DEAFNESS, AUTOSOMAL RECESSIVE 44	disease	C23;C10;C09	Disease or Syndrome	0.60	1	2014	2014	   0	   1	CTD_human;GENOMICS_ENGLAND
      107	ADCY1	0.659	0.462	C3887506	Hyperkinesia	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      108	ADCY2	0.695	0.308	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.31	1	2011	2017	   1	   0	CTD_human
      108	ADCY2	0.695	0.308	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.62	1	2014	2019	   2	  11	CTD_human;PSYGENET
      108	ADCY2	0.695	0.308	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      108	ADCY2	0.695	0.308	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      108	ADCY2	0.695	0.308	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      109	ADCY3	0.678	0.615	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
      109	ADCY3	0.678	0.615	C0011875	Diabetic Angiopathies	disease	C19;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      109	ADCY3	0.678	0.615	C0025945	Microangiopathy, Diabetic	disease	C19;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      109	ADCY3	0.678	0.615	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.49	1	2008	2018	   1	   0	CTD_human
      109	ADCY3	0.678	0.615	C0028756	Obesity, Morbid	disease	C23;C18	Disease or Syndrome	0.31	1	2018	2018	   1	   0	CTD_human
      109	ADCY3	0.678	0.615	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
      111	ADCY5	0.617	0.577	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
      111	ADCY5	0.617	0.577	C0005612	Birth Weight	phenotype	C23	Organism Attribute	0.40	1	2010	2019	   1	   4	CTD_human
      111	ADCY5	0.617	0.577	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.32	1	2010	2018	   2	   0	PSYGENET
      111	ADCY5	0.617	0.577	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2010	2018	   2	   0	PSYGENET
      111	ADCY5	0.617	0.577	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.70	0.947	2002	2019	   2	   3	CTD_human
      111	ADCY5	0.617	0.577	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.47	1	2014	2017	   1	   0	GENOMICS_ENGLAND
      111	ADCY5	0.617	0.577	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.50	1	2003	2003	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2002	2002	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2007	2013	   2	   0	CTD_human
      111	ADCY5	0.617	0.577	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2007	2013	   2	   0	CTD_human
      111	ADCY5	0.617	0.577	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
      111	ADCY5	0.617	0.577	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C0393584	Benign Hereditary Chorea	disease	C23;C10	Disease or Syndrome	0.32	1	2015	2016	   1	   0	ORPHANET
      111	ADCY5	0.617	0.577	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2007	2013	   2	   0	CTD_human
      111	ADCY5	0.617	0.577	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
      111	ADCY5	0.617	0.577	C1535926	Neurodevelopmental Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      111	ADCY5	0.617	0.577	C1847627	Dyskinesia, Familial, with Facial Myokymia	disease	C23;C10	Disease or Syndrome	0.72	1	2001	2017	   4	   5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      111	ADCY5	0.617	0.577	C1859098	Chorea, Benign Familial	disease	C23;C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	ORPHANET
      112	ADCY6	0.729	0.5	C4225385	LETHAL CONGENITAL CONTRACTURE SYNDROME 8	disease		Disease or Syndrome	0.71	1	2014	2020	   1	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
      113	ADCY7	0.656	0.462	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
      113	ADCY7	0.656	0.462	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.41	1	2015	2017	   1	   2	CTD_human
      113	ADCY7	0.656	0.462	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.32	1	2012	2019	   1	   0	PSYGENET
      113	ADCY7	0.656	0.462	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2006	2019	   2	   0	PSYGENET
      113	ADCY7	0.656	0.462	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.32	1	2008	2018	   1	   0	CTD_human
      113	ADCY7	0.656	0.462	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      113	ADCY7	0.656	0.462	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      113	ADCY7	0.656	0.462	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2006	2012	   2	   0	PSYGENET
      113	ADCY7	0.656	0.462	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      113	ADCY7	0.656	0.462	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      113	ADCY7	0.656	0.462	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2006	2012	   2	   0	PSYGENET
      113	ADCY7	0.656	0.462	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      113	ADCY7	0.656	0.462	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.40	1	2009	2015	   1	   1	CTD_human
      113	ADCY7	0.656	0.462	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      113	ADCY7	0.656	0.462	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      113	ADCY7	0.656	0.462	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      114	ADCY8	0.705	0.577	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2008	2009	   2	   0	PSYGENET
      114	ADCY8	0.705	0.577	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      114	ADCY8	0.705	0.577	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
      114	ADCY8	0.705	0.577	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
      114	ADCY8	0.705	0.577	C0011875	Diabetic Angiopathies	disease	C19;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      114	ADCY8	0.705	0.577	C0025945	Microangiopathy, Diabetic	disease	C19;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      114	ADCY8	0.705	0.577	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      114	ADCY8	0.705	0.577	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      114	ADCY8	0.705	0.577	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      114	ADCY8	0.705	0.577	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.51	1	2009	2013	   4	   0	CTD_human;PSYGENET
      114	ADCY8	0.705	0.577	C0751217	Hyperkinesia, Generalized	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      114	ADCY8	0.705	0.577	C3887506	Hyperkinesia	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	0.75	2001	2010	   4	   0	PSYGENET
      116	ADCYAP1	0.51	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2010	2017	   4	   0	PSYGENET
      116	ADCYAP1	0.51	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2017	   4	   0	PSYGENET
      116	ADCYAP1	0.51	0.846	C0020452	Hyperemia	disease	C14	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0026205	Miosis disorder	disease	C23;C11;C10	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.75	2001	2019	   4	   0	PSYGENET
      116	ADCYAP1	0.51	0.846	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0042484	Venous Engorgement	phenotype	C14	Pathologic Function	0.30	1	1995	1995	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0149504	Encephalopathy, Toxic	disease	C10;C25	Injury or Poisoning	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0154659	Toxic Encephalitis	disease	C10;C25	Injury or Poisoning	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0178824	Reactive Hyperemia	phenotype	C14	Pathologic Function	0.30	1	1995	1995	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0235032	Neurotoxicity Syndromes	group	C10;C25	Injury or Poisoning	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0268849	Overactive Detrusor	phenotype	C23;C13;C12	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0333233	Active Hyperemia	phenotype	C14	Pathologic Function	0.30	1	1995	1995	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0392156	Akathisia	phenotype	C23;C10;F01	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C0878773	Overactive Bladder	disease	C23;C13;C12	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C3887612	Psychomotor Agitation	phenotype	C23;C10;F01	Finding	0.30	1	2007	2007	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2018	2018	   1	   0	CTD_human
      116	ADCYAP1	0.51	0.846	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      117	ADCYAP1R1	0.561	0.769	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.31	1	2011	2013	   1	   0	CTD_human
      117	ADCYAP1R1	0.561	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2007	2017	   1	   0	PSYGENET
      118	ADD1	0.612	0.615	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.60	0.861	1995	2019	   2	   0	CTD_human
      118	ADD1	0.612	0.615	C0085580	Essential Hypertension	disease	C14	Disease or Syndrome	0.40	0.944	1995	2017	   0	   0	CTD_human
      118	ADD1	0.612	0.615	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      120	ADD3	0.641	0.5	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2017	2019	   1	   1	CTD_human
      120	ADD3	0.641	0.5	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      120	ADD3	0.641	0.5	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      120	ADD3	0.641	0.5	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      120	ADD3	0.641	0.5	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      120	ADD3	0.641	0.5	C0149504	Encephalopathy, Toxic	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      120	ADD3	0.641	0.5	C0154659	Toxic Encephalitis	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      120	ADD3	0.641	0.5	C0235032	Neurotoxicity Syndromes	group	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      120	ADD3	0.641	0.5	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      120	ADD3	0.641	0.5	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      120	ADD3	0.641	0.5	C2751938	Cerebral Palsy, Spastic Quadriplegic, 1	disease	C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
      120	ADD3	0.641	0.5	C4310767	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3	disease		Disease or Syndrome	0.60	1	2013	2013	   1	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      123	PLIN2	0.564	0.692	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.33	1	2006	2019	   1	   0	CTD_human
      123	PLIN2	0.564	0.692	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      123	PLIN2	0.564	0.692	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      123	PLIN2	0.564	0.692	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      123	PLIN2	0.564	0.692	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      123	PLIN2	0.564	0.692	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.38	1	2006	2019	   1	   0	CTD_human
      124	ADH1A	0.647	0.577	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	1999	2013	   5	   0	PSYGENET
      124	ADH1A	0.647	0.577	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      124	ADH1A	0.647	0.577	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	0.958	1994	2019	   3	   0	CTD_human
      125	ADH1B	0.502	0.846	C0001969	Alcoholic Intoxication	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2006	2014	   5	   0	PSYGENET
      125	ADH1B	0.502	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.70	1	1994	2019	   8	   8	CTD_human;PSYGENET
      125	ADH1B	0.502	0.846	C0007107	Malignant neoplasm of larynx	disease	C04;C08;C09	Neoplastic Process	0.33	1	2003	2016	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0007785	Cerebral Infarction	disease	C23;C10;C14	Disease or Syndrome	0.31	1	2004	2004	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.39	0.889	2006	2018	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	2006	2008	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.50	1	1997	2016	   1	   3	CTD_human
      125	ADH1B	0.502	0.846	C0023055	Laryngeal neoplasm	disease	C04;C08;C09	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.31	1	2011	2015	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0031347	Pharyngeal Neoplasms	group	C04;C07;C09	Neoplastic Process	0.40	1	2008	2016	   1	   1	CTD_human
      125	ADH1B	0.502	0.846	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2015	2015	   1	   0	PSYGENET
      125	ADH1B	0.502	0.846	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.60	1	1994	2019	   8	   0	CTD_human;PSYGENET
      125	ADH1B	0.502	0.846	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.40	1	2008	2016	   1	   1	CTD_human
      125	ADH1B	0.502	0.846	C0153405	Malignant neoplasm of pharynx	disease	C04;C07;C09	Neoplastic Process	0.31	0.5	2001	2008	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.40	1	1997	2019	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0349464	Wernicke-Korsakoff Syndrome	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.31	1	2000	2000	   1	   0	PSYGENET
      125	ADH1B	0.502	0.846	C0393756	Hangover from alcohol	phenotype	C25;F03	Sign or Symptom	0.30	1	2005	2005	   1	   0	PSYGENET
      125	ADH1B	0.502	0.846	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.50	1	1997	2016	   1	   1	CTD_human
      125	ADH1B	0.502	0.846	C0751010	Cerebral Infarction, Left Hemisphere	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0751011	Cerebral Infarction, Right Hemisphere	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0751012	Anterior Choroidal Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0751014	Subcortical Infarction	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C0887799	Posterior Choroidal Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      125	ADH1B	0.502	0.846	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.31	1	2016	2018	   1	   0	CTD_human
      126	ADH1C	0.547	0.731	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.36	1	2005	2019	   1	   0	CTD_human
      126	ADH1C	0.547	0.731	C0001969	Alcoholic Intoxication	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2007	2014	   5	   0	PSYGENET
      126	ADH1C	0.547	0.731	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.70	1	1991	2019	   6	   0	CTD_human;PSYGENET
      126	ADH1C	0.547	0.731	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      126	ADH1C	0.547	0.731	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.53	1	1994	2012	   5	   0	CTD_human;PSYGENET
      126	ADH1C	0.547	0.731	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.34	1	1997	2011	   1	   0	CTD_human
      126	ADH1C	0.547	0.731	C3160718	PARKINSON DISEASE, LATE-ONSET	disease		Disease or Syndrome	0.30				   0	   0	CTD_human
      127	ADH4	0.641	0.462	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2012	2017	   1	   0	PSYGENET
      127	ADH4	0.641	0.462	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.50	1	1994	2019	   4	   2	PSYGENET
      127	ADH4	0.641	0.462	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
      127	ADH4	0.641	0.462	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      127	ADH4	0.641	0.462	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      127	ADH4	0.641	0.462	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2012	2019	   1	   0	CTD_human
      127	ADH4	0.641	0.462	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      128	ADH5	0.604	0.731	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	1994	2006	   1	   0	PSYGENET
      130	ADH6	0.78	0.231	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
      131	ADH7	0.656	0.462	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.36	1	2004	2014	   5	   0	PSYGENET
      131	ADH7	0.656	0.462	C0007107	Malignant neoplasm of larynx	disease	C04;C08;C09	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      131	ADH7	0.656	0.462	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      131	ADH7	0.656	0.462	C0023055	Laryngeal neoplasm	disease	C04;C08;C09	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      131	ADH7	0.656	0.462	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      131	ADH7	0.656	0.462	C0031347	Pharyngeal Neoplasms	group	C04;C07;C09	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      131	ADH7	0.656	0.462	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      131	ADH7	0.656	0.462	C0153405	Malignant neoplasm of pharynx	disease	C04;C07;C09	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      131	ADH7	0.656	0.462	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      132	ADK	0.584	0.769	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      132	ADK	0.584	0.769	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.31	1	2008	2009	   1	   0	CTD_human
      132	ADK	0.584	0.769	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      132	ADK	0.584	0.769	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      132	ADK	0.584	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2018	   1	   0	PSYGENET
      132	ADK	0.584	0.769	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      132	ADK	0.584	0.769	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2009	2009	   1	   0	CTD_human
      132	ADK	0.584	0.769	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      132	ADK	0.584	0.769	C3280381	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	disease		Disease or Syndrome	0.70	1	2011	2016	   2	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      132	ADK	0.584	0.769	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2013	   3	   0	PSYGENET
      133	ADM	0.436	0.808	C0017658	Glomerulonephritis	disease	C13;C12	Disease or Syndrome	0.51	1	2004	2010	   2	   0	CTD_human
      133	ADM	0.436	0.808	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.51	1	2006	2017	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2004	2006	   2	   0	CTD_human
      133	ADM	0.436	0.808	C0030193	Pain	phenotype	C23	Sign or Symptom	0.31	1	2006	2018	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0034189	Pyemia	phenotype	C23;C01	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2004	2016	   2	   0	PSYGENET
      133	ADM	0.436	0.808	C0036690	Septicemia	disease	C23;C01	Disease or Syndrome	0.40	1	2000	2020	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0038358	Gastric ulcer	disease	C06	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.60	1	2000	2020	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2006	2006	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      133	ADM	0.436	0.808	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      133	ADM	0.436	0.808	C1704377	Bright Disease	disease	C13;C12	Disease or Syndrome	0.30	1	2004	2005	   2	   0	CTD_human
      133	ADM	0.436	0.808	C1719672	Severe Sepsis	disease	C23;C01	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      133	ADM	0.436	0.808	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.32	1	2006	2019	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0007370	Catalepsy	disease	C23;C10	Mental or Behavioral Dysfunction	0.30	1	1997	1997	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0007787	Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2017	2017	   0	   1	UNIPROT
      134	ADORA1	0.578	0.692	C0013182	Drug Allergy	group	C20;C25	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2004	2004	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	2004	2008	   2	   0	CTD_human
      134	ADORA1	0.578	0.692	C0022116	Ischemia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0033054	Prenatal Exposure Delayed Effects	disease	C13	Injury or Poisoning	0.30	1	2008	2008	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2009	2009	   1	   0	PSYGENET
      134	ADORA1	0.578	0.692	C0038525	Subarachnoid Hemorrhage	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0233612	Waxy flexibility	phenotype	C23;C10	Sign or Symptom	0.30	1	1997	1997	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0238281	Middle Cerebral Artery Syndrome	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0242973	Ventricular Dysfunction	phenotype	C14	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0270192	Perinatal Subarachnoid Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0428977	Bradycardia	phenotype	C23;C14	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0472381	Posterior Circulation Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0472383	Subarachnoid Hemorrhage, Spontaneous	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0740376	Middle Cerebral Artery Thrombosis	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0740391	Middle Cerebral Artery Occlusion	disease	C23;C10;C14	Acquired Abnormality	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0740392	Infarction, Middle Cerebral Artery	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0751019	Carotid Circulation Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0751020	Transient Ischemic Attack, Vertebrobasilar Circulation	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0751021	Crescendo Transient Ischemic Attacks	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0751022	Brain Stem Ischemia, Transient	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0751530	Subarachnoid Hemorrhage, Aneurysmal	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0751845	Middle Cerebral Artery Embolus	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0751846	Left Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0751847	Embolic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0751848	Thrombotic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0751849	Right Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0795688	Subarachnoid Hemorrhage, Intracranial	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C0917805	Transient Cerebral Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      134	ADORA1	0.578	0.692	C1527335	Transient Ischemic Attack, Anterior Circulation	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.39	0.909	2003	2019	   4	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.32	1	2009	2019	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0011573	Endogenous depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2017	2019	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0013182	Drug Allergy	group	C20;C25	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2004	2004	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	1992	2008	   3	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0021603	Sleep Initiation and Maintenance Disorders	disease	C10;F03	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0025193	Melancholia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0026650	Movement Disorders	group	C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0030319	Panic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.37	0.875	2003	2016	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0033139	Primary Insomnia	disease	C10;F03	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0033937	Psychoses, Drug	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0033941	Psychoses, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0034189	Pyemia	phenotype	C23;C01	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.50	1	2008	2016	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.37	0.75	1996	2019	   4	   0	PSYGENET
      135	ADORA2A	0.526	0.769	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.31	1	2009	2013	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0036690	Septicemia	disease	C23;C01	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2004	2006	   3	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0040822	Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0040827	Saturnine Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0086133	Depressive Syndrome	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2004	2006	   3	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0086769	Panic Attacks	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2003	2005	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2004	2006	   3	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0149840	Senile Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0234370	Persistent Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0234371	Continuous Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0234372	Intermittent Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0234373	Fine Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0234374	Coarse Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0234375	Massive Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0234376	Action Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0234377	Passive Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0234378	Static Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0234379	Resting Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0234381	Darkness Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0235078	Tremor, Perioral	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0235081	Tremor, Limb	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0235082	Tremor, Muscle	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0235083	Nerve Tremors	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0235843	Tremor, Neonatal	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0236733	Amphetamine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0236804	Amphetamine Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0236807	Amphetamine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0242973	Ventricular Dysfunction	phenotype	C14	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0266487	Etat Marbre	disease	C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0270541	Rebound Insomnia	phenotype	C10;F03	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0282126	Depression, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0349255	Nonorganic Insomnia	disease	C10;F03	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2003	2010	   4	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0393759	Transient Insomnia	phenotype	C10;F03	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2006	2006	   1	   0	PSYGENET
      135	ADORA2A	0.526	0.769	C0541798	Early Awakening	phenotype	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0751217	Hyperkinesia, Generalized	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0751249	Chronic Insomnia	disease	C10;F03	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0751250	Psychophysiological Insomnia	disease	C10;F03	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0751251	Secondary Insomnia	phenotype	C10;F03	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0751252	Sleep Initiation Dysfunction	disease	C10;F03	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0751564	Pill Rolling Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0751565	Tremor, Semirhythmic	phenotype	C23;C10	Finding	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C0917801	Sleeplessness	phenotype	C10;F03	Sign or Symptom	0.32	1	2007	2019	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C1262477	Weight decreased	phenotype	C23	Finding	0.30	1	2016	2016	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2003	2010	   4	   0	CTD_human
      135	ADORA2A	0.526	0.769	C1527384	Involuntary Quiver	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C1719672	Severe Sepsis	disease	C23;C01	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C3887506	Hyperkinesia	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      135	ADORA2A	0.526	0.769	C4707658	Acute encephalopathy with biphasic seizures and late reduced diffusion	disease	C10	Disease or Syndrome	0.32	1	2013	2015	   1	   0	ORPHANET
      136	ADORA2B	0.617	0.692	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      136	ADORA2B	0.617	0.692	C0034189	Pyemia	phenotype	C23;C01	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
      136	ADORA2B	0.617	0.692	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.30	1	2016	2016	   1	   0	CTD_human
      136	ADORA2B	0.617	0.692	C0036690	Septicemia	disease	C23;C01	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      136	ADORA2B	0.617	0.692	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      136	ADORA2B	0.617	0.692	C1719672	Severe Sepsis	disease	C23;C01	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      140	ADORA3	0.682	0.5	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      140	ADORA3	0.682	0.5	C0022116	Ischemia	phenotype	C23	Pathologic Function	0.30	1	1995	1995	   1	   0	CTD_human
      140	ADORA3	0.682	0.5	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      140	ADORA3	0.682	0.5	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.30	1	2002	2010	   2	   0	CTD_human
      142	PARP1	0.389	0.923	C0002170	Alopecia	disease	C23;C17	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0002871	Anemia	disease	C15	Disease or Syndrome	0.32	0.5	2010	2017	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.40	1	2003	2019	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.34	1	2009	2019	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.60	0.968	1997	2020	   1	   0	CTD_human;UNIPROT
      142	PARP1	0.389	0.923	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	2010	2019	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2016	2018	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0011603	Dermatitis	disease	C17	Disease or Syndrome	0.31	1	2010	2015	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0014518	Toxic Epidermal Necrolysis	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0015697	Arterial Fatty Streak	phenotype	C23	Acquired Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0019158	Hepatitis	group	C06	Disease or Syndrome	0.32	1	2010	2017	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.32	1	2004	2008	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.31	1	2010	2017	   2	   0	CTD_human
      142	PARP1	0.389	0.923	C0022821	Kyphosis deformity of spine	phenotype	C05	Anatomical Abnormality	0.31	1	2010	2010	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0025202	melanoma	disease	C04	Neoplastic Process	0.50	1	2006	2019	   1	   1	CTD_human
      142	PARP1	0.389	0.923	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.38	1	2007	2020	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.31	1	2010	2013	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.34	1	2003	2018	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.34	1	2004	2019	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.31	1	2017	2019	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0038325	Stevens-Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0042842	Vitamin A Deficiency	disease	C18	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0086873	Pseudopelade	disease	C23;C17	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0162311	Androgenetic Alopecia	disease	C23;C17	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0242422	Parkinsonian Disorders	group	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0242423	Ramsay Hunt Paralysis Syndrome	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0263477	Female pattern alopecia (disorder)	phenotype	C23;C17	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0264956	Atheroma	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.32	1	2011	2011	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	1	2003	2019	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.964	1996	2020	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0752097	Autosomal Dominant Juvenile Parkinson Disease	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0752098	Autosomal Dominant Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0752100	Autosomal Recessive Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0752101	Parkinsonism, Experimental	disease	C10	Experimental Model of Disease	0.30	1	2007	2007	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0752104	Familial Juvenile Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0752105	Parkinsonism, Juvenile	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.31	1	2010	2018	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2010	2010	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C1274933	Drug-Induced Stevens Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	2007	2019	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C1868675	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C2931673	Ceroid lipofuscinosis, neuronal 1, infantile	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C2936350	Plaque, Atherosclerotic	phenotype	C23	Body Substance	0.30	1	2009	2009	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C2936351	Fibroatheroma	disease	C23	Acquired Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C3658301	Mycoplasma-Induced Stevens-Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C3658302	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.34	1	2003	2018	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C4083212	Alopecia, Male Pattern	disease	C23;C17	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      142	PARP1	0.389	0.923	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      143	PARP4	0.729	0.269	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      143	PARP4	0.729	0.269	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      146	ADRA1D	0.636	0.731	C1135196	Heart Failure, Diastolic	disease	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2001	2002	   2	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	2001	2001	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0149504	Encephalopathy, Toxic	disease	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0154659	Toxic Encephalitis	disease	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0235032	Neurotoxicity Syndromes	group	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	PSYGENET
      147	ADRA1B	0.686	0.5	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2001	2002	   2	   0	CTD_human
      147	ADRA1B	0.686	0.5	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      147	ADRA1B	0.686	0.5	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      148	ADRA1A	0.462	0.846	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2009	2009	   1	   0	CTD_human
      148	ADRA1A	0.462	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	PSYGENET
      148	ADRA1A	0.462	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.39	1	1997	2019	   0	   0	UNIPROT
      148	ADRA1A	0.462	0.846	C0006870	Cannabis Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2009	2009	   1	   0	PSYGENET
      148	ADRA1A	0.462	0.846	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
      148	ADRA1A	0.462	0.846	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2007	2009	   1	   0	CTD_human
      148	ADRA1A	0.462	0.846	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      148	ADRA1A	0.462	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2000	2019	   1	   0	PSYGENET
      148	ADRA1A	0.462	0.846	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2009	2009	   1	   0	CTD_human
      148	ADRA1A	0.462	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
      148	ADRA1A	0.462	0.846	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      148	ADRA1A	0.462	0.846	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
      148	ADRA1A	0.462	0.846	C0600519	Ventricular Remodeling	phenotype	C23	Organ or Tissue Function	0.30	1	2010	2010	   1	   0	CTD_human
      148	ADRA1A	0.462	0.846	C0600520	Left Ventricle Remodeling	phenotype	C23	Organ or Tissue Function	0.30	1	2010	2010	   1	   0	CTD_human
      148	ADRA1A	0.462	0.846	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
      148	ADRA1A	0.462	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.35	1	2007	2018	   1	   0	CTD_human
      148	ADRA1A	0.462	0.846	C3496069	cocaine use	disease		Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
      150	ADRA2A	0.578	0.615	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2007	2012	   2	   0	PSYGENET
      150	ADRA2A	0.578	0.615	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.53	0.75	2001	2011	   4	   0	PSYGENET
      150	ADRA2A	0.578	0.615	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	0.75	2001	2011	   4	   0	PSYGENET
      150	ADRA2A	0.578	0.615	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      150	ADRA2A	0.578	0.615	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      150	ADRA2A	0.578	0.615	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      150	ADRA2A	0.578	0.615	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      150	ADRA2A	0.578	0.615	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.52	0.75	1999	2012	   1	   0	CTD_human
      150	ADRA2A	0.578	0.615	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	2006	2009	   2	   0	CTD_human
      150	ADRA2A	0.578	0.615	C0030319	Panic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2000	2003	   1	   0	CTD_human
      150	ADRA2A	0.578	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.34	0.5	2007	2014	   4	   0	PSYGENET
      150	ADRA2A	0.578	0.615	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      150	ADRA2A	0.578	0.615	C0086769	Panic Attacks	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      150	ADRA2A	0.578	0.615	C0236018	Aura	phenotype	C10	Finding	0.30	1	2007	2007	   1	   0	CTD_human
      150	ADRA2A	0.578	0.615	C0271694	Familial partial lipodystrophy	disease	C18;C17	Disease or Syndrome	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      150	ADRA2A	0.578	0.615	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	1998	2006	   2	   0	PSYGENET
      150	ADRA2A	0.578	0.615	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      150	ADRA2A	0.578	0.615	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      150	ADRA2A	0.578	0.615	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      151	ADRA2B	0.465	0.846	C0010520	Cyanosis	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      151	ADRA2B	0.465	0.846	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      151	ADRA2B	0.465	0.846	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.32	1	2010	2017	   1	   0	CTD_human
      151	ADRA2B	0.465	0.846	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      151	ADRA2B	0.465	0.846	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      151	ADRA2B	0.465	0.846	C1832841	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1	disease	C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	ORPHANET
      151	ADRA2B	0.465	0.846	C1842852	EPILEPSY, MYOCLONIC, BENIGN ADULT FAMILIAL, TYPE 2	disease	C10	Disease or Syndrome	0.31	1	2001	2019	   1	   0	GENOMICS_ENGLAND
      151	ADRA2B	0.465	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.33	1	2007	2018	   1	   0	CTD_human
      151	ADRA2B	0.465	0.846	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40	1	2011	2011	   1	   0	CTD_human
      152	ADRA2C	0.682	0.346	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	1994	1994	   1	   0	PSYGENET
      152	ADRA2C	0.682	0.346	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      152	ADRA2C	0.682	0.346	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      152	ADRA2C	0.682	0.346	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.37	0.875	2002	2012	   1	   0	CTD_human
      152	ADRA2C	0.682	0.346	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.38	0.889	2002	2012	   1	   0	CTD_human
      152	ADRA2C	0.682	0.346	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      152	ADRA2C	0.682	0.346	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      152	ADRA2C	0.682	0.346	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	PSYGENET
      152	ADRA2C	0.682	0.346	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      152	ADRA2C	0.682	0.346	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      152	ADRA2C	0.682	0.346	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      152	ADRA2C	0.682	0.346	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C0005612	Birth Weight	phenotype	C23	Organism Attribute	0.40	1	2013	2019	   1	   1	CTD_human
      153	ADRB1	0.555	0.769	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.58	1	1998	2019	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.48	1	2001	2019	   1	   1	CTD_human
      153	ADRB1	0.555	0.769	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2008	2014	   2	   0	PSYGENET
      153	ADRB1	0.555	0.769	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2014	   2	   0	PSYGENET
      153	ADRB1	0.555	0.769	C0011849	Diabetes Mellitus	group	C18;C19	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.60	0.933	1991	2019	   5	   0	CTD_human
      153	ADRB1	0.555	0.769	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.60	0.94	1991	2019	   5	   0	CTD_human
      153	ADRB1	0.555	0.769	C0020452	Hyperemia	disease	C14	Disease or Syndrome	0.31	1	2006	2006	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.60	1	1993	2018	   2	   0	CTD_human
      153	ADRB1	0.555	0.769	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	1995	2010	   5	   0	CTD_human
      153	ADRB1	0.555	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.50	1	2000	2007	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.37	0.875	1997	2018	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C0042484	Venous Engorgement	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.32	1	1998	2017	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C0178824	Reactive Hyperemia	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	1995	2010	   5	   0	CTD_human
      153	ADRB1	0.555	0.769	C0242973	Ventricular Dysfunction	phenotype	C14	Pathologic Function	0.31	1	2003	2003	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C0333233	Active Hyperemia	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	0.5	2003	2006	   2	   0	PSYGENET
      153	ADRB1	0.555	0.769	C0553980	Endomyocardial Fibrosis	phenotype	C14	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.40	1	1998	2019	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      153	ADRB1	0.555	0.769	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	1995	2010	   5	   0	CTD_human
      153	ADRB1	0.555	0.769	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	1995	2010	   5	   0	CTD_human
      154	ADRB2	0.442	0.923	C0001849	AIDS Dementia Complex	disease	C01;C20;C10;F03	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.50	0.956	1993	2020	   0	   0	CTD_human
      154	ADRB2	0.442	0.923	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2010	2012	   1	   0	PSYGENET
      154	ADRB2	0.442	0.923	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.51	1	2002	2008	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0020473	Hyperlipidemia	disease	C18	Disease or Syndrome	0.31	1	2005	2017	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0020621	Hypokalemia	phenotype	C18	Finding	0.31	1	1987	2008	   3	   0	CTD_human
      154	ADRB2	0.442	0.923	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.50	1	2001	2008	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.33	1	2001	2020	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.34	1	2007	2019	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.50	0.884	1997	2019	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2008	2008	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0040822	Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0040827	Saturnine Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0149840	Senile Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.33	1	1998	2017	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0206019	HIV Encephalopathy	disease	C01;C20;C10;F03	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0234370	Persistent Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0234371	Continuous Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0234372	Intermittent Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0234373	Fine Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0234374	Coarse Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0234375	Massive Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0234376	Action Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0234377	Passive Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0234378	Static Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0234379	Resting Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0234381	Darkness Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0235078	Tremor, Perioral	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0235081	Tremor, Limb	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0235082	Tremor, Muscle	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0235083	Nerve Tremors	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0235843	Tremor, Neonatal	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0243010	Viral Encephalitis	group	C01;C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.35	1	2008	2019	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0751564	Pill Rolling Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0751565	Tremor, Semirhythmic	phenotype	C23;C10	Finding	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.31	1	2000	2014	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C0936243	HIV-1-Associated Cognitive Motor Complex	disease	C01;C20;C10;F03	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C1527384	Involuntary Quiver	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1997	   4	   0	CTD_human
      154	ADRB2	0.442	0.923	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.33	1	2006	2016	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C1706412	Lipidemias	phenotype	C18	Finding	0.30	1	2005	2005	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      154	ADRB2	0.442	0.923	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      155	ADRB3	0.533	0.731	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2007	2007	   1	   0	CTD_human
      155	ADRB3	0.533	0.731	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2007	2010	   1	   0	CTD_human
      155	ADRB3	0.533	0.731	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.52	1	2004	2017	   2	   0	CTD_human
      155	ADRB3	0.533	0.731	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.52	1	2004	2017	   2	   0	CTD_human
      155	ADRB3	0.533	0.731	C0020473	Hyperlipidemia	disease	C18	Disease or Syndrome	0.32	0.667	2001	2005	   1	   0	CTD_human
      155	ADRB3	0.533	0.731	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
      155	ADRB3	0.533	0.731	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.50	0.905	1995	2019	   0	   1	CTD_human
      155	ADRB3	0.533	0.731	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2007	2007	   1	   0	CTD_human
      155	ADRB3	0.533	0.731	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      155	ADRB3	0.533	0.731	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
      155	ADRB3	0.533	0.731	C1706412	Lipidemias	phenotype	C18	Finding	0.30	1	2005	2005	   1	   0	CTD_human
      155	ADRB3	0.533	0.731	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
      155	ADRB3	0.533	0.731	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2004	2007	   2	   0	CTD_human
      156	GRK2	0.532	0.654	C0000768	Congenital Abnormality	group	C16	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.34	1	1999	2019	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.34	1	2015	2019	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0012684	Blastocyst Disintegration	phenotype	C23;C13	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0013937	Embryo Resorption	phenotype	C23;C13	Organism Function	0.30	1	2006	2006	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2002	2002	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.60	0.98	1994	2020	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.60	0.98	1994	2020	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.55	1	2000	2019	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0162820	Dermatitis, Allergic Contact	disease	C17;C20	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0752350	Embryo Death	phenotype	C23;C13	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0752351	Embryo Loss	phenotype	C23;C13	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C1136082	Embryo Disintegration	phenotype	C23;C13	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      156	GRK2	0.532	0.654	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      156	GRK2	0.532	0.654	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
      157	GRK3	0.621	0.731	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.56	1	2003	2010	   6	   0	CTD_human;PSYGENET
      157	GRK3	0.621	0.731	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      157	GRK3	0.621	0.731	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      157	GRK3	0.621	0.731	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2003	2003	   1	   0	CTD_human
      158	ADSL	0.631	0.654	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.43	1	1989	2004	   1	   0	CTD_human
      158	ADSL	0.631	0.654	C0268126	Adenylosuccinate lyase deficiency (disorder)	disease	C16;C18;F03	Disease or Syndrome	0.79	1	1992	2017	  11	  25	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      158	ADSL	0.631	0.654	C0543888	Epileptic encephalopathy	disease	C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      158	ADSL	0.631	0.654	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.41	1	1992	2016	   1	   0	GENOMICS_ENGLAND
      158	ADSL	0.631	0.654	C4721811	Adenylosuccinate lyase deficiency type 1	disease	C16;C18;F03	Disease or Syndrome	0.30	1	2000	2003	   3	   0	CTD_human
      158	ADSL	0.631	0.654	C4721812	Adenylosuccinate lyase deficiency type 4	disease	C16;C18;F03	Disease or Syndrome	0.30	1	2000	2003	   3	   0	CTD_human
      158	ADSL	0.631	0.654	C4721813	Adenylosuccinate lyase deficiency type 3	disease	C16;C18;F03	Disease or Syndrome	0.30	1	2000	2003	   3	   0	CTD_human
      158	ADSL	0.631	0.654	C4721814	Adenylosuccinate lyase deficiency type 2	disease	C16;C18;F03	Disease or Syndrome	0.30	1	2000	2003	   3	   0	CTD_human
      159	ADSS2	0.839	0.308	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	PSYGENET
      162	AP1B1	0.716	0.385	C0015544	Failure to Thrive	disease	C23	Disease or Syndrome	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      162	AP1B1	0.716	0.385	C0037268	Skin Abnormalities	group	C16;C17	Congenital Abnormality	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      162	AP1B1	0.716	0.385	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      162	AP1B1	0.716	0.385	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      162	AP1B1	0.716	0.385	C4023689	Abnormality of copper homeostasis	phenotype		Finding	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      162	AP1B1	0.716	0.385	C4025860	Hearing abnormality	disease		Finding	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      163	AP2B1	0.711	0.423	C0086132	Depressive Symptoms	phenotype	F01	Sign or Symptom	0.31	1	2009	2009	   1	   0	PSYGENET
      165	AEBP1	0.631	0.654	C4693870	EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2	disease		Disease or Syndrome	0.40	1	2018	2019	   1	   5	ORPHANET
      166	TLE5	0.695	0.538	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      173	AFM	0.59	0.731	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2017	2017	   1	   0	CTD_human
      173	AFM	0.59	0.731	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      173	AFM	0.59	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      173	AFM	0.59	0.731	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
      173	AFM	0.59	0.731	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      173	AFM	0.59	0.731	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2017	2017	   1	   0	CTD_human
      174	AFP	0.429	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.32	1	1996	2008	   1	   0	CTD_human
      174	AFP	0.429	0.885	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      174	AFP	0.429	0.885	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      174	AFP	0.429	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
      174	AFP	0.429	0.885	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.40	0.966	1981	2019	   1	   0	CTD_human
      174	AFP	0.429	0.885	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      174	AFP	0.429	0.885	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.40	1	2001	2019	   1	   0	CTD_human
      174	AFP	0.429	0.885	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      174	AFP	0.429	0.885	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      174	AFP	0.429	0.885	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      174	AFP	0.429	0.885	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2006	2006	   1	   0	CTD_human
      174	AFP	0.429	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.32	1	1996	2008	   1	   0	CTD_human
      174	AFP	0.429	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      174	AFP	0.429	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      174	AFP	0.429	0.885	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      174	AFP	0.429	0.885	C1863080	ALPHA-FETOPROTEIN, HEREDITARY PERSISTENCE OF	phenotype		Finding	0.40	1	1993	1993	   1	   1	ORPHANET
      174	AFP	0.429	0.885	C1863081	alpha-Fetoprotein Deficiency	disease	C16;C18	Disease or Syndrome	0.60	1	2004	2004	   1	   2	CTD_human;ORPHANET
      174	AFP	0.429	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.972	1977	2020	   4	   0	CTD_human
      174	AFP	0.429	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      175	AGA	0.57	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.35	1	2006	2019	   1	   0	PSYGENET
      175	AGA	0.57	0.808	C0268225	Aspartylglucosaminuria	phenotype	C16;C18	Disease or Syndrome	1.00	0.96	1990	2019	   7	  52	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      175	AGA	0.57	0.808	C2931840	Aspartylglucosamidase (AGA) deficiency	disease	C16;C18	Disease or Syndrome	0.30	1	2001	2001	   1	   0	ORPHANET
      176	ACAN	0.528	0.846	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.40	1	1998	2019	   1	   0	CTD_human
      176	ACAN	0.528	0.846	C0004681	Bagassosis	disease	C08;C24	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      176	ACAN	0.528	0.846	C0032273	Pneumoconiosis	disease	C08;C24	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      176	ACAN	0.528	0.846	C0238288	Muscular Dystrophy, Facioscapulohumeral	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      176	ACAN	0.528	0.846	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
      176	ACAN	0.528	0.846	C1842149	Spondyloepiphyseal Dysplasia, Kimberley Type	disease	C16;C05	Congenital Abnormality	0.61	1	2005	2017	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
      176	ACAN	0.528	0.846	C2748544	Spondyloepimetaphyseal Dysplasia, Aggrecan Type	disease	C16;C05	Disease or Syndrome	0.70	1	2009	2017	   2	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      176	ACAN	0.528	0.846	C3665488	Familial Osteochondritis Dissecans	disease	C05	Disease or Syndrome	0.61	1	2010	2017	   3	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      177	AGER	0.42	0.885	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.47	1	2002	2014	   1	   3	CTD_human
      177	AGER	0.42	0.885	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.60	0.974	1999	2019	   2	   0	CTD_human
      177	AGER	0.42	0.885	C0011875	Diabetic Angiopathies	disease	C19;C14	Disease or Syndrome	0.40	1	2001	2018	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.50	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0020456	Hyperglycemia	disease	C18	Disease or Syndrome	0.40	1	2009	2019	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0020564	Hypertrophy	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.31	1	2004	2012	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0025945	Microangiopathy, Diabetic	disease	C19;C14	Disease or Syndrome	0.32	1	2008	2010	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0027796	Neuralgia	phenotype	C23;C10	Sign or Symptom	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.40	1	2005	2019	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0030286	Pancreatic Diseases	group	C06	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0034067	Pulmonary Emphysema	disease	C08	Disease or Syndrome	0.32	1	2013	2019	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2012	2018	   1	   0	PSYGENET
      177	AGER	0.42	0.885	C0038870	Neuralgia, Supraorbital	phenotype	C23;C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0042656	Neuralgia, Vidian	phenotype	C23;C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0221227	Centriacinar Emphysema	disease	C08	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0234247	Neuralgia, Atypical	phenotype	C23;C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0234249	Neuralgia, Stump	phenotype	C23;C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0264393	Panacinar Emphysema	disease	C08	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0423711	Neuralgia, Perineal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0423712	Neuralgia, Iliohypogastric Nerve	phenotype	C23;C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0751371	Neuralgia, Ilioinguinal	phenotype	C23;C10	Sign or Symptom	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0751372	Nerve Pain	phenotype	C23;C10	Sign or Symptom	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0751373	Paroxysmal Nerve Pain	phenotype	C23;C10	Sign or Symptom	0.30	1	2014	2014	   1	   0	CTD_human
      177	AGER	0.42	0.885	C0752347	Lewy Body Disease	disease	C10;F03	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      177	AGER	0.42	0.885	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2009	2010	   2	   0	CTD_human
      177	AGER	0.42	0.885	C1855520	Hyperglycemia, Postprandial	phenotype	C18	Finding	0.30	1	2013	2013	   1	   0	CTD_human
      177	AGER	0.42	0.885	C2350878	Focal Emphysema	disease	C08	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      177	AGER	0.42	0.885	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.32	1	2014	2018	   1	   0	CTD_human
      177	AGER	0.42	0.885	C4721610	Carcinoma, Ovarian Epithelial	disease	C04;C13;C19	Neoplastic Process	0.32	1	2013	2017	   1	   0	CTD_human
      178	AGL	0.644	0.615	C0017919	Glycogen Storage Disease	group	C16;C18	Disease or Syndrome	0.43	1	1996	2016	   1	   1	GENOMICS_ENGLAND
      178	AGL	0.644	0.615	C0017922	Glycogen Storage Disease Type III	disease	C16;C18	Disease or Syndrome	1.00	0.988	1987	2020	   8	 124	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      178	AGL	0.644	0.615	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      178	AGL	0.644	0.615	C0369183	Erythrocyte Mean Corpuscular Hemoglobin Test	phenotype		Laboratory Procedure	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      178	AGL	0.644	0.615	C1261502	Finding of Mean Corpuscular Hemoglobin	phenotype		Finding	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      178	AGL	0.644	0.615	C2936915	Amylo-1,6-glucosidase deficiency	disease	C16;C18	Disease or Syndrome	0.30	1	1999	2007	   2	   0	ORPHANET
      181	AGRP	0.488	0.769	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.70	0.938	1997	2019	   0	   0	CTD_human
      182	JAG1	0.429	0.808	C0005940	Bone Diseases	group	C05	Disease or Syndrome	0.31	1	1997	2016	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.96	2004	2019	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0010038	Corneal Opacity	phenotype	C11	Finding	0.30	1	2002	2002	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0011052	Prelingual Deafness	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0011053	Deafness	phenotype	C23;C10;C09	Finding	0.31	1	2002	2002	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0015393	Eye Abnormalities	group	C16;C11	Congenital Abnormality	0.30	1	1997	2002	   3	   0	CTD_human
      182	JAG1	0.429	0.808	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.34	1	2010	2018	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0018798	Congenital Heart Defects	group	C16;C14	Congenital Abnormality	0.43	0.857	1997	2013	   1	   1	CTD_human
      182	JAG1	0.429	0.808	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0026654	Moyamoya Disease	disease	C10;C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
      182	JAG1	0.429	0.808	C0036095	Salivary Gland Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
      182	JAG1	0.429	0.808	C0039685	Tetralogy of Fallot	disease	C16;C14	Congenital Abnormality	0.80	1	1999	2018	   3	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      182	JAG1	0.429	0.808	C0085280	Alagille Syndrome	disease	C16;C06;C14	Congenital Abnormality	0.90	0.952	1997	2019	   5	   3	CTD_human;GENOMICS_ENGLAND
      182	JAG1	0.429	0.808	C0086395	Hearing Loss, Extreme	phenotype	C23;C10;C09	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0220636	Malignant neoplasm of salivary gland	disease	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.33	1	2007	2018	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0282631	Facies	group	C23	Organism Attribute	0.30	1	1997	1997	   2	   0	CTD_human
      182	JAG1	0.429	0.808	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0581883	Complete Hearing Loss	phenotype	C23;C10;C09	Finding	0.30	1	2002	2002	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.957	2004	2019	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0751068	Deafness, Acquired	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C0887833	Carcinoma, Pancreatic Ductal	disease	C06;C04;C19	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.34	1	2007	2014	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.34	1	2010	2018	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C1857761	Alagille Syndrome 2	disease	C16;C06;C14	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      182	JAG1	0.429	0.808	C1866053	Deafness, Congenital Heart Defects, and Posterior Embryotoxon	disease	C23;C16;C10;C09;C14	Disease or Syndrome	0.60	1	2002	2010	   2	   2	GENOMICS_ENGLAND;UNIPROT
      182	JAG1	0.429	0.808	C1956125	Alagille Syndrome 1	disease	C16;C06;C14	Disease or Syndrome	0.71	1	1997	2016	  19	  48	CTD_human;GENOMICS_ENGLAND;UNIPROT
      182	JAG1	0.429	0.808	C2930797	Hepatic ductular hypoplasia	disease	C16;C06;C14	Disease or Syndrome	0.31	1	1997	2011	   3	   0	CTD_human
      182	JAG1	0.429	0.808	C3665473	Bilateral Deafness	phenotype	C23;C10;C09	Finding	0.30	1	2002	2002	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C4082305	Deaf Mutism	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      182	JAG1	0.429	0.808	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      183	AGT	0.367	0.923	C0001925	Albuminuria	phenotype	C23;C13;C12	Finding	0.30	1	2002	2011	   3	   0	CTD_human
      183	AGT	0.367	0.923	C0002063	Alkalosis	phenotype	C18	Disease or Syndrome	0.30	1	1982	1982	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2008	   3	   0	CTD_human
      183	AGT	0.367	0.923	C0002871	Anemia	disease	C15	Disease or Syndrome	0.31	1	1986	2019	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0002949	Aneurysm, Dissecting	disease	C14	Disease or Syndrome	0.32	1	2007	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0003460	Anuria	phenotype	C13;C12	Disease or Syndrome	0.40	1	1995	1995	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0003486	Aortic Aneurysm	disease	C14	Disease or Syndrome	0.40	1	2011	2019	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0003811	Cardiac Arrhythmia	phenotype	C23;C14	Disease or Syndrome	0.33	1	1989	2018	   2	   0	CTD_human
      183	AGT	0.367	0.923	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.60	1	1998	2019	   2	   0	CTD_human
      183	AGT	0.367	0.923	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2000	2008	   2	   0	PSYGENET
      183	AGT	0.367	0.923	C0007192	Cardiomyopathy, Alcoholic	disease	C25;C14	Disease or Syndrome	0.31	1	2012	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.40	0.976	1995	2020	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0007273	Carotid Artery Diseases	group	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0007370	Catalepsy	disease	C23;C10	Mental or Behavioral Dysfunction	0.30	1	1977	1977	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0009241	Cognition Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0011071	Sudden death	phenotype	C23	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.33	1	2005	2014	   5	   0	PSYGENET
      183	AGT	0.367	0.923	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2005	2014	   5	   0	PSYGENET
      183	AGT	0.367	0.923	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2008	   3	   0	CTD_human
      183	AGT	0.367	0.923	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.40	0.929	1996	2020	   2	   0	CTD_human
      183	AGT	0.367	0.923	C0011884	Diabetic Retinopathy	disease	C11;C19;C14	Disease or Syndrome	0.58	1	2000	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0015934	Fetal Growth Retardation	phenotype	C23;C16;C13	Disease or Syndrome	0.60	1	1998	2019	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.51	1	2002	2015	   5	   0	CTD_human
      183	AGT	0.367	0.923	C0017658	Glomerulonephritis	disease	C13;C12	Disease or Syndrome	0.55	1	1999	2019	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0017661	IGA Glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.40	0.957	1995	2020	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0017667	Nodular glomerulosclerosis	disease	C13;C12;C19	Disease or Syndrome	0.31	1	2008	2016	   2	   0	CTD_human
      183	AGT	0.367	0.923	C0017668	Focal glomerulosclerosis	disease	C13;C12	Disease or Syndrome	0.54	0.833	1998	2011	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.37	1	1998	2019	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.50	1	2001	2019	  21	   0	CTD_human
      183	AGT	0.367	0.923	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.60	0.989	1992	2020	   3	   0	CTD_human
      183	AGT	0.367	0.923	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.60	0.991	1992	2020	   3	   0	CTD_human
      183	AGT	0.367	0.923	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2018	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0019284	Diaphragmatic Hernia	phenotype	C23	Disease or Syndrome	0.31	1	2004	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	1998	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0020452	Hyperemia	disease	C14	Disease or Syndrome	0.30	1	1990	1990	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.60	0.971	1979	2020	  77	   0	CTD_human
      183	AGT	0.367	0.923	C0020540	Malignant Hypertension	disease	C14	Disease or Syndrome	0.37	1	1989	2017	   2	   0	CTD_human
      183	AGT	0.367	0.923	C0020544	Renal hypertension	disease	C13;C12;C14	Disease or Syndrome	0.32	1	1996	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0020564	Hypertrophy	phenotype	C23	Pathologic Function	0.30	1	2002	2015	   6	   0	CTD_human
      183	AGT	0.367	0.923	C0020621	Hypokalemia	phenotype	C18	Finding	0.30	1	1982	1982	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0020649	Hypotension	phenotype	C14	Finding	0.40	1	1988	1997	   3	   0	CTD_human
      183	AGT	0.367	0.923	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2005	2018	   4	   0	CTD_human
      183	AGT	0.367	0.923	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.40	0.941	1995	2019	   5	   0	CTD_human
      183	AGT	0.367	0.923	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	1992	2010	   3	   0	CTD_human
      183	AGT	0.367	0.923	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.56	1	2005	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2003	2003	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.60	0.955	1991	2020	   2	   0	CTD_human
      183	AGT	0.367	0.923	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.30	1	1989	2009	   2	   0	CTD_human
      183	AGT	0.367	0.923	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	1992	2002	   2	   0	CTD_human
      183	AGT	0.367	0.923	C0027720	Nephrosis	disease	C13;C12	Disease or Syndrome	0.30	1	1991	1991	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0029944	Drug Overdose	disease	C25	Injury or Poisoning	0.30	1	1995	1995	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0030922	Peptic Ulcer Hemorrhage	phenotype	C23;C06	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.32	1	2018	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0032914	Pre-Eclampsia	phenotype	C13	Pathologic Function	0.35	1	1993	2008	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.30	1	1979	2015	   6	   0	CTD_human
      183	AGT	0.367	0.923	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.55	1	2007	2019	   2	   0	CTD_human
      183	AGT	0.367	0.923	C0035078	Kidney Failure	disease	C13;C12	Disease or Syndrome	0.38	1	1997	2015	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0035344	Retinopathy of Prematurity	disease	C16;C11	Disease or Syndrome	0.32	1	2004	2017	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.31	1	2006	2008	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2008	   3	   0	CTD_human
      183	AGT	0.367	0.923	C0040053	Thrombosis	phenotype	C14	Pathologic Function	0.30	1	2000	2011	   2	   0	CTD_human
      183	AGT	0.367	0.923	C0041956	Ureteral obstruction	phenotype	C13;C12	Disease or Syndrome	0.34	1	2012	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0042484	Venous Engorgement	phenotype	C14	Pathologic Function	0.30	1	1990	1990	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0085580	Essential Hypertension	disease	C14	Disease or Syndrome	0.60	0.932	1988	2020	   1	   0	CTD_human;GENOMICS_ENGLAND
      183	AGT	0.367	0.923	C0086432	Hyalinosis, Segmental Glomerular	disease	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0087086	Thrombus	phenotype	C14	Pathologic Function	0.30	1	2000	2011	   2	   0	CTD_human
      183	AGT	0.367	0.923	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.40	1	1992	2019	   7	   0	CTD_human
      183	AGT	0.367	0.923	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.40	1	1997	2017	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0162871	Aortic Aneurysm, Abdominal	disease	C14	Disease or Syndrome	0.40	0.985	2005	2020	   4	   0	CTD_human
      183	AGT	0.367	0.923	C0178824	Reactive Hyperemia	phenotype	C14	Pathologic Function	0.30	1	1990	1990	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0233612	Waxy flexibility	phenotype	C23;C10	Sign or Symptom	0.30	1	1977	1977	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.31	1	1992	2019	   3	   0	CTD_human
      183	AGT	0.367	0.923	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.37	1	2003	2019	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	2014	2019	   3	   0	CTD_human
      183	AGT	0.367	0.923	C0243050	Cardiovascular Abnormalities	group	C16;C14	Congenital Abnormality	0.31	1	2000	2015	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0266313	Allanson Pantzar McLeod syndrome	disease	C16;C13;C12	Disease or Syndrome	0.71	1	2005	2015	   4	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      183	AGT	0.367	0.923	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0271650	Impaired glucose tolerance	phenotype	C18	Disease or Syndrome	0.31	1	2016	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0333233	Active Hyperemia	phenotype	C14	Pathologic Function	0.30	1	1990	1990	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0340643	Dissection of aorta	disease	C14	Disease or Syndrome	0.37	1	2007	2019	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0428977	Bradycardia	phenotype	C23;C14	Finding	0.30	1	1998	1998	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	1998	1998	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0553980	Endomyocardial Fibrosis	phenotype	C14	Pathologic Function	0.30	1	2010	2019	   5	   0	CTD_human
      183	AGT	0.367	0.923	C0577631	Carotid Atherosclerosis	disease	C10;C14	Disease or Syndrome	0.35	1	1998	2007	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0600178	External Carotid Artery Diseases	group	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0600519	Ventricular Remodeling	phenotype	C23	Organ or Tissue Function	0.30	1	2018	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0600520	Left Ventricle Remodeling	phenotype	C23	Organ or Tissue Function	0.30	1	2018	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0750986	Internal Carotid Artery Diseases	group	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0750987	Arterial Diseases, Common Carotid	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	1998	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	1998	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	1998	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	1998	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0853897	Diabetic Cardiomyopathies	disease	C19;C14	Disease or Syndrome	0.33	1	2013	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.40	0.909	1995	2019	   1	   0	CTD_human
      183	AGT	0.367	0.923	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2018	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2001	2019	  21	   0	CTD_human
      183	AGT	0.367	0.923	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2011	2012	   2	   0	CTD_human
      183	AGT	0.367	0.923	C1565489	Renal Insufficiency	disease	C13;C12	Disease or Syndrome	0.40	1	1997	2019	   1	   0	CTD_human
      183	AGT	0.367	0.923	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.33	1	2002	2018	   5	   0	CTD_human
      183	AGT	0.367	0.923	C1704377	Bright Disease	disease	C13;C12	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      183	AGT	0.367	0.923	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	1992	2010	   3	   0	CTD_human
      183	AGT	0.367	0.923	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	1992	2010	   3	   0	CTD_human
      183	AGT	0.367	0.923	C2678367	Renal Tubular Dysgenesis With Choanal Atresia And Athelia	disease	C16;C08;C09	Disease or Syndrome	0.30	1	2005	2012	   2	   0	ORPHANET
      183	AGT	0.367	0.923	C2936380	Neointima	disease	C23	Acquired Abnormality	0.30	1	2009	2018	   2	   0	CTD_human
      183	AGT	0.367	0.923	C2936381	Neointima Formation	phenotype	C23	Pathologic Function	0.30	1	2009	2018	   2	   0	CTD_human
      183	AGT	0.367	0.923	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	1998	   1	   0	CTD_human
      183	AGT	0.367	0.923	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.31	1	2018	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C3850148	Vascular Remodeling	phenotype	C23	Organ or Tissue Function	0.30	1	2014	2016	   2	   0	CTD_human
      183	AGT	0.367	0.923	C3852953	Pulmonary Arterial Remodeling	phenotype	C23	Organ or Tissue Function	0.30	1	2014	2016	   2	   0	CTD_human
      183	AGT	0.367	0.923	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C4277533	Dissection, Blood Vessel	phenotype	C14	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
      183	AGT	0.367	0.923	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      183	AGT	0.367	0.923	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      183	AGT	0.367	0.923	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2018	2019	   2	   0	CTD_human
      185	AGTR1	0.423	0.846	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.31	1	2004	2008	   1	   0	CTD_human
      185	AGTR1	0.423	0.846	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      185	AGTR1	0.423	0.846	C0011884	Diabetic Retinopathy	disease	C11;C19;C14	Disease or Syndrome	0.32	1	2002	2006	   1	   0	CTD_human
      185	AGTR1	0.423	0.846	C0013274	Patent ductus arteriosus	disease	C16;C14	Congenital Abnormality	0.35	1	2003	2016	   2	   0	CTD_human
      185	AGTR1	0.423	0.846	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.60	0.963	1997	2019	   3	   0	CTD_human
      185	AGTR1	0.423	0.846	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.60	0.971	1997	2019	   3	   0	CTD_human
      185	AGTR1	0.423	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.60	0.944	1993	2020	   4	   0	CTD_human
      185	AGTR1	0.423	0.846	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.60	0.95	1997	2018	   1	   0	CTD_human
      185	AGTR1	0.423	0.846	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2007	2008	   3	   0	CTD_human
      185	AGTR1	0.423	0.846	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.33	1	2007	2019	   1	   0	CTD_human
      185	AGTR1	0.423	0.846	C0032000	Pituitary Adenoma	disease	C04;C10;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      185	AGTR1	0.423	0.846	C0032019	Pituitary Neoplasms	group	C04;C10;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      185	AGTR1	0.423	0.846	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.50	1	2006	2010	   1	   0	CTD_human
      185	AGTR1	0.423	0.846	C0085580	Essential Hypertension	disease	C14	Disease or Syndrome	0.60	0.941	1994	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
      185	AGTR1	0.423	0.846	C0162871	Aortic Aneurysm, Abdominal	disease	C14	Disease or Syndrome	0.39	1	2005	2019	   1	   0	CTD_human
      185	AGTR1	0.423	0.846	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.31	1	2007	2018	   3	   0	CTD_human
      185	AGTR1	0.423	0.846	C0266313	Allanson Pantzar McLeod syndrome	disease	C16;C13;C12	Disease or Syndrome	0.70	1	2005	2015	   3	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      185	AGTR1	0.423	0.846	C0346300	Pituitary carcinoma	disease	C04;C10;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      185	AGTR1	0.423	0.846	C0887833	Carcinoma, Pancreatic Ductal	disease	C06;C04;C19	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      185	AGTR1	0.423	0.846	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2007	2008	   3	   0	CTD_human
      185	AGTR1	0.423	0.846	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2007	2008	   3	   0	CTD_human
      185	AGTR1	0.423	0.846	C2678367	Renal Tubular Dysgenesis With Choanal Atresia And Athelia	disease	C16;C08;C09	Disease or Syndrome	0.30	1	2005	2012	   2	   0	ORPHANET
      185	AGTR1	0.423	0.846	C2936170	Patent Ductus Arteriosus Familial	disease	C16;C14	Congenital Abnormality	0.30	1	2003	2009	   2	   0	CTD_human
      185	AGTR1	0.423	0.846	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      185	AGTR1	0.423	0.846	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      186	AGTR2	0.496	0.808	C0010093	Corpus Luteum Cyst	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      186	AGTR2	0.496	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.60	1	2001	2019	   1	   0	CTD_human
      186	AGTR2	0.496	0.808	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      186	AGTR2	0.496	0.808	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1993	1993	   1	   0	CTD_human
      186	AGTR2	0.496	0.808	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      186	AGTR2	0.496	0.808	C0029927	Ovarian Cysts	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      186	AGTR2	0.496	0.808	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      186	AGTR2	0.496	0.808	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.36	1	2002	2013	   1	   0	CTD_human
      186	AGTR2	0.496	0.808	C0206692	Carcinoma, Lobular	disease	C04;C17	Neoplastic Process	0.30	1	1993	1993	   1	   0	CTD_human
      186	AGTR2	0.496	0.808	C0853897	Diabetic Cardiomyopathies	disease	C19;C14	Disease or Syndrome	0.30	1	2004	2005	   2	   0	CTD_human
      186	AGTR2	0.496	0.808	C1136249	Mental Retardation, X-Linked	disease	C16;C10	Disease or Syndrome	0.32	1	2002	2005	   1	   0	CTD_human
      186	AGTR2	0.496	0.808	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      186	AGTR2	0.496	0.808	C2931498	Mental Retardation, X-Linked 1	disease	C16;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	ORPHANET
      186	AGTR2	0.496	0.808	C3275444	MENTAL RETARDATION, X-LINKED 88 (disorder)	disease		Disease or Syndrome	0.30	1	2013	2013	   1	   0	GENOMICS_ENGLAND
      186	AGTR2	0.496	0.808	C3501611	Mental Retardation, X-Linked Nonsyndromic	disease	C16;C10	Disease or Syndrome	0.30	1	2002	2013	   5	   0	CLINGEN
      189	AGXT	0.593	0.731	C0020500	Hyperoxaluria	disease	C13;C12	Disease or Syndrome	0.48	1	2000	2018	   0	   0	GENOMICS_ENGLAND
      189	AGXT	0.593	0.731	C0020501	Primary Hyperoxaluria	disease	C16;C18;C13;C12	Disease or Syndrome	0.50	0.964	1990	2019	   0	   6	GENOMICS_ENGLAND
      189	AGXT	0.593	0.731	C0268164	Primary hyperoxaluria, type I	disease	C16;C18;C13;C12	Disease or Syndrome	0.80	1	1973	2019	  27	 166	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      190	NR0B1	0.494	0.808	C0020619	Hypogonadism	disease	C19	Disease or Syndrome	0.37	1	1994	2017	   1	   0	CTD_human
      190	NR0B1	0.494	0.808	C0028960	Oligospermia	disease	C12	Disease or Syndrome	0.42	1	2006	2013	   1	   0	CTD_human
      190	NR0B1	0.494	0.808	C0220766	Congenital hypoplasia of adrenal gland	disease	C16;C19	Congenital Abnormality	0.40	1	1994	2019	   1	   0	GENOMICS_ENGLAND
      190	NR0B1	0.494	0.808	C0271623	Hypogonadotropic hypogonadism	disease	C19	Disease or Syndrome	0.50	0.972	1994	2019	   1	   0	CTD_human
      190	NR0B1	0.494	0.808	C0342482	X-linked Adrenal Hypoplasia	disease	C19	Disease or Syndrome	1.00	1	1994	2019	  19	  58	CTD_human;GENOMICS_ENGLAND;UNIPROT
      190	NR0B1	0.494	0.808	C0432475	XX males	disease	C16	Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
      190	NR0B1	0.494	0.808	C0795887	Complex Glycerol Kinase Deficiency	disease	C19	Disease or Syndrome	0.33	1	1994	2018	   2	   0	CTD_human
      190	NR0B1	0.494	0.808	C0948896	Primary hypogonadism	disease	C19	Disease or Syndrome	0.40	1	1994	1994	   1	   0	CTD_human
      190	NR0B1	0.494	0.808	C1848296	DOSAGE-SENSITIVE SEX REVERSAL	disease	C16;C13;C12;C19	Disease or Syndrome	0.70	0.972	1997	2019	   1	   6	CTD_human;GENOMICS_ENGLAND
      190	NR0B1	0.494	0.808	C1868690	Hypoadrenocorticism, familial	disease	C19	Disease or Syndrome	0.30	1	1994	2003	   2	   0	CTD_human
      190	NR0B1	0.494	0.808	C2936419	46, XX Testicular Disorders of Sex Development	disease	C16;C13;C12;C19	Congenital Abnormality	0.31	1	2013	2017	   1	   0	ORPHANET
      190	NR0B1	0.494	0.808	C3489396	Hypogonadism, Isolated Hypogonadotropic	disease	C19	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
      190	NR0B1	0.494	0.808	C4505291	Xp21 Contiguous Gene Deletion Syndrome	disease	C19	Disease or Syndrome	0.30	1	1994	2003	   2	   0	CTD_human
      190	NR0B1	0.494	0.808	C4510744	46,XY partial gonadal dysgenesis	disease		Disease or Syndrome	0.30	1	2008	2008	   1	   0	ORPHANET
      191	AHCY	0.582	0.692	C0002514	Amino Acid Metabolism, Inborn Errors	group	C16;C18	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      191	AHCY	0.582	0.692	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      191	AHCY	0.582	0.692	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      191	AHCY	0.582	0.692	C0019202	Hepatolenticular Degeneration	disease	C16;C06;C18;C10	Disease or Syndrome	0.32	1	2013	2018	   1	   0	CTD_human
      191	AHCY	0.582	0.692	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      191	AHCY	0.582	0.692	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      191	AHCY	0.582	0.692	C0268621	Hepatic methionine adenosyltransferase deficiency	disease	C16;C18	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      191	AHCY	0.582	0.692	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      191	AHCY	0.582	0.692	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2009	2009	   1	   0	CTD_human
      191	AHCY	0.582	0.692	C0750905	Amino Acid Metabolism, Inherited Disorders	disease	C16;C18	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      191	AHCY	0.582	0.692	C1527352	Hepatic Form of Wilson Disease	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      191	AHCY	0.582	0.692	C1847720	Hypermethioninemia due to deficiency of glycine N-methyltransferase	disease	C16;C18	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      191	AHCY	0.582	0.692	C3151058	S-adenosylhomocysteine hydrolase deficiency	disease	C16;C18	Disease or Syndrome	0.70	1	1959	2018	  13	   5	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      191	AHCY	0.582	0.692	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.31	1	2018	2018	   1	   0	CTD_human
      191	AHCY	0.582	0.692	C4048705	Hypermethioninemia	phenotype	C16;C18	Disease or Syndrome	0.40	1	2016	2016	   1	   0	CTD_human
      191	AHCY	0.582	0.692	C4510276	Psychomotor retardation due to S-adenosylhomocysteine hydrolase deficiency	phenotype	C23;C16;C18;C10;F03;F01	Disease or Syndrome	0.30	1	1959	2018	  10	   0	CLINGEN
      196	AHR	0.41	0.923	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0003865	Arthritis, Adjuvant-Induced	disease	C05	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.40	0.929	2008	2020	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.35	1	2004	2019	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0004943	Behcet Syndrome	disease	C16;C11;C17;C07;C14	Disease or Syndrome	0.32	1	2014	2017	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0005612	Birth Weight	phenotype	C23	Organism Attribute	0.30	1	2016	2016	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0005683	Urinary Bladder Calculi (disorder)	disease	C23;C13;C12	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0005974	Bone Resorption	phenotype	C05	Organ or Tissue Function	0.30	1	2010	2010	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.952	1993	2019	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.952	1991	2020	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0009319	Colitis	disease	C06	Disease or Syndrome	0.40	1	2010	2019	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0018273	Growth Disorders	group	C23	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0018798	Congenital Heart Defects	group	C16;C14	Congenital Abnormality	0.32	1	2009	2020	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2016	2017	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.36	1	2008	2019	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0020564	Hypertrophy	phenotype	C23	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0020578	Hyperventilation	phenotype	C23;C08	Finding	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.34	1	2004	2019	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.31	1	2005	2015	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.31	1	2018	2019	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	1996	2011	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.40	1	1994	2019	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.36	0.857	2002	2018	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0025517	Metabolic Diseases	group	C18	Disease or Syndrome	0.35	1	2015	2020	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2015	2015	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2015	2017	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	0.941	2010	2019	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0027651	Neoplasms	group	C04	Neoplastic Process	0.40	0.967	2000	2020	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1998	1998	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0028043	Nicotine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.45	1	2015	2019	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2002	2015	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.33	1	2008	2019	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2010	2017	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.31	1	2018	2018	   1	   0	ORPHANET
      196	AHR	0.41	0.923	C0037116	Silicosis	disease	C08;C24	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0037997	Splenic Diseases	group	C15	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0038002	Splenomegaly	phenotype	C23	Finding	0.30	1	1996	1996	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2002	2006	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0039231	Tachycardia	phenotype	C23;C14	Finding	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0040332	Tobacco Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0041955	Ureteral Neoplasms	group	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0042373	Vascular Diseases	group	C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2016	2019	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0080203	Tachyarrhythmia	phenotype	C23;C14	Finding	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	1996	2011	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.31	1	2003	2019	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.40	1	1999	2018	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0153619	Malignant neoplasm of ureter	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0162834	Hyperpigmentation	phenotype	C17	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0236811	Chronobiology Disorders	group	C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.32	1	2014	2019	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0242339	Dyslipidemias	group	C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0242706	Hyperoxia	phenotype	C23	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0273115	Lung Injury	disease	C08;C26	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0333641	Atrophic	phenotype	C23	Pathologic Function	0.30	1	1994	2011	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.34	1	2008	2019	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.32	1	2002	2019	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	1	2002	2018	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0376384	Nicotine Use Disorder	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.33	1	2017	2020	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0559470	Allergy to peanuts	phenotype	C20	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0598784	Dyslipoproteinemias	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.952	1993	2019	   2	   0	CTD_human
      196	AHR	0.41	0.923	C0700501	Congenital nystagmus	disease	C16;C11;C10	Congenital Abnormality	0.50	1	1997	2013	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0813142	Circadian Rhythm Disorders	disease	C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0848676	Subfertility, Male	phenotype	C12	Sign or Symptom	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.31	1	2011	2017	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0887800	Psychogenic Inversion of Circadian Rhythm	disease	C10	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0917731	Male sterility	phenotype	C12	Finding	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0971858	Arthritis, Collagen-Induced	disease	C05	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      196	AHR	0.41	0.923	C0993582	Arthritis, Experimental	disease	C05	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      196	AHR	0.41	0.923	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   2	   0	CTD_human
      196	AHR	0.41	0.923	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      196	AHR	0.41	0.923	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.39	1	2000	2018	   2	   0	CTD_human
      196	AHR	0.41	0.923	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      196	AHR	0.41	0.923	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      196	AHR	0.41	0.923	C2350344	Chronic Lung Injury	disease	C08;C26	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      196	AHR	0.41	0.923	C2673809	Infantile nystagmus	phenotype		Finding	0.30	1	2013	2013	   1	   0	GENOMICS_ENGLAND
      196	AHR	0.41	0.923	C2931037	Pancreatic cancer, adult	disease	C06;C04;C19	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      196	AHR	0.41	0.923	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.31	1	2018	2019	   1	   0	CTD_human
      196	AHR	0.41	0.923	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.33	1	2008	2019	   1	   0	CTD_human
      196	AHR	0.41	0.923	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2016	2016	   1	   0	CTD_human
      196	AHR	0.41	0.923	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      196	AHR	0.41	0.923	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.31	1	2016	2017	   1	   0	CTD_human
      196	AHR	0.41	0.923	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   2	   0	CTD_human
      197	AHSG	0.506	0.846	C0006663	Calcinosis	phenotype	C18	Pathologic Function	0.31	1	2002	2005	   1	   0	CTD_human
      197	AHSG	0.506	0.846	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2017	2017	   1	   0	CTD_human
      197	AHSG	0.506	0.846	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      197	AHSG	0.506	0.846	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
      197	AHSG	0.506	0.846	C0263628	Tumoral calcinosis	disease	C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      197	AHSG	0.506	0.846	C0521174	Microcalcification	phenotype	C18	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
      197	AHSG	0.506	0.846	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      197	AHSG	0.506	0.846	C1859878	Alopecia-Mental Retardation Syndrome 1	disease	C23;C17;C10;F03;F01	Disease or Syndrome	0.50	1	2017	2017	   1	   1	CTD_human;UNIPROT
      197	AHSG	0.506	0.846	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2017	2017	   1	   0	CTD_human
      197	AHSG	0.506	0.846	C2931280	Perniola Krajewska Carnevale syndrome	disease	C23;C17;C10;F03;F01	Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
      197	AHSG	0.506	0.846	C4551986	AMR Syndrome	disease	C23;C17;C10;F03;F01	Disease or Syndrome	0.31	1	2017	2017	   0	   0	CTD_human
      199	AIF1	0.521	0.808	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.54	1	2007	2020	   1	   0	CTD_human
      199	AIF1	0.521	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      199	AIF1	0.521	0.808	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.34	1	2009	2019	   1	   0	CTD_human
      199	AIF1	0.521	0.808	C0040997	Trigeminal Neuralgia	disease	C10;C07	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      199	AIF1	0.521	0.808	C0393786	Trigeminal Neuralgia, Idiopathic	disease	C10;C07	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      199	AIF1	0.521	0.808	C0393787	Secondary Trigeminal Neuralgia	disease	C10;C07	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      199	AIF1	0.521	0.808	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2016	2016	   1	   0	CTD_human
      199	AIF1	0.521	0.808	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
      199	AIF1	0.521	0.808	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
      199	AIF1	0.521	0.808	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
      199	AIF1	0.521	0.808	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
      199	AIF1	0.521	0.808	C0752347	Lewy Body Disease	disease	C10;F03	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      199	AIF1	0.521	0.808	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.35	1	2016	2020	   1	   0	CTD_human
      202	CRYBG1	0.743	0.462	C0025202	melanoma	disease	C04	Neoplastic Process	0.38	1	1996	2012	   1	   0	CTD_human
      202	CRYBG1	0.743	0.462	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      203	AK1	0.711	0.5	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      203	AK1	0.711	0.5	C0334634	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	disease	C04;C20;C15	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      203	AK1	0.711	0.5	C0751958	Lymphoma, Lymphocytic, Intermediate	disease	C04;C20;C15	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      203	AK1	0.711	0.5	C2675459	Adenylate Kinase Deficiency, Hemolytic Anemia Due To	disease	C15	Disease or Syndrome	0.70	1	1989	2017	   5	   7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      204	AK2	0.678	0.423	C0011052	Prelingual Deafness	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      204	AK2	0.678	0.423	C0011053	Deafness	phenotype	C23;C10;C09	Finding	0.31	1	2009	2009	   1	   0	CTD_human
      204	AK2	0.678	0.423	C0085110	Severe Combined Immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.40	1	2009	2009	   2	   0	CTD_human
      204	AK2	0.678	0.423	C0086395	Hearing Loss, Extreme	phenotype	C23;C10;C09	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      204	AK2	0.678	0.423	C0242583	Bare Lymphocyte Syndrome	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2009	2009	   2	   0	CTD_human
      204	AK2	0.678	0.423	C0272167	Reticular dysgenesis	disease	C16;C18;C20;C15	Disease or Syndrome	0.75	1	2009	2019	   2	   9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      204	AK2	0.678	0.423	C0337443	Sodium measurement	phenotype		Laboratory Procedure	0.30				   0	   0	GENOMICS_ENGLAND
      204	AK2	0.678	0.423	C0581883	Complete Hearing Loss	phenotype	C23;C10;C09	Finding	0.30	1	2009	2009	   1	   0	CTD_human
      204	AK2	0.678	0.423	C0751068	Deafness, Acquired	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      204	AK2	0.678	0.423	C1282908	De Vaal's syndrome	disease	C16;C18;C20;C15	Disease or Syndrome	0.30	1	2009	2009	   1	   0	ORPHANET
      204	AK2	0.678	0.423	C1879645	Adverse Event by CTCAE Category	phenotype		Finding	0.30				   0	   0	GENOMICS_ENGLAND
      204	AK2	0.678	0.423	C2700553	Omenn Syndrome	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2009	2009	   2	   0	CTD_human
      204	AK2	0.678	0.423	C3665473	Bilateral Deafness	phenotype	C23;C10;C09	Finding	0.30	1	2009	2009	   1	   0	CTD_human
      204	AK2	0.678	0.423	C4082305	Deaf Mutism	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      205	AK4	0.705	0.462	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      205	AK4	0.705	0.462	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.39	1	2003	2020	   5	   0	PSYGENET
      207	AKT1	0.311	0.962	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.70	0.993	1999	2020	   3	   1	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
      207	AKT1	0.311	0.962	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.974	2000	2020	   0	   0	CGI
      207	AKT1	0.311	0.962	C0006868	Cannabis Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0006870	Cannabis Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0007112	Adenocarcinoma of prostate	disease	C04;C12	Neoplastic Process	0.34	1	2002	2018	   0	   0	CGI
      207	AKT1	0.311	0.962	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.31	1	2010	2010	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.40	0.986	2002	2020	   0	   0	CGI
      207	AKT1	0.311	0.962	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.40	1	2002	2019	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.60	0.984	2002	2020	   1	   0	CTD_human;GENOMICS_ENGLAND
      207	AKT1	0.311	0.962	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.35	1	2004	2010	   0	   0	CTD_human
      207	AKT1	0.311	0.962	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.35	1	2012	2019	   5	   0	PSYGENET
      207	AKT1	0.311	0.962	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2012	2019	   5	   0	PSYGENET
      207	AKT1	0.311	0.962	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.36	1	2010	2019	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0018553	Hamartoma Syndrome, Multiple	disease	C16;C04	Neoplastic Process	0.33	1	2002	2013	   1	   0	ORPHANET
      207	AKT1	0.311	0.962	C0018614	Hashish Abuse	disease	C25;F03	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0020507	Hyperplasia	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2014	2015	   2	   0	CTD_human
      207	AKT1	0.311	0.962	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.34	1	2003	2019	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.50	1	2003	2019	   3	   0	CTD_human
      207	AKT1	0.311	0.962	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.37	0.857	2011	2016	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0025202	melanoma	disease	C04	Neoplastic Process	0.50	0.976	2002	2020	   0	   1	CGI
      207	AKT1	0.311	0.962	C0025286	Meningioma	disease	C04;C10	Neoplastic Process	0.70	1	2013	2019	   1	   0	CGI;CTD_human
      207	AKT1	0.311	0.962	C0026846	Muscular Atrophy	phenotype	C23;C10	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.40	1	2008	2020	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0029463	Osteosarcoma	disease	C04	Neoplastic Process	0.40	1	2005	2020	   0	   0	CGI
      207	AKT1	0.311	0.962	C0029925	Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.33	1	2007	2014	   0	   0	CGI
      207	AKT1	0.311	0.962	C0030193	Pain	phenotype	C23	Sign or Symptom	0.31	1	2007	2017	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0032580	Adenomatous Polyposis Coli	disease	C16;C06;C04	Neoplastic Process	0.32	1	2007	2018	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.33	1	2002	2018	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.40	1	2000	2019	   2	   0	CTD_human
      207	AKT1	0.311	0.962	C0033937	Psychoses, Drug	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0033941	Psychoses, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.90	0.865	2001	2019	   5	   0	CTD_human;GENOMICS_ENGLAND
      207	AKT1	0.311	0.962	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.33	1	2001	2019	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0079772	T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.35	1	2005	2020	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0085261	Proteus Syndrome	disease	C16;C04;C05	Neoplastic Process	0.69	1	2008	2019	   3	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      207	AKT1	0.311	0.962	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.39	1	2002	2019	   0	   0	CGI
      207	AKT1	0.311	0.962	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.32	1	2018	2020	   0	   0	CGI
      207	AKT1	0.311	0.962	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.40	1	2008	2020	   0	   0	CGI
      207	AKT1	0.311	0.962	C0205834	Meningiomas, Multiple	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0206644	Histiocytoma, Benign Fibrous	disease	C04	Neoplastic Process	0.30				   0	   0	CGI
      207	AKT1	0.311	0.962	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0236018	Aura	phenotype	C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0236733	Amphetamine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0236735	Cannabis-Related Disorder	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0236804	Amphetamine Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0236807	Amphetamine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	0.988	2003	2019	   3	   0	CTD_human
      207	AKT1	0.311	0.962	C0259785	Malignant Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0270948	Neurogenic Muscular Atrophy	phenotype	C23;C10	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0281784	Benign Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0334605	Meningothelial meningioma	disease	C04;C10	Neoplastic Process	0.31	1	2013	2017	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0334606	Fibrous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0334607	Psammomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0334608	Angiomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0334609	Hemangioblastic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0334610	Hemangiopericytic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0334611	Transitional Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0347515	Spinal Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0349604	Intracranial Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.992	2000	2019	   2	   0	CTD_human
      207	AKT1	0.311	0.962	C0428791	Aortic valve calcification	disease	C18;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0431121	Clear Cell Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0457190	Xanthomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0496920	Neoplasm of uncertain or unknown behavior of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
      207	AKT1	0.311	0.962	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
      207	AKT1	0.311	0.962	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.33	1	2004	2016	   2	   0	PSYGENET
      207	AKT1	0.311	0.962	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.70	0.992	1999	2020	   1	   0	CGI;CTD_human
      207	AKT1	0.311	0.962	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0751303	Cerebral Convexity Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0751304	Parasagittal Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
      207	AKT1	0.311	0.962	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.31	1	2013	2014	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.70	0.966	2005	2020	   2	   0	CGI;CTD_human
      207	AKT1	0.311	0.962	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.70	0.974	2005	2020	   3	   0	CGI;CTD_human;GENOMICS_ENGLAND
      207	AKT1	0.311	0.962	C1153706	Endometrial adenocarcinoma	disease	C04;C13	Neoplastic Process	0.33	1	2016	2018	   0	   0	CGI
      207	AKT1	0.311	0.962	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.40	1	2005	2020	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      207	AKT1	0.311	0.962	C1334261	Intraorbital Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C1334271	Intraventricular Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C1335107	Olfactory Groove Meningioma	disease	C04;C10	Neoplastic Process	0.31	1	2013	2017	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C1384406	Secretory meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C1384408	Microcystic meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	2002	2020	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C1527197	Angioblastic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C1565950	Posterior Fossa Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C1565951	Sphenoid Wing Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.31	1	2009	2014	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C1866398	Proteus-Like Syndrome (disorder)	disease	C16;C04;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
      207	AKT1	0.311	0.962	C2713442	Polyposis, Adenomatous Intestinal	disease	C16;C06;C04	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C2713443	Familial Intestinal Polyposis	disease	C16;C06;C04	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C3163622	Papillary Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      207	AKT1	0.311	0.962	C3554519	COWDEN SYNDROME 6	disease		Disease or Syndrome	0.70	1	2013	2013	   1	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
      207	AKT1	0.311	0.962	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      208	AKT2	0.474	0.769	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
      208	AKT2	0.474	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.60	1	1995	2019	   1	   0	CGI;CTD_human
      208	AKT2	0.474	0.769	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.966	2002	2019	   0	   0	CGI
      208	AKT2	0.474	0.769	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.46	1	2010	2018	   0	   1	CGI
      208	AKT2	0.474	0.769	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.96	1	2001	2018	   4	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      208	AKT2	0.474	0.769	C0029925	Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.31	1	1996	1996	   0	   0	CGI
      208	AKT2	0.474	0.769	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.32	1	2002	2012	   0	   0	CGI
      208	AKT2	0.474	0.769	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.36	1	1996	2017	   0	   0	CGI
      208	AKT2	0.474	0.769	C0271694	Familial partial lipodystrophy	disease	C18;C17	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      208	AKT2	0.474	0.769	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.40	1	1996	2017	   0	   0	CGI
      208	AKT2	0.474	0.769	C0347284	Benign tumor of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30				   0	   0	CGI
      208	AKT2	0.474	0.769	C0496920	Neoplasm of uncertain or unknown behavior of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
      208	AKT2	0.474	0.769	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
      208	AKT2	0.474	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.60	1	1995	2019	   1	   0	CGI;CTD_human
      208	AKT2	0.474	0.769	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
      208	AKT2	0.474	0.769	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.38	1	1999	2018	   0	   0	CGI
      208	AKT2	0.474	0.769	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.38	1	1992	2018	   0	   0	CGI
      208	AKT2	0.474	0.769	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      208	AKT2	0.474	0.769	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      208	AKT2	0.474	0.769	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.32	1	2005	2009	   1	   0	CTD_human
      208	AKT2	0.474	0.769	C1720859	Familial Partial Lipodystrophy, Type 1	disease	C18;C17	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      208	AKT2	0.474	0.769	C1720860	Familial Partial Lipodystrophy, Type 2	disease	C18;C17	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      208	AKT2	0.474	0.769	C1720861	Familial Partial Lipodystrophy, Type 3	disease	C18;C17	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      208	AKT2	0.474	0.769	C2931822	Nasopharyngeal carcinoma	disease	C04;C07;C09	Neoplastic Process	0.31	1	2014	2019	   1	   0	CTD_human
      208	AKT2	0.474	0.769	C3278384	HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY	disease		Disease or Syndrome	0.70	1	2004	2017	   5	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      208	AKT2	0.474	0.769	C4316789	Partial lipodystrophy	disease	C18;C17	Disease or Syndrome	0.30	1	2007	2007	   1	   0	GENOMICS_ENGLAND
      208	AKT2	0.474	0.769	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0018939	Hematological Disease	group	C15	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.32	1	2001	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.30	1	2013	2014	   2	   0	CTD_human
      210	ALAD	0.556	0.615	C0023176	Lead Poisoning	disease	C25	Injury or Poisoning	0.50	1	2006	2014	   3	   0	CTD_human
      210	ALAD	0.556	0.615	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.50	1	1983	2014	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0025286	Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.40	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0162533	Porphyrias, Hepatic	group	C16;C06;C18;C17	Disease or Syndrome	0.50	1	1984	1991	   2	   0	CTD_human
      210	ALAD	0.556	0.615	C0205834	Meningiomas, Multiple	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0259785	Malignant Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0268328	Porphobilinogen synthase deficiency	disease	C16;C06;C18;C17	Disease or Syndrome	0.73	1	1991	2016	   7	   5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      210	ALAD	0.556	0.615	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.50	1	2007	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0281784	Benign Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0334605	Meningothelial meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0334606	Fibrous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0334607	Psammomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0334608	Angiomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0334609	Hemangioblastic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0334610	Hemangiopericytic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0334611	Transitional Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0347515	Spinal Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0349604	Intracranial Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2014	2014	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0431121	Clear Cell Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0457190	Xanthomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0751303	Cerebral Convexity Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0751304	Parasagittal Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C0751859	Lead Poisoning, Nervous System	disease	C10;C25	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C1334261	Intraorbital Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C1334271	Intraventricular Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C1335107	Olfactory Groove Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C1384406	Secretory meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C1384408	Microcystic meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C1527197	Angioblastic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C1565950	Posterior Fossa Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C1565951	Sphenoid Wing Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C2748608	LEAD POISONING, SUSCEPTIBILITY TO	phenotype		Finding	0.30	1	1991	2006	   2	   0	ORPHANET
      210	ALAD	0.556	0.615	C3163622	Papillary Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      210	ALAD	0.556	0.615	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      211	ALAS1	0.705	0.462	C0032708	Disorders of Porphyrin Metabolism	group	C18	Disease or Syndrome	0.52	1	1995	2019	   1	   0	CTD_human
      212	ALAS2	0.606	0.577	C0002896	Sideroblastic anemia	disease	C15	Disease or Syndrome	0.50	1	1992	2017	   2	   1	CTD_human
      212	ALAS2	0.606	0.577	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      212	ALAS2	0.606	0.577	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      212	ALAS2	0.606	0.577	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      212	ALAS2	0.606	0.577	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      212	ALAS2	0.606	0.577	C2677889	Protoporphyria, Erythropoietic, X-Linked Dominant	disease	C16;C06;C18;C17	Disease or Syndrome	0.60	1	1999	2018	   3	   4	CTD_human;GENOMICS_ENGLAND
      212	ALAS2	0.606	0.577	C4551511	X-linked sideroblastic anemia	disease	C16;C15	Disease or Syndrome	0.80	1	1992	2019	  13	  20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      213	ALB	0.317	0.962	C0002994	Angioedema	phenotype	C17;C20;C14	Pathologic Function	0.30	1	1993	1993	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0003460	Anuria	phenotype	C13;C12	Disease or Syndrome	0.30	1	1984	1984	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0003865	Arthritis, Adjuvant-Induced	disease	C05	Experimental Model of Disease	0.30	1	2010	2010	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0004509	Azoospermia	disease	C12	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0005398	Cholestasis, Extrahepatic	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0006111	Brain Diseases	group	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.40	0.965	1993	2020	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0008312	Primary biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.35	1	2018	2020	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0011573	Endogenous depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.37	1	1996	2020	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0011875	Diabetic Angiopathies	disease	C19;C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.60	0.96	1989	2020	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2014	2017	   2	   0	CTD_human
      213	ALB	0.317	0.962	C0013502	Echinococcosis	disease	C01	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0014518	Toxic Epidermal Necrolysis	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.34	1	2004	2019	   2	   0	CTD_human
      213	ALB	0.317	0.962	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0017658	Glomerulonephritis	disease	C13;C12	Disease or Syndrome	0.39	1	1980	2020	   8	   0	CTD_human
      213	ALB	0.317	0.962	C0017662	Glomerulonephritis, Membranoproliferative	disease	C13;C12;C20	Disease or Syndrome	0.31	1	1992	2019	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0017665	Membranous glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.39	1	1992	2018	   6	   0	CTD_human
      213	ALB	0.317	0.962	C0017667	Nodular glomerulosclerosis	disease	C13;C12;C19	Disease or Syndrome	0.31	1	2005	2006	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.35	1	2014	2019	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.40	1	2001	2020	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.40	1	2001	2020	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0019061	Hemolytic-Uremic Syndrome	disease	C13;C12;C15	Disease or Syndrome	0.30	1	1984	1984	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0019158	Hepatitis	group	C06	Disease or Syndrome	0.36	1	2006	2018	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2008	2012	   2	   0	CTD_human
      213	ALB	0.317	0.962	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2018	2018	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.38	1	2006	2019	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0019699	HIV Seropositivity	phenotype	C01;C20	Laboratory or Test Result	0.30	1	2007	2007	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	1993	1993	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0020522	Delayed Hypersensitivity	phenotype	C20	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.40	0.947	1989	2020	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0020649	Hypotension	phenotype	C14	Finding	0.40	1	1974	2001	   2	   0	CTD_human
      213	ALB	0.317	0.962	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.40	0.973	1978	2020	   8	   0	CTD_human
      213	ALB	0.317	0.962	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.40	0.983	1991	2020	   4	   0	CTD_human
      213	ALB	0.317	0.962	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.40	0.919	1997	2020	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.40	1	1987	2020	   2	   0	CTD_human
      213	ALB	0.317	0.962	C0023892	Biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2010	   3	   0	CTD_human
      213	ALB	0.317	0.962	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.40	1	2003	2019	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0025193	Melancholia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0025290	Aseptic Meningitis	disease	C10	Disease or Syndrome	0.30	1	1970	1971	   3	   0	CTD_human
      213	ALB	0.317	0.962	C0025945	Microangiopathy, Diabetic	disease	C19;C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0026848	Myopathy	group	C05;C10	Disease or Syndrome	0.30	1	1973	1973	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.30	1	1998	1998	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0027697	Nephritis	disease	C13;C12	Disease or Syndrome	0.32	1	1979	2019	   6	   0	CTD_human
      213	ALB	0.317	0.962	C0027707	Nephritis, Interstitial	disease	C13;C12	Disease or Syndrome	0.30	1	2000	2013	   4	   0	CTD_human
      213	ALB	0.317	0.962	C0027720	Nephrosis	disease	C13;C12	Disease or Syndrome	0.31	1	1987	1990	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0027726	Nephrotic Syndrome	group	C13;C12	Disease or Syndrome	0.40	0.913	1990	2019	   2	   0	CTD_human
      213	ALB	0.317	0.962	C0028797	Occupational Diseases	group	C24	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0030193	Pain	phenotype	C23	Sign or Symptom	0.34	0.6	1973	2019	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0030286	Pancreatic Diseases	group	C06	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0030305	Pancreatitis	disease	C06	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.30	1	1976	2008	   9	   0	CTD_human
      213	ALB	0.317	0.962	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.32	1	2002	2019	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0035242	Respiratory Tract Diseases	group	C08	Disease or Syndrome	0.31	1	1993	2017	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0035457	Rhinitis, Allergic, Perennial	disease	C08;C20;C09	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0036830	Serum Sickness	disease	C17;C20;C25	Disease or Syndrome	0.30	1	1978	1997	   2	   0	CTD_human
      213	ALB	0.317	0.962	C0038325	Stevens-Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.40	0.958	1998	2020	   4	   0	CTD_human
      213	ALB	0.317	0.962	C0040034	Thrombocytopenia	phenotype	C15	Disease or Syndrome	0.35	1	1984	2019	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0041349	Nephritis, Tubulointerstitial	disease	C13;C12	Disease or Syndrome	0.30	1	2000	2013	   4	   0	CTD_human
      213	ALB	0.317	0.962	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2014	2017	   2	   0	CTD_human
      213	ALB	0.317	0.962	C0042109	Urticaria	disease	C17;C20	Disease or Syndrome	0.31	1	1993	2017	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0042164	Uveitis	disease	C11	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0085584	Encephalopathies	group	C10	Disease or Syndrome	0.34	1	2005	2019	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0086133	Depressive Syndrome	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
      213	ALB	0.317	0.962	C0086445	Idiopathic Membranous Glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.37	0.923	1992	2019	   6	   0	CTD_human
      213	ALB	0.317	0.962	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.34	1	2006	2019	   2	   0	CTD_human
      213	ALB	0.317	0.962	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	1973	1973	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	1973	1973	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	1973	1973	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0236018	Aura	phenotype	C10	Finding	0.30	1	2004	2007	   2	   0	CTD_human
      213	ALB	0.317	0.962	C0238065	Secondary Biliary Cholangitis	disease	C23;C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.40	0.9	1987	2020	   2	   0	CTD_human
      213	ALB	0.317	0.962	C0239981	Hypoalbuminemia	disease	C15	Disease or Syndrome	0.50	0.973	1998	2020	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0268742	Membranoproliferative Glomerulonephritis, Type I	disease	C13;C12;C20	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0268743	Membranoproliferative Glomerulonephritis, Type II	disease	C13;C12;C20	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0273115	Lung Injury	disease	C08;C26	Injury or Poisoning	0.30	1	2019	2019	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0282126	Depression, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0342185	Hyperthyroxinemia, Familial Dysalbuminemic	disease	C16;C19	Disease or Syndrome	0.80	0.941	1986	2019	   6	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
      213	ALB	0.317	0.962	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	1973	1973	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	1973	1973	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
      213	ALB	0.317	0.962	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	1973	1973	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	1973	1973	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0751956	Acute Cerebrovascular Accidents	disease	C10;C14	Disease or Syndrome	0.33	1	2003	2018	   4	   0	CTD_human
      213	ALB	0.317	0.962	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.33	1	2008	2019	   2	   0	CTD_human
      213	ALB	0.317	0.962	C0878666	Analbuminemia	phenotype		Finding	0.40	1	1994	2005	   2	   3	ORPHANET
      213	ALB	0.317	0.962	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0971858	Arthritis, Collagen-Induced	disease	C05	Experimental Model of Disease	0.30	1	2010	2010	   1	   0	CTD_human
      213	ALB	0.317	0.962	C0993582	Arthritis, Experimental	disease	C05	Experimental Model of Disease	0.30	1	2010	2010	   1	   0	CTD_human
      213	ALB	0.317	0.962	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2012	   2	   0	CTD_human
      213	ALB	0.317	0.962	C1274933	Drug-Induced Stevens Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      213	ALB	0.317	0.962	C1306571	Hepatic Insufficiency	phenotype	C06	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      213	ALB	0.317	0.962	C1527304	Allergic Reaction	phenotype	C20	Pathologic Function	0.30	1	1993	1993	   1	   0	CTD_human
      213	ALB	0.317	0.962	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	1991	2017	   4	   0	CTD_human
      213	ALB	0.317	0.962	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.40	1	1987	2020	   1	   0	CTD_human
      213	ALB	0.317	0.962	C1704377	Bright Disease	disease	C13;C12	Disease or Syndrome	0.30	1	1980	2009	   8	   0	CTD_human
      213	ALB	0.317	0.962	C1704378	Heymann Nephritis	disease	C13;C12;C20	Disease or Syndrome	0.30	1	1992	2007	   6	   0	CTD_human
      213	ALB	0.317	0.962	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      213	ALB	0.317	0.962	C1720821	Membranoproliferative Glomerulonephritis, Type III	disease	C13;C12;C20	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
      213	ALB	0.317	0.962	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      213	ALB	0.317	0.962	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
      213	ALB	0.317	0.962	C2350344	Chronic Lung Injury	disease	C08;C26	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      213	ALB	0.317	0.962	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	1991	2017	   4	   0	CTD_human
      213	ALB	0.317	0.962	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2012	   2	   0	CTD_human
      213	ALB	0.317	0.962	C3658301	Mycoplasma-Induced Stevens-Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      213	ALB	0.317	0.962	C3658302	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      213	ALB	0.317	0.962	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2012	   2	   0	CTD_human
      213	ALB	0.317	0.962	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2012	   2	   0	CTD_human
      213	ALB	0.317	0.962	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      213	ALB	0.317	0.962	C4551595	Biliary Cirrhosis, Primary, 1	disease	C23;C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      213	ALB	0.317	0.962	C4553297	Cystic Echinocccosis	disease	C01	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      214	ALCAM	0.502	0.808	C0007097	Carcinoma	group	C04	Neoplastic Process	0.32	1	2005	2011	   1	   0	CTD_human
      214	ALCAM	0.502	0.808	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      214	ALCAM	0.502	0.808	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      214	ALCAM	0.502	0.808	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      214	ALCAM	0.502	0.808	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      214	ALCAM	0.502	0.808	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      214	ALCAM	0.502	0.808	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      214	ALCAM	0.502	0.808	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      215	ABCD1	0.563	0.731	C0001623	Adrenal gland hypofunction	phenotype	C19	Disease or Syndrome	0.31	1	2007	2013	   2	   0	GENOMICS_ENGLAND
      215	ABCD1	0.563	0.731	C0037771	Paraparesis, Spastic	phenotype	C23;C10	Sign or Symptom	0.31	1	2005	2013	   2	   0	GENOMICS_ENGLAND
      215	ABCD1	0.563	0.731	C0037773	Spastic Paraplegia, Hereditary	disease	C16;C10	Disease or Syndrome	0.31	1	2007	2015	   2	   0	GENOMICS_ENGLAND
      215	ABCD1	0.563	0.731	C0162309	Adrenoleukodystrophy	disease	C16;C18;C10;C19	Disease or Syndrome	1.00	0.977	1981	2020	  33	  89	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      215	ABCD1	0.563	0.731	C1527231	Adrenomyeloneuropathy	disease	C16;C18;C10;C19	Disease or Syndrome	0.60	0.974	1984	2019	   8	   0	CLINGEN;CTD_human
      215	ABCD1	0.563	0.731	C1845408	Contiguous Abcd1-Dxs1375e Deletion Syndrome	disease	C16	Disease or Syndrome	0.31	1	2002	2013	   2	   0	ORPHANET
      216	ALDH1A1	0.46	0.846	C0001969	Alcoholic Intoxication	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	1988	1988	   1	   0	PSYGENET
      216	ALDH1A1	0.46	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.39	1	1983	2017	   5	   0	PSYGENET
      216	ALDH1A1	0.46	0.846	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.31	1	2004	2013	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0022336	Creutzfeldt-Jakob disease	disease	C01;C10;F03	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	0.37	1	2015	2019	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2003	2009	   1	   0	PSYGENET
      216	ALDH1A1	0.46	0.846	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	PSYGENET
      216	ALDH1A1	0.46	0.846	C0242422	Parkinsonian Disorders	group	C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0242423	Ramsay Hunt Paralysis Syndrome	disease	C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.32	1	2004	2013	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0376329	New Variant Creutzfeldt-Jakob Disease	disease	C01;C10;F03	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0751254	Creutzfeldt-Jakob Disease, Familial	disease	C01;C10;F03	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0752097	Autosomal Dominant Juvenile Parkinson Disease	disease	C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0752098	Autosomal Dominant Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0752100	Autosomal Recessive Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0752101	Parkinsonism, Experimental	disease	C10	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0752104	Familial Juvenile Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C0752105	Parkinsonism, Juvenile	disease	C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C1868675	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	disease	C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      216	ALDH1A1	0.46	0.846	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	0.947	1994	2019	   2	   0	CTD_human
      217	ALDH2	0.457	0.885	C0001969	Alcoholic Intoxication	disease	C25;F03	Mental or Behavioral Dysfunction	0.34	1	1982	2017	   5	   0	PSYGENET
      217	ALDH2	0.457	0.885	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.70	1	1991	2019	   7	   1	CTD_human;PSYGENET
      217	ALDH2	0.457	0.885	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.36	1	1994	2017	   2	   0	CTD_human
      217	ALDH2	0.457	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.34	0.5	2010	2018	   2	   0	PSYGENET
      217	ALDH2	0.457	0.885	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.941	1999	2017	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	2006	2008	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.50	0.981	1996	2020	   1	   1	CTD_human
      217	ALDH2	0.457	0.885	C0016382	Flushing	phenotype	C23	Sign or Symptom	0.40	0.959	1993	2019	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0016689	Freckles	phenotype	C17	Finding	0.30	1	2019	2019	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0025209	Melanosis	disease	C17	Disease or Syndrome	0.32	1	2005	2019	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0025218	Chloasma	disease	C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0028796	Dermatitis, Occupational	disease	C17;C24	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0042373	Vascular Diseases	group	C14	Disease or Syndrome	0.31	1	2004	2008	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.60	1	1994	2018	   7	   0	CTD_human;PSYGENET
      217	ALDH2	0.457	0.885	C0086457	Industrial Dermatosis	disease	C17;C24	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0236664	Alcohol-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.43	1	1992	2015	   3	   1	PSYGENET
      217	ALDH2	0.457	0.885	C0236970	Alcohol-Induced Disorders	group	C25	Disease or Syndrome	0.40	1	2014	2016	   1	   1	CTD_human
      217	ALDH2	0.457	0.885	C0242973	Ventricular Dysfunction	phenotype	C14	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.40	0.97	1996	2019	   2	   0	CTD_human
      217	ALDH2	0.457	0.885	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0342257	Complications of Diabetes Mellitus	group	C19	Disease or Syndrome	0.32	1	2000	2013	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0349464	Wernicke-Korsakoff Syndrome	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.31	1	2000	2000	   1	   0	PSYGENET
      217	ALDH2	0.457	0.885	C0393756	Hangover from alcohol	phenotype	C25;F03	Sign or Symptom	0.34	1	2000	2017	   4	   0	PSYGENET
      217	ALDH2	0.457	0.885	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.32	1	2016	2019	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0520459	Necrotizing Enterocolitis	disease	C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.50	0.982	1996	2020	   1	   2	CTD_human
      217	ALDH2	0.457	0.885	C0848676	Subfertility, Male	phenotype	C12	Sign or Symptom	0.30	1	2014	2014	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C0917731	Male sterility	phenotype	C12	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C2674838	ALCOHOL SENSITIVITY, ACUTE	phenotype		Finding	0.30	1	2000	2000	   1	   0	CTD_human
      217	ALDH2	0.457	0.885	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.31	1	2016	2018	   1	   0	CTD_human
      218	ALDH3A1	0.641	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2004	2004	   1	   0	PSYGENET
      218	ALDH3A1	0.641	0.577	C0086543	Cataract	disease	C11	Acquired Abnormality	0.30	1	2017	2017	   1	   0	CTD_human
      218	ALDH3A1	0.641	0.577	C0349702	Corneal Scar	phenotype	C11;C10;C26	Finding	0.30	1	2017	2017	   1	   0	CTD_human
      218	ALDH3A1	0.641	0.577	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      218	ALDH3A1	0.641	0.577	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	2017	2017	   1	   0	CTD_human
      219	ALDH1B1	0.691	0.462	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.31	1	2015	2015	   1	   0	CTD_human
      219	ALDH1B1	0.691	0.462	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      219	ALDH1B1	0.691	0.462	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      219	ALDH1B1	0.691	0.462	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2017	2017	   1	   0	CTD_human
      219	ALDH1B1	0.691	0.462	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2005	2014	   2	   0	CTD_human
      219	ALDH1B1	0.691	0.462	C0268631	succinic semialdehyde dehydrogenase deficiency	disease	C16;C18;F03	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      219	ALDH1B1	0.691	0.462	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      219	ALDH1B1	0.691	0.462	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      220	ALDH1A3	0.578	0.654	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      220	ALDH1A3	0.578	0.654	C0025202	melanoma	disease	C04	Neoplastic Process	0.31	1	2019	2019	   1	   0	CTD_human
      220	ALDH1A3	0.578	0.654	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      220	ALDH1A3	0.578	0.654	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      220	ALDH1A3	0.578	0.654	C1855052	MICROPHTHALMIA, ISOLATED 1	disease	C16;C11	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
      220	ALDH1A3	0.578	0.654	C3554524	MICROPHTHALMIA, ISOLATED 8	disease		Disease or Syndrome	0.70	1	2002	2015	  10	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
      220	ALDH1A3	0.578	0.654	C4551977	Microphthalmos, Autosomal Recessive	disease	C16;C11	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
      221	ALDH3B1	0.821	0.346	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2005	2009	   2	   0	PSYGENET
      221	ALDH3B1	0.821	0.346	C0036349	Paranoid Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2009	2009	   1	   0	PSYGENET
      222	ALDH3B2	1	0.077	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
      223	ALDH9A1	0.76	0.269	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
      223	ALDH9A1	0.76	0.269	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      223	ALDH9A1	0.76	0.269	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      223	ALDH9A1	0.76	0.269	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      223	ALDH9A1	0.76	0.269	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      223	ALDH9A1	0.76	0.269	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      224	ALDH3A2	0.619	0.769	C0037231	Sjogren-Larsson Syndrome	disease	C16;C18;C17	Disease or Syndrome	0.80	1	1981	2019	   9	  26	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      224	ALDH3A2	0.619	0.769	C0598589	Inherited neuropathies	disease	C10	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      224	ALDH3A2	0.619	0.769	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.42	1	2012	2016	   1	   0	GENOMICS_ENGLAND
      225	ABCD2	0.711	0.5	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      225	ABCD2	0.711	0.5	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      225	ABCD2	0.711	0.5	C1335302	Pancreatic Ductal Adenocarcinoma	disease	C06;C04;C19	Neoplastic Process	0.30				   0	   0	UNIPROT
      226	ALDOA	0.631	0.615	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      226	ALDOA	0.631	0.615	C0017919	Glycogen Storage Disease	group	C16;C18	Disease or Syndrome	0.30	1	1981	2016	   3	   0	GENOMICS_ENGLAND
      226	ALDOA	0.631	0.615	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
      226	ALDOA	0.631	0.615	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.31	1	2010	2018	   1	   0	CTD_human
      226	ALDOA	0.631	0.615	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      226	ALDOA	0.631	0.615	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      226	ALDOA	0.631	0.615	C0272066	Glycogen Storage Disease XII	disease	C16;C18	Disease or Syndrome	0.70	1	1981	2016	   7	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      226	ALDOA	0.631	0.615	C0520572	Enzymopathy	group	C18	Disease or Syndrome	0.30	1	1981	1996	   2	   0	GENOMICS_ENGLAND
      226	ALDOA	0.631	0.615	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      226	ALDOA	0.631	0.615	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      226	ALDOA	0.631	0.615	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      226	ALDOA	0.631	0.615	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      229	ALDOB	0.623	0.538	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      229	ALDOB	0.623	0.538	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      229	ALDOB	0.623	0.538	C0016751	Hereditary fructose intolerance syndrome	disease	C16;C18	Disease or Syndrome	0.77	1	1983	2017	  14	  45	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      229	ALDOB	0.623	0.538	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2005	2005	   1	   0	CTD_human
      229	ALDOB	0.623	0.538	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      229	ALDOB	0.623	0.538	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      229	ALDOB	0.623	0.538	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      229	ALDOB	0.623	0.538	C0241910	Autoimmune Chronic Hepatitis	disease	C06;C20	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      229	ALDOB	0.623	0.538	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      229	ALDOB	0.623	0.538	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2009	2009	   1	   0	CTD_human
      229	ALDOB	0.623	0.538	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      229	ALDOB	0.623	0.538	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      229	ALDOB	0.623	0.538	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      229	ALDOB	0.623	0.538	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      229	ALDOB	0.623	0.538	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      229	ALDOB	0.623	0.538	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      231	AKR1B1	0.491	0.885	C0014170	Endometrial Neoplasms	group	C04;C13	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      231	AKR1B1	0.491	0.885	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.31	1	2015	2015	   1	   0	CTD_human
      231	AKR1B1	0.491	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      231	AKR1B1	0.491	0.885	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      231	AKR1B1	0.491	0.885	C0086543	Cataract	disease	C11	Acquired Abnormality	0.40	0.947	1995	2019	   4	   0	CTD_human
      231	AKR1B1	0.491	0.885	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      231	AKR1B1	0.491	0.885	C0342257	Complications of Diabetes Mellitus	group	C19	Disease or Syndrome	0.40	1	1990	2020	   2	   0	CTD_human
      231	AKR1B1	0.491	0.885	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.31	1	2013	2013	   1	   0	CTD_human
      231	AKR1B1	0.491	0.885	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	2011	2017	   4	   0	CTD_human
      231	AKR1B1	0.491	0.885	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	2011	2017	   4	   0	CTD_human
      238	ALK	0.396	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2011	2017	   1	   0	PSYGENET
      238	ALK	0.396	0.846	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.61	1	2009	2012	   1	   3	CGI;CTD_human
      238	ALK	0.396	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.37	1	2009	2018	   1	   0	CTD_human
      238	ALK	0.396	0.846	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.60	0.99	2007	2020	  28	   0	CGI;CTD_human
      238	ALK	0.396	0.846	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.40	0.947	2012	2019	   1	   0	CTD_human
      238	ALK	0.396	0.846	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2012	2013	   2	   0	CTD_human
      238	ALK	0.396	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      238	ALK	0.396	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      238	ALK	0.396	0.846	C0017638	Glioma	disease	C04	Neoplastic Process	0.32	1	2011	2017	   0	   0	CGI
      238	ALK	0.396	0.846	C0018199	Granuloma, Plasma Cell	phenotype	C23	Pathologic Function	0.30	1	2010	2012	   3	   0	CTD_human
      238	ALK	0.396	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	0.39	1	2015	2019	   0	   0	CGI
      238	ALK	0.396	0.846	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	0.983	2007	2020	   2	   0	CTD_human
      238	ALK	0.396	0.846	C0027643	Neoplasm Recurrence, Local	phenotype	C23;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      238	ALK	0.396	0.846	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.70	0.957	2000	2020	  13	   0	CGI;CTD_human;ORPHANET
      238	ALK	0.396	0.846	C0035412	Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.50	1	2009	2020	   0	   1	CGI
      238	ALK	0.396	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2006	2006	   1	   0	PSYGENET
      238	ALK	0.396	0.846	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.40	1	2003	2018	   1	   0	CTD_human
      238	ALK	0.396	0.846	C0085269	Plasma Cell Granuloma, Pulmonary	disease	C08	Neoplastic Process	0.31	1	2001	2011	   1	   0	CTD_human
      238	ALK	0.396	0.846	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
      238	ALK	0.396	0.846	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.70	0.977	2008	2020	   8	   6	CGI;CTD_human
      238	ALK	0.396	0.846	C0153633	Malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.50	1	2012	2012	   1	   0	CGI;CTD_human
      238	ALK	0.396	0.846	C0206180	Ki-1+ Anaplastic Large Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.60	0.973	1995	2020	   6	   0	CGI;CTD_human
      238	ALK	0.396	0.846	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.35	1	2012	2019	   2	   0	ORPHANET
      238	ALK	0.396	0.846	C0278601	Inflammatory Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.32	1	2012	2015	   1	   0	CTD_human
      238	ALK	0.396	0.846	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.40	0.929	2012	2019	   1	   0	CTD_human
      238	ALK	0.396	0.846	C0334121	Inflammatory Myofibroblastic Tumor	disease	C23	Neoplastic Process	0.70	0.966	1999	2019	   4	   0	CGI;CTD_human;ORPHANET
      238	ALK	0.396	0.846	C0496899	Benign neoplasm of brain, unspecified	disease	C04;C10	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      238	ALK	0.396	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.39	0.9	2002	2019	   1	   0	CTD_human
      238	ALK	0.396	0.846	C0750974	Brain Tumor, Primary	disease	C04;C10	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      238	ALK	0.396	0.846	C0750977	Recurrent Brain Neoplasm	disease	C04;C10	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      238	ALK	0.396	0.846	C0750979	Primary malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      238	ALK	0.396	0.846	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      238	ALK	0.396	0.846	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      238	ALK	0.396	0.846	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      238	ALK	0.396	0.846	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      238	ALK	0.396	0.846	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      238	ALK	0.396	0.846	C1332079	Anaplastic Large Cell Lymphoma, ALK-Positive	disease	C04;C20;C15	Neoplastic Process	0.40	0.931	1999	2019	   1	   0	ORPHANET
      238	ALK	0.396	0.846	C1333294	ALK positive large B-cell lymphoma	disease	C04;C20;C15	Neoplastic Process	0.36	1	2011	2017	   0	   0	ORPHANET
      238	ALK	0.396	0.846	C1335177	Ovarian Serous Adenocarcinoma	disease	C04	Neoplastic Process	0.31	1	2016	2016	   0	   1	UNIPROT
      238	ALK	0.396	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	2016	2018	   1	   1	CTD_human
      238	ALK	0.396	0.846	C1527390	Neoplasms, Intracranial	group	C04;C10	Neoplastic Process	0.32	1	2012	2019	   1	   0	CTD_human
      238	ALK	0.396	0.846	C2751681	NEUROBLASTOMA, SUSCEPTIBILITY TO, 3	disease		Finding	0.60	1	2008	2012	   8	  16	CLINGEN;UNIPROT
      238	ALK	0.396	0.846	C2931189	Neural crest tumor	disease	C04;C19	Disease or Syndrome	0.31	1	2007	2008	   1	   0	ORPHANET
      238	ALK	0.396	0.846	C3899155	hereditary neuroblastoma	disease	C16;C04	Neoplastic Process	0.40	0.933	2008	2018	   1	   0	GENOMICS_ENGLAND
      238	ALK	0.396	0.846	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      239	ALOX12	0.558	0.692	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2003	2003	   1	   0	PSYGENET
      239	ALOX12	0.558	0.692	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
      239	ALOX12	0.558	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2010	2014	   1	   0	PSYGENET
      239	ALOX12	0.558	0.692	C0037274	Dermatologic disorders	group	C17	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      239	ALOX12	0.558	0.692	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      239	ALOX12	0.558	0.692	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2003	2003	   1	   0	CTD_human
      239	ALOX12	0.558	0.692	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
      239	ALOX12	0.558	0.692	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
      239	ALOX12	0.558	0.692	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
      239	ALOX12	0.558	0.692	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
      239	ALOX12	0.558	0.692	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
      239	ALOX12	0.558	0.692	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      239	ALOX12	0.558	0.692	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      239	ALOX12	0.558	0.692	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      239	ALOX12	0.558	0.692	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      239	ALOX12	0.558	0.692	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.31	1	2008	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0001430	Adenoma	group	C04	Neoplastic Process	0.32	1	2007	2019	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.35	1	1995	2017	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.50	0.95	1997	2020	   0	   0	CTD_human
      240	ALOX5	0.447	0.885	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.40	0.95	2003	2019	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.37	0.889	2004	2018	   3	   0	CTD_human
      240	ALOX5	0.447	0.885	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.32	1	2005	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0009319	Colitis	disease	C06	Disease or Syndrome	0.31	1	2005	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.33	1	2003	2018	   3	   0	CTD_human
      240	ALOX5	0.447	0.885	C0009376	Colonic Polyps	phenotype	C23	Anatomical Abnormality	0.31	1	2008	2008	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0011609	Drug Eruptions	group	C17;C20;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.50	1	1996	2019	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.35	0.833	2009	2017	   2	   0	CTD_human
      240	ALOX5	0.447	0.885	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.31	1	2010	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0026766	Multiple Organ Failure	phenotype	C23	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.35	1	1994	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0027719	Nephrosclerosis	disease	C13;C12	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.32	1	2003	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.50	1	2003	2009	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0042109	Urticaria	disease	C17;C20	Disease or Syndrome	0.32	1	2005	2016	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.36	0.857	2005	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0238281	Middle Cerebral Artery Syndrome	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.32	1	2005	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.35	1	2004	2019	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0376618	Endotoxemia	phenotype	C23;C01	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0406537	Morbilliform Drug Reaction	disease	C17;C20;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2003	2003	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0740376	Middle Cerebral Artery Thrombosis	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0740391	Middle Cerebral Artery Occlusion	disease	C23;C10;C14	Acquired Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0740392	Infarction, Middle Cerebral Artery	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0751845	Middle Cerebral Artery Embolus	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0751846	Left Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0751847	Embolic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0751848	Thrombotic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0751849	Right Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.31	1	2008	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.31	1	2007	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C1336708	Testicular Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      240	ALOX5	0.447	0.885	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
      241	ALOX5AP	0.612	0.731	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.37	1	2006	2018	   1	   0	CTD_human
      241	ALOX5AP	0.612	0.731	C0007785	Cerebral Infarction	disease	C23;C10;C14	Disease or Syndrome	0.37	0.714	2008	2015	   0	   0	CTD_human
      241	ALOX5AP	0.612	0.731	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      241	ALOX5AP	0.612	0.731	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.30	1	2003	2003	   1	   0	CTD_human
      241	ALOX5AP	0.612	0.731	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      241	ALOX5AP	0.612	0.731	C0149504	Encephalopathy, Toxic	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      241	ALOX5AP	0.612	0.731	C0154659	Toxic Encephalitis	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      241	ALOX5AP	0.612	0.731	C0235032	Neurotoxicity Syndromes	group	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      241	ALOX5AP	0.612	0.731	C0751010	Cerebral Infarction, Left Hemisphere	phenotype	C23;C10;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
      241	ALOX5AP	0.612	0.731	C0751011	Cerebral Infarction, Right Hemisphere	phenotype	C23;C10;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
      241	ALOX5AP	0.612	0.731	C0751012	Anterior Choroidal Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
      241	ALOX5AP	0.612	0.731	C0751014	Subcortical Infarction	disease	C23;C10;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
      241	ALOX5AP	0.612	0.731	C0887799	Posterior Choroidal Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
      241	ALOX5AP	0.612	0.731	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0020758	Congenital ichthyosis	disease	C16;C17	Disease or Syndrome	0.37	0.75	2005	2020	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0079154	Congenital Nonbullous Ichthyosiform Erythroderma	disease	C16;C17	Disease or Syndrome	0.75	0.889	2003	2013	   5	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
      242	ALOX12B	0.603	0.577	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0239849	Harlequin Fetus	disease	C16;C17	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C1336708	Testicular Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C1855789	Self-Healing Collodion Baby	disease	C16;C17	Disease or Syndrome; Congenital Abnormality	0.30	1	2010	2010	   1	   0	ORPHANET
      242	ALOX12B	0.603	0.577	C1855792	ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1	disease	C16;C17	Disease or Syndrome	0.30				   0	   0	CTD_human
      242	ALOX12B	0.603	0.577	C3536797	Ichthyosis Congenita II	disease	C16;C17	Disease or Syndrome; Congenital Abnormality	0.30	1	2011	2011	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C3543867	Collodion Fetus	disease	C16;C17	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      242	ALOX12B	0.603	0.577	C3888093	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	disease	C16;C17	Disease or Syndrome	0.60	1	2002	2016	   5	  28	GENOMICS_ENGLAND;UNIPROT
      242	ALOX12B	0.603	0.577	C4551630	Ichthyosis Congenita I	disease	C16;C17	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      246	ALOX15	0.502	0.846	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.40	0.913	2004	2019	   1	   0	CTD_human
      246	ALOX15	0.502	0.846	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2001	2001	   1	   0	CTD_human
      246	ALOX15	0.502	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.32	1	2004	2018	   1	   0	CTD_human
      246	ALOX15	0.502	0.846	C0027430	Nasal Polyps	disease	C23;C08;C09	Disease or Syndrome	0.41	1	2019	2019	   1	   1	CTD_human
      246	ALOX15	0.502	0.846	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2001	2001	   1	   0	CTD_human
      246	ALOX15	0.502	0.846	C1135196	Heart Failure, Diastolic	disease	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      246	ALOX15	0.502	0.846	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
      249	ALPL	0.546	0.769	C0002382	Alveolar Bone Loss	disease	C05;C07	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      249	ALPL	0.546	0.769	C0005944	Metabolic Bone Disorder	group	C18;C05	Disease or Syndrome	0.33	1	2016	2019	   1	   0	CTD_human
      249	ALPL	0.546	0.769	C0006663	Calcinosis	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      249	ALPL	0.546	0.769	C0020503	Hyperparathyroidism, Secondary	disease	C19	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      249	ALPL	0.546	0.769	C0020630	Hypophosphatasia	disease	C16;C18	Disease or Syndrome	0.70	1	1992	2020	   3	  14	CTD_human;GENOMICS_ENGLAND
      249	ALPL	0.546	0.769	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.31	1	2007	2010	   1	   0	CTD_human
      249	ALPL	0.546	0.769	C0029453	Osteopenia	disease	C18;C05	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      249	ALPL	0.546	0.769	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.45	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      249	ALPL	0.546	0.769	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0220743	Childhood hypophosphatasia (disorder)	disease	C16;C18	Disease or Syndrome; Congenital Abnormality	0.93	1	1992	2019	   5	  17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      249	ALPL	0.546	0.769	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0263628	Tumoral calcinosis	disease	C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      249	ALPL	0.546	0.769	C0268412	Infantile hypophosphatasia	disease	C16;C18	Disease or Syndrome	1.00	1	1987	2019	   9	  72	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      249	ALPL	0.546	0.769	C0268413	Adult hypophosphatasia (disorder)	disease	C16;C18	Disease or Syndrome	0.95	0.975	1988	2019	  33	  54	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      249	ALPL	0.546	0.769	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0521174	Microcalcification	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      249	ALPL	0.546	0.769	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C1840322	ODONTOHYPOPHOSPHATASIA (disorder)	disease	C16;C18;C07	Disease or Syndrome	0.61	1	1995	2015	   2	   3	ORPHANET
      249	ALPL	0.546	0.769	C2673477	Hypophosphatasia, Perinatal Lethal	disease	C16;C18	Disease or Syndrome	0.60	1	1995	2013	   2	   2	ORPHANET
      249	ALPL	0.546	0.769	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.31	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1995	2016	   2	   0	CTD_human
      249	ALPL	0.546	0.769	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1995	2016	   2	   0	CTD_human
      251	ALPG	0.691	0.269	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      251	ALPG	0.691	0.269	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      251	ALPG	0.691	0.269	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      251	ALPG	0.691	0.269	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      257	ALX3	0.578	0.692	C0152427	Polydactyly	disease	C16;C05	Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
      257	ALX3	0.578	0.692	C1876203	Frontonasal dysplasia	disease	C16;C05	Congenital Abnormality	0.76	1	1980	2018	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      258	AMBN	0.716	0.231	C0399367	Amelogenesis imperfecta local hypoplastic form	disease	C16;C07	Congenital Abnormality	0.32	1	2001	2019	   1	   0	ORPHANET
      258	AMBN	0.716	0.231	C4225394	AMELOGENESIS IMPERFECTA, TYPE IF	disease		Disease or Syndrome	0.60	1	2016	2016	   1	   1	CTD_human;GENOMICS_ENGLAND
      259	AMBP	0.537	0.731	C0007138	Carcinoma, Transitional Cell	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      259	AMBP	0.537	0.731	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2017	2017	   1	   0	CTD_human
      259	AMBP	0.537	0.731	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2008	2008	   1	   0	CTD_human
      259	AMBP	0.537	0.731	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.31	0.667	1996	2017	   2	   0	CTD_human
      259	AMBP	0.537	0.731	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
      259	AMBP	0.537	0.731	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
      259	AMBP	0.537	0.731	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      259	AMBP	0.537	0.731	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      259	AMBP	0.537	0.731	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      259	AMBP	0.537	0.731	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	1996	2017	   2	   0	CTD_human
      259	AMBP	0.537	0.731	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	1996	2017	   2	   0	CTD_human
      259	AMBP	0.537	0.731	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      259	AMBP	0.537	0.731	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      259	AMBP	0.537	0.731	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      265	AMELX	0.599	0.769	C0399372	Amelogenesis Imperfecta hypomaturation type	disease	C16;C07	Congenital Abnormality	0.30	1	2012	2012	   1	   0	ORPHANET
      265	AMELX	0.599	0.769	C1845052	AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1	disease	C16;C07	Disease or Syndrome	0.32	1	1995	1997	   0	   0	CTD_human
      265	AMELX	0.599	0.769	C1845053	Amelogenesis Imperfecta, Hypomaturation Type, with Snow-Capped Teeth	disease	C16;C07	Disease or Syndrome	0.60	1	1993	2004	   6	   0	GENOMICS_ENGLAND;UNIPROT
      266	AMELY	0.743	0.269	C0010093	Corpus Luteum Cyst	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      266	AMELY	0.743	0.269	C0029927	Ovarian Cysts	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      267	AMFR	0.599	0.692	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.31	1	2012	2019	   1	   0	CTD_human
      267	AMFR	0.599	0.692	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.30	1	1997	1997	   1	   0	CTD_human
      267	AMFR	0.599	0.692	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	1997	1997	   1	   0	CTD_human
      267	AMFR	0.599	0.692	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.32	1	2006	2016	   0	   1	UNIPROT
      267	AMFR	0.599	0.692	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
      267	AMFR	0.599	0.692	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	1997	1997	   1	   0	CTD_human
      267	AMFR	0.599	0.692	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      267	AMFR	0.599	0.692	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
      267	AMFR	0.599	0.692	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
      267	AMFR	0.599	0.692	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
      267	AMFR	0.599	0.692	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      268	AMH	0.476	0.846	C1720887	Female Urogenital Diseases	group	C13	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      268	AMH	0.476	0.846	C1849930	Persistent Mullerian duct syndrome	disease	C16;C13;C12;C19	Anatomical Abnormality	0.80	0.958	1991	2020	   4	   7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      269	AMHR2	0.638	0.423	C1720887	Female Urogenital Diseases	group	C13	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      269	AMHR2	0.638	0.423	C1849930	Persistent Mullerian duct syndrome	disease	C16;C13;C12;C19	Anatomical Abnormality	0.89	1	1996	2019	   4	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      270	AMPD1	0.573	0.692	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      270	AMPD1	0.573	0.692	C0026846	Muscular Atrophy	phenotype	C23;C10	Pathologic Function	0.30	1	2000	2000	   1	   0	CTD_human
      270	AMPD1	0.573	0.692	C0026848	Myopathy	group	C05;C10	Disease or Syndrome	0.31	1	2000	2008	   2	   0	CTD_human
      270	AMPD1	0.573	0.692	C0035410	Rhabdomyolysis	phenotype	C05	Pathologic Function	0.30	1	2009	2009	   1	   0	GENOMICS_ENGLAND
      270	AMPD1	0.573	0.692	C0151786	Muscle Weakness	phenotype	C23;C05;C10	Sign or Symptom	0.41	1	2000	2000	   1	   0	CTD_human
      270	AMPD1	0.573	0.692	C0268123	Muscle AMP deaminase deficiency	disease	C16;C18	Disease or Syndrome	0.33	1	1993	2017	   0	   0	ORPHANET
      270	AMPD1	0.573	0.692	C0270948	Neurogenic Muscular Atrophy	phenotype	C23;C10	Pathologic Function	0.30	1	2000	2000	   1	   0	CTD_human
      270	AMPD1	0.573	0.692	C2931781	Adenosine monophosphate deaminase deficiency	disease	C16;C18	Disease or Syndrome	0.50	1	1992	2000	   3	   0	CTD_human;ORPHANET
      270	AMPD1	0.573	0.692	C3714933	MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	disease		Disease or Syndrome	0.70	1	2000	2016	   3	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
      271	AMPD2	0.663	0.577	C0266468	Congenital pontocerebellar hypoplasia	disease	C10	Congenital Abnormality	0.32	1	2013	2018	   1	   0	GENOMICS_ENGLAND
      271	AMPD2	0.663	0.577	C3810295	SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.60	1	2014	2016	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
      271	AMPD2	0.663	0.577	C4014354	PONTOCEREBELLAR HYPOPLASIA, TYPE 9	disease		Disease or Syndrome	0.73	1	2013	2020	   3	   7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      272	AMPD3	0.743	0.385	C0268123	Muscle AMP deaminase deficiency	disease	C16;C18	Disease or Syndrome	0.30	1	1994	2001	   2	   0	ORPHANET
      272	AMPD3	0.743	0.385	C2752073	Erythrocyte Amp Deaminase Deficiency	disease	C05;C10	Disease or Syndrome	0.60	1	1994	2001	   4	   8	CTD_human;UNIPROT
      272	AMPD3	0.743	0.385	C2931781	Adenosine monophosphate deaminase deficiency	disease	C16;C18	Disease or Syndrome	0.30	1	1994	2001	   2	   0	ORPHANET
      274	BIN1	0.55	0.692	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.50	0.98	2011	2020	   1	   6	CTD_human
      274	BIN1	0.55	0.692	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.31	0.5	2011	2013	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C0175709	Centronuclear myopathy	disease	C05;C10	Disease or Syndrome	0.40	1	2007	2019	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C0234985	Mental deterioration	phenotype	F03	Mental or Behavioral Dysfunction	0.31	1	2016	2018	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.31	1	2011	2013	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C0338656	Impaired cognition	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2014	2018	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C0410203	X-linked centronuclear myopathy	disease	C05;C10	Congenital Abnormality	0.31	1	2007	2009	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C0410204	Myopathy, Centronuclear, Autosomal Recessive	disease	C05;C10	Disease or Syndrome; Congenital Abnormality	0.73	1	2007	2018	   4	   9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      274	BIN1	0.55	0.692	C0410207	Tubular Aggregate Myopathy	disease	C05;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.40	1	2011	2020	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C0546264	Congenital Fiber Type Disproportion	disease	C05;C10	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C0752282	Congenital Structural Myopathy	disease	C05;C10	Disease or Syndrome	0.31	1	2007	2007	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C1270972	Mild cognitive disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2018	2019	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C1834558	Myopathy, Centronuclear, Autosomal Dominant	disease	C05;C10	Disease or Syndrome	0.51	1	2007	2014	   2	   0	CTD_human;ORPHANET
      274	BIN1	0.55	0.692	C3645536	Autosomal Recessive Centronuclear Myopathy	disease	C05;C10	Disease or Syndrome	0.53	1	2007	2013	   1	   0	CTD_human;ORPHANET
      274	BIN1	0.55	0.692	C3661489	Autosomal Dominant Myotubular Myopathy	disease	C05;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      274	BIN1	0.55	0.692	C4551952	Myopathy, Centronuclear, 1	disease	C05;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      275	AMT	0.674	0.692	C0268561	Hyperglycinemia, Nonketotic, Type I	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      275	AMT	0.674	0.692	C0268562	Hyperglycinemia, Nonketotic, Type II	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      275	AMT	0.674	0.692	C0751747	Hyperglycinemia, Nonketotic, Type III	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      275	AMT	0.674	0.692	C0751748	Nonketotic Hyperglycinemia	disease	C16;C18;C10	Disease or Syndrome	0.80	1	1983	2019	  15	  43	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      283	ANG	0.511	0.769	C0001349	Acute-Phase Reaction	phenotype	C23	Pathologic Function	0.30	1	1998	1998	   1	   0	CTD_human
      283	ANG	0.511	0.769	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.50	0.959	2004	2019	   1	   0	ORPHANET
      283	ANG	0.511	0.769	C0010093	Corpus Luteum Cyst	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      283	ANG	0.511	0.769	C0029927	Ovarian Cysts	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      283	ANG	0.511	0.769	C2678468	Amyotrophic Lateral Sclerosis 9	disease	C18;C10	Disease or Syndrome	0.70	1	2004	2015	   9	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
      284	ANGPT1	0.446	0.808	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.31	1	2008	2008	   2	   0	CTD_human
      284	ANGPT1	0.446	0.808	C0020564	Hypertrophy	phenotype	C23	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      284	ANGPT1	0.446	0.808	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      284	ANGPT1	0.446	0.808	C0034189	Pyemia	phenotype	C23;C01	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
      284	ANGPT1	0.446	0.808	C0036690	Septicemia	disease	C23;C01	Disease or Syndrome	0.40	1	2005	2019	   1	   0	CTD_human
      284	ANGPT1	0.446	0.808	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.40	1	2005	2019	   1	   0	CTD_human
      284	ANGPT1	0.446	0.808	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.31	1	2008	2009	   2	   0	CTD_human
      284	ANGPT1	0.446	0.808	C1719672	Severe Sepsis	disease	C23;C01	Disease or Syndrome	0.32	1	2005	2019	   1	   0	CTD_human
      285	ANGPT2	0.41	0.846	C0018923	Hemangiosarcoma	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      286	ANK1	0.54	0.885	C0005941	Bone Diseases, Developmental	group	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      286	ANK1	0.54	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
      286	ANK1	0.54	0.885	C0037889	Hereditary spherocytosis	disease	C16;C15	Disease or Syndrome	0.40	0.969	1990	2020	   1	   0	ORPHANET
      286	ANK1	0.54	0.885	C0221409	Anemia, hereditary spherocytic hemolytic	disease	C23;C16;C15	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
      286	ANK1	0.54	0.885	C2674218	SPHEROCYTOSIS, TYPE 1 (disorder)	disease	C16;C15	Disease or Syndrome	0.91	1	1980	2011	   3	  12	CTD_human;GENOMICS_ENGLAND;UNIPROT
      286	ANK1	0.54	0.885	C4304505	8p11.2 deletion syndrome	disease		Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
      287	ANK2	0.626	0.538	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
      287	ANK2	0.626	0.538	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      287	ANK2	0.626	0.538	C0035828	Romano-Ward Syndrome	disease	C23;C16;C14	Disease or Syndrome	0.30	1	2003	2009	   3	   0	ORPHANET
      287	ANK2	0.626	0.538	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      287	ANK2	0.626	0.538	C0751956	Acute Cerebrovascular Accidents	disease	C10;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      287	ANK2	0.626	0.538	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.30	1	2004	2016	   4	   0	CLINGEN
      287	ANK2	0.626	0.538	C1535926	Neurodevelopmental Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
      287	ANK2	0.626	0.538	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	disease	C23;C14	Disease or Syndrome	0.32	1	2005	2017	   0	   0	GENOMICS_ENGLAND
      287	ANK2	0.626	0.538	C1970119	CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED	disease	C23;C14	Disease or Syndrome	0.75	1	2003	2017	   5	   6	CTD_human;GENOMICS_ENGLAND;UNIPROT
      288	ANK3	0.578	0.654	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.70	1	2008	2020	   8	  33	CTD_human;PSYGENET
      288	ANK3	0.578	0.654	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2019	   3	   0	CTD_human
      288	ANK3	0.578	0.654	C0015923	Fetal Alcohol Syndrome	disease	C16;C13;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2019	   3	   0	CTD_human
      288	ANK3	0.578	0.654	C0033300	Progeria	disease	C16;C18	Disease or Syndrome	0.31	1	2006	2016	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.33	1	2014	2014	   2	   0	PSYGENET
      288	ANK3	0.578	0.654	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.50	1	2009	2018	   3	   3	PSYGENET
      288	ANK3	0.578	0.654	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.50	1	2009	2009	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C0178417	Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
      288	ANK3	0.578	0.654	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2019	   3	   0	CTD_human
      288	ANK3	0.578	0.654	C0349204	Nonorganic psychosis	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2014	2014	   1	   0	PSYGENET
      288	ANK3	0.578	0.654	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2014	   2	   0	PSYGENET
      288	ANK3	0.578	0.654	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C0814154	Alcohol Related Neurodevelopmental Disorder	disease	C16;C13;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C2985290	Fetal Alcohol Spectrum Disorders	group	C16;C13;C25	Disease or Syndrome; Congenital Abnormality	0.30	1	2018	2018	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C3146244	Alcohol Related Birth Defect	disease	C16;C13;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C3661483	Partial Fetal Alcohol Syndrome	disease	C16;C13;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      288	ANK3	0.578	0.654	C3809672	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	disease		Disease or Syndrome	0.70	1	2013	2013	   1	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
      290	ANPEP	0.462	0.769	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      290	ANPEP	0.462	0.769	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      290	ANPEP	0.462	0.769	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	PSYGENET
      290	ANPEP	0.462	0.769	C0149821	ACUTE ALCOHOL WITHDRAWAL	disease		Disease or Syndrome	0.30	1	2007	2007	   1	   0	PSYGENET
      290	ANPEP	0.462	0.769	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
      291	SLC25A4	0.568	0.692	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.43	1	2003	2018	   2	   0	PSYGENET
      291	SLC25A4	0.568	0.692	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.40	1	2016	2017	   2	   1	GENOMICS_ENGLAND
      291	SLC25A4	0.568	0.692	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      291	SLC25A4	0.568	0.692	C0162670	Mitochondrial Myopathies	group	C18;C05;C10	Disease or Syndrome	0.42	1	2008	2016	   1	   1	GENOMICS_ENGLAND
      291	SLC25A4	0.568	0.692	C0369183	Erythrocyte Mean Corpuscular Hemoglobin Test	phenotype		Laboratory Procedure	0.30				   0	   0	GENOMICS_ENGLAND
      291	SLC25A4	0.568	0.692	C0853897	Diabetic Cardiomyopathies	disease	C19;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      291	SLC25A4	0.568	0.692	C0949658	Cardiomyopathy, Hypertrophic, Familial	disease	C16;C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      291	SLC25A4	0.568	0.692	C1261502	Finding of Mean Corpuscular Hemoglobin	phenotype		Finding	0.30				   0	   0	GENOMICS_ENGLAND
      291	SLC25A4	0.568	0.692	C1834846	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 1	disease	C23;C18;C11;C10	Disease or Syndrome	0.30	1	2000	2011	   2	   0	ORPHANET
      291	SLC25A4	0.568	0.692	C1836460	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 2	disease	C23;C18;C11;C05;C10	Disease or Syndrome	0.70	1	2000	2017	   9	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
      291	SLC25A4	0.568	0.692	C1859317	Cataract and cardiomyopathy	disease	C11;C14	Disease or Syndrome	0.31	1	2002	2012	   1	   0	ORPHANET
      291	SLC25A4	0.568	0.692	C2676780	Progeroid Syndrome, Congenital, Petty Type	phenotype	C23;C16;C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      291	SLC25A4	0.568	0.692	C3809443	MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.70	1	2005	2017	   6	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
      291	SLC25A4	0.568	0.692	C4310676	MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT	disease		Disease or Syndrome	0.70	1	2016	2017	   2	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
      291	SLC25A4	0.568	0.692	C4321247	Mitochondrial DNA Depletion Syndrome 12	disease		Disease or Syndrome	0.30	1	1989	2015	  10	   0	CLINGEN
      301	ANXA1	0.442	0.885	C0007097	Carcinoma	group	C04	Neoplastic Process	0.33	1	2002	2013	   2	   0	CTD_human
      301	ANXA1	0.442	0.885	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.38	1	1996	2017	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.50	1	2006	2012	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.32	1	2010	2018	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	1996	2014	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C0024232	Lymphatic Metastasis	disease	C23;C04	Neoplastic Process	0.31	1	2010	2012	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2012	   3	   0	CTD_human
      301	ANXA1	0.442	0.885	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.50	1	2002	2005	   2	   0	CTD_human
      301	ANXA1	0.442	0.885	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.60	0.958	1998	2019	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.33	1	2005	2016	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C0038354	Stomach Diseases	group	C06	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.33	1	1998	2018	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.31	1	2004	2010	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2005	   2	   0	CTD_human
      301	ANXA1	0.442	0.885	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2005	   2	   0	CTD_human
      301	ANXA1	0.442	0.885	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2005	   2	   0	CTD_human
      301	ANXA1	0.442	0.885	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2005	   2	   0	CTD_human
      301	ANXA1	0.442	0.885	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.35	1	2004	2019	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.39	1	2002	2017	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
      301	ANXA1	0.442	0.885	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2012	   3	   0	CTD_human
      302	ANXA2	0.453	0.808	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.34	1	2004	2017	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.32	1	2002	2019	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2009	2015	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.31	1	2010	2014	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.31	1	2008	2011	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.36	1	2008	2018	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.33	1	2009	2019	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      302	ANXA2	0.453	0.808	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      306	ANXA3	0.61	0.615	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.40	1	2012	2012	   1	   1	CTD_human
      306	ANXA3	0.61	0.615	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      306	ANXA3	0.61	0.615	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.31	1	2012	2012	   1	   0	CTD_human
      306	ANXA3	0.61	0.615	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      306	ANXA3	0.61	0.615	C0242380	Libman-Sacks Disease	disease	C17;C20	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      306	ANXA3	0.61	0.615	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.33	1	2007	2017	   1	   0	CTD_human
      306	ANXA3	0.61	0.615	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.31	1	2010	2012	   1	   0	CTD_human
      306	ANXA3	0.61	0.615	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.31	1	2010	2012	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.33	1	2004	2011	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.33	1	2007	2019	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.32	1	2004	2011	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2007	2016	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      307	ANXA4	0.599	0.692	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2012	2017	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.31	1	2004	2019	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C0019202	Hepatolenticular Degeneration	disease	C16;C06;C18;C10	Disease or Syndrome	0.50	1	2011	2011	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.31	1	2000	2007	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.31	1	2006	2010	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C0032914	Pre-Eclampsia	phenotype	C13	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.32	1	2010	2018	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C1527352	Hepatic Form of Wilson Disease	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      308	ANXA5	0.458	0.769	C3280674	PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3	phenotype		Finding	0.30				   0	   0	CTD_human
      309	ANXA6	0.514	0.846	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
      309	ANXA6	0.514	0.846	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      309	ANXA6	0.514	0.846	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      309	ANXA6	0.514	0.846	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      309	ANXA6	0.514	0.846	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      309	ANXA6	0.514	0.846	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      309	ANXA6	0.514	0.846	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      309	ANXA6	0.514	0.846	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      309	ANXA6	0.514	0.846	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      310	ANXA7	0.631	0.615	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      310	ANXA7	0.631	0.615	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.32	1	2013	2014	   1	   0	CTD_human
      311	ANXA11	0.65	0.692	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.44	1	2017	2019	   1	   0	ORPHANET
      311	ANXA11	0.65	0.692	C0036202	Sarcoidosis	disease	C15	Disease or Syndrome	0.50	0.909	2008	2018	   1	   5	CTD_human
      311	ANXA11	0.65	0.692	C4693381	AMYOTROPHIC LATERAL SCLEROSIS 23	disease		Disease or Syndrome	0.60	1	2017	2018	   2	   6	GENOMICS_ENGLAND;UNIPROT
      313	AOAH	0.722	0.462	C0236733	Amphetamine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      313	AOAH	0.722	0.462	C0236804	Amphetamine Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      313	AOAH	0.722	0.462	C0236807	Amphetamine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      316	AOX1	0.716	0.308	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      316	AOX1	0.716	0.308	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.34	1	2009	2018	   1	   0	CTD_human
      317	APAF1	0.525	0.769	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.33	1	2006	2012	   1	   0	CTD_human
      317	APAF1	0.525	0.769	C0007138	Carcinoma, Transitional Cell	disease	C04	Neoplastic Process	0.32	1	2006	2007	   1	   0	CTD_human
      317	APAF1	0.525	0.769	C0015393	Eye Abnormalities	group	C16;C11	Congenital Abnormality	0.30	1	1998	1998	   1	   0	CTD_human
      317	APAF1	0.525	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      317	APAF1	0.525	0.769	C0035305	Retinal Detachment	disease	C11	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      317	APAF1	0.525	0.769	C0037268	Skin Abnormalities	group	C16;C17	Congenital Abnormality	0.30	1	1998	1998	   1	   0	CTD_human
      317	APAF1	0.525	0.769	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2006	2010	   2	   0	PSYGENET
      317	APAF1	0.525	0.769	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.34	1	2006	2015	   1	   0	CTD_human
      317	APAF1	0.525	0.769	C0339546	Retinal Pigment Epithelial Detachment	disease	C11	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      317	APAF1	0.525	0.769	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	1998	1998	   2	   0	CTD_human
      317	APAF1	0.525	0.769	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      317	APAF1	0.525	0.769	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      317	APAF1	0.525	0.769	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      317	APAF1	0.525	0.769	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2006	2010	   2	   0	PSYGENET
      317	APAF1	0.525	0.769	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      318	NUDT2	0.78	0.154	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      318	NUDT2	0.78	0.154	C0026827	Muscle hypotonia	phenotype	C23;C10	Finding	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      318	NUDT2	0.78	0.154	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      318	NUDT2	0.78	0.154	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.31	1	2011	2011	   1	   0	CTD_human
      318	NUDT2	0.78	0.154	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      318	NUDT2	0.78	0.154	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      318	NUDT2	0.78	0.154	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      318	NUDT2	0.78	0.154	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      319	APOF	0.805	0.231	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2015	2017	   1	   0	CTD_human
      321	APBA2	0.7	0.385	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	PSYGENET
      321	APBA2	0.7	0.385	C0037274	Dermatologic disorders	group	C17	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      323	APBB2	0.76	0.231	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      324	APC	0.373	0.962	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.40	0.982	1992	2019	   2	   0	CTD_human
      324	APC	0.373	0.962	C0001430	Adenoma	group	C04	Neoplastic Process	0.40	0.967	1990	2018	   5	   0	CTD_human
      324	APC	0.373	0.962	C0002886	Anemia, Macrocytic	disease	C15	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      324	APC	0.373	0.962	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	1994	2007	   2	   0	CTD_human
      324	APC	0.373	0.962	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.945	1992	2020	   0	   0	CGI
      324	APC	0.373	0.962	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.50	0.948	1992	2019	   7	   4	CTD_human
      324	APC	0.373	0.962	C0007113	Rectal Carcinoma	disease	C06;C04	Neoplastic Process	0.37	1	1994	2018	   2	   0	CTD_human
      324	APC	0.373	0.962	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.40	1	1992	2018	   1	   0	CTD_human
      324	APC	0.373	0.962	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2009	2011	   2	   0	CTD_human
      324	APC	0.373	0.962	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.60	0.949	1990	2019	   7	   0	CTD_human
      324	APC	0.373	0.962	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.80	0.972	1990	2020	   7	  16	CTD_human;GENOMICS_ENGLAND;UNIPROT
      324	APC	0.373	0.962	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.90	0.982	1990	2019	   7	  12	CTD_human;UNIPROT
      324	APC	0.373	0.962	C0009405	Hereditary Nonpolyposis Colorectal Neoplasms	group	C16;C06;C04;C18	Neoplastic Process	0.30	1	1995	1995	   1	   0	CTD_human
      324	APC	0.373	0.962	C0015393	Eye Abnormalities	group	C16;C11	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      324	APC	0.373	0.962	C0017097	Gardner Syndrome	disease	C16;C06;C04	Disease or Syndrome	0.50	0.938	1991	2018	   0	  10	GENOMICS_ENGLAND
      324	APC	0.373	0.962	C0017181	Gastrointestinal Hemorrhage	phenotype	C23;C06	Pathologic Function	0.40	1	2014	2014	   1	   0	CTD_human
      324	APC	0.373	0.962	C0017185	Gastrointestinal Neoplasms	group	C06;C04	Neoplastic Process	0.33	1	1998	2011	   1	   0	CTD_human
      324	APC	0.373	0.962	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.34	1	1995	2019	   1	   0	CTD_human
      324	APC	0.373	0.962	C0017638	Glioma	disease	C04	Neoplastic Process	0.32	1	1997	2018	   0	   0	CGI
      324	APC	0.373	0.962	C0018932	Hematochezia	phenotype	C23;C06	Disease or Syndrome	0.40	1	2014	2014	   1	   0	CTD_human
      324	APC	0.373	0.962	C0020473	Hyperlipidemia	disease	C18	Disease or Syndrome	0.32	1	2006	2016	   1	   0	CTD_human
      324	APC	0.373	0.962	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1994	1994	   1	   0	CTD_human
      324	APC	0.373	0.962	C0021390	Inflammatory Bowel Diseases	group	C06	Disease or Syndrome	0.37	0.875	1997	2016	   1	   0	CTD_human
      324	APC	0.373	0.962	C0021841	Intestinal Neoplasms	group	C06;C04	Neoplastic Process	0.40	0.913	1994	2019	   6	   0	CTD_human
      324	APC	0.373	0.962	C0021846	Intestinal Polyps	phenotype	C23	Anatomical Abnormality	0.49	1	1995	2017	   3	   1	CTD_human
      324	APC	0.373	0.962	C0023518	Leukocytosis	phenotype	C23;C15	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      324	APC	0.373	0.962	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.54	1	1997	2016	   1	   0	CTD_human
      324	APC	0.373	0.962	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.32	1	2002	2014	   1	   0	CTD_human
      324	APC	0.373	0.962	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.70	0.95	1992	2019	   0	   0	CGI;CTD_human
      324	APC	0.373	0.962	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	1997	1997	   1	   0	CTD_human
      324	APC	0.373	0.962	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.70	1	1995	2020	   2	   2	CTD_human;UNIPROT
      324	APC	0.373	0.962	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1994	1994	   1	   0	CTD_human
      324	APC	0.373	0.962	C0025500	Mesothelioma	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      324	APC	0.373	0.962	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.43	1	2002	2017	   0	   0	CGI
      324	APC	0.373	0.962	C0032580	Adenomatous Polyposis Coli	disease	C16;C06;C04	Neoplastic Process	1.00	0.961	1989	2020	  24	 160	CTD_human;GENOMICS_ENGLAND;UNIPROT
      324	APC	0.373	0.962	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.52	1	2007	2018	   2	   0	CTD_human
      324	APC	0.373	0.962	C0034885	Rectal Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	1994	2005	   2	   0	CTD_human
      324	APC	0.373	0.962	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      324	APC	0.373	0.962	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2005	2005	   1	   0	PSYGENET
      324	APC	0.373	0.962	C0038002	Splenomegaly	phenotype	C23	Finding	0.30	1	2016	2016	   1	   0	CTD_human
      324	APC	0.373	0.962	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.64	1	1993	2019	   0	  12	CGI;CTD_human
      324	APC	0.373	0.962	C0079218	Fibromatosis, Aggressive	disease	C04	Neoplastic Process	0.80	1	1993	2019	   1	   1	CGI;CTD_human;ORPHANET
      324	APC	0.373	0.962	C0085136	Central Nervous System Neoplasms	group	C04;C10	Neoplastic Process	0.31	0	2007	2007	   0	   0	CGI
      324	APC	0.373	0.962	C0151857	Pleocytosis	disease	C23;C15	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      324	APC	0.373	0.962	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.41	1	2008	2018	   0	   1	CGI
      324	APC	0.373	0.962	C0153943	Benign neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      324	APC	0.373	0.962	C0154060	Carcinoma in situ of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      324	APC	0.373	0.962	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	1997	2005	   2	   0	CTD_human
      324	APC	0.373	0.962	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	1997	2005	   2	   0	CTD_human
      324	APC	0.373	0.962	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	1997	2005	   2	   0	CTD_human
      324	APC	0.373	0.962	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	1997	2005	   2	   0	CTD_human
      324	APC	0.373	0.962	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	1997	2005	   2	   0	CTD_human
      324	APC	0.373	0.962	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.31	1	1997	2018	   5	   0	CTD_human
      324	APC	0.373	0.962	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.30	1	1997	2018	   5	   0	CTD_human
      324	APC	0.373	0.962	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.30	1	1997	2018	   5	   0	CTD_human
      324	APC	0.373	0.962	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	1997	2018	   5	   0	CTD_human
      324	APC	0.373	0.962	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	1997	2018	   5	   0	CTD_human
      324	APC	0.373	0.962	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	1997	2018	   5	   0	CTD_human
      324	APC	0.373	0.962	C0205833	Medullomyoblastoma	disease	C04	Neoplastic Process	0.30	1	1995	1995	   1	   0	CTD_human
      324	APC	0.373	0.962	C0206624	Hepatoblastoma	disease	C04	Neoplastic Process	0.70	0.947	1995	2019	   0	   1	CGI
      324	APC	0.373	0.962	C0206646	Fibromatosis, Abdominal	disease	C04	Neoplastic Process	0.31	1	1997	2000	   1	   0	CTD_human
      324	APC	0.373	0.962	C0206677	Adenomatous Polyps	disease	C04	Neoplastic Process	0.40	1	1992	2019	   1	   0	CTD_human
      324	APC	0.373	0.962	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.39	1	1992	2019	   0	   0	CGI
      324	APC	0.373	0.962	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	1	1992	2018	   1	   0	CTD_human
      324	APC	0.373	0.962	C0265325	Turcot syndrome (disorder)	disease	C16;C06;C04;C10	Disease or Syndrome	0.40	1	1994	2018	   1	   0	CTD_human
      324	APC	0.373	0.962	C0278510	Childhood Medulloblastoma	disease	C04	Neoplastic Process	0.38	1	1995	2020	   1	   0	CTD_human
      324	APC	0.373	0.962	C0278876	Adult Medulloblastoma	disease	C04	Neoplastic Process	0.38	1	1995	2020	   1	   0	CTD_human
      324	APC	0.373	0.962	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	1995	1995	   1	   0	CTD_human
      324	APC	0.373	0.962	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.51	1	2016	2018	   1	   0	CTD_human
      324	APC	0.373	0.962	C0346627	Intestinal Cancer	disease	C06;C04	Neoplastic Process	0.35	1	1997	2018	   6	   0	CTD_human
      324	APC	0.373	0.962	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.40	1	1992	2019	   0	   0	CGI
      324	APC	0.373	0.962	C0347284	Benign tumor of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30				   0	   0	CGI
      324	APC	0.373	0.962	C0348374	Malignant Central Nervous System Neoplasm	disease	C04;C10	Neoplastic Process	0.30				   0	   0	CGI
      324	APC	0.373	0.962	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.70	0.96	1994	2019	   2	   0	CTD_human
      324	APC	0.373	0.962	C0496905	Neoplasm of uncertain or unknown behavior of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      324	APC	0.373	0.962	C0685938	Malignant neoplasm of gastrointestinal tract	disease	C06;C04	Neoplastic Process	0.32	1	1999	2011	   1	   0	CTD_human
      324	APC	0.373	0.962	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	1992	2019	   0	   3	CGI
      324	APC	0.373	0.962	C0751291	Desmoplastic Medulloblastoma	disease	C04	Neoplastic Process	0.30	1	1995	1995	   1	   0	CTD_human
      324	APC	0.373	0.962	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1994	1994	   1	   0	CTD_human
      324	APC	0.373	0.962	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	1997	1997	   1	   0	CTD_human
      324	APC	0.373	0.962	C1275668	Melanotic medulloblastoma	disease	C04	Neoplastic Process	0.30	1	1995	1995	   1	   0	CTD_human
      324	APC	0.373	0.962	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.41	1	1995	2019	   0	   1	CGI
      324	APC	0.373	0.962	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.40	0.931	1992	2018	   1	   0	CTD_human
      324	APC	0.373	0.962	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.43	1	1995	2019	   1	   0	CTD_human
      324	APC	0.373	0.962	C1706412	Lipidemias	phenotype	C18	Finding	0.30	1	2007	2007	   1	   0	CTD_human
      324	APC	0.373	0.962	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.32	1	2001	2011	   0	   0	CTD_human
      324	APC	0.373	0.962	C1851124	Desmoid disease, hereditary	disease	C16;C06;C04	Disease or Syndrome	0.64	1	1996	2011	   0	  11	CTD_human;GENOMICS_ENGLAND
      324	APC	0.373	0.962	C1859309	Syndactyly Cenani Lenz type	disease	C16;C05	Disease or Syndrome	0.31	1	2015	2015	   1	   0	ORPHANET
      324	APC	0.373	0.962	C1879526	Aberrant Crypt Foci	phenotype	C04	Finding	0.30	1	2003	2003	   1	   0	CTD_human
      324	APC	0.373	0.962	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.70	0.963	1993	2019	   0	  11	CTD_human
      324	APC	0.373	0.962	C2675440	Desmoid Tumor Caused By Somatic Mutation	disease	C16;C06;C04	Disease or Syndrome	0.30				   0	   0	CTD_human
      324	APC	0.373	0.962	C2713442	Polyposis, Adenomatous Intestinal	disease	C16;C06;C04	Disease or Syndrome	0.40	1	1991	2017	  11	 332	CTD_human
      324	APC	0.373	0.962	C2713443	Familial Intestinal Polyposis	disease	C16;C06;C04	Disease or Syndrome	0.30	1	1994	2017	  11	   0	CTD_human
      324	APC	0.373	0.962	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.31	1	1994	2001	   1	   0	CTD_human
      324	APC	0.373	0.962	C4552100	Lynch Syndrome	disease	C16;C06;C04;C18	Disease or Syndrome	0.40	1	1995	2018	   1	   0	CTD_human
      325	APCS	0.531	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	1	2014	2017	   0	   0	UNIPROT
      325	APCS	0.531	0.808	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      325	APCS	0.531	0.808	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      325	APCS	0.531	0.808	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      325	APCS	0.531	0.808	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      325	APCS	0.531	0.808	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      325	APCS	0.531	0.808	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      325	APCS	0.531	0.808	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      325	APCS	0.531	0.808	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.34	0.8	2003	2014	   1	   0	CTD_human
      325	APCS	0.531	0.808	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      325	APCS	0.531	0.808	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
      325	APCS	0.531	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2008	2009	   1	   0	CTD_human
      326	AIRE	0.516	0.808	C0001403	Addison Disease	disease	C20;C19	Disease or Syndrome	0.45	1	2001	2017	   0	   0	GENOMICS_ENGLAND
      326	AIRE	0.516	0.808	C0006840	Candidiasis	disease	C01	Disease or Syndrome	0.40	0.833	2002	2011	   1	   0	CTD_human
      326	AIRE	0.516	0.808	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      326	AIRE	0.516	0.808	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2015	2018	   1	   0	CTD_human
      326	AIRE	0.516	0.808	C0085409	Polyendocrinopathies, Autoimmune	group	C20;C19	Disease or Syndrome	0.40	1	1998	2019	   1	   0	CTD_human
      326	AIRE	0.516	0.808	C0085859	Polyglandular Type I Autoimmune Syndrome	disease	C20;C19	Disease or Syndrome	1.00	0.985	1991	2020	  24	  73	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      326	AIRE	0.516	0.808	C0085860	Autoimmune Syndrome Type II, Polyglandular	disease	C20;C19	Disease or Syndrome	0.34	1	2006	2016	   1	   0	CTD_human
      326	AIRE	0.516	0.808	C0342482	X-linked Adrenal Hypoplasia	disease	C19	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      326	AIRE	0.516	0.808	C1535942	Polyglandular Type III Autoimmune Syndrome	disease	C20;C19	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      326	AIRE	0.516	0.808	C1855868	Polyglandular Deficiency Syndrome, Persian-Jewish Type	disease	C20;C19	Disease or Syndrome	0.50	1	2002	2007	   0	   0	CTD_human
      326	AIRE	0.516	0.808	C1855869	Autoimmune Polyendocrinopathy Syndrome, Type I, Autosomal Dominant	disease	C20;C19	Disease or Syndrome	0.60	1	2002	2007	   0	   1	CTD_human
      326	AIRE	0.516	0.808	C2749602	AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME, TYPE I, WITH REVERSIBLE METAPHYSEAL DYSPLASIA	disease	C20;C19	Disease or Syndrome	0.40				   0	   2	CTD_human
      326	AIRE	0.516	0.808	C3494489	Autoimmune polyendocrinopathy syndrome, type 1	disease	C20;C19	Disease or Syndrome	0.60	0.988	1999	2020	   2	   0	CTD_human;ORPHANET
      328	APEX1	0.458	0.846	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.38	1	2008	2019	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	0.35	1	2005	2014	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2006	2018	   2	   0	CTD_human
      328	APEX1	0.458	0.846	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.35	1	2011	2018	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2011	2011	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.50	1	2005	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	1	2006	2019	   2	   0	CTD_human
      328	APEX1	0.458	0.846	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C1449861	Micronuclei, Chromosome-Defective	phenotype	C23	Cell Component	0.30	1	2012	2012	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C1449862	Micronuclei, Genotoxicant-Induced	phenotype	C23	Cell Component	0.30	1	2012	2012	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.857	2007	2019	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      328	APEX1	0.458	0.846	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      329	BIRC2	0.535	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	1	2014	2015	   1	   0	CTD_human
      329	BIRC2	0.535	0.731	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      329	BIRC2	0.535	0.731	C0023418	leukemia	disease	C04	Neoplastic Process	0.31	1	2003	2014	   1	   0	CTD_human
      329	BIRC2	0.535	0.731	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      329	BIRC2	0.535	0.731	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2004	2005	   1	   0	CTD_human
      329	BIRC2	0.535	0.731	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.33	1	2014	2015	   1	   0	CTD_human
      329	BIRC2	0.535	0.731	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      329	BIRC2	0.535	0.731	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      329	BIRC2	0.535	0.731	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      329	BIRC2	0.535	0.731	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      329	BIRC2	0.535	0.731	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      330	BIRC3	0.491	0.769	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.31	1	2003	2003	   1	   0	CTD_human
      330	BIRC3	0.491	0.769	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.31	1	2003	2003	   1	   0	CTD_human
      330	BIRC3	0.491	0.769	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      330	BIRC3	0.491	0.769	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      330	BIRC3	0.491	0.769	C0023418	leukemia	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      330	BIRC3	0.491	0.769	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	1	2004	2020	   0	   0	CGI
      330	BIRC3	0.491	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      330	BIRC3	0.491	0.769	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.32	1	2011	2015	   0	   0	CGI
      330	BIRC3	0.491	0.769	C0242647	Mucosa-Associated Lymphoid Tissue Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.60	0.971	1999	2016	   0	   0	CGI;ORPHANET
      330	BIRC3	0.491	0.769	C0334634	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CGI
      330	BIRC3	0.491	0.769	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.31	1	2011	2011	   1	   0	CTD_human
      330	BIRC3	0.491	0.769	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      331	XIAP	0.447	0.808	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.36	1	2007	2019	   1	   0	CTD_human
      331	XIAP	0.447	0.808	C0021390	Inflammatory Bowel Diseases	group	C06	Disease or Syndrome	0.40	1	2012	2020	   1	   0	GENOMICS_ENGLAND
      331	XIAP	0.447	0.808	C0024291	Lymphohistiocytosis, Hemophagocytic	disease	C15	Disease or Syndrome	0.40	1	2009	2020	   1	   0	GENOMICS_ENGLAND
      331	XIAP	0.447	0.808	C0024314	Lymphoproliferative Disorders	group	C20;C15	Neoplastic Process	0.31	1	2010	2010	   0	   0	CTD_human
      331	XIAP	0.447	0.808	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2003	2003	   1	   0	CTD_human
      331	XIAP	0.447	0.808	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      331	XIAP	0.447	0.808	C0038002	Splenomegaly	phenotype	C23	Finding	0.40	1	2012	2012	   1	   0	GENOMICS_ENGLAND
      331	XIAP	0.447	0.808	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.35	1	2007	2019	   1	   0	CTD_human
      331	XIAP	0.447	0.808	C0549463	X-Linked Lymphoproliferative Disorder	disease	C20;C15	Neoplastic Process	0.40	0.964	2006	2020	   0	   0	CTD_human
      331	XIAP	0.447	0.808	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.36	0.857	2002	2019	   1	   0	CTD_human
      331	XIAP	0.447	0.808	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.36	0.857	2003	2019	   1	   0	CTD_human
      331	XIAP	0.447	0.808	C1845076	Lymphoproliferative Syndrome, X-Linked, 2	disease	C16;C20;C15	Disease or Syndrome	0.69	1	2009	2020	   2	  13	CTD_human;GENOMICS_ENGLAND
      331	XIAP	0.447	0.808	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.31	1	2002	2002	   1	   0	CTD_human
      331	XIAP	0.447	0.808	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      331	XIAP	0.447	0.808	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.36	1	2002	2019	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.36	1	2004	2016	   2	   0	CTD_human
      332	BIRC5	0.495	0.731	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.30	1	2005	2009	   2	   0	CTD_human
      332	BIRC5	0.495	0.731	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.35	1	2005	2020	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.34	1	2002	2019	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.39	1	2001	2018	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0007873	Uterine Cervical Neoplasm	disease	C04;C13	Neoplastic Process	0.31	1	2005	2015	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.34	1	2004	2009	   2	   0	CTD_human
      332	BIRC5	0.495	0.731	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.39	1	2001	2016	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.36	1	2003	2008	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0014170	Endometrial Neoplasms	group	C04;C13	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0023462	Acute Megakaryocytic Leukemias	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0023493	Adult T-Cell Lymphoma/Leukemia	disease	C04;C20;C15	Neoplastic Process	0.32	1	2006	2013	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.39	1	2004	2009	   2	   0	CTD_human
      332	BIRC5	0.495	0.731	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.32	1	2005	2019	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.34	1	2003	2018	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.37	1	2002	2008	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.34	1	2005	2019	   2	   0	CTD_human
      332	BIRC5	0.495	0.731	C0262584	Carcinoma, Small Cell	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.32	1	2005	2019	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.33	1	2008	2019	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.32	1	2009	2019	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.37	1	2004	2016	   2	   0	CTD_human
      332	BIRC5	0.495	0.731	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.37	1	2005	2019	   4	   0	CTD_human
      332	BIRC5	0.495	0.731	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.33	1	2005	2018	   4	   0	CTD_human
      332	BIRC5	0.495	0.731	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2005	2006	   2	   0	CTD_human
      332	BIRC5	0.495	0.731	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	2005	2008	   2	   0	CTD_human
      332	BIRC5	0.495	0.731	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	2002	2018	   2	   0	CTD_human
      332	BIRC5	0.495	0.731	C4048328	cervical cancer	disease	C04;C13	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      332	BIRC5	0.495	0.731	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2005	2006	   2	   0	CTD_human
      334	APLP2	0.659	0.462	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2002	2002	   1	   0	CTD_human
      334	APLP2	0.659	0.462	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.31	1	2003	2004	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0004943	Behcet Syndrome	disease	C16;C11;C17;C07;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.40	0.935	1986	2019	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0011609	Drug Eruptions	group	C17;C20;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0013604	Edema	phenotype	C23	Pathologic Function	0.40	1	2011	2011	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0017665	Membranous glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2005	2005	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.32	1	2003	2018	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.36	0.833	1990	2019	   0	   0	GENOMICS_ENGLAND
      335	APOA1	0.429	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.70	1	2002	2019	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.31	1	2008	2011	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.31	1	2008	2009	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2004	2009	   2	   0	CTD_human
      335	APOA1	0.429	0.885	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2009	   2	   0	CTD_human
      335	APOA1	0.429	0.885	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.38	1	2002	2019	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0079221	Determination of Death	phenotype	C23	Diagnostic Procedure	0.30	1	2011	2011	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0086445	Idiopathic Membranous Glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0151603	Anasarca	phenotype	C23	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0154251	Lipid Metabolism Disorders	group	C18	Disease or Syndrome	0.31	1	1982	2015	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.31	1	2009	2018	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0242488	Acute Lung Injury	disease	C08	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0268389	Amyloidosis, familial visceral	disease	C16;C18	Disease or Syndrome	0.70	1	1988	2019	   8	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
      335	APOA1	0.429	0.885	C0268731	Renal glomerular disease	group	C23;C13;C12	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      335	APOA1	0.429	0.885	C0342898	Apolipoprotein A-I deficiency	phenotype	C16;C18	Pathologic Function	0.30	1	1993	1994	   2	   0	ORPHANET
      335	APOA1	0.429	0.885	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0376297	Cardiac Death	phenotype	C23	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0406537	Morbilliform Drug Reaction	disease	C17;C20;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0751956	Acute Cerebrovascular Accidents	disease	C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0853897	Diabetic Cardiomyopathies	disease	C19;C14	Disease or Syndrome	0.31	1	2008	2008	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.32	1	2005	2017	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C1704378	Heymann Nephritis	disease	C13;C12;C20	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C1704429	Hypoalphalipoproteinemia, Familial	disease	C16;C18	Disease or Syndrome	0.56	1	1986	2016	   3	   0	GENOMICS_ENGLAND;ORPHANET
      335	APOA1	0.429	0.885	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2004	2009	   2	   0	CTD_human
      335	APOA1	0.429	0.885	C1848533	Ataxia with vitamin E deficiency	disease	C23;C18;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.40	0.938	1986	2019	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	1991	2019	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C2362324	Pediatric Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C4087498	Familial LCAT deficiency	disease		Disease or Syndrome	0.30	1	1999	1999	   1	   0	GENOMICS_ENGLAND
      335	APOA1	0.429	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C4317171	Adolescent Obesity	phenotype	C23;C18	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C4521075	Childhood Overweight	phenotype	C23;C18	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C4521256	Glomerulopathy Assessment	phenotype		Diagnostic Procedure	0.30				   0	   0	GENOMICS_ENGLAND
      335	APOA1	0.429	0.885	C4553478	Infantile Obesity	phenotype	C23;C18	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C4704955	Infant Overweight	phenotype	C23;C18	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      335	APOA1	0.429	0.885	C4704956	Adolescent Overweight	phenotype	C23;C18	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      336	APOA2	0.582	0.769	C0020445	Hypercholesterolemia, Familial	disease	C16;C18	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      336	APOA2	0.582	0.769	C0745103	Hyperlipoproteinemia Type IIa	disease	C16;C18	Disease or Syndrome	0.51	1	2002	2002	   1	   0	CTD_human;GENOMICS_ENGLAND
      336	APOA2	0.582	0.769	C1704417	Hyperlipoproteinemia Type IIb	disease	C16;C18	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      337	APOA4	0.582	0.577	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.40	1	1994	2019	   1	   0	CTD_human
      337	APOA4	0.582	0.577	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      337	APOA4	0.582	0.577	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      337	APOA4	0.582	0.577	C0020445	Hypercholesterolemia, Familial	disease	C16;C18	Disease or Syndrome	0.32	1	1998	2005	   1	   0	CTD_human
      337	APOA4	0.582	0.577	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      337	APOA4	0.582	0.577	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      337	APOA4	0.582	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
      337	APOA4	0.582	0.577	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      337	APOA4	0.582	0.577	C0745103	Hyperlipoproteinemia Type IIa	disease	C16;C18	Disease or Syndrome	0.31	1	1998	2005	   1	   0	CTD_human
      337	APOA4	0.582	0.577	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
      337	APOA4	0.582	0.577	C1704417	Hyperlipoproteinemia Type IIb	disease	C16;C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      338	APOB	0.453	0.808	C0004943	Behcet Syndrome	disease	C16;C11;C17;C07;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      338	APOB	0.453	0.808	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.50	1	1995	2020	   2	   1	CTD_human
      338	APOB	0.453	0.808	C0007570	Celiac Disease	disease	C06;C18	Disease or Syndrome	0.31	1	2009	2018	   1	   0	CTD_human
      338	APOB	0.453	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2017	2017	   0	   0	UNIPROT
      338	APOB	0.453	0.808	C0010068	Coronary heart disease	disease	C14	Disease or Syndrome	0.50	0.96	1986	2019	   1	   1	CTD_human
      338	APOB	0.453	0.808	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.70	1	2001	2018	   2	   0	CTD_human
      338	APOB	0.453	0.808	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.90	0.985	1987	2019	   3	   0	CTD_human;GENOMICS_ENGLAND
      338	APOB	0.453	0.808	C0020445	Hypercholesterolemia, Familial	disease	C16;C18	Disease or Syndrome	0.70	0.986	1979	2019	   3	  29	CTD_human;GENOMICS_ENGLAND
      338	APOB	0.453	0.808	C0020473	Hyperlipidemia	disease	C18	Disease or Syndrome	0.50	1	1976	2020	   1	   0	CTD_human
      338	APOB	0.453	0.808	C0020557	Hypertriglyceridemia	phenotype	C18	Disease or Syndrome	0.60	1	1991	2019	   1	   0	CTD_human
      338	APOB	0.453	0.808	C0242339	Dyslipidemias	group	C18	Disease or Syndrome	0.40	1	1994	2019	   1	   0	CTD_human
      338	APOB	0.453	0.808	C0598784	Dyslipoproteinemias	phenotype	C18	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      338	APOB	0.453	0.808	C0745103	Hyperlipoproteinemia Type IIa	disease	C16;C18	Disease or Syndrome	0.50	0.992	1988	2019	   1	   2	CTD_human
      338	APOB	0.453	0.808	C1704299	Hypobetalipoproteinemia, Familial, Apolipoprotein B	disease	C18	Disease or Syndrome	0.31	1	1987	1995	   3	   0	CTD_human
      338	APOB	0.453	0.808	C1704417	Hyperlipoproteinemia Type IIb	disease	C16;C18	Disease or Syndrome	0.80	0.986	1978	2018	  17	  11	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      338	APOB	0.453	0.808	C1706412	Lipidemias	phenotype	C18	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      338	APOB	0.453	0.808	C1848533	Ataxia with vitamin E deficiency	disease	C23;C18;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      338	APOB	0.453	0.808	C1862596	Familial hypobetalipoproteinemia	disease	C18	Disease or Syndrome	0.50	0.955	1987	2018	   0	  18	CTD_human
      338	APOB	0.453	0.808	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.50	1	1996	2018	   2	   0	CTD_human
      338	APOB	0.453	0.808	C3888316	Hypercholesterolemia, familial, due to ligand-defective apolipoprotein B	disease		Disease or Syndrome	0.30	1	1987	2014	  10	   0	CLINGEN
      338	APOB	0.453	0.808	C4551990	Acanthocytosis With Hypobetalipoproteinemia	disease	C18	Disease or Syndrome	0.71	1	1989	2018	   5	  17	CTD_human;GENOMICS_ENGLAND;UNIPROT
      339	APOBEC1	0.647	0.385	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      341	APOC1	0.581	0.577	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.50	1	1999	2019	   2	   1	CTD_human
      341	APOC1	0.581	0.577	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.34	1	1998	2018	   2	   0	CTD_human
      341	APOC1	0.581	0.577	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      341	APOC1	0.581	0.577	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      341	APOC1	0.581	0.577	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      341	APOC1	0.581	0.577	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      341	APOC1	0.581	0.577	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2018	2018	   2	   0	CTD_human
      341	APOC1	0.581	0.577	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.33	1	2002	2018	   2	   0	CTD_human
      341	APOC1	0.581	0.577	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   2	   0	CTD_human
      341	APOC1	0.581	0.577	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   2	   0	CTD_human
      341	APOC1	0.581	0.577	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2018	2018	   2	   0	CTD_human
      341	APOC1	0.581	0.577	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      341	APOC1	0.581	0.577	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
      343	AQP8	0.638	0.615	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.31	1	2018	2018	   0	   0	UNIPROT
      344	APOC2	0.606	0.577	C0002726	Amyloidosis	disease	C18	Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      344	APOC2	0.606	0.577	C0011609	Drug Eruptions	group	C17;C20;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      344	APOC2	0.606	0.577	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      344	APOC2	0.606	0.577	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      344	APOC2	0.606	0.577	C0023817	Hyperlipoproteinemia Type I	disease	C16;C18	Disease or Syndrome	0.40	1	1981	2018	   0	   0	CTD_human
      344	APOC2	0.606	0.577	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      344	APOC2	0.606	0.577	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      344	APOC2	0.606	0.577	C0268199	Familial apolipoprotein C-II deficiency	disease	C16;C18	Disease or Syndrome	0.33	1	1979	2018	   1	   0	ORPHANET
      344	APOC2	0.606	0.577	C0406537	Morbilliform Drug Reaction	disease	C17;C20;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      344	APOC2	0.606	0.577	C1720779	Apolipoprotein C-II Deficiency (disorder)	disease	C16;C18	Disease or Syndrome	0.75	1	1993	2017	   4	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      345	APOC3	0.531	0.731	C0002726	Amyloidosis	disease	C18	Disease or Syndrome	0.31	0	2016	2016	   1	   0	GENOMICS_ENGLAND
      345	APOC3	0.531	0.731	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.40	1	2000	2020	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0007570	Celiac Disease	disease	C06;C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.40	1	1997	2019	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0011609	Drug Eruptions	group	C17;C20;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.46	1	2001	2019	   0	   0	GENOMICS_ENGLAND
      345	APOC3	0.531	0.731	C0020445	Hypercholesterolemia, Familial	disease	C16;C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0020476	Hyperlipoproteinemias	disease	C18	Disease or Syndrome	0.30	1	1991	1991	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.31	1	1999	2009	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0342883	Cholesteryl Ester Transfer Protein Deficiency	disease	C16;C18	Disease or Syndrome	0.32	1	1991	2014	   1	   0	ORPHANET
      345	APOC3	0.531	0.731	C0406537	Morbilliform Drug Reaction	disease	C17;C20;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0745103	Hyperlipoproteinemia Type IIa	disease	C16;C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C1704417	Hyperlipoproteinemia Type IIb	disease	C16;C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.40	1	1997	2019	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C3151467	Apolipoprotein C-III Deficiency	disease	C18	Disease or Syndrome	0.61	1	1991	2016	   1	   4	CTD_human;UNIPROT
      346	APOC4	0.743	0.385	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
      347	APOD	0.584	0.577	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2003	2003	   1	   0	PSYGENET
      347	APOD	0.584	0.577	C0017638	Glioma	disease	C04	Neoplastic Process	0.31	1	2006	2006	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0023186	Learning Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.35	0.667	2002	2006	   3	   0	PSYGENET
      347	APOD	0.584	0.577	C0086439	Hypokinesia	phenotype	C23;C10	Finding	0.30	1	2011	2011	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0233565	Bradykinesia	phenotype	C23;C10	Sign or Symptom	0.30	1	2011	2011	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0242684	Hypodynamia	phenotype	C23;C10	Organism Function	0.30	1	2011	2011	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0270715	Degenerative Diseases, Central Nervous System	group	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0524851	Neurodegenerative Disorders	group	C10	Disease or Syndrome	0.31	1	2008	2018	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0751262	Adult Learning Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0751263	Learning Disturbance	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0751265	Learning Disabilities	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0751701	Hypokinesia, Antiorthostatic	phenotype	C23;C10	Sign or Symptom	0.30	1	2011	2011	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0751733	Degenerative Diseases, Spinal Cord	group	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      347	APOD	0.584	0.577	C1330966	Developmental Academic Disorder	phenotype	C23;C10;F03	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.31	0.5	2009	2011	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.34	0.75	2002	2008	   4	   0	PSYGENET
      348	APOE	0.338	0.962	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.70	0.946	1991	2020	   9	   5	CTD_human
      348	APOE	0.338	0.962	C0002726	Amyloidosis	disease	C18	Disease or Syndrome	0.40	0.955	1995	2020	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0003850	Arteriosclerosis	disease	C14	Disease or Syndrome	0.40	0.977	1983	2020	   2	   0	CTD_human
      348	APOE	0.338	0.962	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.40	0.978	1983	2020	  29	   0	CTD_human
      348	APOE	0.338	0.962	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.34	0.5	1997	2016	   2	   0	PSYGENET
      348	APOE	0.338	0.962	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.50	0.953	1995	2020	   1	   1	CTD_human
      348	APOE	0.338	0.962	C0007273	Carotid Artery Diseases	group	C10;C14	Disease or Syndrome	0.34	1	2002	2009	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0007282	Carotid Stenosis	disease	C10;C14	Disease or Syndrome	0.33	1	2001	2012	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0009241	Cognition Disorders	group	F03	Mental or Behavioral Dysfunction	0.40	0.977	1996	2019	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0010068	Coronary heart disease	disease	C14	Disease or Syndrome	0.70	0.966	1983	2019	   1	   1	CTD_human
      348	APOE	0.338	0.962	C0011206	Delirium	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40	0.4	2007	2020	   5	   0	PSYGENET
      348	APOE	0.338	0.962	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.40	0.913	1993	2020	   9	   0	CTD_human
      348	APOE	0.338	0.962	C0013990	Pathological accumulation of air in tissues	phenotype	C23	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0015697	Arterial Fatty Streak	phenotype	C23	Acquired Abnormality	0.30	1	2007	2018	  11	   0	CTD_human
      348	APOE	0.338	0.962	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2005	2005	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0019202	Hepatolenticular Degeneration	disease	C16;C06;C18;C10	Disease or Syndrome	0.36	1	2000	2019	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.70	0.957	1985	2019	   4	   0	CTD_human
      348	APOE	0.338	0.962	C0020445	Hypercholesterolemia, Familial	disease	C16;C18	Disease or Syndrome	0.40	0.875	1991	2020	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0020473	Hyperlipidemia	disease	C18	Disease or Syndrome	0.60	0.957	1979	2020	   4	   0	CTD_human
      348	APOE	0.338	0.962	C0020479	Hyperlipoproteinemia Type III	disease	C16;C18	Disease or Syndrome	0.80	0.977	1977	2020	  16	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      348	APOE	0.338	0.962	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.70	0.897	1994	2019	   2	   1	CTD_human
      348	APOE	0.338	0.962	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.32	1	2008	2019	   2	   0	CTD_human
      348	APOE	0.338	0.962	C0025427	Mercury Poisoning	disease	C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0026769	Multiple Sclerosis	disease	C20;C10	Disease or Syndrome	0.40	0.877	1994	2019	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.40	0.959	1986	2020	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.50	0.974	1988	2019	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0030246	Pustulosis of Palms and Soles	disease	C17	Disease or Syndrome	0.31	1	2006	2006	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.40	1	2010	2010	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0033860	Psoriasis	disease	C17	Disease or Syndrome	0.36	1	2006	2014	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0035078	Kidney Failure	disease	C13;C12	Disease or Syndrome	0.35	1	1998	2014	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.60	0.78	1995	2019	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0036489	Sea-Blue Histiocyte Syndrome	disease	C16;C18;C10;C15	Disease or Syndrome	0.70	1	2000	2014	   2	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
      348	APOE	0.338	0.962	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.40	1	1996	2016	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0038002	Splenomegaly	phenotype	C23	Finding	0.40	1	2000	2000	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0085220	Cerebral Amyloid Angiopathy	disease	C18;C10;C14	Disease or Syndrome	0.50	0.971	1996	2019	   1	   1	CTD_human
      348	APOE	0.338	0.962	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2008	2018	   1	   0	PSYGENET
      348	APOE	0.338	0.962	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.32	1	2005	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0242339	Dyslipidemias	group	C18	Disease or Syndrome	0.40	0.985	1994	2020	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.35	0.833	2008	2019	   2	   0	CTD_human
      348	APOE	0.338	0.962	C0242383	Age related macular degeneration	disease	C11	Disease or Syndrome	0.50	0.902	1998	2019	   1	   1	CTD_human
      348	APOE	0.338	0.962	C0264956	Atheroma	phenotype	C23	Pathologic Function	0.30	1	2007	2018	  11	   0	CTD_human
      348	APOE	0.338	0.962	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.40	0.978	1993	2018	   9	   0	CTD_human
      348	APOE	0.338	0.962	C0338582	Sporadic Cerebral Amyloid Angiopathy	disease	C18;C10;C14	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0340569	Internal Carotid Artery Stenosis	disease	C10;C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0393664	Multiple Sclerosis, Acute Relapsing	disease	C20;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.40	0.956	1993	2020	   9	   0	CTD_human
      348	APOE	0.338	0.962	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.31	1	2012	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1993	2018	   9	   0	CTD_human
      348	APOE	0.338	0.962	C0577631	Carotid Atherosclerosis	disease	C10;C14	Disease or Syndrome	0.40	0.867	1997	2018	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0598784	Dyslipoproteinemias	phenotype	C18	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0600178	External Carotid Artery Diseases	group	C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0745103	Hyperlipoproteinemia Type IIa	disease	C16;C18	Disease or Syndrome	0.60	0.889	1989	2020	   4	   3	CTD_human;UNIPROT
      348	APOE	0.338	0.962	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1993	2018	   9	   0	CTD_human
      348	APOE	0.338	0.962	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.50	0.935	1993	2020	   9	   1	CTD_human
      348	APOE	0.338	0.962	C0750986	Internal Carotid Artery Diseases	group	C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0750987	Arterial Diseases, Common Carotid	disease	C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751324	Multiple Sclerosis, Acute Fulminating	disease	C20;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751633	Carotid Artery Plaque	disease	C10;C14	Acquired Abnormality	0.32	1	2006	2019	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751634	Carotid Ulcer	phenotype	C10;C14	Acquired Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751635	Common Carotid Artery Stenosis	disease	C10;C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751636	External Carotid Artery Stenosis	disease	C10;C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751967	Multiple Sclerosis, Relapsing-Remitting	disease	C20;C10	Disease or Syndrome	0.32	1	2004	2009	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.31	1	2005	2012	   1	   0	CTD_human
      348	APOE	0.338	0.962	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      348	APOE	0.338	0.962	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.33	1	2009	2019	   1	   0	CTD_human
      348	APOE	0.338	0.962	C1527352	Hepatic Form of Wilson Disease	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      348	APOE	0.338	0.962	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	1997	2018	  29	   0	CTD_human
      348	APOE	0.338	0.962	C1565489	Renal Insufficiency	disease	C13;C12	Disease or Syndrome	0.44	0.8	2006	2019	   1	   0	CTD_human
      348	APOE	0.338	0.962	C1704417	Hyperlipoproteinemia Type IIb	disease	C16;C18	Disease or Syndrome	0.32	1	1985	2007	   1	   0	CTD_human
      348	APOE	0.338	0.962	C1706412	Lipidemias	phenotype	C18	Finding	0.30	1	2002	2010	   4	   0	CTD_human
      348	APOE	0.338	0.962	C1847200	ALZHEIMER DISEASE 4	disease	C10;F03	Disease or Syndrome	0.30				   0	   0	CTD_human
      348	APOE	0.338	0.962	C1863051	ALZHEIMER DISEASE 2	disease	C10;F03	Disease or Syndrome	0.80	0.96	1985	2017	  11	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      348	APOE	0.338	0.962	C1864205	Macular Degeneration, Age-Related, 1	disease	C11	Disease or Syndrome	0.30				   0	   0	CTD_human
      348	APOE	0.338	0.962	C2673196	LIPOPROTEIN GLOMERULOPATHY	disease	C13;C12	Disease or Syndrome	0.80	0.95	1997	2020	   6	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      348	APOE	0.338	0.962	C2936350	Plaque, Atherosclerotic	phenotype	C23	Body Substance	0.30	1	2007	2018	  11	   0	CTD_human
      348	APOE	0.338	0.962	C2936351	Fibroatheroma	disease	C23	Acquired Abnormality	0.30	1	2007	2018	  11	   0	CTD_human
      348	APOE	0.338	0.962	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      348	APOE	0.338	0.962	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.32	0.333	2012	2018	   1	   0	CTD_human
      350	APOH	0.563	0.769	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2005	2005	   1	   0	CTD_human
      350	APOH	0.563	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2019	   1	   0	PSYGENET
      350	APOH	0.563	0.769	C0085278	Antiphospholipid Syndrome	disease	C20	Disease or Syndrome	0.40	1	1998	2020	   1	   0	GENOMICS_ENGLAND
      350	APOH	0.563	0.769	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      350	APOH	0.563	0.769	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      350	APOH	0.563	0.769	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      350	APOH	0.563	0.769	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.50	1	2005	2013	   1	   0	CTD_human
      350	APOH	0.563	0.769	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      351	APP	0.422	0.846	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.90	0.981	1987	2020	  63	  14	CTD_human;UNIPROT
      351	APP	0.422	0.846	C0002622	Amnesia	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40	1	1997	2020	   1	   0	CTD_human
      351	APP	0.422	0.846	C0002726	Amyloidosis	disease	C18	Disease or Syndrome	0.40	0.981	1988	2019	   1	   0	CTD_human
      351	APP	0.422	0.846	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.40	0.9	2004	2017	   1	   0	CTD_human
      351	APP	0.422	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2002	2002	   1	   0	PSYGENET
      351	APP	0.422	0.846	C0006111	Brain Diseases	group	C10	Disease or Syndrome	0.31	1	2002	2018	   1	   0	CTD_human
      351	APP	0.422	0.846	C0009241	Cognition Disorders	group	F03	Mental or Behavioral Dysfunction	0.40	0.988	1999	2020	   5	   0	CTD_human
      351	APP	0.422	0.846	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.40	0.981	1991	2020	  35	   0	CTD_human
      351	APP	0.422	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.33	0.8	1999	2018	   5	   0	PSYGENET
      351	APP	0.422	0.846	C0011573	Endogenous depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
      351	APP	0.422	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	0.8	1999	2018	   5	   0	PSYGENET
      351	APP	0.422	0.846	C0016667	Fragile X Syndrome	disease	C16;C10	Disease or Syndrome	0.37	0.875	2009	2018	   1	   0	CTD_human
      351	APP	0.422	0.846	C0023186	Learning Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2018	   8	   0	CTD_human
      351	APP	0.422	0.846	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      351	APP	0.422	0.846	C0025261	Memory Disorders	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.32	0.944	2004	2019	  16	   0	CTD_human
      351	APP	0.422	0.846	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2011	2011	   1	   0	CTD_human
      351	APP	0.422	0.846	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2002	2013	  11	   0	CTD_human
      351	APP	0.422	0.846	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      351	APP	0.422	0.846	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      351	APP	0.422	0.846	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.50	1	2009	2019	   1	   0	GENOMICS_ENGLAND
      351	APP	0.422	0.846	C0037928	Spinal Cord Diseases	group	C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      351	APP	0.422	0.846	C0038002	Splenomegaly	phenotype	C23	Finding	0.30	1	2016	2016	   1	   0	CTD_human
      351	APP	0.422	0.846	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.49	1	2002	2014	   1	   0	GENOMICS_ENGLAND
      351	APP	0.422	0.846	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      351	APP	0.422	0.846	C0085220	Cerebral Amyloid Angiopathy	disease	C18;C10;C14	Disease or Syndrome	0.50	1	1992	2019	   1	   0	CTD_human
      351	APP	0.422	0.846	C0085584	Encephalopathies	group	C10	Disease or Syndrome	0.31	1	2002	2018	   1	   0	CTD_human
      351	APP	0.422	0.846	C0231341	Premature aging syndrome	disease	C23	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      351	APP	0.422	0.846	C0233750	Hysterical amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      351	APP	0.422	0.846	C0233794	Memory impairment	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.50	0.994	1993	2020	  16	   0	CTD_human
      351	APP	0.422	0.846	C0233796	Temporary Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      351	APP	0.422	0.846	C0234544	Todd Paralysis	phenotype	C23;C10	Sign or Symptom	0.30	1	2005	2017	   5	   0	CTD_human
      351	APP	0.422	0.846	C0234985	Mental deterioration	phenotype	F03	Mental or Behavioral Dysfunction	0.40	0.956	1993	2020	   1	   0	CTD_human
      351	APP	0.422	0.846	C0236795	Dissociative Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      351	APP	0.422	0.846	C0262497	Global Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      351	APP	0.422	0.846	C0270612	Leukoencephalopathy	group	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	GENOMICS_ENGLAND
      351	APP	0.422	0.846	C0270715	Degenerative Diseases, Central Nervous System	group	C10	Disease or Syndrome	0.30	1	2005	2013	   2	   0	CTD_human
      351	APP	0.422	0.846	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.40	0.993	1988	2019	  35	   0	CTD_human
      351	APP	0.422	0.846	C0333463	Senile Plaques	disease	C23	Acquired Abnormality	0.40	0.988	1988	2020	   2	   0	CTD_human
      351	APP	0.422	0.846	C0338582	Sporadic Cerebral Amyloid Angiopathy	disease	C18;C10;C14	Disease or Syndrome	0.31	1	2010	2011	   1	   0	CTD_human
      351	APP	0.422	0.846	C0338630	Senile Paranoid Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
      351	APP	0.422	0.846	C0338656	Impaired cognition	disease	F03	Mental or Behavioral Dysfunction	0.60	0.98	1993	2020	   1	   0	CTD_human
      351	APP	0.422	0.846	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      351	APP	0.422	0.846	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.40	0.986	1991	2019	  35	   0	CTD_human
      351	APP	0.422	0.846	C0497327	Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.70	0.964	1993	2020	   3	   0	CTD_human;GENOMICS_ENGLAND
      351	APP	0.422	0.846	C0522224	Paralysed	phenotype	C23;C10	Finding	0.30	1	2005	2017	   5	   0	CTD_human
      351	APP	0.422	0.846	C0524851	Neurodegenerative Disorders	group	C10	Disease or Syndrome	0.40	0.935	1994	2019	   2	   0	CTD_human
      351	APP	0.422	0.846	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1991	2018	  35	   0	CTD_human
      351	APP	0.422	0.846	C0553692	Brain hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2010	2010	   1	   0	GENOMICS_ENGLAND
      351	APP	0.422	0.846	C0600467	Neurogenic Inflammation	disease	C23;C10	Injury or Poisoning	0.30	1	2010	2015	   2	   0	CTD_human
      351	APP	0.422	0.846	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1991	2018	  35	   0	CTD_human
      351	APP	0.422	0.846	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.50	0.984	1991	2020	  35	   1	CTD_human
      351	APP	0.422	0.846	C0750906	Tactile Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      351	APP	0.422	0.846	C0750907	Amnestic State	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      351	APP	0.422	0.846	C0751071	Familial Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.32	1	2005	2015	   1	   0	CTD_human
      351	APP	0.422	0.846	C0751156	FRAXA Syndrome	disease	C16;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      351	APP	0.422	0.846	C0751157	FRAXE Syndrome	disease	C16;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      351	APP	0.422	0.846	C0751262	Adult Learning Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2018	   8	   0	CTD_human
      351	APP	0.422	0.846	C0751263	Learning Disturbance	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2018	   8	   0	CTD_human
      351	APP	0.422	0.846	C0751265	Learning Disabilities	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2018	   8	   0	CTD_human
      351	APP	0.422	0.846	C0751292	Age-Related Memory Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2004	2018	  16	   0	CTD_human
      351	APP	0.422	0.846	C0751293	Memory Disorder, Semantic	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2004	2018	  16	   0	CTD_human
      351	APP	0.422	0.846	C0751294	Memory Disorder, Spatial	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2004	2018	  16	   0	CTD_human
      351	APP	0.422	0.846	C0751295	Memory Loss	phenotype	C23;C10;F01	Sign or Symptom	0.40	1	1997	2020	  16	   0	CTD_human
      351	APP	0.422	0.846	C0751733	Degenerative Diseases, Spinal Cord	group	C10	Disease or Syndrome	0.30	1	2005	2013	   2	   0	CTD_human
      351	APP	0.422	0.846	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      351	APP	0.422	0.846	C0948008	Ischemic stroke	disease	C10;C14	Disease or Syndrome	0.31	1	2010	2020	   1	   0	GENOMICS_ENGLAND
      351	APP	0.422	0.846	C1270972	Mild cognitive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2003	2019	   1	   0	CTD_human
      351	APP	0.422	0.846	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      351	APP	0.422	0.846	C1330966	Developmental Academic Disorder	phenotype	C23;C10;F03	Finding	0.30	1	2006	2018	   8	   0	CTD_human
      351	APP	0.422	0.846	C2751494	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT	disease	C16;C18;C10;C14	Disease or Syndrome	0.30	1	1990	2000	   2	   0	CTD_human
      351	APP	0.422	0.846	C2751536	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED	disease	C16;C18;C10;C14	Disease or Syndrome	0.70	1	1990	2010	   7	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
      351	APP	0.422	0.846	C2931672	Cerebral hemorrhage with amyloidosis, hereditary, Dutch type	disease	C16;C18;C10;C14	Disease or Syndrome	0.60	1	1990	2019	   3	   0	CTD_human;ORPHANET
      351	APP	0.422	0.846	C2936349	Plaque, Amyloid	disease	C23	Acquired Abnormality	0.40	0.973	1996	2019	   2	   0	CTD_human
      351	APP	0.422	0.846	C3888307	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT	disease	C16;C18;C10;C14	Disease or Syndrome	0.30	1	1990	2000	   2	   0	CTD_human
      351	APP	0.422	0.846	C3888308	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT	disease	C16;C18;C10;C14	Disease or Syndrome	0.30	1	1990	2000	   2	   0	CTD_human
      351	APP	0.422	0.846	C3888309	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT	disease	C16;C18;C10;C14	Disease or Syndrome	0.30	1	1990	2000	   2	   0	CTD_human
      353	APRT	0.423	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1988	2018	   1	   0	CTD_human
      353	APRT	0.423	0.846	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.33	1	2002	2018	   1	   0	CTD_human
      353	APRT	0.423	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.33	1	1985	2019	   5	   0	PSYGENET
      353	APRT	0.423	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	1985	2019	   5	   0	PSYGENET
      353	APRT	0.423	0.846	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.31	1	2012	2019	   1	   0	GENOMICS_ENGLAND
      353	APRT	0.423	0.846	C0027707	Nephritis, Interstitial	disease	C13;C12	Disease or Syndrome	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
      353	APRT	0.423	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2000	2000	   1	   0	PSYGENET
      353	APRT	0.423	0.846	C0268120	Adenine phosphoribosyltransferase deficiency	disease	C16;C18;C13;C12	Disease or Syndrome	1.00	1	1986	2016	  11	  11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      353	APRT	0.423	0.846	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.33	1	2002	2018	   1	   0	CTD_human
      353	APRT	0.423	0.846	C0451641	Urolithiasis	disease	C13;C12	Disease or Syndrome	0.33	1	1976	2011	   2	   0	CTD_human
      353	APRT	0.423	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1988	2018	   1	   0	CTD_human
      353	APRT	0.423	0.846	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      353	APRT	0.423	0.846	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      353	APRT	0.423	0.846	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      353	APRT	0.423	0.846	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      353	APRT	0.423	0.846	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2000	2000	   1	   0	PSYGENET
      353	APRT	0.423	0.846	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      353	APRT	0.423	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.32	1	1996	2009	   1	   0	CTD_human
      353	APRT	0.423	0.846	C1561643	Chronic Kidney Diseases	group	C13;C12	Disease or Syndrome	0.39	1	2012	2019	   1	   0	GENOMICS_ENGLAND
      353	APRT	0.423	0.846	C3665382	2,8-Dihydroxyadenine Urolithiasis	disease	C16;C18;C13;C12	Disease or Syndrome	0.80	1	1985	2012	   1	   0	CTD_human;ORPHANET
      353	APRT	0.423	0.846	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C0005001	Benign prostatic hypertrophy	phenotype	C12	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C0027643	Neoplasm Recurrence, Local	phenotype	C23;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.40	0.988	1991	2019	  11	   0	CTD_human
      354	KLK3	0.443	0.885	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2003	2003	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.50	0.958	1989	2020	  11	   2	CTD_human
      354	KLK3	0.443	0.885	C0520477	Prostatic Adenoma	disease	C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C1334615	Malignant Phyllodes Tumor of Prostate	disease	C04;C12	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C1704272	Benign Prostatic Hyperplasia	disease	C12	Disease or Syndrome	0.40	0.927	1990	2020	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C1739363	Prostatic Hypertrophy	disease	C12	Disease or Syndrome	0.31	1	2001	2011	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C2937421	Prostatic Hyperplasia	disease	C12	Disease or Syndrome	0.37	1	2001	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0002897	Anemia, Splenic	disease	C15	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.40	0.974	1989	2020	   3	   0	CTD_human
      355	FAS	0.372	0.923	C0004943	Behcet Syndrome	disease	C16;C11;C17;C07;C14	Disease or Syndrome	0.33	1	2005	2015	   1	   0	ORPHANET
      355	FAS	0.372	0.923	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.38	1	1997	2018	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.37	1	1997	2018	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.60	0.917	1999	2014	   0	   3	CGI;UNIPROT
      355	FAS	0.372	0.923	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.51	1	1999	2007	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2005	2009	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.32	1	2005	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0017658	Glomerulonephritis	disease	C13;C12	Disease or Syndrome	0.41	1	1999	2011	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0018939	Hematological Disease	group	C15	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2019	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2019	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0020532	Hypersplenism	disease	C15	Disease or Syndrome	0.40	1	2005	2005	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.38	1	1995	2018	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2006	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2019	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.36	1	1998	2015	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.40	1	1995	2016	   0	   0	GENOMICS_ENGLAND
      355	FAS	0.372	0.923	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.54	1	1998	2010	   0	   2	CGI;UNIPROT
      355	FAS	0.372	0.923	C0024535	Malaria, Falciparum	disease	C01	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0026896	Myasthenia Gravis	disease	C04;C20;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	1995	1995	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2005	2005	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0027697	Nephritis	disease	C13;C12	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0032963	Pregnancy Complications, Cardiovascular	disease	C13;C14	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2000	2007	   3	   0	CTD_human
      355	FAS	0.372	0.923	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.30	1	2015	2015	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      355	FAS	0.372	0.923	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2000	2007	   3	   0	CTD_human
      355	FAS	0.372	0.923	C0038002	Splenomegaly	phenotype	C23	Finding	0.40	1	2011	2011	   1	   2	CTD_human
      355	FAS	0.372	0.923	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0039338	Taste Disorders	group	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0042170	Uveomeningoencephalitic Syndrome	disease	C11;C20;C10	Disease or Syndrome	0.31	1	2015	2015	   1	   0	ORPHANET
      355	FAS	0.372	0.923	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.37	1	2003	2018	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.37	1	2002	2018	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2019	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.35	1	1995	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234297	Taste Disorder, Primary	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234298	Taste Disorder, Primary, Sweet	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234299	Taste Disorder, Primary, Salt	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234300	Taste Disorder, Primary, Bitter	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234302	Taste Disorder, Anterior Tongue	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234303	Taste Disorder, Secondary	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234304	Taste Disorder, Secondary, Sweet	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234305	Taste Disorder, Secondary, Salt	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234306	Taste Disorder, Secondary, Bitter	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234319	Taste Disorder, Posterior Tongue	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0240327	Taste, Metallic	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	0.923	1999	2017	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0242488	Acute Lung Injury	disease	C08	Injury or Poisoning	0.30	1	2000	2000	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0376407	Granulomatous Slack Skin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.36	1	2011	2018	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0751339	Myasthenia Gravis, Generalized	disease	C04;C20;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0751340	Myasthenia Gravis, Ocular	disease	C04;C20;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2000	2007	   3	   0	CTD_human
      355	FAS	0.372	0.923	C1328840	Autoimmune Lymphoproliferative Syndrome	disease	C16;C20;C15	Disease or Syndrome	1.00	1	1978	2018	  18	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      355	FAS	0.372	0.923	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.31	1	2007	2016	   1	   0	CTD_human
      355	FAS	0.372	0.923	C1704377	Bright Disease	disease	C13;C12	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      355	FAS	0.372	0.923	C1846545	Autoimmune Lymphoproliferative Syndrome Type 2B	disease	C16;C20;C15	Disease or Syndrome	0.31	1	2005	2018	   2	   0	CTD_human
      355	FAS	0.372	0.923	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.31	1	1995	1999	   1	   0	CTD_human
      355	FAS	0.372	0.923	C2717884	Autoimmune Lymphoproliferative Syndrome Type 1, Autosomal Dominant	disease	C16;C20;C15	Disease or Syndrome	0.30	1	2005	2007	   2	   0	CTD_human
      355	FAS	0.372	0.923	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.32	1	2013	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C3496549	Male Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.30				   0	   0	CGI
      356	FASLG	0.43	0.885	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.34	1	2008	2015	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.31	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.34	1	2008	2018	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0007273	Carotid Artery Diseases	group	C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0011875	Diabetic Angiopathies	disease	C19;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0013182	Drug Allergy	group	C20;C25	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0019158	Hepatitis	group	C06	Disease or Syndrome	0.40	1	2009	2009	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0020474	Hyperlipidemia, Familial Combined	disease	C16;C18	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.33	1	2004	2007	   0	   0	CTD_human
      356	FASLG	0.43	0.885	C0025202	melanoma	disease	C04	Neoplastic Process	0.38	1	2001	2019	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0025945	Microangiopathy, Diabetic	disease	C19;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2006	2007	   2	   0	CTD_human
      356	FASLG	0.43	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2006	2007	   2	   0	CTD_human
      356	FASLG	0.43	0.885	C0039584	Testicular Diseases	group	C12;C19	Disease or Syndrome	0.31	1	2009	2019	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.31	1	2009	2018	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.34	1	2002	2008	   0	   0	CTD_human
      356	FASLG	0.43	0.885	C0242488	Acute Lung Injury	disease	C08	Injury or Poisoning	0.30	1	2000	2000	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.33	1	2001	2011	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0577631	Carotid Atherosclerosis	disease	C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0600178	External Carotid Artery Diseases	group	C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0750986	Internal Carotid Artery Diseases	group	C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0750987	Arterial Diseases, Common Carotid	disease	C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.31	1	2006	2007	   2	   0	CTD_human
      356	FASLG	0.43	0.885	C1328840	Autoimmune Lymphoproliferative Syndrome	disease	C16;C20;C15	Disease or Syndrome	0.89	1	1984	2017	   5	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      356	FASLG	0.43	0.885	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C1846545	Autoimmune Lymphoproliferative Syndrome Type 2B	disease	C16;C20;C15	Disease or Syndrome	0.30				   0	   0	CTD_human
      356	FASLG	0.43	0.885	C2717884	Autoimmune Lymphoproliferative Syndrome Type 1, Autosomal Dominant	disease	C16;C20;C15	Disease or Syndrome	0.30				   0	   0	CTD_human
      357	SHROOM2	0.729	0.385	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   1	UNIPROT
      358	AQP1	0.467	0.885	C0007097	Carcinoma	group	C04	Neoplastic Process	0.32	1	2002	2018	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0008340	Choledochal Cyst	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0009439	Choledochal Cyst, Type I	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.31	1	2006	2014	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0013608	Edema, Cardiac	disease	C23;C14	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.55	1	2010	2019	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0020550	Hyperthyroidism	disease	C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2002	2002	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0030193	Pain	phenotype	C23	Sign or Symptom	0.34	1	2010	2019	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0036095	Salivary Gland Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0036981	Endotoxic shock	phenotype	C23;C01	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0036983	Septic Shock	phenotype	C23;C01	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0085548	Autosomal Recessive Polycystic Kidney Disease	disease	C16;C13;C12	Disease or Syndrome	0.51	1	2008	2008	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0220636	Malignant neoplasm of salivary gland	disease	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0340543	Familial primary pulmonary hypertension	disease	C08	Disease or Syndrome	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      358	AQP1	0.467	0.885	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0600327	Toxic Shock Syndrome	disease	C23;C01	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C1150929	2-oxo-hept-3-ene-1,7-dioate hydratase activity	phenotype		Molecular Function	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      358	AQP1	0.467	0.885	C1257796	Choledochal Cyst, Type II	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C1257797	Choledochal Cyst, Type III	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C1257798	Choledochal Cyst, Type IV	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C1257799	Choledochal Cyst, Type V	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C3714618	Primary Hyperthyroidism	disease	C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      359	AQP2	0.581	0.769	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      359	AQP2	0.581	0.769	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      359	AQP2	0.581	0.769	C0162283	Nephrogenic Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.90	1	1988	2020	   5	   4	CTD_human;GENOMICS_ENGLAND
      359	AQP2	0.581	0.769	C0268443	Acquired Nephrogenic Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.31	1	1998	2009	   4	   0	CTD_human
      359	AQP2	0.581	0.769	C0677501	Congenital Nephrogenic Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.40	1	1996	2019	   4	   0	CTD_human
      359	AQP2	0.581	0.769	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      359	AQP2	0.581	0.769	C1563705	Nephrogenic Diabetes Insipidus, Type I	disease	C13;C12	Disease or Syndrome	0.40	0.968	1994	2020	   4	   0	CTD_human
      359	AQP2	0.581	0.769	C1563706	Nephrogenic Diabetes Insipidus, Type II	disease	C13;C12	Disease or Syndrome	0.70	1	1994	2016	  23	  24	CTD_human;GENOMICS_ENGLAND;UNIPROT
      359	AQP2	0.581	0.769	C3542500	ADH-Resistant Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.30	1	2005	2009	   4	   0	CTD_human
      360	AQP3	0.546	0.769	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.32	1	2011	2019	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.33	1	2011	2019	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0024232	Lymphatic Metastasis	disease	C23;C04	Neoplastic Process	0.31	1	2010	2011	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.33	1	2008	2019	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0040411	Tongue Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0153349	Malignant neoplasm of tongue	disease	C04;C07	Neoplastic Process	0.31	1	2011	2012	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2009	2017	   2	   0	PSYGENET
      361	AQP4	0.456	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2017	   1	   0	PSYGENET
      361	AQP4	0.456	0.885	C0027873	Neuromyelitis Optica	disease	C11;C20;C10	Disease or Syndrome	0.40	0.963	2005	2020	   2	   0	CTD_human
      361	AQP4	0.456	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.33	0.5	2005	2018	   2	   0	PSYGENET
      361	AQP4	0.456	0.885	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.50	1	2010	2010	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0038644	Sudden infant death syndrome	disease	C23	Disease or Syndrome	0.33	1	2010	2017	   1	   0	GENOMICS_ENGLAND
      361	AQP4	0.456	0.885	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.33	1	2011	2020	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0338715	Drug-induced depressive state	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2014	   2	   0	PSYGENET
      361	AQP4	0.456	0.885	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      362	AQP5	0.552	0.769	C0019284	Diaphragmatic Hernia	phenotype	C23	Disease or Syndrome	0.30	1	2007	2007	   2	   0	CTD_human
      362	AQP5	0.552	0.769	C1833030	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC	disease	C16;C17	Disease or Syndrome	0.31	1	2013	2013	   1	   0	ORPHANET
      362	AQP5	0.552	0.769	C1838359	Diffuse palmoplantar keratoderma, Bothnian type	disease	C16;C17	Disease or Syndrome	0.70	1	1996	2016	   5	   5	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      362	AQP5	0.552	0.769	C4551675	Keratoderma, Palmoplantar	disease	C16;C17	Disease or Syndrome	0.31	1	2016	2016	   0	   0	GENOMICS_ENGLAND
      364	AQP7	0.67	0.462	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2014	   2	   0	CTD_human
      364	AQP7	0.67	0.462	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.40	1	2006	2019	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0023418	leukemia	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.32	1	2002	2013	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0274861	Arsenic Poisoning, Inorganic	disease	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0274862	Nervous System, Organic Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0311375	Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0751851	Arsenic Encephalopathy	disease	C10;C25	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0751852	Arsenic Induced Polyneuropathy	disease	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.31	1	2007	2007	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      367	AR	0.351	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2011	2014	   2	   0	PSYGENET
      367	AR	0.351	0.846	C0002170	Alopecia	disease	C23;C17	Disease or Syndrome	0.39	1	2000	2016	   1	   0	CTD_human
      367	AR	0.351	0.846	C0004114	Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2005	2013	   1	   0	CTD_human
      367	AR	0.351	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.60	0.947	1990	2020	   2	   2	CTD_human;UNIPROT
      367	AR	0.351	0.846	C0007112	Adenocarcinoma of prostate	disease	C04;C12	Neoplastic Process	0.60	1	2002	2019	   0	   0	CGI
      367	AR	0.351	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.40	0.8	1994	2019	   5	   0	PSYGENET
      367	AR	0.351	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	0.8	1994	2019	   5	   0	PSYGENET
      367	AR	0.351	0.846	C0017412	Genital Diseases, Male	group	C12	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      367	AR	0.351	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.55	1	1999	2019	   1	   0	CTD_human
      367	AR	0.351	0.846	C0021361	Female infertility	phenotype	C13	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      367	AR	0.351	0.846	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.40	0.918	1995	2019	   3	   0	CTD_human
      367	AR	0.351	0.846	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      367	AR	0.351	0.846	C0023418	leukemia	disease	C04	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
      367	AR	0.351	0.846	C0027643	Neoplasm Recurrence, Local	phenotype	C23;C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
      367	AR	0.351	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.60	1	1990	2019	  21	   0	CTD_human
      367	AR	0.351	0.846	C0038279	Sterility, Postpartum	phenotype	C13	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      367	AR	0.351	0.846	C0039585	Androgen-Insensitivity Syndrome	disease	C16;C13;C12;C19	Disease or Syndrome	1.00	0.966	1970	2019	  74	  98	CTD_human;GENOMICS_ENGLAND;UNIPROT
      367	AR	0.351	0.846	C0085207	Gestational Diabetes	phenotype	C18;C13;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      367	AR	0.351	0.846	C0086873	Pseudopelade	disease	C23;C17	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      367	AR	0.351	0.846	C0162311	Androgenetic Alopecia	disease	C23;C17	Disease or Syndrome	0.40	0.9	1998	2019	   1	   0	CTD_human
      367	AR	0.351	0.846	C0205768	Subependymal Giant Cell Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0236663	Alcohol withdrawal syndrome	disease	C25;F03	Disease or Syndrome	0.34	1	2009	2011	   3	   0	PSYGENET
      367	AR	0.351	0.846	C0238033	Carcinoma of Male Breast	disease	C04;C17	Neoplastic Process	0.40	0.958	1992	2019	   2	   0	CTD_human
      367	AR	0.351	0.846	C0242788	Breast Neoplasms, Male	group	C04;C17	Neoplastic Process	0.30	1	1992	1993	   2	   0	CTD_human
      367	AR	0.351	0.846	C0263477	Female pattern alopecia (disorder)	phenotype	C23;C17	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      367	AR	0.351	0.846	C0268301	Reifenstein Syndrome	disease	C16;C13;C12;C19	Disease or Syndrome	0.80	0.989	1984	2019	  41	  31	CTD_human;GENOMICS_ENGLAND;UNIPROT
      367	AR	0.351	0.846	C0280783	Juvenile Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0280785	Diffuse Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0282612	Prostatic Intraepithelial Neoplasias	disease	C04	Neoplastic Process	0.40	1	1996	2017	   1	   0	CTD_human
      367	AR	0.351	0.846	C0334579	Anaplastic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0334580	Protoplasmic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0334581	Gemistocytic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0334582	Fibrillary Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0334583	Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0338070	Childhood Cerebral Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0341869	Subfertility, Female	disease	C13	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      367	AR	0.351	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	1.00	0.982	1992	2020	  21	  16	CTD_human;GENOMICS_ENGLAND;UNIPROT
      367	AR	0.351	0.846	C0393547	Bulbospinal Neuronopathy	disease	C10	Disease or Syndrome	0.36	1	1990	2019	   0	   0	ORPHANET
      367	AR	0.351	0.846	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2006	2017	   1	   0	PSYGENET
      367	AR	0.351	0.846	C0547065	Mixed oligoastrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0556385	Craving for alcohol	phenotype		Finding	0.30	1	2010	2010	   1	   0	PSYGENET
      367	AR	0.351	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.947	1990	2020	   2	   0	CTD_human
      367	AR	0.351	0.846	C0750935	Cerebral Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0750936	Intracranial Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0752353	Atrophy, Muscular, Spinobulbar	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	ORPHANET
      367	AR	0.351	0.846	C0848676	Subfertility, Male	phenotype	C12	Sign or Symptom	0.32	1	2002	2011	   3	   0	CTD_human
      367	AR	0.351	0.846	C0917730	Female sterility	phenotype	C13	Finding	0.30	1	2013	2013	   1	   0	CTD_human
      367	AR	0.351	0.846	C0917731	Male sterility	phenotype	C12	Finding	0.30	1	2002	2010	   3	   0	CTD_human
      367	AR	0.351	0.846	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      367	AR	0.351	0.846	C0936016	Testicular Feminization	disease	C16;C13;C12;C19	Disease or Syndrome	0.60	0.955	1970	2019	   2	   0	CTD_human
      367	AR	0.351	0.846	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   2	   0	CTD_human
      367	AR	0.351	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	2001	2019	   2	   0	CTD_human
      367	AR	0.351	0.846	C1704230	Grade I Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C1839259	Bulbo-Spinal Atrophy, X-Linked	disease	C16;C10	Disease or Syndrome	0.70	0.988	1990	2019	   0	  27	GENOMICS_ENGLAND;ORPHANET
      367	AR	0.351	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	1990	2020	   1	   0	CTD_human
      367	AR	0.351	0.846	C2678098	Hypospadias 1, X-Linked	disease	C16;C13;C12	Disease or Syndrome	0.60				   0	   3	CTD_human;GENOMICS_ENGLAND
      367	AR	0.351	0.846	C2713546	Androgen Receptor Deficiency	disease	C16;C13;C12;C19	Disease or Syndrome	0.32	0.75	1984	2018	   2	   0	CTD_human
      367	AR	0.351	0.846	C2931395	Bulbospinal neuronopathy, X-linked recessive	disease	C16;C10	Disease or Syndrome	0.35	0.8	1992	1999	   0	   0	CTD_human
      367	AR	0.351	0.846	C3658266	Prostatic Cancer, Castration-Resistant	disease	C04;C12	Neoplastic Process	0.30	1	2008	2017	   4	   0	CTD_human
      367	AR	0.351	0.846	C3658267	Prostatic Neoplasms, Castration-Resistant	disease	C04;C12	Neoplastic Process	0.30	1	2008	2017	   4	   0	CTD_human
      367	AR	0.351	0.846	C4083212	Alopecia, Male Pattern	disease	C23;C17	Disease or Syndrome	0.50	0.963	1998	2019	   1	  11	CTD_human
      367	AR	0.351	0.846	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   2	   0	CTD_human
      368	ABCC6	0.54	0.654	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      368	ABCC6	0.54	0.654	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      368	ABCC6	0.54	0.654	C0026654	Moyamoya Disease	disease	C10;C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      368	ABCC6	0.54	0.654	C0033847	Pseudoxanthoma Elasticum	disease	C16;C17;C15;C14	Disease or Syndrome	1.00	0.982	1978	2020	  26	 312	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      368	ABCC6	0.54	0.654	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      368	ABCC6	0.54	0.654	C0264955	Idiopathic arterial calcification of infancy	disease	C18;C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
      368	ABCC6	0.54	0.654	C0376359	Gronblad-Strandberg Syndrome	disease	C16;C17;C15;C14	Disease or Syndrome	0.30	1	2002	2015	   8	   0	CTD_human
      368	ABCC6	0.54	0.654	C1859727	Arterial calcification of infancy	disease	C18	Disease or Syndrome	0.58	1	2011	2020	   2	   0	CTD_human;ORPHANET
      368	ABCC6	0.54	0.654	C1867450	Pseudoxanthoma Elasticum, Incomplete	disease	C16;C17;C15;C14	Disease or Syndrome	0.60	1	1978	2016	  11	   6	CTD_human;GENOMICS_ENGLAND
      368	ABCC6	0.54	0.654	C3276161	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2	disease		Disease or Syndrome	0.60	1	2000	2012	   2	  16	GENOMICS_ENGLAND;UNIPROT
      369	ARAF	0.619	0.654	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      369	ARAF	0.619	0.654	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.41	1	2014	2016	   0	   2	CGI
      369	ARAF	0.619	0.654	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      369	ARAF	0.619	0.654	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      369	ARAF	0.619	0.654	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      369	ARAF	0.619	0.654	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      369	ARAF	0.619	0.654	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C0004134	Ataxia	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C0240991	Ataxia, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C0278161	Ataxia, Motor	phenotype	C23;C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C0427190	Ataxia, Truncal	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C0520966	Abnormal coordination	phenotype	C23;C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C0750937	Ataxia, Appendicular	phenotype	C23;C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C0750940	Tremor, Rubral	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C4310686	SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY	disease		Disease or Syndrome	0.40	1	2016	2016	   1	   3	GENOMICS_ENGLAND
      374	AREG	0.487	0.769	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.38	1	2005	2019	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1993	2020	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.39	1	2004	2019	   2	   0	CTD_human
      374	AREG	0.487	0.769	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.34	1	2001	2019	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0018671	Head and Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0018675	Head Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.36	1	2005	2019	   3	   0	CTD_human
      374	AREG	0.487	0.769	C0027533	Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.33	1	2005	2019	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2005	2006	   3	   0	CTD_human
      374	AREG	0.487	0.769	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.32	1	2005	2020	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0162568	Erythropoietic Protoporphyria	disease	C16;C06;C18;C17	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.31	1	2004	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0349426	Ferrochelatase deficiency	disease	C16;C06;C18;C17	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1993	2020	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0746787	Cancer of Neck	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0751177	Cancer of Head	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0887900	Upper Aerodigestive Tract Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.35	1	2002	2017	   1	   0	CTD_human
      374	AREG	0.487	0.769	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.34	1	2002	2017	   1	   0	CTD_human
      374	AREG	0.487	0.769	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
      374	AREG	0.487	0.769	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.34	1	2001	2018	   1	   0	CTD_human
      374	AREG	0.487	0.769	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2005	2006	   3	   0	CTD_human
      374	AREG	0.487	0.769	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
      374	AREG	0.487	0.769	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      375	ARF1	0.626	0.615	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.32	1	2013	2016	   1	   0	CTD_human
      375	ARF1	0.626	0.615	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
      375	ARF1	0.626	0.615	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.32	1	2013	2016	   1	   0	CTD_human
      375	ARF1	0.626	0.615	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      375	ARF1	0.626	0.615	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2008	2016	   1	   0	CTD_human
      375	ARF1	0.626	0.615	C1868720	Periventricular Nodular Heterotopia	disease	C16;C10	Disease or Syndrome	0.41	1	2009	2016	   1	   0	ORPHANET
      375	ARF1	0.626	0.615	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      375	ARF1	0.626	0.615	C4748602	PERIVENTRICULAR NODULAR HETEROTOPIA 8	disease		Disease or Syndrome	0.40	1	2016	2016	   1	   3	UNIPROT
      383	ARG1	0.476	0.846	C0002514	Amino Acid Metabolism, Inborn Errors	group	C16;C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0003949	Asbestosis	disease	C08;C24	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.40	0.909	2003	2018	   2	   0	CTD_human
      383	ARG1	0.476	0.846	C0018500	Hair Diseases	group	C17	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2012	2012	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0021053	Immune System Diseases	group	C20	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0023281	Leishmaniasis	disease	C01;C17	Disease or Syndrome	0.31	1	2011	2018	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0026848	Myopathy	group	C05;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.31	1	2012	2015	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0037116	Silicosis	disease	C08;C24	Disease or Syndrome	0.50	1	2004	2007	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.31	1	2016	2019	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0268548	Hyperargininemia	phenotype	C16;C18;C10	Disease or Syndrome	1.00	1	1944	2020	  12	   3	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      383	ARG1	0.476	0.846	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0750905	Amino Acid Metabolism, Inherited Disorders	disease	C16;C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C2930617	Pulmonary Fibrosis - from Asbestos Exposure	disease	C08;C24	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.39	1	2003	2017	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2013	2013	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2008	2013	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0035304	Retinal Degeneration	phenotype	C11	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2013	2013	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2008	2013	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0887833	Carcinoma, Pancreatic Ductal	disease	C06;C04;C19	Neoplastic Process	0.31	1	2013	2013	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0000771	Abnormalities, Drug-Induced	group	C16	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0002170	Alopecia	disease	C23;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.32	1	2014	2016	   0	   0	CGI
      387	RHOA	0.502	0.808	C0007097	Carcinoma	group	C04	Neoplastic Process	0.31	1	2014	2018	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0013575	Ectodermal Dysplasia	disease	C16;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0020981	Angioimmunoblastic Lymphadenopathy	disease	C20;C15	Neoplastic Process	0.40	1	2014	2019	   2	   0	CTD_human
      387	RHOA	0.502	0.808	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.34	1	2014	2019	   0	   0	CGI
      387	RHOA	0.502	0.808	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.39	1	2004	2020	   3	   0	CTD_human
      387	RHOA	0.502	0.808	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	2004	2014	   3	   0	CTD_human
      387	RHOA	0.502	0.808	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0040435	Tooth Diseases	group	C07	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0079772	T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.32	1	2014	2017	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0079774	Peripheral T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.38	1	2014	2019	   2	   0	CTD_human
      387	RHOA	0.502	0.808	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2018	2018	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0086873	Pseudopelade	disease	C23;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2018	2018	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0162311	Androgenetic Alopecia	disease	C23;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0162361	Hidrotic Ectodermal Dysplasia	disease	C16;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0162835	Hypopigmentation disorder	disease	C17	Disease or Syndrome	0.31	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0235833	Congenital diaphragmatic hernia	disease	C23;C16	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      387	RHOA	0.502	0.808	C0263477	Female pattern alopecia (disorder)	phenotype	C23;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0265316	Neurocutaneous Syndromes	disease	C16;C17;C10	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0265699	Congenital hernia of foramen of Morgagni	disease	C23;C16	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0265700	Congenital hernia of foramen of Bochdalek	disease	C23;C16	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0270612	Leukoencephalopathy	group	C10	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0282160	Aplasia Cutis Congenita	disease	C16;C17	Congenital Abnormality	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0376407	Granulomatous Slack Skin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C1706004	Anhydrotic Ectodermal Dysplasias	disease	C16;C17	Congenital Abnormality	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2004	2014	   3	   0	CTD_human
      387	RHOA	0.502	0.808	C1744559	Congenital ectodermal dysplasia of face	disease	C16;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C1858991	Childhood Ataxia with Central Nervous System Hypomyelinization	disease	C10	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C4083212	Alopecia, Male Pattern	disease	C23;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      388	RHOB	0.653	0.423	C0036421	Systemic Scleroderma	disease	C17	Disease or Syndrome	0.33	0.667	2011	2014	   1	   0	CTD_human
      389	RHOC	0.641	0.308	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	1	2003	2019	   1	   0	CTD_human
      389	RHOC	0.641	0.308	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      390	RND3	0.656	0.385	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2012	2017	   1	   0	CTD_human
      392	ARHGAP1	0.638	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      393	ARHGAP4	0.736	0.5	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      393	ARHGAP4	0.736	0.5	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      395	ARHGAP6	0.769	0.269	C2931456	Prostate cancer, familial	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      395	ARHGAP6	0.769	0.269	C4722327	PROSTATE CANCER, HEREDITARY, 1	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.32	1	2010	2014	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.35	1	2008	2016	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.32	1	2010	2014	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2010	2015	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C1868672	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	disease	C13;C12	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
      396	ARHGDIA	0.663	0.577	C3808874	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2	disease		Disease or Syndrome	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      396	ARHGDIA	0.663	0.577	C3808953	NEPHROTIC SYNDROME, TYPE 8	disease		Disease or Syndrome	0.60				   0	   3	CTD_human;GENOMICS_ENGLAND
      396	ARHGDIA	0.663	0.577	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      397	ARHGDIB	0.633	0.654	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      397	ARHGDIB	0.633	0.654	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      397	ARHGDIB	0.633	0.654	C0948089	Acute Coronary Syndrome	disease	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      397	ARHGDIB	0.633	0.654	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      399	RHOH	0.666	0.462	C0014522	Epidermodysplasia Verruciformis	disease	C01;C17	Neoplastic Process	0.32	1	2012	2013	   1	   0	GENOMICS_ENGLAND
      399	RHOH	0.666	0.462	C0494261	Combined immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2013	2013	   1	   0	GENOMICS_ENGLAND
      399	RHOH	0.666	0.462	C4749042	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4	phenotype		Finding	0.30	1	2012	2012	   1	   0	ORPHANET
      401	PHOX2A	0.7	0.346	C1865915	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2	disease	C23;C16;C11;C10	Disease or Syndrome	0.73	0.8	2001	2012	   2	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      402	ARL2	0.743	0.269	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      403	ARL3	0.603	0.615	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.34	1	2006	2019	   1	   0	ORPHANET
      403	ARL3	0.603	0.615	C0431399	Familial aplasia of the vermis	disease	C16;C13;C11;C12	Disease or Syndrome	0.33	1	2014	2018	   1	   0	ORPHANET
      403	ARL3	0.603	0.615	C3553264	JOUBERT SYNDROME 17	disease		Disease or Syndrome	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      403	ARL3	0.603	0.615	C4551568	Joubert syndrome 1	disease	C16;C13;C11;C12	Disease or Syndrome	0.30	1	2018	2018	   1	   0	ORPHANET
      403	ARL3	0.603	0.615	C4748442	JOUBERT SYNDROME 35	disease		Disease or Syndrome	0.40	1	2018	2018	   1	   2	UNIPROT
      403	ARL3	0.603	0.615	C4748536	RETINITIS PIGMENTOSA 83	disease		Disease or Syndrome	0.30	1	2016	2016	   1	   0	UNIPROT
      405	ARNT	0.575	0.692	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.33	1	2011	2015	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.33	0.75	2002	2015	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0025202	melanoma	disease	C04	Neoplastic Process	0.37	1	2006	2019	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1998	1998	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2006	2012	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.31	1	2006	2008	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0000772	Multiple congenital anomalies	group	C16	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.37	1	2006	2019	   5	   0	PSYGENET
      406	ARNTL	0.51	0.885	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.36	1	2009	2018	   3	   0	PSYGENET
      406	ARNTL	0.51	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2009	2018	   3	   0	PSYGENET
      406	ARNTL	0.51	0.885	C0021361	Female infertility	phenotype	C13	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.31	1	2006	2011	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0038279	Sterility, Postpartum	phenotype	C13	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0085159	Seasonal Affective Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2007	2015	   1	   0	PSYGENET
      406	ARNTL	0.51	0.885	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0268548	Hyperargininemia	phenotype	C16;C18;C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0341869	Subfertility, Female	disease	C13	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2009	2016	   2	   0	PSYGENET
      406	ARNTL	0.51	0.885	C0917730	Female sterility	phenotype	C13	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      407	ARR3	0.46	0.846	C4538795	MYOPIA 26, X-LINKED, FEMALE-LIMITED	disease		Disease or Syndrome	0.40	1	2016	2016	   1	   3	UNIPROT
      408	ARRB1	0.588	0.846	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      408	ARRB1	0.588	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2013	2015	   1	   0	PSYGENET
      408	ARRB1	0.588	0.846	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.32	1	2016	2019	   1	   0	CTD_human
      408	ARRB1	0.588	0.846	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2013	2015	   1	   0	PSYGENET
      408	ARRB1	0.588	0.846	C3178803	Social Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	PSYGENET
      409	ARRB2	0.561	0.769	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      409	ARRB2	0.561	0.769	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      409	ARRB2	0.561	0.769	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      409	ARRB2	0.561	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      409	ARRB2	0.561	0.769	C0236733	Amphetamine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      409	ARRB2	0.561	0.769	C0236804	Amphetamine Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      409	ARRB2	0.561	0.769	C0236807	Amphetamine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      409	ARRB2	0.561	0.769	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
      410	ARSA	0.448	0.923	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	1984	2002	   4	   0	PSYGENET
      410	ARSA	0.448	0.923	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.40				   0	   0	GENOMICS_ENGLAND
      410	ARSA	0.448	0.923	C0023522	Leukodystrophy, Metachromatic	disease	C16;C18;C10	Disease or Syndrome	1.00	0.978	1975	2019	  44	 142	CTD_human;GENOMICS_ENGLAND;UNIPROT
      410	ARSA	0.448	0.923	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	1996	1996	   1	   0	PSYGENET
      410	ARSA	0.448	0.923	C0751276	Metachromatic leukodystrophy, juvenile type	disease	C16;C18;C10	Disease or Syndrome	0.43	1	1983	2006	   0	   5	CTD_human
      410	ARSA	0.448	0.923	C0751278	Metachromatic Leukodystrophy, Infant	disease	C16;C18;C10	Disease or Syndrome	0.50	1	1991	2004	   0	   4	CTD_human
      410	ARSA	0.448	0.923	C0751279	Metachromatic Leukodystrophy, Adult-Type (disorder)	disease	C16;C18;C10	Disease or Syndrome	0.45	1	1978	2011	   0	   7	CTD_human
      410	ARSA	0.448	0.923	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	1996	1996	   1	   0	PSYGENET
      410	ARSA	0.448	0.923	C2713319	Arylsulfatase A Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.57	1	1980	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
      411	ARSB	0.595	0.692	C0026709	Mucopolysaccharidosis VI	disease	C16;C18;C17	Disease or Syndrome	1.00	1	1979	2019	  15	 121	CTD_human;GENOMICS_ENGLAND;UNIPROT
      411	ARSB	0.595	0.692	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.40				   0	   0	GENOMICS_ENGLAND
      412	STS	0.431	0.846	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.32	1	2005	2019	   1	   0	CTD_human
      412	STS	0.431	0.846	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C0019187	Hepatitis, Alcoholic	disease	C06;C25	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      412	STS	0.431	0.846	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.35	1	2014	2019	   1	   0	CTD_human
      412	STS	0.431	0.846	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C0041671	Attention Deficit Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      412	STS	0.431	0.846	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C0079588	Ichthyosis, X-Linked	disease	C16;C18;C17	Disease or Syndrome	0.80	0.974	1978	2019	   8	   5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      412	STS	0.431	0.846	C0524610	Chronic Alcoholic Hepatitis	disease	C06;C25	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      412	STS	0.431	0.846	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C1263846	Attention deficit hyperactivity disorder	disease	F03	Mental or Behavioral Dysfunction	0.46	1	2008	2017	   1	   0	CTD_human
      412	STS	0.431	0.846	C1321905	Minimal Brain Dysfunction	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      412	STS	0.431	0.846	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C2717836	Steroid Sulfatase Deficiency Disease	disease	C16;C18;C17	Disease or Syndrome	0.60	0.909	1978	2018	   5	   0	CTD_human;ORPHANET
      412	STS	0.431	0.846	C2720163	Placental Steroid Sulfatase Deficiency	disease	C16;C18;C17	Disease or Syndrome	0.60	0.978	1979	2017	   5	   0	CTD_human;ORPHANET
      412	STS	0.431	0.846	C4274085	Syndromic recessive X-linked ichthyosis	disease	C16;C18;C17	Disease or Syndrome	0.30	1	1988	2008	   4	   0	ORPHANET
      415	ARSL	0.663	0.654	C0008445	Chondrodysplasia Punctata	disease	C05	Congenital Abnormality	0.40	0.875	1995	2017	   1	   0	GENOMICS_ENGLAND
      415	ARSL	0.663	0.654	C1844853	Brachytelephalangic Chondrodysplasia Punctata	disease		Disease or Syndrome	0.63	1	1995	2013	   3	  11	GENOMICS_ENGLAND;UNIPROT
      415	ARSL	0.663	0.654	C3669395	X-Linked Chondrodysplasia Punctata 1	disease	C16;C05	Disease or Syndrome	0.51	1	1995	2008	   1	   0	CTD_human;GENOMICS_ENGLAND
      421	ARVCF	0.54	0.769	C0012236	DiGeorge Syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.30				   0	   0	ORPHANET
      421	ARVCF	0.54	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.46	1	2005	2019	   4	   0	PSYGENET
      421	ARVCF	0.54	0.769	C0220704	Shprintzen syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.30				   0	   0	ORPHANET
      421	ARVCF	0.54	0.769	C0431406	Asymmetric crying face association	disease	C23;C10;C07	Disease or Syndrome	0.30				   0	   0	ORPHANET
      421	ARVCF	0.54	0.769	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.30				   0	   0	ORPHANET
      421	ARVCF	0.54	0.769	C0809983	Schizophrenia and related disorders	group	F03	Disease or Syndrome	0.31	1	2010	2010	   1	   0	PSYGENET
      421	ARVCF	0.54	0.769	C2936346	22q11 Deletion Syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.30				   0	   0	ORPHANET
      421	ARVCF	0.54	0.769	C3266101	22q11 partial monosomy syndrome	disease		Disease or Syndrome	0.30				   0	   0	ORPHANET
      421	ARVCF	0.54	0.769	C3888239	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	disease		Finding	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      427	ASAH1	0.526	0.808	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.40	1	2017	2018	   2	   1	CTD_human
      427	ASAH1	0.526	0.808	C0020305	Hydrops Fetalis	disease	C23;C16;C13;C20;C15	Disease or Syndrome	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
      427	ASAH1	0.526	0.808	C0023794	Lipoidosis	disease	C16;C18	Disease or Syndrome	0.30	1	2005	2006	   2	   0	CTD_human
      427	ASAH1	0.526	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      427	ASAH1	0.526	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      427	ASAH1	0.526	0.808	C0221765	Chronic schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      427	ASAH1	0.526	0.808	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   2	   0	CTD_human
      427	ASAH1	0.526	0.808	C0268255	Farber Lipogranulomatosis	disease	C16;C18;C10	Disease or Syndrome	1.00	1	1989	2019	  15	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      427	ASAH1	0.526	0.808	C0455988	Hydrops Fetalis, Non-Immune	disease	C23;C16;C13;C20;C15	Disease or Syndrome	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
      427	ASAH1	0.526	0.808	C1834569	Jankovic Rivera syndrome	disease	C23;C16;C05;C10	Disease or Syndrome	0.75	1	2012	2019	   4	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      427	ASAH1	0.526	0.808	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
      427	ASAH1	0.526	0.808	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
      427	ASAH1	0.526	0.808	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.41	1	2008	2014	   1	   0	GENOMICS_ENGLAND
      429	ASCL1	0.552	0.692	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      429	ASCL1	0.552	0.692	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      429	ASCL1	0.552	0.692	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      429	ASCL1	0.552	0.692	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.40	1	1997	2020	   1	   0	CTD_human
      429	ASCL1	0.552	0.692	C0242488	Acute Lung Injury	disease	C08	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      429	ASCL1	0.552	0.692	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      429	ASCL1	0.552	0.692	C1275808	Congenital central hypoventilation	disease	C23;C08;C10	Disease or Syndrome	0.61	1	2003	2003	   0	   0	CTD_human;GENOMICS_ENGLAND
      429	ASCL1	0.552	0.692	C1859049	CCHS WITH HIRSCHSPRUNG DISEASE	disease	C23;C08;C10	Disease or Syndrome; Congenital Abnormality	0.50				   0	   0	CTD_human;ORPHANET
      429	ASCL1	0.552	0.692	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40	1	2011	2011	   1	   0	CTD_human
      430	ASCL2	0.691	0.423	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.35	0.833	2004	2019	   1	   0	CTD_human
      430	ASCL2	0.691	0.423	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      434	ASIP	0.584	0.692	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.31	1	2008	2009	   1	   0	CTD_human
      434	ASIP	0.584	0.692	C0025202	melanoma	disease	C04	Neoplastic Process	0.38	1	2002	2013	   3	   0	CTD_human
      434	ASIP	0.584	0.692	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      434	ASIP	0.584	0.692	C1368275	Pigmented Basal Cell Carcinoma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      434	ASIP	0.584	0.692	C4721806	Carcinoma, Basal Cell	disease	C04	Neoplastic Process	0.32	1	2008	2009	   1	   0	CTD_human
      435	ASL	0.593	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.31	1	2015	2015	   0	   0	UNIPROT
      435	ASL	0.593	0.731	C0268547	Argininosuccinic Aciduria	disease	C16;C18;C10	Disease or Syndrome	1.00	1	1976	2019	  12	  83	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      438	ASMT	0.691	0.346	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2008	2014	   1	   0	CTD_human
      438	ASMT	0.691	0.346	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2012	2014	   1	   0	PSYGENET
      438	ASMT	0.691	0.346	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2012	2014	   2	   0	PSYGENET
      438	ASMT	0.691	0.346	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2014	   2	   0	PSYGENET
      438	ASMT	0.691	0.346	C0019202	Hepatolenticular Degeneration	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      438	ASMT	0.691	0.346	C1527352	Hepatic Form of Wilson Disease	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      440	ASNS	0.595	0.692	C0023794	Lipoidosis	disease	C16;C18	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      440	ASNS	0.595	0.692	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      440	ASNS	0.595	0.692	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.50	1	1976	2017	   1	   0	CTD_human
      440	ASNS	0.595	0.692	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.51	1	1976	2019	   1	   0	CTD_human
      440	ASNS	0.595	0.692	C3809971	ASPARAGINE SYNTHETASE DEFICIENCY	disease		Disease or Syndrome	0.73	1	1968	2019	  16	  12	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      443	ASPA	0.564	0.731	C0206307	Canavan Disease	disease	C16;C18;C10	Disease or Syndrome	1.00	0.967	1990	2020	  17	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
      443	ASPA	0.564	0.731	C0751663	Canavan Disease, Familial Form	disease	C16;C18;C10	Disease or Syndrome	0.40	1	1993	2013	   2	   0	CTD_human
      443	ASPA	0.564	0.731	C0751664	Canavan Disease, Neonatal	disease	C16;C18;C10	Disease or Syndrome	0.50	1	2006	2011	   3	   0	CTD_human;ORPHANET
      443	ASPA	0.564	0.731	C0751665	Canavan Disease, Sporadic Form	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2006	2007	   2	   0	CTD_human
      443	ASPA	0.564	0.731	C0751666	Canavan Disease, Infantile	disease	C16;C18;C10	Disease or Syndrome	0.50	1	2006	2011	   3	   0	CTD_human;ORPHANET
      443	ASPA	0.564	0.731	C0751667	Canavan Disease, Juvenile	disease	C16;C18;C10	Disease or Syndrome	0.50	1	2006	2011	   3	   0	CTD_human;ORPHANET
      443	ASPA	0.564	0.731	C3542499	Aminoacylase 2 Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.31	1	2005	2007	   2	   0	CTD_human
      444	ASPH	0.61	0.615	C1832167	Ectopia Lentis, Spontaneous Filtering Blebs, and Craniofacial Dysmorphism	disease	C16;C11;C05	Disease or Syndrome	0.72	1	2014	2018	   1	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      445	ASS1	0.523	0.731	C0011875	Diabetic Angiopathies	disease	C19;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      445	ASS1	0.523	0.731	C0025945	Microangiopathy, Diabetic	disease	C19;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      445	ASS1	0.523	0.731	C0175683	Citrullinemia	disease	C16;C18;C10	Disease or Syndrome	0.90	1	1982	2020	  10	   0	CLINGEN;CTD_human;GENOMICS_ENGLAND
      445	ASS1	0.523	0.731	C0751750	Argininosuccinic Acid Synthetase Deficiency Disease, Partial	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
      445	ASS1	0.523	0.731	C0751751	Argininosuccinic Acid Synthetase Deficiency, Complete	disease	C16;C18;C10	Disease or Syndrome	0.55	1	1982	2017	   9	   0	CLINGEN;CTD_human
      445	ASS1	0.523	0.731	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40	1	2009	2009	   1	   0	GENOMICS_ENGLAND
      445	ASS1	0.523	0.731	C4721769	Citrullinemia Type 1	disease	C16;C18;C10	Disease or Syndrome	0.80	1	1982	2019	  22	  85	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      460	ASTN1	0.736	0.308	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      460	ASTN1	0.736	0.308	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
      460	ASTN1	0.736	0.308	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      460	ASTN1	0.736	0.308	C2748861	Cortical malformations	phenotype		Finding	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
      460	ASTN1	0.736	0.308	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
      462	SERPINC1	0.507	0.769	C0005779	Blood Coagulation Disorders	group	C15	Disease or Syndrome	0.30	1	1976	1976	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0012739	Disseminated Intravascular Coagulation	disease	C15	Disease or Syndrome	0.33	1	1984	2019	   3	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0027726	Nephrotic Syndrome	group	C13;C12	Disease or Syndrome	0.50	1	1994	2001	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0040053	Thrombosis	phenotype	C14	Pathologic Function	0.51	1	1983	2007	   4	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0042487	Venous Thrombosis	phenotype	C14	Pathologic Function	0.34	1	1976	2007	   3	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0079102	Cerebral Thrombosis	disease	C10;C14	Disease or Syndrome	0.31	1	1980	1983	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0087086	Thrombus	phenotype	C14	Pathologic Function	0.30	1	1983	2000	   4	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0149871	Deep Vein Thrombosis	disease	C14	Disease or Syndrome	0.50	1	1976	2019	   3	   2	CTD_human
      462	SERPINC1	0.507	0.769	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.31	1	1985	2017	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0272375	Antithrombin III Deficiency	disease	C16;C15	Disease or Syndrome	1.00	0.987	1984	2019	  38	  43	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      462	SERPINC1	0.507	0.769	C0752143	Intracranial Thrombosis	disease	C10;C14	Disease or Syndrome	0.30	1	1983	1983	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0752144	Brain Thrombosis	disease	C10;C14	Disease or Syndrome	0.30	1	1983	1983	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0936261	Brain Thrombus	disease	C10;C14	Disease or Syndrome	0.30	1	1983	1983	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0936263	Cerebral Thrombus	disease	C10;C14	Disease or Syndrome	0.30	1	1983	1983	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0948089	Acute Coronary Syndrome	disease	C14	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C1861172	Venous Thromboembolism	phenotype	C14	Disease or Syndrome	0.40	1	1979	2019	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	1983	1983	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C3658294	Hereditary Antithrombin Deficiency	disease	C16;C15	Disease or Syndrome	0.34	1	1984	2019	   1	   0	CTD_human
      463	ZFHX3	0.621	0.654	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.50	0.966	2009	2019	   5	   7	CTD_human
      463	ZFHX3	0.621	0.654	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      463	ZFHX3	0.621	0.654	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.33	1	2005	2018	   3	   0	CTD_human
      463	ZFHX3	0.621	0.654	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.48	1	2012	2019	   1	   3	CTD_human
      463	ZFHX3	0.621	0.654	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.31	1	2009	2018	   5	   0	CTD_human
      463	ZFHX3	0.621	0.654	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.47	1	2005	2019	   3	   0	CTD_human
      463	ZFHX3	0.621	0.654	C0751956	Acute Cerebrovascular Accidents	disease	C10;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      463	ZFHX3	0.621	0.654	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2009	2018	   5	   0	CTD_human
      463	ZFHX3	0.621	0.654	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2009	2018	   5	   0	CTD_human
      465	ATD	0.656	0.731	C4551856	Asphyxiating Thoracic Dystrophy 1	disease	C16;C17;C05	Disease or Syndrome; Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
      466	ATF1	0.588	0.577	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      466	ATF1	0.588	0.577	C0206651	Clear Cell Sarcoma of Soft Tissue	disease	C04	Neoplastic Process	0.40	0.977	1993	2019	   1	   0	ORPHANET
      466	ATF1	0.588	0.577	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.32	1	2007	2016	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2008	2018	   1	   0	PSYGENET
      467	ATF3	0.494	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2018	   1	   0	PSYGENET
      467	ATF3	0.494	0.885	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.34	1	2005	2017	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0021400	Influenza	disease	C01;C08	Disease or Syndrome	0.31	1	2007	2013	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.30	1	2008	2008	   2	   0	CTD_human
      467	ATF3	0.494	0.885	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2006	2008	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0238281	Middle Cerebral Artery Syndrome	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.31	1	2010	2019	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.35	1	2006	2016	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0740376	Middle Cerebral Artery Thrombosis	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0740391	Middle Cerebral Artery Occlusion	disease	C23;C10;C14	Acquired Abnormality	0.31	1	2002	2010	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0740392	Infarction, Middle Cerebral Artery	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0751845	Middle Cerebral Artery Embolus	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0751846	Left Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0751847	Embolic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0751848	Thrombotic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0751849	Right Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0848558	Hypospadias	disease	C16;C13;C12	Congenital Abnormality	0.37	1	2005	2018	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.32	1	2014	2018	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2008	   2	   0	PSYGENET
      468	ATF4	0.507	0.769	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      468	ATF4	0.507	0.769	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      468	ATF4	0.507	0.769	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.33	1	2016	2019	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C0021367	Mammary Ductal Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2004	2004	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2008	2020	   1	   0	PSYGENET
      468	ATF4	0.507	0.769	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2004	2004	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C1134719	Invasive Ductal Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.34	1	2016	2020	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.34	1	2004	2016	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0155003	Blindness, Transient	phenotype	C23;C11;C10	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0221473	Blindness, Hysterical	phenotype	C23;C11;C10	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0271215	Blindness, Legal	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0339730	Blindness, Acquired	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0376288	Amaurosis	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0456909	Blindness	phenotype	C23;C11;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0750958	Blindness, Monocular	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C1837530	AICAR Transformylase Inosine Monophosphate Cyclohydrolase Deficiency	disease	C23;C16;C10;F03;F01	Disease or Syndrome	0.70	1	2004	2004	   1	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      471	ATIC	0.576	0.731	C1879328	Blindness both eyes NOS (disorder)	phenotype	C23;C11;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0004135	Ataxia Telangiectasia	disease	C16;C18;C20;C10;C14	Disease or Syndrome	1.00	0.982	1953	2020	  37	 414	CTD_human;GENOMICS_ENGLAND;UNIPROT
      472	ATM	0.374	0.885	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.69	1	2008	2017	   1	   1	CGI;CTD_human
      472	ATM	0.374	0.885	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.58	1	2008	2017	   1	   0	CGI;CTD_human
      472	ATM	0.374	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.70	0.932	1996	2020	   1	  22	CTD_human;GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.959	1995	2020	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0007112	Adenocarcinoma of prostate	disease	C04;C12	Neoplastic Process	0.30				   0	   0	CGI
      472	ATM	0.374	0.885	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.40	1	2004	2017	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0009405	Hereditary Nonpolyposis Colorectal Neoplasms	group	C16;C06;C04;C18	Neoplastic Process	0.30	1	2012	2017	   6	   0	CLINGEN
      472	ATM	0.374	0.885	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.31	1	2013	2018	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.42	0.5	2012	2015	   0	   0	GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0017638	Glioma	disease	C04	Neoplastic Process	0.60	0.938	2001	2019	   1	   0	CGI;GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.42	1	2001	2016	   1	   1	GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0023418	leukemia	disease	C04	Neoplastic Process	0.90	1	1998	2018	   1	   0	CGI;GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.70	0.966	1998	2019	   2	   2	CTD_human;ORPHANET;UNIPROT
      472	ATM	0.374	0.885	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.90	0.955	1998	2020	   1	   0	CGI;GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.60	1	1998	2019	   1	   0	CGI;CTD_human
      472	ATM	0.374	0.885	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.51	0.5	2003	2017	   1	   0	CGI;GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0025202	melanoma	disease	C04	Neoplastic Process	0.50	1	2007	2019	   1	   2	CTD_human
      472	ATM	0.374	0.885	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.38	1	1994	2019	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0027651	Neoplasms	group	C04	Neoplastic Process	0.50	0.946	1995	2020	   1	   2	CTD_human
      472	ATM	0.374	0.885	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.33	1	2007	2019	   2	   0	CTD_human
      472	ATM	0.374	0.885	C0033054	Prenatal Exposure Delayed Effects	disease	C13	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.32	1	2004	2018	   4	   0	CTD_human
      472	ATM	0.374	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2008	2013	   1	   0	PSYGENET
      472	ATM	0.374	0.885	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.52	1	2001	2015	   1	   0	CGI;CTD_human
      472	ATM	0.374	0.885	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0079774	Peripheral T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.33	1	2003	2015	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0086543	Cataract	disease	C11	Acquired Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.40	0.9	2009	2019	   0	   1	UNIPROT
      472	ATM	0.374	0.885	C0153943	Benign neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      472	ATM	0.374	0.885	C0154017	Benign neoplasm of bladder	disease	C04;C13;C12	Neoplastic Process	0.30				   0	   0	CGI
      472	ATM	0.374	0.885	C0154060	Carcinoma in situ of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      472	ATM	0.374	0.885	C0154091	Carcinoma in situ of bladder	disease	C04;C13;C12	Neoplastic Process	0.30				   0	   0	CGI
      472	ATM	0.374	0.885	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      472	ATM	0.374	0.885	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.33	1	2013	2018	   0	   0	UNIPROT
      472	ATM	0.374	0.885	C0334634	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	disease	C04;C20;C15	Neoplastic Process	0.80	1	1999	2017	   1	   1	CGI;GENOMICS_ENGLAND;UNIPROT
      472	ATM	0.374	0.885	C0346153	Breast Cancer, Familial	disease	C04;C17	Neoplastic Process	0.40	1	1998	2019	   5	   0	CLINGEN
      472	ATM	0.374	0.885	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.40	1	2004	2020	   2	   0	CTD_human
      472	ATM	0.374	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.943	2000	2019	   4	   0	CTD_human
      472	ATM	0.374	0.885	C0376407	Granulomatous Slack Skin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0496905	Neoplasm of uncertain or unknown behavior of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      472	ATM	0.374	0.885	C0496930	Neoplasm of uncertain or unknown behavior of bladder	disease	C04;C13;C12	Neoplastic Process	0.30				   0	   0	CGI
      472	ATM	0.374	0.885	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0555202	Malignant lymphoma - lymphocytic, intermediate differentiation	disease		Neoplastic Process	0.30	1	2000	2000	   1	   0	ORPHANET
      472	ATM	0.374	0.885	C0598589	Inherited neuropathies	disease	C10	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.50	0.934	1996	2020	   0	   3	CTD_human
      472	ATM	0.374	0.885	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	1998	2019	   0	   0	CGI
      472	ATM	0.374	0.885	C0699885	Carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.39	1	2008	2017	   0	   0	CGI
      472	ATM	0.374	0.885	C0855095	Small Lymphocytic Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	0.5	1999	2014	   1	   0	ORPHANET
      472	ATM	0.374	0.885	C1112155	Hereditary non-polyposis colorectal cancer syndrome	disease		Congenital Abnormality	0.30	1	2012	2017	   6	   0	CLINGEN
      472	ATM	0.374	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CTD_human
      472	ATM	0.374	0.885	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.60				   0	   4	CGI;UNIPROT
      472	ATM	0.374	0.885	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.33	1	2005	2018	   6	   0	CLINGEN
      472	ATM	0.374	0.885	C1333991	Hereditary Non-Polyposis Colon Cancer Type 2	disease	C16;C04	Neoplastic Process	0.30	1	2012	2017	   6	   0	CLINGEN
      472	ATM	0.374	0.885	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      472	ATM	0.374	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.50	0.974	1996	2018	   0	   0	CTD_human
      472	ATM	0.374	0.885	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	2006	2006	   1	   0	CTD_human
      472	ATM	0.374	0.885	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      472	ATM	0.374	0.885	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      472	ATM	0.374	0.885	C1843542	T-CELL PROLYMPHOCYTIC LEUKEMIA, SOMATIC	disease		Disease or Syndrome	0.30	1	2009	2009	   1	   0	GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C1868683	B-CELL MALIGNANCY, LOW-GRADE	disease		Neoplastic Process	0.40	1	1998	2015	   1	   0	ORPHANET
      472	ATM	0.374	0.885	C1876175	Ataxia-Telangiectasia Variant	disease	C16;C18;C20;C10;C14	Disease or Syndrome	0.40	1	2013	2013	   1	   1	ORPHANET
      472	ATM	0.374	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.37	1	1995	2020	   1	   0	CTD_human
      472	ATM	0.374	0.885	C2363142	T-Cell Prolymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.50	1	1997	2018	   0	   2	CGI
      472	ATM	0.374	0.885	C2931456	Prostate cancer, familial	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      472	ATM	0.374	0.885	C2936783	Colorectal cancer, hereditary nonpolyposis, type 1	disease	C16;C06;C04;C18	Neoplastic Process	0.30	1	2012	2017	   6	   0	CLINGEN
      472	ATM	0.374	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CTD_human
      472	ATM	0.374	0.885	C4722327	PROSTATE CANCER, HEREDITARY, 1	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      473	RERE	0.526	0.846	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      473	RERE	0.526	0.846	C1842870	Chromosome 1p36 Deletion Syndrome	disease	C23;C16	Disease or Syndrome	0.31	1	2016	2016	   1	   0	ORPHANET
      473	RERE	0.526	0.846	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      473	RERE	0.526	0.846	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      473	RERE	0.526	0.846	C4310772	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART	disease		Disease or Syndrome	0.71	1	2015	2018	   3	  11	CTD_human;GENOMICS_ENGLAND;UNIPROT
      473	RERE	0.526	0.846	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      473	RERE	0.526	0.846	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      474	ATOH1	0.633	0.5	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.40	1	2007	2019	   1	   0	CTD_human
      474	ATOH1	0.633	0.5	C0205833	Medullomyoblastoma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      474	ATOH1	0.633	0.5	C0278510	Childhood Medulloblastoma	disease	C04	Neoplastic Process	0.39	1	2008	2019	   1	   0	CTD_human
      474	ATOH1	0.633	0.5	C0278876	Adult Medulloblastoma	disease	C04	Neoplastic Process	0.39	1	2008	2019	   1	   0	CTD_human
      474	ATOH1	0.633	0.5	C0751291	Desmoplastic Medulloblastoma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      474	ATOH1	0.633	0.5	C1275668	Melanotic medulloblastoma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      474	ATOH1	0.633	0.5	C1879677	Alcohol Toxicity	disease		Injury or Poisoning	0.30	1	2008	2008	   1	   0	PSYGENET
      475	ATOX1	0.656	0.5	C0019189	Hepatitis, Chronic	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      475	ATOX1	0.656	0.5	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      475	ATOX1	0.656	0.5	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      475	ATOX1	0.656	0.5	C0149519	Chronic Persistent Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      475	ATOX1	0.656	0.5	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.31	1	2013	2013	   1	   0	CTD_human
      475	ATOX1	0.656	0.5	C0520463	Chronic active hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      475	ATOX1	0.656	0.5	C0524611	Cryptogenic Chronic Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0001430	Adenoma	group	C04	Neoplastic Process	0.34	1	2013	2017	   2	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1998	1998	   1	   0	PSYGENET
      476	ATP1A1	0.601	0.808	C0017162	Gastroenteritis, Transmissible, of Swine	disease	C01;C22	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0020428	Hyperaldosteronism	disease	C19	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.56	1	1994	2015	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.31	1	2018	2020	   1	   0	GENOMICS_ENGLAND
      476	ATP1A1	0.601	0.808	C0042594	Vestibular Diseases	group	C09	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0151723	Hypomagnesemia	phenotype	C18	Disease or Syndrome	0.42	1	2018	2020	   1	   0	GENOMICS_ENGLAND
      476	ATP1A1	0.601	0.808	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0206667	Adrenal Cortical Adenoma	disease	C04;C19	Neoplastic Process	0.31	1	2016	2016	   0	   0	CGI
      476	ATP1A1	0.601	0.808	C1384514	Conn Syndrome	disease	C19	Disease or Syndrome	0.32	1	2013	2019	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      476	ATP1A1	0.601	0.808	C4552839	Hypomagnesemia, CTCAE	phenotype		Finding	0.40	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      476	ATP1A1	0.601	0.808	C4747974	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD	disease		Disease or Syndrome	0.70	1	2018	2018	   2	   1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
      477	ATP1A2	0.597	0.615	C0003886	Arthrogryposis	disease	C16;C05	Disease or Syndrome	0.40	1	2020	2020	   1	   2	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2009	2009	   1	   0	PSYGENET
      477	ATP1A2	0.597	0.615	C0009421	Comatose	phenotype	C23;C10	Disease or Syndrome	0.40	1	2009	2009	   1	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.40	1	2003	2003	   2	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0020305	Hydrops Fetalis	disease	C23;C16;C13;C20;C15	Disease or Syndrome	0.41	1	2020	2020	   1	   2	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.50	1	2001	2005	   2	   0	CTD_human
      477	ATP1A2	0.597	0.615	C0025958	Microcephaly	disease	C16;C05;C10	Congenital Abnormality	0.30	1	2020	2020	   1	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0085584	Encephalopathies	group	C10	Disease or Syndrome	0.31	1	2009	2018	   1	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0149931	Migraine Disorders	group	C10	Disease or Syndrome	0.40	0.958	2003	2019	   2	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0220669	Familial benign neonatal epilepsy	disease	C16;C10	Disease or Syndrome	0.32	1	2003	2004	   1	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0238358	Hypokalemic periodic paralysis	disease	C16;C18;C05;C10	Disease or Syndrome	0.31	1	2007	2018	   1	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0270816	epilepsy and migraine	disease		Disease or Syndrome	0.31	1	2003	2008	   1	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0338488	Alternating hemiplegia of childhood	disease	C23;C10	Disease or Syndrome	0.54	1	2004	2019	   1	   0	CTD_human;ORPHANET
      477	ATP1A2	0.597	0.615	C1865322	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	disease	C10	Disease or Syndrome	0.80	1	2003	2020	   9	  13	CTD_human;GENOMICS_ENGLAND;UNIPROT
      477	ATP1A2	0.597	0.615	C2733158	Cerebral Small Vessel Diseases	group	C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C3549447	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1	disease		Disease or Syndrome	0.61	1	2003	2020	   4	   1	GENOMICS_ENGLAND;UNIPROT
      478	ATP1A3	0.544	0.615	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.52	0.5	1998	2001	   2	   0	PSYGENET
      478	ATP1A3	0.544	0.615	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
      478	ATP1A3	0.544	0.615	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2011	2011	   1	   0	PSYGENET
      478	ATP1A3	0.544	0.615	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.50	1	1999	2016	   1	   2	CTD_human
      478	ATP1A3	0.544	0.615	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0178417	Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
      478	ATP1A3	0.544	0.615	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0242422	Parkinsonian Disorders	group	C10	Disease or Syndrome	0.48	1	2004	2016	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0242423	Ramsay Hunt Paralysis Syndrome	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0338488	Alternating hemiplegia of childhood	disease	C23;C10	Disease or Syndrome	0.90	0.977	2009	2019	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
      478	ATP1A3	0.544	0.615	C0393588	Dystonia, Paroxysmal	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0393610	Dystonia, Diurnal	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0751093	Dystonia, Limb	phenotype	C23;C10	Sign or Symptom	0.40	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0752097	Autosomal Dominant Juvenile Parkinson Disease	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0752098	Autosomal Dominant Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0752100	Autosomal Recessive Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0752101	Parkinsonism, Experimental	disease	C10	Experimental Model of Disease	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0752104	Familial Juvenile Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0752105	Parkinsonism, Juvenile	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C1832466	CAPOS syndrome	disease	C23;C16;C11;C05;C10;C09	Disease or Syndrome	0.80	1	2012	2019	   4	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      478	ATP1A3	0.544	0.615	C1868675	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C1868681	DYSTONIA 12	disease	C10	Disease or Syndrome	0.80	0.982	2004	2019	   6	  25	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      478	ATP1A3	0.544	0.615	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C3549447	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1	disease		Disease or Syndrome	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
      478	ATP1A3	0.544	0.615	C3553788	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	disease		Disease or Syndrome	0.61	1	2004	2017	   6	  38	GENOMICS_ENGLAND;UNIPROT
      480	ATP1A4	0.805	0.269	C0003165	Anthracosis	disease	C08	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0013170	Drug habituation	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0013222	Drug Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0029231	Organic Mental Disorders, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0038580	Substance Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0038586	Substance Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0085580	Essential Hypertension	disease	C14	Disease or Syndrome	0.31	1	2009	2009	   0	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0236969	Substance-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C4316881	Prescription Drug Abuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      482	ATP1B2	0.705	0.308	C0017638	Glioma	disease	C04	Neoplastic Process	0.32	1	2003	2006	   1	   0	CTD_human
      482	ATP1B2	0.705	0.308	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      482	ATP1B2	0.705	0.308	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.40	1	2014	2014	   1	   1	CTD_human
      482	ATP1B2	0.705	0.308	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.31	1	2003	2006	   1	   0	CTD_human
      486	FXYD2	0.78	0.346	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      486	FXYD2	0.78	0.346	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      486	FXYD2	0.78	0.346	C0024473	Magnesium Deficiency	disease	C18	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      486	FXYD2	0.78	0.346	C0268448	Primary hypomagnesemia (disorder)	disease	C23;C16;C18;C13;C12	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      486	FXYD2	0.78	0.346	C1835171	Hypomagnesemia 2, renal	disease	C16;C18;C13;C12	Disease or Syndrome	0.70	1	2000	2016	   4	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      487	ATP2A1	0.682	0.423	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      487	ATP2A1	0.682	0.423	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      487	ATP2A1	0.682	0.423	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      487	ATP2A1	0.682	0.423	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      487	ATP2A1	0.682	0.423	C1832918	Brody myopathy	disease	C16;C05;C10	Disease or Syndrome	0.80	1	1995	2014	   3	  11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      487	ATP2A1	0.682	0.423	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      487	ATP2A1	0.682	0.423	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2001	2004	   2	   0	PSYGENET
      488	ATP2A2	0.529	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2001	2004	   2	   0	PSYGENET
      488	ATP2A2	0.529	0.808	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2005	2017	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.51	1	2005	2016	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.51	0.667	2009	2015	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.50	1	2001	2018	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.60	0.929	1996	2019	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.80	0.929	1996	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
      488	ATP2A2	0.529	0.808	C0022595	Keratosis Follicularis	disease	C16;C17	Disease or Syndrome	1.00	0.974	1999	2018	  12	   8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      488	ATP2A2	0.529	0.808	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.50	1	2000	2017	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.43	1	2012	2019	   1	   1	PSYGENET
      488	ATP2A2	0.529	0.808	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0206145	Stunned Myocardium	disease	C23;C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0206146	Myocardial Stunning	disease	C23;C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0264716	Chronic heart failure	disease	C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      488	ATP2A2	0.529	0.808	C0265971	Acrokeratosis Verruciformis of Hopf	disease	C16;C17	Disease or Syndrome; Congenital Abnormality	0.74	1	2003	2017	   3	   2	CTD_human;ORPHANET;UNIPROT
      488	ATP2A2	0.529	0.808	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0376416	Hibernation, Myocardial	disease	C23;C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0473575	Acantholytic Dyskeratotic Epidermal Nevus	disease	C16;C17	Neoplastic Process	0.30	1	2006	2010	   2	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2001	2002	   2	   0	PSYGENET
      488	ATP2A2	0.529	0.808	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0853897	Diabetic Cardiomyopathies	disease	C19;C14	Disease or Syndrome	0.52	0.75	2002	2014	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0001430	Adenoma	group	C04	Neoplastic Process	0.32	1	2005	2014	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.35	1	2016	2019	   0	   1	UNIPROT
      489	ATP2A3	0.617	0.577	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2005	2010	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.32	1	1999	2019	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      490	ATP2B1	0.666	0.5	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.31	1	2012	2019	   1	   0	CTD_human
      490	ATP2B1	0.666	0.5	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.70	0.966	1999	2019	   1	   9	CTD_human
      490	ATP2B1	0.666	0.5	C0086543	Cataract	disease	C11	Acquired Abnormality	0.30	1	2004	2004	   1	   0	CTD_human
      490	ATP2B1	0.666	0.5	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      490	ATP2B1	0.666	0.5	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	2004	2004	   1	   0	CTD_human
      490	ATP2B1	0.666	0.5	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.43	1	2012	2019	   1	   3	CTD_human
      491	ATP2B2	0.659	0.731	C1832394	Deafness, Autosomal Recessive 12	disease	C23;C10;C09	Disease or Syndrome	0.50	1	2007	2007	   1	   0	CTD_human;GENOMICS_ENGLAND
      492	ATP2B3	0.631	0.692	C0001430	Adenoma	group	C04	Neoplastic Process	0.31	1	2013	2013	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0020428	Hyperaldosteronism	disease	C19	Disease or Syndrome	0.31	1	2013	2015	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.31	1	2013	2017	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0796205	SPINOCEREBELLAR ATAXIA, X-LINKED 1	disease	C16;C10	Disease or Syndrome	0.70	1	2012	2012	   1	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      492	ATP2B3	0.631	0.692	C1384514	Conn Syndrome	disease	C19	Disease or Syndrome	0.31	1	2013	2015	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C4707849	X-linked non progressive cerebellar ataxia	disease	C23;C16;C10	Disease or Syndrome	0.30				   0	   0	ORPHANET
      498	ATP5F1A	0.604	0.731	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.54	1	2003	2017	   1	   0	CTD_human
      498	ATP5F1A	0.604	0.731	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
      498	ATP5F1A	0.604	0.731	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      498	ATP5F1A	0.604	0.731	C0376618	Endotoxemia	phenotype	C23;C01	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      498	ATP5F1A	0.604	0.731	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
      498	ATP5F1A	0.604	0.731	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
      498	ATP5F1A	0.604	0.731	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
      498	ATP5F1A	0.604	0.731	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      498	ATP5F1A	0.604	0.731	C3808899	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4	disease		Disease or Syndrome	0.70	1	2013	2013	   2	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      498	ATP5F1A	0.604	0.731	C4015062	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	disease		Disease or Syndrome	0.70	1	2013	2013	   2	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      498	ATP5F1A	0.604	0.731	C4757950	Isolated ATP synthase deficiency	disease		Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
      501	ALDH7A1	0.551	0.769	C0005940	Bone Diseases	group	C05	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      501	ALDH7A1	0.551	0.769	C0009363	Congenital ocular coloboma (disorder)	disease	C16;C11	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
      501	ALDH7A1	0.551	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      501	ALDH7A1	0.551	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      501	ALDH7A1	0.551	0.769	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2011	2011	   1	   0	CTD_human
      501	ALDH7A1	0.551	0.769	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      501	ALDH7A1	0.551	0.769	C1849508	EPILEPSY, PYRIDOXINE-DEPENDENT	disease	C10	Disease or Syndrome	0.80	1	2006	2020	   9	  25	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      501	ALDH7A1	0.551	0.769	C4554007	Uveoretinal Coloboma	disease	C16;C11	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.50	1	2015	2015	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2009	2009	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.50	1	2015	2015	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C1846707	SPINOCEREBELLAR ATAXIA 17	disease	C16;C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.50	1	2015	2015	   1	   0	CTD_human
      513	ATP5F1D	0.674	0.5	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      513	ATP5F1D	0.674	0.5	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      513	ATP5F1D	0.674	0.5	C4748269	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5	disease		Disease or Syndrome	0.60	1	2018	2018	   1	   2	GENOMICS_ENGLAND;UNIPROT
      513	ATP5F1D	0.674	0.5	C4757950	Isolated ATP synthase deficiency	disease		Disease or Syndrome	0.30	1	2018	2018	   1	   0	ORPHANET
      514	ATP5F1E	0.686	0.5	C3279708	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3	disease		Disease or Syndrome	0.70	1	2010	2016	   3	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      514	ATP5F1E	0.686	0.5	C4757950	Isolated ATP synthase deficiency	disease		Disease or Syndrome	0.30	1	2010	2010	   1	   0	ORPHANET
      522	ATP5PF	0.716	0.538	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      523	ATP6V1A	0.579	0.615	C0268355	Cutis Laxa, Autosomal Recessive, Type IIA	disease	C16;C17	Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
      523	ATP6V1A	0.579	0.615	C4479387	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC	disease		Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
      523	ATP6V1A	0.579	0.615	C4479409	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID	disease		Disease or Syndrome	0.70	1	2017	2017	   1	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      523	ATP6V1A	0.579	0.615	C4693934	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3	disease		Disease or Syndrome	0.60	1	2017	2018	   2	   5	GENOMICS_ENGLAND;UNIPROT
      525	ATP6V1B1	0.695	0.346	C0027707	Nephritis, Interstitial	disease	C13;C12	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      525	ATP6V1B1	0.695	0.346	C0041349	Nephritis, Tubulointerstitial	disease	C13;C12	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      525	ATP6V1B1	0.695	0.346	C0403554	Renal Tubular Acidosis, Distal, with Progressive Nerve Deafness	disease	C23;C16;C18;C13;C12;C10;C09	Disease or Syndrome	0.70	1	1999	2017	   4	   0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      525	ATP6V1B1	0.695	0.346	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.30	1	1999	1999	   1	   0	GENOMICS_ENGLAND
      525	ATP6V1B1	0.695	0.346	C1704380	Distal Renal Tubular Acidosis	disease	C16;C18;C13;C12	Disease or Syndrome	0.40	1	2001	2020	   0	   0	GENOMICS_ENGLAND
      525	ATP6V1B1	0.695	0.346	C1864498	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE	disease	C16;C18;C13;C12	Disease or Syndrome	0.36	1	2002	2017	   1	   0	ORPHANET
      525	ATP6V1B1	0.695	0.346	C4302514	Distal renal tubular acidosis co-occurrent with sensorineural deafness	phenotype	C23;C16;C18;C13;C12;C10;C09	Disease or Syndrome	0.30	1	1999	2017	   2	   0	CLINGEN
      526	ATP6V1B2	0.606	0.577	C0024301	Lymphoma, Follicular	disease	C04;C20;C15	Neoplastic Process	0.31	1	2016	2019	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C0079745	Lymphoma, Large-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C0079758	Lymphoma, Mixed-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C0079765	Lymphoma, Small Cleaved-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C0796013	Zimmerman Laband syndrome	disease	C16;C05;C07	Disease or Syndrome	0.61	1	2015	2015	   1	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
      526	ATP6V1B2	0.606	0.577	C1956130	Lymphoma, Follicular, Grade 1	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C1956131	Lymphoma, Follicular, Grade 3	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C1956132	Lymphoma, Follicular, Grade 2	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C2675730	Deafness, Congenital, and Onychodystrophy, Autosomal Dominant	disease	C23;C16;C10;C07;C09	Disease or Syndrome	0.62	1	2014	2019	   1	   1	CTD_human;ORPHANET
      526	ATP6V1B2	0.606	0.577	C4225321	ZIMMERMANN-LABAND SYNDROME 2	disease		Disease or Syndrome	0.41	1	2015	2019	   1	   2	UNIPROT
      529	ATP6V1E1	0.61	0.769	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      529	ATP6V1E1	0.61	0.769	C0268355	Cutis Laxa, Autosomal Recessive, Type IIA	disease	C16;C17	Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
      529	ATP6V1E1	0.61	0.769	C4479387	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC	disease		Disease or Syndrome	0.70	1	2017	2017	   1	   2	CTD_human;ORPHANET;UNIPROT
      529	ATP6V1E1	0.61	0.769	C4479409	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID	disease		Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
      533	ATP6V0B	0.931	0.115	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   1	UNIPROT
      537	ATP6AP1	0.691	0.577	C0024301	Lymphoma, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      537	ATP6AP1	0.691	0.577	C0079745	Lymphoma, Large-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      537	ATP6AP1	0.691	0.577	C0079758	Lymphoma, Mixed-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      537	ATP6AP1	0.691	0.577	C0079765	Lymphoma, Small Cleaved-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      537	ATP6AP1	0.691	0.577	C1956130	Lymphoma, Follicular, Grade 1	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      537	ATP6AP1	0.691	0.577	C1956131	Lymphoma, Follicular, Grade 3	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      537	ATP6AP1	0.691	0.577	C1956132	Lymphoma, Follicular, Grade 2	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      537	ATP6AP1	0.691	0.577	C4310819	IMMUNODEFICIENCY 47	disease		Disease or Syndrome	0.70	1	2016	2018	   1	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
      538	ATP7A	0.494	0.769	C0002871	Anemia	disease	C15	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0003496	Aortic Rupture	disease	C14;C26	Disease or Syndrome	0.30	1	1990	2015	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0004134	Ataxia	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.31	1	2007	2007	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0010495	Cutis Laxa	disease	C16;C17	Disease or Syndrome	0.40	1	2010	2010	   1	   0	GENOMICS_ENGLAND
      538	ATP7A	0.494	0.769	C0018273	Growth Disorders	group	C23	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0019054	Hemolysis (disorder)	phenotype	C23	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0019189	Hepatitis, Chronic	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0022716	Menkes Kinky Hair Syndrome	disease	C16;C18;C17;C10	Disease or Syndrome	1.00	1	1953	2019	  46	   0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      538	ATP7A	0.494	0.769	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0026654	Moyamoya Disease	disease	C10;C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      538	ATP7A	0.494	0.769	C0027854	Neurologic Manifestations	phenotype	C23;C10	Finding	0.30	1	2012	2012	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.40	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0040822	Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0040827	Saturnine Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0149519	Chronic Persistent Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0149840	Senile Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234370	Persistent Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234371	Continuous Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234372	Intermittent Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234373	Fine Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234374	Coarse Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234375	Massive Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234376	Action Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234377	Passive Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234378	Static Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234379	Resting Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234381	Darkness Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234544	Todd Paralysis	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0235031	Neurologic Symptoms	group	C23;C10	Sign or Symptom	0.32	1	2011	2017	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0235078	Tremor, Perioral	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0235081	Tremor, Limb	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0235082	Tremor, Muscle	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0235083	Nerve Tremors	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0235574	Intravascular hemolysis	disease	C23	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0235843	Tremor, Neonatal	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0240991	Ataxia, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0268353	Cutis laxa, x-linked	disease	C16;C17;C15;C14	Congenital Abnormality	0.80	1	1996	2019	   7	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
      538	ATP7A	0.494	0.769	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0278161	Ataxia, Motor	phenotype	C23;C10	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0312854	Extravascular Hemolysis	disease	C23	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0422837	Neurological observations	group	C23;C10	Finding	0.30	1	2012	2012	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0427190	Ataxia, Truncal	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0520463	Chronic active hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0520966	Abnormal coordination	phenotype	C23;C10	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0521654	Neurologic Deficits	group	C23;C10	Finding	0.30	1	2012	2012	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0522224	Paralysed	phenotype	C23;C10	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0524611	Cryptogenic Chronic Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0598589	Inherited neuropathies	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	GENOMICS_ENGLAND
      538	ATP7A	0.494	0.769	C0741160	Aortic Aneurysm, Ruptured	disease	C14;C26	Disease or Syndrome	0.50	1	1990	2015	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0746857	Focal Neurologic Deficits	phenotype	C23;C10	Finding	0.30	1	2012	2012	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0750937	Ataxia, Appendicular	phenotype	C23;C10	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0750940	Tremor, Rubral	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751377	Neurologic Dysfunction	phenotype	C23;C10	Finding	0.30	1	2012	2012	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751378	Neurologic Signs	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751564	Pill Rolling Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751565	Tremor, Semirhythmic	phenotype	C23;C10	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C1527384	Involuntary Quiver	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C1845359	Spinal Muscular Atrophy, Distal, X-Linked 3	disease	C16;C10	Disease or Syndrome	0.90	1	2004	2012	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      538	ATP7A	0.494	0.769	C2936380	Neointima	disease	C23	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C2936381	Neointima Formation	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0007097	Carcinoma	group	C04	Neoplastic Process	0.32	1	2002	2008	   2	   0	CTD_human
      540	ATP7B	0.529	0.654	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.41	1	2007	2017	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0019158	Hepatitis	group	C06	Disease or Syndrome	0.31	1	2003	2007	   2	   0	CTD_human
      540	ATP7B	0.529	0.654	C0019202	Hepatolenticular Degeneration	disease	C16;C06;C18;C10	Disease or Syndrome	1.00	0.98	1983	2020	 136	 318	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      540	ATP7B	0.529	0.654	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0022665	Kidney Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.41	1	2014	2015	   1	   1	CTD_human
      540	ATP7B	0.529	0.654	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.36	1	2010	2018	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.34	1	2001	2017	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
      540	ATP7B	0.529	0.654	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2011	2011	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.44	0.75	2000	2019	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   2	   0	CTD_human
      540	ATP7B	0.529	0.654	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   2	   0	CTD_human
      540	ATP7B	0.529	0.654	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   2	   0	CTD_human
      540	ATP7B	0.529	0.654	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   2	   0	CTD_human
      540	ATP7B	0.529	0.654	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2002	2009	   3	   0	CTD_human
      540	ATP7B	0.529	0.654	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0242339	Dyslipidemias	group	C18	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.32	1	2001	2019	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0598784	Dyslipoproteinemias	phenotype	C18	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.31	1	2002	2002	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.32	1	2002	2015	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.33	1	2002	2015	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.32	1	2003	2019	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
      540	ATP7B	0.529	0.654	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C1527352	Hepatic Form of Wilson Disease	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2000	2014	  51	   0	CTD_human
      540	ATP7B	0.529	0.654	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.42	1	2007	2017	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      545	ATR	0.456	0.923	C0004681	Bagassosis	disease	C08;C24	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      545	ATR	0.456	0.923	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.965	1999	2020	   0	   0	CGI
      545	ATR	0.456	0.923	C0007103	Malignant neoplasm of endometrium	disease	C04;C13	Neoplastic Process	0.31	1	2019	2019	   0	   0	CGI
      545	ATR	0.456	0.923	C0017638	Glioma	disease	C04	Neoplastic Process	0.31	1	2010	2010	   0	   0	CGI
      545	ATR	0.456	0.923	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.32	1	1999	2005	   0	   0	CGI
      545	ATR	0.456	0.923	C0029925	Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0032273	Pneumoconiosis	disease	C08;C24	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      545	ATR	0.456	0.923	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2014	2018	   1	   0	CTD_human
      545	ATR	0.456	0.923	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0042076	Urologic Neoplasms	group	C04;C13;C12	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      545	ATR	0.456	0.923	C0149782	Squamous cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30				   0	   0	UNIPROT
      545	ATR	0.456	0.923	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.32	1	2017	2019	   0	   0	UNIPROT
      545	ATR	0.456	0.923	C0153943	Benign neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0154060	Carcinoma in situ of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0265202	Seckel syndrome	disease	C23;C16;C05;C10;C19	Disease or Syndrome	0.80	1	2003	2018	   1	   0	GENOMICS_ENGLAND;ORPHANET
      545	ATR	0.456	0.923	C0280313	Squamous cell carcinoma of oropharynx	disease	C04;C07;C09	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0345958	Large cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30				   0	   0	UNIPROT
      545	ATR	0.456	0.923	C0346191	Carcinoma in situ of endometrium	disease	C04;C13	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2014	2019	   1	   0	CTD_human
      545	ATR	0.456	0.923	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.31	1	2019	2019	   0	   0	CGI
      545	ATR	0.456	0.923	C0496905	Neoplasm of uncertain or unknown behavior of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0496920	Neoplasm of uncertain or unknown behavior of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	1999	1999	   0	   0	CGI
      545	ATR	0.456	0.923	C0751571	Cancer of Urinary Tract	disease	C04;C13;C12	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      545	ATR	0.456	0.923	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.32	0.5	2005	2017	   0	   0	CGI
      545	ATR	0.456	0.923	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.32	0.5	2005	2017	   0	   0	CGI
      545	ATR	0.456	0.923	C1292778	Chronic myeloproliferative disorder	disease	C04;C15	Neoplastic Process	0.30				   0	   0	GENOMICS_ENGLAND
      545	ATR	0.456	0.923	C3165106	Infiltrating duct carcinoma of female breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
      545	ATR	0.456	0.923	C3281203	CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL	disease		Neoplastic Process	0.70	1	1990	2012	   2	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      545	ATR	0.456	0.923	C4551474	Seckel syndrome 1	disease	C23;C16;C05;C10;C19	Disease or Syndrome	0.61	1	2003	2009	   1	   8	CTD_human;GENOMICS_ENGLAND
      546	ATRX	0.452	0.808	C0010417	Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.41	1	2009	2009	   1	   1	CTD_human
      546	ATRX	0.452	0.808	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0017638	Glioma	disease	C04	Neoplastic Process	0.40	1	2012	2020	   2	   0	CTD_human
      546	ATRX	0.452	0.808	C0018273	Growth Disorders	group	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.40	1	2012	2019	   2	   0	CTD_human
      546	ATRX	0.452	0.808	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0030846	Penile Diseases	group	C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0039978	Thoracic Diseases	group	C08	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0206754	Neuroendocrine Tumors	group	C04	Neoplastic Process	0.38	1	2011	2018	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2013	2014	   2	   0	CTD_human
      546	ATRX	0.452	0.808	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0431663	Bilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0431664	Unilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.32	1	2013	2019	   2	   0	CTD_human
      546	ATRX	0.452	0.808	C0585216	Alpha-Thalassemia Myelodysplasia Syndrome	disease	C16;C15	Neoplastic Process	0.71	1	2003	2006	   1	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET
      546	ATRX	0.452	0.808	C0796003	Juberg-Marsidi syndrome	disease	C23;C16;C10;C19;C09	Disease or Syndrome	0.72	1	1995	2020	  17	  10	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      546	ATRX	0.452	0.808	C0796159	Mental retardation Smith Fineman Myers type	disease	C23;C10;F03;F01	Disease or Syndrome	0.31	1	2000	2000	   1	   0	ORPHANET
      546	ATRX	0.452	0.808	C1136249	Mental Retardation, X-Linked	disease	C16;C10	Disease or Syndrome	0.40	1	1997	2011	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C1328479	Pancreatic Endocrine Carcinoma	disease	C06;C04;C19	Neoplastic Process	0.30				   0	   0	CGI
      546	ATRX	0.452	0.808	C1563730	Abdominal Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C1563731	Inguinal Cryptorchidism	phenotype	C16;C12;C19	Finding	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.38	1	2015	2018	   0	   0	CGI
      546	ATRX	0.452	0.808	C1845055	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED	disease	C16;C10;C15	Disease or Syndrome	1.00	0.982	1995	2019	  16	  22	CTD_human;GENOMICS_ENGLAND;UNIPROT
      546	ATRX	0.452	0.808	C2713368	Hematopoetic Myelodysplasia	phenotype	C15	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.47	1	2003	2019	   1	   0	CTD_human
      547	KIF1A	0.559	0.692	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      547	KIF1A	0.559	0.692	C0008073	Developmental Disabilities	group	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      547	KIF1A	0.559	0.692	C0011849	Diabetes Mellitus	group	C18;C19	Disease or Syndrome	0.31	1	2013	2018	   1	   0	CTD_human
      547	KIF1A	0.559	0.692	C0085996	Child Development Deviations	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      547	KIF1A	0.559	0.692	C0085997	Child Development Disorders, Specific	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      547	KIF1A	0.559	0.692	C0270914	Hereditary Motor and Sensory-Neuropathy Type II	disease	C16;C10	Disease or Syndrome	0.30	1	2011	2015	   2	   0	GENOMICS_ENGLAND
      547	KIF1A	0.559	0.692	C1835896	SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE (disorder)	disease	C23;C10	Disease or Syndrome	0.93	1	2011	2020	   4	  22	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      547	KIF1A	0.559	0.692	C1850055	PEHO syndrome	disease	C11;C10	Disease or Syndrome	0.42	1	2016	2019	   1	   3	ORPHANET
      547	KIF1A	0.559	0.692	C2752089	Neuropathy, Hereditary Sensory And Autonomic, Type IIA	disease	C16;C10	Disease or Syndrome	0.40				   0	   1	CTD_human
      547	KIF1A	0.559	0.692	C3280168	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC	disease		Disease or Syndrome	0.61	1	2011	2017	   3	  19	CTD_human;GENOMICS_ENGLAND
      547	KIF1A	0.559	0.692	C3280283	MENTAL RETARDATION, AUTOSOMAL DOMINANT 9	disease		Disease or Syndrome	0.70	1	2011	2017	   6	  37	CTD_human;GENOMICS_ENGLAND;UNIPROT
      549	AUH	0.686	0.346	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.40	1	2010	2010	   1	   0	GENOMICS_ENGLAND
      549	AUH	0.686	0.346	C0342727	3-@METHYLGLUTACONIC ACIDURIA, TYPE I	disease	C16;C18	Disease or Syndrome	0.75	1	1982	2017	  11	   3	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      549	AUH	0.686	0.346	C0342728	3-Methylglutaconic aciduria type 1	disease	C16;C18	Disease or Syndrome	0.61	1	2002	2017	   9	   0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
      551	AVP	0.437	0.846	C0002622	Amnesia	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0002962	Angina Pectoris	phenotype	C23;C14	Sign or Symptom	0.30	1	2000	2002	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0003811	Cardiac Arrhythmia	phenotype	C23;C14	Disease or Syndrome	0.30	1	1982	1982	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	1995	2019	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2013	2017	   1	   0	PSYGENET
      551	AVP	0.437	0.846	C0009178	Cocaine withdrawal	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	PSYGENET
      551	AVP	0.437	0.846	C0010398	Cruveilhier-Baumgarten Syndrome	disease	C06	Disease or Syndrome	0.30	1	1984	1984	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0011175	Dehydration	phenotype	C23;C18	Disease or Syndrome	0.60	1	1989	2019	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0011848	Diabetes Insipidus	disease	C13;C12;C19	Disease or Syndrome	0.70	1	1981	2020	   3	   0	CTD_human;ORPHANET
      551	AVP	0.437	0.846	C0013390	Dysmenorrhea	phenotype	C23	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0017181	Gastrointestinal Hemorrhage	phenotype	C23;C06	Pathologic Function	0.30	1	1982	1982	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.40	1	1999	2020	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.40	1	1999	2020	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0018932	Hematochezia	phenotype	C23;C06	Disease or Syndrome	0.30	1	1982	1982	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.31	1	1998	2017	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.60	1	1984	2020	   5	   0	CTD_human
      551	AVP	0.437	0.846	C0020541	Portal Hypertension	disease	C06	Disease or Syndrome	0.50	1	1984	2009	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0020625	Hyponatremia	phenotype	C18	Disease or Syndrome	0.40	0.921	1981	2019	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0020649	Hypotension	phenotype	C14	Finding	0.32	1	1985	2008	   5	   0	CTD_human
      551	AVP	0.437	0.846	C0020683	Hypovolemic Shock	phenotype	C23	Pathologic Function	0.30	1	1999	1999	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0021141	Inappropriate ADH Syndrome	phenotype	C18;C10;C19	Disease or Syndrome	0.37	0.889	1979	2019	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0022116	Ischemia	phenotype	C23	Pathologic Function	0.30	1	1990	1999	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.34	1	1990	2017	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0025261	Memory Disorders	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0029944	Drug Overdose	disease	C25	Injury or Poisoning	0.30	1	2002	2002	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0030193	Pain	phenotype	C23	Sign or Symptom	0.35	1	1984	2019	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0032617	Polyuria	phenotype	C23;C13;C12	Sign or Symptom	0.40	1	1999	2020	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0033958	Psychosis, Brief Reactive	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1987	1987	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	1987	1987	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0036337	Schizoaffective Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1987	1987	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.38	1	1987	2018	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0036358	Schizophreniform Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	1987	1987	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0036974	Shock	phenotype	C23	Pathologic Function	0.30	1	1999	1999	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0037019	Shy-Drager Syndrome	disease	C10;C14	Disease or Syndrome	0.30	1	1983	1983	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1985	1985	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2004	2006	   1	   0	PSYGENET
      551	AVP	0.437	0.846	C0086132	Depressive Symptoms	phenotype	F01	Sign or Symptom	0.31	1	2011	2017	   1	   0	PSYGENET
      551	AVP	0.437	0.846	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	1985	1985	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	1985	1985	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.39	1	1987	2017	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0233750	Hysterical amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0233794	Memory impairment	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.32	1	2001	2020	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0233796	Temporary Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	1984	1990	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	1984	1990	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	1984	1990	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0236795	Dissociative Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0262497	Global Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0344315	Depressed mood	phenotype	F01	Mental or Behavioral Dysfunction	0.40	1	2001	2019	   1	   0	PSYGENET
      551	AVP	0.437	0.846	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	1998	1998	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	1984	1990	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	1984	1990	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2011	   2	   0	PSYGENET
      551	AVP	0.437	0.846	C0687720	Central Diabetes Insipidus	disease	C13;C12;C19	Disease or Syndrome	1.00	0.988	1978	2020	  28	  17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      551	AVP	0.437	0.846	C0750906	Tactile Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0750907	Amnestic State	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	1998	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	1998	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	1998	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	1998	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751292	Age-Related Memory Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751293	Memory Disorder, Semantic	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751294	Memory Disorder, Spatial	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751295	Memory Loss	phenotype	C23;C10;F01	Sign or Symptom	0.30	1	2001	2001	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	1984	1990	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	1984	1990	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      551	AVP	0.437	0.846	C1136135	Water Stress	disease	C23;C18	Disease or Syndrome	0.30	1	1989	1989	   1	   0	CTD_human
      551	AVP	0.437	0.846	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2004	2018	   1	   0	PSYGENET
      551	AVP	0.437	0.846	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	1990	1990	   1	   0	CTD_human
      551	AVP	0.437	0.846	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      551	AVP	0.437	0.846	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      551	AVP	0.437	0.846	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	1990	1990	   1	   0	CTD_human
      551	AVP	0.437	0.846	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.31	1	1998	2019	   1	   0	CTD_human
      552	AVPR1A	0.663	0.5	C0001627	Congenital adrenal hyperplasia	disease	C16;C18;C13;C12;C19	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      552	AVPR1A	0.663	0.5	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.39	1	2002	2017	   1	   0	CTD_human
      552	AVPR1A	0.663	0.5	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.52	0.5	2007	2017	   2	   0	PSYGENET
      552	AVPR1A	0.663	0.5	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2006	2019	   1	   0	CTD_human
      553	AVPR1B	0.705	0.385	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	0.5	2012	2013	   2	   0	PSYGENET
      553	AVPR1B	0.705	0.385	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.33	1	2004	2013	   4	   0	PSYGENET
      554	AVPR2	0.568	0.769	C0001627	Congenital adrenal hyperplasia	disease	C16;C18;C13;C12;C19	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   1	UNIPROT
      554	AVPR2	0.568	0.769	C0018273	Growth Disorders	group	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.32	1	2002	2018	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.32	1	2002	2018	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0028961	Oliguria	phenotype	C23;C13;C12	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0162283	Nephrogenic Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.90	1	1992	2019	   6	  30	CTD_human;GENOMICS_ENGLAND
      554	AVPR2	0.568	0.769	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0268443	Acquired Nephrogenic Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.30	1	2002	2010	   5	   0	CTD_human
      554	AVPR2	0.568	0.769	C0677501	Congenital Nephrogenic Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.40	0.973	1994	2018	   5	   0	CTD_human
      554	AVPR2	0.568	0.769	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C1563705	Nephrogenic Diabetes Insipidus, Type I	disease	C13;C12	Disease or Syndrome	0.80	0.978	1989	2020	  30	  23	CTD_human;GENOMICS_ENGLAND;UNIPROT
      554	AVPR2	0.568	0.769	C1563706	Nephrogenic Diabetes Insipidus, Type II	disease	C13;C12	Disease or Syndrome	0.30	1	2002	2010	   5	   0	CTD_human
      554	AVPR2	0.568	0.769	C1845202	Nephrogenic Syndrome of Inappropriate Antidiuresis	disease	C16;C18;C10;C19	Disease or Syndrome	0.77	1	2005	2019	   3	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      554	AVPR2	0.568	0.769	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C3542500	ADH-Resistant Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.30	1	2002	2010	   5	   0	CTD_human
      558	AXL	0.489	0.615	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.40	1	2011	2019	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0017667	Nodular glomerulosclerosis	disease	C13;C12;C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0022665	Kidney Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	1	1999	2019	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2015	2015	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0027809	Neurilemmoma	disease	C04	Neoplastic Process	0.31	1	2014	2014	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0206728	Plexiform Neurofibroma	disease	C04;C10	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
      558	AXL	0.489	0.615	C0342384	Idiopathic hypogonadotropic hypogonadism	disease	C19	Disease or Syndrome	0.31	1	2014	2014	   0	   0	CTD_human
      558	AXL	0.489	0.615	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.36	1	2009	2019	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.31	1	2014	2017	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0751374	Schwannomatosis, Plexiform	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.32	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.33	1	2011	2020	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2006	2007	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0037199	Sinusitis	disease	C01;C08;C09	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.31	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.39	1	2006	2019	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.31	1	2006	2011	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2017	2017	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0020455	Hypergammaglobulinemia	disease	C23;C20;C15	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.48	1	1990	2020	   3	   0	CTD_human
      567	B2M	0.447	0.846	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.35	1	1989	2019	   3	   0	CTD_human
      567	B2M	0.447	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2007	2008	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.35	1	1993	2020	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0079774	Peripheral T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2014	2019	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0268389	Amyloidosis, familial visceral	disease	C16;C18	Disease or Syndrome	0.70	1	2012	2012	   1	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      567	B2M	0.447	0.846	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2011	2018	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.33	1	2007	2015	   1	   0	CTD_human
      567	B2M	0.447	0.846	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	1989	2017	   3	   0	CTD_human
      567	B2M	0.447	0.846	C1855796	Hypoproteinemia, Hypercatabolic	disease	C16;C18	Disease or Syndrome	0.71	1	2006	2015	   2	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
      567	B2M	0.447	0.846	C1858266	Bare Lymphocyte Syndrome, Type I	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2015	2015	   1	   0	ORPHANET
      567	B2M	0.447	0.846	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.50	1	1989	2017	   3	   0	CTD_human
      567	B2M	0.447	0.846	C4302669	Autosomal dominant beta2-microglobulinic amyloidosis	disease	C16;C18	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
      570	BAAT	0.578	0.654	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.30	1	2003	2013	   2	   0	GENOMICS_ENGLAND
      570	BAAT	0.578	0.654	C1843139	Hypercholanemia, Familial	disease	C16;C18	Disease or Syndrome	0.71	1	2003	2013	   2	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      570	BAAT	0.578	0.654	C4747366	Hypercholanemia	phenotype		Finding	0.30				   0	   0	GENOMICS_ENGLAND
      572	BAD	0.553	0.769	C0007787	Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C0023418	leukemia	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.35	1	2002	2013	   2	   0	CTD_human
      572	BAD	0.553	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2007	2017	   2	   0	CTD_human
      572	BAD	0.553	0.769	C0472381	Posterior Circulation Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C0751019	Carotid Circulation Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C0751020	Transient Ischemic Attack, Vertebrobasilar Circulation	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C0751021	Crescendo Transient Ischemic Attacks	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C0751022	Brain Stem Ischemia, Transient	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C0917805	Transient Cerebral Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C1527335	Transient Ischemic Attack, Anterior Circulation	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      573	BAG1	0.538	0.769	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2005	2013	   5	   0	PSYGENET
      573	BAG1	0.538	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1999	2019	   1	   0	CTD_human
      573	BAG1	0.538	0.769	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      573	BAG1	0.538	0.769	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      573	BAG1	0.538	0.769	C0021367	Mammary Ductal Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      573	BAG1	0.538	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2002	2013	   1	   0	PSYGENET
      573	BAG1	0.538	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1999	2019	   1	   0	CTD_human
      573	BAG1	0.538	0.769	C1134719	Invasive Ductal Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
      573	BAG1	0.538	0.769	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      573	BAG1	0.538	0.769	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.34	1	2003	2016	   1	   0	CTD_human
      573	BAG1	0.538	0.769	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
      579	NKX3-2	0.736	0.308	C0152423	Congenital small ears	disease	C16;C09	Congenital Abnormality	0.30	1	1997	1997	   1	   0	GENOMICS_ENGLAND
      579	NKX3-2	0.736	0.308	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
      579	NKX3-2	0.736	0.308	C2750066	Spondylo-Megaepiphyseal-Metaphyseal Dysplasia	disease	C16;C05	Disease or Syndrome	0.72	1	1997	2019	   2	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET
      580	BARD1	0.597	0.538	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	1.00	0.896	1996	2020	   0	  63	CTD_human;GENOMICS_ENGLAND;UNIPROT
      580	BARD1	0.597	0.538	C0009405	Hereditary Nonpolyposis Colorectal Neoplasms	group	C16;C06;C04;C18	Neoplastic Process	0.30	1	2001	2016	   4	   0	CLINGEN
      580	BARD1	0.597	0.538	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.50	1	2009	2019	   2	  13	CTD_human
      580	BARD1	0.597	0.538	C0153567	Uterine Cancer	disease	C04;C13	Neoplastic Process	0.32	1	1998	2006	   0	   1	UNIPROT
      580	BARD1	0.597	0.538	C0346153	Breast Cancer, Familial	disease	C04;C17	Neoplastic Process	0.35	0.938	2001	2019	  11	   0	CLINGEN
      580	BARD1	0.597	0.538	C0677776	Hereditary Breast and Ovarian Cancer Syndrome	disease	C16;C04;C13;C17;C19	Neoplastic Process	0.40	1	2004	2017	   1	   5	ORPHANET
      580	BARD1	0.597	0.538	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.50	0.86	1996	2020	   0	   0	CTD_human
      580	BARD1	0.597	0.538	C1112155	Hereditary non-polyposis colorectal cancer syndrome	disease		Congenital Abnormality	0.30	1	2001	2016	   4	   0	CLINGEN
      580	BARD1	0.597	0.538	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CTD_human
      580	BARD1	0.597	0.538	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.30	1	2001	2016	   4	   0	CLINGEN
      580	BARD1	0.597	0.538	C1333991	Hereditary Non-Polyposis Colon Cancer Type 2	disease	C16;C04	Neoplastic Process	0.30	1	2001	2016	   4	   0	CLINGEN
      580	BARD1	0.597	0.538	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.45	1	2004	2008	   0	   1	CTD_human
      580	BARD1	0.597	0.538	C1518693	Clear cell adenocarcinoma of ovary	disease	C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      580	BARD1	0.597	0.538	C2936783	Colorectal cancer, hereditary nonpolyposis, type 1	disease	C16;C06;C04;C18	Neoplastic Process	0.30	1	2001	2016	   4	   0	CLINGEN
      580	BARD1	0.597	0.538	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CTD_human
      581	BAX	0.417	0.885	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.52	1	1997	2018	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1999	2019	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.34	1	1998	2002	   0	   0	UNIPROT
      581	BAX	0.417	0.885	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.40	1	1997	2019	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.37	1	1997	2007	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2009	2013	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	2007	2015	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2008	2008	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.31	1	2003	2019	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0021841	Intestinal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0022116	Ischemia	phenotype	C23	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.31	1	2011	2019	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.35	1	1998	2019	   2	   0	CTD_human
      581	BAX	0.417	0.885	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.50	1	2009	2014	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.31	1	1998	2011	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.32	1	2002	2007	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.31	1	2003	2003	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0346627	Intestinal Cancer	disease	C06;C04	Neoplastic Process	0.31	1	2003	2011	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.37	1	2000	2018	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0376407	Granulomatous Slack Skin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.32	1	2007	2018	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1996	2019	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0848676	Subfertility, Male	phenotype	C12	Sign or Symptom	0.30	1	2014	2014	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0917731	Male sterility	phenotype	C12	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0920269	Microsatellite Instability	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
      581	BAX	0.417	0.885	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      581	BAX	0.417	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      581	BAX	0.417	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      581	BAX	0.417	0.885	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.31	1	2002	2002	   0	   0	CGI
      581	BAX	0.417	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.37	1	2002	2018	   1	   0	CTD_human
      581	BAX	0.417	0.885	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      581	BAX	0.417	0.885	C1721098	Replication Error Phenotype	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
      581	BAX	0.417	0.885	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.41	1	2000	2000	   0	   2	CGI
      581	BAX	0.417	0.885	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.50	1	2010	2011	   1	   0	CTD_human
      581	BAX	0.417	0.885	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
      581	BAX	0.417	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      581	BAX	0.417	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      581	BAX	0.417	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      581	BAX	0.417	0.885	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      581	BAX	0.417	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      582	BBS1	0.593	0.692	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      582	BBS1	0.593	0.692	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.62	1	2002	2013	   0	   0	GENOMICS_ENGLAND
      582	BBS1	0.593	0.692	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.43	1	2002	2019	   2	   1	GENOMICS_ENGLAND
      582	BBS1	0.593	0.692	C0152427	Polydactyly	disease	C16;C05	Congenital Abnormality	0.40	1	2001	2001	   1	   0	GENOMICS_ENGLAND
      582	BBS1	0.593	0.692	C2936862	Bardet-Biedl syndrome 1 (disorder)	disease	C16;C11;C10	Disease or Syndrome	0.94	1	1999	2017	   9	  22	CTD_human;GENOMICS_ENGLAND;UNIPROT
      582	BBS1	0.593	0.692	C4277690	Ciliopathies	disease	C16	Congenital Abnormality	0.31	1	2019	2019	   0	   0	GENOMICS_ENGLAND
      583	BBS2	0.565	0.654	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      583	BBS2	0.565	0.654	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.42	1	2004	2006	   0	   0	GENOMICS_ENGLAND
      583	BBS2	0.565	0.654	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.42	1	2015	2019	   1	   4	ORPHANET
      583	BBS2	0.565	0.654	C0152427	Polydactyly	disease	C16;C05	Congenital Abnormality	0.42	1	2005	2011	   0	   3	GENOMICS_ENGLAND
      583	BBS2	0.565	0.654	C2936862	Bardet-Biedl syndrome 1 (disorder)	disease	C16;C11;C10	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      583	BBS2	0.565	0.654	C2936863	Bardet-Biedl syndrome 2 (disorder)	disease	C16;C11;C10	Disease or Syndrome	0.91	1	2001	2019	   9	  53	CTD_human;GENOMICS_ENGLAND;UNIPROT
      583	BBS2	0.565	0.654	C4225281	RETINITIS PIGMENTOSA 74	disease		Disease or Syndrome	0.70	1	2015	2015	   1	   8	CTD_human;GENOMICS_ENGLAND;UNIPROT
      583	BBS2	0.565	0.654	C4277690	Ciliopathies	disease	C16	Congenital Abnormality	0.36	1	2011	2019	   0	   0	GENOMICS_ENGLAND
      585	BBS4	0.647	0.615	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      585	BBS4	0.647	0.615	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.66	1	2001	2019	   0	   0	GENOMICS_ENGLAND
      585	BBS4	0.647	0.615	C0152427	Polydactyly	disease	C16;C05	Congenital Abnormality	0.41	1	1998	1998	   0	   2	GENOMICS_ENGLAND
      585	BBS4	0.647	0.615	C2936862	Bardet-Biedl syndrome 1 (disorder)	disease	C16;C11;C10	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      585	BBS4	0.647	0.615	C2936864	Bardet-Biedl syndrome 4 (disorder)	disease	C16;C11;C10	Disease or Syndrome	0.91	1	2001	2019	   6	   9	CTD_human;GENOMICS_ENGLAND;UNIPROT
      585	BBS4	0.647	0.615	C4277690	Ciliopathies	disease	C16	Congenital Abnormality	0.31	1	2019	2019	   0	   0	GENOMICS_ENGLAND
      586	BCAT1	0.606	0.538	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      586	BCAT1	0.606	0.538	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      587	BCAT2	0.686	0.385	C0024776	Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.52	1	2004	2019	   1	   0	CTD_human
      587	BCAT2	0.686	0.385	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      587	BCAT2	0.686	0.385	C0268568	Classic Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      587	BCAT2	0.686	0.385	C0268569	Intermittent Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      587	BCAT2	0.686	0.385	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      587	BCAT2	0.686	0.385	C0751285	Maple Syrup Urine Disease, Thiamine Responsive	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      587	BCAT2	0.686	0.385	C1621920	Intermediate Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0001969	Alcoholic Intoxication	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1986	1986	   1	   0	PSYGENET
      590	BCHE	0.447	0.923	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.40	0.962	1995	2020	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0003578	Apnea	phenotype	C23;C08	Sign or Symptom	0.40	1	1967	2018	  31	   0	CTD_human
      590	BCHE	0.447	0.923	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	1985	1985	   1	   0	PSYGENET
      590	BCHE	0.447	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.34	1	2002	2018	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.31	1	2008	2010	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.34	1	2008	2015	   8	   0	CTD_human
      590	BCHE	0.447	0.923	C0009241	Cognition Disorders	group	F03	Mental or Behavioral Dysfunction	0.34	1	2001	2019	   2	   0	CTD_human
      590	BCHE	0.447	0.923	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.40	0.973	1997	2020	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	1987	1987	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0014549	Tonic-Clonic Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0015644	Muscular fasciculation	phenotype	C23;C10	Sign or Symptom	0.31	1	1984	2019	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.31	1	1990	1990	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0018989	Hemiparesis	phenotype	C23;C10	Sign or Symptom	0.30	1	1990	1990	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0020529	Hypersomnia with Periodic Respiration	disease	C08;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0020557	Hypertriglyceridemia	phenotype	C18	Disease or Syndrome	0.32	1	2013	2013	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0026769	Multiple Sclerosis	disease	C20;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0026850	Muscular Dystrophy	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.33	0.667	1990	2017	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.39	1	2008	2019	   4	   0	CTD_human
      590	BCHE	0.447	0.923	C0030552	Paresis	phenotype	C23;C10	Disease or Syndrome	0.30	1	1990	1990	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0030569	Secondary Parkinson Disease	disease	C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0032787	Postoperative Complications	group	C23	Pathologic Function	0.30	1	1967	1967	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.34	1	1996	2019	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0037315	Sleep Apnea Syndromes	disease	C08;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0039231	Tachycardia	phenotype	C23;C14	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0041105	Trismus	disease	C23;C10	Disease or Syndrome	0.30	1	1980	1980	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	1987	1987	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0079221	Determination of Death	phenotype	C23	Diagnostic Procedure	0.30	1	2008	2008	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0080203	Tachyarrhythmia	phenotype	C23;C14	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0149504	Encephalopathy, Toxic	disease	C10;C25	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0154659	Toxic Encephalitis	disease	C10;C25	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0234544	Todd Paralysis	phenotype	C23;C10	Sign or Symptom	0.30	1	1970	2011	  10	   0	CTD_human
      590	BCHE	0.447	0.923	C0235032	Neurotoxicity Syndromes	group	C10;C25	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2015	   8	   0	CTD_human
      590	BCHE	0.447	0.923	C0239548	Fasciculation, Tongue	phenotype	C23;C10	Finding	0.30	1	1984	1984	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0240302	Masseter Muscle Spasm	phenotype	C23;C10	Finding	0.30	1	1980	1980	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0268379	Pseudocholinesterase deficiency	disease	C23;C16;C18;C08	Disease or Syndrome	0.31	1	1997	2018	   5	   0	CTD_human
      590	BCHE	0.447	0.923	C0270795	Monoparesis	phenotype	C23;C10	Sign or Symptom	0.30	1	1990	1990	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	1990	1990	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0338495	Sleep Apnea, Mixed Central and Obstructive	disease	C08;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0343495	Lockjaw	phenotype	C23;C10	Finding	0.30	1	1980	1980	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0353676	Organophosphorus Poisoning	disease	C25	Injury or Poisoning	0.30	1	2013	2019	   8	   0	CTD_human
      590	BCHE	0.447	0.923	C0376297	Cardiac Death	phenotype	C23	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.40	0.909	1998	2019	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0522224	Paralysed	phenotype	C23;C10	Finding	0.40	1	1970	2011	  10	   0	CTD_human
      590	BCHE	0.447	0.923	C0541957	Fasciculation, Skeletal Muscle	phenotype	C23;C10	Finding	0.30	1	1984	1984	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.37	1	2008	2020	   8	   0	CTD_human
      590	BCHE	0.447	0.923	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.34	1	2002	2018	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0700359	Organophosphate poisoning	disease	C25	Injury or Poisoning	0.30	1	2013	2019	   8	   0	CTD_human
      590	BCHE	0.447	0.923	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0751117	Cryptogenic Tonic-Clonic Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0751118	Epilepsy, Tonic-Clonic, Familial	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0751119	Epilepsy, Tonic-Clonic, Symptomatic	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0751144	Fasciculation, Benign	phenotype	C23;C10	Sign or Symptom	0.30	1	1984	1984	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0751217	Hyperkinesia, Generalized	phenotype	C23;C10	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0751324	Multiple Sclerosis, Acute Fulminating	disease	C20;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0751409	Upper Extremity Paresis	phenotype	C23;C10	Sign or Symptom	0.30	1	1990	1990	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0751410	Lower Extremity Paresis	phenotype	C23;C10	Sign or Symptom	0.30	1	1990	1990	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0751414	Parkinson Disease, Secondary Vascular	disease	C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0751415	Atherosclerotic Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C0876994	Cardiotoxicity	disease	C23;C25;C14;C26	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C1283400	Butyrylcholinesterase deficiency	disease	C23;C16;C18;C08	Disease or Syndrome	0.72	1	1957	2016	  25	  43	CTD_human;ORPHANET;UNIPROT
      590	BCHE	0.447	0.923	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2010	2013	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.31	1	1990	1990	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C1622434	Suxamethonium sensitivity	phenotype	C23;C16;C18;C08	Pathologic Function	0.30	1	1997	2014	   5	   0	CTD_human
      590	BCHE	0.447	0.923	C1855794	Bamforth syndrome	disease	C16;C17;C05;C19;C07	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C1867468	Apnea, Postanesthetic	phenotype	C23;C16;C18;C08	Pathologic Function	0.40	1	1997	2014	   5	   1	CTD_human
      590	BCHE	0.447	0.923	C1968699	Hypothyroidism, Thyroidal, With Spiky Hair And Cleft Palate	disease	C16;C17;C05;C19;C07	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C3494247	Organothiophosphonate Poisoning	disease	C25	Injury or Poisoning	0.30	1	2013	2019	   8	   0	CTD_human
      590	BCHE	0.447	0.923	C3494248	Organothiophosphate Poisoning	disease	C25	Injury or Poisoning	0.30	1	2013	2019	   8	   0	CTD_human
      590	BCHE	0.447	0.923	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C3887506	Hyperkinesia	phenotype	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.33	1	1996	2017	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	2011	   3	   0	CTD_human
      590	BCHE	0.447	0.923	C4551689	Sleep-Disordered Breathing	disease	C08;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      590	BCHE	0.447	0.923	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      593	BCKDHA	0.695	0.423	C0024776	Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.80	1	1989	2019	  11	  44	CTD_human;GENOMICS_ENGLAND;UNIPROT
      593	BCKDHA	0.695	0.423	C0268568	Classic Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.31	1	2018	2018	   0	   0	CTD_human
      593	BCKDHA	0.695	0.423	C0268569	Intermittent Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
      593	BCKDHA	0.695	0.423	C0751285	Maple Syrup Urine Disease, Thiamine Responsive	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
      593	BCKDHA	0.695	0.423	C1621920	Intermediate Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
      593	BCKDHA	0.695	0.423	C1855369	Maple Syrup Urine Disease, Type IA	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      594	BCKDHB	0.682	0.5	C0024776	Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.80	1	1973	2019	   5	  62	CTD_human;GENOMICS_ENGLAND;UNIPROT
      594	BCKDHB	0.682	0.5	C0268568	Classic Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
      594	BCKDHB	0.682	0.5	C0268569	Intermittent Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
      594	BCKDHB	0.682	0.5	C0751285	Maple Syrup Urine Disease, Thiamine Responsive	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
      594	BCKDHB	0.682	0.5	C1621920	Intermediate Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
      594	BCKDHB	0.682	0.5	C2930990	Maple syrup urine disease, type 1B	disease	C16;C18;C10	Disease or Syndrome	0.31	1	2016	2019	   1	   0	GENOMICS_ENGLAND
      595	CCND1	0.344	0.923	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.40	1	1990	2019	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0006079	Bowen's Disease	disease	C04	Neoplastic Process	0.32	0.5	2011	2018	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.35	1	1996	2019	   2	   0	CTD_human
      595	CCND1	0.344	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.971	1990	2020	   6	   0	CTD_human
      595	CCND1	0.344	0.923	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.978	1989	2020	   0	   0	CGI
      595	CCND1	0.344	0.923	C0007097	Carcinoma	group	C04	Neoplastic Process	0.40	0.962	1990	2019	   4	   0	CTD_human
      595	CCND1	0.344	0.923	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.40	0.958	2001	2018	   4	   0	CTD_human
      595	CCND1	0.344	0.923	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.40	0.988	1989	2019	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0007138	Carcinoma, Transitional Cell	disease	C04	Neoplastic Process	0.56	0.875	1997	2017	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0007528	Cecal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2011	2014	   2	   0	CTD_human
      595	CCND1	0.344	0.923	C0007873	Uterine Cervical Neoplasm	disease	C04;C13	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	1999	2011	   4	   0	CTD_human
      595	CCND1	0.344	0.923	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.953	1997	2019	   0	   0	GENOMICS_ENGLAND
      595	CCND1	0.344	0.923	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.33	1	2000	2006	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0014170	Endometrial Neoplasms	group	C04;C13	Neoplastic Process	0.34	1	2004	2017	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.40	0.963	1993	2019	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0018923	Hemangiosarcoma	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0019562	Von Hippel-Lindau Syndrome	disease	C16;C10;C14	Disease or Syndrome	0.53	1	2002	2005	   0	   0	CTD_human;GENOMICS_ENGLAND
      595	CCND1	0.344	0.923	C0020502	Hyperparathyroidism	disease	C19	Disease or Syndrome	0.34	1	1998	2011	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0020507	Hyperplasia	phenotype	C23	Pathologic Function	0.32	1	2002	2011	   2	   0	CTD_human
      595	CCND1	0.344	0.923	C0021846	Intestinal Polyps	phenotype	C23	Anatomical Abnormality	0.31	1	2003	2009	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0022665	Kidney Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0023418	leukemia	disease	C04	Neoplastic Process	0.40	1	1992	2018	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	0.884	1988	2018	   0	   0	ORPHANET
      595	CCND1	0.344	0.923	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.34	1	2009	2016	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.50	1	2007	2017	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.38	1	1997	2008	   2	   0	CTD_human
      595	CCND1	0.344	0.923	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.40	0.926	2001	2019	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2007	   4	   0	CTD_human
      595	CCND1	0.344	0.923	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.50	1	2002	2005	   3	   0	CTD_human
      595	CCND1	0.344	0.923	C0025202	melanoma	disease	C04	Neoplastic Process	0.40	0.953	1996	2018	   0	   0	CGI
      595	CCND1	0.344	0.923	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.70	0.975	1992	2019	   1	   2	CTD_human;ORPHANET
      595	CCND1	0.344	0.923	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0030354	Papilloma	disease	C04	Neoplastic Process	0.33	1	2002	2017	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.33	1	1999	2019	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.57	1	1999	2015	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0036095	Salivary Gland Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.33	1	1999	2016	   1	   0	PSYGENET
      595	CCND1	0.344	0.923	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.35	1	2006	2011	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0040136	Thyroid Neoplasm	disease	C04;C19	Neoplastic Process	0.40	1	1998	2019	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	PSYGENET
      595	CCND1	0.344	0.923	C0042076	Urologic Neoplasms	group	C04;C13;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0151468	Thyroid Gland Follicular Adenoma	disease	C04;C19	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.35	1	2002	2012	   0	   0	CGI
      595	CCND1	0.344	0.923	C0153437	Malignant neoplasm of cecum	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0153633	Malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.30	1	2011	2017	   2	   0	CTD_human
      595	CCND1	0.344	0.923	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2007	   4	   0	CTD_human
      595	CCND1	0.344	0.923	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2007	   4	   0	CTD_human
      595	CCND1	0.344	0.923	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2007	   4	   0	CTD_human
      595	CCND1	0.344	0.923	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2007	   4	   0	CTD_human
      595	CCND1	0.344	0.923	C0205874	Papilloma, Squamous Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0205875	Papillomatosis	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0220636	Malignant neoplasm of salivary gland	disease	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2018	2018	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	1	1990	2020	   2	   0	CTD_human
      595	CCND1	0.344	0.923	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.40	1	1995	2019	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0334634	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	disease	C04;C20;C15	Neoplastic Process	0.40	0.979	1992	2020	   2	   0	CTD_human
      595	CCND1	0.344	0.923	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.39	1	2005	2020	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.60	0.952	1998	2020	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.40	1	1996	2019	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0496899	Benign neoplasm of brain, unspecified	disease	C04;C10	Neoplastic Process	0.30	1	2011	2017	   2	   0	CTD_human
      595	CCND1	0.344	0.923	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.40	0.962	1993	2019	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.38	1	1998	2019	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0555202	Malignant lymphoma - lymphocytic, intermediate differentiation	disease		Neoplastic Process	0.33	1	1993	1994	   0	   0	ORPHANET
      595	CCND1	0.344	0.923	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.50	0.966	1990	2020	   6	   1	CTD_human
      595	CCND1	0.344	0.923	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.31	1	2011	2017	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0750974	Brain Tumor, Primary	disease	C04;C10	Neoplastic Process	0.31	1	2011	2017	   2	   0	CTD_human
      595	CCND1	0.344	0.923	C0750977	Recurrent Brain Neoplasm	disease	C04;C10	Neoplastic Process	0.30	1	2011	2017	   2	   0	CTD_human
      595	CCND1	0.344	0.923	C0750979	Primary malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.30	1	2011	2017	   2	   0	CTD_human
      595	CCND1	0.344	0.923	C0751571	Cancer of Urinary Tract	disease	C04;C13;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C0751958	Lymphoma, Lymphocytic, Intermediate	disease	C04;C20;C15	Disease or Syndrome	0.30	1	2012	2016	   2	   0	CTD_human
      595	CCND1	0.344	0.923	C0855095	Small Lymphocytic Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.37	1	1988	1998	   0	   0	ORPHANET
      595	CCND1	0.344	0.923	C0919532	Genomic Instability	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.40	1	1994	2019	   2	   0	CTD_human
      595	CCND1	0.344	0.923	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2007	   4	   0	CTD_human
      595	CCND1	0.344	0.923	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2014	   6	   0	CTD_human
      595	CCND1	0.344	0.923	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	PSYGENET
      595	CCND1	0.344	0.923	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	1992	2019	   6	   0	CTD_human
      595	CCND1	0.344	0.923	C1527390	Neoplasms, Intracranial	group	C04;C10	Neoplastic Process	0.30	1	2011	2017	   2	   0	CTD_human
      595	CCND1	0.344	0.923	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C1868683	B-CELL MALIGNANCY, LOW-GRADE	disease		Neoplastic Process	0.33	0.667	1993	1997	   0	   0	ORPHANET
      595	CCND1	0.344	0.923	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.967	1993	2020	   5	   0	CTD_human
      595	CCND1	0.344	0.923	C2931822	Nasopharyngeal carcinoma	disease	C04;C07;C09	Neoplastic Process	0.40	0.958	2000	2019	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C4048328	cervical cancer	disease	C04;C13	Neoplastic Process	0.40	0.88	2001	2019	   1	   0	CTD_human
      595	CCND1	0.344	0.923	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2014	   6	   0	CTD_human
      596	BCL2	0.291	0.885	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.40	0.911	1993	2019	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0001430	Adenoma	group	C04	Neoplastic Process	0.40	0.95	1994	2011	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2006	2013	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.60	1	1996	2019	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.35	1	1998	2019	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2001	2010	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0004509	Azoospermia	disease	C12	Disease or Syndrome	0.31	1	2010	2010	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.35	1	2000	2016	   3	   0	PSYGENET
      596	BCL2	0.291	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.961	1994	2020	   3	   0	CTD_human
      596	BCL2	0.291	0.885	C0007097	Carcinoma	group	C04	Neoplastic Process	0.40	0.911	1994	2018	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.60	1	1997	2019	   3	   0	CTD_human
      596	BCL2	0.291	0.885	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	1988	2012	   3	   0	CTD_human
      596	BCL2	0.291	0.885	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.56	1	1998	2009	   3	   0	CTD_human
      596	BCL2	0.291	0.885	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.978	1994	2020	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.40	1	1996	2018	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.33	1	2006	2018	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2006	2019	   5	   0	PSYGENET
      596	BCL2	0.291	0.885	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2005	2013	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.67	1	2006	2020	   1	   1	CTD_human
      596	BCL2	0.291	0.885	C0013366	Dyschondroplasias	group	C16;C05	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.40	1	1996	2020	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0015923	Fetal Alcohol Syndrome	disease	C16;C13;C25	Disease or Syndrome	0.31	1	2008	2018	   2	   0	PSYGENET
      596	BCL2	0.291	0.885	C0016978	gallbladder neoplasm	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0018671	Head and Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0018675	Head Neoplasms	group	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1999	2017	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1999	2017	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.53	1	1998	2017	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.31	1	2014	2017	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0021841	Intestinal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0023186	Learning Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.50	0.974	1987	2020	   2	   3	CTD_human
      596	BCL2	0.291	0.885	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.40	0.986	1990	2020	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0023891	Liver Cirrhosis, Alcoholic	disease	C23;C06;C25	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1999	2017	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.50	0.981	1987	2020	   0	   0	CGI
      596	BCL2	0.291	0.885	C0024301	Lymphoma, Follicular	disease	C04;C20;C15	Neoplastic Process	0.60	0.969	1985	2020	   4	   0	CTD_human;ORPHANET
      596	BCL2	0.291	0.885	C0024302	Reticulosarcoma	disease	C04;C20;C15	Neoplastic Process	0.35	1	1988	2015	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0024304	Lymphoma, Mixed-Cell	disease	C04;C20;C15	Neoplastic Process	0.31	1	1988	2015	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.60	0.973	1988	2019	   2	   0	CTD_human;UNIPROT
      596	BCL2	0.291	0.885	C0024306	Lymphoma, Undifferentiated	disease	C04;C20;C15	Neoplastic Process	0.30	1	1988	2015	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0025237	Melnick-Needles Syndrome	disease	C16;C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0025261	Memory Disorders	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0025568	Metaplasia	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0026760	Multiple Epiphyseal Dysplasia	disease	C16;C05	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.40	1	1992	2020	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.40	1	2009	2019	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0027533	Neck Neoplasms	group	C04	Neoplastic Process	0.31	1	2008	2011	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2002	2006	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2000	2007	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0029422	Osteochondrodysplasias	group	C16;C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.55	1	1998	2018	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.40	1	1999	2018	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.32	1	2004	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0035304	Retinal Degeneration	phenotype	C11	Pathologic Function	0.50	1	1996	2014	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	0.5	2009	2015	   2	   0	PSYGENET
      596	BCL2	0.291	0.885	C0036391	Schwartz-Jampel Syndrome	disease	C16;C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0037579	Soft Tissue Neoplasms	group	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0038015	Spondyloepiphyseal Dysplasia	disease	C16;C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2006	2013	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0039101	synovial sarcoma	disease	C04	Neoplastic Process	0.40	0.867	2000	2019	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0079740	High Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.39	1	1988	2018	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0079741	Lymphoma, Intermediate-Grade	disease	C04;C20;C15	Neoplastic Process	0.30	1	1988	2015	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.40	0.964	1991	2020	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0079745	Lymphoma, Large-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.40	1	1988	2019	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0079747	Low Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.35	1	1988	2015	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0079757	Diffuse Mixed-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	1988	2015	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0079758	Lymphoma, Mixed-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.31	1	1988	2012	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0079765	Lymphoma, Small Cleaved-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.32	1	1988	2003	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0079770	Lymphoma, Small Noncleaved-Cell	disease	C04;C20;C15	Neoplastic Process	0.31	1	1988	2015	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1999	2017	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0153452	Malignant neoplasm of gallbladder	disease	C06;C04	Neoplastic Process	0.34	1	2006	2017	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0162820	Dermatitis, Allergic Contact	disease	C17;C20	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.31	1	2002	2011	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	1999	1999	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.30	1	1999	1999	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.30	1	1999	1999	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	1999	1999	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	1999	1999	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	1999	1999	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.34	1	1994	1999	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0206637	Mesenchymal Chondrosarcoma	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0206681	Adenocarcinoma, Clear Cell	disease	C04	Neoplastic Process	0.30	1	1998	1998	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0233794	Memory impairment	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.34	1	2007	2018	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2005	2011	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C0242350	Erectile dysfunction	disease	C12;F03	Disease or Syndrome	0.51	1	2002	2018	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0276535	AIDS with Kaposi's sarcoma	disease	C04;C01;C20	Neoplastic Process	0.30	1	2000	2000	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.40	1	1999	2015	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0334660	Angioendotheliomatosis	disease	C04;C20;C15	Neoplastic Process	0.30	1	2009	2009	   1	   0	ORPHANET
      596	BCL2	0.291	0.885	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.33	1	2001	2019	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0346627	Intestinal Cancer	disease	C06;C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	1	1994	2019	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0432272	Van Buchem disease	disease	C16;C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.40	1	1996	2020	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.962	1994	2020	   3	   0	CTD_human
      596	BCL2	0.291	0.885	C0746787	Cancer of Neck	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751177	Cancer of Head	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751262	Adult Learning Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751263	Learning Disturbance	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751265	Learning Disabilities	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751292	Age-Related Memory Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751293	Memory Disorder, Semantic	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751294	Memory Disorder, Spatial	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751295	Memory Loss	phenotype	C23;C10;F01	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0848676	Subfertility, Male	phenotype	C12	Sign or Symptom	0.30	1	2014	2014	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0853193	Bipolar I disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2011	2013	   2	   0	PSYGENET
      596	BCL2	0.291	0.885	C0887900	Upper Aerodigestive Tract Neoplasms	group	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0917731	Male sterility	phenotype	C12	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2013	   3	   0	CTD_human
      596	BCL2	0.291	0.885	C1330966	Developmental Academic Disorder	phenotype	C23;C10;F03	Finding	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	0.978	1998	2019	   3	   0	CTD_human
      596	BCL2	0.291	0.885	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.31	1	1999	2013	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C1956130	Lymphoma, Follicular, Grade 1	disease	C04;C20;C15	Neoplastic Process	0.32	1	1988	2003	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C1956131	Lymphoma, Follicular, Grade 3	disease	C04;C20;C15	Neoplastic Process	0.32	1	1988	2013	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C1956132	Lymphoma, Follicular, Grade 2	disease	C04;C20;C15	Neoplastic Process	0.31	1	1988	2012	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.40	1	1999	2020	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C2931456	Prostate cancer, familial	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C2985290	Fetal Alcohol Spectrum Disorders	group	C16;C13;C25	Disease or Syndrome; Congenital Abnormality	0.31	1	2012	2018	   1	   0	PSYGENET
      596	BCL2	0.291	0.885	C3541456	Spondyloepiphyseal Dysplasia Tarda, X-Linked	disease	C16;C05	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C3714542	Lymphoma, Diffuse	disease	C04;C20;C15	Neoplastic Process	0.33	1	1988	2015	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C4551479	Schwartz-Jampel Syndrome, Type 1	disease	C16;C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2013	   3	   0	CTD_human
      596	BCL2	0.291	0.885	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.40	1	1988	2019	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C4722327	PROSTATE CANCER, HEREDITARY, 1	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      597	BCL2A1	0.529	0.731	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.31	1	2009	2017	   1	   0	CTD_human
      597	BCL2A1	0.529	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.35	1	2003	2019	   2	   0	CTD_human
      597	BCL2A1	0.529	0.731	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      597	BCL2A1	0.529	0.731	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      597	BCL2A1	0.529	0.731	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.35	1	2003	2019	   2	   0	CTD_human
      597	BCL2A1	0.529	0.731	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2005	2008	   2	   0	CTD_human
      597	BCL2A1	0.529	0.731	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2003	2008	   2	   0	CTD_human
      597	BCL2A1	0.529	0.731	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2005	2008	   2	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0001430	Adenoma	group	C04	Neoplastic Process	0.31	1	1999	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0007097	Carcinoma	group	C04	Neoplastic Process	0.33	1	1996	2005	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0010417	Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2006	2007	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0018671	Head and Neck Neoplasms	group	C04	Neoplastic Process	0.31	1	2004	2008	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0018675	Head Neoplasms	group	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1999	2017	   2	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1999	2017	   2	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1999	2017	   2	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.33	1	2005	2013	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.32	1	2015	2019	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.36	1	1998	2014	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.50	1	2007	2009	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0027533	Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1999	2017	   2	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0149504	Encephalopathy, Toxic	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0154659	Toxic Encephalitis	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0235032	Neurotoxicity Syndromes	group	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0242350	Erectile dysfunction	disease	C12;F03	Disease or Syndrome	0.50	1	2002	2002	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.32	1	2005	2019	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.31	1	2008	2010	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0431663	Bilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0431664	Unilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0746787	Cancer of Neck	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0751177	Cancer of Head	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0887900	Upper Aerodigestive Tract Neoplasms	group	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C1563730	Abdominal Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C1563731	Inguinal Cryptorchidism	phenotype	C16;C12;C19	Finding	0.30	1	2015	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.38	1	2000	2019	   2	   0	CTD_human
      598	BCL2L1	0.493	0.885	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      602	BCL3	0.541	0.731	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.31	1	2015	2015	   1	   0	CTD_human
      602	BCL3	0.541	0.731	C0242339	Dyslipidemias	group	C18	Disease or Syndrome	0.31	1	2018	2018	   1	   0	CTD_human
      602	BCL3	0.541	0.731	C0598784	Dyslipoproteinemias	phenotype	C18	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      602	BCL3	0.541	0.731	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	0.933	1996	2020	   0	   0	CGI
      604	BCL6	0.444	0.808	C0024301	Lymphoma, Follicular	disease	C04;C20;C15	Neoplastic Process	0.40	0.961	1995	2020	   1	   0	ORPHANET
      604	BCL6	0.444	0.808	C0024302	Reticulosarcoma	disease	C04;C20;C15	Neoplastic Process	0.32	1	1997	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0024304	Lymphoma, Mixed-Cell	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.60	0.956	1993	2015	   1	   0	CGI;CTD_human
      604	BCL6	0.444	0.808	C0024306	Lymphoma, Undifferentiated	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0079740	High Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0079741	Lymphoma, Intermediate-Grade	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0079747	Low Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0079757	Diffuse Mixed-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0079770	Lymphoma, Small Noncleaved-Cell	disease	C04;C20;C15	Neoplastic Process	0.33	1	1994	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0079772	T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.34	1	2002	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0334660	Angioendotheliomatosis	disease	C04;C20;C15	Neoplastic Process	0.31	1	2001	2001	   0	   0	ORPHANET
      604	BCL6	0.444	0.808	C1292754	Mediastinal (Thymic) Large B-Cell Lymphoma	disease	C04;C08;C20;C15	Neoplastic Process	0.31	1	2006	2016	   1	   0	ORPHANET
      604	BCL6	0.444	0.808	C3714542	Lymphoma, Diffuse	disease	C04;C20;C15	Neoplastic Process	0.31	1	1997	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.40	0.935	1994	2015	   1	   0	CTD_human
      607	BCL9	0.595	0.615	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
      607	BCL9	0.595	0.615	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
      607	BCL9	0.595	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.43	1	2011	2015	   2	   1	PSYGENET
      607	BCL9	0.595	0.615	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
      607	BCL9	0.595	0.615	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.32	1	2011	2019	   1	   0	CTD_human
      607	BCL9	0.595	0.615	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.32	1	2011	2019	   1	   0	CTD_human
      607	BCL9	0.595	0.615	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
      611	OPN1SW	0.519	0.769	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      611	OPN1SW	0.519	0.769	C0155017	Color Blindness, Blue	disease	C23;C11;C10	Disease or Syndrome	0.74	0.667	1992	2018	   3	   4	CTD_human;ORPHANET;UNIPROT
      611	OPN1SW	0.519	0.769	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      611	OPN1SW	0.519	0.769	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      611	OPN1SW	0.519	0.769	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      613	BCR	0.431	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2005	2008	   4	   0	PSYGENET
      613	BCR	0.431	0.885	C0005699	Blast Phase	disease	C23;C04;C15	Neoplastic Process	0.40	0.941	1975	2019	   1	   0	CTD_human
      613	BCR	0.431	0.885	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.34	1	1985	2017	   1	   0	ORPHANET
      613	BCR	0.431	0.885	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	0.948	1987	2019	   0	   0	CTD_human
      613	BCR	0.431	0.885	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CTD_human
      613	BCR	0.431	0.885	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.70	0.969	1980	2020	   3	   0	CTD_human;ORPHANET
      613	BCR	0.431	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      613	BCR	0.431	0.885	C0027022	Myeloproliferative disease	group	C15	Neoplastic Process	0.50	0.976	1979	2019	   1	   0	CTD_human
      613	BCR	0.431	0.885	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2013	2013	   1	   0	CTD_human
      613	BCR	0.431	0.885	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2009	2009	   1	   0	CTD_human
      613	BCR	0.431	0.885	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2005	2005	   1	   0	PSYGENET
      613	BCR	0.431	0.885	C0279680	Transitional cell carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.30				   0	   0	UNIPROT
      613	BCR	0.431	0.885	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2005	2005	   1	   0	PSYGENET
      613	BCR	0.431	0.885	C1292769	Precursor B-cell lymphoblastic leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	0.92	1991	2019	   1	   0	ORPHANET
      613	BCR	0.431	0.885	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.38	1	1989	2019	   0	   0	ORPHANET
      613	BCR	0.431	0.885	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.50	0.978	1988	2020	   0	   0	CTD_human
      613	BCR	0.431	0.885	C2678480	Chromosome 22q11.2 Deletion Syndrome, Distal	disease	C23;C16;C05;C19;C15;C14	Disease or Syndrome	0.30				   0	   0	ORPHANET
      617	BCS1L	0.534	0.808	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.40	1	1998	2002	   2	   0	GENOMICS_ENGLAND
      617	BCS1L	0.534	0.808	C0023264	Leigh Disease	disease	C16;C18;C10	Disease or Syndrome	0.70	1	1998	2017	  10	   3	CLINGEN;CTD_human;GENOMICS_ENGLAND
      617	BCS1L	0.534	0.808	C0266006	Pili torti-deafness syndrome	disease	C23;C18;C17;C10;C09	Disease or Syndrome	0.75	1	1998	2017	   9	  10	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      617	BCS1L	0.534	0.808	C0751267	Encephalopathy, Subacute Necrotizing, Infantile	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
      617	BCS1L	0.534	0.808	C0751268	Encephalopathy, Subacute Necrotizing, Juvenile	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
      617	BCS1L	0.534	0.808	C0751651	Mitochondrial Diseases	group	C18	Disease or Syndrome	0.33	1	2007	2019	   1	   0	GENOMICS_ENGLAND
      617	BCS1L	0.534	0.808	C1838951	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1999	2017	   6	   0	CLINGEN
      617	BCS1L	0.534	0.808	C1850597	Leigh Syndrome Due To Mitochondrial Complex II Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1999	2017	   6	   0	CLINGEN
      617	BCS1L	0.534	0.808	C1850598	Leigh Syndrome due to Mitochondrial Complex III Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.40	1	1999	2017	   6	   1	CLINGEN
      617	BCS1L	0.534	0.808	C1850599	Leigh Syndrome due to Mitochondrial Complex IV Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1999	2017	   6	   0	CLINGEN
      617	BCS1L	0.534	0.808	C1850600	Leigh Syndrome due to Mitochondrial Complex V Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1999	2017	   6	   0	CLINGEN
      617	BCS1L	0.534	0.808	C1864002	GRACILE SYNDROME (disorder)	disease	C23;C16;C06;C18;C13;C12	Disease or Syndrome	0.77	1	1998	2019	   7	  27	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      617	BCS1L	0.534	0.808	C2931891	Necrotizing encephalopathy, infantile subacute, of Leigh	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1999	2017	   6	   0	CLINGEN
      617	BCS1L	0.534	0.808	C3541471	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	disease		Disease or Syndrome	0.70	1	1998	2017	  11	  13	CTD_human;GENOMICS_ENGLAND;UNIPROT
      622	BDH1	0.729	0.423	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
      622	BDH1	0.729	0.423	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2014	   2	   0	CTD_human
      622	BDH1	0.729	0.423	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      622	BDH1	0.729	0.423	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      622	BDH1	0.729	0.423	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      622	BDH1	0.729	0.423	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      622	BDH1	0.729	0.423	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2002	2011	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0014556	Epilepsy, Temporal Lobe	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0014558	Uncinate Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.50	1	2003	2010	   3	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.31	1	2005	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0030193	Pain	phenotype	C23	Sign or Symptom	0.50	1	2007	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0038002	Splenomegaly	phenotype	C23	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0393672	Epilepsy, Benign Psychomotor, Childhood	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0393682	Epilepsy, Lateral Temporal	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2008	2010	   3	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	PSYGENET
      624	BDKRB2	0.585	0.808	C0014556	Epilepsy, Temporal Lobe	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0014558	Uncinate Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0015378	Extravasation of Contrast Media	phenotype	C23;C26	Pathologic Function	0.30	1	1998	1998	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0019080	Hemorrhage	phenotype	C23	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2019	2019	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.50	1	1999	2010	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0020452	Hyperemia	disease	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.57	1	1996	2016	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	1992	2005	   2	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.51	1	1995	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0028796	Dermatitis, Occupational	disease	C17;C24	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0030193	Pain	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0040053	Thrombosis	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2009	2009	   1	   0	PSYGENET
      624	BDKRB2	0.585	0.808	C0042484	Venous Engorgement	phenotype	C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0086457	Industrial Dermatosis	disease	C17;C24	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0087086	Thrombus	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0178824	Reactive Hyperemia	phenotype	C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0333233	Active Hyperemia	phenotype	C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0393672	Epilepsy, Benign Psychomotor, Childhood	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0393682	Epilepsy, Lateral Temporal	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2008	2010	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2009	2009	   1	   0	PSYGENET
      624	BDKRB2	0.585	0.808	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.31	1	2008	2018	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0001969	Alcoholic Intoxication	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	PSYGENET
      627	BDNF	0.345	0.923	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	0.4	2004	2020	   5	   0	PSYGENET
      627	BDNF	0.345	0.923	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.60	0.958	1991	2020	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	0.957	2005	2019	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.60	1	2002	2019	   7	   0	CTD_human;PSYGENET
      627	BDNF	0.345	0.923	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.34	0.833	2004	2019	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0005910	Body Weight	phenotype	C23	Organism Attribute	0.40	1	2009	2017	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.33	1	2002	2017	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2004	2018	   7	   0	CTD_human
      627	BDNF	0.345	0.923	C0011052	Prelingual Deafness	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2009	2009	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0011053	Deafness	phenotype	C23;C10;C09	Finding	0.30	1	2009	2009	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.40	1	2007	2020	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.60	1	2003	2020	   5	   0	PSYGENET
      627	BDNF	0.345	0.923	C0011573	Endogenous depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2006	2012	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.60	1	2003	2020	   7	   0	CTD_human;PSYGENET
      627	BDNF	0.345	0.923	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.40	0.974	1993	2020	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0014549	Tonic-Clonic Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0017639	Gliosis	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0019337	Heroin Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.38	0.889	2007	2017	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.53	1	2003	2010	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.32	1	2006	2019	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2008	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0025193	Melancholia	disease	F03	Mental or Behavioral Dysfunction	0.35	1	2006	2015	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.50	1	1996	2009	   5	   0	CTD_human
      627	BDNF	0.345	0.923	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.40	1	2010	2020	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0028043	Nicotine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	0.909	2005	2019	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0028756	Obesity, Morbid	disease	C23;C18	Disease or Syndrome	0.33	1	2011	2019	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.40	0.906	1995	2020	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0033958	Psychosis, Brief Reactive	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.40	0.857	2004	2020	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0036337	Schizoaffective Disorder	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2004	2019	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.932	1998	2020	   4	   0	CTD_human
      627	BDNF	0.345	0.923	C0036358	Schizophreniform Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.50	0.952	1997	2020	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.56	1	1996	2019	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0040332	Tobacco Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.60	1	2005	2020	   7	   0	CTD_human;PSYGENET
      627	BDNF	0.345	0.923	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	0.667	2003	2014	   3	   0	PSYGENET
      627	BDNF	0.345	0.923	C0086133	Depressive Syndrome	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2006	2012	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0086395	Hearing Loss, Extreme	phenotype	C23;C10;C09	Sign or Symptom	0.30	1	2009	2009	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.33	1	2003	2019	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0206115	WAGR Syndrome	disease	C16;C04;C13;C11;C12;C10;C19	Disease or Syndrome	0.37	1	1994	2017	   1	   0	ORPHANET
      627	BDNF	0.345	0.923	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.31	1	1997	2018	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0236018	Aura	phenotype	C10	Finding	0.30	1	2004	2004	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0236733	Amphetamine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2004	2010	   7	   0	CTD_human
      627	BDNF	0.345	0.923	C0236804	Amphetamine Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0236807	Amphetamine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0282126	Depression, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2006	2012	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0338715	Drug-induced depressive state	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2013	   3	   0	PSYGENET
      627	BDNF	0.345	0.923	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.39	0.909	2004	2019	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0376384	Nicotine Use Disorder	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.37	1	2001	2020	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.40	1	2002	2020	   5	   0	PSYGENET
      627	BDNF	0.345	0.923	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0581883	Complete Hearing Loss	phenotype	C23;C10;C09	Finding	0.30	1	2009	2009	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0600241	heroin abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2007	2010	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2004	2019	   7	   0	CTD_human
      627	BDNF	0.345	0.923	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2006	2006	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0751068	Deafness, Acquired	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2009	2009	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0751117	Cryptogenic Tonic-Clonic Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0751118	Epilepsy, Tonic-Clonic, Familial	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0751119	Epilepsy, Tonic-Clonic, Symptomatic	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.31	1	2001	2010	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2003	2020	   5	   0	PSYGENET
      627	BDNF	0.345	0.923	C1275808	Congenital central hypoventilation	disease	C23;C08;C10	Disease or Syndrome	0.62	1	2002	2018	   4	   0	GENOMICS_ENGLAND;ORPHANET;UNIPROT
      627	BDNF	0.345	0.923	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.40	0.957	2009	2020	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C1861063	TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)	phenotype		Finding	0.30	1	2010	2010	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C2931803	Deletion 11p13	disease	C23	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
      627	BDNF	0.345	0.923	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.31	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C3665473	Bilateral Deafness	phenotype	C23;C10;C09	Finding	0.30	1	2009	2009	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.50	1	1994	2018	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C3887640	Astrocytosis	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C4082305	Deaf Mutism	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2009	2009	   2	   0	CTD_human
      627	BDNF	0.345	0.923	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.33	1	1997	2019	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1997	2011	   3	   0	CTD_human
      627	BDNF	0.345	0.923	C4505390	Heroin Smoking	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1997	2011	   3	   0	CTD_human
      629	CFB	0.532	0.769	C0017662	Glomerulonephritis, Membranoproliferative	disease	C13;C12;C20	Disease or Syndrome	0.31	1	2016	2017	   1	   0	GENOMICS_ENGLAND
      629	CFB	0.532	0.769	C0019061	Hemolytic-Uremic Syndrome	disease	C13;C12;C15	Disease or Syndrome	0.40	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      629	CFB	0.532	0.769	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.40	1	2008	2015	   1	   0	CTD_human
      629	CFB	0.532	0.769	C0026896	Myasthenia Gravis	disease	C04;C20;C10	Disease or Syndrome	0.40	1	1983	2012	   1	   0	CTD_human
      629	CFB	0.532	0.769	C0242380	Libman-Sacks Disease	disease	C17;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      629	CFB	0.532	0.769	C0242383	Age related macular degeneration	disease	C11	Disease or Syndrome	0.70	0.966	2006	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
      629	CFB	0.532	0.769	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.30	1	1972	1972	   1	   0	GENOMICS_ENGLAND
      629	CFB	0.532	0.769	C0751339	Myasthenia Gravis, Generalized	disease	C04;C20;C10	Disease or Syndrome	0.30	1	1983	1983	   1	   0	CTD_human
      629	CFB	0.532	0.769	C0751340	Myasthenia Gravis, Ocular	disease	C04;C20;C10	Disease or Syndrome	0.30	1	1983	1983	   1	   0	CTD_human
      629	CFB	0.532	0.769	C2752038	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4	disease		Finding	0.60	1	2007	2016	   5	   0	GENOMICS_ENGLAND;UNIPROT
      629	CFB	0.532	0.769	C2931788	Atypical Hemolytic Uremic Syndrome	disease	C13;C12;C15	Disease or Syndrome	0.60	1	1972	2019	   3	   0	CTD_human;GENOMICS_ENGLAND
      629	CFB	0.532	0.769	C3809653	MACULAR DEGENERATION, AGE-RELATED, 14	disease		Disease or Syndrome	0.30				   0	   0	CTD_human
      629	CFB	0.532	0.769	C3809950	COMPLEMENT FACTOR B DEFICIENCY	disease		Disease or Syndrome	0.60	1	1972	1972	   1	   0	CTD_human;GENOMICS_ENGLAND
      629	CFB	0.532	0.769	C4087273	C3 glomerulopathy	disease		Disease or Syndrome	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      631	BFSP1	0.729	0.231	C0392557	Nuclear cataract	disease	C11	Disease or Syndrome	0.40	1	2013	2013	   1	   0	ORPHANET
      631	BFSP1	0.729	0.231	C1112705	Nuclear non-senile cataract	disease	C11	Disease or Syndrome	0.40	1	2013	2013	   1	   0	ORPHANET
      631	BFSP1	0.729	0.231	C1969644	Cataract, Cortical, Juvenile-Onset	disease	C11	Disease or Syndrome	0.30				   0	   0	CTD_human
      631	BFSP1	0.729	0.231	C3808107	CATARACT 33, MULTIPLE TYPES	disease		Disease or Syndrome	0.50	1	2007	2017	   3	   1	GENOMICS_ENGLAND;UNIPROT
      632	BGLAP	0.462	0.846	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.31	1	1993	2019	   1	   0	CTD_human
      632	BGLAP	0.462	0.846	C0006663	Calcinosis	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      632	BGLAP	0.462	0.846	C0018824	Heart valve disease	group	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      632	BGLAP	0.462	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.33	1	2000	2009	   1	   0	CTD_human
      632	BGLAP	0.462	0.846	C0263628	Tumoral calcinosis	disease	C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      632	BGLAP	0.462	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	1	2000	2017	   1	   0	CTD_human
      632	BGLAP	0.462	0.846	C0521174	Microcalcification	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      633	BGN	0.484	0.808	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.32	1	2004	2018	   1	   0	CTD_human
      633	BGN	0.484	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.32	1	2009	2019	   0	   0	UNIPROT
      633	BGN	0.484	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      633	BGN	0.484	0.808	C1848097	Spondyloepimetaphyseal Dysplasia, X-Linked	disease	C16;C05	Disease or Syndrome	0.71	1	2016	2017	   2	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      633	BGN	0.484	0.808	C4310811	MEESTER-LOEYS SYNDROME	disease		Disease or Syndrome	0.70	1	2017	2017	   1	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
      633	BGN	0.484	0.808	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.50	1	2007	2017	   2	   0	CLINGEN;GENOMICS_ENGLAND
      634	CEACAM1	0.525	0.731	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      634	CEACAM1	0.525	0.731	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      634	CEACAM1	0.525	0.731	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.32	1	2007	2011	   1	   0	CTD_human
      634	CEACAM1	0.525	0.731	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.32	1	2008	2011	   1	   0	CTD_human
      634	CEACAM1	0.525	0.731	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      634	CEACAM1	0.525	0.731	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      634	CEACAM1	0.525	0.731	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      634	CEACAM1	0.525	0.731	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      634	CEACAM1	0.525	0.731	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      634	CEACAM1	0.525	0.731	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.31	1	1992	2011	   1	   0	CTD_human
      634	CEACAM1	0.525	0.731	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      634	CEACAM1	0.525	0.731	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0000832	Abruptio Placentae	phenotype	C13	Pathologic Function	0.31	1	2007	2007	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
      635	BHMT	0.595	0.731	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0011999	Diastematomyelia	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0019202	Hepatolenticular Degeneration	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0024302	Reticulosarcoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0024304	Lymphoma, Mixed-Cell	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0024306	Lymphoma, Undifferentiated	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0027794	Neural Tube Defects	group	C16;C10	Congenital Abnormality	0.34	0.8	2003	2019	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0027806	Neurenteric Cyst	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0079740	High Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0079741	Lymphoma, Intermediate-Grade	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0079747	Low Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0079757	Diffuse Mixed-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0079770	Lymphoma, Small Noncleaved-Cell	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0080218	Tethered Cord Syndrome	disease	C16;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0152234	Iniencephaly	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0152426	Craniorachischisis	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0266453	Exencephaly	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0344479	Spinal Cord Myelodysplasia	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C0702169	Acrania	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C1527352	Hepatic Form of Wilson Disease	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C3714542	Lymphoma, Diffuse	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      635	BHMT	0.595	0.731	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      637	BID	0.555	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      637	BID	0.555	0.808	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.31	1	2004	2004	   1	   0	CTD_human
      637	BID	0.555	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2012	2019	   1	   0	PSYGENET
      637	BID	0.555	0.808	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      637	BID	0.555	0.808	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      637	BID	0.555	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2004	2018	   1	   0	CTD_human
      639	PRDM1	0.538	0.731	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.33	0.833	2009	2019	   3	   0	CTD_human
      639	PRDM1	0.538	0.731	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.40	1	2011	2016	   1	   1	CTD_human
      639	PRDM1	0.538	0.731	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.55	1	2009	2017	   1	   0	CTD_human
      639	PRDM1	0.538	0.731	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.40	0.889	2005	2017	   0	   0	CGI
      639	PRDM1	0.538	0.731	C0086981	Sicca Syndrome	disease	C11;C17;C05;C20;C07	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      639	PRDM1	0.538	0.731	C0242380	Libman-Sacks Disease	disease	C17;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      639	PRDM1	0.538	0.731	C1527336	Sjogren's Syndrome	disease	C11;C17;C05;C20;C07	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      640	BLK	0.585	0.769	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.46	1	2009	2016	   2	   1	CTD_human
      640	BLK	0.585	0.769	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.70	0.976	2008	2020	   7	   9	CTD_human;ORPHANET
      640	BLK	0.585	0.769	C0026691	Mucocutaneous Lymph Node Syndrome	disease	C17;C15;C14	Disease or Syndrome	0.46	1	2012	2017	   1	  44	CTD_human
      640	BLK	0.585	0.769	C0242380	Libman-Sacks Disease	disease	C17;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      640	BLK	0.585	0.769	C0342276	Maturity onset diabetes mellitus in young	disease	C18;C19	Disease or Syndrome	0.62	1	2009	2013	   1	   0	GENOMICS_ENGLAND;ORPHANET
      640	BLK	0.585	0.769	C3150618	Maturity-onset diabetes of the young, type 11	disease	C18;C19	Disease or Syndrome	0.60				   0	   1	CTD_human;GENOMICS_ENGLAND
      640	BLK	0.585	0.769	C3888631	Monogenic diabetes	disease	C18;C19	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      641	BLM	0.535	0.808	C0005859	Bloom Syndrome	disease	C16;C18;C20	Disease or Syndrome	1.00	0.994	1994	2020	  10	 126	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      641	BLM	0.535	0.808	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.979	1999	2019	   0	   0	CGI
      641	BLM	0.535	0.808	C0007097	Carcinoma	group	C04	Neoplastic Process	0.31	1	2017	2018	   1	   0	GENOMICS_ENGLAND
      641	BLM	0.535	0.808	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.40				   0	   0	CGI
      641	BLM	0.535	0.808	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.30	1	2007	2007	   1	   0	GENOMICS_ENGLAND
      641	BLM	0.535	0.808	C0023418	leukemia	disease	C04	Neoplastic Process	0.61	1	2005	2017	   1	   0	CGI;GENOMICS_ENGLAND
      641	BLM	0.535	0.808	C0023449	Acute lymphocytic leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      641	BLM	0.535	0.808	C0023465	Acute monocytic leukemia	disease	C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      641	BLM	0.535	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      641	BLM	0.535	0.808	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.61	1	2002	2017	   1	   0	CGI;GENOMICS_ENGLAND
      641	BLM	0.535	0.808	C0265219	Miller Dieker syndrome	disease	C16;C10	Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      641	BLM	0.535	0.808	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      641	BLM	0.535	0.808	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      643	CXCR5	0.524	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.36	0.833	2008	2019	   0	   0	UNIPROT
      643	CXCR5	0.524	0.769	C0008312	Primary biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.31	1	2011	2015	   1	   0	CTD_human
      643	CXCR5	0.524	0.769	C0023892	Biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      643	CXCR5	0.524	0.769	C0238065	Secondary Biliary Cholangitis	disease	C23;C06	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      643	CXCR5	0.524	0.769	C4551595	Biliary Cirrhosis, Primary, 1	disease	C23;C06	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      644	BLVRA	0.663	0.423	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.40	1	2008	2008	   1	   0	CTD_human
      644	BLVRA	0.663	0.423	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      644	BLVRA	0.663	0.423	C3279964	Hyperbiliverdinemia	disease	C06	Disease or Syndrome	0.61	1	2009	2011	   1	   2	CTD_human;ORPHANET
      645	BLVRB	0.695	0.423	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
      645	BLVRB	0.695	0.423	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      645	BLVRB	0.695	0.423	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      645	BLVRB	0.695	0.423	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      645	BLVRB	0.695	0.423	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      645	BLVRB	0.695	0.423	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      645	BLVRB	0.695	0.423	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      645	BLVRB	0.695	0.423	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      645	BLVRB	0.695	0.423	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      645	BLVRB	0.695	0.423	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.40	1	2009	2019	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C0017638	Glioma	disease	C04	Neoplastic Process	0.40	1	2008	2018	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C0019569	Hirschsprung Disease	disease	C16;C06	Disease or Syndrome	0.31	1	2018	2018	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C0023472	Leukemia, Myeloid, Accelerated Phase	disease	C04;C15	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C0027686	Pathologic Neovascularization	phenotype	C23	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C0029463	Osteosarcoma	disease	C04	Neoplastic Process	0.38	1	2010	2018	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C0085758	Aganglionosis, Colonic	disease	C16;C06	Congenital Abnormality	0.30	1	2018	2018	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C1257840	Aganglionosis, Rectosigmoid Colon	disease	C16;C06	Congenital Abnormality	0.30	1	2018	2018	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.40	1	2009	2019	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C2713368	Hematopoetic Myelodysplasia	phenotype	C15	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.37	1	2007	2014	   1	   0	CTD_human
      648	BMI1	0.448	0.808	C3661523	Congenital Intestinal Aganglionosis	disease	C16;C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      649	BMP1	0.554	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.31	1	2016	2016	   0	   0	UNIPROT
      649	BMP1	0.554	0.769	C0268362	Osteogenesis imperfecta type III (disorder)	disease	C16;C17;C05	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
      649	BMP1	0.554	0.769	C3553887	OSTEOGENESIS IMPERFECTA, TYPE XIII	disease		Disease or Syndrome	0.71	1	2012	2019	   4	   6	CTD_human;GENOMICS_ENGLAND;UNIPROT
      650	BMP2	0.432	0.846	C0005940	Bone Diseases	group	C05	Disease or Syndrome	0.31	1	2012	2017	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1999	2019	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.33	1	2002	2017	   1	   0	GENOMICS_ENGLAND
      650	BMP2	0.432	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.38	0.889	2011	2019	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2007	2019	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0010278	Craniosynostosis	disease	C16;C05	Disease or Syndrome	0.34	1	2012	2019	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0018995	Hemochromatosis	disease	C16;C18	Disease or Syndrome	0.31	1	2019	2019	   0	   0	CTD_human
      650	BMP2	0.432	0.846	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.35	1	2006	2019	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0027092	Myopia	disease	C11	Disease or Syndrome	0.32	1	2009	2013	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0030044	Acrocephaly	disease	C16;C05	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0033054	Prenatal Exposure Delayed Effects	disease	C13	Injury or Poisoning	0.30	1	2018	2018	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0041948	Uremia	disease	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0221356	Brachycephaly	disease	C16;C05	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0265534	Scaphycephaly	disease	C16;C05	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0265535	Trigonocephaly	disease	C16;C05	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0392514	Hereditary hemochromatosis	disease	C16;C18	Disease or Syndrome	0.30				   0	   0	CTD_human
      650	BMP2	0.432	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1999	2019	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C0876994	Cardiotoxicity	disease	C23;C25;C14;C26	Injury or Poisoning	0.30	1	2018	2018	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.35	1	2000	2018	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C1704436	Peripheral Arterial Diseases	group	C14	Disease or Syndrome	0.32	1	2016	2019	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C1832702	BRACHYDACTYLY, TYPE A2	disease	C16;C05	Congenital Abnormality	0.75	1	2005	2018	   4	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
      650	BMP2	0.432	0.846	C1833340	Synostotic Posterior Plagiocephaly	disease	C16;C05	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C1848587	Isolated hypoplasia of the right ventricle	disease	C16;C14	Disease or Syndrome; Congenital Abnormality	0.30	1	2018	2018	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C1860819	Metopic synostosis	disease	C16;C05	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C2931150	Synostotic Anterior Plagiocephaly	disease	C16;C05	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C3469186	HEMOCHROMATOSIS, TYPE 1	disease	C16;C18	Disease or Syndrome	0.31	1	2017	2019	   1	   0	GENOMICS_ENGLAND
      650	BMP2	0.432	0.846	C4304539	20p12.3 microdeletion syndrome	disease		Disease or Syndrome	0.30	1	2009	2011	   2	   0	ORPHANET
      650	BMP2	0.432	0.846	C4551902	Craniosynostosis, Type 1	disease	C16;C05	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      650	BMP2	0.432	0.846	C4693481	SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES	disease		Disease or Syndrome	0.40	1	2013	2018	   3	   3	GENOMICS_ENGLAND
      650	BMP2	0.432	0.846	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C0003872	Arthritis, Psoriatic	disease	C17;C05	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.32	1	2006	2019	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.929	2007	2019	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C0008924	Cleft upper lip	disease	C16;C07	Congenital Abnormality	0.43	1	2008	2018	   0	   0	GENOMICS_ENGLAND
      652	BMP4	0.422	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.50	0.952	2008	2020	   1	   1	CTD_human
      652	BMP4	0.422	0.808	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.41	1	2008	2019	   1	   1	CTD_human
      652	BMP4	0.422	0.808	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.32	1	2008	2011	   0	   0	GENOMICS_ENGLAND
      652	BMP4	0.422	0.808	C0019284	Diaphragmatic Hernia	phenotype	C23	Disease or Syndrome	0.50	1	2008	2008	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.32	1	2006	2019	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C0033375	Prolactinoma	disease	C04;C10;C19	Neoplastic Process	0.54	1	2003	2020	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C0042842	Vitamin A Deficiency	disease	C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C0152427	Polydactyly	disease	C16;C05	Congenital Abnormality	0.32	1	2008	2011	   1	   0	GENOMICS_ENGLAND
      652	BMP4	0.422	0.808	C0158646	Cleft palate with cleft lip	disease	C16;C05;C07	Congenital Abnormality	0.32	1	2008	2016	   1	   0	ORPHANET
      652	BMP4	0.422	0.808	C0266294	Unilateral agenesis of kidney	disease	C23;C13;C12	Congenital Abnormality	0.30	1	2012	2012	   1	   0	ORPHANET
      652	BMP4	0.422	0.808	C0344452	Microprolactinoma	disease	C04;C10;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C0344453	Macroprolactinoma	disease	C04;C10;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.40				   0	   0	GENOMICS_ENGLAND
      652	BMP4	0.422	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.929	2007	2019	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C0810364	Cleft Lip with or without Cleft Palate	disease		Congenital Abnormality	0.37	1	2008	2019	   0	   0	GENOMICS_ENGLAND
      652	BMP4	0.422	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C1306214	ACTH-Secreting Pituitary Adenoma	disease	C04;C10;C19	Neoplastic Process	0.31	1	2006	2017	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.32	1	2007	2013	   1	   0	CTD_human
      652	BMP4	0.422	0.808	C1864689	MICROPHTHALMIA, SYNDROMIC 6 (disorder)	disease	C16;C13;C11;C05;C12;C10	Disease or Syndrome	0.70	1	1986	2013	   4	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      652	BMP4	0.422	0.808	C1968949	Cakut	disease	C16;C13;C12	Disease or Syndrome	0.34	1	2008	2019	   1	   0	GENOMICS_ENGLAND
      652	BMP4	0.422	0.808	C2677434	OROFACIAL CLEFT 11	disease	C16;C05;C07	Disease or Syndrome	0.71	1	1986	2009	   3	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
      652	BMP4	0.422	0.808	C3266076	Orofacial cleft	disease		Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
      652	BMP4	0.422	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      653	BMP5	0.653	0.577	C0152423	Congenital small ears	disease	C16;C09	Congenital Abnormality	0.31	1	2009	2009	   0	   0	GENOMICS_ENGLAND
      653	BMP5	0.653	0.577	C3850155	Congenital Microtia	disease	C16;C09	Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
      654	BMP6	0.531	0.808	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.31	1	2003	2010	   1	   0	CTD_human
      654	BMP6	0.531	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2012	2014	   0	   1	UNIPROT
      654	BMP6	0.531	0.808	C0018995	Hemochromatosis	disease	C16;C18	Disease or Syndrome	0.35	0.667	2009	2019	   2	   0	CTD_human
      654	BMP6	0.531	0.808	C0023493	Adult T-Cell Lymphoma/Leukemia	disease	C04;C20;C15	Neoplastic Process	0.31	1	2008	2008	   1	   0	CTD_human
      654	BMP6	0.531	0.808	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.31	1	2010	2018	   1	   0	CTD_human
      654	BMP6	0.531	0.808	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      654	BMP6	0.531	0.808	C0162820	Dermatitis, Allergic Contact	disease	C17;C20	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      654	BMP6	0.531	0.808	C0282193	Iron Overload	disease	C18	Disease or Syndrome	0.39	0.889	2009	2018	   1	   0	GENOMICS_ENGLAND
      654	BMP6	0.531	0.808	C0392514	Hereditary hemochromatosis	disease	C16;C18	Disease or Syndrome	0.33	1	2009	2017	   2	   0	CTD_human
      655	BMP7	0.498	0.769	C0005974	Bone Resorption	phenotype	C05	Organ or Tissue Function	0.30	1	2007	2007	   1	   0	CTD_human
      655	BMP7	0.498	0.769	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      655	BMP7	0.498	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2007	2007	   1	   0	CTD_human
      655	BMP7	0.498	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      655	BMP7	0.498	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.33	1	1998	2010	   2	   0	CTD_human
      655	BMP7	0.498	0.769	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.32	1	2008	2017	   1	   0	CTD_human
      655	BMP7	0.498	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      655	BMP7	0.498	0.769	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      655	BMP7	0.498	0.769	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      655	BMP7	0.498	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.37	1	2003	2018	   2	   0	CTD_human
      655	BMP7	0.498	0.769	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      655	BMP7	0.498	0.769	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      655	BMP7	0.498	0.769	C1968949	Cakut	disease	C16;C13;C12	Disease or Syndrome	0.30	1	1995	1995	   1	   0	GENOMICS_ENGLAND
      655	BMP7	0.498	0.769	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      657	BMPR1A	0.522	0.731	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.34	1	2015	2018	   0	   0	GENOMICS_ENGLAND
      657	BMPR1A	0.522	0.731	C0015393	Eye Abnormalities	group	C16;C11	Congenital Abnormality	0.30	1	2005	2005	   1	   0	CTD_human
      657	BMPR1A	0.522	0.731	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
      657	BMPR1A	0.522	0.731	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30				   0	   0	UNIPROT
      657	BMPR1A	0.522	0.731	C0345893	Juvenile polyposis syndrome	disease	C16;C06;C04	Neoplastic Process	1.00	0.978	1993	2019	  12	  49	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      657	BMPR1A	0.522	0.731	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2005	2005	   1	   0	CTD_human
      657	BMPR1A	0.522	0.731	C1720887	Female Urogenital Diseases	group	C13	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      657	BMPR1A	0.522	0.731	C1832587	POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	disease	C16;C06;C04	Disease or Syndrome	0.30	1	2006	2006	   1	   0	ORPHANET
      657	BMPR1A	0.522	0.731	C1832940	JUVENILE POLYPOSIS OF STOMACH	disease	C16;C06;C04	Disease or Syndrome	0.80	1	2001	2009	   5	   0	CLINGEN;CTD_human;ORPHANET
      657	BMPR1A	0.522	0.731	C1864730	Polyposis Syndrome, Hereditary Mixed, 2	disease	C16;C06;C04	Disease or Syndrome	0.50	1	2013	2013	   1	   0	CTD_human;GENOMICS_ENGLAND
      657	BMPR1A	0.522	0.731	C1868081	Juvenile Polyposis Coli	disease	C16;C06;C04	Disease or Syndrome	0.80	1	2001	2009	   5	   0	CLINGEN;CTD_human;ORPHANET
      657	BMPR1A	0.522	0.731	C2677290	COLORECTAL CANCER, SUSCEPTIBILITY TO, 4	phenotype		Finding	0.30	1	2006	2006	   1	   0	ORPHANET
      657	BMPR1A	0.522	0.731	C2677291	COLORECTAL CANCER, SUSCEPTIBILITY TO, ON CHROMOSOME 15	phenotype		Finding	0.30	1	2006	2006	   1	   0	ORPHANET
      657	BMPR1A	0.522	0.731	C3714239	Bmpr1a-Related Juvenile Polyposis	disease	C16;C06;C04	Disease or Syndrome	0.30				   0	   0	CTD_human
      657	BMPR1A	0.522	0.731	C3714240	Smad4-Related Juvenile Polyposis	disease	C16;C06;C04	Disease or Syndrome	0.30				   0	   0	CTD_human
      657	BMPR1A	0.522	0.731	C3896578	Familial Colorectal Cancer Type X	disease	C16;C06;C04;C18	Neoplastic Process	0.31	1	2011	2018	   1	   0	ORPHANET
      658	BMPR1B	0.573	0.615	C0005941	Bone Diseases, Developmental	group	C05	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      658	BMPR1B	0.573	0.615	C0015393	Eye Abnormalities	group	C16;C11	Congenital Abnormality	0.30	1	2005	2005	   1	   0	CTD_human
      658	BMPR1B	0.573	0.615	C0025322	Premature Menopause	disease	C13	Disease or Syndrome	0.31	1	2005	2020	   1	   0	GENOMICS_ENGLAND
      658	BMPR1B	0.573	0.615	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2007	2007	   1	   0	CTD_human
      658	BMPR1B	0.573	0.615	C0152171	Idiopathic pulmonary hypertension	disease	C08;C14	Disease or Syndrome	0.32	1	2004	2012	   1	   0	GENOMICS_ENGLAND
      658	BMPR1B	0.573	0.615	C0265260	Chondrodysplasia, Grebe type	disease	C16;C05	Disease or Syndrome	0.31	1	2014	2015	   1	   0	ORPHANET
      658	BMPR1B	0.573	0.615	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
      658	BMPR1B	0.573	0.615	C0278883	Metastatic melanoma	disease	C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      658	BMPR1B	0.573	0.615	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2007	2012	   1	   0	CTD_human
      658	BMPR1B	0.573	0.615	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2005	2005	   1	   0	CTD_human
      658	BMPR1B	0.573	0.615	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
      658	BMPR1B	0.573	0.615	C1300268	Brachydactyly syndrome type C	disease	C16;C05;C19	Disease or Syndrome	0.30	1	2006	2006	   1	   0	ORPHANET
      658	BMPR1B	0.573	0.615	C1832702	BRACHYDACTYLY, TYPE A2	disease	C16;C05	Congenital Abnormality	0.76	0.875	2003	2014	   3	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      658	BMPR1B	0.573	0.615	C1836182	Chondrodysplasia, acromesomelic, with genital anomalies	disease	C16;C13;C05;C19	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      658	BMPR1B	0.573	0.615	C1856738	Fibular hypoplasia and complex brachydactyly	disease	C16;C05	Disease or Syndrome	0.40	1	2015	2015	   1	   1	ORPHANET
      658	BMPR1B	0.573	0.615	C1862103	Brachydactyly type C	disease	C16;C05	Congenital Abnormality	0.41	1	2006	2006	   1	   0	ORPHANET
      658	BMPR1B	0.573	0.615	C1862151	BRACHYDACTYLY, TYPE A1 (disorder)	disease	C16;C05	Disease or Syndrome	0.31	1	2015	2015	   1	   0	ORPHANET
      658	BMPR1B	0.573	0.615	C2930970	Acromesomelic dysplasia Hunter-Thompson type	disease	C16;C05;C19	Congenital Abnormality	0.34	1	2015	2018	   1	   0	CTD_human
      658	BMPR1B	0.573	0.615	C3203102	Idiopathic pulmonary arterial hypertension	disease	C08	Disease or Syndrome	0.32	1	2004	2012	   1	   0	GENOMICS_ENGLAND
      658	BMPR1B	0.573	0.615	C4225183	BRACHYDACTYLY, TYPE A1, D	disease		Disease or Syndrome	0.70	1	2015	2015	   1	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
      658	BMPR1B	0.573	0.615	C4225404	ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE	disease		Disease or Syndrome	0.60	1	2005	2015	   3	   5	GENOMICS_ENGLAND;UNIPROT
      658	BMPR1B	0.573	0.615	C4317009	Diverticular Diseases	group	C06	Disease or Syndrome	0.40	1	2018	2018	   1	   1	CTD_human
      658	BMPR1B	0.573	0.615	C4505353	Diverticular Bleeding	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      659	BMPR2	0.538	0.654	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	1	2007	2015	   1	   0	CTD_human
      659	BMPR2	0.538	0.654	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.37	1	2001	2013	   9	   0	CTD_human
      659	BMPR2	0.538	0.654	C0034091	Pulmonary Veno-Occlusive Disease (disorder)	disease	C08;C14	Disease or Syndrome	0.72	1	2003	2016	   3	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
      659	BMPR2	0.538	0.654	C0152171	Idiopathic pulmonary hypertension	disease	C08;C14	Disease or Syndrome	0.60	1	2000	2019	   1	   0	GENOMICS_ENGLAND
      659	BMPR2	0.538	0.654	C0206081	Hyperandrogenism	disease	C16;C13;C12;C19	Disease or Syndrome	0.31	1	2012	2012	   1	   0	CTD_human
      659	BMPR2	0.538	0.654	C0340543	Familial primary pulmonary hypertension	disease	C08	Disease or Syndrome	0.70	1	1997	2019	   4	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
      659	BMPR2	0.538	0.654	C0340544	Pulmonary arterial hypertension induced by drug	disease		Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
      659	BMPR2	0.538	0.654	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.33	1	2007	2015	   1	   0	CTD_human
      659	BMPR2	0.538	0.654	C1150929	2-oxo-hept-3-ene-1,7-dioate hydratase activity	phenotype		Molecular Function	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      659	BMPR2	0.538	0.654	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      659	BMPR2	0.538	0.654	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2003	2013	   1	   0	CTD_human
      659	BMPR2	0.538	0.654	C1701939	Familial pulmonary arterial hypertension	disease		Disease or Syndrome	0.40	1	2005	2018	   2	   0	ORPHANET
      659	BMPR2	0.538	0.654	C1969342	PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED	disease	C08	Disease or Syndrome	0.40	1	2002	2014	   1	   3	CTD_human
      659	BMPR2	0.538	0.654	C1969343	Pulmonary Hypertension, Primary, Fenfluramine-Associated	disease	C08	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      659	BMPR2	0.538	0.654	C2973725	Pulmonary arterial hypertension	disease	C08;C14	Disease or Syndrome	0.50	0.927	2002	2020	   1	  47	GENOMICS_ENGLAND
      659	BMPR2	0.538	0.654	C3203102	Idiopathic pulmonary arterial hypertension	disease	C08	Disease or Syndrome	0.70	0.978	2000	2020	   2	   0	CTD_human;GENOMICS_ENGLAND
      659	BMPR2	0.538	0.654	C3714844	Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia	disease	C08	Disease or Syndrome	0.40	1	2014	2014	   1	   1	CTD_human
      659	BMPR2	0.538	0.654	C3806932	PULMONARY VENOOCCLUSIVE DISEASE 1	disease		Finding	0.40				   0	   4	GENOMICS_ENGLAND
      659	BMPR2	0.538	0.654	C3887658	PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT	disease	C08;C14	Disease or Syndrome	0.43	1	2003	2016	   1	   2	GENOMICS_ENGLAND
      659	BMPR2	0.538	0.654	C4552070	Pulmonary Hypertension, Primary, 1	disease	C08	Disease or Syndrome	0.70	1	2000	2018	  12	 308	CTD_human;GENOMICS_ENGLAND;UNIPROT
      659	BMPR2	0.538	0.654	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      660	BMX	0.663	0.385	C0345958	Large cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30				   0	   1	UNIPROT
      664	BNIP3	0.52	0.731	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.31	1	2005	2006	   1	   0	CTD_human
      664	BNIP3	0.52	0.731	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.33	1	2005	2009	   1	   0	CTD_human
      664	BNIP3	0.52	0.731	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2008	2008	   1	   0	CTD_human
      664	BNIP3	0.52	0.731	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      664	BNIP3	0.52	0.731	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2008	2013	   1	   0	CTD_human
      664	BNIP3	0.52	0.731	C0677050	Manganese Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
      664	BNIP3	0.52	0.731	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      667	DST	0.552	0.846	C0079298	Epidermolysis Bullosa Simplex	disease	C16;C17	Disease or Syndrome	0.32	1	1991	2017	   2	   0	GENOMICS_ENGLAND
      667	DST	0.552	0.846	C1832926	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE (disorder)	disease	C16;C17	Disease or Syndrome	0.32	1	2010	2015	   0	   0	CTD_human
      667	DST	0.552	0.846	C3539003	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI	disease		Disease or Syndrome	0.71	1	2010	2017	   2	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET
      667	DST	0.552	0.846	C3809470	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 2	disease		Disease or Syndrome	0.60	1	2010	2015	   3	   6	GENOMICS_ENGLAND;ORPHANET
      668	FOXL2	0.542	0.692	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2007	2017	   1	   0	CTD_human
      668	FOXL2	0.542	0.692	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      668	FOXL2	0.542	0.692	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
      668	FOXL2	0.542	0.692	C0220663	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS (disorder)	disease	C16;C13;C11;C17;C12	Disease or Syndrome	1.00	1	1995	2020	  13	  90	CTD_human;GENOMICS_ENGLAND;UNIPROT
      668	FOXL2	0.542	0.692	C0334401	Malignant Granulosa Cell Tumor	disease	C04;C13;C19	Neoplastic Process	0.30	1	2009	2009	   1	   0	ORPHANET
      668	FOXL2	0.542	0.692	C1332218	Adult Type Ovarian Granulosa Cell Tumor	disease	C04;C13;C19	Neoplastic Process	0.32	1	2010	2011	   0	   0	CGI
      668	FOXL2	0.542	0.692	C1370419	Ovarian Granulosa Cell Tumor	disease	C04;C13;C19	Neoplastic Process	0.34	0.75	2010	2014	   0	   0	CGI
      668	FOXL2	0.542	0.692	C1567257	Granulosa Cell Cancer	disease	C04;C13;C19	Neoplastic Process	0.30	1	2009	2009	   1	   0	ORPHANET
      668	FOXL2	0.542	0.692	C1837008	PREMATURE OVARIAN FAILURE 3 (disorder)	disease	C13;C19	Disease or Syndrome	0.70	1	2002	2009	   2	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
      668	FOXL2	0.542	0.692	C1862262	Bpes With Ovarian Failure	disease	C16;C11;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      668	FOXL2	0.542	0.692	C1862263	Bpes Without Ovarian Failure	disease	C16;C11;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      668	FOXL2	0.542	0.692	C1862264	Bpes With Duane Retraction Syndrome	disease	C16;C11;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      668	FOXL2	0.542	0.692	C1970106	Bpes, Type I, Autosomal Recessive	disease	C16;C11;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      668	FOXL2	0.542	0.692	C2931135	Blepharophimosis syndrome type 1	disease	C16;C13;C11;C17	Disease or Syndrome	0.40	1	2005	2011	   3	  10	CTD_human
      668	FOXL2	0.542	0.692	C3714208	Blepharophimosis, Ptosis, and Epicanthus Inversus Type II	disease	C16;C13;C11;C17;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
      669	BPGM	0.821	0.154	C1291620	Deficiency of bisphosphoglycerate mutase	disease	C16;C18	Disease or Syndrome	0.70	1	1989	2004	   3	   3	CTD_human;ORPHANET;UNIPROT
      672	BRCA1	0.367	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	1.00	0.956	1992	2020	  34	 160	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
      672	BRCA1	0.367	0.923	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.60	0.968	1993	2020	   1	   0	CGI;CTD_human
      672	BRCA1	0.367	0.923	C0007097	Carcinoma	group	C04	Neoplastic Process	0.40	0.975	1996	2020	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0007112	Adenocarcinoma of prostate	disease	C04;C12	Neoplastic Process	0.30				   0	   0	CGI
      672	BRCA1	0.367	0.923	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.31	1	2012	2013	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.35	1	1998	2016	   5	   0	PSYGENET
      672	BRCA1	0.367	0.923	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.35	1	1998	2016	   5	   0	PSYGENET
      672	BRCA1	0.367	0.923	C0015625	Fanconi Anemia	disease	C16;C18;C15	Disease or Syndrome	0.60	1	2001	2020	   4	   0	GENOMICS_ENGLAND;ORPHANET
      672	BRCA1	0.367	0.923	C0023465	Acute monocytic leukemia	disease	C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      672	BRCA1	0.367	0.923	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.33	1	2002	2017	   1	   0	GENOMICS_ENGLAND
      672	BRCA1	0.367	0.923	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.50	1	2002	2012	   2	   0	CTD_human
      672	BRCA1	0.367	0.923	C0026636	Mouth Diseases	group	C07	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0027651	Neoplasms	group	C04	Neoplastic Process	0.50	0.964	1993	2020	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0029925	Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.50	0.978	1993	2019	   0	   0	CGI
      672	BRCA1	0.367	0.923	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.62	1	2005	2015	   1	   0	CGI;CTD_human
      672	BRCA1	0.367	0.923	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.40	1	1998	2013	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
      672	BRCA1	0.367	0.923	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.31	1	2004	2004	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.31	1	2002	2017	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.31	1	2002	2008	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.40	1	1997	2020	   0	   0	CGI
      672	BRCA1	0.367	0.923	C0265219	Miller Dieker syndrome	disease	C16;C10	Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      672	BRCA1	0.367	0.923	C0333704	Chromosome Breaks	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0346153	Breast Cancer, Familial	disease	C04;C17	Neoplastic Process	0.40	0.946	1993	2019	   3	   0	ORPHANET
      672	BRCA1	0.367	0.923	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.60	1	1997	2020	   1	   0	CGI;CTD_human
      672	BRCA1	0.367	0.923	C0347284	Benign tumor of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30				   0	   0	CGI
      672	BRCA1	0.367	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.50	0.928	1995	2020	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0376628	Chromosome Breakage	phenotype	C23	Cell or Molecular Dysfunction	0.40	1	2005	2005	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C0496920	Neoplasm of uncertain or unknown behavior of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
      672	BRCA1	0.367	0.923	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
      672	BRCA1	0.367	0.923	C0677776	Hereditary Breast and Ovarian Cancer Syndrome	disease	C16;C04;C13;C17;C19	Neoplastic Process	0.80	0.986	1990	2020	   5	 873	CTD_human;GENOMICS_ENGLAND;ORPHANET
      672	BRCA1	0.367	0.923	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.70	0.955	1992	2020	  12	   5	CGI;CTD_human
      672	BRCA1	0.367	0.923	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.33	1	2004	2008	   0	   0	CGI
      672	BRCA1	0.367	0.923	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.70	0.965	1992	2020	   5	  67	CGI;CTD_human
      672	BRCA1	0.367	0.923	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.80	0.965	1992	2020	   9	  15	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
      672	BRCA1	0.367	0.923	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      672	BRCA1	0.367	0.923	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	1994	2017	  12	   0	CTD_human
      672	BRCA1	0.367	0.923	C1336076	Sporadic Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.97	1994	2019	   0	   1	UNIPROT
      672	BRCA1	0.367	0.923	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.50	0.976	1976	2019	  12	  58	CTD_human
      672	BRCA1	0.367	0.923	C1514428	Primary peritoneal carcinoma	disease	C06;C04	Neoplastic Process	0.50	1	1995	2017	   1	   0	ORPHANET
      672	BRCA1	0.367	0.923	C2676676	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	disease		Finding	0.70	1	1976	2019	  16	2258	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      672	BRCA1	0.367	0.923	C2676677	BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	phenotype		Finding	0.30	1	1994	2005	  10	   0	CLINGEN
      672	BRCA1	0.367	0.923	C2676678	OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	phenotype		Finding	0.30	1	1994	2005	  10	   0	CLINGEN
      672	BRCA1	0.367	0.923	C2931038	Pancreatic carcinoma, familial	disease	C06;C04;C19	Neoplastic Process	0.32	1	2009	2015	   1	   0	ORPHANET
      672	BRCA1	0.367	0.923	C2931456	Prostate cancer, familial	disease	C04;C12	Neoplastic Process	0.36	1	1999	2017	   2	   0	ORPHANET
      672	BRCA1	0.367	0.923	C3280442	PANCREATIC CANCER, SUSCEPTIBILITY TO, 4	disease		Finding	0.40	1	2003	2018	   2	  22	GENOMICS_ENGLAND
      672	BRCA1	0.367	0.923	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.40	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      672	BRCA1	0.367	0.923	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40				   0	   0	GENOMICS_ENGLAND
      672	BRCA1	0.367	0.923	C3842001	Adult only	phenotype		Finding	0.30				   0	   0	GENOMICS_ENGLAND
      672	BRCA1	0.367	0.923	C4225275	MENTAL RETARDATION, AUTOSOMAL DOMINANT 40	disease		Disease or Syndrome	0.30	1	2003	2003	   1	   0	GENOMICS_ENGLAND
      672	BRCA1	0.367	0.923	C4554406	FANCONI ANEMIA, COMPLEMENTATION GROUP S	disease		Disease or Syndrome	0.70	1	2013	2019	   7	  28	CLINGEN;GENOMICS_ENGLAND;UNIPROT
      672	BRCA1	0.367	0.923	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	1994	2017	  12	   0	CTD_human
      672	BRCA1	0.367	0.923	C4749652	Hereditary site-specific ovarian cancer syndrome	disease		Disease or Syndrome	0.30	1	2005	2005	   1	   0	ORPHANET
      673	BRAF	0.319	0.846	C0002448	Ameloblastoma	disease	C04	Neoplastic Process	0.40	0.955	2014	2019	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0004114	Astrocytoma	disease	C04	Neoplastic Process	0.40	1	2008	2019	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0004565	Melanoma, B16	disease	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2018	2018	   2	   0	CTD_human
      673	BRAF	0.319	0.846	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.50	1	2010	2019	   0	   3	CGI
      673	BRAF	0.319	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	2007	2020	   0	   0	CGI
      673	BRAF	0.319	0.846	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.982	2002	2020	   0	   0	CGI
      673	BRAF	0.319	0.846	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.40	0.971	2003	2019	   0	   2	UNIPROT
      673	BRAF	0.319	0.846	C0007112	Adenocarcinoma of prostate	disease	C04;C12	Neoplastic Process	0.43	0.75	2006	2016	   0	   6	CGI
      673	BRAF	0.319	0.846	C0007115	Malignant neoplasm of thyroid	disease	C04;C19	Neoplastic Process	0.40	0.994	2003	2019	   0	   0	CGI
      673	BRAF	0.319	0.846	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.50	1	2002	2020	   0	  15	CGI
      673	BRAF	0.319	0.846	C0009075	Melanoma, Cloudman S91	disease	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2018	2018	   2	   0	CTD_human
      673	BRAF	0.319	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.70	0.976	2002	2020	   8	   5	CTD_human;UNIPROT
      673	BRAF	0.319	0.846	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.50	0.978	2002	2019	   4	  10	CTD_human
      673	BRAF	0.319	0.846	C0010276	Craniopharyngioma	disease	C04	Neoplastic Process	0.60	1	2014	2019	   1	   0	CTD_human;ORPHANET
      673	BRAF	0.319	0.846	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.40	1	2017	2017	   1	   1	CTD_human
      673	BRAF	0.319	0.846	C0017638	Glioma	disease	C04	Neoplastic Process	0.60	1	2005	2020	   1	   0	CGI;CTD_human
      673	BRAF	0.319	0.846	C0018598	Melanoma, Harding-Passey	disease	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2018	2018	   2	   0	CTD_human
      673	BRAF	0.319	0.846	C0019621	Histiocytosis, Langerhans-Cell	disease	C08;C15	Neoplastic Process	0.80	1	2010	2019	   1	   0	CGI;ORPHANET
      673	BRAF	0.319	0.846	C0022665	Kidney Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.34	1	2011	2017	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0023418	leukemia	disease	C04	Neoplastic Process	0.49	1	1995	2018	   0	   1	GENOMICS_ENGLAND
      673	BRAF	0.319	0.846	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.47	0.9	2007	2019	   0	   6	CGI
      673	BRAF	0.319	0.846	C0023443	Hairy Cell Leukemia	disease	C04;C20;C15	Neoplastic Process	0.60	0.938	2011	2020	   2	   0	CGI;ORPHANET
      673	BRAF	0.319	0.846	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.43	1	2011	2015	   0	   1	CGI
      673	BRAF	0.319	0.846	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.33	1	2003	2015	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.55	1	2004	2017	   0	   0	CGI;CTD_human
      673	BRAF	0.319	0.846	C0024232	Lymphatic Metastasis	disease	C23;C04	Neoplastic Process	0.31	1	2018	2018	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.37	0.857	2012	2018	   0	   0	GENOMICS_ENGLAND
      673	BRAF	0.319	0.846	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.32	1	2003	2017	   0	   0	CGI
      673	BRAF	0.319	0.846	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.38	1	2003	2018	   0	   0	CGI
      673	BRAF	0.319	0.846	C0024694	Mandibular Neoplasms	group	C04;C05;C07	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	1.00	0.983	1986	2020	  24	  31	CGI;CTD_human;UNIPROT
      673	BRAF	0.319	0.846	C0025205	Melanoma, Experimental	disease	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2018	2018	   2	   0	CTD_human
      673	BRAF	0.319	0.846	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.50	0.944	2003	2019	   0	  11	CGI
      673	BRAF	0.319	0.846	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0027962	Melanocytic nevus	disease	C04	Neoplastic Process	0.50	0.892	2003	2019	   1	   1	GENOMICS_ENGLAND
      673	BRAF	0.319	0.846	C0028326	Noonan Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.77	1	2003	2019	   8	  18	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
      673	BRAF	0.319	0.846	C0029925	Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.34	1	2003	2014	   0	   0	CGI
      673	BRAF	0.319	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.32	1	2006	2018	   2	   0	CTD_human
      673	BRAF	0.319	0.846	C0036920	Sezary Syndrome	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	2003	2007	   0	   0	CGI
      673	BRAF	0.319	0.846	C0040136	Thyroid Neoplasm	disease	C04;C19	Neoplastic Process	0.70	0.99	2003	2020	   6	   3	CGI;CTD_human
      673	BRAF	0.319	0.846	C0041409	Turner Syndrome, Male	disease	C16;C17;C05;C14	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0151468	Thyroid Gland Follicular Adenoma	disease	C04;C19	Neoplastic Process	0.36	1	2003	2019	   6	   0	CTD_human
      673	BRAF	0.319	0.846	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.50	0.979	2003	2020	   0	  12	CGI
      673	BRAF	0.319	0.846	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.70	1	2002	2019	   2	  14	CGI;CTD_human
      673	BRAF	0.319	0.846	C0153633	Malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.34	1	2011	2019	   0	   0	CGI
      673	BRAF	0.319	0.846	C0153943	Benign neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      673	BRAF	0.319	0.846	C0154060	Carcinoma in situ of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      673	BRAF	0.319	0.846	C0175704	LEOPARD Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.65	1	2009	2017	   6	   2	CLINGEN;GENOMICS_ENGLAND
      673	BRAF	0.319	0.846	C0205768	Subependymal Giant Cell Astrocytoma	disease	C04	Neoplastic Process	0.31	0.5	2013	2015	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0206686	Adrenocortical carcinoma	disease	C04;C19	Neoplastic Process	0.42	1	2009	2016	   1	   2	CTD_human
      673	BRAF	0.319	0.846	C0206698	Cholangiocarcinoma	disease	C04	Neoplastic Process	0.39	1	2003	2019	   0	   0	CGI
      673	BRAF	0.319	0.846	C0206754	Neuroendocrine Tumors	group	C04	Neoplastic Process	0.37	0.875	2005	2019	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.37	1	2003	2020	   0	   0	CGI
      673	BRAF	0.319	0.846	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.50	1	2002	2019	   0	   1	CGI
      673	BRAF	0.319	0.846	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.90	0.968	2003	2020	   8	   1	CTD_human;ORPHANET
      673	BRAF	0.319	0.846	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.60	1	2002	2020	   0	   0	CGI;CTD_human
      673	BRAF	0.319	0.846	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0278600	Childhood Brain Stem Glioma	disease		Neoplastic Process	0.30				   0	   0	CGI
      673	BRAF	0.319	0.846	C0278875	Adult Craniopharyngioma	disease	C04	Neoplastic Process	0.35	1	2014	2019	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0280783	Juvenile Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.31	1	2010	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0280785	Diffuse Astrocytoma	disease	C04	Neoplastic Process	0.33	1	2009	2016	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0334579	Anaplastic astrocytoma	disease	C04	Neoplastic Process	0.51	1	2013	2015	   1	   0	CGI;CTD_human
      673	BRAF	0.319	0.846	C0334580	Protoplasmic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0334581	Gemistocytic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0334582	Fibrillary Astrocytoma	disease	C04	Neoplastic Process	0.31	1	2013	2014	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0334583	Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.60	0.957	2008	2020	   1	   0	CGI;CTD_human
      673	BRAF	0.319	0.846	C0338070	Childhood Cerebral Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.32	1	2007	2018	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.36	1	2006	2018	   2	   0	CTD_human
      673	BRAF	0.319	0.846	C0376407	Granulomatous Slack Skin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0406803	Syringocystadenoma Papilliferum	disease	C04	Neoplastic Process	0.33	1	2009	2019	   1	   0	GENOMICS_ENGLAND
      673	BRAF	0.319	0.846	C0431128	Papillary craniopharyngioma	disease	C04	Neoplastic Process	0.40	1	2014	2019	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0431129	Adamantinous Craniopharyngioma	disease	C04	Neoplastic Process	0.36	1	2014	2019	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0496905	Neoplasm of uncertain or unknown behavior of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      673	BRAF	0.319	0.846	C0496920	Neoplasm of uncertain or unknown behavior of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
      673	BRAF	0.319	0.846	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
      673	BRAF	0.319	0.846	C0547065	Mixed oligoastrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.60	0.99	2003	2019	   6	   0	CGI;CTD_human
      673	BRAF	0.319	0.846	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.34	1	2013	2019	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0587248	Costello syndrome (disorder)	disease	C16;C05	Disease or Syndrome	0.54	1	2006	2016	   2	   0	CLINGEN;CTD_human
      673	BRAF	0.319	0.846	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.40	0.924	2003	2020	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	2007	2020	   0	   0	CGI
      673	BRAF	0.319	0.846	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.70	1	2002	2019	   1	  12	CGI;UNIPROT
      673	BRAF	0.319	0.846	C0699790	Colon Carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.978	2003	2019	   0	   0	CGI
      673	BRAF	0.319	0.846	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.36	1	2003	2018	   0	   0	CGI
      673	BRAF	0.319	0.846	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.31	1	2003	2011	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0750935	Cerebral Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0750936	Intracranial Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0751061	Craniopharyngioma, Child	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.31	0	2019	2019	   0	   0	CGI
      673	BRAF	0.319	0.846	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      673	BRAF	0.319	0.846	C0878675	Erdheim-Chester Disease	disease	C15	Disease or Syndrome	0.40	1	2012	2020	   0	   0	CGI
      673	BRAF	0.319	0.846	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.50	0.958	2002	2019	   0	   3	CGI
      673	BRAF	0.319	0.846	C0920269	Microsatellite Instability	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.60	0.941	2003	2019	   0	   1	CGI;UNIPROT
      673	BRAF	0.319	0.846	C1266158	Nongerminomatous Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.40				   0	   1	CGI
      673	BRAF	0.319	0.846	C1275081	Cardio-facio-cutaneous syndrome	disease	C23;C16;C17;C14	Congenital Abnormality	1.00	0.972	2003	2019	  14	  48	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      673	BRAF	0.319	0.846	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.60	1	2011	2019	   0	   3	CGI;UNIPROT
      673	BRAF	0.319	0.846	C1519086	Pilomyxoid astrocytoma	disease	C04	Neoplastic Process	0.33	0.833	2008	2016	   3	   0	ORPHANET
      673	BRAF	0.319	0.846	C1527404	Female Pseudo-Turner Syndrome	disease	C16;C17;C05;C14	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C1704230	Grade I Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C1721098	Replication Error Phenotype	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C1843181	Noonan syndrome-like disorder with loose anagen hair	disease	C23;C17	Disease or Syndrome	0.30				   0	   0	CLINGEN
      673	BRAF	0.319	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.38	1	2003	2019	   1	   0	CTD_human
      673	BRAF	0.319	0.846	C3150970	NOONAN SYNDROME 7	disease		Disease or Syndrome	0.70	1	2006	2017	   5	   8	CTD_human;GENOMICS_ENGLAND;UNIPROT
      673	BRAF	0.319	0.846	C3150971	LEOPARD SYNDROME 3	disease		Disease or Syndrome	0.70	1	2006	2013	   4	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
      673	BRAF	0.319	0.846	C3501843	Nonmedullary Thyroid Carcinoma	disease	C04;C19	Neoplastic Process	0.30	1	2016	2017	   2	   0	CTD_human
      673	BRAF	0.319	0.846	C3501844	Familial Nonmedullary Thyroid Cancer	disease	C04;C19	Neoplastic Process	0.31	1	2005	2017	   2	   0	CTD_human
      673	BRAF	0.319	0.846	C3501846	Noonan-Like Syndrome With Loose Anagen Hair	disease	C23;C16;C17;C05;C14	Disease or Syndrome	0.30				   0	   0	CLINGEN
      673	BRAF	0.319	0.846	C4551484	Leopard Syndrome 1	disease	C16;C17;C05;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	GENOMICS_ENGLAND
      673	BRAF	0.319	0.846	C4551602	Noonan Syndrome 1	disease	C16;C17;C05;C14	Disease or Syndrome	0.40	1	2007	2007	   1	   8	CTD_human
      673	BRAF	0.319	0.846	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.42	1	2003	2017	   1	   3	UNIPROT
      673	BRAF	0.319	0.846	C4733333	familial non-medullary thyroid cancer	disease	C16;C04	Neoplastic Process	0.31	1	2012	2015	   1	   0	GENOMICS_ENGLAND
      675	BRCA2	0.379	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
      675	BRCA2	0.379	0.846	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.31	1	2019	2019	   0	   1	UNIPROT
      675	BRCA2	0.379	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	1.00	0.951	1994	2020	  30	 174	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
      675	BRCA2	0.379	0.846	C0007112	Adenocarcinoma of prostate	disease	C04;C12	Neoplastic Process	0.30				   0	   0	CGI
      675	BRCA2	0.379	0.846	C0015625	Fanconi Anemia	disease	C16;C18;C15	Disease or Syndrome	0.50	0.97	1998	2019	   3	   1	GENOMICS_ENGLAND
      675	BRCA2	0.379	0.846	C0017638	Glioma	disease	C04	Neoplastic Process	0.30				   0	   0	CTD_human
      675	BRCA2	0.379	0.846	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.60	1	2014	2014	   1	   0	CGI;CTD_human
      675	BRCA2	0.379	0.846	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.63	1	2003	2018	   3	  22	CTD_human;GENOMICS_ENGLAND
      675	BRCA2	0.379	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	0.50	0.87	1996	2019	   0	   3	UNIPROT
      675	BRCA2	0.379	0.846	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	Neoplastic Process	0.72	1	2005	2018	   4	  22	CTD_human;GENOMICS_ENGLAND;ORPHANET
      675	BRCA2	0.379	0.846	C0029925	Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.50	0.947	1998	2018	   0	   0	CGI
      675	BRCA2	0.379	0.846	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.65	0.857	2003	2017	   2	   0	CGI;CTD_human
      675	BRCA2	0.379	0.846	C0030312	Pancytopenia	disease	C15	Disease or Syndrome	0.31	1	2017	2018	   1	   0	GENOMICS_ENGLAND
      675	BRCA2	0.379	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.58	1	2000	2018	   1	   0	CTD_human
      675	BRCA2	0.379	0.846	C0205833	Medullomyoblastoma	disease	C04	Neoplastic Process	0.30				   0	   0	CTD_human
      675	BRCA2	0.379	0.846	C0206720	Squamous Cell Neoplasms	group	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      675	BRCA2	0.379	0.846	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.40	0.986	1995	2019	   0	   0	CGI
      675	BRCA2	0.379	0.846	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.80	0.833	2007	2018	   1	   1	CGI;CTD_human;UNIPROT
      675	BRCA2	0.379	0.846	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30				   0	   0	CTD_human
      675	BRCA2	0.379	0.846	C0265219	Miller Dieker syndrome	disease	C16;C10	Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      675	BRCA2	0.379	0.846	C0278510	Childhood Medulloblastoma	disease	C04	Neoplastic Process	0.33	1	2003	2011	   0	   0	CTD_human
      675	BRCA2	0.379	0.846	C0278876	Adult Medulloblastoma	disease	C04	Neoplastic Process	0.33	1	2003	2011	   0	   0	CTD_human
      675	BRCA2	0.379	0.846	C0346153	Breast Cancer, Familial	disease	C04;C17	Neoplastic Process	0.40	0.961	1995	2019	   3	   0	ORPHANET
      675	BRCA2	0.379	0.846	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.80	0.988	1996	2019	   2	   4	CGI;CTD_human;UNIPROT
      675	BRCA2	0.379	0.846	C0347284	Benign tumor of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30				   0	   0	CGI
      675	BRCA2	0.379	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.90	0.948	1996	2020	   5	  24	CTD_human;GENOMICS_ENGLAND
      675	BRCA2	0.379	0.846	C0496920	Neoplasm of uncertain or unknown behavior of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
      675	BRCA2	0.379	0.846	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
      675	BRCA2	0.379	0.846	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.30				   0	   0	CTD_human
      675	BRCA2	0.379	0.846	C0677776	Hereditary Breast and Ovarian Cancer Syndrome	disease	C16;C04;C13;C17;C19	Neoplastic Process	0.80	0.993	1990	2020	   4	1160	CTD_human;GENOMICS_ENGLAND;ORPHANET
      675	BRCA2	0.379	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.70	0.95	1994	2020	   3	   9	CGI;CTD_human
      675	BRCA2	0.379	0.846	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.50	0.846	2000	2018	   0	   2	CGI
      675	BRCA2	0.379	0.846	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.30				   0	   1	UNIPROT
      675	BRCA2	0.379	0.846	C0751291	Desmoplastic Medulloblastoma	disease	C04	Neoplastic Process	0.30				   0	   0	CTD_human
      675	BRCA2	0.379	0.846	C0751688	Malignant Squamous Cell Neoplasm	disease	C04	Neoplastic Process	0.31	1	2014	2018	   1	   0	CTD_human
      675	BRCA2	0.379	0.846	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
      675	BRCA2	0.379	0.846	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.90	0.947	1994	2020	   1	  38	CGI;CTD_human
      675	BRCA2	0.379	0.846	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.80	0.948	1994	2020	   1	  10	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
      675	BRCA2	0.379	0.846	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2017	   3	   0	CTD_human
      675	BRCA2	0.379	0.846	C1275668	Melanotic medulloblastoma	disease	C04	Neoplastic Process	0.30				   0	   0	CTD_human
      675	BRCA2	0.379	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.50	0.987	1995	2019	   3	  49	CTD_human
      675	BRCA2	0.379	0.846	C1838457	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	disease	C16;C18;C15	Disease or Syndrome	0.92	1	2002	2018	  14	  37	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      675	BRCA2	0.379	0.846	C1855710	Bone marrow hypocellularity	phenotype		Finding	0.40	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      675	BRCA2	0.379	0.846	C2675520	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	disease		Finding	0.70	1	1988	2019	  13	2632	CLINGEN;CTD_human;GENOMICS_ENGLAND
      675	BRCA2	0.379	0.846	C2675521	BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	phenotype		Finding	0.30	1	1996	2017	  10	   0	CLINGEN
      675	BRCA2	0.379	0.846	C2675522	OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	phenotype		Finding	0.30	1	1996	2017	  10	   0	CLINGEN
      675	BRCA2	0.379	0.846	C2751641	GLIOMA SUSCEPTIBILITY 3	disease		Finding	0.40	1	2007	2013	   2	  22	GENOMICS_ENGLAND
      675	BRCA2	0.379	0.846	C2930471	Bilateral Wilms Tumor	disease	C16;C04;C13;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
      675	BRCA2	0.379	0.846	C2931038	Pancreatic carcinoma, familial	disease	C06;C04;C19	Neoplastic Process	0.40	1	2001	2018	   1	   0	ORPHANET
      675	BRCA2	0.379	0.846	C2931456	Prostate cancer, familial	disease	C04;C12	Neoplastic Process	0.38	1	1998	2017	   1	   0	ORPHANET
      675	BRCA2	0.379	0.846	C3150546	PANCREATIC CANCER, SUSCEPTIBILITY TO, 2	disease		Finding	0.40	1	2007	2013	   2	  21	GENOMICS_ENGLAND
      675	BRCA2	0.379	0.846	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.41	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      675	BRCA2	0.379	0.846	C3842001	Adult only	phenotype		Finding	0.30				   0	   0	GENOMICS_ENGLAND
      675	BRCA2	0.379	0.846	C4228778	Abnormality of radial ray	phenotype		Finding	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      675	BRCA2	0.379	0.846	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2017	   3	   0	CTD_human
      675	BRCA2	0.379	0.846	C4749652	Hereditary site-specific ovarian cancer syndrome	disease		Disease or Syndrome	0.30	1	2005	2005	   1	   0	ORPHANET
      676	BRDT	0.751	0.231	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
      676	BRDT	0.751	0.231	C4539991	SPERMATOGENIC FAILURE 21	disease		Disease or Syndrome	0.30	1	2017	2017	   1	   1	UNIPROT
      678	ZFP36L2	0.686	0.5	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      678	ZFP36L2	0.686	0.5	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      678	ZFP36L2	0.686	0.5	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      678	ZFP36L2	0.686	0.5	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      678	ZFP36L2	0.686	0.5	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	0.5	2010	2017	   1	   0	CTD_human
      682	BSG	0.458	0.769	C0015697	Arterial Fatty Streak	phenotype	C23	Acquired Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
      682	BSG	0.458	0.769	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      682	BSG	0.458	0.769	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	0.974	2003	2020	   1	   0	CTD_human
      682	BSG	0.458	0.769	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
      682	BSG	0.458	0.769	C0264956	Atheroma	phenotype	C23	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      682	BSG	0.458	0.769	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      682	BSG	0.458	0.769	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      682	BSG	0.458	0.769	C2936350	Plaque, Atherosclerotic	phenotype	C23	Body Substance	0.30	1	2008	2008	   1	   0	CTD_human
      682	BSG	0.458	0.769	C2936351	Fibroatheroma	disease	C23	Acquired Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
      682	BSG	0.458	0.769	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      683	BST1	0.67	0.423	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      683	BST1	0.67	0.423	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.50	0.92	2009	2019	   1	   7	CTD_human
      685	BTC	0.644	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
      685	BTC	0.644	0.577	C0162568	Erythropoietic Protoporphyria	disease	C16;C06;C18;C17	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      685	BTC	0.644	0.577	C0349426	Ferrochelatase deficiency	disease	C16;C06;C18;C17	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      686	BTD	0.628	0.654	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      686	BTD	0.628	0.654	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2004	2004	   1	   0	CTD_human
      686	BTD	0.628	0.654	C0220754	Biotinidase Deficiency	disease	C16;C18	Disease or Syndrome	1.00	0.988	1993	2019	  13	 187	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      686	BTD	0.628	0.654	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      686	BTD	0.628	0.654	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      686	BTD	0.628	0.654	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.40				   0	   0	GENOMICS_ENGLAND
      686	BTD	0.628	0.654	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      686	BTD	0.628	0.654	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      686	BTD	0.628	0.654	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      687	KLF9	0.595	0.577	C0005910	Body Weight	phenotype	C23	Organism Attribute	0.30	1	2012	2012	   1	   0	CTD_human
      687	KLF9	0.595	0.577	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.33	1	2011	2019	   1	   0	CTD_human
      687	KLF9	0.595	0.577	C0040128	Thyroid Diseases	group	C19	Disease or Syndrome	0.31	1	2013	2017	   1	   0	CTD_human
      687	KLF9	0.595	0.577	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      687	KLF9	0.595	0.577	C1135196	Heart Failure, Diastolic	disease	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      688	KLF5	0.534	0.769	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.37	1	2003	2017	   1	   0	CTD_human
      688	KLF5	0.534	0.769	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.37	1	2003	2017	   1	   0	CTD_human
      688	KLF5	0.534	0.769	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.31	1	2011	2016	   1	   0	CTD_human
      688	KLF5	0.534	0.769	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.64	1	2011	2019	   1	   1	CTD_human;UNIPROT
      688	KLF5	0.534	0.769	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.41	1	2008	2019	   1	   1	CTD_human
      688	KLF5	0.534	0.769	C0024117	Chronic Obstructive Airway Disease	disease	C08	Disease or Syndrome	0.31	1	2019	2019	   1	   0	CTD_human
      688	KLF5	0.534	0.769	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      688	KLF5	0.534	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	PSYGENET
      688	KLF5	0.534	0.769	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.31	1	2016	2018	   1	   0	CTD_human
      688	KLF5	0.534	0.769	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.33	1	2009	2019	   1	   0	CTD_human
      688	KLF5	0.534	0.769	C1527303	Chronic Airflow Obstruction	disease	C08	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      688	KLF5	0.534	0.769	C2936380	Neointima	disease	C23	Acquired Abnormality	0.50	1	1999	2005	   1	   0	CTD_human
      688	KLF5	0.534	0.769	C2936381	Neointima Formation	phenotype	C23	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
      694	BTG1	0.564	0.692	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      694	BTG1	0.564	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2005	2005	   1	   0	CTD_human
      694	BTG1	0.564	0.692	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      694	BTG1	0.564	0.692	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      694	BTG1	0.564	0.692	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      694	BTG1	0.564	0.692	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      694	BTG1	0.564	0.692	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      695	BTK	0.464	0.808	C0001768	Agammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.50	1	1994	2020	   1	   1	CTD_human
      695	BTK	0.464	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.32	1	2013	2016	   0	   0	CGI
      695	BTK	0.464	0.808	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	0.982	2011	2020	   0	   0	CGI
      695	BTK	0.464	0.808	C0086438	Hypogammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.34	1	1993	2004	   1	   0	CTD_human
      695	BTK	0.464	0.808	C0221026	X-linked agammaglobulinemia	disease	C16;C20;C15	Disease or Syndrome	1.00	0.964	1975	2020	  27	  68	CTD_human;GENOMICS_ENGLAND;UNIPROT
      695	BTK	0.464	0.808	C0345958	Large cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30				   0	   0	UNIPROT
      695	BTK	0.464	0.808	C0472813	X-linked agammaglobulinemia with growth hormone deficiency	disease	C16;C05;C20;C10;C19;C15	Disease or Syndrome	0.70	1	1994	2017	   4	  17	CTD_human;GENOMICS_ENGLAND;ORPHANET
      695	BTK	0.464	0.808	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
      695	BTK	0.464	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.32	1	2013	2016	   0	   0	CGI
      695	BTK	0.464	0.808	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
      699	BUB1	0.528	0.731	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.70	1	2000	2018	   0	   4	CTD_human;UNIPROT
      699	BUB1	0.528	0.731	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2002	2002	   0	   0	CTD_human
      699	BUB1	0.528	0.731	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.31	1	2003	2003	   0	   0	UNIPROT
      699	BUB1	0.528	0.731	C1850343	Mosaic variegated aneuploidy syndrome 1	disease	C16	Disease or Syndrome	0.31	1	2013	2018	   1	   0	ORPHANET
      699	BUB1	0.528	0.731	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.33	1	2001	2019	   1	   0	CTD_human
      699	BUB1	0.528	0.731	C2931286	Warburton Anyane Yeboa syndrome	phenotype	C23;C16;C05;C10;F03;F01	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
      701	BUB1B	0.502	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.54	1	2002	2016	   0	   1	CTD_human;UNIPROT
      701	BUB1B	0.502	0.808	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.33	1	2002	2009	   0	   0	CTD_human
      701	BUB1B	0.502	0.808	C0018273	Growth Disorders	group	C23	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C0025958	Microcephaly	disease	C16;C05;C10	Congenital Abnormality	0.41	1	2004	2019	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C0027654	Embryonal Neoplasm	disease	C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C0027658	Neoplasms, Germ Cell and Embryonal	group	C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C0035412	Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.42	1	2006	2012	   0	   0	CGI
      701	BUB1B	0.502	0.808	C0205851	Germ cell tumor	disease	C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C0205852	Neoplasms, Embryonal and Mixed	disease	C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C0206656	Embryonal Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.32	1	2004	2006	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.33	1	2008	2018	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C0740345	Germ Cell Cancer	disease	C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C0751364	Cancer, Embryonal	phenotype	C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C0751365	Cancer, Embryonal and Mixed	disease	C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C1850343	Mosaic variegated aneuploidy syndrome 1	disease	C16	Disease or Syndrome	1.00	1	2004	2019	   6	  15	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      701	BUB1B	0.502	0.808	C1864389	PREMATURE CHROMATID SEPARATION TRAIT	disease		Disease or Syndrome	0.64	1	2006	2014	   1	   8	CTD_human;UNIPROT
      701	BUB1B	0.502	0.808	C1956147	Microlissencephaly	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.33	0.75	2002	2018	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C2931286	Warburton Anyane Yeboa syndrome	phenotype	C23;C16;C05;C10;F03;F01	Disease or Syndrome	0.30	1	2004	2004	   1	   0	ORPHANET
      701	BUB1B	0.502	0.808	C2931383	Chromosomal mosaicism due to mitotic instability	phenotype	C16	Cell or Molecular Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C3853041	Severe Congenital Microcephaly	disease	C16;C05;C10	Disease or Syndrome; Congenital Abnormality	0.30	1	2004	2004	   1	   0	CTD_human
      701	BUB1B	0.502	0.808	C4733331	mosaic variegated aneuploidy	disease	C16;C04	Disease or Syndrome	0.40	1	2006	2020	   0	   0	GENOMICS_ENGLAND
      706	TSPO	0.444	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2013	2019	   1	   0	PSYGENET
      706	TSPO	0.444	0.885	C0019147	Hepatic Coma	disease	C06;C18;C10	Disease or Syndrome	0.30	1	1998	1999	   2	   0	CTD_human
      706	TSPO	0.444	0.885	C0019151	Hepatic Encephalopathy	disease	C06;C18;C10	Disease or Syndrome	0.30	1	1998	1999	   2	   0	CTD_human
      706	TSPO	0.444	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      706	TSPO	0.444	0.885	C0745744	End Stage Liver Disease	disease	C06	Disease or Syndrome	0.31	1	1998	2003	   1	   0	CTD_human
      706	TSPO	0.444	0.885	C0751197	Fulminant Hepatic Failure with Cerebral Edema	disease	C06;C18;C10	Disease or Syndrome	0.30	1	1998	1999	   2	   0	CTD_human
      706	TSPO	0.444	0.885	C0751198	Hepatic Stupor	disease	C06;C18;C10	Disease or Syndrome	0.30	1	1998	1999	   2	   0	CTD_human
      706	TSPO	0.444	0.885	C2936476	Chronic Liver Failure	disease	C06	Disease or Syndrome	0.31	1	1998	2003	   1	   0	CTD_human
      708	C1QBP	0.569	0.692	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.36	1	2004	2019	   1	   0	CTD_human
      708	C1QBP	0.569	0.692	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.35	1	2004	2019	   1	   0	CTD_human
      708	C1QBP	0.569	0.692	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      708	C1QBP	0.569	0.692	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2011	2018	   1	   0	CTD_human
      708	C1QBP	0.569	0.692	C4540209	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33	disease		Disease or Syndrome	0.60	1	2017	2017	   1	   6	GENOMICS_ENGLAND;UNIPROT
      708	C1QBP	0.569	0.692	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      710	SERPING1	0.507	0.769	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
      710	SERPING1	0.507	0.769	C0019243	Angioedemas, Hereditary	disease	C16;C17;C20;C14	Disease or Syndrome	0.60	0.991	1971	2020	   7	   0	CTD_human;GENOMICS_ENGLAND
      710	SERPING1	0.507	0.769	C0021400	Influenza	disease	C01;C08	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      710	SERPING1	0.507	0.769	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.31	1	2016	2018	   1	   0	CTD_human
      710	SERPING1	0.507	0.769	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      710	SERPING1	0.507	0.769	C0024143	Lupus Nephritis	disease	C13;C17;C12;C20	Disease or Syndrome	0.30	1	1985	1985	   1	   0	CTD_human
      710	SERPING1	0.507	0.769	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      710	SERPING1	0.507	0.769	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      710	SERPING1	0.507	0.769	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.32	1	1989	2018	   1	   0	GENOMICS_ENGLAND
      710	SERPING1	0.507	0.769	C0398775	Hereditary C1 esterase inhibitor deficiency - deficient factor	disease	C16;C17;C20;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	ORPHANET
      710	SERPING1	0.507	0.769	C0398776	Hereditary C1 esterase inhibitor deficiency - dysfunctional factor	disease	C16;C17;C20;C14	Disease or Syndrome	0.40	1	2014	2014	   1	   5	ORPHANET
      710	SERPING1	0.507	0.769	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      710	SERPING1	0.507	0.769	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      710	SERPING1	0.507	0.769	C1852700	Complement Component 4, Partial Deficiency Of	disease	C16;C20	Disease or Syndrome	0.60	1	1995	1995	   1	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
      710	SERPING1	0.507	0.769	C1862892	Hereditary Angioedema Type II	disease	C17;C20;C14	Disease or Syndrome	0.50	1	1992	2014	   4	   0	CTD_human;ORPHANET
      710	SERPING1	0.507	0.769	C2717905	Hereditary Angioedema Types I and II	disease	C17;C20;C14	Disease or Syndrome	0.30	1	1992	2009	   3	   0	CTD_human
      710	SERPING1	0.507	0.769	C2717906	Hereditary Angioedema Type I	disease	C17;C20;C14	Disease or Syndrome	0.73	0.958	1988	2018	  19	  35	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      710	SERPING1	0.507	0.769	C2931758	Acquired angioedema	disease	C17;C20;C14	Disease or Syndrome	0.40	1	1989	2019	   2	   0	CTD_human
      710	SERPING1	0.507	0.769	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      710	SERPING1	0.507	0.769	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      710	SERPING1	0.507	0.769	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      712	C1QA	0.623	0.654	C0015230	Exanthema	phenotype	C17	Sign or Symptom	0.31	1	1996	2018	   1	   0	CTD_human
      712	C1QA	0.623	0.654	C0017661	IGA Glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.30	1	1996	2014	   2	   0	CTD_human
      712	C1QA	0.623	0.654	C0017662	Glomerulonephritis, Membranoproliferative	disease	C13;C12;C20	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
      712	C1QA	0.623	0.654	C0020951	Immune Complex Diseases	group	C20	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
      712	C1QA	0.623	0.654	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      712	C1QA	0.623	0.654	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.67	0.7	1996	2012	   1	   0	CTD_human
      712	C1QA	0.623	0.654	C0242380	Libman-Sacks Disease	disease	C17;C20	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
      712	C1QA	0.623	0.654	C0268742	Membranoproliferative Glomerulonephritis, Type I	disease	C13;C12;C20	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
      712	C1QA	0.623	0.654	C0268743	Membranoproliferative Glomerulonephritis, Type II	disease	C13;C12;C20	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
      712	C1QA	0.623	0.654	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      712	C1QA	0.623	0.654	C1720821	Membranoproliferative Glomerulonephritis, Type III	disease	C13;C12;C20	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
      712	C1QA	0.623	0.654	C3150902	C1q DEFICIENCY	disease		Disease or Syndrome	0.61	1	2012	2017	   1	   2	CTD_human;GENOMICS_ENGLAND
      712	C1QA	0.623	0.654	C3280742	SYSTEMIC LUPUS ERYTHEMATOSUS 16	disease		Disease or Syndrome	0.30	1	2004	2004	   1	   0	ORPHANET
      713	C1QB	0.711	0.538	C0003257	Antibody Deficiency Syndrome	disease	C20	Disease or Syndrome	0.30	1	1988	1988	   1	   0	CTD_human
      713	C1QB	0.711	0.538	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   1	UNIPROT
      713	C1QB	0.711	0.538	C0010093	Corpus Luteum Cyst	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      713	C1QB	0.711	0.538	C0017661	IGA Glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      713	C1QB	0.711	0.538	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.30	1	1988	1988	   1	   0	CTD_human
      713	C1QB	0.711	0.538	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      713	C1QB	0.711	0.538	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      713	C1QB	0.711	0.538	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.32	1	2002	2013	   1	   0	GENOMICS_ENGLAND
      713	C1QB	0.711	0.538	C0029927	Ovarian Cysts	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      713	C1QB	0.711	0.538	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
      713	C1QB	0.711	0.538	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      713	C1QB	0.711	0.538	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      713	C1QB	0.711	0.538	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.30	1	2002	2002	   1	   0	GENOMICS_ENGLAND
      713	C1QB	0.711	0.538	C3150902	C1q DEFICIENCY	disease		Disease or Syndrome	0.71	1	1997	2015	   2	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
      714	C1QC	0.751	0.423	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      714	C1QC	0.751	0.423	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
      714	C1QC	0.751	0.423	C3150902	C1q DEFICIENCY	disease		Disease or Syndrome	0.70	1	1996	1996	   1	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
      715	C1R	0.638	0.654	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      715	C1R	0.638	0.654	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.41	1	2011	2017	   1	   0	GENOMICS_ENGLAND
      715	C1R	0.638	0.654	C0030524	Paratuberculosis	disease	C01;C22	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      715	C1R	0.638	0.654	C0268347	Ehlers-Danlos Syndrome, Type VIII	disease	C16;C17;C15;C14	Disease or Syndrome	0.50	1	2016	2016	   1	   0	CTD_human;ORPHANET
      715	C1R	0.638	0.654	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      715	C1R	0.638	0.654	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      715	C1R	0.638	0.654	C4551499	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1	disease	C16;C17;C15;C14	Disease or Syndrome	0.60	1	2016	2017	   2	  12	GENOMICS_ENGLAND;UNIPROT
      716	C1S	0.705	0.462	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      716	C1S	0.705	0.462	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.40	1	2010	2010	   1	   0	GENOMICS_ENGLAND
      716	C1S	0.705	0.462	C0241910	Autoimmune Chronic Hepatitis	disease	C06;C20	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      716	C1S	0.705	0.462	C0268347	Ehlers-Danlos Syndrome, Type VIII	disease	C16;C17;C15;C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	ORPHANET
      716	C1S	0.705	0.462	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.30	1	2010	2010	   1	   0	GENOMICS_ENGLAND
      716	C1S	0.705	0.462	C0677607	Hashimoto Disease	disease	C19	Disease or Syndrome	0.40	1	2001	2001	   1	   0	CTD_human
      716	C1S	0.705	0.462	C1862892	Hereditary Angioedema Type II	disease	C17;C20;C14	Disease or Syndrome	0.30	1	1988	1988	   1	   0	CTD_human
      716	C1S	0.705	0.462	C2717905	Hereditary Angioedema Types I and II	disease	C17;C20;C14	Disease or Syndrome	0.30	1	1988	1988	   1	   0	CTD_human
      716	C1S	0.705	0.462	C2717906	Hereditary Angioedema Type I	disease	C17;C20;C14	Disease or Syndrome	0.30	1	1988	1988	   1	   0	CTD_human
      716	C1S	0.705	0.462	C3151078	Complement Component C1s Deficiency	disease	C16;C20	Disease or Syndrome	0.60	1	2010	2010	   1	   1	CTD_human;GENOMICS_ENGLAND
      716	C1S	0.705	0.462	C4310681	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2	disease		Disease or Syndrome	0.70	1	2016	2017	   2	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
      717	C2	0.617	0.692	C0011633	Dermatomyositis	disease	C17;C05;C10	Disease or Syndrome	0.31	1	1975	1987	   1	   0	CTD_human
      717	C2	0.617	0.692	C0017661	IGA Glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      717	C2	0.617	0.692	C0024131	Lupus Vulgaris	disease	C01;C17	Disease or Syndrome	0.30	1	1993	1993	   1	   0	GENOMICS_ENGLAND
      717	C2	0.617	0.692	C0024138	Lupus Erythematosus, Discoid	disease	C17	Disease or Syndrome	0.32	1	1976	1993	   2	   0	GENOMICS_ENGLAND
      717	C2	0.617	0.692	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.45	1	1976	2015	   1	   0	GENOMICS_ENGLAND
      717	C2	0.617	0.692	C0162823	Dermatitis, Irritant	disease	C17	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      717	C2	0.617	0.692	C0221056	Adult type dermatomyositis	disease	C17;C05;C10	Disease or Syndrome	0.31	1	1975	1987	   1	   0	CTD_human
      717	C2	0.617	0.692	C0242383	Age related macular degeneration	disease	C11	Disease or Syndrome	0.68	1	2006	2018	   1	   0	CTD_human;GENOMICS_ENGLAND
      717	C2	0.617	0.692	C0263666	Dermatomyositis, Childhood Type	disease	C17;C05;C10	Disease or Syndrome	0.30	1	1987	1987	   1	   0	CTD_human
      717	C2	0.617	0.692	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.33	1	1985	2010	   1	   0	GENOMICS_ENGLAND
      717	C2	0.617	0.692	C0409974	Lupus Erythematosus	disease	C23;C17;C20	Disease or Syndrome	0.30	1	1993	1993	   1	   0	GENOMICS_ENGLAND
      717	C2	0.617	0.692	C3150275	COMPLEMENT COMPONENT 2 DEFICIENCY	disease		Disease or Syndrome	0.77	0.9	1975	2010	   3	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
      717	C2	0.617	0.692	C3809653	MACULAR DEGENERATION, AGE-RELATED, 14	disease		Disease or Syndrome	0.30				   0	   0	CTD_human
      718	C3	0.445	0.885	C0003257	Antibody Deficiency Syndrome	disease	C20	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
      718	C3	0.445	0.885	C0007787	Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.50	1	2011	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.33	1	2010	2020	   1	   0	CTD_human
      718	C3	0.445	0.885	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2017	2017	   1	   0	CTD_human
      718	C3	0.445	0.885	C0017665	Membranous glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.50	1	2000	2015	   1	   0	CTD_human
      718	C3	0.445	0.885	C0019061	Hemolytic-Uremic Syndrome	disease	C13;C12;C15	Disease or Syndrome	0.41	1	2008	2016	   1	   0	GENOMICS_ENGLAND
      718	C3	0.445	0.885	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2005	2005	   1	   0	CTD_human
      718	C3	0.445	0.885	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
      718	C3	0.445	0.885	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      718	C3	0.445	0.885	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.31	1	2007	2017	   1	   0	CTD_human
      718	C3	0.445	0.885	C0030524	Paratuberculosis	disease	C01;C22	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      718	C3	0.445	0.885	C0030807	Pemphigus	disease	C17;C20	Disease or Syndrome	0.31	1	1977	2019	   1	   0	CTD_human
      718	C3	0.445	0.885	C0030809	Pemphigus Vulgaris	disease	C17;C20	Disease or Syndrome	0.32	1	1977	2019	   1	   0	CTD_human
      718	C3	0.445	0.885	C0034152	Henoch-Schoenlein Purpura	disease	C23;C20;C15;C14	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
      718	C3	0.445	0.885	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
      718	C3	0.445	0.885	C0042386	Vasculitis, Hemorrhagic	phenotype	C23;C20;C15;C14	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
      718	C3	0.445	0.885	C0086445	Idiopathic Membranous Glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      718	C3	0.445	0.885	C0086922	Rheumatoid Purpura	phenotype	C23;C20;C15;C14	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
      718	C3	0.445	0.885	C0238281	Middle Cerebral Artery Syndrome	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0242383	Age related macular degeneration	disease	C11	Disease or Syndrome	0.70	1	2007	2020	   4	   2	CTD_human;GENOMICS_ENGLAND
      718	C3	0.445	0.885	C0242461	Purpura, Nonthrombocytopenic	phenotype	C23;C20;C15;C14	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
      718	C3	0.445	0.885	C0263313	Pemphigus Foliaceus	disease	C17;C20	Disease or Syndrome	0.30	1	1977	1977	   1	   0	CTD_human
      718	C3	0.445	0.885	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.30	1	1972	1972	   1	   0	GENOMICS_ENGLAND
      718	C3	0.445	0.885	C0376362	Purpura Hemorrhagica	phenotype	C23;C20;C15;C14	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
      718	C3	0.445	0.885	C0472381	Posterior Circulation Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0740376	Middle Cerebral Artery Thrombosis	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0740391	Middle Cerebral Artery Occlusion	disease	C23;C10;C14	Acquired Abnormality	0.31	1	2013	2020	   1	   0	CTD_human
      718	C3	0.445	0.885	C0740392	Infarction, Middle Cerebral Artery	disease	C23;C10;C14	Disease or Syndrome	0.50	1	2011	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0751019	Carotid Circulation Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0751020	Transient Ischemic Attack, Vertebrobasilar Circulation	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0751021	Crescendo Transient Ischemic Attacks	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0751022	Brain Stem Ischemia, Transient	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0751845	Middle Cerebral Artery Embolus	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0751846	Left Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0751847	Embolic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0751848	Thrombotic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0751849	Right Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      718	C3	0.445	0.885	C0917805	Transient Cerebral Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      718	C3	0.445	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      718	C3	0.445	0.885	C1332655	Complement component 3 deficiency	disease		Disease or Syndrome	0.63	1	1972	2013	   1	   1	GENOMICS_ENGLAND
      718	C3	0.445	0.885	C1527335	Transient Ischemic Attack, Anterior Circulation	disease	C10;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      718	C3	0.445	0.885	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      718	C3	0.445	0.885	C1704378	Heymann Nephritis	disease	C13;C12;C20	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      718	C3	0.445	0.885	C1969651	Macular Degeneration, Age-Related, 9	disease	C11	Disease or Syndrome	0.50	1	2007	2013	   2	   1	CTD_human;UNIPROT
      718	C3	0.445	0.885	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.40	1	2017	2017	   1	   0	CTD_human
      718	C3	0.445	0.885	C2752037	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5	disease		Finding	0.60	1	2005	2016	   4	   8	GENOMICS_ENGLAND;UNIPROT
      718	C3	0.445	0.885	C2931788	Atypical Hemolytic Uremic Syndrome	disease	C13;C12;C15	Disease or Syndrome	0.60	1	2008	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
      718	C3	0.445	0.885	C3151071	COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE	disease	C16;C20	Disease or Syndrome	0.70	1	1972	2016	   5	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      718	C3	0.445	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      718	C3	0.445	0.885	C4087273	C3 glomerulopathy	disease		Disease or Syndrome	0.33	1	2014	2019	   1	   0	GENOMICS_ENGLAND
      718	C3	0.445	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      718	C3	0.445	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      720	C4A	0.563	0.769	C0003257	Antibody Deficiency Syndrome	disease	C20	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
      720	C4A	0.563	0.769	C0004943	Behcet Syndrome	disease	C16;C11;C17;C07;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
      720	C4A	0.563	0.769	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
      720	C4A	0.563	0.769	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.70	0.957	1987	2018	   6	   0	ORPHANET
      720	C4A	0.563	0.769	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.40	1	2011	2011	   1	   0	GENOMICS_ENGLAND
      720	C4A	0.563	0.769	C3280642	Complement Component 4a Deficiency	disease	C16;C20	Disease or Syndrome	0.55	1	1990	2016	   1	   0	CTD_human;GENOMICS_ENGLAND
      720	C4A	0.563	0.769	C3280742	SYSTEMIC LUPUS ERYTHEMATOSUS 16	disease		Disease or Syndrome	0.30	1	2004	2004	   1	   0	ORPHANET
      721	C4B	0.603	0.808	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	0.75	1996	2010	   2	   0	CTD_human
      721	C4B	0.603	0.808	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.36	1	1984	2017	   1	   0	CTD_human
      721	C4B	0.603	0.808	C0011609	Drug Eruptions	group	C17;C20;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      721	C4B	0.603	0.808	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.60	0.944	1985	2019	   7	   0	ORPHANET
      721	C4B	0.603	0.808	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.30	1	1992	1992	   1	   0	GENOMICS_ENGLAND
      721	C4B	0.603	0.808	C0406537	Morbilliform Drug Reaction	disease	C17;C20;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      721	C4B	0.603	0.808	C3280641	Decreased serum complement C4b	disease		Disease or Syndrome	0.63	1	1992	2016	   1	   0	CTD_human;GENOMICS_ENGLAND
      726	CAPN5	0.663	0.615	C0242852	Proliferative vitreoretinopathy	disease	C11	Disease or Syndrome	0.71	1	2012	2019	   1	   3	CTD_human;ORPHANET;UNIPROT
      726	CAPN5	0.663	0.615	C4721549	Autosomal dominant neovascular inflammatory vitreoretinopathy	phenotype	C23	Disease or Syndrome	0.39	1	2012	2019	   1	   0	ORPHANET
      727	C5	0.55	0.731	C0003257	Antibody Deficiency Syndrome	disease	C20	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
      727	C5	0.55	0.731	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
      727	C5	0.55	0.731	C0024138	Lupus Erythematosus, Discoid	disease	C17	Disease or Syndrome	0.30	1	1991	1991	   1	   0	GENOMICS_ENGLAND
      727	C5	0.55	0.731	C0031154	Peritonitis	disease	C06;C01	Pathologic Function	0.30	1	2009	2009	   2	   0	CTD_human
      727	C5	0.55	0.731	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.40	1	2015	2015	   1	   0	GENOMICS_ENGLAND
      727	C5	0.55	0.731	C0343047	Complement component 5 deficiency	disease	C16;C20	Disease or Syndrome	0.61	1	1977	2015	   1	   5	CTD_human;GENOMICS_ENGLAND
      727	C5	0.55	0.731	C1449646	Primary Peritonitis	disease	C06;C01	Disease or Syndrome	0.30	1	2009	2009	   2	   0	CTD_human
      727	C5	0.55	0.731	C1449647	Secondary Peritonitis	disease	C06;C01	Disease or Syndrome	0.30	1	2009	2009	   2	   0	CTD_human
      728	C5AR1	0.513	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      728	C5AR1	0.513	0.808	C0036981	Endotoxic shock	phenotype	C23;C01	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      728	C5AR1	0.513	0.808	C0036983	Septic Shock	phenotype	C23;C01	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      728	C5AR1	0.513	0.808	C0600327	Toxic Shock Syndrome	disease	C23;C01	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      729	C6	0.7	0.615	C0006663	Calcinosis	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      729	C6	0.7	0.615	C0018824	Heart valve disease	group	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      729	C6	0.7	0.615	C0263628	Tumoral calcinosis	disease	C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      729	C6	0.7	0.615	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.40	1	2003	2003	   1	   0	GENOMICS_ENGLAND
      729	C6	0.7	0.615	C0521174	Microcalcification	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      729	C6	0.7	0.615	C2676232	Complement Component 6 Deficiency	disease	C16;C20	Disease or Syndrome	0.62	1	1987	2012	   1	   3	CTD_human;GENOMICS_ENGLAND
      730	C7	0.751	0.423	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      730	C7	0.751	0.423	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.42	1	1977	2004	   1	   0	GENOMICS_ENGLAND
      730	C7	0.751	0.423	C1864694	Complement Component 7 Deficiency	disease	C16;C20	Disease or Syndrome	0.72	1	1989	2007	   4	   8	CTD_human;GENOMICS_ENGLAND;UNIPROT
      731	C8A	0.821	0.192	C0003257	Antibody Deficiency Syndrome	disease	C20	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
      731	C8A	0.821	0.192	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
      731	C8A	0.821	0.192	C0025289	Meningitis	disease	C10	Disease or Syndrome	0.40	1	1998	1998	   1	   0	CTD_human
      731	C8A	0.821	0.192	C0030167	Pachymeningitis	disease	C10	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
      731	C8A	0.821	0.192	C0085396	Neisseriaceae Infections	group	C01	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
      731	C8A	0.821	0.192	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.30	1	1998	1998	   1	   0	GENOMICS_ENGLAND
      731	C8A	0.821	0.192	C3151081	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I	disease		Disease or Syndrome	0.50	1	1998	1998	   1	   0	CTD_human;GENOMICS_ENGLAND
      732	C8B	0.76	0.269	C0003257	Antibody Deficiency Syndrome	disease	C20	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
      732	C8B	0.76	0.269	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
      732	C8B	0.76	0.269	C0025289	Meningitis	disease	C10	Disease or Syndrome	0.40	1	1993	1993	   1	   0	CTD_human
      732	C8B	0.76	0.269	C0030167	Pachymeningitis	disease	C10	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
      732	C8B	0.76	0.269	C0085396	Neisseriaceae Infections	group	C01	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
      732	C8B	0.76	0.269	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
      732	C8B	0.76	0.269	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.30	1	2009	2009	   1	   0	GENOMICS_ENGLAND
      732	C8B	0.76	0.269	C3151080	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II	disease		Disease or Syndrome	0.62	1	1990	2009	   1	   7	CTD_human;GENOMICS_ENGLAND
      732	C8B	0.76	0.269	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
      732	C8B	0.76	0.269	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
      732	C8B	0.76	0.269	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
      732	C8B	0.76	0.269	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
      733	C8G	1	0.077	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      733	C8G	1	0.077	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      735	C9	0.619	0.692	C0003257	Antibody Deficiency Syndrome	disease	C20	Disease or Syndrome	0.30	1	1998	2001	   2	   0	CTD_human
      735	C9	0.619	0.692	C0011633	Dermatomyositis	disease	C17;C05;C10	Disease or Syndrome	0.31	1	2001	2001	   1	   0	CTD_human
      735	C9	0.619	0.692	C0015456	Facial Dermatoses	disease	C17	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      735	C9	0.619	0.692	C0015704	Favre-Racouchot Syndrome	disease	C17	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      735	C9	0.619	0.692	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.30	1	1998	2001	   2	   0	CTD_human
      735	C9	0.619	0.692	C0025294	Meningococcal meningitis	disease	C01;C10	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
      735	C9	0.619	0.692	C0027412	Opioid-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      735	C9	0.619	0.692	C0029095	Opioid abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      735	C9	0.619	0.692	C0041834	Erythema	phenotype	C23;C17	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      735	C9	0.619	0.692	C0221056	Adult type dermatomyositis	disease	C17;C05;C10	Disease or Syndrome	0.31	1	2001	2001	   1	   0	CTD_human
      735	C9	0.619	0.692	C0242383	Age related macular degeneration	disease	C11	Disease or Syndrome	0.42	1	2013	2018	   1	   1	CTD_human
      735	C9	0.619	0.692	C0263666	Dermatomyositis, Childhood Type	disease	C17;C05;C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      735	C9	0.619	0.692	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.31	1	1998	1999	   1	   0	GENOMICS_ENGLAND
      735	C9	0.619	0.692	C0343097	Nodular Elastoidosis	disease	C17	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      735	C9	0.619	0.692	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      735	C9	0.619	0.692	C0524661	Narcotic Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      735	C9	0.619	0.692	C0524662	Opiate Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      735	C9	0.619	0.692	C1135745	Meningitis, Meningococcal, Serogroup A	disease	C01;C10	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
      735	C9	0.619	0.692	C1135746	Meningitis, Meningococcal, Serogroup B	disease	C01;C10	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
      735	C9	0.619	0.692	C1135747	Meningitis, Meningococcal, Serogroup C	disease	C01;C10	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
      735	C9	0.619	0.692	C1136209	Meningitis, Meningococcal, Serogroup Y	disease	C01;C10	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
      735	C9	0.619	0.692	C1136210	Meningitis, Meningococcal, Serogroup W-135	disease	C01;C10	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
      735	C9	0.619	0.692	C1527402	Narcotic Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      735	C9	0.619	0.692	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2009	2017	   2	   0	CTD_human
      735	C9	0.619	0.692	C3151189	C9 Deficiency	disease	C16;C20	Disease or Syndrome	0.75	1	1998	2017	   2	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
      735	C9	0.619	0.692	C3810042	MACULAR DEGENERATION, AGE-RELATED, 15	disease		Disease or Syndrome	0.60	1	2013	2013	   1	   1	CTD_human;UNIPROT
      735	C9	0.619	0.692	C4551628	Opiate Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      740	MRPL49	0.89	0.115	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      741	ZNHIT2	0.805	0.115	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
      745	MYRF	0.584	0.731	C0026010	Microphthalmos	disease	C16;C11	Congenital Abnormality	0.32	1	2019	2019	   2	   0	GENOMICS_ENGLAND
      745	MYRF	0.584	0.731	C0239761	Gonadal hypoplasia	disease		Congenital Abnormality	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      745	MYRF	0.584	0.731	C1855925	Hyperopia, High	phenotype	C16;C11	Finding	0.30	1	2019	2019	   2	   0	GENOMICS_ENGLAND
      745	MYRF	0.584	0.731	C4722446	ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION	disease		Disease or Syndrome	0.40	1	2018	2018	   1	   0	UNIPROT
      745	MYRF	0.584	0.731	C4748946	CARDIAC-UROGENITAL SYNDROME	disease		Disease or Syndrome	0.60	1	2018	2018	   3	   1	GENOMICS_ENGLAND;UNIPROT
      750	GAS8-AS1	0.751	0.192	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.35	1	2016	2019	   1	   0	ORPHANET
      752	FMNL1	0.711	0.577	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      755	CFAP410	0.633	0.615	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.62	1	2016	2019	   2	   1	CTD_human;ORPHANET
      755	CFAP410	0.633	0.615	C0265275	Jeune thoracic dystrophy	disease	C16;C17;C05	Disease or Syndrome	0.32	1	2013	2017	   2	   0	GENOMICS_ENGLAND
      755	CFAP410	0.633	0.615	C0393554	Amyotrophic Lateral Sclerosis With Dementia	disease	C18;C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      755	CFAP410	0.633	0.615	C0543859	Amyotrophic Lateral Sclerosis, Guam Form	disease	C18;C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      755	CFAP410	0.633	0.615	C1865695	Spondylometaphyseal dysplasia, axial	disease	C16;C05	Disease or Syndrome	0.63	1	2013	2017	   5	   8	GENOMICS_ENGLAND;UNIPROT
      755	CFAP410	0.633	0.615	C3489532	Cone-Rod Dystrophy 2	disease	C16;C11	Disease or Syndrome	0.31	1	2013	2016	   1	   0	ORPHANET
      755	CFAP410	0.633	0.615	C4479651	RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA	disease		Disease or Syndrome	0.50	1	2013	2016	   4	   2	GENOMICS_ENGLAND;UNIPROT
      759	CA1	0.623	0.769	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      759	CA1	0.623	0.769	C0004681	Bagassosis	disease	C08;C24	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      759	CA1	0.623	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2004	2009	   2	   0	CTD_human
      759	CA1	0.623	0.769	C0032273	Pneumoconiosis	disease	C08;C24	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      759	CA1	0.623	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2009	   2	   0	CTD_human
      759	CA1	0.623	0.769	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      759	CA1	0.623	0.769	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      759	CA1	0.623	0.769	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      759	CA1	0.623	0.769	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      759	CA1	0.623	0.769	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      759	CA1	0.623	0.769	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      759	CA1	0.623	0.769	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2004	2009	   2	   0	CTD_human
      760	CA2	0.506	0.808	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.31	1	2004	2012	   1	   0	CTD_human
      760	CA2	0.506	0.808	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      760	CA2	0.506	0.808	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      760	CA2	0.506	0.808	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.32	1	2008	2020	   1	   0	CTD_human
      760	CA2	0.506	0.808	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      760	CA2	0.506	0.808	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      760	CA2	0.506	0.808	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      760	CA2	0.506	0.808	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      760	CA2	0.506	0.808	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      760	CA2	0.506	0.808	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      760	CA2	0.506	0.808	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      760	CA2	0.506	0.808	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2011	2015	   1	   0	CTD_human
      760	CA2	0.506	0.808	C0345407	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3	disease	C16;C18;C13;C05;C12;C10	Disease or Syndrome	0.99	1	1985	2020	   6	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
      760	CA2	0.506	0.808	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      760	CA2	0.506	0.808	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      760	CA2	0.506	0.808	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      760	CA2	0.506	0.808	C1849435	Renal tubular acidosis, distal, type 3	disease	C16;C18;C13;C12	Disease or Syndrome	0.30				   0	   0	ORPHANET
      760	CA2	0.506	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.35	1	1996	2019	   1	   0	CTD_human
      760	CA2	0.506	0.808	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.43	1	1991	2002	   1	   0	GENOMICS_ENGLAND
      761	CA3	0.682	0.5	C0004681	Bagassosis	disease	C08;C24	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      761	CA3	0.682	0.5	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.50	1	2014	2015	   1	   0	CTD_human
      761	CA3	0.682	0.5	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2006	2014	   1	   0	CTD_human
      761	CA3	0.682	0.5	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.31	1	2011	2017	   1	   0	CTD_human
      761	CA3	0.682	0.5	C0032273	Pneumoconiosis	disease	C08;C24	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      761	CA3	0.682	0.5	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.50	1	2014	2015	   1	   0	CTD_human
      761	CA3	0.682	0.5	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.50	1	2014	2015	   1	   0	CTD_human
      761	CA3	0.682	0.5	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.50	1	2014	2015	   1	   0	CTD_human
      761	CA3	0.682	0.5	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.50	1	2014	2015	   1	   0	CTD_human
      761	CA3	0.682	0.5	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.50	1	2014	2015	   1	   0	CTD_human
      762	CA4	0.674	0.577	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30	1	2004	2004	   1	   0	GENOMICS_ENGLAND
      762	CA4	0.674	0.577	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.47	1	1997	2010	   1	   1	GENOMICS_ENGLAND
      762	CA4	0.674	0.577	C1833245	Retinitis Pigmentosa 17	disease	C16;C11	Disease or Syndrome	0.74	1	2000	2010	   4	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
      763	CA5A	0.686	0.5	C3810404	CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	disease		Disease or Syndrome	0.70	1	1995	2016	   4	   4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      767	CA8	0.595	0.654	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      767	CA8	0.595	0.654	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      767	CA8	0.595	0.654	C0394006	Dysequilibrium syndrome	disease	C10	Disease or Syndrome	0.31	1	2011	2011	   1	   0	ORPHANET
      767	CA8	0.595	0.654	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      767	CA8	0.595	0.654	C2750509	Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 3	disease	C23;C10;F03;F01	Disease or Syndrome	0.90	1	2005	2016	   3	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
      767	CA8	0.595	0.654	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.41	1	2011	2013	   1	   0	CTD_human
      768	CA9	0.483	0.731	C0002793	Anaplasia	disease	C23;C04	Neoplastic Process	0.31	1	2010	2018	   1	   0	CTD_human
      768	CA9	0.483	0.731	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      768	CA9	0.483	0.731	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.40	1	2001	2008	   1	   0	CTD_human
      768	CA9	0.483	0.731	C0007124	Noninfiltrating Intraductal Carcinoma	disease	C04	Neoplastic Process	0.33	1	2010	2020	   1	   0	CTD_human
      768	CA9	0.483	0.731	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.38	1	2003	2019	   1	   0	CTD_human
      768	CA9	0.483	0.731	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      768	CA9	0.483	0.731	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.31	1	2006	2006	   1	   0	CTD_human
      768	CA9	0.483	0.731	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      768	CA9	0.483	0.731	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2006	2006	   1	   0	CTD_human
      768	CA9	0.483	0.731	C1176475	Ductal Carcinoma	disease	C04	Neoplastic Process	0.32	1	2010	2012	   1	   0	CTD_human
      768	CA9	0.483	0.731	C1332347	Atypical Ductal Breast Hyperplasia	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      771	CA12	0.592	0.731	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      771	CA12	0.592	0.731	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.31	1	2017	2019	   1	   0	CTD_human
      771	CA12	0.592	0.731	C1840437	Isolated hyperchlorhidrosis	phenotype		Finding	0.70	1	2010	2016	   3	   5	CTD_human;ORPHANET;UNIPROT
      773	CACNA1A	0.489	0.769	C0001890	Akinetic Petit Mal	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      773	CACNA1A	0.489	0.769	C0004134	Ataxia	phenotype	C23;C10	Sign or Symptom	0.50	1	1997	2019	   1	   0	CTD_human
      773	CACNA1A	0.489	0.769	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
      773	CACNA1A	0.489	0.769	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.48	1	1999	2020	   1	   0	GENOMICS_ENGLAND
      773	CACNA1A	0.489	0.769	C0014553	Absence Epilepsy	disease	C10	Disease or Syndrome	0.76	1	1996	2020	   2	   0	CTD_human;GENOMICS_ENGLAND
      773	CACNA1A	0.489	0.769	C0087012	Ataxia, Spinocerebellar	disease	C16;C10	Disease or Syndrome	0.40	1	1997	2019	   2	   0	CTD_human
      773	CACNA1A	0.489	0.769	C0206368	Exfoliation Syndrome	disease	C11	Disease or Syndrome	0.43	1	2015	2020	   1	   1	CTD_human
      773	CACNA1A	0.489	0.769	C0240991	Ataxia, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
      773	CACNA1A	0.489	0.769	C0270816	epilepsy and migraine	disease		Disease or Syndrome	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
      773	CACNA1A	0.489	0.769	C0278161	Ataxia, Motor	phenotype	C23;C10	Finding	0.30	1	2007	2007	   1	   0	CTD_human
      773	CACNA1A	0.489	0.769	C0338488	Alternating hemiplegia of childhood	disease	C23;C10	Disease or Syndrome	0.31	1	2008	2008	   1	   0	ORPHANET
      773	CACNA1A	0.489	0.769	C0427190	Ataxia, Truncal	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
      773	CACNA1A	0.489	0.769	C0520966	Abnormal coordination	phenotype	C23;C10	Finding	0.40	1	2007	2007	   1	   0	CTD_human
      773	CACNA1A	0.489	0.769	C0543888	Epileptic encephalopathy	disease	C10	Disease or Syndrome	0.43	1	2015	2018	   1	   3	GENOMICS_ENGLAND
      773	CACNA1A	0.489	0.769	C0750937	Ataxia, Appendicular	phenotype	C23;C10	Finding	0.30	1	2007	2007	   1	   0	CTD_human
      773	CACNA1A	0.489	0.769	C0750940	Tremor, Rubral	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      773	CACNA1A	0.489	0.769	C0751124	Epilepsy, Absence, Atypical	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      773	CACNA1A	0.489	0.769	C0752120	Spinocerebellar Ataxia Type 1	disease	C16;C10	Disease or Syndrome	0.32	1	1998	2007	   2	   0	CTD_human
      773	CACNA1A	0.489	0.769	C0752121	Spinocerebellar Ataxia Type 2	disease	C16;C10	Disease or Syndrome	0.31	1	2002	2007	   2	   0	CTD_human
      773	CACNA1A	0.489	0.769	C0752122	Spinocerebellar Ataxia Type 4	disease	C16;C10	Disease or Syndrome	0.30	1	2002	2007	   2	   0	CTD_human
      773	CACNA1A	0.489	0.769	C0752123	Spinocerebellar Ataxia Type 5	disease	C16;C10	Disease or Syndrome	0.30	1	2002	2007	   2	   0	CTD_human
      773	CACNA1A	0.489	0.769	C0752124	Spinocerebellar Ataxia Type 6 (disorder)	disease	C16;C10	Disease or Syndrome	1.00	0.986	1997	2019	  12	  11	CTD_human;GENOMICS_ENGLAND;UNIPROT
      773	CACNA1A	0.489	0.769	C0752125	Spinocerebellar Ataxia Type 7	disease	C16;C10	Disease or Syndrome	0.31	1	2002	2007	   2	   0	CTD_human
      773	CACNA1A	0.489	0.769	C1720416	Episodic ataxia type 2 (disorder)	disease	C23;C11;C10	Disease or Syndrome	1.00	0.988	1996	2019	  21	  60	CTD_human;GENOMICS_ENGLAND;UNIPROT
      773	CACNA1A	0.489	0.769	C1832884	Hemiplegic migraine, familial type 1	disease	C23;C10	Disease or Syndrome	0.80	0.966	1996	2018	  15	  21	CTD_human;GENOMICS_ENGLAND;UNIPROT
      773	CACNA1A	0.489	0.769	C3494934	Benign paroxysmal torticollis of infancy	phenotype	C23;C10	Finding	0.30	1	2002	2002	   1	   0	ORPHANET
      773	CACNA1A	0.489	0.769	C4281785	Childhood Absence Epilepsy	disease	C10	Disease or Syndrome	0.31	1	2007	2020	   1	   0	CTD_human
      773	CACNA1A	0.489	0.769	C4310716	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42	disease		Disease or Syndrome	0.70	1	1996	2017	   4	  28	CTD_human;GENOMICS_ENGLAND;UNIPROT
      773	CACNA1A	0.489	0.769	C4317339	Juvenile Absence Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      773	CACNA1A	0.489	0.769	C4552765	Epilepsy, Minor	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      773	CACNA1A	0.489	0.769	C4553705	Absence Seizure Disorder	disease	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      774	CACNA1B	0.65	0.577	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
      774	CACNA1B	0.65	0.577	C0026650	Movement Disorders	group	C10	Disease or Syndrome	0.30	1	2015	2019	   2	   0	GENOMICS_ENGLAND
      774	CACNA1B	0.65	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.42	1	2010	2017	   2	   1	PSYGENET
      774	CACNA1B	0.65	0.577	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.40	1	2015	2019	   2	   0	GENOMICS_ENGLAND
      774	CACNA1B	0.65	0.577	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.40	1	2015	2019	   2	   0	GENOMICS_ENGLAND
      774	CACNA1B	0.65	0.577	C1836830	Developmental regression	disease	F03	Disease or Syndrome	0.40	1	2015	2019	   2	   0	GENOMICS_ENGLAND
      774	CACNA1B	0.65	0.577	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40	1	2015	2019	   2	   0	GENOMICS_ENGLAND
      774	CACNA1B	0.65	0.577	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0002895	Anemia, Sickle Cell	disease	C16;C15	Disease or Syndrome	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      775	CACNA1C	0.51	0.846	C0003257	Antibody Deficiency Syndrome	disease	C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.34	1	2010	2018	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0003811	Cardiac Arrhythmia	phenotype	C23;C14	Disease or Syndrome	0.38	1	2004	2019	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.45	1	2004	2019	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.70	0.8	2008	2020	   9	   6	CTD_human;PSYGENET
      775	CACNA1C	0.51	0.846	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2019	   4	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.33	1	2014	2018	   1	   0	GENOMICS_ENGLAND
      775	CACNA1C	0.51	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.37	0.8	2010	2017	   5	   0	PSYGENET
      775	CACNA1C	0.51	0.846	C0011574	Involutional Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.38	0.8	2010	2019	   5	   0	PSYGENET
      775	CACNA1C	0.51	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.33	1	2006	2016	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0020615	Hypoglycemia	disease	C18	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2019	   4	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.50	1	2011	2019	   3	   1	PSYGENET
      775	CACNA1C	0.51	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.50	1	2009	2019	   4	  10	PSYGENET
      775	CACNA1C	0.51	0.846	C0038441	Stress Disorders, Traumatic	group	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0039070	Syncope	phenotype	C23;C10	Sign or Symptom	0.41	1	2018	2019	   1	   0	GENOMICS_ENGLAND
      775	CACNA1C	0.51	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2010	2019	   5	   0	PSYGENET
      775	CACNA1C	0.51	0.846	C0085298	Sudden Cardiac Death	phenotype	C23;C14	Pathologic Function	0.41	1	2007	2018	   1	   0	GENOMICS_ENGLAND
      775	CACNA1C	0.51	0.846	C0151879	Shortened QT interval	phenotype	C23;C14	Finding	0.40	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      775	CACNA1C	0.51	0.846	C0178417	Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.32	1	2011	2014	   2	   0	PSYGENET
      775	CACNA1C	0.51	0.846	C0206762	Limb Deformities, Congenital	group	C16;C05	Congenital Abnormality	0.30	1	2004	2004	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0234985	Mental deterioration	phenotype	F03	Mental or Behavioral Dysfunction	0.31	1	2018	2018	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0271708	Fasting Hypoglycemia	phenotype	C18	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0271710	Reactive hypoglycemia	disease	C18	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0338656	Impaired cognition	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2014	2018	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2019	   4	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0342788	Renal carnitine transport defect	disease	C23;C05;C10;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      775	CACNA1C	0.51	0.846	C0349204	Nonorganic psychosis	disease	F03	Mental or Behavioral Dysfunction	0.39	1	2011	2019	   1	   0	PSYGENET
      775	CACNA1C	0.51	0.846	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0392156	Akathisia	phenotype	C23;C10;F01	Sign or Symptom	0.30	1	2018	2018	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.39	1	2010	2019	   5	   0	PSYGENET
      775	CACNA1C	0.51	0.846	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.57	1	1993	2019	   7	   0	CLINGEN;GENOMICS_ENGLAND
      775	CACNA1C	0.51	0.846	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.70	1	2010	2019	   6	  19	CTD_human;PSYGENET
      775	CACNA1C	0.51	0.846	C1270972	Mild cognitive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C1571983	Involutional paraphrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C1571984	Psychosis, Involutional	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      775	CACNA1C	0.51	0.846	C1832916	Timothy syndrome	disease	C23;C16;C05;F03;C14	Disease or Syndrome	1.00	0.969	2004	2019	   8	   5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      775	CACNA1C	0.51	0.846	C2678478	Brugada Syndrome 3	disease	C16;C14	Disease or Syndrome	0.70	1	2007	2018	   5	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
      775	CACNA1C	0.51	0.846	C3887612	Psychomotor Agitation	phenotype	C23;C10;F01	Finding	0.30	1	2018	2018	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0001430	Adenoma	group	C04	Neoplastic Process	0.35	1	2013	2017	   2	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0004331	Auriculo-Ventricular Dissociation	phenotype	C23;C14	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2016	2017	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0011052	Prelingual Deafness	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0011053	Deafness	phenotype	C23;C10;C09	Finding	0.30	1	2004	2004	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0018794	Heart Block	disease	C23;C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0020428	Hyperaldosteronism	disease	C19	Disease or Syndrome	0.41	1	2013	2016	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0037052	Sick Sinus Syndrome	disease	C23;C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0039240	Supraventricular tachycardia	disease	C23;C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0086395	Hearing Loss, Extreme	phenotype	C23;C10;C09	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0428908	Sinus Node Dysfunction (disorder)	disease	C23;C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0428977	Bradycardia	phenotype	C23;C14	Finding	0.40	1	2016	2016	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
      776	CACNA1D	0.582	0.577	C0581883	Complete Hearing Loss	phenotype	C23;C10;C09	Finding	0.30	1	2004	2004	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C0751068	Deafness, Acquired	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C1384514	Conn Syndrome	disease	C19	Disease or Syndrome	0.34	1	2013	2018	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C3554018	SINOATRIAL NODE DYSFUNCTION AND DEAFNESS	disease	C23;C14	Disease or Syndrome	0.72	1	2004	2019	   5	   2	CLINGEN;GENOMICS_ENGLAND;ORPHANET
      776	CACNA1D	0.582	0.577	C3665473	Bilateral Deafness	phenotype	C23;C10;C09	Finding	0.30	1	2004	2004	   1	   0	CTD_human
      776	CACNA1D	0.582	0.577	C3809609	PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	disease		Disease or Syndrome	0.71	1	2013	2018	   2	   2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
      776	CACNA1D	0.582	0.577	C4082305	Deaf Mutism	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      777	CACNA1E	0.65	0.577	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.40	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      777	CACNA1E	0.65	0.577	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      777	CACNA1E	0.65	0.577	C0221355	Macrocephaly	disease	C16;C05;C10	Congenital Abnormality	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      777	CACNA1E	0.65	0.577	C0332878	Congenital contracture	group	C16;C05	Congenital Abnormality	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      777	CACNA1E	0.65	0.577	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      777	CACNA1E	0.65	0.577	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      777	CACNA1E	0.65	0.577	C4748988	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69	disease		Disease or Syndrome	0.60	1	2018	2018	   1	   8	GENOMICS_ENGLAND;UNIPROT
      778	CACNA1F	0.595	0.5	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.33	1	2007	2014	   0	   0	GENOMICS_ENGLAND
      778	CACNA1F	0.595	0.5	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2006	2006	   1	   0	PSYGENET
      778	CACNA1F	0.595	0.5	C0268505	Ocular albinism, type II	disease	C16;C18;C11;C17	Disease or Syndrome	0.76	1	1989	2019	   3	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      778	CACNA1F	0.595	0.5	C0339535	Night blindness, congenital stationary	disease	C16;C11	Congenital Abnormality	0.70	1	1993	2018	   0	  12	CTD_human;GENOMICS_ENGLAND
      778	CACNA1F	0.595	0.5	C1845407	CONE-ROD DYSTROPHY, X-LINKED, 3	disease	C16;C11	Disease or Syndrome	0.61	1	2009	2015	   1	   3	CTD_human;GENOMICS_ENGLAND
      778	CACNA1F	0.595	0.5	C1848172	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	disease	C16;C11	Disease or Syndrome	1.00	1	1998	2019	   8	   9	CTD_human;GENOMICS_ENGLAND;UNIPROT
      778	CACNA1F	0.595	0.5	C1850362	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
      778	CACNA1F	0.595	0.5	C1864877	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
      778	CACNA1F	0.595	0.5	C3489532	Cone-Rod Dystrophy 2	disease	C16;C11	Disease or Syndrome	0.31	1	2006	2016	   2	   0	ORPHANET
      778	CACNA1F	0.595	0.5	C3495587	Night Blindness, Congenital Stationary, Type 1A	disease	C16;C11	Disease or Syndrome	0.40				   0	   1	CTD_human
      778	CACNA1F	0.595	0.5	C3501847	Night blindness, congenital stationary, type 1	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
      778	CACNA1F	0.595	0.5	C3711543	X-Linked Csnb	disease	C16;C11	Disease or Syndrome	0.33	1	1998	2002	   0	   0	CTD_human
      778	CACNA1F	0.595	0.5	C4041558	Cone-rod synaptic disorder, congenital nonprogressive	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
      779	CACNA1S	0.595	0.692	C0024591	Malignant hyperpyrexia due to anesthesia	disease	C23	Disease or Syndrome	0.50	1	1995	2019	   2	   0	ORPHANET
      779	CACNA1S	0.595	0.692	C0035229	Respiratory Insufficiency	phenotype	C08	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      779	CACNA1S	0.595	0.692	C0235063	Respiratory Depression	phenotype	C08	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      779	CACNA1S	0.595	0.692	C0238358	Hypokalemic periodic paralysis	disease	C16;C18;C05;C10	Disease or Syndrome	0.70	1	1994	2018	   2	   5	CTD_human
      779	CACNA1S	0.595	0.692	C0268446	Thyrotoxic periodic paralysis	disease	C16;C18;C05;C10	Disease or Syndrome	0.32	1	2003	2007	   1	   0	ORPHANET
      779	CACNA1S	0.595	0.692	C0270960	Congenital myopathy (disorder)	group	C05;C10	Congenital Abnormality	0.32	1	2017	2018	   1	   0	GENOMICS_ENGLAND
      779	CACNA1S	0.595	0.692	C1145670	Respiratory Failure	disease	C08	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      779	CACNA1S	0.595	0.692	C1866077	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	phenotype		Finding	0.60	1	1994	2015	   2	  11	GENOMICS_ENGLAND;UNIPROT
      779	CACNA1S	0.595	0.692	C2749982	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1	disease		Finding	0.60				   0	   1	CTD_human;GENOMICS_ENGLAND
      779	CACNA1S	0.595	0.692	C2930984	Malignant hyperthermia susceptibility type 5	disease	C23	Pathologic Function	0.30				   0	   0	CTD_human
      779	CACNA1S	0.595	0.692	C3714580	Hypokalemic periodic paralysis type 1	disease		Disease or Syndrome	0.80	0.974	1994	2018	   6	  14	CTD_human;GENOMICS_ENGLAND;UNIPROT
      779	CACNA1S	0.595	0.692	C4751572	Periodic paralysis with transient compartment-like syndrome	disease	C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
      780	DDR1	0.497	0.808	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.31	1	2010	2011	   1	   0	CTD_human
      780	DDR1	0.497	0.808	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.32	1	2011	2016	   1	   0	CTD_human
      780	DDR1	0.497	0.808	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
      780	DDR1	0.497	0.808	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2008	2014	   1	   0	CTD_human
      780	DDR1	0.497	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.43	1	2007	2019	   1	   1	PSYGENET
      780	DDR1	0.497	0.808	C0149782	Squamous cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30				   0	   0	UNIPROT
      780	DDR1	0.497	0.808	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      780	DDR1	0.497	0.808	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      780	DDR1	0.497	0.808	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      780	DDR1	0.497	0.808	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      780	DDR1	0.497	0.808	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      780	DDR1	0.497	0.808	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.35	0.833	2007	2019	   1	   0	CTD_human
      780	DDR1	0.497	0.808	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.35	1	2003	2020	   1	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0003811	Cardiac Arrhythmia	phenotype	C23;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
      781	CACNA2D1	0.641	0.5	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0011071	Sudden death	phenotype	C23	Pathologic Function	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
      781	CACNA2D1	0.641	0.5	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.30	1	2001	2013	   3	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0027796	Neuralgia	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2013	   4	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0030193	Pain	phenotype	C23	Sign or Symptom	0.31	1	2006	2018	   1	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0038870	Neuralgia, Supraorbital	phenotype	C23;C10	Disease or Syndrome	0.30	1	2007	2013	   4	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0042656	Neuralgia, Vidian	phenotype	C23;C10	Disease or Syndrome	0.30	1	2007	2013	   4	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0151879	Shortened QT interval	phenotype	C23;C14	Finding	0.40	1	2005	2005	   1	   0	GENOMICS_ENGLAND
      781	CACNA2D1	0.641	0.5	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0234247	Neuralgia, Atypical	phenotype	C23;C10	Disease or Syndrome	0.30	1	2007	2013	   4	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0234249	Neuralgia, Stump	phenotype	C23;C10	Disease or Syndrome	0.30	1	2007	2013	   4	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0264893	Nodal rhythm disorder	phenotype	C23;C14	Disease or Syndrome	0.30	1	2009	2015	   4	   0	CLINGEN
      781	CACNA2D1	0.641	0.5	C0348626	Other specified cardiac arrhythmias	phenotype	C23;C14	Disease or Syndrome	0.30	1	2009	2015	   4	   0	CLINGEN
      781	CACNA2D1	0.641	0.5	C0423711	Neuralgia, Perineal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2007	2013	   4	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0423712	Neuralgia, Iliohypogastric Nerve	phenotype	C23;C10	Disease or Syndrome	0.30	1	2007	2013	   4	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0428908	Sinus Node Dysfunction (disorder)	disease	C23;C14	Disease or Syndrome	0.30	1	2009	2015	   4	   0	CLINGEN
      781	CACNA2D1	0.641	0.5	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2001	2013	   3	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2001	2013	   3	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2001	2013	   3	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2001	2013	   3	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2001	2013	   3	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0751371	Neuralgia, Ilioinguinal	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2013	   4	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0751372	Nerve Pain	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2013	   4	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0751373	Paroxysmal Nerve Pain	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2013	   4	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.62	1	2005	2015	   6	   0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
      781	CACNA2D1	0.641	0.5	C1399226	Ectopic rhythm	phenotype	C23;C14	Disease or Syndrome	0.30	1	2009	2015	   4	   0	CLINGEN
      781	CACNA2D1	0.641	0.5	C1865020	Short QT Syndrome 1	disease	C23;C16;C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	ORPHANET
      781	CACNA2D1	0.641	0.5	C2748542	CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder)	disease	C16;C14	Disease or Syndrome	0.30	1	2009	2015	   4	   0	CLINGEN
      781	CACNA2D1	0.641	0.5	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2001	2013	   3	   0	CTD_human
      781	CACNA2D1	0.641	0.5	C4551804	Brugada Syndrome 1	disease	C16;C14	Disease or Syndrome	0.30	1	2009	2015	   4	   0	CLINGEN
      782	CACNB1	0.792	0.154	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
      783	CACNB2	0.659	0.538	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.42	1	2013	2019	   1	   1	PSYGENET
      783	CACNB2	0.659	0.538	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.30				   0	   0	CLINGEN
      783	CACNB2	0.659	0.538	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
      783	CACNB2	0.659	0.538	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.43	1	2013	2019	   1	   5	PSYGENET
      783	CACNB2	0.659	0.538	C0151879	Shortened QT interval	phenotype	C23;C14	Finding	0.40	1	2005	2005	   1	   0	GENOMICS_ENGLAND
      783	CACNB2	0.659	0.538	C0264893	Nodal rhythm disorder	phenotype	C23;C14	Disease or Syndrome	0.30	1	2000	2012	   6	   0	CLINGEN
      783	CACNB2	0.659	0.538	C0348626	Other specified cardiac arrhythmias	phenotype	C23;C14	Disease or Syndrome	0.30	1	2000	2012	   6	   0	CLINGEN
      783	CACNB2	0.659	0.538	C0428908	Sinus Node Dysfunction (disorder)	disease	C23;C14	Disease or Syndrome	0.30	1	2000	2012	   6	   0	CLINGEN
      783	CACNB2	0.659	0.538	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.51	1	2000	2012	   7	   0	CLINGEN;GENOMICS_ENGLAND
      783	CACNB2	0.659	0.538	C1399226	Ectopic rhythm	phenotype	C23;C14	Disease or Syndrome	0.30	1	2000	2012	   6	   0	CLINGEN
      783	CACNB2	0.659	0.538	C2678477	Brugada Syndrome 4	disease	C16;C14	Disease or Syndrome	0.70	1	2005	2016	   3	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
      783	CACNB2	0.659	0.538	C2748542	CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder)	disease	C16;C14	Disease or Syndrome	0.30	1	2000	2012	   6	   0	CLINGEN
      783	CACNB2	0.659	0.538	C4551804	Brugada Syndrome 1	disease	C16;C14	Disease or Syndrome	0.30	1	2000	2012	   6	   0	CLINGEN
      784	CACNB3	0.821	0.346	C0010093	Corpus Luteum Cyst	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      784	CACNB3	0.821	0.346	C0029927	Ovarian Cysts	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C0004134	Ataxia	phenotype	C23;C10	Sign or Symptom	0.32	1	2000	2014	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.32	1	1997	2017	   6	   0	CLINGEN
      785	CACNB4	0.653	0.231	C0014548	Epilepsy, Generalized	disease	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C0017332	Generalized Nonconvulsive Seizure Disorder	disease	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C0086236	Epilepsy, Atonic	disease	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C0086241	Epilepsy, Tonic	disease	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C0240991	Ataxia, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C0270850	Idiopathic generalized epilepsy	disease	C10	Disease or Syndrome	0.31	1	2000	2000	   0	   0	CTD_human
      785	CACNB4	0.653	0.231	C0270853	Juvenile Myoclonic Epilepsy	disease	C10	Disease or Syndrome	0.51	1	2000	2014	   2	   0	CTD_human;ORPHANET
      785	CACNB4	0.653	0.231	C0270854	Symptomatic Generalized Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C0278161	Ataxia, Motor	phenotype	C23;C10	Finding	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C0311334	Generalized convulsive epilepsy	disease	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C0347869	Epilepsy, Akinetic	disease	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C0427190	Ataxia, Truncal	phenotype	C23;C10	Sign or Symptom	0.40	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C0520966	Abnormal coordination	phenotype	C23;C10	Finding	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C0598589	Inherited neuropathies	disease	C10	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      785	CACNB4	0.653	0.231	C0750937	Ataxia, Appendicular	phenotype	C23;C10	Finding	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C0750940	Tremor, Rubral	disease	C23;C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C1720189	Episodic Ataxia	disease	C23;C10	Disease or Syndrome	0.41	1	2000	2000	   1	   0	GENOMICS_ENGLAND
      785	CACNB4	0.653	0.231	C1839565	Optic Atrophy Spastic Paraplegia Syndrome	phenotype	C23;C16;C11;C10	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      785	CACNB4	0.653	0.231	C1866039	EPISODIC ATAXIA, TYPE 5	disease	C23;C10	Disease or Syndrome	0.70	1	2000	2008	   2	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      785	CACNB4	0.653	0.231	C2750887	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9	disease		Finding	0.40	1	2000	2000	   1	   2	GENOMICS_ENGLAND
      785	CACNB4	0.653	0.231	C4013473	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13	disease		Finding	0.30				   0	   0	GENOMICS_ENGLAND
      785	CACNB4	0.653	0.231	C4551857	Juvenile Myoclonic Epilepsy of Janz	disease	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C4552768	Myoclonic Epilepsy, Adolescent	disease	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C4553087	Myoclonic Epilepsy, Juvenile, 1	disease	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      785	CACNB4	0.653	0.231	C4553298	Impulsive Petit Mal Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      788	SLC25A20	0.563	0.769	C0342791	Carnitine-Acylcarnitine Translocase Deficiency	disease	C16;C18	Disease or Syndrome	0.77	1	1997	2019	  12	  15	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      790	CAD	0.482	0.846	C0002875	Cooley's anemia	disease	C16;C15	Disease or Syndrome	0.30	1	1979	1979	   1	   0	CTD_human
      790	CAD	0.482	0.846	C0002895	Anemia, Sickle Cell	disease	C16;C15	Disease or Syndrome	0.30	1	1979	1979	   1	   0	CTD_human
      790	CAD	0.482	0.846	C0005283	beta Thalassemia	disease	C16;C15	Disease or Syndrome	0.30	1	1979	1979	   1	   0	CTD_human
      790	CAD	0.482	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2003	2015	   0	   1	UNIPROT
      790	CAD	0.482	0.846	C0019025	Hemoglobin F Disease	disease	C16;C15	Disease or Syndrome	0.30	1	1979	1979	   1	   0	CTD_human
      790	CAD	0.482	0.846	C0023440	Acute Erythroblastic Leukemia	disease	C04;C15	Neoplastic Process	0.30	1	1979	1979	   1	   0	CTD_human
      790	CAD	0.482	0.846	C0037889	Hereditary spherocytosis	disease	C16;C15	Disease or Syndrome	0.30	1	1979	1979	   1	   0	CTD_human
      790	CAD	0.482	0.846	C0085578	Thalassemia Minor	disease	C16;C15	Disease or Syndrome	0.30	1	1979	1979	   1	   0	CTD_human
      790	CAD	0.482	0.846	C0271979	Thalassemia Intermedia	disease	C16;C15	Disease or Syndrome	0.30	1	1979	1979	   1	   0	CTD_human
      790	CAD	0.482	0.846	C0949116	Congenital hypoplastic anemia	disease	C16;C15	Disease or Syndrome	0.30	1	1979	1979	   1	   0	CTD_human
      790	CAD	0.482	0.846	C4225320	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50	disease		Disease or Syndrome	0.70	1	2015	2019	   4	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      793	CALB1	0.606	0.615	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.30	1	2011	2011	   2	   0	CTD_human
      793	CALB1	0.606	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2008	2019	   2	   0	PSYGENET
      794	CALB2	0.545	0.692	C0031149	Peritoneal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      794	CALB2	0.545	0.692	C0042164	Uveitis	disease	C11	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      794	CALB2	0.545	0.692	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.40	0.933	2001	2019	   1	   0	CTD_human
      794	CALB2	0.545	0.692	C0346990	Carcinomatosis of peritoneal cavity	disease	C06;C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      794	CALB2	0.545	0.692	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      794	CALB2	0.545	0.692	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      794	CALB2	0.545	0.692	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0003865	Arthritis, Adjuvant-Induced	disease	C05	Experimental Model of Disease	0.30	1	2007	2007	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0007370	Catalepsy	disease	C23;C10	Mental or Behavioral Dysfunction	0.30	1	1982	1983	   3	   0	CTD_human
      796	CALCA	0.416	0.923	C0007852	Cervical Migraine Syndrome	disease	C10	Disease or Syndrome	0.30	1	2003	2007	   2	   0	CTD_human
      796	CALCA	0.416	0.923	C0013080	Down Syndrome	disease	C16;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0013604	Edema	phenotype	C23	Pathologic Function	0.30	1	1993	1993	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0018984	Hemicrania migraine	disease	C10	Disease or Syndrome	0.30	1	2003	2007	   2	   0	CTD_human
      796	CALCA	0.416	0.923	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.54	1	2003	2019	   4	   0	CTD_human
      796	CALCA	0.416	0.923	C0020437	Hypercalcemia	disease	C18	Disease or Syndrome	0.40	1	1975	2019	   2	   0	CTD_human
      796	CALCA	0.416	0.923	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.40	1	1991	2019	   2	   0	CTD_human
      796	CALCA	0.416	0.923	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.30	1	1992	1992	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.50	1	2001	2011	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0026141	Milk-Alkali Syndrome	disease	C18	Disease or Syndrome	0.30	1	1975	2003	   2	   0	CTD_human
      796	CALCA	0.416	0.923	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.36	0.857	2007	2018	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.34	1	2005	2008	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0040997	Trigeminal Neuralgia	disease	C10;C07	Disease or Syndrome	0.31	1	2016	2018	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0085129	Bronchial Hyperreactivity	disease	C08	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
      796	CALCA	0.416	0.923	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0149931	Migraine Disorders	group	C10	Disease or Syndrome	0.40	0.98	2003	2020	   2	   0	CTD_human
      796	CALCA	0.416	0.923	C0149940	Sciatic Neuropathy	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0151603	Anasarca	phenotype	C23	Pathologic Function	0.30	1	1993	1993	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0154748	Lesion of Sciatic Nerve	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0233612	Waxy flexibility	phenotype	C23;C10	Sign or Symptom	0.30	1	1982	1983	   3	   0	CTD_human
      796	CALCA	0.416	0.923	C0242013	Sciatic Neuritis	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0270858	Abdominal Migraine	disease	C10	Disease or Syndrome	0.30	1	2003	2007	   2	   0	CTD_human
      796	CALCA	0.416	0.923	C0338480	Common Migraine	disease	C10	Disease or Syndrome	0.32	0.75	2000	2017	   2	   0	CTD_human
      796	CALCA	0.416	0.923	C0338489	Status Migrainosus	disease	C10	Disease or Syndrome	0.30	1	2003	2007	   2	   0	CTD_human
      796	CALCA	0.416	0.923	C0344315	Depressed mood	phenotype	F01	Mental or Behavioral Dysfunction	0.33	1	2006	2018	   1	   0	PSYGENET
      796	CALCA	0.416	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	1	2001	2019	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0393786	Trigeminal Neuralgia, Idiopathic	disease	C10;C07	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0393787	Secondary Trigeminal Neuralgia	disease	C10;C07	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0432416	Down Syndrome, Partial Trisomy 21	disease	C16;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0432417	Trisomy 21, Meiotic Nondisjunction	disease	C16;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2003	2016	   4	   0	CTD_human
      796	CALCA	0.416	0.923	C0521664	Acute Confusional Migraine	disease	C10	Disease or Syndrome	0.30	1	2003	2007	   2	   0	CTD_human
      796	CALCA	0.416	0.923	C0600467	Neurogenic Inflammation	disease	C23;C10	Injury or Poisoning	0.30	1	2007	2007	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0700438	Sick Headaches	disease	C10	Disease or Syndrome	0.30	1	2003	2007	   2	   0	CTD_human
      796	CALCA	0.416	0.923	C0751081	Trisomy 21, Mitotic Nondisjunction	disease	C16;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2016	   4	   0	CTD_human
      796	CALCA	0.416	0.923	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2016	   4	   0	CTD_human
      796	CALCA	0.416	0.923	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.31	1	2003	2019	   4	   0	CTD_human
      796	CALCA	0.416	0.923	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2016	   4	   0	CTD_human
      796	CALCA	0.416	0.923	C0751217	Hyperkinesia, Generalized	phenotype	C23;C10	Sign or Symptom	0.30	1	1982	1983	   2	   0	CTD_human
      796	CALCA	0.416	0.923	C0751924	Neuralgia-Neuritis, Sciatic Nerve	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0751925	Sciatic Nerve Palsy	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0971858	Arthritis, Collagen-Induced	disease	C05	Experimental Model of Disease	0.30	1	2007	2007	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C0993582	Arthritis, Experimental	disease	C05	Experimental Model of Disease	0.30	1	2007	2007	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2016	   4	   0	CTD_human
      796	CALCA	0.416	0.923	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      796	CALCA	0.416	0.923	C3887506	Hyperkinesia	phenotype	C23;C10	Disease or Syndrome	0.30	1	1982	1983	   2	   0	CTD_human
      796	CALCA	0.416	0.923	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      799	CALCR	0.464	0.846	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
      799	CALCR	0.464	0.846	C0020437	Hypercalcemia	disease	C18	Disease or Syndrome	0.31	1	1995	2008	   1	   0	CTD_human
      799	CALCR	0.464	0.846	C0026141	Milk-Alkali Syndrome	disease	C18	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      799	CALCR	0.464	0.846	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.50	1	2000	2018	   0	   0	CTD_human
      799	CALCR	0.464	0.846	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
      799	CALCR	0.464	0.846	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
      800	CALD1	0.578	0.692	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      800	CALD1	0.578	0.692	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      800	CALD1	0.578	0.692	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      800	CALD1	0.578	0.692	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      800	CALD1	0.578	0.692	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      800	CALD1	0.578	0.692	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.33	1	2001	2019	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0006868	Cannabis Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0006870	Cannabis Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0018614	Hashish Abuse	disease	C25;F03	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2006	2020	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0031391	Phencyclidine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0035828	Romano-Ward Syndrome	disease	C23;C16;C14	Disease or Syndrome	0.30	1	2013	2014	   2	   0	ORPHANET
      801	CALM1	0.472	0.808	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0236735	Cannabis-Related Disorder	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0236742	Phencyclidine-Related Disorders	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0340485	Familial ventricular tachycardia	disease	C23;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
      801	CALM1	0.472	0.808	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	disease	C23;C14	Disease or Syndrome	0.74	1	2009	2019	   2	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET
      801	CALM1	0.472	0.808	C2677794	Stress-induced polymorphic ventricular tachycardia	disease	C23;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
      801	CALM1	0.472	0.808	C3554047	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4	disease		Disease or Syndrome	0.60	1	2005	2016	   6	   3	GENOMICS_ENGLAND;UNIPROT
      801	CALM1	0.472	0.808	C4015671	LONG QT SYNDROME 14	disease		Disease or Syndrome	0.70	1	2005	2016	   7	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
      805	CALM2	0.472	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2000	2013	   2	   0	PSYGENET
      805	CALM2	0.472	0.808	C0006868	Cannabis Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0006870	Cannabis Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	0.8	2005	2014	   5	   0	PSYGENET
      805	CALM2	0.472	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	0.8	2005	2014	   5	   0	PSYGENET
      805	CALM2	0.472	0.808	C0018614	Hashish Abuse	disease	C25;F03	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2006	2020	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0031391	Phencyclidine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0035828	Romano-Ward Syndrome	disease	C23;C16;C14	Disease or Syndrome	0.40	1	2013	2014	   2	   1	ORPHANET
      805	CALM2	0.472	0.808	C0236735	Cannabis-Related Disorder	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0236742	Phencyclidine-Related Disorders	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0588008	Severe depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	PSYGENET
      805	CALM2	0.472	0.808	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	ORPHANET
      805	CALM2	0.472	0.808	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	disease	C23;C14	Disease or Syndrome	0.34	1	2014	2019	   1	   0	ORPHANET
      805	CALM2	0.472	0.808	C4015695	LONG QT SYNDROME 15	disease		Disease or Syndrome	0.70	1	2013	2016	   6	   6	CTD_human;GENOMICS_ENGLAND;UNIPROT
      808	CALM3	0.485	0.846	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	disease	C23;C14	Disease or Syndrome	0.34	1	2016	2019	   0	   0	ORPHANET
      810	CALML3	0.621	0.5	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.31	1	2017	2019	   1	   0	CTD_human
      810	CALML3	0.621	0.5	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0001815	Primary Myelofibrosis	disease	C15	Neoplastic Process	0.80	0.929	2013	2020	   2	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
      811	CALR	0.413	0.923	C0004565	Melanoma, B16	disease	C04	Neoplastic Process; Experimental Model of Disease	0.31	1	2006	2006	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	PSYGENET
      811	CALR	0.413	0.923	C0009075	Melanoma, Cloudman S91	disease	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.909	2007	2020	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0018598	Melanoma, Harding-Passey	disease	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0025205	Melanoma, Experimental	disease	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0026987	Myelofibrosis	disease	C23;C04;C15	Neoplastic Process	0.60	0.933	2013	2020	   2	   0	GENOMICS_ENGLAND;ORPHANET
      811	CALR	0.413	0.923	C0027022	Myeloproliferative disease	group	C15	Neoplastic Process	0.50	1	2013	2020	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2007	2009	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0033937	Psychoses, Drug	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
      811	CALR	0.413	0.923	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.33	1	2011	2012	   2	   0	PSYGENET
      811	CALR	0.413	0.923	C0036337	Schizoaffective Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2008	2010	   2	   0	PSYGENET
      811	CALR	0.413	0.923	C0036349	Paranoid Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      811	CALR	0.413	0.923	C0036939	Shared Paranoid Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      811	CALR	0.413	0.923	C0040028	Thrombocythemia, Essential	disease	C15	Disease or Syndrome	0.60	0.969	2013	2020	   2	   0	CTD_human;ORPHANET
      811	CALR	0.413	0.923	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.31	1	2005	2017	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.40	1	2009	2020	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0349204	Nonorganic psychosis	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2011	2012	   2	   0	PSYGENET
      811	CALR	0.413	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.923	2003	2020	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0376545	Hematologic Neoplasms	group	C04;C15	Neoplastic Process	0.43	1	2014	2018	   0	   0	CGI
      811	CALR	0.413	0.923	C3277671	THROMBOCYTHEMIA 1	disease		Disease or Syndrome	0.40	1	2013	2013	   1	   1	GENOMICS_ENGLAND
      811	CALR	0.413	0.923	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.42	1	2015	2020	   0	   0	CGI
      811	CALR	0.413	0.923	C3489628	Thrombocytosis, Autosomal Dominant	disease	C15	Disease or Syndrome	0.30				   0	   0	CTD_human
      813	CALU	0.7	0.385	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      813	CALU	0.7	0.385	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      813	CALU	0.7	0.385	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      813	CALU	0.7	0.385	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      813	CALU	0.7	0.385	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      814	CAMK4	0.621	0.654	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      814	CAMK4	0.621	0.654	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      814	CAMK4	0.621	0.654	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      814	CAMK4	0.621	0.654	C0345958	Large cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30				   0	   1	UNIPROT
      814	CAMK4	0.621	0.654	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.51	1	2008	2008	   1	   0	CTD_human;PSYGENET
      815	CAMK2A	0.612	0.538	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
      815	CAMK2A	0.612	0.538	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.52	1	2011	2019	   1	   0	PSYGENET
      815	CAMK2A	0.612	0.538	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.32	1	2006	2011	   1	   0	PSYGENET
      815	CAMK2A	0.612	0.538	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2006	2011	   1	   0	PSYGENET
      815	CAMK2A	0.612	0.538	C0019202	Hepatolenticular Degeneration	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2017	2017	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.50	1	2007	2010	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      815	CAMK2A	0.612	0.538	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2004	2014	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      815	CAMK2A	0.612	0.538	C1527352	Hepatic Form of Wilson Disease	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.43	1	2014	2018	   2	   0	GENOMICS_ENGLAND
      815	CAMK2A	0.612	0.538	C4540481	MENTAL RETARDATION, AUTOSOMAL DOMINANT 53	disease		Mental or Behavioral Dysfunction	0.40	1	2015	2018	   4	   8	UNIPROT
      815	CAMK2A	0.612	0.538	C4748167	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63	disease		Disease or Syndrome	0.30	1	2018	2018	   1	   1	UNIPROT
      816	CAMK2B	0.626	0.538	C0006868	Cannabis Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0006870	Cannabis Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0018614	Hashish Abuse	disease	C25;F03	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0031391	Phencyclidine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0033937	Psychoses, Drug	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0033941	Psychoses, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2000	2010	   2	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0236735	Cannabis-Related Disorder	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0236742	Phencyclidine-Related Disorders	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
      816	CAMK2B	0.626	0.538	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.41	1	2017	2018	   1	   0	GENOMICS_ENGLAND
      816	CAMK2B	0.626	0.538	C4540484	MENTAL RETARDATION, AUTOSOMAL DOMINANT 54	disease		Disease or Syndrome	0.60	1	2017	2018	   2	   7	GENOMICS_ENGLAND;UNIPROT
      817	CAMK2D	0.743	0.308	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.40	1	2018	2018	   2	   2	CTD_human
      817	CAMK2D	0.743	0.308	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      817	CAMK2D	0.743	0.308	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      817	CAMK2D	0.743	0.308	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      817	CAMK2D	0.743	0.308	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   2	   0	CTD_human
      817	CAMK2D	0.743	0.308	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      817	CAMK2D	0.743	0.308	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
      817	CAMK2D	0.743	0.308	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
      818	CAMK2G	0.67	0.462	C4552072	X-linked infantile spasms	disease	C10	Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      821	CANX	0.582	0.769	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
      821	CANX	0.582	0.769	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      821	CANX	0.582	0.769	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      821	CANX	0.582	0.769	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      821	CANX	0.582	0.769	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      821	CANX	0.582	0.769	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      821	CANX	0.582	0.769	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.32	1	1999	2019	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C0025202	melanoma	disease	C04	Neoplastic Process	0.32	1	2012	2019	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C0027651	Neoplasms	group	C04	Neoplastic Process	0.38	0.778	1999	2019	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C0029134	Optic Neuritis	disease	C11;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C0085582	Retrobulbar Neuritis	disease	C11;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C0524679	Neuropapillitis	disease	C11;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C4310800	SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.71	1	2016	2019	   2	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      824	CAPN2	0.59	0.692	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      824	CAPN2	0.59	0.692	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      824	CAPN2	0.59	0.692	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      825	CAPN3	0.564	0.615	C0686353	Muscular Dystrophies, Limb-Girdle	group	C16;C05;C10	Disease or Syndrome	0.40	0.986	1993	2020	   0	   0	GENOMICS_ENGLAND
      825	CAPN3	0.564	0.615	C1299884	Eosinophilic myositis (disorder)	disease	C16;C05;C10	Disease or Syndrome	0.62	1	2000	2010	   0	   1	CTD_human
      825	CAPN3	0.564	0.615	C1869123	Limb-girdle muscular dystrophy type 2A	disease	C16;C05;C10	Disease or Syndrome	1.00	0.994	1995	2019	  10	 146	CTD_human;GENOMICS_ENGLAND;UNIPROT
      826	CAPNS1	0.674	0.538	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      826	CAPNS1	0.674	0.538	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2007	2018	   1	   0	CTD_human
      827	CAPN6	0.839	0.077	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      829	CAPZA1	0.821	0.115	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      831	CAST	0.541	0.846	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2007	2007	   1	   0	CTD_human
      831	CAST	0.541	0.846	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      831	CAST	0.541	0.846	C4225381	PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS	disease		Disease or Syndrome	0.72	1	2015	2019	   1	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET
      832	CAPZB	0.729	0.308	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C0948089	Acute Coronary Syndrome	disease	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      833	CARS1	0.722	0.538	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
      833	CARS1	0.722	0.538	C0025958	Microcephaly	disease	C16;C05;C10	Congenital Abnormality	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      833	CARS1	0.722	0.538	C0263490	Brittle hair	disease		Disease or Syndrome	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      833	CARS1	0.722	0.538	C0334121	Inflammatory Myofibroblastic Tumor	disease	C23	Neoplastic Process	0.31	1	2002	2003	   2	   0	ORPHANET
      833	CARS1	0.722	0.538	C1856963	Fragile nails	phenotype	C23	Finding	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      833	CARS1	0.722	0.538	C4022738	Neurodevelopmental delay	phenotype		Finding	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      834	CASP1	0.413	0.885	C0001925	Albuminuria	phenotype	C23;C13;C12	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.32	1	2012	2019	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0026769	Multiple Sclerosis	disease	C20;C10	Disease or Syndrome	0.36	1	1999	2018	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.32	1	2011	2018	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.31	1	2011	2019	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0598608	Hyperhomocysteinemia	disease	C16;C18	Disease or Syndrome	0.31	1	2012	2017	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0751324	Multiple Sclerosis, Acute Fulminating	disease	C20;C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C1527304	Allergic Reaction	phenotype	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.31	1	2002	2002	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.31	1	2000	2011	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.31	1	2002	2004	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.31	1	2010	2010	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.31	1	2010	2010	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2010	2010	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.60	0.98	1999	2020	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0006663	Calcinosis	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.34	1	2002	2019	   2	   0	CTD_human
      836	CASP3	0.351	0.923	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.31	1	2013	2015	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0010417	Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.50	1	2015	2018	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2008	2017	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.39	1	2004	2020	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0011875	Diabetic Angiopathies	disease	C19;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0011882	Diabetic Neuropathies	group	C10;C19	Disease or Syndrome	0.51	1	2003	2017	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0011884	Diabetic Retinopathy	disease	C11;C19;C14	Disease or Syndrome	0.51	0.667	2008	2019	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0013604	Edema	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0014476	Eperythrozoonosis	disease	C01	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0018824	Heart valve disease	group	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0019189	Hepatitis, Chronic	disease	C06	Disease or Syndrome	0.31	1	1999	2012	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0025945	Microangiopathy, Diabetic	disease	C19;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0026936	Mycoplasma Infections	group	C01	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.60	1	2002	2019	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.50	1	2004	2018	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.32	1	2002	2018	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0034189	Pyemia	phenotype	C23;C01	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.50	1	2008	2018	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0035305	Retinal Detachment	disease	C11	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
      836	CASP3	0.351	0.923	C0036690	Septicemia	disease	C23;C01	Disease or Syndrome	0.40	1	2005	2020	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.57	1	2006	2019	   2	   0	CTD_human
      836	CASP3	0.351	0.923	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2010	2010	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0038525	Subarachnoid Hemorrhage	disease	C23;C10;C14	Disease or Syndrome	0.60	0.96	2014	2019	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0149504	Encephalopathy, Toxic	disease	C10;C25	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0149519	Chronic Persistent Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0151603	Anasarca	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0154659	Toxic Encephalitis	disease	C10;C25	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0235032	Neurotoxicity Syndromes	group	C10;C25	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.60	1	2005	2020	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0263628	Tumoral calcinosis	disease	C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0270192	Perinatal Subarachnoid Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2008	   2	   0	CTD_human
      836	CASP3	0.351	0.923	C0271673	Symmetric Diabetic Proximal Motor Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0271674	Asymmetric Diabetic Proximal Motor Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0271678	Diabetic Mononeuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0271680	Diabetic Polyneuropathies	group	C10;C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0271685	Diabetic Amyotrophy	disease	C10;C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0271686	Diabetic Autonomic Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.33	1	2001	2008	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2008	   2	   0	CTD_human
      836	CASP3	0.351	0.923	C0339546	Retinal Pigment Epithelial Detachment	disease	C11	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2008	   2	   0	CTD_human
      836	CASP3	0.351	0.923	C0393835	Diabetic Asymmetric Polyneuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0431663	Bilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0431664	Unilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0472383	Subarachnoid Hemorrhage, Spontaneous	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0520463	Chronic active hepatitis	disease	C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0521174	Microcalcification	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0524611	Cryptogenic Chronic Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0751074	Diabetic Neuralgia	disease	C10;C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2008	   2	   0	CTD_human
      836	CASP3	0.351	0.923	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2008	   2	   0	CTD_human
      836	CASP3	0.351	0.923	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2008	   2	   0	CTD_human
      836	CASP3	0.351	0.923	C0751530	Subarachnoid Hemorrhage, Aneurysmal	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0795688	Subarachnoid Hemorrhage, Intracranial	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2002	2008	   2	   0	CTD_human
      836	CASP3	0.351	0.923	C1563730	Abdominal Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C1563731	Inguinal Cryptorchidism	phenotype	C16;C12;C19	Finding	0.30	1	2015	2015	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C1719672	Severe Sepsis	disease	C23;C01	Disease or Syndrome	0.31	1	2005	2018	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C1876165	Copper-Overload Cirrhosis	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.50	1	2008	2017	   1	   0	CTD_human
      837	CASP4	0.636	0.654	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      837	CASP4	0.636	0.654	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      840	CASP7	0.581	0.654	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.32	1	2006	2018	   1	   0	CTD_human
      840	CASP7	0.581	0.654	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      840	CASP7	0.581	0.654	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      840	CASP7	0.581	0.654	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      840	CASP7	0.581	0.654	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.50	1	2004	2018	   1	   0	CTD_human
      840	CASP7	0.581	0.654	C0042900	Vitiligo	disease	C17	Disease or Syndrome	0.40	1	2012	2016	   1	   2	CTD_human
      840	CASP7	0.581	0.654	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.31	1	2006	2011	   1	   0	CTD_human
      840	CASP7	0.581	0.654	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      840	CASP7	0.581	0.654	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      840	CASP7	0.581	0.654	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      840	CASP7	0.581	0.654	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.32	1	2005	2013	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2001	2001	   1	   0	PSYGENET
      841	CASP8	0.404	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.60	0.979	2004	2019	   4	   0	CGI;CTD_human
      841	CASP8	0.404	0.923	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.50	1	2007	2019	   1	   1	CTD_human
      841	CASP8	0.404	0.923	C0007873	Uterine Cervical Neoplasm	disease	C04;C13	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.944	2003	2019	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2003	2007	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0013604	Edema	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.41	1	2007	2012	   2	   1	CTD_human
      841	CASP8	0.404	0.923	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.34	1	2010	2017	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.35	1	2002	2007	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.37	1	2002	2018	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0025202	melanoma	disease	C04	Neoplastic Process	0.47	1	2001	2015	   2	   1	CTD_human
      841	CASP8	0.404	0.923	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.50	1	2002	2004	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.50	1	2004	2008	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0151603	Anasarca	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0162820	Dermatitis, Allergic Contact	disease	C17;C20	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.37	1	2002	2014	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0279607	Adult Hepatocellular Carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	ORPHANET
      841	CASP8	0.404	0.923	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0343641	Human papilloma virus infection	disease	C01	Disease or Syndrome	0.31	1	2011	2013	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
      841	CASP8	0.404	0.923	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2007	2011	   2	   0	CTD_human
      841	CASP8	0.404	0.923	C0585362	Squamous cell carcinoma of mouth	disease	C06;C04;C07	Neoplastic Process	0.30				   0	   0	CGI
      841	CASP8	0.404	0.923	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.70	0.98	2004	2019	   4	   1	CGI;CTD_human
      841	CASP8	0.404	0.923	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
      841	CASP8	0.404	0.923	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.36	1	2009	2016	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2004	2018	   4	   0	CTD_human
      841	CASP8	0.404	0.923	C1328840	Autoimmune Lymphoproliferative Syndrome	disease	C16;C20;C15	Disease or Syndrome	0.33	1	2004	2019	   0	   0	CTD_human
      841	CASP8	0.404	0.923	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.38	1	2004	2018	   4	   0	CTD_human
      841	CASP8	0.404	0.923	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C1846545	Autoimmune Lymphoproliferative Syndrome Type 2B	disease	C16;C20;C15	Disease or Syndrome	0.94	1	2002	2019	   3	   1	CTD_human;ORPHANET;UNIPROT
      841	CASP8	0.404	0.923	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.32	1	2006	2011	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.90	1	1998	2019	   0	   1	CGI;CTD_human
      841	CASP8	0.404	0.923	C2717884	Autoimmune Lymphoproliferative Syndrome Type 1, Autosomal Dominant	disease	C16;C20;C15	Disease or Syndrome	0.30				   0	   0	CTD_human
      841	CASP8	0.404	0.923	C2931456	Prostate cancer, familial	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.50	1	2008	2017	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C4048328	cervical cancer	disease	C04;C13	Neoplastic Process	0.35	0.667	2007	2018	   1	   0	CTD_human
      841	CASP8	0.404	0.923	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2004	2018	   4	   0	CTD_human
      841	CASP8	0.404	0.923	C4722327	PROSTATE CANCER, HEREDITARY, 1	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0007787	Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.50	1	2001	2011	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0013604	Edema	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.50	1	2002	2018	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2006	2007	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0035305	Retinal Detachment	disease	C11	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0151603	Anasarca	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0339546	Retinal Pigment Epithelial Detachment	disease	C11	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.909	2001	2017	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0472381	Posterior Circulation Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0751019	Carotid Circulation Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0751020	Transient Ischemic Attack, Vertebrobasilar Circulation	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0751021	Crescendo Transient Ischemic Attacks	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0751022	Brain Stem Ischemia, Transient	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C0917805	Transient Cerebral Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C1527335	Transient Ischemic Attack, Anterior Circulation	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      842	CASP9	0.458	0.808	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      843	CASP10	0.528	0.692	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      843	CASP10	0.528	0.692	C0024302	Reticulosarcoma	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CTD_human
      843	CASP10	0.528	0.692	C0024304	Lymphoma, Mixed-Cell	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CTD_human
      843	CASP10	0.528	0.692	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.54	1	2002	2017	   0	   0	CGI;CTD_human
      843	CASP10	0.528	0.692	C0024306	Lymphoma, Undifferentiated	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CTD_human
      843	CASP10	0.528	0.692	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.61	1	2002	2002	   0	   0	CGI;CTD_human
      843	CASP10	0.528	0.692	C0025202	melanoma	disease	C04	Neoplastic Process	0.31	1	2008	2008	   1	   0	CTD_human
      843	CASP10	0.528	0.692	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      843	CASP10	0.528	0.692	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.60				   0	   2	CGI;CTD_human
      843	CASP10	0.528	0.692	C0079740	High Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CTD_human
      843	CASP10	0.528	0.692	C0079741	Lymphoma, Intermediate-Grade	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CTD_human
      843	CASP10	0.528	0.692	C0079747	Low Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CTD_human
      843	CASP10	0.528	0.692	C0079757	Diffuse Mixed-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CTD_human
      843	CASP10	0.528	0.692	C0079770	Lymphoma, Small Noncleaved-Cell	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CTD_human
      843	CASP10	0.528	0.692	C0153943	Benign neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      843	CASP10	0.528	0.692	C0154060	Carcinoma in situ of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      843	CASP10	0.528	0.692	C0496905	Neoplasm of uncertain or unknown behavior of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      843	CASP10	0.528	0.692	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.51	1	2002	2002	   1	   1	CGI;UNIPROT
      843	CASP10	0.528	0.692	C1328840	Autoimmune Lymphoproliferative Syndrome	disease	C16;C20;C15	Disease or Syndrome	0.40	1	1999	2019	   2	   0	ORPHANET
      843	CASP10	0.528	0.692	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CTD_human
      843	CASP10	0.528	0.692	C1858968	Autoimmune Lymphoproliferative Syndrome, Type IIA	disease	C16;C20;C15	Disease or Syndrome	0.73	1	1999	2011	   2	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      843	CASP10	0.528	0.692	C3714542	Lymphoma, Diffuse	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CTD_human
      843	CASP10	0.528	0.692	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.62	1	2002	2017	   1	   3	CTD_human;UNIPROT
      844	CASQ1	0.722	0.423	C0410207	Tubular Aggregate Myopathy	disease	C05;C10	Disease or Syndrome	0.32	1	2017	2018	   2	   0	ORPHANET
      844	CASQ1	0.722	0.423	C4011726	MYOPATHY, TUBULAR AGGREGATE, 1	disease	C05;C10	Disease or Syndrome	0.30	1	2017	2017	   1	   2	UNIPROT
      844	CASQ1	0.722	0.423	C4015624	MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES	disease		Disease or Syndrome	0.70	1	2014	2017	   4	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      845	CASQ2	0.691	0.385	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.41	1	2018	2018	   2	   2	CTD_human
      845	CASQ2	0.691	0.385	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.50				   0	   0	CLINGEN;GENOMICS_ENGLAND
      845	CASQ2	0.691	0.385	C0042514	Tachycardia, Ventricular	disease	C23;C14	Disease or Syndrome	0.69	1	2001	2017	   1	   0	CTD_human
      845	CASQ2	0.691	0.385	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   2	   0	CTD_human
      845	CASQ2	0.691	0.385	C0340485	Familial ventricular tachycardia	disease	C23;C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      845	CASQ2	0.691	0.385	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.31	1	2015	2015	   0	   0	GENOMICS_ENGLAND
      845	CASQ2	0.691	0.385	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	disease	C23;C14	Disease or Syndrome	0.70	0.979	2001	2019	   1	   8	CTD_human;GENOMICS_ENGLAND
      845	CASQ2	0.691	0.385	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
      845	CASQ2	0.691	0.385	C2677794	Stress-induced polymorphic ventricular tachycardia	disease	C23;C14	Disease or Syndrome	0.95	1	2001	2018	   7	   7	CTD_human;GENOMICS_ENGLAND;UNIPROT
      845	CASQ2	0.691	0.385	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
      846	CASR	0.41	0.846	C0020437	Hypercalcemia	disease	C18	Disease or Syndrome	0.50	0.955	1976	2020	   1	   2	CTD_human
      846	CASR	0.41	0.846	C0020502	Hyperparathyroidism	disease	C19	Disease or Syndrome	0.70	0.966	1996	2019	   2	   0	CTD_human
      846	CASR	0.41	0.846	C0020598	Hypocalcemia	phenotype	C18	Disease or Syndrome	0.50	1	1994	2019	   2	   0	CTD_human
      846	CASR	0.41	0.846	C0020626	Hypoparathyroidism	disease	C19	Disease or Syndrome	0.50	0.917	1995	2019	   1	   1	CTD_human
      846	CASR	0.41	0.846	C0026141	Milk-Alkali Syndrome	disease	C18	Disease or Syndrome	0.30	1	1997	1997	   1	   0	CTD_human
      846	CASR	0.41	0.846	C0030305	Pancreatitis	disease	C06	Disease or Syndrome	0.46	0.667	1996	2014	   1	   0	GENOMICS_ENGLAND
      846	CASR	0.41	0.846	C0238339	Hereditary pancreatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	ORPHANET
      846	CASR	0.41	0.846	C0270850	Idiopathic generalized epilepsy	disease	C10	Disease or Syndrome	0.31	1	2008	2008	   0	   0	CTD_human
      846	CASR	0.41	0.846	C0342342	Idiopathic Hypoparathyroidism	disease	C19	Disease or Syndrome	0.40	1	2000	2017	   1	   0	CTD_human
      846	CASR	0.41	0.846	C0342637	Hypocalciuric hypercalcemia, familial, type 1	disease	C18	Disease or Syndrome	1.00	0.993	1976	2020	  32	  42	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      846	CASR	0.41	0.846	C1809471	Familial benign hypercalcemia	disease	C16;C18;C19	Disease or Syndrome	0.70	0.989	1991	2018	   0	  32	ORPHANET
      846	CASR	0.41	0.846	C1832612	Hypocalcemia, Autosomal Dominant, with Bartter Syndrome	disease	C18;C13;C12;C19	Disease or Syndrome	0.30				   0	   0	CTD_human
      846	CASR	0.41	0.846	C1832615	HYPERPARATHYROIDISM, NEONATAL SEVERE	disease	C16;C19	Disease or Syndrome	0.80	0.962	1995	2020	  10	  11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      846	CASR	0.41	0.846	C1832648	Hypoparathyroidism familial isolated	disease	C19	Disease or Syndrome	0.33	0.667	1997	2017	   1	   0	CTD_human
      846	CASR	0.41	0.846	C2752062	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8	disease		Finding	0.30	1	2008	2008	   1	   3	UNIPROT
      846	CASR	0.41	0.846	C3715128	HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	disease		Disease or Syndrome	0.92	1	1994	2019	  24	  22	GENOMICS_ENGLAND;ORPHANET;UNIPROT
      846	CASR	0.41	0.846	C3875492	Hypocalciuric hypercalcemia	disease	C18	Disease or Syndrome	0.37	1	1998	2017	   0	   0	GENOMICS_ENGLAND
      846	CASR	0.41	0.846	C4048195	Autosomal dominant hypocalcemia	disease	C16;C18	Disease or Syndrome	0.70	1	1995	2019	   3	   1	ORPHANET
      846	CASR	0.41	0.846	C4551961	Familial Isolated Hyperparathyroidism	disease	C19	Disease or Syndrome	0.35	1	2004	2019	   1	   0	GENOMICS_ENGLAND
      846	CASR	0.41	0.846	C4552089	HYPOCALCEMIA, AUTOSOMAL DOMINANT 1, WITH BARTTER SYNDROME	disease		Disease or Syndrome	0.50	1	1999	2012	   3	   0	ORPHANET
      847	CAT	0.359	0.962	C0000771	Abnormalities, Drug-Induced	group	C16	Congenital Abnormality	0.30	1	2011	2015	   2	   0	CTD_human
      847	CAT	0.359	0.962	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	1995	2015	   2	   0	PSYGENET
      847	CAT	0.359	0.962	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2002	2010	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0003493	Aortic Diseases	group	C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0003865	Arthritis, Adjuvant-Induced	disease	C05	Experimental Model of Disease	0.30	1	2012	2012	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.40	0.917	2006	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0004045	Asphyxia Neonatorum	disease	C16	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.40	0.857	1995	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0004943	Behcet Syndrome	disease	C16;C11;C17;C07;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.963	1997	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.968	2001	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.33	1	1995	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2010	2017	   6	   0	CTD_human
      847	CAT	0.359	0.962	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.51	1	2004	2018	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.52	1	2011	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0008909	Claustrophobia	phenotype	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0011574	Involutional Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0011849	Diabetes Mellitus	group	C18;C19	Disease or Syndrome	0.40	0.976	2000	2020	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2002	2010	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0011854	Diabetes Mellitus, Insulin-Dependent	disease	C18;C20;C19	Disease or Syndrome	0.40	0.923	2001	2018	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.40	0.952	1992	2019	   2	   0	CTD_human
      847	CAT	0.359	0.962	C0011882	Diabetic Neuropathies	group	C10;C19	Disease or Syndrome	0.33	1	2000	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0013386	Dyskinesia, Drug-Induced	disease	C23;C10;C25	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0013604	Edema	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.51	1	1995	2011	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0015923	Fetal Alcohol Syndrome	disease	C16;C13;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0017638	Glioma	disease	C04	Neoplastic Process	0.33	1	2008	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.31	1	2005	2017	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.34	1	2005	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0019158	Hepatitis	group	C06	Disease or Syndrome	0.32	1	1991	2017	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0019189	Hepatitis, Chronic	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2011	2015	   2	   0	CTD_human
      847	CAT	0.359	0.962	C0020452	Hyperemia	disease	C14	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.60	0.957	2001	2020	   4	   0	CTD_human
      847	CAT	0.359	0.962	C0020550	Hyperthyroidism	disease	C19	Disease or Syndrome	0.52	1	2010	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	2004	2004	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0022593	Keratosis	disease	C17	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0022594	Keratosis Blennorrhagica	disease	C17	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0022650	Kidney Calculi	disease	C23;C13;C12	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.50	1	2006	2010	   2	   0	CTD_human
      847	CAT	0.359	0.962	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0023891	Liver Cirrhosis, Alcoholic	disease	C23;C06;C25	Disease or Syndrome	0.31	1	2009	2013	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.40	0.818	2005	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0024796	Marfan Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0025500	Mesothelioma	disease	C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.54	1	2003	2018	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.50	1	2001	2011	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	1998	2007	   2	   0	CTD_human
      847	CAT	0.359	0.962	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2011	2012	   2	   0	CTD_human
      847	CAT	0.359	0.962	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.39	1	1996	2019	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0027651	Neoplasms	group	C04	Neoplastic Process	0.40	1	1986	2020	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0029458	Osteoporosis, Postmenopausal	disease	C18;C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0030246	Pustulosis of Palms and Soles	disease	C17	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.31	1	2003	2003	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0033626	Protein Deficiency	disease	C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0033860	Psoriasis	disease	C17	Disease or Syndrome	0.33	1	2002	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0034063	Pulmonary Edema	phenotype	C08	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0034065	Pulmonary Embolism	disease	C08;C14	Pathologic Function	0.30	1	1989	1989	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.32	1	2009	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.50	1	1993	2014	   4	   0	CTD_human
      847	CAT	0.359	0.962	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.36	1	2001	2019	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.31	1	2004	2018	   4	   0	CTD_human
      847	CAT	0.359	0.962	C0038358	Gastric ulcer	disease	C06	Disease or Syndrome	0.50	1	1991	2007	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2002	2010	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0041408	Turner Syndrome	disease	C16;C13;C12;C19;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2019	   1	   0	PSYGENET
      847	CAT	0.359	0.962	C0042484	Venous Engorgement	phenotype	C14	Pathologic Function	0.30	1	2000	2000	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0086501	Keratoma	disease	C17	Acquired Abnormality	0.30	1	2003	2003	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0149519	Chronic Persistent Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0151526	Premature Birth	phenotype	C13	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0151603	Anasarca	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0178824	Reactive Hyperemia	phenotype	C14	Pathologic Function	0.30	1	2000	2000	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0205734	Diabetes, Autoimmune	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2000	2005	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0242380	Libman-Sacks Disease	disease	C17;C20	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0242488	Acute Lung Injury	disease	C08	Injury or Poisoning	0.30	1	2004	2004	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0242526	Gonadal Dysgenesis, 45,X	disease	C16;C13;C12;C19;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0268419	Acatalasia	disease	C16;C18	Disease or Syndrome	0.70	1	1988	2019	   7	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
      847	CAT	0.359	0.962	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2008	   4	   0	CTD_human
      847	CAT	0.359	0.962	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0271673	Symmetric Diabetic Proximal Motor Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0271674	Asymmetric Diabetic Proximal Motor Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0271678	Diabetic Mononeuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0271680	Diabetic Polyneuropathies	group	C10;C19	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0271685	Diabetic Amyotrophy	disease	C10;C19	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0271686	Diabetic Autonomic Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2008	   4	   0	CTD_human
      847	CAT	0.359	0.962	C0333233	Active Hyperemia	phenotype	C14	Pathologic Function	0.30	1	2000	2000	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0333704	Chromosome Breaks	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0342302	Brittle diabetes	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0349231	Phobic anxiety disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0376628	Chromosome Breakage	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2008	   4	   0	CTD_human
      847	CAT	0.359	0.962	C0393835	Diabetic Asymmetric Polyneuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.37	1	2007	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0520463	Chronic active hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0524611	Cryptogenic Chronic Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0524702	Pulmonary Thromboembolisms	disease	C08;C14	Disease or Syndrome	0.30	1	1989	1989	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.31	1	2011	2013	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.964	1987	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0751074	Diabetic Neuralgia	disease	C10;C19	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0751088	Dyskinesia, Medication-Induced	phenotype	C23;C10;C25	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2008	   4	   0	CTD_human
      847	CAT	0.359	0.962	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2008	   4	   0	CTD_human
      847	CAT	0.359	0.962	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2008	   4	   0	CTD_human
      847	CAT	0.359	0.962	C0752048	Hypocatalasemia	disease	C16;C18	Disease or Syndrome	0.32	1	1990	2015	   5	   0	CTD_human
      847	CAT	0.359	0.962	C0814154	Alcohol Related Neurodevelopmental Disorder	disease	C16;C13;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2011	2015	   2	   0	CTD_human
      847	CAT	0.359	0.962	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.34	0.8	2000	2018	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0971858	Arthritis, Collagen-Induced	disease	C05	Experimental Model of Disease	0.30	1	2012	2012	   1	   0	CTD_human
      847	CAT	0.359	0.962	C0993582	Arthritis, Experimental	disease	C05	Experimental Model of Disease	0.30	1	2012	2012	   1	   0	CTD_human
      847	CAT	0.359	0.962	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      847	CAT	0.359	0.962	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2015	   2	   0	CTD_human
      847	CAT	0.359	0.962	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.51	1	2011	2014	   2	   0	CTD_human;PSYGENET
      847	CAT	0.359	0.962	C1456865	Ureteral Calculi	disease	C23;C13;C12	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      847	CAT	0.359	0.962	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.35	1	1995	2018	   1	   0	CTD_human
      847	CAT	0.359	0.962	C1527168	Bonnevie-Ullrich Syndrome	disease	C16;C13;C12;C19;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      847	CAT	0.359	0.962	C1571983	Involutional paraphrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      847	CAT	0.359	0.962	C1571984	Psychosis, Involutional	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      847	CAT	0.359	0.962	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      847	CAT	0.359	0.962	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
      847	CAT	0.359	0.962	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.34	1	1995	2019	   1	   0	CTD_human
      847	CAT	0.359	0.962	C2931868	Catalase deficiency	disease	C16;C18	Disease or Syndrome	0.54	1	1990	2015	   5	   0	CTD_human;ORPHANET
      847	CAT	0.359	0.962	C2936847	Acatalasemia Japanese type	disease	C16;C18	Disease or Syndrome	0.31	1	1990	2015	   5	   0	CTD_human
      847	CAT	0.359	0.962	C2936848	Acatalasemia Swiss type	disease	C16;C18	Disease or Syndrome	0.30	1	1990	2015	   5	   0	CTD_human
      847	CAT	0.359	0.962	C2985290	Fetal Alcohol Spectrum Disorders	group	C16;C13;C25	Disease or Syndrome; Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      847	CAT	0.359	0.962	C3146244	Alcohol Related Birth Defect	disease	C16;C13;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      847	CAT	0.359	0.962	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.31	1	2018	2018	   1	   0	CTD_human
      847	CAT	0.359	0.962	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2015	   2	   0	CTD_human
      847	CAT	0.359	0.962	C3661483	Partial Fetal Alcohol Syndrome	disease	C16;C13;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      847	CAT	0.359	0.962	C3714618	Primary Hyperthyroidism	disease	C19	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      847	CAT	0.359	0.962	C3837958	Diabetes Mellitus, Ketosis-Prone	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      847	CAT	0.359	0.962	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.50	1	2011	2015	   2	   0	CTD_human
      847	CAT	0.359	0.962	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2015	   2	   0	CTD_human
      847	CAT	0.359	0.962	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2011	   3	   0	CTD_human
      847	CAT	0.359	0.962	C4554117	Diabetes Mellitus, Sudden-Onset	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      847	CAT	0.359	0.962	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      847	CAT	0.359	0.962	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      847	CAT	0.359	0.962	C4721845	Marfan Syndrome, Type I	disease	C16;C17;C05;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2008	2008	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.50	0.944	2010	2019	   3	   4	CTD_human
      857	CAV1	0.388	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.80	0.977	1999	2019	   4	   1	CTD_human;UNIPROT
      857	CAV1	0.388	0.885	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2008	2014	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0011859	Lipoatrophic Diabetes Mellitus	disease	C18;C19	Disease or Syndrome	0.30	1	2008	2008	   1	   0	ORPHANET
      857	CAV1	0.388	0.885	C0014518	Toxic Epidermal Necrolysis	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0017612	Glaucoma, Open-Angle	disease	C11	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.50	1	2006	2006	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.60	1	1992	2020	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.32	1	2009	2018	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.40	1	2006	2017	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	0.99	2001	2019	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.40	1	2002	2019	   2	   0	CTD_human
      857	CAV1	0.388	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2017	   1	   0	PSYGENET
      857	CAV1	0.388	0.885	C0038325	Stevens-Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2006	2017	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2008	2008	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0206138	CREST Syndrome	disease	C06;C18;C17;C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
      857	CAV1	0.388	0.885	C0221032	Familial generalized lipodystrophy	disease	C16;C18;C17	Disease or Syndrome	0.46	1	2008	2016	   1	   0	ORPHANET
      857	CAV1	0.388	0.885	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2010	2018	   3	   0	CTD_human
      857	CAV1	0.388	0.885	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	0.957	1999	2020	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0271148	Secondary Open Angle Glaucoma	disease	C11	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0271694	Familial partial lipodystrophy	disease	C18;C17	Disease or Syndrome	0.31	1	2009	2009	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0339573	Glaucoma, Primary Open Angle	disease	C11	Disease or Syndrome	0.40	1	2010	2019	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0340543	Familial primary pulmonary hypertension	disease	C08	Disease or Syndrome	0.64	1	2012	2018	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
      857	CAV1	0.388	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.976	1998	2019	   2	   0	CTD_human
      857	CAV1	0.388	0.885	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.40	0.979	2002	2019	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.963	1999	2019	   4	   0	CTD_human
      857	CAV1	0.388	0.885	C0748540	Scleroderma, Limited	disease	C17	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
      857	CAV1	0.388	0.885	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.33	1	2005	2019	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.36	1	2000	2019	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C1150929	2-oxo-hept-3-ene-1,7-dioate hydratase activity	phenotype		Molecular Function	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      857	CAV1	0.388	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2011	   4	   0	CTD_human
      857	CAV1	0.388	0.885	C1258104	Diffuse Scleroderma	disease	C17	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
      857	CAV1	0.388	0.885	C1274933	Drug-Induced Stevens Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	1999	2017	   4	   0	CTD_human
      857	CAV1	0.388	0.885	C1701939	Familial pulmonary arterial hypertension	disease		Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
      857	CAV1	0.388	0.885	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C1720859	Familial Partial Lipodystrophy, Type 1	disease	C18;C17	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C1720860	Familial Partial Lipodystrophy, Type 2	disease	C18;C17	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C1720861	Familial Partial Lipodystrophy, Type 3	disease	C18;C17	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C1969342	PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED	disease	C08	Disease or Syndrome	0.30				   0	   0	CTD_human
      857	CAV1	0.388	0.885	C1969343	Pulmonary Hypertension, Primary, Fenfluramine-Associated	disease	C08	Disease or Syndrome	0.30				   0	   0	CTD_human
      857	CAV1	0.388	0.885	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2010	2018	   3	   0	CTD_human
      857	CAV1	0.388	0.885	C2675861	Lipodystrophy, Congenital Generalized, Type 3	disease	C16;C18;C17	Disease or Syndrome	0.61	1	2008	2015	   2	   3	CTD_human;GENOMICS_ENGLAND
      857	CAV1	0.388	0.885	C2973725	Pulmonary arterial hypertension	disease	C08;C14	Disease or Syndrome	0.50	0.909	2012	2019	   1	   0	GENOMICS_ENGLAND
      857	CAV1	0.388	0.885	C3203102	Idiopathic pulmonary arterial hypertension	disease	C08	Disease or Syndrome	0.70	0.955	2007	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
      857	CAV1	0.388	0.885	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2010	2018	   3	   0	CTD_human
      857	CAV1	0.388	0.885	C3658301	Mycoplasma-Induced Stevens-Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C3658302	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      857	CAV1	0.388	0.885	C3714844	Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia	disease	C08	Disease or Syndrome	0.30				   0	   0	CTD_human
      857	CAV1	0.388	0.885	C3807567	PARTIAL LIPODYSTROPHY, CONGENITAL CATARACTS, AND NEURODEGENERATION SYNDROME	disease		Disease or Syndrome	0.60	1	2008	2012	   2	   3	CTD_human;GENOMICS_ENGLAND
      857	CAV1	0.388	0.885	C3809192	PULMONARY HYPERTENSION, PRIMARY, 3	disease		Disease or Syndrome	0.40	1	2012	2018	   1	   4	GENOMICS_ENGLAND
      857	CAV1	0.388	0.885	C4552070	Pulmonary Hypertension, Primary, 1	disease	C08	Disease or Syndrome	0.30				   0	   0	CTD_human
      857	CAV1	0.388	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2011	   4	   0	CTD_human
      858	CAV2	0.575	0.692	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.31	1	2007	2007	   1	   0	CTD_human
      858	CAV2	0.575	0.692	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.32	1	2010	2014	   1	   0	CTD_human
      858	CAV2	0.575	0.692	C0017612	Glaucoma, Open-Angle	disease	C11	Disease or Syndrome	0.40	1	2010	2010	   1	   1	CTD_human
      858	CAV2	0.575	0.692	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      858	CAV2	0.575	0.692	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      858	CAV2	0.575	0.692	C0271148	Secondary Open Angle Glaucoma	disease	C11	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      858	CAV2	0.575	0.692	C0339573	Glaucoma, Primary Open Angle	disease	C11	Disease or Syndrome	0.40	1	2010	2018	   1	   0	CTD_human
      858	CAV2	0.575	0.692	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      858	CAV2	0.575	0.692	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      858	CAV2	0.575	0.692	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      859	CAV3	0.564	0.692	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2008	2008	   1	   0	CTD_human
      859	CAV3	0.564	0.692	C0011071	Sudden death	phenotype	C23	Pathologic Function	0.40				   0	   0	GENOMICS_ENGLAND
      859	CAV3	0.564	0.692	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.30	1	2008	2008	   1	   0	CTD_human
      859	CAV3	0.564	0.692	C0018798	Congenital Heart Defects	group	C16;C14	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
      859	CAV3	0.564	0.692	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2009	2009	   1	   0	CTD_human
      859	CAV3	0.564	0.692	C0035828	Romano-Ward Syndrome	disease	C23;C16;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
      859	CAV3	0.564	0.692	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2008	2008	   1	   0	CTD_human
      859	CAV3	0.564	0.692	C0038644	Sudden infant death syndrome	disease	C23	Disease or Syndrome	0.55	1	2007	2013	   1	   2	GENOMICS_ENGLAND;UNIPROT
      859	CAV3	0.564	0.692	C0241005	Creatine phosphokinase serum increased	phenotype		Finding	0.70	1	2000	2005	   5	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
      859	CAV3	0.564	0.692	C0686353	Muscular Dystrophies, Limb-Girdle	group	C16;C05;C10	Disease or Syndrome	0.60	1	1998	2016	   1	   0	CTD_human;GENOMICS_ENGLAND
      859	CAV3	0.564	0.692	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.35	1	2003	2016	   0	   0	GENOMICS_ENGLAND
      859	CAV3	0.564	0.692	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      859	CAV3	0.564	0.692	C1720824	Sudden Cardiac Arrest	phenotype	C23;C14	Pathologic Function	0.30				   0	   0	GENOMICS_ENGLAND
      859	CAV3	0.564	0.692	C1832560	RIPPLING MUSCLE DISEASE 2 (disorder)	disease	C05;C10	Disease or Syndrome	0.70	1	1998	2018	  15	  10	CTD_human;GENOMICS_ENGLAND;UNIPROT
      859	CAV3	0.564	0.692	C1832567	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C	disease	C16;C05;C10	Disease or Syndrome	0.40	1	2000	2019	   1	   0	CTD_human
      859	CAV3	0.564	0.692	C1838254	RIPPLING MUSCLE DISEASE 1	disease	C05;C10	Disease or Syndrome	0.31	1	2000	2018	   5	   0	CTD_human
      859	CAV3	0.564	0.692	C1853698	Rippling muscle disease	disease	C05;C10	Disease or Syndrome	0.90	1	2001	2018	   6	   1	CTD_human;ORPHANET
      859	CAV3	0.564	0.692	C2678485	LONG QT SYNDROME 9 (disorder)	disease	C23;C16;C14	Disease or Syndrome	0.74	1	2006	2018	   2	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
      859	CAV3	0.564	0.692	C2931337	Chromosome 3, monosomy 3p25	disease	C23	Cell or Molecular Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      859	CAV3	0.564	0.692	C3280443	MYOPATHY, DISTAL, TATEYAMA TYPE	disease		Disease or Syndrome	0.70	1	2002	2009	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      859	CAV3	0.564	0.692	C3495498	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	disease	C16;C14	Disease or Syndrome	0.60	1	2004	2004	   1	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      859	CAV3	0.564	0.692	C4751434	Isolated asymptomatic elevation of creatine phosphokinase	phenotype	C10	Finding	0.30	1	2000	2000	   1	   0	ORPHANET
      860	RUNX2	0.437	0.846	C0003872	Arthritis, Psoriatic	disease	C17;C05	Disease or Syndrome	0.31	1	2010	2016	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0008928	Cleidocranial Dysplasia	disease	C16;C05	Disease or Syndrome	1.00	0.976	1997	2019	  21	  16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      860	RUNX2	0.437	0.846	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0010278	Craniosynostosis	disease	C16;C05	Disease or Syndrome	0.37	1	2001	2019	   1	   0	GENOMICS_ENGLAND
      860	RUNX2	0.437	0.846	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.40	1	2008	2020	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0029410	Osteoarthritis of hip	disease	C05	Disease or Syndrome	0.40	1	2018	2019	   1	   2	CTD_human
      860	RUNX2	0.437	0.846	C0029463	Osteosarcoma	disease	C04	Neoplastic Process	0.40	1	2000	2020	   2	   0	CTD_human
      860	RUNX2	0.437	0.846	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0040427	Tooth Abnormalities	group	C16;C07	Anatomical Abnormality	0.30	1	2004	2004	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0041948	Uremia	disease	C13;C12	Disease or Syndrome	0.31	1	2003	2009	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2018	2018	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2018	2018	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0243057	Stomatognathic System Abnormalities	group	C16;C07	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.31	1	2004	2011	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0524730	Odontome	disease	C16;C07	Congenital Abnormality	0.30	1	2004	2004	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
      860	RUNX2	0.437	0.846	C0949690	Spondylarthritis	disease	C05	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      860	RUNX2	0.437	0.846	C1834969	Metaphyseal Dysplasia with Maxillary Hypoplasia and Brachydactyly	disease	C23;C16;C05	Disease or Syndrome	0.32	1	2013	2015	   0	   0	CTD_human
      860	RUNX2	0.437	0.846	C3549874	METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY	disease		Disease or Syndrome	0.63	1	2013	2018	   2	   1	GENOMICS_ENGLAND;ORPHANET
      861	RUNX1	0.425	0.808	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.49	0.786	2003	2019	   1	   2	CTD_human
      861	RUNX1	0.425	0.808	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.31	1	2013	2016	   1	   0	ORPHANET
      861	RUNX1	0.425	0.808	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.33	1	2012	2019	   1	   0	CTD_human
      861	RUNX1	0.425	0.808	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	0.969	1995	2019	   1	   0	CTD_human
      861	RUNX1	0.425	0.808	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      861	RUNX1	0.425	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.80	0.985	1991	2020	   4	   3	CGI;CTD_human;GENOMICS_ENGLAND
      861	RUNX1	0.425	0.808	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.40	1	1993	2019	   1	   0	ORPHANET
      861	RUNX1	0.425	0.808	C0023485	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.36	1	1998	2014	   2	   0	CTD_human
      861	RUNX1	0.425	0.808	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2008	2019	   3	   0	CTD_human
      861	RUNX1	0.425	0.808	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      861	RUNX1	0.425	0.808	C0040034	Thrombocytopenia	phenotype	C15	Disease or Syndrome	0.50	0.968	1999	2019	   1	   3	GENOMICS_ENGLAND
      861	RUNX1	0.425	0.808	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      861	RUNX1	0.425	0.808	C0349639	Juvenile Myelomonocytic Leukemia	disease	C04;C15	Neoplastic Process	0.38	1	1997	2018	   1	   0	CTD_human
      861	RUNX1	0.425	0.808	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.34	1	2007	2018	   1	   0	CTD_human
      861	RUNX1	0.425	0.808	C1292769	Precursor B-cell lymphoblastic leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	1	1996	2017	   1	   0	ORPHANET
      861	RUNX1	0.425	0.808	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.34	1	2012	2019	   1	   0	CTD_human
      861	RUNX1	0.425	0.808	C1832388	Platelet Disorder, Familial, with Associated Myeloid Malignancy	disease	C16;C04;C15	Disease or Syndrome	0.73	1	1998	2019	  11	  19	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      861	RUNX1	0.425	0.808	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.39	1	1994	2019	   3	   0	CTD_human
      861	RUNX1	0.425	0.808	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.40	0.99	1995	2019	   1	   0	CTD_human
      861	RUNX1	0.425	0.808	C2713368	Hematopoetic Myelodysplasia	phenotype	C15	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
      861	RUNX1	0.425	0.808	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.50	1	1993	2020	   1	   0	CTD_human
      862	RUNX1T1	0.53	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2016	2016	   0	   3	UNIPROT
      862	RUNX1T1	0.53	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.40	0.986	1993	2020	   2	   0	CTD_human
      862	RUNX1T1	0.53	0.808	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2008	2016	   2	   0	CTD_human
      862	RUNX1T1	0.53	0.808	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      862	RUNX1T1	0.53	0.808	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.40	1	1994	2019	   2	   0	CTD_human
      863	CBFA2T3	0.638	0.462	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   3	UNIPROT
      864	RUNX3	0.459	0.731	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.39	0.9	2003	2017	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0007570	Celiac Disease	disease	C06;C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.35	0.833	2005	2017	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.33	1	2007	2014	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.40	1	1994	2019	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.36	1	2004	2019	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.40	0.95	2002	2018	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0030246	Pustulosis of Palms and Soles	disease	C17	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0033860	Psoriasis	disease	C17	Disease or Syndrome	0.32	1	2012	2016	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0038013	Ankylosing spondylitis	disease	C05	Disease or Syndrome	0.37	0.857	2011	2018	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.40	1	2003	2012	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	1	2004	2015	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.34	0.8	2007	2017	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.34	1	2007	2019	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	2004	2020	   1	   0	CTD_human
      864	RUNX3	0.459	0.731	C2930967	Gastro-enteropancreatic neuroendocrine tumor	disease	C06;C04;C19	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      865	CBFB	0.601	0.538	C0005941	Bone Diseases, Developmental	group	C05	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      865	CBFB	0.601	0.538	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	1	1998	2019	   0	   1	UNIPROT
      865	CBFB	0.601	0.538	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      865	CBFB	0.601	0.538	C0018798	Congenital Heart Defects	group	C16;C14	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      865	CBFB	0.601	0.538	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.50	0.966	1993	2020	   2	   0	CTD_human
      865	CBFB	0.601	0.538	C0023479	Acute myelomonocytic leukemia	disease	C04	Neoplastic Process	0.55	1	2000	2009	   2	   0	CTD_human;ORPHANET
      865	CBFB	0.601	0.538	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.31	1	2008	2020	   2	   0	CTD_human
      865	CBFB	0.601	0.538	C0029396	Heterotopic Ossification	phenotype	C23	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      865	CBFB	0.601	0.538	C1837218	Cleft palate, isolated	disease	C16;C05;C07	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      865	CBFB	0.601	0.538	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2008	2016	   2	   0	CTD_human
      866	SERPINA6	0.606	0.731	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
      866	SERPINA6	0.606	0.731	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
      866	SERPINA6	0.606	0.731	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      866	SERPINA6	0.606	0.731	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
      866	SERPINA6	0.606	0.731	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      866	SERPINA6	0.606	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      866	SERPINA6	0.606	0.731	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      866	SERPINA6	0.606	0.731	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      866	SERPINA6	0.606	0.731	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      866	SERPINA6	0.606	0.731	C1852529	Corticosteroid-Binding Globulin Deficiency	disease	C23;C16	Disease or Syndrome	0.95	1	1992	2019	   5	   2	CTD_human;ORPHANET;UNIPROT
      866	SERPINA6	0.606	0.731	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      866	SERPINA6	0.606	0.731	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      866	SERPINA6	0.606	0.731	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      866	SERPINA6	0.606	0.731	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      867	CBL	0.527	0.769	C0008073	Developmental Disabilities	group	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      867	CBL	0.527	0.769	C0010417	Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.41	1	2010	2015	   1	   0	CTD_human
      867	CBL	0.527	0.769	C0018273	Growth Disorders	group	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      867	CBL	0.527	0.769	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      867	CBL	0.527	0.769	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.50	1	2003	2019	   0	   9	CGI
      867	CBL	0.527	0.769	C0027019	Myelomonocytic leukemia	disease	C04	Neoplastic Process	0.31	1	2018	2018	   0	   0	CGI
      867	CBL	0.527	0.769	C0028326	Noonan Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.46	1	2009	2016	   1	   4	GENOMICS_ENGLAND
      867	CBL	0.527	0.769	C0042384	Vasculitis	disease	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      867	CBL	0.527	0.769	C0085996	Child Development Deviations	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      867	CBL	0.527	0.769	C0085997	Child Development Disorders, Specific	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      867	CBL	0.527	0.769	C0349639	Juvenile Myelomonocytic Leukemia	disease	C04;C15	Neoplastic Process	0.80	1	2009	2019	   5	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET
      867	CBL	0.527	0.769	C0376545	Hematologic Neoplasms	group	C04;C15	Neoplastic Process	0.41	1	2012	2013	   0	   2	CGI
      867	CBL	0.527	0.769	C0431663	Bilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
      867	CBL	0.527	0.769	C0431664	Unilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
      867	CBL	0.527	0.769	C0848676	Subfertility, Male	phenotype	C12	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
      867	CBL	0.527	0.769	C0917731	Male sterility	phenotype	C12	Finding	0.30	1	2005	2005	   1	   0	CTD_human
      867	CBL	0.527	0.769	C1563730	Abdominal Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
      867	CBL	0.527	0.769	C1563731	Inguinal Cryptorchidism	phenotype	C16;C12;C19	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      867	CBL	0.527	0.769	C3150803	NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	disease		Disease or Syndrome	0.72	1	2008	2017	   8	   8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      867	CBL	0.527	0.769	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.40	1	2009	2016	   0	   0	CGI
      867	CBL	0.527	0.769	C4230920	Fetal hydrops (in some patients)	phenotype		Finding	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
      868	CBLB	0.691	0.423	C0014072	Experimental Autoimmune Encephalomyelitis	disease	C20;C10	Experimental Model of Disease	0.30	1	2010	2010	   1	   0	CTD_human
      868	CBLB	0.691	0.423	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.31	1	2007	2007	   0	   0	CGI
      868	CBLB	0.691	0.423	C0026769	Multiple Sclerosis	disease	C20;C10	Disease or Syndrome	0.44	0.8	2010	2017	   1	   1	CTD_human
      868	CBLB	0.691	0.423	C0751324	Multiple Sclerosis, Acute Fulminating	disease	C20;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      871	SERPINH1	0.545	0.769	C0022116	Ischemia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      871	SERPINH1	0.545	0.769	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      871	SERPINH1	0.545	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2008	2014	   2	   0	CTD_human
      871	SERPINH1	0.545	0.769	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      871	SERPINH1	0.545	0.769	C0238281	Middle Cerebral Artery Syndrome	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      871	SERPINH1	0.545	0.769	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.36	0.857	2013	2019	   1	   0	CTD_human
      871	SERPINH1	0.545	0.769	C0268362	Osteogenesis imperfecta type III (disorder)	disease	C16;C17;C05	Disease or Syndrome	0.50	1	2010	2011	   2	   0	GENOMICS_ENGLAND;ORPHANET
      871	SERPINH1	0.545	0.769	C0729264	Preterm premature rupture of membranes (disorder)	phenotype	C13	Pathologic Function	0.50	1	2010	2010	   1	   0	CTD_human;GENOMICS_ENGLAND
      871	SERPINH1	0.545	0.769	C0740376	Middle Cerebral Artery Thrombosis	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      871	SERPINH1	0.545	0.769	C0740391	Middle Cerebral Artery Occlusion	disease	C23;C10;C14	Acquired Abnormality	0.30	1	2002	2002	   1	   0	CTD_human
      871	SERPINH1	0.545	0.769	C0740392	Infarction, Middle Cerebral Artery	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      871	SERPINH1	0.545	0.769	C0751845	Middle Cerebral Artery Embolus	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      871	SERPINH1	0.545	0.769	C0751846	Left Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      871	SERPINH1	0.545	0.769	C0751847	Embolic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      871	SERPINH1	0.545	0.769	C0751848	Thrombotic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      871	SERPINH1	0.545	0.769	C0751849	Right Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      871	SERPINH1	0.545	0.769	C3151211	OSTEOGENESIS IMPERFECTA, TYPE X	disease		Disease or Syndrome	0.91	1	2010	2018	   1	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
      873	CBR1	0.572	0.654	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.35	1	2011	2019	   1	   0	CTD_human
      873	CBR1	0.572	0.654	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2009	2011	   1	   0	CTD_human
      873	CBR1	0.572	0.654	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.50	1	2015	2015	   1	   0	CTD_human
      873	CBR1	0.572	0.654	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      873	CBR1	0.572	0.654	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      873	CBR1	0.572	0.654	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      873	CBR1	0.572	0.654	C0162823	Dermatitis, Irritant	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      873	CBR1	0.572	0.654	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2007	2017	   1	   0	CTD_human
      873	CBR1	0.572	0.654	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.31	1	2000	2012	   1	   0	CTD_human
      873	CBR1	0.572	0.654	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2011	2013	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
      875	CBS	0.465	0.885	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.39	0.778	1996	2015	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.32	1	2013	2019	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0019880	Homocystinuria	disease	C16;C18;C17;C10	Disease or Syndrome	0.90	0.983	1988	2019	   0	  17	CTD_human;GENOMICS_ENGLAND
      875	CBS	0.465	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.42	1	2005	2019	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0024302	Reticulosarcoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0024304	Lymphoma, Mixed-Cell	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.34	1	2007	2015	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0024306	Lymphoma, Undifferentiated	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0024796	Marfan Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.31	1	2009	2018	   1	   0	GENOMICS_ENGLAND
      875	CBS	0.465	0.885	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2009	2009	   1	   0	PSYGENET
      875	CBS	0.465	0.885	C0079740	High Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0079741	Lymphoma, Intermediate-Grade	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0079747	Low Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0079757	Diffuse Mixed-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0079770	Lymphoma, Small Noncleaved-Cell	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0162429	Malnutrition	disease	C18	Disease or Syndrome	0.31	1	2006	2014	   1	   0	CTD_human
      875	CBS	0.465	0.885	C0338715	Drug-induced depressive state	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
      875	CBS	0.465	0.885	C0598608	Hyperhomocysteinemia	disease	C16;C18	Disease or Syndrome	0.60	0.941	1995	2019	   3	   0	CTD_human
      875	CBS	0.465	0.885	C0751202	Cystathionine beta-Synthase Deficiency Disease	disease	C16;C18;C17;C10	Disease or Syndrome	0.80	1	1959	2019	  51	 113	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      875	CBS	0.465	0.885	C3714542	Lymphoma, Diffuse	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      875	CBS	0.465	0.885	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      875	CBS	0.465	0.885	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      883	KYAT1	0.736	0.308	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      883	KYAT1	0.736	0.308	C0022665	Kidney Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      883	KYAT1	0.736	0.308	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      883	KYAT1	0.736	0.308	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      883	KYAT1	0.736	0.308	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      883	KYAT1	0.736	0.308	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      883	KYAT1	0.736	0.308	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.34	0.5	1998	2005	   2	   0	PSYGENET
      885	CCK	0.453	0.846	C0003123	Anorexia	disease	C23	Disease or Syndrome	0.36	1	2012	2019	   2	   0	CTD_human
      885	CCK	0.453	0.846	C0007370	Catalepsy	disease	C23;C10	Mental or Behavioral Dysfunction	0.30	1	1985	1985	   2	   0	CTD_human
      885	CCK	0.453	0.846	C0009438	Common Bile Duct Calculi	phenotype	C23;C06	Body Substance	0.30	1	1992	1992	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0013386	Dyskinesia, Drug-Induced	disease	C23;C10;C25	Disease or Syndrome	0.30	1	1990	1990	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0015967	Fever	phenotype	C23	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0017178	Gastrointestinal Diseases	group	C06	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0030305	Pancreatitis	disease	C06	Disease or Syndrome	0.37	1	1998	2020	   2	   0	CTD_human
      885	CCK	0.453	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	1	1995	2016	   2	   0	PSYGENET
      885	CCK	0.453	0.846	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.31	1	1981	1994	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0038358	Gastric ulcer	disease	C06	Disease or Syndrome	0.30	1	1998	2004	   6	   0	CTD_human
      885	CCK	0.453	0.846	C0041657	Unconscious State	phenotype	C23;C10	Finding	0.30	1	1982	1982	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0149504	Encephalopathy, Toxic	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0154659	Toxic Encephalitis	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0233612	Waxy flexibility	phenotype	C23;C10	Sign or Symptom	0.30	1	1985	1985	   2	   0	CTD_human
      885	CCK	0.453	0.846	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0235032	Neurotoxicity Syndromes	group	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0242216	Biliary calculi	phenotype	C23;C06	Body Substance	0.31	1	1992	2008	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
      885	CCK	0.453	0.846	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0525041	Neurobehavioral Manifestations	phenotype	C23;C10;F01	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0559031	Functional Gastrointestinal Disorders	disease	C06	Disease or Syndrome	0.31	1	1995	2005	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0564408	Manic mood	phenotype	F01	Finding	0.30	1	2014	2014	   1	   0	PSYGENET
      885	CCK	0.453	0.846	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0751088	Dyskinesia, Medication-Induced	phenotype	C23;C10;C25	Disease or Syndrome	0.30	1	1990	1990	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0751217	Hyperkinesia, Generalized	phenotype	C23;C10	Sign or Symptom	0.30	1	1986	1987	   2	   0	CTD_human
      885	CCK	0.453	0.846	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C1565321	Cholera Infantum	disease	C06	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
      885	CCK	0.453	0.846	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C3887506	Hyperkinesia	phenotype	C23;C10	Disease or Syndrome	0.30	1	1986	1987	   2	   0	CTD_human
      885	CCK	0.453	0.846	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1981	1981	   1	   0	CTD_human
      885	CCK	0.453	0.846	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1981	1981	   1	   0	CTD_human
      886	CCKAR	0.615	0.5	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1998	1998	   1	   0	CTD_human
      886	CCKAR	0.615	0.5	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.53	0.8	1998	2005	   6	   0	CTD_human;PSYGENET
      886	CCKAR	0.615	0.5	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      886	CCKAR	0.615	0.5	C0016978	gallbladder neoplasm	disease	C06;C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      886	CCKAR	0.615	0.5	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	PSYGENET
      886	CCKAR	0.615	0.5	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.39	0.8	1999	2017	   5	   0	PSYGENET
      886	CCKAR	0.615	0.5	C0036349	Paranoid Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      886	CCKAR	0.615	0.5	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	PSYGENET
      886	CCKAR	0.615	0.5	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1998	1998	   1	   0	CTD_human
      886	CCKAR	0.615	0.5	C0153452	Malignant neoplasm of gallbladder	disease	C06;C04	Neoplastic Process	0.32	1	2013	2014	   1	   0	CTD_human
      886	CCKAR	0.615	0.5	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2006	2006	   1	   0	PSYGENET
      887	CCKBR	0.573	0.615	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1998	1998	   1	   0	CTD_human
      887	CCKBR	0.573	0.615	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.51	1	2002	2019	   1	   0	CTD_human
      887	CCKBR	0.573	0.615	C0028768	Obsessive-Compulsive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
      887	CCKBR	0.573	0.615	C0030319	Panic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	0.909	1996	2012	   1	   0	CTD_human
      887	CCKBR	0.573	0.615	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1998	2002	   2	   0	CTD_human
      887	CCKBR	0.573	0.615	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	1998	2002	   2	   0	CTD_human
      887	CCKBR	0.573	0.615	C0086769	Panic Attacks	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
      887	CCKBR	0.573	0.615	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	1998	2002	   2	   0	CTD_human
      887	CCKBR	0.573	0.615	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1998	1998	   1	   0	CTD_human
      887	CCKBR	0.573	0.615	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2002	2002	   1	   0	CTD_human
      887	CCKBR	0.573	0.615	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1998	1998	   1	   0	CTD_human
      887	CCKBR	0.573	0.615	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
      887	CCKBR	0.573	0.615	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
      887	CCKBR	0.573	0.615	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
      887	CCKBR	0.573	0.615	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
      887	CCKBR	0.573	0.615	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
      889	KRIT1	0.5	0.808	C0752160	Hemangioma, Cavernous, Central Nervous System	disease	C16;C04;C10;C15;C14	Congenital Abnormality	0.30				   0	   0	CTD_human
      889	KRIT1	0.5	0.808	C0752161	Cavernous Hemangioma, Extracerebral	disease	C16;C04;C10;C15;C14	Congenital Abnormality	0.30				   0	   0	CTD_human
      889	KRIT1	0.5	0.808	C0752164	Cavernous Hemangioma, Intracerebral	disease	C16;C04;C10;C15;C14	Congenital Abnormality	0.30				   0	   0	CTD_human
      889	KRIT1	0.5	0.808	C1140710	Cerebral Cavernous Hemangioma	disease	C16;C04;C10;C15;C14	Congenital Abnormality	0.31	1	2006	2006	   0	   0	CTD_human
      889	KRIT1	0.5	0.808	C1956260	Cavernous Angioma, Central Nervous System	disease	C16;C04;C10;C15;C14	Neoplastic Process	0.30				   0	   0	CTD_human
      889	KRIT1	0.5	0.808	C2919945	Cavernous Hemangioma of Brain	disease	C16;C04;C10;C15;C14	Anatomical Abnormality	1.00	0.991	1992	2019	   1	  35	CTD_human;GENOMICS_ENGLAND;UNIPROT
      890	CCNA2	0.578	0.654	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      890	CCNA2	0.578	0.654	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      890	CCNA2	0.578	0.654	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      890	CCNA2	0.578	0.654	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	PSYGENET
      890	CCNA2	0.578	0.654	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      890	CCNA2	0.578	0.654	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      890	CCNA2	0.578	0.654	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      891	CCNB1	0.512	0.731	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.31	1	2011	2011	   1	   0	CTD_human
      891	CCNB1	0.512	0.731	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      891	CCNB1	0.512	0.731	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      891	CCNB1	0.512	0.731	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	2008	2019	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	1	1995	2019	   0	   0	CGI
      894	CCND2	0.477	0.808	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.61	1	2004	2019	   1	   3	CTD_human
      894	CCND2	0.477	0.808	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.45	1	2010	2019	   1	   4	CTD_human
      894	CCND2	0.477	0.808	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.42	1	2011	2019	   1	   3	CTD_human
      894	CCND2	0.477	0.808	C0009451	Communicating Hydrocephalus	disease	C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.42	1	2014	2019	   1	   1	CTD_human
      894	CCND2	0.477	0.808	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2005	2005	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0020255	Hydrocephalus	disease	C10	Disease or Syndrome	0.40	1	2018	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0020256	Congenital Hydrocephalus	disease	C10	Congenital Abnormality	0.30	1	2018	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.32	1	2010	2017	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.31	1	2010	2010	   0	   0	CGI
      894	CCND2	0.477	0.808	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.32	1	2003	2017	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
      894	CCND2	0.477	0.808	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0152427	Polydactyly	disease	C16;C05	Congenital Abnormality	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
      894	CCND2	0.477	0.808	C0220697	POLYDACTYLY, POSTAXIAL	disease	C16;C05	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0221355	Macrocephaly	disease	C16;C05;C10	Congenital Abnormality	0.40	1	2018	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.31	1	2003	2003	   0	   0	CGI
      894	CCND2	0.477	0.808	C0270720	Hydrocephalus Ex-Vacuo	disease	C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.818	2003	2019	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0477432	Post-Traumatic Hydrocephalus	disease	C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0549423	Obstructive Hydrocephalus	disease	C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30				   0	   0	CGI
      894	CCND2	0.477	0.808	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.32	1	2007	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.32	1	2007	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C1531647	Cerebral ventriculomegaly	phenotype	C10	Finding	0.40	1	2018	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C1845668	Perisylvian syndrome	disease	C23;C16;C10;F03;F01	Congenital Abnormality	0.30	1	2018	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C1863924	Megalanecephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome	disease	C16;C05;C10	Disease or Syndrome	0.50	1	2014	2018	   2	   0	CTD_human;ORPHANET
      894	CCND2	0.477	0.808	C1868120	POSTAXIAL POLYDACTYLY, TYPE B	disease	C16;C05	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C1879677	Alcohol Toxicity	disease		Injury or Poisoning	0.30	1	2008	2008	   1	   0	PSYGENET
      894	CCND2	0.477	0.808	C2936718	Fetal Cerebral Ventriculomegaly	disease	C10	Congenital Abnormality	0.30	1	2018	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C2936786	Aqueductal Stenosis	disease	C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C3887487	Postaxial polydactyly type A	disease	C16;C05	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      894	CCND2	0.477	0.808	C4012727	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1	disease	C16;C05;C10	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      894	CCND2	0.477	0.808	C4014742	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3	disease		Disease or Syndrome	0.60	1	2014	2014	   1	   6	GENOMICS_ENGLAND;UNIPROT
      894	CCND2	0.477	0.808	C4282400	Polydactyly, Postaxial, Type A1	disease	C16;C05	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      896	CCND3	0.554	0.654	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	1	1996	2019	   0	   0	CGI
      896	CCND3	0.554	0.654	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.33	1	2007	2017	   1	   0	CTD_human
      898	CCNE1	0.538	0.731	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.37	1	2000	2019	   2	   0	CTD_human
      898	CCNE1	0.538	0.731	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.36	1	2010	2019	   2	   0	CTD_human
      898	CCNE1	0.538	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.952	2002	2019	   2	   0	CTD_human
      898	CCNE1	0.538	0.731	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	1	2000	2019	   0	   0	CGI
      898	CCNE1	0.538	0.731	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      898	CCNE1	0.538	0.731	C0029925	Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.33	1	2014	2017	   0	   0	CGI
      898	CCNE1	0.538	0.731	C0205833	Medullomyoblastoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      898	CCNE1	0.538	0.731	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2009	2009	   1	   0	CTD_human
      898	CCNE1	0.538	0.731	C0278510	Childhood Medulloblastoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      898	CCNE1	0.538	0.731	C0278876	Adult Medulloblastoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      898	CCNE1	0.538	0.731	C0496920	Neoplasm of uncertain or unknown behavior of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
      898	CCNE1	0.538	0.731	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.947	2002	2019	   2	   0	CTD_human
      898	CCNE1	0.538	0.731	C0751291	Desmoplastic Medulloblastoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      898	CCNE1	0.538	0.731	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.60	1	2008	2019	   1	   0	CGI;CTD_human
      898	CCNE1	0.538	0.731	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.60	1	2008	2020	   1	   0	CGI;CTD_human
      898	CCNE1	0.538	0.731	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      898	CCNE1	0.538	0.731	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2013	   2	   0	CTD_human
      898	CCNE1	0.538	0.731	C1275668	Melanotic medulloblastoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      898	CCNE1	0.538	0.731	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.37	1	2002	2013	   2	   0	CTD_human
      898	CCNE1	0.538	0.731	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.60	0.941	2002	2020	   2	   0	CTD_human
      898	CCNE1	0.538	0.731	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2013	   2	   0	CTD_human
      899	CCNF	0.7	0.615	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.46	1	2016	2019	   1	   0	ORPHANET
      899	CCNF	0.7	0.615	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      900	CCNG1	0.628	0.615	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      900	CCNG1	0.628	0.615	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      900	CCNG1	0.628	0.615	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.31	1	2006	2018	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.31	1	2016	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.31	1	2018	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0024232	Lymphatic Metastasis	disease	C23;C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.50	1	2003	2003	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2013	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.31	1	2016	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	1996	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      902	CCNH	0.595	0.769	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
      914	CD2	0.641	0.577	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.31	1	2012	2017	   1	   0	CTD_human
      914	CD2	0.641	0.577	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
      914	CD2	0.641	0.577	C0027726	Nephrotic Syndrome	group	C13;C12	Disease or Syndrome	0.30	1	1989	1989	   1	   0	CTD_human
      914	CD2	0.641	0.577	C0040053	Thrombosis	phenotype	C14	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
      914	CD2	0.641	0.577	C0087086	Thrombus	phenotype	C14	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
      915	CD3D	0.626	0.577	C0008312	Primary biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      915	CD3D	0.626	0.577	C0023892	Biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      915	CD3D	0.626	0.577	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      915	CD3D	0.626	0.577	C0085110	Severe Combined Immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.54	1	2003	2014	   1	   0	CTD_human;GENOMICS_ENGLAND
      915	CD3D	0.626	0.577	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      915	CD3D	0.626	0.577	C0149504	Encephalopathy, Toxic	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      915	CD3D	0.626	0.577	C0154659	Toxic Encephalitis	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      915	CD3D	0.626	0.577	C0162820	Dermatitis, Allergic Contact	disease	C17;C20	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      915	CD3D	0.626	0.577	C0235032	Neurotoxicity Syndromes	group	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      915	CD3D	0.626	0.577	C0238065	Secondary Biliary Cholangitis	disease	C23;C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      915	CD3D	0.626	0.577	C0242583	Bare Lymphocyte Syndrome	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      915	CD3D	0.626	0.577	C2700553	Omenn Syndrome	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      915	CD3D	0.626	0.577	C3810147	IMMUNODEFICIENCY 19	disease		Disease or Syndrome	0.61	1	2003	2017	   0	   3	CTD_human;GENOMICS_ENGLAND
      915	CD3D	0.626	0.577	C4551595	Biliary Cirrhosis, Primary, 1	disease	C23;C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      916	CD3E	0.615	0.615	C0003257	Antibody Deficiency Syndrome	disease	C20	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
      916	CD3E	0.615	0.615	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      916	CD3E	0.615	0.615	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.41	1	1993	2010	   1	   0	CTD_human
      916	CD3E	0.615	0.615	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      916	CD3E	0.615	0.615	C0085110	Severe Combined Immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.62	1	1991	2014	   6	   0	CLINGEN;CTD_human;GENOMICS_ENGLAND
      916	CD3E	0.615	0.615	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      916	CD3E	0.615	0.615	C0242583	Bare Lymphocyte Syndrome	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      916	CD3E	0.615	0.615	C1861284	Immunodeficiency due to Defect in CD3-Epsilon	disease	C20	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      916	CD3E	0.615	0.615	C2700553	Omenn Syndrome	disease	C16;C18;C20	Disease or Syndrome	0.31	1	2004	2012	   1	   0	CTD_human
      916	CD3E	0.615	0.615	C3179349	Gastrointestinal Stromal Sarcoma	disease	C06;C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      916	CD3E	0.615	0.615	C3810127	IMMUNODEFICIENCY 18	disease		Disease or Syndrome	0.60	1	1993	2004	   1	   3	CTD_human;GENOMICS_ENGLAND
      916	CD3E	0.615	0.615	C3810129	IMMUNODEFICIENCY 18, SCID VARIANT	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      917	CD3G	0.695	0.346	C0494261	Combined immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2007	2007	   1	   0	GENOMICS_ENGLAND
      917	CD3G	0.695	0.346	C3810107	IMMUNODEFICIENCY 17	disease		Disease or Syndrome	0.70	1	2007	2014	   2	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET
      919	CD247	0.539	0.731	C0036421	Systemic Scleroderma	disease	C17	Disease or Syndrome	0.46	0.875	1998	2019	   1	   1	CTD_human
      919	CD247	0.539	0.731	C0085110	Severe Combined Immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.40	1	2015	2015	   1	   1	GENOMICS_ENGLAND
      919	CD247	0.539	0.731	C1857798	Immunodeficiency due to Defect in CD3-Zeta	disease	C16;C20	Disease or Syndrome	0.60	1	2015	2015	   1	   6	CTD_human;GENOMICS_ENGLAND
      919	CD247	0.539	0.731	C2931171	Juvenile pauciarticular chronic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
      920	CD4	0.604	0.654	C0013264	Muscular Dystrophy, Duchenne	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      920	CD4	0.604	0.654	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	1998	1998	   1	   0	CTD_human
      920	CD4	0.604	0.654	C0162526	AIDS-Related Opportunistic Infections	group	C01;C20	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
      920	CD4	0.604	0.654	C0917713	Becker Muscular Dystrophy	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      920	CD4	0.604	0.654	C3542021	Duchenne and Becker Muscular Dystrophy	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      921	CD5	0.682	0.308	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      921	CD5	0.682	0.308	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	1	1986	2008	   1	   0	CTD_human
      922	CD5L	0.593	0.846	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      922	CD5L	0.593	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.35	1	2017	2019	   1	   0	CTD_human
      923	CD6	0.489	0.808	C0026769	Multiple Sclerosis	disease	C20;C10	Disease or Syndrome	0.42	1	2009	2016	   2	   1	CTD_human
      923	CD6	0.489	0.808	C0751324	Multiple Sclerosis, Acute Fulminating	disease	C20;C10	Disease or Syndrome	0.30	1	2009	2013	   2	   0	CTD_human
      924	CD7	0.722	0.385	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      924	CD7	0.722	0.385	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      924	CD7	0.722	0.385	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      924	CD7	0.722	0.385	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      924	CD7	0.722	0.385	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      924	CD7	0.722	0.385	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      924	CD7	0.722	0.385	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      924	CD7	0.722	0.385	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      925	CD8A	0.587	0.769	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      925	CD8A	0.587	0.769	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      925	CD8A	0.587	0.769	C0024117	Chronic Obstructive Airway Disease	disease	C08	Disease or Syndrome	0.31	1	2007	2007	   1	   0	CTD_human
      925	CD8A	0.587	0.769	C1527303	Chronic Airflow Obstruction	disease	C08	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      925	CD8A	0.587	0.769	C1837065	CD8 Deficiency, Familial	disease	C16;C20	Disease or Syndrome	0.70	1	2001	2008	   2	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      925	CD8A	0.587	0.769	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      925	CD8A	0.587	0.769	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      926	CD8B	0.674	0.462	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      926	CD8B	0.674	0.462	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      926	CD8B	0.674	0.462	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      926	CD8B	0.674	0.462	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      926	CD8B	0.674	0.462	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.33	1	1995	2007	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2014	2019	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.33	1	2009	2016	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.33	1	2005	2014	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0027654	Embryonal Neoplasm	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0027658	Neoplasms, Germ Cell and Embryonal	group	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2007	2007	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0205851	Germ cell tumor	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0205852	Neoplasms, Embryonal and Mixed	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2007	2018	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0740345	Germ Cell Cancer	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0751364	Cancer, Embryonal	phenotype	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      928	CD9	0.528	0.769	C0751365	Cancer, Embryonal and Mixed	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      928	CD9	0.528	0.769	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.33	1	2009	2016	   1	   0	CTD_human
      928	CD9	0.528	0.769	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      929	CD14	0.392	0.885	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.40	0.836	2001	2020	   1	   0	CTD_human
      929	CD14	0.392	0.885	C0011991	Diarrhea	phenotype	C23	Sign or Symptom	0.31	1	2009	2011	   1	   0	CTD_human
      929	CD14	0.392	0.885	C0013595	Eczema	disease	C17	Disease or Syndrome	0.39	0.889	2002	2019	   1	   0	CTD_human
      929	CD14	0.392	0.885	C0018099	Gout	disease	C16;C18;C05	Disease or Syndrome	0.31	1	2015	2019	   1	   0	CTD_human
      929	CD14	0.392	0.885	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.39	0.9	2003	2019	   1	   0	CTD_human
      929	CD14	0.392	0.885	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      929	CD14	0.392	0.885	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      929	CD14	0.392	0.885	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.32	1	2010	2017	   1	   0	CTD_human
      929	CD14	0.392	0.885	C1262477	Weight decreased	phenotype	C23	Finding	0.30	1	2017	2017	   1	   0	CTD_human
      929	CD14	0.392	0.885	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      929	CD14	0.392	0.885	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.31	1	2009	2009	   1	   0	CTD_human
      929	CD14	0.392	0.885	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      929	CD14	0.392	0.885	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      929	CD14	0.392	0.885	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      930	CD19	0.43	0.885	C0001768	Agammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.32	1	2006	2020	   1	   0	CTD_human
      930	CD19	0.43	0.885	C0001969	Alcoholic Intoxication	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	PSYGENET
      930	CD19	0.43	0.885	C0009447	Common Variable Immunodeficiency	disease	C20	Disease or Syndrome	0.60	1	2002	2020	   1	   0	CTD_human;ORPHANET
      930	CD19	0.43	0.885	C0086438	Hypogammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.57	0.75	1991	2019	   2	   0	CTD_human;GENOMICS_ENGLAND
      930	CD19	0.43	0.885	C2936664	Acquired Hypogammaglobulinemia	disease	C20	Disease or Syndrome	0.32	1	2006	2006	   1	   0	CTD_human
      930	CD19	0.43	0.885	C2936665	Immunoglobulin Deficiency, Late-Onset	disease	C20	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      930	CD19	0.43	0.885	C3150738	Antibody Deficiency due to Defect in CD19	disease	C16;C20	Disease or Syndrome	0.40	1	2011	2011	   1	   1	GENOMICS_ENGLAND
      931	MS4A1	0.411	0.846	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.33	0.75	2012	2019	   1	   0	CTD_human
      931	MS4A1	0.411	0.846	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.31	1	2012	2017	   1	   0	CTD_human
      931	MS4A1	0.411	0.846	C0009447	Common Variable Immunodeficiency	disease	C20	Disease or Syndrome	0.51	1	2010	2011	   2	   0	CTD_human;ORPHANET
      931	MS4A1	0.411	0.846	C0010093	Corpus Luteum Cyst	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      931	MS4A1	0.411	0.846	C0029927	Ovarian Cysts	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      931	MS4A1	0.411	0.846	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.31	1	2012	2019	   1	   0	CTD_human
      931	MS4A1	0.411	0.846	C0239998	Recurrent infections	phenotype	C23;C01;C05	Finding	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      931	MS4A1	0.411	0.846	C2936664	Acquired Hypogammaglobulinemia	disease	C20	Disease or Syndrome	0.30				   0	   0	CTD_human
      931	MS4A1	0.411	0.846	C2936665	Immunoglobulin Deficiency, Late-Onset	disease	C20	Disease or Syndrome	0.30				   0	   0	CTD_human
      931	MS4A1	0.411	0.846	C3150740	IMMUNODEFICIENCY, COMMON VARIABLE, 5	disease		Disease or Syndrome	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      939	CD27	0.517	0.692	C0006625	Cachexia	phenotype	C23	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
      939	CD27	0.517	0.692	C0494261	Combined immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.31	1	2013	2015	   1	   0	GENOMICS_ENGLAND
      939	CD27	0.517	0.692	C3554540	LYMPHOPROLIFERATIVE SYNDROME 2	disease		Disease or Syndrome	0.72	0.75	2012	2017	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      940	CD28	0.436	0.885	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.50	1	1996	2018	   3	   1	CTD_human
      940	CD28	0.436	0.885	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.40	1	1998	2019	   2	   0	CTD_human
      940	CD28	0.436	0.885	C0005138	Berylliosis	disease	C08;C24	Injury or Poisoning	0.30	1	2003	2003	   1	   0	CTD_human
      940	CD28	0.436	0.885	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.39	0.9	1995	2017	   1	   0	CTD_human
      940	CD28	0.436	0.885	C0023493	Adult T-Cell Lymphoma/Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      940	CD28	0.436	0.885	C0026948	Mycosis Fungoides	group	C04;C20;C15	Neoplastic Process	0.31	1	1994	2015	   1	   0	ORPHANET
      940	CD28	0.436	0.885	C0036920	Sezary Syndrome	disease	C04;C20;C15	Neoplastic Process	0.31	1	2003	2015	   1	   0	ORPHANET
      940	CD28	0.436	0.885	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.41	1	2015	2017	   2	   0	CTD_human
      940	CD28	0.436	0.885	C0079774	Peripheral T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2015	2016	   1	   0	CTD_human
      940	CD28	0.436	0.885	C0263454	Chloracne	disease	C17	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      940	CD28	0.436	0.885	C0376407	Granulomatous Slack Skin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   2	   0	CTD_human
      940	CD28	0.436	0.885	C2350873	Beryllium Disease	disease	C08;C24	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      940	CD28	0.436	0.885	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
      941	CD80	0.475	0.769	C0007570	Celiac Disease	disease	C06;C18	Disease or Syndrome	0.31	1	2002	2010	   1	   0	CTD_human
      941	CD80	0.475	0.769	C0008312	Primary biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.33	1	2011	2019	   1	   0	CTD_human
      941	CD80	0.475	0.769	C0023892	Biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      941	CD80	0.475	0.769	C0042900	Vitiligo	disease	C17	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      941	CD80	0.475	0.769	C0238065	Secondary Biliary Cholangitis	disease	C23;C06	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      941	CD80	0.475	0.769	C4551595	Biliary Cirrhosis, Primary, 1	disease	C23;C06	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      942	CD86	0.483	0.769	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      942	CD86	0.483	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      942	CD86	0.483	0.769	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      942	CD86	0.483	0.769	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.34	1	1999	2019	   1	   0	CTD_human
      942	CD86	0.483	0.769	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      942	CD86	0.483	0.769	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
      942	CD86	0.483	0.769	C2930967	Gastro-enteropancreatic neuroendocrine tumor	disease	C06;C04;C19	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      943	TNFRSF8	0.444	0.808	C0019829	Hodgkin Disease	disease	C04;C20;C15	Neoplastic Process	0.40	0.991	1987	2020	   2	   0	CTD_human
      943	TNFRSF8	0.444	0.808	C0152266	Mixed Cellularity Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2002	2006	   2	   0	CTD_human
      943	TNFRSF8	0.444	0.808	C0152267	Hodgkin lymphoma, lymphocyte depletion	disease	C04;C20;C15	Neoplastic Process	0.30	1	2002	2006	   2	   0	CTD_human
      943	TNFRSF8	0.444	0.808	C0220597	Adult Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.40	0.98	1993	2019	   2	   0	CTD_human
      943	TNFRSF8	0.444	0.808	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      943	TNFRSF8	0.444	0.808	C1266194	Lymphocyte Rich Classical Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2002	2006	   2	   0	CTD_human
      943	TNFRSF8	0.444	0.808	C1334968	Nodular Lymphocyte Predominant Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.32	1	2002	2015	   2	   0	CTD_human
      945	CD33	0.524	0.769	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.40	0.972	2011	2019	   2	   0	CTD_human
      945	CD33	0.524	0.769	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   2	   0	CTD_human
      945	CD33	0.524	0.769	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.40	0.958	1991	2020	   1	   0	CTD_human
      945	CD33	0.524	0.769	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.31	1	1989	2003	   1	   0	CTD_human
      945	CD33	0.524	0.769	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2011	2011	   2	   0	CTD_human
      945	CD33	0.524	0.769	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.40	1	2011	2019	   2	   0	CTD_human
      945	CD33	0.524	0.769	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   2	   0	CTD_human
      945	CD33	0.524	0.769	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   2	   0	CTD_human
      945	CD33	0.524	0.769	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2011	2011	   2	   0	CTD_human
      945	CD33	0.524	0.769	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.32	1	1999	2006	   1	   0	CTD_human
      946	SIGLEC6	0.861	0.192	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.31	1	2016	2019	   1	   0	CTD_human
      946	SIGLEC6	0.861	0.192	C0242380	Libman-Sacks Disease	disease	C17;C20	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      947	CD34	0.368	0.808	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      947	CD34	0.368	0.808	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
      947	CD34	0.368	0.808	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	PSYGENET
      947	CD34	0.368	0.808	C0349204	Nonorganic psychosis	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
      947	CD34	0.368	0.808	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	PSYGENET
      947	CD34	0.368	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.955	1995	2020	   1	   0	CTD_human
      948	CD36	0.446	0.846	C0003257	Antibody Deficiency Syndrome	disease	C20	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      948	CD36	0.446	0.846	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.31	1	1997	2000	   1	   0	CTD_human
      948	CD36	0.446	0.846	C0007570	Celiac Disease	disease	C06;C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      948	CD36	0.446	0.846	C0010068	Coronary heart disease	disease	C14	Disease or Syndrome	0.40	1	1998	2019	   0	   0	CTD_human
      948	CD36	0.446	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.60	1	2000	2019	   1	   0	CTD_human
      948	CD36	0.446	0.846	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.33	1	2005	2017	   1	   0	CTD_human
      948	CD36	0.446	0.846	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.50	1	2001	2015	   1	   0	CTD_human
      948	CD36	0.446	0.846	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      948	CD36	0.446	0.846	C0024530	Malaria	disease	C01	Disease or Syndrome	0.40	0.958	1992	2019	   0	   0	CTD_human
      948	CD36	0.446	0.846	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
      948	CD36	0.446	0.846	C0038160	Staphylococcal Infections	group	C01	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      948	CD36	0.446	0.846	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      948	CD36	0.446	0.846	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.31	1	2005	2019	   1	   0	CTD_human
      948	CD36	0.446	0.846	C0162820	Dermatitis, Allergic Contact	disease	C17;C20	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      948	CD36	0.446	0.846	C0271650	Impaired glucose tolerance	phenotype	C18	Disease or Syndrome	0.33	1	2003	2015	   1	   0	CTD_human
      948	CD36	0.446	0.846	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
      948	CD36	0.446	0.846	C1318973	Staphylococcus aureus infection	disease	C01	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      948	CD36	0.446	0.846	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.33	1	1997	2019	   1	   0	CTD_human
      948	CD36	0.446	0.846	C1842090	Platelet Glycoprotein IV Deficiency	disease	C16;C15	Disease or Syndrome	0.90	0.973	1993	2019	   2	   8	CTD_human;UNIPROT
      949	SCARB1	0.559	0.731	C0006868	Cannabis Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0006870	Cannabis Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.40	1	2011	2017	   1	   1	CTD_human
      949	SCARB1	0.559	0.731	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0016427	Follicular cyst	disease	C04	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0018614	Hashish Abuse	disease	C25;F03	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0019196	Hepatitis C	disease	C06;C01	Disease or Syndrome	0.40	1	2003	2018	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.35	1	2003	2019	   0	   0	GENOMICS_ENGLAND
      949	SCARB1	0.559	0.731	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2002	2002	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0031391	Phencyclidine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0236735	Cannabis-Related Disorder	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0236742	Phencyclidine-Related Disorders	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.31	1	2011	2015	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      949	SCARB1	0.559	0.731	C1853096	HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6	phenotype		Finding	0.60	1	2016	2016	   1	   4	CTD_human;GENOMICS_ENGLAND
      949	SCARB1	0.559	0.731	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      950	SCARB2	0.606	0.615	C0751779	Action Myoclonus-Renal Failure Syndrome	disease	C10	Disease or Syndrome	0.80	1	2008	2018	   7	  20	CTD_human;GENOMICS_ENGLAND;UNIPROT
      950	SCARB2	0.606	0.615	C0751785	Unverricht-Lundborg Syndrome	disease	C16;C10	Disease or Syndrome	0.39	1	2008	2018	   1	   0	ORPHANET
      950	SCARB2	0.606	0.615	C1961835	Gaucher Disease, Type 1	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	ORPHANET
      952	CD38	0.407	0.885	C0001925	Albuminuria	phenotype	C23;C13;C12	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      952	CD38	0.407	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2005	2014	   1	   0	CTD_human
      952	CD38	0.407	0.885	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.50	1	2002	2005	   1	   0	CTD_human
      953	ENTPD1	0.499	0.769	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      953	ENTPD1	0.499	0.769	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      953	ENTPD1	0.499	0.769	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      953	ENTPD1	0.499	0.769	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40	1	2011	2011	   1	   0	CTD_human
      953	ENTPD1	0.499	0.769	C3810289	SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.70	1	2014	2018	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      954	ENTPD2	0.76	0.269	C0008312	Primary biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      954	ENTPD2	0.76	0.269	C0023892	Biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.31	1	2004	2004	   1	   0	CTD_human
      954	ENTPD2	0.76	0.269	C0238065	Secondary Biliary Cholangitis	disease	C23;C06	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      954	ENTPD2	0.76	0.269	C4551595	Biliary Cirrhosis, Primary, 1	disease	C23;C06	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      955	ENTPD6	0.89	0.154	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      955	ENTPD6	0.89	0.154	C0036631	Seminoma	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.50	0.848	2002	2019	   3	   3	CTD_human
      958	CD40	0.396	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.37	1	1999	2019	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0020456	Hyperglycemia	disease	C18	Disease or Syndrome	0.31	1	2018	2018	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0020459	Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0026691	Mucocutaneous Lymph Node Syndrome	disease	C17;C15;C14	Disease or Syndrome	0.37	0.875	2012	2019	   2	   0	CTD_human
      958	CD40	0.396	0.846	C0026769	Multiple Sclerosis	disease	C20;C10	Disease or Syndrome	0.50	0.958	2000	2019	   1	   1	CTD_human
      958	CD40	0.396	0.846	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.52	1	2011	2018	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0272236	Hyperimmunoglobulin M syndrome	disease	C16;C20;C15	Disease or Syndrome	0.40	1	1994	2019	   0	   0	CTD_human
      958	CD40	0.396	0.846	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.36	0.857	1999	2018	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0751324	Multiple Sclerosis, Acute Fulminating	disease	C20;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      958	CD40	0.396	0.846	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      958	CD40	0.396	0.846	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      958	CD40	0.396	0.846	C1257963	Endogenous Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      958	CD40	0.396	0.846	C1257964	Exogenous Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      958	CD40	0.396	0.846	C1257965	Compensatory Hyperinsulinemia	disease	C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      958	CD40	0.396	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2000	2006	   1	   0	CTD_human
      958	CD40	0.396	0.846	C1720956	Hyper-IgM Immunodeficiency Syndrome, Type 2	disease	C16;C20;C15	Disease or Syndrome	0.30				   0	   0	CTD_human
      958	CD40	0.396	0.846	C1720957	Hyper-IgM Immunodeficiency Syndrome, Type 3	disease	C16;C20;C15	Disease or Syndrome	0.70	1	2001	2016	   3	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      958	CD40	0.396	0.846	C1720958	Hyper-IgM Immunodeficiency Syndrome, Type 5	disease	C16;C20;C15	Disease or Syndrome	0.30				   0	   0	CTD_human
      958	CD40	0.396	0.846	C1855520	Hyperglycemia, Postprandial	phenotype	C18	Finding	0.30	1	2018	2018	   1	   0	CTD_human
      958	CD40	0.396	0.846	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.31	1	2010	2010	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.40	1	1996	2020	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.52	1	2006	2013	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.50	1	2004	2015	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2012	2012	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.32	1	2011	2019	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C0333704	Chromosome Breaks	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C0376628	Chromosome Breakage	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C0393554	Amyotrophic Lateral Sclerosis With Dementia	disease	C18;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C0398689	Hyper-IgM Immunodeficiency Syndrome, Type 1	disease	C16;C20;C15	Disease or Syndrome	0.80	0.983	1992	2020	  14	  19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      959	CD40LG	0.414	0.846	C0543859	Amyotrophic Lateral Sclerosis, Guam Form	disease	C18;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C1527304	Allergic Reaction	phenotype	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.36	0.857	2004	2018	   1	   0	CTD_human
      959	CD40LG	0.414	0.846	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0009405	Hereditary Nonpolyposis Colorectal Neoplasms	group	C16;C06;C04;C18	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0017661	IGA Glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.31	1	2013	2018	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.40	1	1991	2019	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.32	1	2005	2012	   2	   0	CTD_human
      960	CD44	0.363	0.962	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.40	0.982	1993	2019	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	0.979	1990	2020	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.36	1	2001	2019	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0032580	Adenomatous Polyposis Coli	disease	C16;C06;C04	Neoplastic Process	0.31	1	1999	2017	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0037274	Dermatologic disorders	group	C17	Disease or Syndrome	0.31	1	1998	2006	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	2005	2011	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0042900	Vitiligo	disease	C17	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0274861	Arsenic Poisoning, Inorganic	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0274862	Nervous System, Organic Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0311375	Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.40	0.933	1996	2019	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0751851	Arsenic Encephalopathy	disease	C10;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      960	CD44	0.363	0.962	C0751852	Arsenic Induced Polyneuropathy	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
      960	CD44	0.363	0.962	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      960	CD44	0.363	0.962	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      960	CD44	0.363	0.962	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      960	CD44	0.363	0.962	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      960	CD44	0.363	0.962	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2013	2013	   1	   0	CTD_human
      960	CD44	0.363	0.962	C2713442	Polyposis, Adenomatous Intestinal	disease	C16;C06;C04	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      960	CD44	0.363	0.962	C2713443	Familial Intestinal Polyposis	disease	C16;C06;C04	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      960	CD44	0.363	0.962	C4552100	Lynch Syndrome	disease	C16;C06;C04;C18	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      961	CD47	0.468	0.769	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2019	2019	   1	   1	CTD_human
      961	CD47	0.468	0.769	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      961	CD47	0.468	0.769	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      961	CD47	0.468	0.769	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      962	CD48	0.592	0.692	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      963	CD53	0.736	0.423	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      963	CD53	0.736	0.423	C2930967	Gastro-enteropancreatic neuroendocrine tumor	disease	C06;C04;C19	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      965	CD58	0.584	0.769	C0026769	Multiple Sclerosis	disease	C20;C10	Disease or Syndrome	0.50	1	2008	2019	   2	   3	CTD_human
      965	CD58	0.584	0.769	C0079774	Peripheral T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2014	2014	   1	   0	CTD_human
      965	CD58	0.584	0.769	C0751324	Multiple Sclerosis, Acute Fulminating	disease	C20;C10	Disease or Syndrome	0.30	1	2009	2013	   2	   0	CTD_human
      966	CD59	0.469	0.808	C0024790	Paroxysmal nocturnal hemoglobinuria	disease	C15	Disease or Syndrome	0.50	1	1992	2020	   1	   0	GENOMICS_ENGLAND
      966	CD59	0.469	0.808	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
      966	CD59	0.469	0.808	C1148551	X-Linked Dyskeratosis Congenita	disease	C16;C17;C15	Disease or Syndrome	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
      966	CD59	0.469	0.808	C2676767	CD59 Deficiency	disease	C23;C13;C12;C15	Disease or Syndrome	0.76	1	1992	2019	   4	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      966	CD59	0.469	0.808	C4727002	Chronic Hemolysis	disease		Disease or Syndrome	0.33	1	2015	2019	   1	   0	GENOMICS_ENGLAND
      966	CD59	0.469	0.808	C4755276	Primary CD59 deficiency	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
      967	CD63	0.542	0.731	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      967	CD63	0.542	0.731	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      967	CD63	0.542	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      967	CD63	0.542	0.731	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      967	CD63	0.542	0.731	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      968	CD68	0.408	0.808	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      968	CD68	0.408	0.808	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      968	CD68	0.408	0.808	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2010	2010	   1	   0	CTD_human
      968	CD68	0.408	0.808	C0003872	Arthritis, Psoriatic	disease	C17;C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      968	CD68	0.408	0.808	C0005398	Cholestasis, Extrahepatic	disease	C06	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      968	CD68	0.408	0.808	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.30	1	2010	2010	   1	   0	CTD_human
      968	CD68	0.408	0.808	C0020459	Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      968	CD68	0.408	0.808	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      968	CD68	0.408	0.808	C0022116	Ischemia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      968	CD68	0.408	0.808	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.31	1	2009	2009	   1	   0	CTD_human
      968	CD68	0.408	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      968	CD68	0.408	0.808	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.35	1	2006	2018	   1	   0	CTD_human
      968	CD68	0.408	0.808	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2010	2010	   1	   0	CTD_human
      968	CD68	0.408	0.808	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      968	CD68	0.408	0.808	C1257963	Endogenous Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      968	CD68	0.408	0.808	C1257964	Exogenous Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      968	CD68	0.408	0.808	C1257965	Compensatory Hyperinsulinemia	disease	C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      968	CD68	0.408	0.808	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      968	CD68	0.408	0.808	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      968	CD68	0.408	0.808	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      968	CD68	0.408	0.808	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      968	CD68	0.408	0.808	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      969	CD69	0.488	0.923	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      969	CD69	0.488	0.923	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      969	CD69	0.488	0.923	C0003864	Arthritis	disease	C05	Disease or Syndrome	0.33	1	2003	2011	   1	   0	CTD_human
      969	CD69	0.488	0.923	C0003865	Arthritis, Adjuvant-Induced	disease	C05	Experimental Model of Disease	0.30	1	2003	2003	   1	   0	CTD_human
      969	CD69	0.488	0.923	C0011854	Diabetes Mellitus, Insulin-Dependent	disease	C18;C20;C19	Disease or Syndrome	0.41	1	2009	2019	   1	   2	CTD_human
      969	CD69	0.488	0.923	C0162323	Polyarthritis	disease	C05	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      969	CD69	0.488	0.923	C0205734	Diabetes, Autoimmune	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      969	CD69	0.488	0.923	C0342302	Brittle diabetes	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      969	CD69	0.488	0.923	C0971858	Arthritis, Collagen-Induced	disease	C05	Experimental Model of Disease	0.30	1	2003	2003	   1	   0	CTD_human
      969	CD69	0.488	0.923	C0993582	Arthritis, Experimental	disease	C05	Experimental Model of Disease	0.30	1	2003	2003	   1	   0	CTD_human
      969	CD69	0.488	0.923	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      969	CD69	0.488	0.923	C3837958	Diabetes Mellitus, Ketosis-Prone	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      969	CD69	0.488	0.923	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.31	1	2008	2017	   1	   0	CTD_human
      969	CD69	0.488	0.923	C4554117	Diabetes Mellitus, Sudden-Onset	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      970	CD70	0.542	0.692	C0494261	Combined immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      970	CD70	0.542	0.692	C1333432	EBV-Related Malignant Neoplasm	disease		Neoplastic Process	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      970	CD70	0.542	0.692	C4748863	LYMPHOPROLIFERATIVE SYNDROME 3	disease		Disease or Syndrome	0.41	1	2017	2017	   3	   3	ORPHANET
      972	CD74	0.512	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.36	0.857	2004	2017	   1	   0	CTD_human
      972	CD74	0.512	0.808	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.35	1	2012	2019	   1	   0	CTD_human
      972	CD74	0.512	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      972	CD74	0.512	0.808	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      972	CD74	0.512	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.37	0.875	2004	2017	   1	   0	CTD_human
      972	CD74	0.512	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      972	CD74	0.512	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.33	1	2007	2017	   1	   0	CTD_human
      972	CD74	0.512	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      973	CD79A	0.536	0.731	C0001768	Agammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.62	1	2002	2018	   1	   0	CTD_human;GENOMICS_ENGLAND
      973	CD79A	0.536	0.731	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.31	1	2007	2007	   0	   0	CGI
      973	CD79A	0.536	0.731	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.55	1	2003	2014	   1	   0	CGI;CTD_human
      973	CD79A	0.536	0.731	C0086438	Hypogammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.30				   0	   0	CTD_human
      973	CD79A	0.536	0.731	C1832241	Agammaglobulinemia, non-Bruton type	disease	C20;C15	Disease or Syndrome	0.30	1	2002	2002	   1	   0	ORPHANET
      973	CD79A	0.536	0.731	C3150751	AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.40	1	2009	2009	   1	   1	GENOMICS_ENGLAND
      973	CD79A	0.536	0.731	C4015923	AGAMMAGLOBULINEMIA 3	phenotype		Finding	0.30	1	2009	2009	   1	   0	GENOMICS_ENGLAND
      974	CD79B	0.576	0.577	C0001768	Agammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.61	1	2008	2014	   1	   0	CTD_human;GENOMICS_ENGLAND
      974	CD79B	0.576	0.577	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      974	CD79B	0.576	0.577	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.33	1	2007	2017	   0	   0	CGI
      974	CD79B	0.576	0.577	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.60	1	2010	2020	   1	   0	CGI;CTD_human
      974	CD79B	0.576	0.577	C0086438	Hypogammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.30				   0	   0	CTD_human
      974	CD79B	0.576	0.577	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      974	CD79B	0.576	0.577	C1832241	Agammaglobulinemia, non-Bruton type	disease	C20;C15	Disease or Syndrome	0.30	1	2007	2007	   2	   0	ORPHANET
      974	CD79B	0.576	0.577	C3150207	AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.60	1	2007	2014	   2	   2	GENOMICS_ENGLAND;UNIPROT
      974	CD79B	0.576	0.577	C4016221	AGAMMAGLOBULINEMIA 6	phenotype		Finding	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
      975	CD81	0.555	0.846	C0009447	Common Variable Immunodeficiency	disease	C20	Disease or Syndrome	0.51	1	2011	2011	   1	   0	CTD_human;ORPHANET
      975	CD81	0.555	0.846	C0019196	Hepatitis C	disease	C06;C01	Disease or Syndrome	0.40	0.947	1998	2020	   1	   0	CTD_human
      975	CD81	0.555	0.846	C0086438	Hypogammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      975	CD81	0.555	0.846	C2936664	Acquired Hypogammaglobulinemia	disease	C20	Disease or Syndrome	0.30				   0	   0	CTD_human
      975	CD81	0.555	0.846	C2936665	Immunoglobulin Deficiency, Late-Onset	disease	C20	Disease or Syndrome	0.30				   0	   0	CTD_human
      975	CD81	0.555	0.846	C3150741	IMMUNODEFICIENCY, COMMON VARIABLE, 6	disease		Disease or Syndrome	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      976	ADGRE5	0.601	0.538	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      977	CD151	0.564	0.654	C1836823	Nephropathy with Pretibial Epidermolysis Bullosa and Deafness	disease	C23;C16;C13;C17;C12;C10;C09	Disease or Syndrome	0.70	1	2004	2018	   2	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
      978	CDA	0.558	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	1	2000	2015	   2	   0	CTD_human
      978	CDA	0.558	0.731	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.33	1	2000	2015	   2	   0	CTD_human
      978	CDA	0.558	0.731	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2000	2014	   2	   0	CTD_human
      978	CDA	0.558	0.731	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2000	2018	   2	   0	CTD_human
      978	CDA	0.558	0.731	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2000	2014	   2	   0	CTD_human
      983	CDK1	0.482	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      983	CDK1	0.482	0.808	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.32	1	2009	2013	   1	   0	CTD_human
      983	CDK1	0.482	0.808	C1306067	Drug-induced paranoid state	disease		Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
      983	CDK1	0.482	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.60	1	1999	2019	   1	   0	CTD_human
      987	LRBA	0.608	0.692	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
      987	LRBA	0.608	0.692	C3553512	IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY	disease		Disease or Syndrome	0.70	1	2012	2017	   7	   9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      989	SEPTIN7	0.7	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2011	   2	   0	PSYGENET
      990	CDC6	0.552	0.731	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      990	CDC6	0.552	0.731	C0152423	Congenital small ears	disease	C16;C09	Congenital Abnormality	0.40	1	1998	1998	   1	   0	GENOMICS_ENGLAND
      990	CDC6	0.552	0.731	C0265202	Seckel syndrome	disease	C23;C16;C05;C10;C19	Disease or Syndrome	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
      990	CDC6	0.552	0.731	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      990	CDC6	0.552	0.731	C1292778	Chronic myeloproliferative disorder	disease	C04;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
      990	CDC6	0.552	0.731	C1868684	EAR, PATELLA, SHORT STATURE SYNDROME	disease	C23;C16;C05;C07;C09	Disease or Syndrome	0.54	1	2011	2017	   2	   0	CTD_human;ORPHANET
      990	CDC6	0.552	0.731	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.33	1	2008	2018	   1	   0	CTD_human
      990	CDC6	0.552	0.731	C3151126	MEIER-GORLIN SYNDROME 5	disease		Disease or Syndrome	0.50	1	1998	2012	   4	   1	GENOMICS_ENGLAND;UNIPROT
      991	CDC20	0.587	0.577	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.35	0.833	2002	2017	   1	   0	CTD_human
      994	CDC25B	0.601	0.654	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
      994	CDC25B	0.601	0.654	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      994	CDC25B	0.601	0.654	C1135196	Heart Failure, Diastolic	disease	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      994	CDC25B	0.601	0.654	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      994	CDC25B	0.601	0.654	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      994	CDC25B	0.601	0.654	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      994	CDC25B	0.601	0.654	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      995	CDC25C	0.576	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.41	1	2011	2019	   1	   0	PSYGENET
      995	CDC25C	0.576	0.769	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.35	1	2003	2017	   1	   0	CTD_human
      996	CDC27	0.729	0.308	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	1	2013	2016	   0	   0	UNIPROT
      996	CDC27	0.729	0.308	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      996	CDC27	0.729	0.308	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	0.5	2013	2018	   1	   0	CTD_human
      998	CDC42	0.458	0.846	C0001624	Adrenal Gland Neoplasms	group	C04;C19	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      998	CDC42	0.458	0.846	C0005818	Blood Platelet Disorders	group	C15	Disease or Syndrome	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      998	CDC42	0.458	0.846	C0007097	Carcinoma	group	C04	Neoplastic Process	0.33	1	2005	2014	   1	   0	CTD_human
      998	CDC42	0.458	0.846	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.31	1	2004	2005	   1	   0	CTD_human
      998	CDC42	0.458	0.846	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      998	CDC42	0.458	0.846	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      998	CDC42	0.458	0.846	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2009	2009	   1	   0	CTD_human
      998	CDC42	0.458	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.35	1	2006	2017	   4	   0	PSYGENET
      998	CDC42	0.458	0.846	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      998	CDC42	0.458	0.846	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      998	CDC42	0.458	0.846	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      998	CDC42	0.458	0.846	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      998	CDC42	0.458	0.846	C0750887	Adrenal Cancer	disease	C04;C19	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      998	CDC42	0.458	0.846	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      998	CDC42	0.458	0.846	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.43	1	2003	2018	   1	   0	GENOMICS_ENGLAND
      998	CDC42	0.458	0.846	C4225222	TAKENOUCHI-KOSAKI SYNDROME	disease		Disease or Syndrome	0.71	1	2015	2018	   3	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      998	CDC42	0.458	0.846	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.69	1	2000	2016	   2	   1	CTD_human
      999	CDH1	0.401	0.808	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.60	1	2000	2016	   2	   0	CTD_human
      999	CDH1	0.401	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.80	1	1991	2019	   4	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
      999	CDH1	0.401	0.808	C0007097	Carcinoma	group	C04	Neoplastic Process	0.40	1	1994	2019	   3	   0	CTD_human
      999	CDH1	0.401	0.808	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.40	1	1998	2018	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.39	1	1997	2015	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.50	0.939	1997	2020	   2	   2	CTD_human
      999	CDH1	0.401	0.808	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.50	0.95	1999	2019	   2	   2	CTD_human
      999	CDH1	0.401	0.808	C0009405	Hereditary Nonpolyposis Colorectal Neoplasms	group	C16;C06;C04;C18	Neoplastic Process	0.30	1	1998	2016	   6	   0	CLINGEN
      999	CDH1	0.401	0.808	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.34	1	2002	2017	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0014170	Endometrial Neoplasms	group	C04;C13	Neoplastic Process	0.32	1	1994	2015	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0014476	Eperythrozoonosis	disease	C01	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2010	2014	   2	   0	CTD_human
      999	CDH1	0.401	0.808	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2010	2014	   2	   0	CTD_human
      999	CDH1	0.401	0.808	C0021367	Mammary Ductal Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	1995	2007	   2	   0	CTD_human
      999	CDH1	0.401	0.808	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2010	2014	   2	   0	CTD_human
      999	CDH1	0.401	0.808	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.80	0.933	1996	2020	   6	   1	CGI;CTD_human;UNIPROT
      999	CDH1	0.401	0.808	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0025500	Mesothelioma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0026936	Mycoplasma Infections	group	C01	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2010	2012	   2	   0	CTD_human
      999	CDH1	0.401	0.808	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	0.96	1993	2020	   2	   0	CTD_human
      999	CDH1	0.401	0.808	C0027645	Neoplasm Seeding	phenotype	C23;C04	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2016	2016	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2002	2002	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0029925	Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.31	1	2004	2004	   0	   1	UNIPROT
      999	CDH1	0.401	0.808	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.35	1	2002	2019	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.32	1	2003	2012	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.40	0.96	1997	2019	   4	   0	CTD_human
      999	CDH1	0.401	0.808	C0036095	Salivary Gland Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.60	1	1998	2017	   6	   0	CGI;CTD_human
      999	CDH1	0.401	0.808	C0079487	Helicobacter Infections	group	C01	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2010	2014	   2	   0	CTD_human
      999	CDH1	0.401	0.808	C0153943	Benign neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      999	CDH1	0.401	0.808	C0154060	Carcinoma in situ of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      999	CDH1	0.401	0.808	C0158646	Cleft palate with cleft lip	disease	C16;C05;C07	Congenital Abnormality	0.33	1	2006	2019	   1	   0	ORPHANET
      999	CDH1	0.401	0.808	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	1994	2007	   3	   0	CTD_human
      999	CDH1	0.401	0.808	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	1994	2007	   3	   0	CTD_human
      999	CDH1	0.401	0.808	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.31	1	1994	2007	   3	   0	CTD_human
      999	CDH1	0.401	0.808	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	1994	2007	   3	   0	CTD_human
      999	CDH1	0.401	0.808	C0206692	Carcinoma, Lobular	disease	C04;C17	Neoplastic Process	0.69	1	1995	2013	   2	   0	CGI;CTD_human;UNIPROT
      999	CDH1	0.401	0.808	C0220636	Malignant neoplasm of salivary gland	disease	C04;C07	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0282612	Prostatic Intraepithelial Neoplasias	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0346153	Breast Cancer, Familial	disease	C04;C17	Neoplastic Process	0.31	1	1991	2018	  12	   0	CLINGEN
      999	CDH1	0.401	0.808	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.35	0.8	2001	2018	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.70	0.903	1997	2019	   4	   2	CTD_human;GENOMICS_ENGLAND
      999	CDH1	0.401	0.808	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.70	0.938	1994	2018	   1	   2	CTD_human;GENOMICS_ENGLAND
      999	CDH1	0.401	0.808	C0496905	Neoplasm of uncertain or unknown behavior of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      999	CDH1	0.401	0.808	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.32	1	2007	2016	   0	   1	UNIPROT
      999	CDH1	0.401	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.50	1	1991	2019	   4	   0	CTD_human
      999	CDH1	0.401	0.808	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.70	0.937	1996	2020	   0	   3	CGI;UNIPROT
      999	CDH1	0.401	0.808	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.48	1	1994	2017	   1	   2	CTD_human
      999	CDH1	0.401	0.808	C1112155	Hereditary non-polyposis colorectal cancer syndrome	disease		Congenital Abnormality	0.30	1	1998	2016	   6	   0	CLINGEN
      999	CDH1	0.401	0.808	C1134719	Invasive Ductal Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.39	1	1995	2019	   2	   0	CTD_human
      999	CDH1	0.401	0.808	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.69	1	1994	2017	   1	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      999	CDH1	0.401	0.808	C1176475	Ductal Carcinoma	disease	C04	Neoplastic Process	0.36	0.857	1995	2018	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      999	CDH1	0.401	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2007	2013	   4	   0	CTD_human
      999	CDH1	0.401	0.808	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.32	1	1998	2016	   6	   0	CLINGEN
      999	CDH1	0.401	0.808	C1333991	Hereditary Non-Polyposis Colon Cancer Type 2	disease	C16;C04	Neoplastic Process	0.30	1	1998	2016	   6	   0	CLINGEN
      999	CDH1	0.401	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	2002	2019	   4	   0	CTD_human
      999	CDH1	0.401	0.808	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.80	0.972	1990	2020	  15	 109	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      999	CDH1	0.401	0.808	C1861536	Blepharo-cheilo-dontic syndrome	disease	C16;C11;C05;C07	Disease or Syndrome	0.32	1	2017	2018	   1	   0	ORPHANET
      999	CDH1	0.401	0.808	C2931456	Prostate cancer, familial	disease	C04;C12	Neoplastic Process	0.31	1	2004	2005	   2	   0	CTD_human
      999	CDH1	0.401	0.808	C2936783	Colorectal cancer, hereditary nonpolyposis, type 1	disease	C16;C06;C04;C18	Neoplastic Process	0.30	1	1998	2016	   6	   0	CLINGEN
      999	CDH1	0.401	0.808	C4551988	BLEPHAROCHEILODONTIC SYNDROME 1	disease	C16;C11;C05;C07	Disease or Syndrome	0.60	1	2016	2017	   2	   6	GENOMICS_ENGLAND;UNIPROT
      999	CDH1	0.401	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2007	2013	   4	   0	CTD_human
      999	CDH1	0.401	0.808	C4721610	Carcinoma, Ovarian Epithelial	disease	C04;C13;C19	Neoplastic Process	0.40	1	2004	2019	   0	   1	UNIPROT
      999	CDH1	0.401	0.808	C4722327	PROSTATE CANCER, HEREDITARY, 1	disease	C04;C12	Neoplastic Process	0.30	1	2004	2005	   2	   0	CTD_human
     1000	CDH2	0.535	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.32	1	2012	2016	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0013261	Duane Retraction Syndrome	disease	C16;C11;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	GENOMICS_ENGLAND
     1000	CDH2	0.535	0.731	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.38	1	2010	2019	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2002	2002	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2006	2007	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0454455	Mirror movements disorder	disease	C10	Disease or Syndrome	0.31	1	2007	2019	   1	   0	GENOMICS_ENGLAND
     1000	CDH2	0.535	0.731	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	GENOMICS_ENGLAND
     1000	CDH2	0.535	0.731	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.32	1	2012	2016	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0744356	Abnormality of the genital system	phenotype	C16;C13;C12	Finding	0.30	1	2007	2007	   1	   0	GENOMICS_ENGLAND
     1000	CDH2	0.535	0.731	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1000	CDH2	0.535	0.731	C1837249	Malformations of Cortical Development, Group II	disease	C16;C10	Congenital Abnormality	0.30	1	2007	2007	   1	   0	GENOMICS_ENGLAND
     1000	CDH2	0.535	0.731	C1842581	Abnormal corpus callosum morphology	phenotype	C23	Finding	0.30	1	2007	2007	   1	   0	GENOMICS_ENGLAND
     1000	CDH2	0.535	0.731	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.31	1	2007	2019	   1	   0	GENOMICS_ENGLAND
     1000	CDH2	0.535	0.731	C4316870	Abnormality of the eye	phenotype		Anatomical Abnormality	0.30	1	2007	2007	   1	   0	GENOMICS_ENGLAND
     1000	CDH2	0.535	0.731	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
     1001	CDH3	0.56	0.615	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.40	1	2009	2011	   1	   1	CTD_human
     1001	CDH3	0.56	0.615	C0010093	Corpus Luteum Cyst	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1001	CDH3	0.56	0.615	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1001	CDH3	0.56	0.615	C0029927	Ovarian Cysts	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1001	CDH3	0.56	0.615	C1832162	HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY	disease	C11;C17	Disease or Syndrome	0.70	1	2001	2010	   3	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1001	CDH3	0.56	0.615	C1857041	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	disease	C16;C11;C17;C05	Disease or Syndrome; Congenital Abnormality	0.74	1	2002	2017	   3	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1003	CDH5	0.561	0.692	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     1003	CDH5	0.561	0.692	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.37	1	2000	2018	   1	   0	CTD_human
     1003	CDH5	0.561	0.692	C0008312	Primary biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1003	CDH5	0.561	0.692	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1003	CDH5	0.561	0.692	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1003	CDH5	0.561	0.692	C0023892	Biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1003	CDH5	0.561	0.692	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1003	CDH5	0.561	0.692	C0232347	No-Reflow Phenomenon	phenotype	C23	Finding	0.30	1	2007	2007	   1	   0	CTD_human
     1003	CDH5	0.561	0.692	C0238065	Secondary Biliary Cholangitis	disease	C23;C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1003	CDH5	0.561	0.692	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.37	1	2000	2018	   1	   0	CTD_human
     1003	CDH5	0.561	0.692	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1003	CDH5	0.561	0.692	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.32	1	2008	2008	   1	   0	CTD_human
     1003	CDH5	0.561	0.692	C2713615	Slow-Flow Phenomenon	phenotype	C23	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
     1003	CDH5	0.561	0.692	C4551595	Biliary Cirrhosis, Primary, 1	disease	C23;C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1003	CDH5	0.561	0.692	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1004	CDH6	0.691	0.385	C0006625	Cachexia	phenotype	C23	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1005	CDH7	0.769	0.231	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
     1005	CDH7	0.769	0.231	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1005	CDH7	0.769	0.231	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1005	CDH7	0.769	0.231	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
     1005	CDH7	0.769	0.231	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
     1006	CDH8	0.743	0.385	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     1007	CDH9	0.751	0.308	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     1007	CDH9	0.751	0.308	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2009	2019	   1	   0	CTD_human
     1008	CDH10	0.76	0.385	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     1008	CDH10	0.76	0.385	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2009	2017	   1	   0	CTD_human
     1008	CDH10	0.76	0.385	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
     1008	CDH10	0.76	0.385	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2016	2017	   1	   0	CTD_human
     1009	CDH11	0.512	0.808	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2011	2012	   2	   0	PSYGENET
     1009	CDH11	0.512	0.808	C0809936	Branchio-skeleto-genital syndrome	disease	C05	Disease or Syndrome	0.63	1	2017	2018	   2	   3	GENOMICS_ENGLAND;ORPHANET
     1009	CDH11	0.512	0.808	C1863870	Hypospadias, Hypertelorism, Upper Lid Coloboma, and Mixed-Type Hearing Loss	phenotype	C23;C16;C13;C11;C05;C12;C10;C09	Disease or Syndrome	0.30	1	2017	2018	   2	   0	ORPHANET
     1010	CDH12	0.821	0.308	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	0.5	2011	2012	   2	   0	PSYGENET
     1010	CDH12	0.821	0.308	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1010	CDH12	0.821	0.308	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2009	2012	   3	   0	PSYGENET
     1012	CDH13	0.501	0.846	C0004763	Barrett Esophagus	disease	C06;C04	Disease or Syndrome	0.31	1	2008	2008	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.38	1	2002	2014	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2012	2019	   1	   0	PSYGENET
     1012	CDH13	0.501	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2019	   1	   0	PSYGENET
     1012	CDH13	0.501	0.846	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0013170	Drug habituation	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0013222	Drug Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2008	2016	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.51	1	2006	2008	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0029231	Organic Mental Disorders, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2007	2008	   2	   0	CTD_human
     1012	CDH13	0.501	0.846	C0038580	Substance Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0038586	Substance Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2008	2017	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0236733	Amphetamine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0236804	Amphetamine Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0236807	Amphetamine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0236969	Substance-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	1	1998	2018	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2007	2014	   2	   0	CTD_human
     1012	CDH13	0.501	0.846	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2008	2016	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2010	2015	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C1258085	Barrett Epithelium	disease	C06;C04	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1012	CDH13	0.501	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.35	1	2006	2017	   3	   0	CTD_human
     1012	CDH13	0.501	0.846	C4316881	Prescription Drug Abuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1013	CDH15	0.653	0.615	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
     1013	CDH15	0.653	0.615	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1013	CDH15	0.653	0.615	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1013	CDH15	0.653	0.615	C2675488	Mental Retardation, Autosomal Dominant 3	disease	C23;C10;F03;F01	Disease or Syndrome	0.60	1	2008	2015	   2	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1015	CDH17	0.636	0.615	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2006	2008	   2	   0	PSYGENET
     1015	CDH17	0.636	0.615	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
     1015	CDH17	0.636	0.615	C0264423	Asthma, Occupational	disease	C08;C20;C24	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1015	CDH17	0.636	0.615	C0349204	Nonorganic psychosis	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
     1015	CDH17	0.636	0.615	C1839839	MAJOR AFFECTIVE DISORDER 2	disease	C16;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
     1016	CDH18	0.769	0.269	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     1016	CDH18	0.769	0.269	C3495676	Anorectal Malformations	group	C16;C06	Anatomical Abnormality	0.30	1	2013	2013	   1	   0	GENOMICS_ENGLAND
     1017	CDK2	0.456	0.692	C0019829	Hodgkin Disease	disease	C04;C20;C15	Neoplastic Process	0.33	1	1995	1997	   0	   0	CGI
     1017	CDK2	0.456	0.692	C0025202	melanoma	disease	C04	Neoplastic Process	0.40	0.941	1994	2019	   1	   0	CTD_human
     1017	CDK2	0.456	0.692	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.33	1	1998	2007	   0	   0	CGI
     1017	CDK2	0.456	0.692	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.34	0.8	1994	2018	   1	   0	CTD_human
     1017	CDK2	0.456	0.692	C1332201	Adult Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CGI
     1017	CDK2	0.456	0.692	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.38	1	1995	2017	   0	   0	UNIPROT
     1018	CDK3	0.716	0.385	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.31	1	2008	2008	   0	   0	UNIPROT
     1019	CDK4	0.412	0.808	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.35	0.833	1996	2019	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.966	1995	2019	   0	   0	CGI
     1019	CDK4	0.412	0.808	C0007097	Carcinoma	group	C04	Neoplastic Process	0.40	1	1996	2018	   2	   0	CTD_human
     1019	CDK4	0.412	0.808	C0023827	liposarcoma	disease	C04	Neoplastic Process	0.60	1	1995	2019	   2	   0	CGI;CTD_human
     1019	CDK4	0.412	0.808	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.39	1	1996	2018	   0	   0	CGI
     1019	CDK4	0.412	0.808	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.36	1	2011	2019	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2003	   2	   0	CTD_human
     1019	CDK4	0.412	0.808	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.50	1	2002	2014	   3	   0	CTD_human
     1019	CDK4	0.412	0.808	C0025202	melanoma	disease	C04	Neoplastic Process	0.70	0.961	1994	2020	   0	   1	CGI;GENOMICS_ENGLAND
     1019	CDK4	0.412	0.808	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.40	1	2011	2011	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.50	1	1999	2016	   0	   2	CGI
     1019	CDK4	0.412	0.808	C0153633	Malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.32	1	1996	2019	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2003	   2	   0	CTD_human
     1019	CDK4	0.412	0.808	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2003	   2	   0	CTD_human
     1019	CDK4	0.412	0.808	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2003	   2	   0	CTD_human
     1019	CDK4	0.412	0.808	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2003	   2	   0	CTD_human
     1019	CDK4	0.412	0.808	C0205824	Liposarcoma, Dedifferentiated	disease	C04	Neoplastic Process	0.60	1	2003	2020	   2	   0	CTD_human;ORPHANET
     1019	CDK4	0.412	0.808	C0205825	Liposarcoma, Pleomorphic	disease	C04	Neoplastic Process	0.33	1	2010	2017	   2	   0	CTD_human
     1019	CDK4	0.412	0.808	C0496899	Benign neoplasm of brain, unspecified	disease	C04;C10	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C0677866	Brain Stem Neoplasms	group	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C0750974	Brain Tumor, Primary	disease	C04;C10	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C0750977	Recurrent Brain Neoplasm	disease	C04;C10	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C0750979	Primary malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C0751886	Brain Stem Neoplasms, Primary	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C0751887	Medullary Neoplasms	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C0751888	Mesencephalic Neoplasms	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C0751889	Pontine Tumors	group	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.39	1	1995	2019	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2003	   2	   0	CTD_human
     1019	CDK4	0.412	0.808	C1370889	Liposarcoma, well differentiated	disease	C04	Neoplastic Process	0.60	0.95	2000	2019	   2	   0	CTD_human;ORPHANET
     1019	CDK4	0.412	0.808	C1512419	Hereditary Melanoma	disease	C16;C04;C17	Neoplastic Process	0.50	1	1996	2019	   0	   1	GENOMICS_ENGLAND
     1019	CDK4	0.412	0.808	C1527390	Neoplasms, Intracranial	group	C04;C10	Neoplastic Process	0.31	1	2011	2017	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C1836892	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3	disease		Finding	0.70	1	1995	2019	   9	   3	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1019	CDK4	0.412	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	1996	2020	   1	   0	CTD_human
     1019	CDK4	0.412	0.808	C2314896	Familial Atypical Mole Melanoma Syndrome	disease	C16;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	ORPHANET
     1020	CDK5	0.495	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
     1020	CDK5	0.495	0.846	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2001	2019	   2	   0	PSYGENET
     1020	CDK5	0.495	0.846	C0949664	Tauopathies	group	C10	Disease or Syndrome	0.32	1	2013	2017	   1	   0	CTD_human
     1020	CDK5	0.495	0.846	C4225359	LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA	disease		Disease or Syndrome	0.60	1	2015	2015	   1	   1	CTD_human;GENOMICS_ENGLAND
     1021	CDK6	0.471	0.731	C0002871	Anemia	disease	C15	Disease or Syndrome	0.31	1	2017	2017	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.44	0.714	2008	2019	   1	   1	CTD_human
     1021	CDK6	0.471	0.731	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.40	1	2018	2018	   2	   2	CTD_human
     1021	CDK6	0.471	0.731	C0004403	Autosome Abnormalities	group	C23	Cell or Molecular Dysfunction	0.30	1	2014	2014	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	1	1995	2020	   0	   0	CGI
     1021	CDK6	0.471	0.731	C0008625	Chromosome Aberrations	group	C23	Cell or Molecular Dysfunction	0.30	1	2014	2014	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.35	1	2000	2017	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.31	1	2009	2014	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.37	1	2008	2018	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0023827	liposarcoma	disease	C04	Neoplastic Process	0.30				   0	   0	CGI
     1021	CDK6	0.471	0.731	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.31	1	2000	2000	   0	   0	CGI
     1021	CDK6	0.471	0.731	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.38	1	2005	2018	   2	   0	CTD_human
     1021	CDK6	0.471	0.731	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.40	1	2018	2018	   1	   1	CTD_human
     1021	CDK6	0.471	0.731	C0205833	Medullomyoblastoma	disease	C04	Neoplastic Process	0.30	1	2009	2013	   2	   0	CTD_human
     1021	CDK6	0.471	0.731	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   2	   0	CTD_human
     1021	CDK6	0.471	0.731	C0263454	Chloracne	disease	C17	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0278510	Childhood Medulloblastoma	disease	C04	Neoplastic Process	0.38	1	2005	2018	   2	   0	CTD_human
     1021	CDK6	0.471	0.731	C0278876	Adult Medulloblastoma	disease	C04	Neoplastic Process	0.38	1	2005	2018	   2	   0	CTD_human
     1021	CDK6	0.471	0.731	C0278883	Metastatic melanoma	disease	C04	Neoplastic Process	0.31	1	2017	2017	   0	   0	UNIPROT
     1021	CDK6	0.471	0.731	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0677866	Brain Stem Neoplasms	group	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0751291	Desmoplastic Medulloblastoma	disease	C04	Neoplastic Process	0.30	1	2009	2013	   2	   0	CTD_human
     1021	CDK6	0.471	0.731	C0751886	Brain Stem Neoplasms, Primary	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0751887	Medullary Neoplasms	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0751888	Mesencephalic Neoplasms	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0751889	Pontine Tumors	group	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C0751956	Acute Cerebrovascular Accidents	disease	C10;C14	Disease or Syndrome	0.31	1	2018	2018	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.32	1	2016	2018	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C1275668	Melanotic medulloblastoma	disease	C04	Neoplastic Process	0.30	1	2009	2013	   2	   0	CTD_human
     1021	CDK6	0.471	0.731	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.37	1	2000	2017	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2009	2014	   1	   0	CTD_human
     1021	CDK6	0.471	0.731	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
     1021	CDK6	0.471	0.731	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
     1021	CDK6	0.471	0.731	C3711387	Autosomal Recessive Primary Microcephaly	disease	C16;C05;C10	Disease or Syndrome	0.31	1	2013	2015	   1	   0	ORPHANET
     1021	CDK6	0.471	0.731	C4015156	MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.70	1	2013	2013	   1	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1024	CDK8	0.597	0.654	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1024	CDK8	0.597	0.654	C0232466	Feeding difficulties	phenotype		Finding	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1024	CDK8	0.597	0.654	C0233514	Abnormal behavior	phenotype	F01	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1024	CDK8	0.597	0.654	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1024	CDK8	0.597	0.654	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     1024	CDK8	0.597	0.654	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1024	CDK8	0.597	0.654	C1858120	Generalized hypotonia	phenotype	C23;C10	Finding	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1024	CDK8	0.597	0.654	C2677504	AUTISM, SUSCEPTIBILITY TO, 15	disease		Finding	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1024	CDK8	0.597	0.654	C3495676	Anorectal Malformations	group	C16;C06	Anatomical Abnormality	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1024	CDK8	0.597	0.654	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1024	CDK8	0.597	0.654	C4025846	Abnormality of vision	disease		Finding	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1024	CDK8	0.597	0.654	C4049796	Abnormality of cardiovascular system morphology	disease	C16;C14	Congenital Abnormality	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1026	CDKN1A	0.403	0.769	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.40	1	2018	2018	   1	   1	CTD_human
     1026	CDKN1A	0.403	0.769	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.40	1	1996	2018	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.40	1	1996	2018	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.987	1994	2019	   0	   0	CGI
     1026	CDKN1A	0.403	0.769	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.40	0.941	1996	2019	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0007138	Carcinoma, Transitional Cell	disease	C04	Neoplastic Process	0.32	1	1996	2008	   2	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.40	1	2002	2010	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.31	1	2016	2019	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0017667	Nodular glomerulosclerosis	disease	C13;C12;C19	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.31	1	2003	2014	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0020564	Hypertrophy	phenotype	C23	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0021841	Intestinal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2001	2002	   2	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.34	1	2002	2014	   2	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.40	0.917	2001	2019	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0025267	Multiple Endocrine Neoplasia Type 1	disease	C16;C04;C19	Neoplastic Process	0.30	1	2009	2009	   1	   0	ORPHANET
     1026	CDKN1A	0.403	0.769	C0030354	Papilloma	disease	C04	Neoplastic Process	0.32	1	2002	2017	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.38	1	2002	2016	   2	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.50	1	1999	2007	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.52	1	2004	2017	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0205874	Papilloma, Squamous Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0205875	Papillomatosis	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0238288	Muscular Dystrophy, Facioscapulohumeral	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	0.938	1998	2017	   2	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.40	1	1998	2019	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0346627	Intestinal Cancer	disease	C06;C04	Neoplastic Process	0.31	1	2001	2011	   2	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.966	1995	2019	   2	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     1026	CDKN1A	0.403	0.769	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.60	0.964	1996	2019	   1	   0	CGI;CTD_human
     1027	CDKN1B	0.409	0.769	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.976	1995	2019	   0	   0	CGI
     1027	CDKN1B	0.409	0.769	C0007113	Rectal Carcinoma	disease	C06;C04	Neoplastic Process	0.33	1	2001	2017	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0009405	Hereditary Nonpolyposis Colorectal Neoplasms	group	C16;C06;C04;C18	Neoplastic Process	0.30	1	1998	2015	   8	   0	CLINGEN
     1027	CDKN1B	0.409	0.769	C0021841	Intestinal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0022665	Kidney Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.34	1	1999	2006	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.32	1	1998	2010	   3	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.36	0.857	2000	2016	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0025267	Multiple Endocrine Neoplasia Type 1	disease	C16;C04;C19	Neoplastic Process	0.40	0.952	2007	2019	   2	   0	ORPHANET
     1027	CDKN1B	0.409	0.769	C0025500	Mesothelioma	disease	C04	Neoplastic Process	0.31	1	1995	2006	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0027662	Multiple Endocrine Neoplasia	disease	C16;C04;C19	Neoplastic Process	0.60	0.957	2006	2017	   0	   0	GENOMICS_ENGLAND
     1027	CDKN1B	0.409	0.769	C0032000	Pituitary Adenoma	disease	C04;C10;C19	Neoplastic Process	0.71	1	2006	2010	   2	   0	CGI;CTD_human;GENOMICS_ENGLAND
     1027	CDKN1B	0.409	0.769	C0032019	Pituitary Neoplasms	group	C04;C10;C19	Neoplastic Process	0.32	1	2002	2014	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.40	1	1997	2018	   3	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0034885	Rectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0036920	Sezary Syndrome	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2002	2004	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0042138	Uterine Neoplasms	group	C04;C13	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0079487	Helicobacter Infections	group	C01	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0153567	Uterine Cancer	disease	C04;C13	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0206669	Hepatocellular Adenoma	disease	C06;C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0206695	Carcinoma, Neuroendocrine	disease	C04	Neoplastic Process	0.31	1	2008	2008	   0	   0	GENOMICS_ENGLAND
     1027	CDKN1B	0.409	0.769	C0206754	Neuroendocrine Tumors	group	C04	Neoplastic Process	0.44	1	2008	2015	   1	   3	CTD_human
     1027	CDKN1B	0.409	0.769	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	1	1998	2017	   3	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0262587	Parathyroid Adenoma	disease	C04;C19	Neoplastic Process	0.44	1	2011	2017	   0	   0	CGI
     1027	CDKN1B	0.409	0.769	C0263454	Chloracne	disease	C17	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0282612	Prostatic Intraepithelial Neoplasias	disease	C04	Neoplastic Process	0.32	1	1998	2010	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.31	1	2006	2015	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0346300	Pituitary carcinoma	disease	C04;C10;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0346627	Intestinal Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.875	1996	2019	   3	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
     1027	CDKN1B	0.409	0.769	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.33	1	2000	2010	   1	   0	GENOMICS_ENGLAND
     1027	CDKN1B	0.409	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.60	0.965	1996	2019	   1	   0	CGI;CTD_human
     1027	CDKN1B	0.409	0.769	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.33	1	2004	2018	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
     1027	CDKN1B	0.409	0.769	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.39	0.9	1999	2016	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C1112155	Hereditary non-polyposis colorectal cancer syndrome	disease		Congenital Abnormality	0.30	1	1998	2015	   8	   0	CLINGEN
     1027	CDKN1B	0.409	0.769	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.37	1	2006	2016	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.30	1	1998	2015	   8	   0	CLINGEN
     1027	CDKN1B	0.409	0.769	C1333991	Hereditary Non-Polyposis Colon Cancer Type 2	disease	C16;C04	Neoplastic Process	0.30	1	1998	2015	   8	   0	CLINGEN
     1027	CDKN1B	0.409	0.769	C1336005	Small Intestinal Neuroendocrine Neoplasm	disease		Neoplastic Process	0.30				   0	   0	CGI
     1027	CDKN1B	0.409	0.769	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	2002	2016	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C1704374	Carcinoma of Endocrine Gland	disease	C04;C19	Neoplastic Process	0.30				   0	   0	GENOMICS_ENGLAND
     1027	CDKN1B	0.409	0.769	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C1970712	Multiple Endocrine Neoplasia, Type IV	disease	C16;C04;C19	Neoplastic Process	0.79	1	1996	2019	  11	   9	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
     1027	CDKN1B	0.409	0.769	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	1998	2019	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C2931456	Prostate cancer, familial	disease	C04;C12	Neoplastic Process	0.33	1	2004	2018	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C2936783	Colorectal cancer, hereditary nonpolyposis, type 1	disease	C16;C06;C04;C18	Neoplastic Process	0.30	1	1998	2015	   8	   0	CLINGEN
     1027	CDKN1B	0.409	0.769	C4274947	Multiple endocrine neoplasia type 4	disease	C16;C04;C19	Neoplastic Process	0.33	1	1996	2019	   9	   0	CLINGEN
     1027	CDKN1B	0.409	0.769	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1027	CDKN1B	0.409	0.769	C4722327	PROSTATE CANCER, HEREDITARY, 1	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.31	1	2011	2019	   1	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0004048	Inspiration function	phenotype		Organism Function	0.30				   0	   0	GENOMICS_ENGLAND
     1028	CDKN1C	0.456	0.846	C0004903	Beckwith-Wiedemann Syndrome	disease	C16	Disease or Syndrome	0.80	1	1992	2019	   6	  25	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1028	CDKN1C	0.456	0.846	C0014170	Endometrial Neoplasms	group	C04;C13	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0014173	Endometrial Hyperplasia	disease	C13	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2010	2011	   2	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	Neoplastic Process	0.48	1	1996	2006	   1	   0	GENOMICS_ENGLAND
     1028	CDKN1C	0.456	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	PSYGENET
     1028	CDKN1C	0.456	0.846	C0175693	Russell-Silver syndrome	disease	C16;C05	Disease or Syndrome	0.40	0.929	1996	2016	   1	   0	GENOMICS_ENGLAND
     1028	CDKN1C	0.456	0.846	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.32	1	1996	2011	   2	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0268731	Renal glomerular disease	group	C23;C13;C12	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1028	CDKN1C	0.456	0.846	C0349578	Complex Endometrial Hyperplasia	disease	C13	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0349579	Atypical Endometrial Hyperplasia	disease	C13	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0456483	Simple Endometrial Hyperplasia	disease	C13	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
     1028	CDKN1C	0.456	0.846	C1846009	Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, And Genital Anomalies	disease	C23;C16;C13;C05;C12;C19	Disease or Syndrome	0.80	1	1997	2020	   4	   7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1028	CDKN1C	0.456	0.846	C1856184	HEMIHYPERPLASIA, ISOLATED	disease	C23	Disease or Syndrome	0.32	1	2010	2016	   0	   0	GENOMICS_ENGLAND
     1028	CDKN1C	0.456	0.846	C1859977	Adrenal Hypoplasia, Cytomegalic Type	phenotype	C23;C16;C13;C05;C12;C19	Disease or Syndrome	0.30				   0	   0	CTD_human
     1028	CDKN1C	0.456	0.846	C4521256	Glomerulopathy Assessment	phenotype		Diagnostic Procedure	0.30				   0	   0	GENOMICS_ENGLAND
     1029	CDKN2A	0.3	0.885	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.40	0.941	1995	2020	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0001624	Adrenal Gland Neoplasms	group	C04;C19	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0005426	Biliary Tract Neoplasm	disease	C06;C04	Neoplastic Process	0.30				   0	   3	UNIPROT
     1029	CDKN2A	0.3	0.885	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.40	1	1995	2019	   2	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.60	1	1995	2019	   2	   0	CTD_human;UNIPROT
     1029	CDKN2A	0.3	0.885	C0005940	Bone Diseases	group	C05	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.40	0.938	1994	2017	   2	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.50	0.933	1995	2020	   1	   1	CTD_human
     1029	CDKN2A	0.3	0.885	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.40	1	1995	2017	   1	   0	ORPHANET
     1029	CDKN2A	0.3	0.885	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.60	0.946	1994	2020	   2	   0	CGI;CTD_human
     1029	CDKN2A	0.3	0.885	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.60	0.957	1994	2020	   2	   3	CTD_human;UNIPROT
     1029	CDKN2A	0.3	0.885	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.70	0.96	1994	2020	   1	   2	CTD_human;UNIPROT
     1029	CDKN2A	0.3	0.885	C0008628	Chromosome Deletion	group	C23	Cell or Molecular Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.32	1	2002	2019	   3	   0	PSYGENET
     1029	CDKN2A	0.3	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2002	2019	   3	   0	PSYGENET
     1029	CDKN2A	0.3	0.885	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.80	0.957	1994	2019	   1	   2	CTD_human;UNIPROT
     1029	CDKN2A	0.3	0.885	C0016325	Fluoride Poisoning	disease	C25	Injury or Poisoning	0.30	1	2019	2019	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0017601	Glaucoma	disease	C11	Disease or Syndrome	0.32	1	2011	2015	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0017638	Glioma	disease	C04	Neoplastic Process	0.60	0.936	1994	2020	   2	   0	CGI;CTD_human
     1029	CDKN2A	0.3	0.885	C0022783	Vulvar Lichen Sclerosus	disease	C13	Disease or Syndrome	0.32	1	2007	2012	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0023418	leukemia	disease	C04	Neoplastic Process	0.40	0.958	1994	2016	   0	   1	UNIPROT
     1029	CDKN2A	0.3	0.885	C0023449	Acute lymphocytic leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	0.988	1994	2019	   1	   0	GENOMICS_ENGLAND
     1029	CDKN2A	0.3	0.885	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.60	0.955	1994	2019	   2	   0	CTD_human;GENOMICS_ENGLAND
     1029	CDKN2A	0.3	0.885	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.69	0.929	1997	2019	   3	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.80	1	1997	2019	   4	   0	CTD_human;UNIPROT
     1029	CDKN2A	0.3	0.885	C0024232	Lymphatic Metastasis	disease	C23;C04	Neoplastic Process	0.31	1	2008	2018	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.50	0.951	1995	2019	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.40	0.947	1996	2017	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0025202	melanoma	disease	C04	Neoplastic Process	0.80	0.95	1994	2020	   2	   6	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1029	CDKN2A	0.3	0.885	C0025500	Mesothelioma	disease	C04	Neoplastic Process	0.60	0.965	1995	2019	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.34	1	2003	2014	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.50	0.925	1996	2018	   1	   1	CTD_human
     1029	CDKN2A	0.3	0.885	C0027533	Neck Neoplasms	group	C04	Neoplastic Process	0.34	1	2001	2014	   0	   1	UNIPROT
     1029	CDKN2A	0.3	0.885	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0027651	Neoplasms	group	C04	Neoplastic Process	0.50	0.944	1984	2020	   2	   7	CTD_human
     1029	CDKN2A	0.3	0.885	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.40	0.88	1995	2014	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.80	1	1996	2019	   2	   2	CGI;CTD_human;UNIPROT
     1029	CDKN2A	0.3	0.885	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.40	0.941	1997	2018	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0036920	Sezary Syndrome	disease	C04;C20;C15	Neoplastic Process	0.31	1	2002	2015	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.45	1	1997	2008	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0040100	Thymoma	disease	C04;C15	Neoplastic Process	0.31	1	1997	2014	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0040715	Chromosomal translocation	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2011	2011	   2	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0041107	Trisomy	group	C23	Cell or Molecular Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2013	   2	   0	PSYGENET
     1029	CDKN2A	0.3	0.885	C0042065	Genitourinary Neoplasms	group	C04;C13;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.40	0.971	1998	2016	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.35	0.833	2004	2018	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0085390	Li-Fraumeni Syndrome	disease	C16;C04;C18	Disease or Syndrome	0.35	1	1999	2017	   2	   0	ORPHANET
     1029	CDKN2A	0.3	0.885	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.38	0.8	1999	2017	   2	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.70	0.949	1995	2016	   1	   7	CGI;CTD_human
     1029	CDKN2A	0.3	0.885	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.40	1	2001	2019	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0153633	Malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.31	1	1996	2007	   2	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0205969	Thymic Carcinoma	disease	C04;C15	Neoplastic Process	0.32	1	1997	2017	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0206686	Adrenocortical carcinoma	disease	C04;C19	Neoplastic Process	0.31	1	2012	2014	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0206727	Nerve Sheath Tumors	group	C04;C10	Neoplastic Process	0.31	1	2003	2014	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.60	0.98	1995	2019	   0	   1	CGI;UNIPROT
     1029	CDKN2A	0.3	0.885	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	0.953	1994	2020	   4	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2005	2009	   2	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.40	0.923	1994	2020	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0279628	Adenocarcinoma Of Esophagus	disease	C06;C04	Neoplastic Process	0.40	1	1997	2018	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.59	1	1996	2019	   3	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.40	0.968	1994	2020	   3	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.60	0.979	1995	2019	   2	   0	CGI;CTD_human
     1029	CDKN2A	0.3	0.885	C0347284	Benign tumor of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30				   0	   0	CGI
     1029	CDKN2A	0.3	0.885	C0376407	Granulomatous Slack Skin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0496899	Benign neoplasm of brain, unspecified	disease	C04;C10	Neoplastic Process	0.30	1	2004	2007	   2	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.40	0.964	1994	2019	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.40	0.957	1994	2019	   2	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.40	0.92	1994	2019	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0677866	Brain Stem Neoplasms	group	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.50	0.899	1994	2020	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0750887	Adrenal Cancer	disease	C04;C19	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0750974	Brain Tumor, Primary	disease	C04;C10	Neoplastic Process	0.31	1	2004	2015	   2	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0750977	Recurrent Brain Neoplasm	disease	C04;C10	Neoplastic Process	0.30	1	2004	2007	   2	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0750979	Primary malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.30	1	2004	2007	   2	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0751569	Genitourinary Cancer	disease	C04;C13;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0751606	Adult Acute Lymphocytic Leukemia	disease		Neoplastic Process	0.40	0.977	1994	2019	   1	   0	GENOMICS_ENGLAND
     1029	CDKN2A	0.3	0.885	C0751689	Peripheral Nerve Sheath Neoplasm	disease	C04;C10	Neoplastic Process	0.31	1	2014	2018	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0751691	Perineurioma	disease	C04;C10	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0751886	Brain Stem Neoplasms, Primary	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0751887	Medullary Neoplasms	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0751888	Mesencephalic Neoplasms	disease	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0751889	Pontine Tumors	group	C04;C10	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C0887833	Carcinoma, Pancreatic Ductal	disease	C06;C04;C19	Neoplastic Process	0.34	1	1998	2014	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.50	0.983	1994	2019	   3	   7	CTD_human
     1029	CDKN2A	0.3	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2013	   2	   0	PSYGENET
     1029	CDKN2A	0.3	0.885	C1292769	Precursor B-cell lymphoblastic leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	1	1995	2019	   1	   0	ORPHANET
     1029	CDKN2A	0.3	0.885	C1297882	Partial Trisomy	disease	C23	Congenital Abnormality	0.30	1	2011	2011	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C1449861	Micronuclei, Chromosome-Defective	phenotype	C23	Cell Component	0.30	1	2016	2016	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C1449862	Micronuclei, Genotoxicant-Induced	phenotype	C23	Cell Component	0.30	1	2016	2016	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.50	0.955	1995	2018	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C1512419	Hereditary Melanoma	disease	C16;C04;C17	Neoplastic Process	0.50	0.971	1947	2019	   0	  46	UNIPROT
     1029	CDKN2A	0.3	0.885	C1527390	Neoplasms, Intracranial	group	C04;C10	Neoplastic Process	0.33	1	2004	2017	   2	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C1835042	Melanoma astrocytoma syndrome	disease	C04;C10	Neoplastic Process	0.61	1	2001	2018	   1	   2	CTD_human;ORPHANET
     1029	CDKN2A	0.3	0.885	C1835044	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	disease		Finding	0.70	1	1994	2010	  13	  25	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1029	CDKN2A	0.3	0.885	C1838547	MELANOMA-PANCREATIC CANCER SYNDROME	disease	C16;C06;C04;C19	Disease or Syndrome	0.60	1	1994	2016	  10	   9	CLINGEN;CTD_human
     1029	CDKN2A	0.3	0.885	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.40	0.931	1995	2019	   1	   0	ORPHANET
     1029	CDKN2A	0.3	0.885	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.40	1	1995	2019	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.70	0.984	1996	2019	   2	   3	CTD_human
     1029	CDKN2A	0.3	0.885	C2314896	Familial Atypical Mole Melanoma Syndrome	disease	C16;C04	Neoplastic Process	0.40	1	1995	2019	   1	   0	ORPHANET
     1029	CDKN2A	0.3	0.885	C2930745	Partial Monosomy	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C2931038	Pancreatic carcinoma, familial	disease	C06;C04;C19	Neoplastic Process	0.38	1	1997	2015	   1	   0	ORPHANET
     1029	CDKN2A	0.3	0.885	C2931822	Nasopharyngeal carcinoma	disease	C04;C07;C09	Neoplastic Process	0.40	1	1995	2019	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C4283859	Cutaneous Malignant Melanoma 2	disease		Neoplastic Process	0.30	1	2010	2010	   1	   0	GENOMICS_ENGLAND
     1029	CDKN2A	0.3	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1029	CDKN2A	0.3	0.885	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1030	CDKN2B	0.417	0.769	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.947	1995	2018	   0	   0	CGI
     1030	CDKN2B	0.417	0.769	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.36	1	2008	2019	   1	   0	CTD_human
     1030	CDKN2B	0.417	0.769	C0017601	Glaucoma	disease	C11	Disease or Syndrome	0.45	1	2011	2017	   1	   0	CTD_human
     1030	CDKN2B	0.417	0.769	C0017638	Glioma	disease	C04	Neoplastic Process	0.70	0.882	1995	2019	   2	   0	CGI;CTD_human
     1030	CDKN2B	0.417	0.769	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.40	1	1995	2011	   1	   0	CTD_human
     1030	CDKN2B	0.417	0.769	C0025267	Multiple Endocrine Neoplasia Type 1	disease	C16;C04;C19	Neoplastic Process	0.31	1	2009	2010	   1	   0	ORPHANET
     1030	CDKN2B	0.417	0.769	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.33	1	2004	2014	   0	   0	UNIPROT
     1030	CDKN2B	0.417	0.769	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2009	2009	   2	   0	CTD_human
     1030	CDKN2B	0.417	0.769	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.34	1	1995	2009	   2	   0	CTD_human
     1030	CDKN2B	0.417	0.769	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.50	1	2008	2019	   1	   0	CTD_human
     1030	CDKN2B	0.417	0.769	C2314896	Familial Atypical Mole Melanoma Syndrome	disease	C16;C04	Neoplastic Process	0.30				   0	   0	ORPHANET
     1030	CDKN2B	0.417	0.769	C2713368	Hematopoetic Myelodysplasia	phenotype	C15	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
     1030	CDKN2B	0.417	0.769	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.40	0.97	1995	2019	   1	   0	CTD_human
     1031	CDKN2C	0.527	0.654	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.34	0.75	1998	2016	   0	   1	UNIPROT
     1031	CDKN2C	0.527	0.654	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.818	1993	2018	   0	   0	CGI
     1031	CDKN2C	0.527	0.654	C0017638	Glioma	disease	C04	Neoplastic Process	0.32	1	2003	2013	   0	   0	CGI
     1031	CDKN2C	0.527	0.654	C0025267	Multiple Endocrine Neoplasia Type 1	disease	C16;C04;C19	Neoplastic Process	0.32	1	2009	2011	   1	   0	ORPHANET
     1031	CDKN2C	0.527	0.654	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.34	1	1997	2011	   0	   0	CGI
     1031	CDKN2C	0.527	0.654	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.34	1	2002	2017	   1	   0	CTD_human
     1032	CDKN2D	0.547	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1032	CDKN2D	0.547	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1032	CDKN2D	0.547	0.769	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1033	CDKN3	0.514	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1033	CDKN3	0.514	0.769	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.59	0.9	1997	2017	   2	   2	CTD_human;UNIPROT
     1036	CDO1	0.592	0.654	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.36	1	2012	2019	   0	   0	UNIPROT
     1036	CDO1	0.592	0.654	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1036	CDO1	0.592	0.654	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
     1040	CDS1	0.647	0.462	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
     1040	CDS1	0.647	0.462	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1040	CDS1	0.647	0.462	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
     1040	CDS1	0.647	0.462	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1040	CDS1	0.647	0.462	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     1040	CDS1	0.647	0.462	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1040	CDS1	0.647	0.462	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1040	CDS1	0.647	0.462	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1040	CDS1	0.647	0.462	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1040	CDS1	0.647	0.462	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1040	CDS1	0.647	0.462	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1040	CDS1	0.647	0.462	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1040	CDS1	0.647	0.462	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1040	CDS1	0.647	0.462	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1040	CDS1	0.647	0.462	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1041	CDSN	0.585	0.731	C1840299	Hypotrichosis Simplex of Scalp	disease	C17	Disease or Syndrome	0.70	1	2003	2012	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1041	CDSN	0.585	0.731	C1849193	PEELING SKIN SYNDROME	disease	C16;C17	Disease or Syndrome	0.63	1	2010	2013	   2	   0	CTD_human;GENOMICS_ENGLAND
     1044	CDX1	0.644	0.346	C3495676	Anorectal Malformations	group	C16;C06	Anatomical Abnormality	0.32	1	2013	2018	   1	   0	GENOMICS_ENGLAND
     1045	CDX2	0.458	0.769	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.40	0.909	1999	2019	   1	   0	CTD_human
     1045	CDX2	0.458	0.769	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.36	1	2001	2018	   1	   0	CTD_human
     1045	CDX2	0.458	0.769	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1045	CDX2	0.458	0.769	C0266225	Persistent cloaca	disease	C16;C13;C12	Congenital Abnormality	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     1045	CDX2	0.458	0.769	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1048	CEACAM5	0.42	0.846	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1048	CEACAM5	0.42	0.846	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1048	CEACAM5	0.42	0.846	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1048	CEACAM5	0.42	0.846	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.31	1	2011	2012	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.31	1	2007	2011	   2	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0013990	Pathological accumulation of air in tissues	phenotype	C23	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0018671	Head and Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0018675	Head Neoplasms	group	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0021361	Female infertility	phenotype	C13	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0023465	Acute monocytic leukemia	disease	C04	Neoplastic Process	0.40	1	2005	2019	   1	   0	GENOMICS_ENGLAND
     1050	CEBPA	0.496	0.692	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	1.00	0.985	1992	2020	  21	  14	CGI;CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1050	CEBPA	0.496	0.692	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.36	1	2002	2018	   2	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.31	1	2002	2019	   3	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0027533	Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0027666	Neoplasms, Radiation-Induced	phenotype	C04;C26	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.31	1	2010	2017	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0038279	Sterility, Postpartum	phenotype	C13	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0220615	Adult Acute Myeloblastic Leukemia	disease	C04	Neoplastic Process	0.34	1	2009	2016	   1	   0	GENOMICS_ENGLAND
     1050	CEBPA	0.496	0.692	C0220621	Childhood Acute Myeloid Leukemia	disease	C04	Neoplastic Process	0.33	1	2009	2014	   1	   0	GENOMICS_ENGLAND
     1050	CEBPA	0.496	0.692	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0341869	Subfertility, Female	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0746787	Cancer of Neck	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0751177	Cancer of Head	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0751366	Radiation-Induced Cancer	disease	C04;C26	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0887900	Upper Aerodigestive Tract Neoplasms	group	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C0917730	Female sterility	phenotype	C13	Finding	0.30	1	2011	2011	   1	   0	CTD_human
     1050	CEBPA	0.496	0.692	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2009	2019	   3	   0	CTD_human
     1050	CEBPA	0.496	0.692	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	2003	2020	   2	   0	CTD_human
     1050	CEBPA	0.496	0.692	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.40	0.923	2002	2020	   0	   0	CGI
     1050	CEBPA	0.496	0.692	C4707178	Acute myeloid leukemia with CEBPA somatic mutations	disease		Neoplastic Process	0.30	1	2009	2012	   2	   0	ORPHANET
     1050	CEBPA	0.496	0.692	C4707228	Inherited acute myeloid leukemia	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	ORPHANET
     1050	CEBPA	0.496	0.692	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     1051	CEBPB	0.508	0.731	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1051	CEBPB	0.508	0.731	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1051	CEBPB	0.508	0.731	C0021361	Female infertility	phenotype	C13	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1051	CEBPB	0.508	0.731	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.32	1	2007	2019	   1	   0	CTD_human
     1051	CEBPB	0.508	0.731	C0038279	Sterility, Postpartum	phenotype	C13	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1051	CEBPB	0.508	0.731	C0341869	Subfertility, Female	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1051	CEBPB	0.508	0.731	C0917730	Female sterility	phenotype	C13	Finding	0.30	1	2011	2011	   1	   0	CTD_human
     1051	CEBPB	0.508	0.731	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
     1051	CEBPB	0.508	0.731	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.39	1	1993	2019	   1	   0	CTD_human
     1051	CEBPB	0.508	0.731	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.31	1	2014	2014	   1	   0	CTD_human
     1051	CEBPB	0.508	0.731	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1052	CEBPD	0.57	0.769	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.31	1	2007	2007	   1	   0	CTD_human
     1052	CEBPD	0.57	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1052	CEBPD	0.57	0.769	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1052	CEBPD	0.57	0.769	C0033375	Prolactinoma	disease	C04;C10;C19	Neoplastic Process	0.31	1	2011	2012	   1	   0	CTD_human
     1052	CEBPD	0.57	0.769	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1052	CEBPD	0.57	0.769	C0344452	Microprolactinoma	disease	C04;C10;C19	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1052	CEBPD	0.57	0.769	C0344453	Macroprolactinoma	disease	C04;C10;C19	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1052	CEBPD	0.57	0.769	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1052	CEBPD	0.57	0.769	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.34	1	2004	2019	   1	   0	CTD_human
     1053	CEBPE	0.674	0.385	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	1	2009	2019	   1	   0	CTD_human
     1053	CEBPE	0.674	0.385	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1053	CEBPE	0.674	0.385	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.31	0.5	2006	2017	   1	   0	CTD_human
     1053	CEBPE	0.674	0.385	C0398593	Specific granule deficiency	disease	C15	Disease or Syndrome	0.72	1	1999	2018	   3	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1053	CEBPE	0.674	0.385	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.35	1	2008	2017	   1	   0	CTD_human
     1053	CEBPE	0.674	0.385	C4479548	SPECIFIC GRANULE DEFICIENCY 2	disease		Disease or Syndrome	0.30	1	1999	1999	   1	   0	ORPHANET
     1053	CEBPE	0.674	0.385	C4551556	SPECIFIC GRANULE DEFICIENCY 1	disease	C15	Disease or Syndrome	0.50	1	1999	2018	   2	   0	GENOMICS_ENGLAND;ORPHANET
     1055	CECR	0.599	0.731	C0000772	Multiple congenital anomalies	group	C16	Congenital Abnormality	0.30	1	2001	2001	   1	   0	CTD_human
     1055	CECR	0.599	0.731	C0015393	Eye Abnormalities	group	C16;C11	Congenital Abnormality	0.30	1	2001	2001	   1	   0	CTD_human
     1055	CECR	0.599	0.731	C0265493	Cat eye syndrome	disease	C23;C16;C11	Disease or Syndrome	0.31	1	1999	2001	   1	   0	CTD_human
     1055	CECR	0.599	0.731	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2001	2001	   1	   0	CTD_human
     1056	CEL	0.514	0.808	C0149521	Pancreatitis, Chronic	disease	C06	Disease or Syndrome	0.37	0.714	2013	2019	   1	   0	CTD_human
     1056	CEL	0.514	0.808	C0342276	Maturity onset diabetes mellitus in young	disease	C18;C19	Disease or Syndrome	0.45	1	2006	2015	   1	   0	ORPHANET
     1056	CEL	0.514	0.808	C1853297	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION	disease	C18;C19	Disease or Syndrome	0.65	1	2006	2018	   2	   1	CTD_human;GENOMICS_ENGLAND
     1057	CELP	0.769	0.423	C0149521	Pancreatitis, Chronic	disease	C06	Disease or Syndrome	0.33	1	2015	2019	   1	   0	CTD_human
     1058	CENPA	0.678	0.385	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2011	2019	   1	   0	CTD_human
     1061	CENPCP1	0.931	0.077	C0236733	Amphetamine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1061	CENPCP1	0.931	0.077	C0236804	Amphetamine Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1061	CENPCP1	0.931	0.077	C0236807	Amphetamine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1062	CENPE	0.636	0.692	C0265202	Seckel syndrome	disease	C23;C16;C05;C10;C19	Disease or Syndrome	0.51	1	2014	2014	   1	   0	GENOMICS_ENGLAND;ORPHANET
     1062	CENPE	0.636	0.692	C1292778	Chronic myeloproliferative disorder	disease	C04;C15	Neoplastic Process	0.31	1	2014	2014	   0	   0	GENOMICS_ENGLAND
     1062	CENPE	0.636	0.692	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2009	2019	   1	   0	CTD_human
     1062	CENPE	0.636	0.692	C4015080	MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.70	1	2014	2014	   1	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1063	CENPF	0.601	0.654	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	1	2007	2019	   1	   0	CTD_human
     1063	CENPF	0.601	0.654	C0025958	Microcephaly	disease	C16;C05;C10	Congenital Abnormality	0.41	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1063	CENPF	0.601	0.654	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1063	CENPF	0.601	0.654	C0152427	Polydactyly	disease	C16;C05	Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
     1063	CENPF	0.601	0.654	C0265202	Seckel syndrome	disease	C23;C16;C05;C10;C19	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1063	CENPF	0.601	0.654	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	1	2014	2019	   1	   0	CTD_human
     1063	CENPF	0.601	0.654	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.33	1	2007	2019	   1	   0	CTD_human
     1063	CENPF	0.601	0.654	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1063	CENPF	0.601	0.654	C1292778	Chronic myeloproliferative disorder	disease	C04;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1063	CENPF	0.601	0.654	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2007	2008	   1	   0	CTD_human
     1063	CENPF	0.601	0.654	C1855705	Jejunal Atresia with Microcephaly and Ocular Anomalies	disease	C16;C06;C11;C05;C10	Disease or Syndrome	0.72	1	2015	2020	   3	   9	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1063	CENPF	0.601	0.654	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.33	1	2015	2019	   1	   0	CTD_human
     1063	CENPF	0.601	0.654	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1066	CES1	0.59	0.692	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   2	   0	CTD_human
     1066	CES1	0.59	0.692	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.31	1	2003	2018	   1	   0	CTD_human
     1066	CES1	0.59	0.692	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2007	2007	   2	   0	CTD_human
     1066	CES1	0.59	0.692	C0025521	Inborn Errors of Metabolism	group	C16;C18	Disease or Syndrome; Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     1066	CES1	0.59	0.692	C0027412	Opioid-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     1066	CES1	0.59	0.692	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.34	1	2010	2018	   1	   0	CTD_human
     1066	CES1	0.59	0.692	C0029095	Opioid abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     1066	CES1	0.59	0.692	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   2	   0	CTD_human
     1066	CES1	0.59	0.692	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.30	1	2007	2007	   2	   0	CTD_human
     1066	CES1	0.59	0.692	C0524661	Narcotic Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     1066	CES1	0.59	0.692	C0524662	Opiate Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     1066	CES1	0.59	0.692	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   2	   0	CTD_human
     1066	CES1	0.59	0.692	C1527402	Narcotic Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     1066	CES1	0.59	0.692	C4551628	Opiate Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     1068	CETN1	0.584	0.654	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2015	   2	   0	PSYGENET
     1071	CETP	0.512	0.731	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.40	0.982	1994	2020	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.40	0.914	2002	2020	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.50	0.923	1995	2019	   0	   0	GENOMICS_ENGLAND
     1071	CETP	0.512	0.731	C0020445	Hypercholesterolemia, Familial	disease	C16;C18	Disease or Syndrome	0.39	1	1997	2011	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C0020473	Hyperlipidemia	disease	C18	Disease or Syndrome	0.46	1	1994	2020	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C0020476	Hyperlipoproteinemias	disease	C18	Disease or Syndrome	0.31	1	1990	2001	   2	   0	CTD_human
     1071	CETP	0.512	0.731	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.33	1	1999	2017	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C0020557	Hypertriglyceridemia	phenotype	C18	Disease or Syndrome	0.39	1	1994	2017	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C0242339	Dyslipidemias	group	C18	Disease or Syndrome	0.40	1	1996	2019	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C0342883	Cholesteryl Ester Transfer Protein Deficiency	disease	C16;C18	Disease or Syndrome	0.40	0.923	1989	2018	   2	   0	ORPHANET
     1071	CETP	0.512	0.731	C0598784	Dyslipoproteinemias	phenotype	C18	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C0745103	Hyperlipoproteinemia Type IIa	disease	C16;C18	Disease or Syndrome	0.36	1	1997	2011	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C1704417	Hyperlipoproteinemia Type IIb	disease	C16;C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C1706412	Lipidemias	phenotype	C18	Finding	0.30	1	1999	1999	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C2362324	Pediatric Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C3149462	HYPERALPHALIPOPROTEINEMIA 1	disease		Disease or Syndrome	0.80	0.933	1990	2018	   4	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1071	CETP	0.512	0.731	C4317171	Adolescent Obesity	phenotype	C23;C18	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C4521075	Childhood Overweight	phenotype	C23;C18	Finding	0.30	1	2014	2014	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C4553478	Infantile Obesity	phenotype	C23;C18	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C4704955	Infant Overweight	phenotype	C23;C18	Finding	0.30	1	2014	2014	   1	   0	CTD_human
     1071	CETP	0.512	0.731	C4704956	Adolescent Overweight	phenotype	C23;C18	Finding	0.30	1	2014	2014	   1	   0	CTD_human
     1072	CFL1	0.529	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.36	1	1998	2018	   1	   0	CTD_human
     1072	CFL1	0.529	0.769	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
     1072	CFL1	0.529	0.769	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.39	1	2010	2019	   1	   0	CTD_human
     1072	CFL1	0.529	0.769	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1072	CFL1	0.529	0.769	C0038219	Status Dysraphicus	disease	C16;C10	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
     1072	CFL1	0.529	0.769	C0080178	Spina Bifida	disease	C16;C10	Congenital Abnormality	0.31	1	2007	2007	   1	   0	CTD_human
     1072	CFL1	0.529	0.769	C0266508	Rachischisis	disease	C16;C10	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
     1072	CFL1	0.529	0.769	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2010	2011	   1	   0	CTD_human
     1072	CFL1	0.529	0.769	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1072	CFL1	0.529	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.35	1	1998	2018	   1	   0	CTD_human
     1072	CFL1	0.529	0.769	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1072	CFL1	0.529	0.769	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	1996	2010	   1	   0	CTD_human
     1072	CFL1	0.529	0.769	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1073	CFL2	0.659	0.5	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1073	CFL2	0.659	0.5	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.31	1	2013	2013	   0	   0	UNIPROT
     1073	CFL2	0.659	0.5	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1073	CFL2	0.659	0.5	C1853154	Nemaline Myopathy 7	disease	C05;C10	Disease or Syndrome	0.70	1	2001	2018	   9	   2	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1073	CFL2	0.659	0.5	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     1073	CFL2	0.659	0.5	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     1075	CTSC	0.541	0.731	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1075	CTSC	0.541	0.731	C0030360	Papillon-Lefevre Disease	disease	C16;C17	Disease or Syndrome	0.80	0.968	1998	2020	  17	  16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1075	CTSC	0.541	0.731	C0031090	Periodontal Diseases	group	C07	Disease or Syndrome	0.33	1	1999	2001	   1	   0	CTD_human
     1075	CTSC	0.541	0.731	C0031106	Aggressive Periodontitis	disease	C07	Disease or Syndrome	0.40	0.909	1999	2019	   0	   0	CTD_human
     1075	CTSC	0.541	0.731	C0034219	Alveolar pyorrhea	disease	C07	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
     1075	CTSC	0.541	0.731	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1075	CTSC	0.541	0.731	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1075	CTSC	0.541	0.731	C0162820	Dermatitis, Allergic Contact	disease	C17;C20	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1075	CTSC	0.541	0.731	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2011	2011	   1	   0	CTD_human
     1075	CTSC	0.541	0.731	C0600298	Periodontosis	disease	C07	Disease or Syndrome	0.30				   0	   0	CTD_human
     1075	CTSC	0.541	0.731	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1075	CTSC	0.541	0.731	C1855627	HAIM-MUNK SYNDROME	disease	C16;C17;C05	Disease or Syndrome	0.75	1	2000	2020	   4	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1075	CTSC	0.541	0.731	C2713394	Haim-Monk Syndrome	disease	C16;C17	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1075	CTSC	0.541	0.731	C4025886	Severe periodontitis	disease	C07	Disease or Syndrome	0.42	1	2000	2019	   1	   0	GENOMICS_ENGLAND
     1075	CTSC	0.541	0.731	C4551675	Keratoderma, Palmoplantar	disease	C16;C17	Disease or Syndrome	0.44	1	1999	2012	   1	   0	GENOMICS_ENGLAND
     1075	CTSC	0.541	0.731	C4551681	Periodontitis, Aggressive, 1	disease	C07	Disease or Syndrome	0.70	1	2000	2016	   3	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1080	CFTR	0.424	0.885	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1998	1998	   1	   0	PSYGENET
     1080	CFTR	0.424	0.885	C0004509	Azoospermia	disease	C12	Disease or Syndrome	0.50	1	1996	2019	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0006267	Bronchiectasis	disease	C08	Disease or Syndrome	0.50	0.952	1995	2019	   0	   2	GENOMICS_ENGLAND
     1080	CFTR	0.424	0.885	C0008340	Choledochal Cyst	disease	C16;C06;C04	Congenital Abnormality	0.40	1	2008	2008	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.50	1	1999	2005	   1	   0	GENOMICS_ENGLAND
     1080	CFTR	0.424	0.885	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.33	1	2004	2019	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0009439	Choledochal Cyst, Type I	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0010674	Cystic Fibrosis	disease	C16;C06;C08	Disease or Syndrome	1.00	0.979	1989	2020	  91	 605	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1080	CFTR	0.424	0.885	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0013170	Drug habituation	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0013222	Drug Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0019284	Diaphragmatic Hernia	phenotype	C23	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.50	1	1995	2020	   2	   0	CTD_human
     1080	CFTR	0.424	0.885	C0029231	Organic Mental Disorders, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0030305	Pancreatitis	disease	C06	Disease or Syndrome	0.50	0.936	1998	2020	   2	   1	CTD_human
     1080	CFTR	0.424	0.885	C0035455	Rhinitis	disease	C01;C08;C09	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0037199	Sinusitis	disease	C01;C08;C09	Disease or Syndrome	0.33	1	1999	2015	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0038580	Substance Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0038586	Substance Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0085548	Autosomal Recessive Polycystic Kidney Disease	disease	C16;C13;C12	Disease or Syndrome	0.50	1	2008	2008	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0149521	Pancreatitis, Chronic	disease	C06	Disease or Syndrome	0.50	1	1998	2019	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0236969	Substance-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0238339	Hereditary pancreatitis	disease	C06	Disease or Syndrome	0.73	1	1999	2013	   3	  33	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1080	CFTR	0.424	0.885	C0267937	Acute recurrent pancreatitis	disease	C06	Disease or Syndrome	0.40	1	2003	2019	   2	   0	ORPHANET
     1080	CFTR	0.424	0.885	C0339985	Idiopathic bronchiectasis	disease	C08	Disease or Syndrome	0.32	1	2006	2015	   2	   0	ORPHANET
     1080	CFTR	0.424	0.885	C0392164	Pulmonary Cystic Fibrosis	disease	C16;C06;C08	Disease or Syndrome	0.39	1	1991	2017	  15	   0	CTD_human
     1080	CFTR	0.424	0.885	C0403814	Congenital bilateral aplasia of vas deferens	disease	C12	Congenital Abnormality	1.00	0.965	1992	2019	   8	 187	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1080	CFTR	0.424	0.885	C0449439	Carrier status	phenotype		Finding	0.30				   0	   0	GENOMICS_ENGLAND
     1080	CFTR	0.424	0.885	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C0848676	Subfertility, Male	phenotype	C12	Sign or Symptom	0.31	1	2007	2017	   2	   0	CTD_human
     1080	CFTR	0.424	0.885	C0917731	Male sterility	phenotype	C12	Finding	0.30	1	2007	2008	   2	   0	CTD_human
     1080	CFTR	0.424	0.885	C1257796	Choledochal Cyst, Type II	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C1257797	Choledochal Cyst, Type III	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C1257798	Choledochal Cyst, Type IV	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C1257799	Choledochal Cyst, Type V	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1080	CFTR	0.424	0.885	C1527396	Fibrocystic Disease of Pancreas	disease	C16;C06;C08	Disease or Syndrome	0.33	1	1991	2018	  15	   0	CTD_human
     1080	CFTR	0.424	0.885	C2749757	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1	disease	C08	Disease or Syndrome	0.60				   0	  31	CTD_human;GENOMICS_ENGLAND
     1080	CFTR	0.424	0.885	C4080064	Autosomal Dominant Hereditary Pancreatitis	disease	C06	Disease or Syndrome	0.30				   0	   0	CTD_human
     1080	CFTR	0.424	0.885	C4277690	Ciliopathies	disease	C16	Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
     1080	CFTR	0.424	0.885	C4316881	Prescription Drug Abuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0001621	Adrenal Gland Diseases	group	C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0018991	Hemiplegia	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0028960	Oligospermia	disease	C12	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0029928	Ovarian Diseases	group	C13;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0042131	Uterine Diseases	group	C13	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0085622	Monoplegia	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0154693	Hemiplegia, Flaccid	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0154694	Hemiplegia, Spastic	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	1999	1999	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0278110	Hemiplegia, Crossed	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0392550	Hemiplegia, Infantile	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0521662	Hemiplegia, Transient	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C0751195	Hemiplegia, Post-Ictal	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C1720816	Endometrial Diseases	group	C13	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C2931367	Thyroid cancer, follicular	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
     1081	CGA	0.508	0.808	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     1082	CGB3	0.57	0.654	C0015951	Fetal Resorption	disease	C23;C13	Disease or Syndrome	0.30	1	1986	1986	   1	   0	CTD_human
     1082	CGB3	0.57	0.654	C0020619	Hypogonadism	disease	C19	Disease or Syndrome	0.30	1	1993	1997	   2	   0	CTD_human
     1082	CGB3	0.57	0.654	C0271623	Hypogonadotropic hypogonadism	disease	C19	Disease or Syndrome	0.30	1	1993	1997	   2	   0	CTD_human
     1082	CGB3	0.57	0.654	C0948896	Primary hypogonadism	disease	C19	Disease or Syndrome	0.30	1	1993	1997	   2	   0	CTD_human
     1082	CGB3	0.57	0.654	C3489396	Hypogonadism, Isolated Hypogonadotropic	disease	C19	Disease or Syndrome	0.30	1	1993	1997	   2	   0	CTD_human
     1103	CHAT	0.52	0.808	C0001969	Alcoholic Intoxication	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1986	1986	   1	   0	PSYGENET
     1103	CHAT	0.52	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.32	0.5	2009	2011	   2	   0	PSYGENET
     1103	CHAT	0.52	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	0.5	2009	2011	   2	   0	PSYGENET
     1103	CHAT	0.52	0.808	C0017605	Angle Closure Glaucoma	disease	C11	Disease or Syndrome	0.32	1	2016	2019	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.30	1	2013	2013	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0035309	Retinal Diseases	group	C11	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.33	1	1999	2007	   2	   0	PSYGENET
     1103	CHAT	0.52	0.808	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.41	1	2010	2019	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0393929	Familial infantile myasthenia	disease	C23;C04;C08;C20;C10	Disease or Syndrome	0.91	1	2001	2017	   2	  16	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1103	CHAT	0.52	0.808	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     1103	CHAT	0.52	0.808	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1105	CHD1	0.628	0.692	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
     1105	CHD1	0.628	0.692	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	2019	2019	   1	   1	CTD_human
     1105	CHD1	0.628	0.692	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.40	1	2019	2019	   1	   1	CTD_human
     1105	CHD1	0.628	0.692	C0025261	Memory Disorders	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
     1105	CHD1	0.628	0.692	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1105	CHD1	0.628	0.692	C0233794	Memory impairment	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
     1105	CHD1	0.628	0.692	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	1	2012	2019	   1	   0	CTD_human
     1105	CHD1	0.628	0.692	C0751292	Age-Related Memory Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
     1105	CHD1	0.628	0.692	C0751293	Memory Disorder, Semantic	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
     1105	CHD1	0.628	0.692	C0751294	Memory Disorder, Spatial	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
     1105	CHD1	0.628	0.692	C0751295	Memory Loss	phenotype	C23;C10;F01	Sign or Symptom	0.30	1	2019	2019	   1	   0	CTD_human
     1105	CHD1	0.628	0.692	C4540131	PILAROWSKI-BJORNSSON SYNDROME	disease		Disease or Syndrome	0.70	1	2018	2018	   1	   4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1106	CHD2	0.585	0.577	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.40	1	2012	2019	   2	   0	CTD_human
     1106	CHD2	0.585	0.577	C0040517	Gilles de la Tourette syndrome	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
     1106	CHD2	0.585	0.577	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2013	2018	   2	   0	CTD_human
     1106	CHD2	0.585	0.577	C0236018	Aura	phenotype	C10	Finding	0.30	1	2013	2018	   2	   0	CTD_human
     1106	CHD2	0.585	0.577	C0238111	Lennox-Gastaut syndrome	disease	C16;C10	Disease or Syndrome	0.32	1	2013	2018	   1	   0	ORPHANET
     1106	CHD2	0.585	0.577	C0393702	Myoclonic Astatic Epilepsy	disease	C10	Disease or Syndrome	0.40	1	2013	2013	   1	   0	ORPHANET
     1106	CHD2	0.585	0.577	C0543888	Epileptic encephalopathy	disease	C10	Disease or Syndrome	0.43	1	2013	2015	   1	   0	GENOMICS_ENGLAND
     1106	CHD2	0.585	0.577	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2013	2018	   2	   0	CTD_human
     1106	CHD2	0.585	0.577	C0751776	Atypical Inclusion-Body Disease	disease	C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1106	CHD2	0.585	0.577	C0751777	Familial Progressive Myoclonic Epilepsy	disease	C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1106	CHD2	0.585	0.577	C0751778	Myoclonic Epilepsies, Progressive	disease	C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1106	CHD2	0.585	0.577	C0751779	Action Myoclonus-Renal Failure Syndrome	disease	C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1106	CHD2	0.585	0.577	C0751780	Biotin-Responsive Encephalopathy	disease	C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1106	CHD2	0.585	0.577	C0751781	Dentatorubral-Pallidoluysian Atrophy	disease	C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1106	CHD2	0.585	0.577	C0751782	May-White Syndrome	disease	C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1106	CHD2	0.585	0.577	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2014	2017	   1	   0	CTD_human
     1106	CHD2	0.585	0.577	C1535926	Neurodevelopmental Disorders	group	F03	Mental or Behavioral Dysfunction	0.36	1	2017	2018	   1	   0	CTD_human
     1106	CHD2	0.585	0.577	C3809278	EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET	disease		Disease or Syndrome	0.60	1	2013	2017	   2	  43	GENOMICS_ENGLAND;UNIPROT
     1107	CHD3	0.67	0.577	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1107	CHD3	0.67	0.577	C0036920	Sezary Syndrome	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1107	CHD3	0.67	0.577	C0221355	Macrocephaly	disease	C16;C05;C10	Congenital Abnormality	0.44	1	2018	2019	   1	   0	GENOMICS_ENGLAND
     1107	CHD3	0.67	0.577	C0264611	Apraxia of Phonation	disease	C23;C10;F01	Disease or Syndrome	0.41	1	2019	2019	   0	   0	GENOMICS_ENGLAND
     1107	CHD3	0.67	0.577	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1107	CHD3	0.67	0.577	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.40	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1107	CHD3	0.67	0.577	C2931456	Prostate cancer, familial	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1107	CHD3	0.67	0.577	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.31	1	2018	2019	   1	   0	GENOMICS_ENGLAND
     1107	CHD3	0.67	0.577	C4722327	PROSTATE CANCER, HEREDITARY, 1	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1107	CHD3	0.67	0.577	C4748701	SNIJDERS BLOK-CAMPEAU SYNDROME	disease		Disease or Syndrome	0.60	1	2018	2019	   2	  18	GENOMICS_ENGLAND;UNIPROT
     1108	CHD4	0.593	0.654	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
     1108	CHD4	0.593	0.654	C0008073	Developmental Disabilities	group	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
     1108	CHD4	0.593	0.654	C0014170	Endometrial Neoplasms	group	C04;C13	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1108	CHD4	0.593	0.654	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1108	CHD4	0.593	0.654	C0085996	Child Development Deviations	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
     1108	CHD4	0.593	0.654	C0085997	Child Development Disorders, Specific	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
     1108	CHD4	0.593	0.654	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.33	1	2012	2018	   1	   0	CTD_human
     1108	CHD4	0.593	0.654	C4310688	SIFRIM-HITZ-WEISS SYNDROME	disease		Disease or Syndrome	0.60	1	2016	2016	   2	   7	GENOMICS_ENGLAND;UNIPROT
     1109	AKR1C4	0.587	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
     1109	AKR1C4	0.587	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.51	1	2011	2012	   2	   0	CTD_human;PSYGENET
     1109	AKR1C4	0.587	0.846	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1109	AKR1C4	0.587	0.846	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1109	AKR1C4	0.587	0.846	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2011	2012	   1	   0	CTD_human
     1109	AKR1C4	0.587	0.846	C1456784	Paranoia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	CTD_human
     1109	AKR1C4	0.587	0.846	C1839840	MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE	disease	C16;C13;C12;C19	Disease or Syndrome	0.60	1	2011	2011	   1	   1	CTD_human;ORPHANET
     1111	CHEK1	0.492	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	2005	2019	   1	   0	CTD_human
     1111	CHEK1	0.492	0.808	C0032578	Polyploidy	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2014	2014	   1	   0	CTD_human
     1111	CHEK1	0.492	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
     1111	CHEK1	0.492	0.808	C0346153	Breast Cancer, Familial	disease	C04;C17	Neoplastic Process	0.32	1	2003	2010	   0	   0	CLINGEN
     1111	CHEK1	0.492	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	2005	2019	   1	   0	CTD_human
     1111	CHEK1	0.492	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1111	CHEK1	0.492	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.33	1	2012	2018	   1	   0	CTD_human
     1111	CHEK1	0.492	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1113	CHGA	0.49	0.808	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.35	1	1998	2020	   1	   0	CTD_human
     1113	CHGA	0.49	0.808	C0031511	Pheochromocytoma	disease	C04	Neoplastic Process	0.40	1	1986	2020	   1	   0	CTD_human
     1113	CHGA	0.49	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2004	2006	   1	   0	PSYGENET
     1113	CHGA	0.49	0.808	C1257877	Pheochromocytoma, Extra-Adrenal	disease	C04	Neoplastic Process	0.30	1	2000	2000	   1	   0	CTD_human
     1114	CHGB	0.599	0.654	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2002	2017	   3	   0	PSYGENET
     1114	CHGB	0.599	0.654	C0221765	Chronic schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	PSYGENET
     1116	CHI3L1	0.419	0.885	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.40	0.966	2003	2020	   1	   0	CTD_human
     1116	CHI3L1	0.419	0.885	C0017638	Glioma	disease	C04	Neoplastic Process	0.40	0.933	2002	2018	   1	   0	CTD_human
     1116	CHI3L1	0.419	0.885	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.31	1	2005	2010	   1	   0	CTD_human
     1116	CHI3L1	0.419	0.885	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.35	1	1993	2019	   1	   0	CTD_human
     1116	CHI3L1	0.419	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.50	0.9	2003	2019	   0	   0	CTD_human
     1116	CHI3L1	0.419	0.885	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1116	CHI3L1	0.419	0.885	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1116	CHI3L1	0.419	0.885	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1116	CHI3L1	0.419	0.885	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.32	1	2011	2016	   1	   0	CTD_human
     1116	CHI3L1	0.419	0.885	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.40	0.913	2002	2020	   1	   0	CTD_human
     1116	CHI3L1	0.419	0.885	C2677770	ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7	phenotype		Finding	0.30				   0	   0	CTD_human
     1118	CHIT1	0.525	0.692	C0017205	Gaucher Disease	disease	C16;C18;C10	Disease or Syndrome	0.40	1	1999	2020	   1	   0	CTD_human
     1118	CHIT1	0.525	0.692	C0268250	Gaucher Disease, Type 2 (disorder)	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1118	CHIT1	0.525	0.692	C0268251	Gaucher Disease, Type 3 (disorder)	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1118	CHIT1	0.525	0.692	C1961835	Gaucher Disease, Type 1	disease	C16;C18;C10	Disease or Syndrome	0.34	1	2001	2017	   1	   0	CTD_human
     1119	CHKA	0.615	0.615	C0038219	Status Dysraphicus	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
     1119	CHKA	0.615	0.615	C0080178	Spina Bifida	disease	C16;C10	Congenital Abnormality	0.31	1	2006	2006	   1	   0	CTD_human
     1119	CHKA	0.615	0.615	C0266508	Rachischisis	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
     1120	CHKB	0.663	0.423	C0027404	Narcolepsy	disease	C10;F03	Disease or Syndrome	0.34	1	2008	2014	   1	   0	CTD_human
     1120	CHKB	0.663	0.423	C0751362	Narcolepsy-Cataplexy Syndrome	disease	C10;F03	Disease or Syndrome	0.31	1	2008	2009	   1	   0	CTD_human
     1120	CHKB	0.663	0.423	C1833453	Proximal Myopathy with Focal Depletion of Mitochondria	disease	C18;C05;C10	Disease or Syndrome	0.32	1	2016	2019	   2	   0	ORPHANET
     1120	CHKB	0.663	0.423	C1865233	Muscular Dystrophy, Congenital, Megaconial Type	disease	C16;C05;C10	Disease or Syndrome	0.93	1	2006	2019	  10	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1121	CHM	0.592	0.654	C0008525	Choroideremia	disease	C16;C11	Disease or Syndrome	1.00	0.965	1987	2020	   3	  15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1121	CHM	0.592	0.654	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.33	1	1997	2017	   0	   0	GENOMICS_ENGLAND
     1121	CHM	0.592	0.654	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.44	1	2008	2019	   0	   1	GENOMICS_ENGLAND
     1123	CHN1	0.573	0.615	C0013261	Duane Retraction Syndrome	disease	C16;C11;C10	Disease or Syndrome	0.70	1	2007	2017	   1	   0	CTD_human;ORPHANET
     1123	CHN1	0.573	0.615	C0751083	Duane Retraction Syndrome, Type 2	disease	C16;C11;C10	Disease or Syndrome	0.61	1	2007	2008	   1	  10	CTD_human;UNIPROT
     1123	CHN1	0.573	0.615	C0751084	Duane Retraction Syndrome, Type 3	disease	C16;C11;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1123	CHN1	0.573	0.615	C0994516	Type 1 Duane Retraction Syndrome	disease	C16;C11;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1123	CHN1	0.573	0.615	C1623209	Okihiro Syndrome	disease	C16;C11;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1124	CHN2	0.711	0.615	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1124	CHN2	0.711	0.615	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1124	CHN2	0.711	0.615	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1124	CHN2	0.711	0.615	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0025261	Memory Disorders	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.5	2002	2019	   4	   0	PSYGENET
     1128	CHRM1	0.653	0.577	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0233794	Memory impairment	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.31	1	2011	2017	   1	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0236018	Aura	phenotype	C10	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0751292	Age-Related Memory Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0751293	Memory Disorder, Semantic	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0751294	Memory Disorder, Spatial	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0751295	Memory Loss	phenotype	C23;C10;F01	Sign or Symptom	0.31	1	2011	2017	   1	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1128	CHRM1	0.653	0.577	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1994	2003	   5	   0	CTD_human
     1128	CHRM1	0.653	0.577	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   5	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	1	2004	2018	   5	   0	PSYGENET
     1129	CHRM2	0.585	0.615	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2008	2008	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
     1129	CHRM2	0.585	0.615	C0005697	Neurogenic Urinary Bladder	disease	C23;C13;C12;C10	Disease or Syndrome	0.31	1	2004	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.54	1	2002	2011	   4	   0	PSYGENET
     1129	CHRM2	0.585	0.615	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2002	2011	   4	   0	PSYGENET
     1129	CHRM2	0.585	0.615	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.30	1	2008	2008	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0011854	Diabetes Mellitus, Insulin-Dependent	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0011882	Diabetic Neuropathies	group	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0013170	Drug habituation	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0013222	Drug Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.31	1	2008	2019	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0029231	Organic Mental Disorders, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2010	2019	   1	   0	PSYGENET
     1129	CHRM2	0.585	0.615	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2008	2008	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0038580	Substance Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2007	2014	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0038586	Substance Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0149622	Neurogenic Urinary Bladder, Atonic	phenotype	C23;C13;C12;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0205734	Diabetes, Autoimmune	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0236018	Aura	phenotype	C10	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0236969	Substance-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0271673	Symmetric Diabetic Proximal Motor Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0271674	Asymmetric Diabetic Proximal Motor Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0271678	Diabetic Mononeuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0271680	Diabetic Polyneuropathies	group	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0271685	Diabetic Amyotrophy	disease	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0271686	Diabetic Autonomic Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0342302	Brittle diabetes	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0392115	Neurogenic Urinary Bladder, Uninhibited	disease	C23;C13;C12;C10	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0393835	Diabetic Asymmetric Polyneuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0428977	Bradycardia	phenotype	C23;C14	Finding	0.30	1	2001	2001	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2005	2005	   1	   0	PSYGENET
     1129	CHRM2	0.585	0.615	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0750953	Urinary Bladder Neurogenesis	phenotype	C23;C13;C12;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0750955	Neurogenic Urinary Bladder, Spastic	phenotype	C23;C13;C12;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0751074	Diabetic Neuralgia	disease	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.32	0.667	2007	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C3837958	Diabetes Mellitus, Ketosis-Prone	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C4316881	Prescription Drug Abuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1129	CHRM2	0.585	0.615	C4554117	Diabetes Mellitus, Sudden-Onset	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1130	LYST	0.621	0.692	C0001916	Albinism	disease	C16;C18;C11;C17	Disease or Syndrome	0.30	1	2002	2014	   3	   0	GENOMICS_ENGLAND
     1130	LYST	0.621	0.692	C0007965	Chediak-Higashi Syndrome	disease	C16;C11;C20;C15	Disease or Syndrome	1.00	0.982	1968	2019	  12	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1130	LYST	0.621	0.692	C0037772	Spastic Paraplegia	disease	C23;C10	Disease or Syndrome	0.31	1	2014	2014	   2	   0	GENOMICS_ENGLAND
     1130	LYST	0.621	0.692	C0242422	Parkinsonian Disorders	group	C10	Disease or Syndrome	0.30	1	2002	2014	   3	   0	GENOMICS_ENGLAND
     1130	LYST	0.621	0.692	C4304022	Attenuated Chédiak-Higashi syndrome	disease	C16;C11;C20;C15	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     1130	LYST	0.621	0.692	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.40	1	2002	2014	   3	   0	GENOMICS_ENGLAND
     1131	CHRM3	0.464	0.885	C0003962	Ascites	phenotype	C23	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1131	CHRM3	0.464	0.885	C0005686	Urinary Bladder Diseases	group	C13;C12	Disease or Syndrome	0.32	1	2011	2019	   1	   0	CTD_human
     1131	CHRM3	0.464	0.885	C0010417	Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.40	1	2011	2011	   1	   0	CTD_human
     1131	CHRM3	0.464	0.885	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
     1131	CHRM3	0.464	0.885	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1131	CHRM3	0.464	0.885	C0033770	Prune Belly Syndrome	disease	C16	Disease or Syndrome	0.65	1	2011	2019	   1	   1	CTD_human;ORPHANET
     1131	CHRM3	0.464	0.885	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1131	CHRM3	0.464	0.885	C0265363	Urethral obstruction sequence	disease	C23;C16;C13;C12;C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	ORPHANET
     1131	CHRM3	0.464	0.885	C0431663	Bilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2011	2011	   1	   0	CTD_human
     1131	CHRM3	0.464	0.885	C0431664	Unilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2011	2011	   1	   0	CTD_human
     1131	CHRM3	0.464	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1131	CHRM3	0.464	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1131	CHRM3	0.464	0.885	C1563730	Abdominal Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2011	2011	   1	   0	CTD_human
     1131	CHRM3	0.464	0.885	C1563731	Inguinal Cryptorchidism	phenotype	C16;C12;C19	Finding	0.30	1	2011	2011	   1	   0	CTD_human
     1131	CHRM3	0.464	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1131	CHRM3	0.464	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1131	CHRM3	0.464	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0007398	Catatonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2002	2019	   2	   0	PSYGENET
     1132	CHRM4	0.821	0.231	C0040822	Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0040827	Saturnine Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0149840	Senile Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0234370	Persistent Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0234371	Continuous Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0234372	Intermittent Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0234373	Fine Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0234374	Coarse Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0234375	Massive Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0234376	Action Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0234377	Passive Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0234378	Static Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0234379	Resting Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0234381	Darkness Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0235078	Tremor, Perioral	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0235081	Tremor, Limb	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0235082	Tremor, Muscle	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0235083	Nerve Tremors	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0235843	Tremor, Neonatal	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0338650	Catatonia, Organic	phenotype	C23;C10;F01	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0750992	Catatonia, Malignant	disease	C23;C10;F01	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0750993	Schizophreniform Catatonia	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0751564	Pill Rolling Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C0751565	Tremor, Semirhythmic	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
     1132	CHRM4	0.821	0.231	C1527384	Involuntary Quiver	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1133	CHRM5	0.769	0.346	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     1133	CHRM5	0.769	0.346	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
     1133	CHRM5	0.769	0.346	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2004	2004	   1	   0	PSYGENET
     1133	CHRM5	0.769	0.346	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2002	2002	   1	   0	CTD_human
     1133	CHRM5	0.769	0.346	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     1133	CHRM5	0.769	0.346	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     1133	CHRM5	0.769	0.346	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     1133	CHRM5	0.769	0.346	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     1134	CHRNA1	0.615	0.577	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     1134	CHRNA1	0.615	0.577	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1134	CHRNA1	0.615	0.577	C1837122	Myasthenic Syndrome, Congenital, Fast-Channel	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1134	CHRNA1	0.615	0.577	C1854678	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	disease	C23;C16;C17	Disease or Syndrome	0.70	1	1982	2018	   2	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1134	CHRNA1	0.615	0.577	C2931107	Myasthenic syndrome, congenital, postsynaptic slow-channel	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1134	CHRNA1	0.615	0.577	C4084823	MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL	disease		Disease or Syndrome	0.60	1	1995	2006	   6	   8	GENOMICS_ENGLAND;UNIPROT
     1134	CHRNA1	0.615	0.577	C4225405	MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL	disease		Disease or Syndrome	0.60	1	1999	2004	   3	   4	GENOMICS_ENGLAND;UNIPROT
     1135	CHRNA2	0.705	0.385	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2009	   2	   0	PSYGENET
     1135	CHRNA2	0.705	0.385	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	PSYGENET
     1135	CHRNA2	0.705	0.385	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	PSYGENET
     1135	CHRNA2	0.705	0.385	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     1135	CHRNA2	0.705	0.385	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     1135	CHRNA2	0.705	0.385	C1835905	Epilepsy, Nocturnal Frontal Lobe, Type 4	disease	C10;F03	Disease or Syndrome	0.70	1	2006	2015	   2	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1135	CHRNA2	0.705	0.385	C3696898	Autosomal Dominant Nocturnal Frontal Lobe Epilepsy	disease	C10	Disease or Syndrome	0.48	1	2006	2015	   1	   1	ORPHANET
     1136	CHRNA3	0.588	0.692	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.53	1	2009	2014	   4	   0	CTD_human;PSYGENET
     1136	CHRNA3	0.588	0.692	C0013363	Dysautonomia	disease	C10	Disease or Syndrome	0.31	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1136	CHRNA3	0.588	0.692	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.32	1	2008	2008	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0028043	Nicotine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.50	1	2008	2018	   1	   1	CTD_human
     1136	CHRNA3	0.588	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.42	1	2010	2019	   1	   7	PSYGENET
     1136	CHRNA3	0.588	0.692	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0040332	Tobacco Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2009	2014	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.50	1	2008	2020	   1	   6	CTD_human
     1136	CHRNA3	0.588	0.692	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.50	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0376384	Nicotine Use Disorder	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2008	2014	   2	   0	PSYGENET
     1136	CHRNA3	0.588	0.692	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C1861063	TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)	phenotype		Finding	0.30	1	2010	2010	   2	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C1968949	Cakut	disease	C16;C13;C12	Disease or Syndrome	0.31	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1136	CHRNA3	0.588	0.692	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1136	CHRNA3	0.588	0.692	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2005	2019	   4	   0	PSYGENET
     1137	CHRNA4	0.492	0.808	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2004	2004	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0008073	Developmental Disabilities	group	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     1137	CHRNA4	0.492	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.34	1	2008	2019	   3	   0	PSYGENET
     1137	CHRNA4	0.492	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2008	2019	   3	   0	PSYGENET
     1137	CHRNA4	0.492	0.808	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.31	1	1995	2010	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2001	2019	   4	   0	PSYGENET
     1137	CHRNA4	0.492	0.808	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.44	1	1999	2019	   2	   1	CTD_human
     1137	CHRNA4	0.492	0.808	C0041671	Attention Deficit Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0085541	Epilepsy, Frontal Lobe	disease	C10	Disease or Syndrome	0.40	1	1998	2014	   3	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0085996	Child Development Deviations	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0085997	Child Development Disorders, Specific	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0344315	Depressed mood	phenotype	F01	Mental or Behavioral Dysfunction	0.34	1	2008	2019	   3	   0	PSYGENET
     1137	CHRNA4	0.492	0.808	C0393588	Dystonia, Paroxysmal	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0393610	Dystonia, Diurnal	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0393671	Frontal Epilepsy, Benign, Childhood	disease	C10	Disease or Syndrome	0.30	1	2003	2007	   3	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0393683	Epilepsy, Supplementary Motor	disease	C10	Disease or Syndrome	0.30	1	2003	2007	   3	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0393684	Epilepsy, Cingulate	disease	C10	Disease or Syndrome	0.30	1	2003	2007	   3	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0393688	Epilepsy, Opercular	disease	C10	Disease or Syndrome	0.30	1	2003	2007	   3	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.31	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0751093	Dystonia, Limb	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.42	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0751508	Long Sleeper Syndrome	phenotype	C23;C10;F03	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0751509	Short Sleeper Syndrome	disease	C23;C10;F03	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0751510	Sleep-Related Neurogenic Tachypnea	phenotype	C23;C10;F03	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0751511	Subwakefullness Syndrome	phenotype	C23;C10;F03	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0751642	Epilepsy, Anterior Fronto-Polar	disease	C10	Disease or Syndrome	0.30	1	2003	2007	   3	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0751643	Epilepsy, Orbito-Frontal	disease	C10	Disease or Syndrome	0.30	1	2003	2007	   3	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C0851578	Sleep Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.31	1	2005	2015	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C1263846	Attention deficit hyperactivity disorder	disease	F03	Mental or Behavioral Dysfunction	0.37	1	2003	2019	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C1321905	Minimal Brain Dysfunction	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C1838049	Epilepsy, Nocturnal Frontal Lobe, Type 1	disease	C10	Disease or Syndrome	0.70	1	1995	2003	   4	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1137	CHRNA4	0.492	0.808	C1861063	TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)	phenotype		Finding	0.50	1	2003	2003	   1	   0	CTD_human;GENOMICS_ENGLAND
     1137	CHRNA4	0.492	0.808	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C3696898	Autosomal Dominant Nocturnal Frontal Lobe Epilepsy	disease	C10	Disease or Syndrome	0.50	1	1995	2015	   1	   1	ORPHANET
     1137	CHRNA4	0.492	0.808	C4042891	Sleep Wake Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.31	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2000	2005	   2	   0	CTD_human
     1137	CHRNA4	0.492	0.808	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2000	2005	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2009	2013	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.56	1	2009	2019	   5	   0	CTD_human;PSYGENET
     1138	CHRNA5	0.593	0.577	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2018	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0013170	Drug habituation	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0013222	Drug Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.33	1	2008	2008	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0028043	Nicotine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	1	2006	2018	   3	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0029231	Organic Mental Disorders, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.48	1	2011	2019	   2	   1	PSYGENET
     1138	CHRNA5	0.593	0.577	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0038580	Substance Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0038586	Substance Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0040332	Tobacco Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2008	2018	   3	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0236969	Substance-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.50	0.934	2008	2018	   1	   2	CTD_human
     1138	CHRNA5	0.593	0.577	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2018	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0376384	Nicotine Use Disorder	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2018	   3	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2008	2015	   4	   0	PSYGENET
     1138	CHRNA5	0.593	0.577	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2018	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C1861063	TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)	phenotype		Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C4316881	Prescription Drug Abuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	2004	   2	   0	CTD_human
     1138	CHRNA5	0.593	0.577	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   2	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.40	1	2001	2017	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0004310	Auditory Perceptual Disorders	group	C23;C10;F03;C09;F01	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.43	1	2004	2015	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.47	0.8	2004	2016	   5	   0	PSYGENET
     1139	CHRNA7	0.532	0.654	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.34	0.8	2007	2017	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0014548	Epilepsy, Generalized	disease	C10	Disease or Syndrome	0.32	1	2008	2015	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0017332	Generalized Nonconvulsive Seizure Disorder	disease	C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.31	1	2008	2013	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0025261	Memory Disorders	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0028043	Nicotine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.34	1	2006	2018	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.70	0.75	1998	2019	   4	   0	PSYGENET
     1139	CHRNA7	0.532	0.654	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.44	1	1998	2017	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0037917	Spina Bifida Cystica	disease	C16;C10	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0038644	Sudden infant death syndrome	disease	C23	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0040332	Tobacco Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0086236	Epilepsy, Atonic	disease	C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0086241	Epilepsy, Tonic	disease	C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0233794	Memory impairment	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.31	1	2009	2017	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.31	1	2013	2015	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0270854	Symptomatic Generalized Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0311334	Generalized convulsive epilepsy	disease	C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0347869	Epilepsy, Akinetic	disease	C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0376384	Nicotine Use Disorder	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.31	1	2007	2016	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0525041	Neurobehavioral Manifestations	phenotype	C23;C10;F01	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0750942	Auditory Inattention	phenotype	C23;C10;F03;C09;F01	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0751292	Age-Related Memory Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0751293	Memory Disorder, Semantic	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0751294	Memory Disorder, Spatial	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0751295	Memory Loss	phenotype	C23;C10;F01	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0795690	Congenital omphalocele	disease	C23;C16	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C0917813	Spina Bifida, Open	disease	C16;C10	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C1306503	Congenital exomphalos	disease	C23;C16	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C2677613	Chromosome 15q13.3 Microdeletion Syndrome	disease	C23;C16;C10;F03;F01	Congenital Abnormality	0.50	1	2013	2013	   1	   0	CTD_human;ORPHANET
     1139	CHRNA7	0.532	0.654	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	2004	   5	   0	CTD_human
     1139	CHRNA7	0.532	0.654	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1998	2004	   5	   0	CTD_human
     1140	CHRNB1	0.7	0.462	C0751882	Myasthenic Syndromes, Congenital	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1140	CHRNB1	0.7	0.462	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1140	CHRNB1	0.7	0.462	C0751884	Congenital Myasthenic Syndromes, Presynaptic	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1140	CHRNB1	0.7	0.462	C0751885	Myasthenic Syndromes, Congenital, Slow Channel	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1140	CHRNB1	0.7	0.462	C1837092	Myasthenic Syndrome, Congenital, with Facial Dysmorphism, associated with Acetylcholine Receptor Deficiency	disease	C16;C05;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1140	CHRNB1	0.7	0.462	C4084823	MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL	disease		Disease or Syndrome	0.30	1	1977	1977	   1	   0	GENOMICS_ENGLAND
     1140	CHRNB1	0.7	0.462	C4225373	MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	disease		Disease or Syndrome	0.30	1	1977	1977	   1	   0	GENOMICS_ENGLAND
     1140	CHRNB1	0.7	0.462	C4225374	MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL	disease		Disease or Syndrome	0.60	1	1977	2016	   4	   4	GENOMICS_ENGLAND;UNIPROT
     1141	CHRNB2	0.617	0.308	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.34	1	1999	2007	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2004	2004	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0020672	Hypothermia, natural	phenotype	C23	Finding	0.30	1	2004	2004	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0034933	Reflex, Abnormal	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	0.5	2006	2008	   2	   0	PSYGENET
     1141	CHRNB2	0.617	0.308	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0038644	Sudden infant death syndrome	disease	C23	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0041671	Attention Deficit Disorder	disease	F03	Mental or Behavioral Dysfunction	0.50	1	2003	2012	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0085541	Epilepsy, Frontal Lobe	disease	C10	Disease or Syndrome	0.40	1	2002	2015	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0151572	Reflex, Corneal, Decreased	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0151888	Hyporeflexia	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0151889	Hyperreflexia	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0234146	Absent reflex	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0234784	Reflex, Gag, Absent	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0241772	Reflex, Deep Tendon, Absent	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0277839	Hoffman's Reflex	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0277850	Reflex, Pendular	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0278211	Reflex, Corneal, Absent	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0393671	Frontal Epilepsy, Benign, Childhood	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0393683	Epilepsy, Supplementary Motor	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0393684	Epilepsy, Cingulate	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0393688	Epilepsy, Opercular	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0522345	Reflex, Acoustic, Abnormal	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0558845	Reflex, Ankle, Absent	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0558846	Reflex, Triceps, Absent	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0558847	Reflex, Biceps, Absent	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0576612	Reflex, Anal, Absent	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0743002	Abnormal Deep Tendon Reflex	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751468	Bulbocavernosus Reflex, Decreased	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751469	Bulbocavernousus Reflex Absent	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751470	Palmo-Mental Reflex	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751471	Reflex, Anal, Decreased	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751472	Reflex, Ankle, Abnormal	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751473	Reflex, Ankle, Decreased	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751474	Reflex, Biceps, Abnormal	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751475	Reflex, Biceps, Decreased	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751476	Reflex, Gag, Decreased	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751477	Reflex, Knee, Abnormal	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751478	Reflex, Knee, Decreased	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751479	Reflex, Moro, Asymmetric	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751480	Reflex, Triceps, Abnormal	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751481	Reflex, Triceps, Decreased	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751508	Long Sleeper Syndrome	phenotype	C23;C10;F03	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751509	Short Sleeper Syndrome	disease	C23;C10;F03	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751510	Sleep-Related Neurogenic Tachypnea	phenotype	C23;C10;F03	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751511	Subwakefullness Syndrome	phenotype	C23;C10;F03	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751642	Epilepsy, Anterior Fronto-Polar	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0751643	Epilepsy, Orbito-Frontal	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C0851578	Sleep Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2002	2002	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C1263846	Attention deficit hyperactivity disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C1321905	Minimal Brain Dysfunction	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     1141	CHRNB2	0.617	0.308	C1854335	Epilepsy, Nocturnal Frontal Lobe, Type 3	disease	C10	Disease or Syndrome	0.90	1	2000	2011	   3	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1141	CHRNB2	0.617	0.308	C3696898	Autosomal Dominant Nocturnal Frontal Lobe Epilepsy	disease	C10	Disease or Syndrome	0.50	1	2000	2013	   1	   1	ORPHANET
     1141	CHRNB2	0.617	0.308	C4042891	Sleep Wake Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2002	2002	   1	   0	CTD_human
     1142	CHRNB3	0.705	0.308	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2014	2017	   1	   0	PSYGENET
     1142	CHRNB3	0.705	0.308	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2009	2014	   3	   0	PSYGENET
     1142	CHRNB3	0.705	0.308	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	PSYGENET
     1142	CHRNB3	0.705	0.308	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	PSYGENET
     1142	CHRNB3	0.705	0.308	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2014	2014	   1	   0	PSYGENET
     1142	CHRNB3	0.705	0.308	C1861063	TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)	phenotype		Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1142	CHRNB3	0.705	0.308	C3496069	cocaine use	disease		Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
     1143	CHRNB4	0.644	0.423	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2009	2012	   3	   0	PSYGENET
     1143	CHRNB4	0.644	0.423	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.50	1	2008	2018	   1	  11	CTD_human
     1143	CHRNB4	0.644	0.423	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2014	   2	   0	PSYGENET
     1143	CHRNB4	0.644	0.423	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   2	   0	CTD_human
     1143	CHRNB4	0.644	0.423	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   2	   0	CTD_human
     1144	CHRND	0.641	0.462	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
     1144	CHRND	0.641	0.462	C0234544	Todd Paralysis	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1144	CHRND	0.641	0.462	C0522224	Paralysed	phenotype	C23;C10	Finding	0.30	1	2009	2009	   1	   0	CTD_human
     1144	CHRND	0.641	0.462	C0751882	Myasthenic Syndromes, Congenital	disease	C16;C10	Disease or Syndrome	0.52	1	2002	2017	   1	   0	CTD_human;GENOMICS_ENGLAND
     1144	CHRND	0.641	0.462	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1144	CHRND	0.641	0.462	C0751884	Congenital Myasthenic Syndromes, Presynaptic	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1144	CHRND	0.641	0.462	C0751885	Myasthenic Syndromes, Congenital, Slow Channel	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1144	CHRND	0.641	0.462	C1837092	Myasthenic Syndrome, Congenital, with Facial Dysmorphism, associated with Acetylcholine Receptor Deficiency	disease	C16;C05;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1144	CHRND	0.641	0.462	C1837122	Myasthenic Syndrome, Congenital, Fast-Channel	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1144	CHRND	0.641	0.462	C1854678	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	disease	C23;C16;C17	Disease or Syndrome	0.70	1	2006	2008	   2	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1144	CHRND	0.641	0.462	C4084823	MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL	disease		Disease or Syndrome	0.30	1	2001	2001	   1	   0	GENOMICS_ENGLAND
     1144	CHRND	0.641	0.462	C4225370	MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	disease		Disease or Syndrome	0.60	1	2001	2008	   3	   1	GENOMICS_ENGLAND;UNIPROT
     1144	CHRND	0.641	0.462	C4225371	MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL	disease		Disease or Syndrome	0.60	1	2001	2008	   4	   5	GENOMICS_ENGLAND;UNIPROT
     1144	CHRND	0.641	0.462	C4225372	MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL	disease		Disease or Syndrome	0.80	1	1996	2006	   4	   2	GENOMICS_ENGLAND;UNIPROT
     1145	CHRNE	0.636	0.577	C1837091	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	disease	C16;C10	Disease or Syndrome	0.90	1	1996	2011	   2	   7	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1145	CHRNE	0.636	0.577	C1837122	Myasthenic Syndrome, Congenital, Fast-Channel	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1145	CHRNE	0.636	0.577	C1853949	MYASTHENIA, FAMILIAL INFANTILE, 1	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1145	CHRNE	0.636	0.577	C4084823	MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL	disease		Disease or Syndrome	0.30	1	2011	2011	   1	   0	GENOMICS_ENGLAND
     1145	CHRNE	0.636	0.577	C4225369	MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL	disease		Disease or Syndrome	0.60	1	1996	2012	   4	   2	GENOMICS_ENGLAND;UNIPROT
     1145	CHRNE	0.636	0.577	C4225413	MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL	disease		Disease or Syndrome	0.80	1	1995	2016	   6	   6	GENOMICS_ENGLAND;UNIPROT
     1146	CHRNG	0.573	0.692	C0003886	Arthrogryposis	disease	C16;C05	Disease or Syndrome	0.42	1	2006	2016	   2	   0	CTD_human
     1146	CHRNG	0.573	0.692	C0005941	Bone Diseases, Developmental	group	C05	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1146	CHRNG	0.573	0.692	C0265261	Multiple pterygium syndrome	disease	C23;C16;C17	Congenital Abnormality	0.78	1	2006	2019	   4	  11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1146	CHRNG	0.573	0.692	C0751882	Myasthenic Syndromes, Congenital	disease	C16;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1146	CHRNG	0.573	0.692	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	disease	C16;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1146	CHRNG	0.573	0.692	C0751884	Congenital Myasthenic Syndromes, Presynaptic	disease	C16;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1146	CHRNG	0.573	0.692	C0751885	Myasthenic Syndromes, Congenital, Slow Channel	disease	C16;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1146	CHRNG	0.573	0.692	C1854678	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	disease	C23;C16;C17	Disease or Syndrome	0.71	1	2006	2019	   3	   5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1147	CHUK	0.556	0.731	C0000772	Multiple congenital anomalies	group	C16	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     1147	CHUK	0.556	0.731	C0005941	Bone Diseases, Developmental	group	C05	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     1147	CHUK	0.556	0.731	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
     1147	CHUK	0.556	0.731	C0013949	Embryopathies	disease	C16;C13	Disease or Syndrome	0.30	1	1999	2010	   4	   0	CTD_human
     1147	CHUK	0.556	0.731	C0015929	Fetal Diseases	group	C16;C13	Disease or Syndrome	0.30	1	1999	2010	   4	   0	CTD_human
     1147	CHUK	0.556	0.731	C0037268	Skin Abnormalities	group	C16;C17	Congenital Abnormality	0.30	1	1999	1999	   3	   0	CTD_human
     1147	CHUK	0.556	0.731	C0206762	Limb Deformities, Congenital	group	C16;C05	Congenital Abnormality	0.30	1	1999	2010	   4	   0	CTD_human
     1147	CHUK	0.556	0.731	C1837218	Cleft palate, isolated	disease	C16;C05;C07	Congenital Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
     1147	CHUK	0.556	0.731	C3150891	COCOON SYNDROME	disease		Disease or Syndrome	0.92	1	1999	2015	   1	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1149	CIDEA	0.751	0.269	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1149	CIDEA	0.751	0.269	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1149	CIDEA	0.751	0.269	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1149	CIDEA	0.751	0.269	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1149	CIDEA	0.751	0.269	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2014	2017	   2	   0	CTD_human
     1149	CIDEA	0.751	0.269	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.37	1	2005	2019	   1	   0	CTD_human
     1149	CIDEA	0.751	0.269	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1149	CIDEA	0.751	0.269	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2014	2017	   2	   0	CTD_human
     1149	CIDEA	0.751	0.269	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1149	CIDEA	0.751	0.269	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.31	1	1982	2004	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.31	1	2004	2015	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2009	2012	   1	   0	PSYGENET
     1152	CKB	0.608	0.615	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2004	2015	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.31	0.5	1987	1988	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C0857501	Acute schizophrenia	disease		Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     1152	CKB	0.608	0.615	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C0948089	Acute Coronary Syndrome	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1152	CKB	0.608	0.615	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1153	CIRBP	0.592	0.731	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.31	1	2005	2017	   1	   0	CTD_human
     1153	CIRBP	0.592	0.731	C0600467	Neurogenic Inflammation	disease	C23;C10	Injury or Poisoning	0.30	1	2013	2013	   1	   0	CTD_human
     1153	CIRBP	0.592	0.731	C0751865	Alcohol-Induced Disorders, Nervous System	disease	C10;C25	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1153	CIRBP	0.592	0.731	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	CTD_human
     1154	CISH	0.5	0.808	C0004610	Bacteremia	disease	C23;C01	Disease or Syndrome	0.31	1	2010	2010	   0	   0	CTD_human
     1154	CISH	0.5	0.808	C0024530	Malaria	disease	C01	Disease or Syndrome	0.30				   0	   0	CTD_human
     1154	CISH	0.5	0.808	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1154	CISH	0.5	0.808	C0162820	Dermatitis, Allergic Contact	disease	C17;C20	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1154	CISH	0.5	0.808	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1154	CISH	0.5	0.808	C1834752	MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding)	disease		Finding	0.30				   0	   0	CTD_human
     1155	TBCB	0.931	0.115	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1158	CKM	0.743	0.423	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1158	CKM	0.743	0.423	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1158	CKM	0.743	0.423	C0022116	Ischemia	phenotype	C23	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1158	CKM	0.743	0.423	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.31	1	1988	2018	   2	   0	CTD_human
     1158	CKM	0.743	0.423	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1158	CKM	0.743	0.423	C0948089	Acute Coronary Syndrome	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1161	ERCC8	0.551	0.885	C0009207	Cockayne Syndrome	disease	C16;C18;C05;C10	Disease or Syndrome	0.80	0.978	1996	2020	   3	   0	CTD_human;GENOMICS_ENGLAND
     1161	ERCC8	0.551	0.885	C0751037	Cockayne Syndrome, Type III	disease	C16;C18;C05;C10	Disease or Syndrome	0.30	1	2012	2012	   2	   0	CTD_human
     1161	ERCC8	0.551	0.885	C0751038	Cockayne Syndrome, Type II	disease	C16;C18;C05;C10	Disease or Syndrome	0.33	1	2004	2015	   2	   0	CTD_human
     1161	ERCC8	0.551	0.885	C0751039	Cockayne Syndrome, Type I	disease	C16;C18;C05;C10	Disease or Syndrome	0.80	1	1995	2019	   8	  26	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1161	ERCC8	0.551	0.885	C1833561	UV-Sensitive Syndrome	disease	C17	Disease or Syndrome	0.62	1	2009	2017	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1161	ERCC8	0.551	0.885	C3553298	UV-SENSITIVE SYNDROME 2	disease		Disease or Syndrome	0.60	1	2009	2009	   1	   2	GENOMICS_ENGLAND;UNIPROT
     1164	CKS2	0.644	0.462	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1164	CKS2	0.644	0.462	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1173	AP2M1	0.751	0.231	C0004134	Ataxia	phenotype	C23;C10	Sign or Symptom	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1173	AP2M1	0.751	0.231	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1173	AP2M1	0.751	0.231	C0393702	Myoclonic Astatic Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2019	2019	   1	   0	ORPHANET
     1173	AP2M1	0.751	0.231	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1173	AP2M1	0.751	0.231	C0856975	Autistic behavior	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1173	AP2M1	0.751	0.231	C1858120	Generalized hypotonia	phenotype	C23;C10	Finding	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1173	AP2M1	0.751	0.231	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1174	AP1S1	0.743	0.308	C0008372	Intrahepatic Cholestasis	disease	C06	Disease or Syndrome	0.40	1	2013	2013	   1	   0	CTD_human
     1174	AP1S1	0.743	0.308	C0023794	Lipoidosis	disease	C16;C18	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1174	AP1S1	0.743	0.308	C1836330	ERYTHROKERATODERMIA VARIABILIS 3 (disorder)	disease	C16;C17	Disease or Syndrome	0.75	1	2005	2019	   3	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1175	AP2S1	0.705	0.346	C0342637	Hypocalciuric hypercalcemia, familial, type 1	disease	C18	Disease or Syndrome	0.40	0.909	2013	2017	   1	   0	GENOMICS_ENGLAND
     1175	AP2S1	0.705	0.346	C1833372	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	disease	C18	Disease or Syndrome	0.70	1	2013	2016	   4	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1176	AP3S1	0.931	0.154	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1180	CLCN1	0.641	0.423	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   1	UNIPROT
     1180	CLCN1	0.641	0.423	C0027125	Myotonia	phenotype	C23;C10	Finding	0.43	1	2002	2012	   1	   5	GENOMICS_ENGLAND
     1180	CLCN1	0.641	0.423	C0027127	Myotonia Congenita	disease	C16;C05;C10	Disease or Syndrome	0.90	0.968	1982	2019	   2	  27	CTD_human;GENOMICS_ENGLAND
     1180	CLCN1	0.641	0.423	C0238357	Hyperkalemic periodic paralysis	disease	C16;C18;C05;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
     1180	CLCN1	0.641	0.423	C0270959	Myotonia Levior	disease	C16;C05;C10	Disease or Syndrome	0.41	1	1995	2010	   1	   1	CTD_human
     1180	CLCN1	0.641	0.423	C0751360	Becker Generalized Myotonia	disease	C16;C05;C10	Disease or Syndrome	0.80	1	1992	2018	  23	  65	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1180	CLCN1	0.641	0.423	C2936781	Generalized Myotonia of Thomsen	disease	C16;C05;C10	Disease or Syndrome	0.80	0.977	1992	2019	  15	  51	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1181	CLCN2	0.626	0.462	C0017638	Glioma	disease	C04	Neoplastic Process	0.31	1	2003	2003	   1	   0	CTD_human
     1181	CLCN2	0.626	0.462	C0020428	Hyperaldosteronism	disease	C19	Disease or Syndrome	0.32	1	2018	2019	   1	   0	CTD_human
     1181	CLCN2	0.626	0.462	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     1181	CLCN2	0.626	0.462	C0270850	Idiopathic generalized epilepsy	disease	C10	Disease or Syndrome	0.35	1	2003	2013	   0	   0	CTD_human
     1181	CLCN2	0.626	0.462	C0270853	Juvenile Myoclonic Epilepsy	disease	C10	Disease or Syndrome	0.33	1	2003	2013	   3	   0	ORPHANET
     1181	CLCN2	0.626	0.462	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     1181	CLCN2	0.626	0.462	C1384514	Conn Syndrome	disease	C19	Disease or Syndrome	0.44	1	2018	2019	   1	   4	CTD_human
     1181	CLCN2	0.626	0.462	C1854107	Hyperaldosteronism, Familial, Type II	disease	C19	Disease or Syndrome	0.61	1	2018	2019	   2	   5	CTD_human;UNIPROT
     1181	CLCN2	0.626	0.462	C2750893	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11	disease		Finding	0.60	1	2009	2013	   3	   3	GENOMICS_ENGLAND;UNIPROT
     1181	CLCN2	0.626	0.462	C3810242	LEUKOENCEPHALOPATHY WITH ATAXIA	disease		Disease or Syndrome	0.70	1	2003	2015	   5	  17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1181	CLCN2	0.626	0.462	C4554120	Leukoencephalopathy with mild cerebellar ataxia and white matter edema	phenotype	C23;C16;C10	Disease or Syndrome	0.32	1	2015	2019	   1	   0	GENOMICS_ENGLAND
     1182	CLCN3	0.621	0.615	C0017638	Glioma	disease	C04	Neoplastic Process	0.34	1	2003	2018	   1	   0	CTD_human
     1182	CLCN3	0.621	0.615	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.32	1	2011	2018	   1	   0	CTD_human
     1182	CLCN3	0.621	0.615	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1182	CLCN3	0.621	0.615	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2011	2011	   1	   0	CTD_human
     1182	CLCN3	0.621	0.615	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     1182	CLCN3	0.621	0.615	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     1182	CLCN3	0.621	0.615	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1182	CLCN3	0.621	0.615	C2931822	Nasopharyngeal carcinoma	disease	C04;C07;C09	Neoplastic Process	0.40	1	2008	2019	   1	   0	CTD_human
     1183	CLCN4	0.587	0.654	C0796221	MENTAL RETARDATION, X-LINKED 15	disease		Disease or Syndrome	0.70	1	2013	2016	   2	   6	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1183	CLCN4	0.587	0.654	C2931498	Mental Retardation, X-Linked 1	disease	C16;C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	ORPHANET
     1183	CLCN4	0.587	0.654	C3501611	Mental Retardation, X-Linked Nonsyndromic	disease	C16;C10	Disease or Syndrome	0.30	1	2013	2018	   3	   0	CLINGEN
     1184	CLCN5	0.593	0.577	C0017638	Glioma	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     1184	CLCN5	0.593	0.577	C0018021	Goiter	phenotype	C19	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1184	CLCN5	0.593	0.577	C0027707	Nephritis, Interstitial	disease	C13;C12	Disease or Syndrome	0.31	1	2020	2020	   0	   0	GENOMICS_ENGLAND
     1184	CLCN5	0.593	0.577	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.30	1	2005	2005	   1	   0	CTD_human
     1184	CLCN5	0.593	0.577	C0041349	Nephritis, Tubulointerstitial	disease	C13;C12	Disease or Syndrome	0.31	1	2020	2020	   0	   0	GENOMICS_ENGLAND
     1184	CLCN5	0.593	0.577	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     1184	CLCN5	0.593	0.577	C0268731	Renal glomerular disease	group	C23;C13;C12	Disease or Syndrome	0.31	1	2020	2020	   0	   0	GENOMICS_ENGLAND
     1184	CLCN5	0.593	0.577	C0403720	X-linked recessive nephrolithiasis with renal failure	disease	C16;C13;C12	Disease or Syndrome	0.62	1	1996	2013	   4	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1184	CLCN5	0.593	0.577	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     1184	CLCN5	0.593	0.577	C0733682	Hypophosphatemic Rickets, X-Linked Dominant	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
     1184	CLCN5	0.593	0.577	C0878681	Dent's disease	disease	C16;C13;C12	Disease or Syndrome	0.90	0.949	1978	2019	   4	  10	CTD_human;GENOMICS_ENGLAND
     1184	CLCN5	0.593	0.577	C1839874	Low Molecular Weight Proteinuria with Hypercalciuria and Nephrocalcinosis	disease	C16;C13;C12	Disease or Syndrome	0.70	1	1997	2013	   4	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1184	CLCN5	0.593	0.577	C1845168	Hypophosphatemic Rickets, X-Linked Recessive	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.70	1	1996	2013	   4	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1184	CLCN5	0.593	0.577	C1848336	Dent disease 1	disease	C16;C13;C12	Disease or Syndrome	0.98	0.977	1996	2020	  16	  22	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1184	CLCN5	0.593	0.577	C3536983	Familial Hypophosphatemic Rickets	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.32	1	2012	2017	   0	   0	CTD_human
     1184	CLCN5	0.593	0.577	C3536984	Vitamin D-Resistant Rickets, X-Linked	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
     1184	CLCN5	0.593	0.577	C3540852	Rickets, X-Linked Hypophosphatemic	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
     1184	CLCN5	0.593	0.577	C4521256	Glomerulopathy Assessment	phenotype		Diagnostic Procedure	0.30				   0	   0	GENOMICS_ENGLAND
     1186	CLCN7	0.59	0.731	C0029454	Osteopetrosis	disease	C05	Disease or Syndrome	0.50	0.947	2001	2019	   0	   0	CTD_human
     1186	CLCN7	0.59	0.731	C0432261	Osteopetrosis - intermediate type	disease	C05	Disease or Syndrome	0.30	1	2003	2003	   1	   0	ORPHANET
     1186	CLCN7	0.59	0.731	C1318518	Infantile malignant osteopetrosis	disease	C05	Congenital Abnormality	0.37	1	2001	2018	   3	   0	ORPHANET
     1186	CLCN7	0.59	0.731	C1969093	Osteopetrosis, Autosomal Recessive 6	disease	C05	Disease or Syndrome	0.30	1	2003	2003	   1	   0	ORPHANET
     1186	CLCN7	0.59	0.731	C1969106	Osteopetrosis, Autosomal Recessive 4	disease	C05	Disease or Syndrome	0.90	1	2001	2016	   7	  20	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1186	CLCN7	0.59	0.731	C3179239	Osteopetrosis Autosomal Dominant Type 2	disease	C05	Disease or Syndrome	0.93	1	2001	2019	   5	   7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1186	CLCN7	0.59	0.731	C3645711	Congenital Osteopetrosis	disease	C05	Disease or Syndrome	0.30				   0	   0	CTD_human
     1187	CLCNKA	0.711	0.385	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.33	1	2007	2017	   1	   0	CTD_human
     1187	CLCNKA	0.711	0.385	C2751312	BARTTER SYNDROME, TYPE 4B	disease	C23;C13;C12;C10;C19;C09	Disease or Syndrome	0.30				   0	   0	CTD_human
     1187	CLCNKA	0.711	0.385	C4310805	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	disease		Disease or Syndrome	0.60	1	2004	2008	   2	   2	GENOMICS_ENGLAND;UNIPROT
     1188	CLCNKB	0.593	0.692	C0004775	Bartter Disease	disease	C13;C12;C19	Disease or Syndrome	0.40	0.973	1997	2020	   1	   0	CTD_human
     1188	CLCNKB	0.593	0.692	C0268450	Gitelman Syndrome	disease	C16;C13;C12	Disease or Syndrome	0.40	1	1999	2019	   3	   0	ORPHANET
     1188	CLCNKB	0.593	0.692	C1846343	Bartter syndrome, type 3	disease	C13;C12;C19	Disease or Syndrome	0.80	1	1997	2019	   4	   9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1188	CLCNKB	0.593	0.692	C2751312	BARTTER SYNDROME, TYPE 4B	disease	C23;C13;C12;C10;C19;C09	Disease or Syndrome	0.30				   0	   0	CTD_human
     1188	CLCNKB	0.593	0.692	C4310805	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	disease		Disease or Syndrome	0.30	1	2006	2013	   3	   0	GENOMICS_ENGLAND
     1191	CLU	0.426	0.885	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.50	0.94	1991	2020	   3	   7	CTD_human
     1191	CLU	0.426	0.885	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.37	0.9	1998	2019	   3	   0	CTD_human
     1191	CLU	0.426	0.885	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2014	2017	   2	   0	CTD_human
     1191	CLU	0.426	0.885	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.31	1	2011	2014	   3	   0	CTD_human
     1191	CLU	0.426	0.885	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.31	1	2010	2019	   6	   0	CTD_human
     1191	CLU	0.426	0.885	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.36	0.833	2003	2017	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0025202	melanoma	disease	C04	Neoplastic Process	0.31	1	2005	2005	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0027686	Pathologic Neovascularization	phenotype	C23	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.33	1	2006	2019	   2	   0	CTD_human
     1191	CLU	0.426	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.40	1	1996	2019	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2010	2019	   1	   0	PSYGENET
     1191	CLU	0.426	0.885	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2014	2017	   2	   0	CTD_human
     1191	CLU	0.426	0.885	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2007	2009	   2	   0	CTD_human
     1191	CLU	0.426	0.885	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.31	1	2009	2016	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0234985	Mental deterioration	phenotype	F03	Mental or Behavioral Dysfunction	0.35	1	2011	2018	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0242380	Libman-Sacks Disease	disease	C17;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2009	2011	   3	   0	CTD_human
     1191	CLU	0.426	0.885	C0333641	Atrophic	phenotype	C23	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0338656	Impaired cognition	disease	F03	Mental or Behavioral Dysfunction	0.38	1	2011	2019	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.978	2000	2019	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.40	1	2009	2019	   3	   0	CTD_human
     1191	CLU	0.426	0.885	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2011	   3	   0	CTD_human
     1191	CLU	0.426	0.885	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2011	   3	   0	CTD_human
     1191	CLU	0.426	0.885	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2009	2011	   3	   0	CTD_human
     1191	CLU	0.426	0.885	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C1270972	Mild cognitive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	0.909	2013	2019	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2010	2017	   6	   0	CTD_human
     1191	CLU	0.426	0.885	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.31	1	1999	2002	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.50	1	2010	2017	   6	   0	CTD_human
     1191	CLU	0.426	0.885	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1191	CLU	0.426	0.885	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1192	CLIC1	0.601	0.5	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1192	CLIC1	0.601	0.5	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1192	CLIC1	0.601	0.5	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     1192	CLIC1	0.601	0.5	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1192	CLIC1	0.601	0.5	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.37	1	2009	2019	   1	   0	CTD_human
     1192	CLIC1	0.601	0.5	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1192	CLIC1	0.601	0.5	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1192	CLIC1	0.601	0.5	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2011	2018	   1	   0	CTD_human
     1192	CLIC1	0.601	0.5	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1192	CLIC1	0.601	0.5	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1192	CLIC1	0.601	0.5	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1192	CLIC1	0.601	0.5	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1192	CLIC1	0.601	0.5	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1193	CLIC2	0.7	0.5	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1193	CLIC2	0.7	0.5	C3550913	MENTAL RETARDATION, X-LINKED, SYNDROMIC 32	disease		Disease or Syndrome	0.70	1	2012	2015	   2	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1200	TPP1	0.551	0.808	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     1200	TPP1	0.551	0.808	C0004138	Ataxias, Hereditary	disease	C16;C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     1200	TPP1	0.551	0.808	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
     1200	TPP1	0.551	0.808	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1200	TPP1	0.551	0.808	C0022340	Late-Infantile Neuronal Ceroid Lipfuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.80	1	1993	2019	   2	   0	CTD_human;GENOMICS_ENGLAND
     1200	TPP1	0.551	0.808	C0022797	Adult Neuronal Ceroid Lipofuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.50	1	1999	2008	   2	   0	CTD_human
     1200	TPP1	0.551	0.808	C0027877	Neuronal Ceroid-Lipofuscinoses	disease	C16;C18;C10	Disease or Syndrome	0.70	0.968	1991	2019	   2	  23	CTD_human
     1200	TPP1	0.551	0.808	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1200	TPP1	0.551	0.808	C0268281	Infantile neuronal ceroid lipofuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.33	1	1991	2017	   2	   0	CTD_human
     1200	TPP1	0.551	0.808	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     1200	TPP1	0.551	0.808	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1200	TPP1	0.551	0.808	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
     1200	TPP1	0.551	0.808	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
     1200	TPP1	0.551	0.808	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
     1200	TPP1	0.551	0.808	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     1200	TPP1	0.551	0.808	C0751383	Juvenile Neuronal Ceroid Lipofuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.60	1	1997	2019	   2	   0	CTD_human
     1200	TPP1	0.551	0.808	C1834207	Ceroid Lipofuscinosis, Neuronal, Parry Type	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1999	2001	   2	   0	CTD_human
     1200	TPP1	0.551	0.808	C1836474	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7	disease	C16;C10	Disease or Syndrome	0.71	1	2013	2013	   1	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1200	TPP1	0.551	0.808	C1876161	CEROID LIPOFUSCINOSIS, NEURONAL, 2	disease	C16;C18;C10	Disease or Syndrome	1.00	1	1997	2019	  16	  66	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1200	TPP1	0.551	0.808	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     1201	CLN3	0.572	0.692	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1201	CLN3	0.572	0.692	C0022340	Late-Infantile Neuronal Ceroid Lipfuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.54	1	1994	2017	   0	   0	CTD_human
     1201	CLN3	0.572	0.692	C0022797	Adult Neuronal Ceroid Lipofuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.50	1	1999	2016	   0	   0	CTD_human
     1201	CLN3	0.572	0.692	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1201	CLN3	0.572	0.692	C0027877	Neuronal Ceroid-Lipofuscinoses	disease	C16;C18;C10	Disease or Syndrome	0.70	0.957	1993	2019	   0	  12	CTD_human
     1201	CLN3	0.572	0.692	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.41	1	2000	2014	   0	   4	GENOMICS_ENGLAND
     1201	CLN3	0.572	0.692	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1201	CLN3	0.572	0.692	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2011	2011	   1	   0	CTD_human
     1201	CLN3	0.572	0.692	C0268281	Infantile neuronal ceroid lipofuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1201	CLN3	0.572	0.692	C0751383	Juvenile Neuronal Ceroid Lipofuscinosis	disease	C16;C18;C10	Disease or Syndrome	1.00	0.994	1990	2019	   7	  72	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1201	CLN3	0.572	0.692	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1201	CLN3	0.572	0.692	C1834207	Ceroid Lipofuscinosis, Neuronal, Parry Type	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1203	CLN5	0.705	0.269	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1203	CLN5	0.705	0.269	C1850442	CEROID LIPOFUSCINOSIS, NEURONAL, 5	disease	C16;C18;C10	Disease or Syndrome	0.97	1	1998	2019	  11	   9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1207	CLNS1A	1	0.038	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1209	CLPTM1	0.769	0.346	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1209	CLPTM1	0.769	0.346	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1212	CLTB	0.821	0.231	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     1212	CLTB	0.821	0.231	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     1213	CLTC	0.558	0.769	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2007	2012	   1	   0	CTD_human
     1213	CLTC	0.558	0.769	C0334121	Inflammatory Myofibroblastic Tumor	disease	C23	Neoplastic Process	0.35	1	2001	2007	   1	   0	ORPHANET
     1213	CLTC	0.558	0.769	C4518356	MiT family translocation renal cell carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2003	2010	   2	   0	ORPHANET
     1213	CLTC	0.558	0.769	C4693389	MENTAL RETARDATION, AUTOSOMAL DOMINANT 56	disease		Mental or Behavioral Dysfunction	0.60	1	2016	2017	   2	   1	GENOMICS_ENGLAND;UNIPROT
     1215	CMA1	0.514	0.692	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.33	1	2003	2018	   1	   0	CTD_human
     1215	CMA1	0.514	0.692	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1215	CMA1	0.514	0.692	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.31	1	2003	2005	   1	   0	CTD_human
     1215	CMA1	0.514	0.692	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0004943	Behcet Syndrome	disease	C16;C11;C17;C07;C14	Disease or Syndrome	0.54	1	2012	2019	   2	   0	CTD_human;ORPHANET
     1230	CCR1	0.531	0.769	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C1527304	Allergic Reaction	phenotype	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.36	1	2003	2019	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0011615	Dermatitis, Atopic	disease	C16;C17;C20	Disease or Syndrome	0.34	1	1999	2018	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.32	1	1999	2017	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.31	1	2005	2005	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0035228	Respiratory Hypersensitivity	phenotype	C08;C20	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0086196	Eczema, Infantile	disease	C16;C17;C20	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C1319853	Asthma, Aspirin-Induced	disease	C08;C20;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0007570	Celiac Disease	disease	C06;C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0017638	Glioma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0023493	Adult T-Cell Lymphoma/Leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	1	2002	2020	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0036920	Sezary Syndrome	disease	C04;C20;C15	Neoplastic Process	0.36	1	2005	2020	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
     1234	CCR5	0.398	0.885	C0011615	Dermatitis, Atopic	disease	C16;C17;C20	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1234	CCR5	0.398	0.885	C0019196	Hepatitis C	disease	C06;C01	Disease or Syndrome	0.40	0.839	2002	2019	   0	   0	CTD_human
     1234	CCR5	0.398	0.885	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1234	CCR5	0.398	0.885	C0027697	Nephritis	disease	C13;C12	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1234	CCR5	0.398	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2006	2016	   1	   0	PSYGENET
     1234	CCR5	0.398	0.885	C0043124	West Nile Fever	disease	C01;C10	Disease or Syndrome	0.36	0.833	2006	2016	   0	   0	CTD_human
     1234	CCR5	0.398	0.885	C0086196	Eczema, Infantile	disease	C16;C17;C20	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1234	CCR5	0.398	0.885	C0751583	Encephalitis, West Nile Fever	disease	C01;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1234	CCR5	0.398	0.885	C0751584	West Nile Fever Meningitis	disease	C01;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1234	CCR5	0.398	0.885	C0751585	West Nile Fever Meningoencephalitis	disease	C01;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1234	CCR5	0.398	0.885	C0751586	West Nile Fever Myelitis	disease	C01;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1234	CCR5	0.398	0.885	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1234	CCR5	0.398	0.885	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2016	2016	   1	   0	CTD_human
     1234	CCR5	0.398	0.885	C2675864	DIABETES MELLITUS, INSULIN-DEPENDENT, 22 (disorder)	disease	C18;C20;C19	Disease or Syndrome	0.30				   0	   0	CTD_human
     1235	CCR6	0.485	0.808	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.50	1	2001	2019	   3	   6	CTD_human
     1235	CCR6	0.485	0.808	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.35	1	2005	2019	   1	   0	CTD_human
     1235	CCR6	0.485	0.808	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1235	CCR6	0.485	0.808	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1235	CCR6	0.485	0.808	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1235	CCR6	0.485	0.808	C0042900	Vitiligo	disease	C17	Disease or Syndrome	0.31	1	2010	2019	   1	   0	CTD_human
     1235	CCR6	0.485	0.808	C0178417	Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
     1235	CCR6	0.485	0.808	C0206138	CREST Syndrome	disease	C06;C18;C17;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     1235	CCR6	0.485	0.808	C0748540	Scleroderma, Limited	disease	C17	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     1235	CCR6	0.485	0.808	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
     1235	CCR6	0.485	0.808	C1258104	Diffuse Scleroderma	disease	C17	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     1235	CCR6	0.485	0.808	C1527304	Allergic Reaction	phenotype	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1235	CCR6	0.485	0.808	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0023493	Adult T-Cell Lymphoma/Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0178417	Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
     1236	CCR7	0.443	0.769	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1237	CCR8	0.597	0.692	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1237	CCR8	0.597	0.692	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1237	CCR8	0.597	0.692	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1237	CCR8	0.597	0.692	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1237	CCR8	0.597	0.692	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1237	CCR8	0.597	0.692	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1237	CCR8	0.597	0.692	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1240	CMKLR1	0.612	0.692	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2012	2018	   1	   0	PSYGENET
     1240	CMKLR1	0.612	0.692	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2018	   1	   0	PSYGENET
     1240	CMKLR1	0.612	0.692	C0018206	granulosa cell tumor	disease	C04;C13;C19	Neoplastic Process	0.31	1	2018	2018	   1	   0	CTD_human
     1240	CMKLR1	0.612	0.692	C1567257	Granulosa Cell Cancer	disease	C04;C13;C19	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1241	LTB4R	0.576	0.692	C0002792	anaphylaxis	phenotype	C20	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
     1241	LTB4R	0.576	0.692	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.31	1	2000	2005	   1	   0	CTD_human
     1241	LTB4R	0.576	0.692	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1241	LTB4R	0.576	0.692	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0002170	Alopecia	disease	C23;C17	Disease or Syndrome	0.31	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0008312	Primary biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.52	1	2003	2005	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.80	0.963	2000	2020	   5	   0	CTD_human;GENOMICS_ENGLAND
     1244	ABCC2	0.483	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.34	1	2012	2015	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2008	2012	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0013182	Drug Allergy	group	C20;C25	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2010	2014	   3	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0017178	Gastrointestinal Diseases	group	C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2008	2008	   2	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0020433	Hyperbilirubinemia	disease	C23	Disease or Syndrome	0.59	1	1996	2019	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0022350	Jaundice, Chronic Idiopathic	disease	C16;C18	Disease or Syndrome	1.00	1	1996	2020	  11	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1244	ABCC2	0.483	0.808	C0023892	Biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.50	1	2004	2005	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.33	1	2006	2020	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.50	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2010	2014	   3	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0086873	Pseudopelade	disease	C23;C17	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.31	1	2006	2013	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0162311	Androgenetic Alopecia	disease	C23;C17	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0238065	Secondary Biliary Cholangitis	disease	C23;C06	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0263477	Female pattern alopecia (disorder)	phenotype	C23;C17	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0268318	Cholestasis of pregnancy	disease	C06;C13	Disease or Syndrome	0.35	1	2008	2018	   2	   0	GENOMICS_ENGLAND
     1244	ABCC2	0.483	0.808	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.50	1	2003	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2011	2011	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.32	1	2009	2020	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0559031	Functional Gastrointestinal Disorders	disease	C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.36	0.875	2008	2020	   2	   0	CTD_human
     1244	ABCC2	0.483	0.808	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.32	1	2014	2019	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   2	   0	CTD_human
     1244	ABCC2	0.483	0.808	C1565321	Cholera Infantum	disease	C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   2	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.31	1	2006	2020	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4083212	Alopecia, Male Pattern	disease	C23;C17	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   2	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   2	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4551595	Biliary Cirrhosis, Primary, 1	disease	C23;C06	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1258	CNGB1	0.628	0.538	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1258	CNGB1	0.628	0.538	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.68	1	2001	2019	   1	  12	CTD_human;GENOMICS_ENGLAND
     1258	CNGB1	0.628	0.538	C3151066	RETINITIS PIGMENTOSA 45	disease		Disease or Syndrome	0.70	1	2001	2001	   1	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1259	CNGA1	0.695	0.269	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1259	CNGA1	0.695	0.269	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.64	1	1995	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
     1259	CNGA1	0.695	0.269	C3151059	RETINITIS PIGMENTOSA 49	disease		Disease or Syndrome	0.70	1	1995	2014	   2	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1260	CNGA2	0.931	0.154	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   2	UNIPROT
     1260	CNGA2	0.931	0.154	C0393778	Congenital anosmia	disease	C23;C10	Congenital Abnormality	0.32	1	2015	2017	   1	   0	ORPHANET
     1261	CNGA3	0.65	0.154	C0009398	Color vision defect	phenotype	C23;C11;C10	Disease or Syndrome	0.43	1	2004	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.31	1	2014	2017	   1	   0	GENOMICS_ENGLAND
     1261	CNGA3	0.65	0.154	C0152200	Achromatopsia	disease	C23;C11;C10	Disease or Syndrome	0.80	0.982	2000	2019	   1	  17	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1261	CNGA3	0.65	0.154	C0155015	Color Blindness, Red	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0155016	Color Blindness, Red-Green	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0155017	Color Blindness, Blue	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0155018	Color Blindness, Acquired	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0239777	Color Blindness, Green	phenotype	C23;C11;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0242225	Color blindness	disease	C23;C11;C10	Disease or Syndrome	0.31	1	2008	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0751042	Color Blindness, Inherited	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0751043	Monochromatopsia	phenotype	C23;C11;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C1857618	Achromatopsia 2	disease	C23;C11;C10	Disease or Syndrome	0.94	1	1998	2019	   9	  43	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1261	CNGA3	0.65	0.154	C3489532	Cone-Rod Dystrophy 2	disease	C16;C11	Disease or Syndrome	0.32	1	2015	2019	   1	   0	ORPHANET
     1265	CNN2	0.666	0.538	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1265	CNN2	0.666	0.538	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1265	CNN2	0.666	0.538	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1265	CNN2	0.666	0.538	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1265	CNN2	0.666	0.538	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1265	CNN2	0.666	0.538	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2002	2002	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1267	CNP	0.604	0.692	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1267	CNP	0.604	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.4	2006	2018	   5	   0	PSYGENET
     1267	CNP	0.604	0.692	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
     1267	CNP	0.604	0.692	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2015	   1	   0	PSYGENET
     1268	CNR1	0.446	0.808	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.37	1	2002	2014	   5	   0	PSYGENET
     1268	CNR1	0.446	0.808	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.40	1	2004	2019	   2	   0	CTD_human
     1268	CNR1	0.446	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	0.5	2010	2013	   2	   0	PSYGENET
     1268	CNR1	0.446	0.808	C0006868	Cannabis Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	0.5	2009	2016	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0006870	Cannabis Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.37	1	2006	2016	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0007370	Catalepsy	disease	C23;C10	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2006	2017	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.40	1	2005	2019	   5	   0	PSYGENET
     1268	CNR1	0.446	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2005	2019	   5	   0	PSYGENET
     1268	CNR1	0.446	0.808	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.32	1	1999	2017	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0013170	Drug habituation	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1999	2011	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0013222	Drug Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1999	2011	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0014556	Epilepsy, Temporal Lobe	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0014558	Uncinate Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0018614	Hashish Abuse	disease	C25;F03	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0020179	Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.36	1	2009	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.32	1	2007	2018	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0020649	Hypotension	phenotype	C14	Finding	0.50	1	1999	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0020672	Hypothermia, natural	phenotype	C23	Finding	0.30	1	1999	1999	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.31	1	2001	2011	   2	   0	CTD_human
     1268	CNR1	0.446	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	1	1997	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0026650	Movement Disorders	group	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0026769	Multiple Sclerosis	disease	C20;C10	Disease or Syndrome	0.37	1	2003	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0026838	Muscle Spasticity	phenotype	C23;C05;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.50	1	2001	2014	   2	   0	CTD_human
     1268	CNR1	0.446	0.808	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.60	0.982	2005	2020	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0029231	Organic Mental Disorders, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1999	2011	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0030193	Pain	phenotype	C23	Sign or Symptom	0.60	1	2009	2020	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0030305	Pancreatitis	disease	C06	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0035412	Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.60	0.951	2000	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.37	0.75	2003	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.51	1	2009	2018	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0038580	Substance Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.35	1	1999	2013	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0038586	Substance Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.34	1	1999	2019	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0041671	Attention Deficit Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2008	2015	   4	   0	PSYGENET
     1268	CNR1	0.446	0.808	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.31	1	2017	2017	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0233612	Waxy flexibility	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0236735	Cannabis-Related Disorder	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2009	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0236969	Substance-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1999	2011	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.32	1	2001	2017	   2	   0	CTD_human
     1268	CNR1	0.446	0.808	C0266487	Etat Marbre	disease	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0277820	Clasp-Knife Spasticity	phenotype	C23;C05;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2008	   2	   0	CTD_human
     1268	CNR1	0.446	0.808	C0393574	Huntington Disease, Late Onset	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0393672	Epilepsy, Benign Psychomotor, Childhood	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0393682	Epilepsy, Lateral Temporal	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0443306	Spastic	disease	C23;C05;C10	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0596170	Binge eating disorder	phenotype	F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.53	1	2006	2013	   4	   0	CTD_human;PSYGENET
     1268	CNR1	0.446	0.808	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.34	1	1999	2020	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751207	Akinetic-Rigid Variant of Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751208	Juvenile Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751324	Multiple Sclerosis, Acute Fulminating	disease	C20;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C1263846	Attention deficit hyperactivity disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2008	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.35	1	2008	2018	   4	   0	PSYGENET
     1268	CNR1	0.446	0.808	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2008	   2	   0	CTD_human
     1268	CNR1	0.446	0.808	C1321905	Minimal Brain Dysfunction	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.38	1	1997	2019	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.31	0.5	2003	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C4316881	Prescription Drug Abuse	phenotype	C25;F03	Finding	0.30	1	1999	2011	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.31	1	2003	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
     1269	CNR2	0.509	0.846	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.36	1	2005	2019	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2011	2019	   1	   0	PSYGENET
     1269	CNR2	0.509	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	1	2006	2017	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.35	1	2006	2019	   5	   0	PSYGENET
     1269	CNR2	0.509	0.846	C0011573	Endogenous depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.55	1	2006	2019	   5	   0	CTD_human;PSYGENET
     1269	CNR2	0.509	0.846	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.31	1	2006	2008	   2	   0	CTD_human
     1269	CNR2	0.509	0.846	C0021053	Immune System Diseases	group	C20	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.32	1	2003	2004	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.31	1	2005	2006	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2014	2018	   1	   0	PSYGENET
     1269	CNR2	0.509	0.846	C0025193	Melancholia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0030305	Pancreatitis	disease	C06	Disease or Syndrome	0.51	1	2007	2009	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0030569	Secondary Parkinson Disease	disease	C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.34	0.75	2010	2017	   4	   0	PSYGENET
     1269	CNR2	0.509	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
     1269	CNR2	0.509	0.846	C0086133	Depressive Syndrome	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.33	1	2005	2017	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0282126	Depression, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2007	2008	   2	   0	CTD_human
     1269	CNR2	0.509	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.33	1	2006	2017	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2008	   2	   0	CTD_human
     1269	CNR2	0.509	0.846	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2008	   2	   0	CTD_human
     1269	CNR2	0.509	0.846	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2008	   2	   0	CTD_human
     1269	CNR2	0.509	0.846	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2008	   2	   0	CTD_human
     1269	CNR2	0.509	0.846	C0751414	Parkinson Disease, Secondary Vascular	disease	C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0751415	Atherosclerotic Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.32	1	2007	2019	   2	   0	CTD_human
     1269	CNR2	0.509	0.846	C3160814	Cannabis use	disease		Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
     1269	CNR2	0.509	0.846	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1270	CNTF	0.561	0.615	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.32	1	2004	2019	   4	   0	PSYGENET
     1270	CNTF	0.561	0.615	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2004	2019	   4	   0	PSYGENET
     1270	CNTF	0.561	0.615	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     1270	CNTF	0.561	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.39	0.25	1996	2008	   4	   0	PSYGENET
     1270	CNTF	0.561	0.615	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.31	1	2002	2002	   1	   0	CTD_human
     1270	CNTF	0.561	0.615	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.31	0	2002	2002	   1	   0	CTD_human
     1270	CNTF	0.561	0.615	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
     1270	CNTF	0.561	0.615	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.32	1	1995	2002	   1	   0	CTD_human
     1272	CNTN1	0.599	0.577	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     1272	CNTN1	0.599	0.577	C2675527	Myopathy, Congenital, Compton-North	disease	C16;C10	Disease or Syndrome	0.90	1	2008	2011	   1	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1277	COL1A1	0.43	0.808	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0002949	Aneurysm, Dissecting	disease	C14	Disease or Syndrome	0.40	1	1996	1996	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0003504	Aortic Valve Insufficiency	disease	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0005398	Cholestasis, Extrahepatic	disease	C06	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0005779	Blood Coagulation Disorders	group	C15	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C0006663	Calcinosis	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0008311	Cholangitis	disease	C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0013720	Ehlers-Danlos Syndrome	disease	C16;C17;C15;C14	Disease or Syndrome	0.60	1	1991	2020	   1	   0	GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0018824	Heart valve disease	group	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0020497	Cortical Congenital Hyperostosis	disease	C16;C05	Disease or Syndrome	0.77	1	1993	2019	   3	   8	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1277	COL1A1	0.43	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.40	1	2001	2001	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.32	1	1993	2019	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.32	1	2009	2018	   4	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2005	2016	   3	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0023931	Lobstein Disease	disease	C16;C17;C05	Disease or Syndrome	1.00	0.976	1988	2019	  15	 191	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1277	COL1A1	0.43	0.808	C0027719	Nephrosclerosis	disease	C13;C12	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0027726	Nephrotic Syndrome	group	C13;C12	Disease or Syndrome	0.31	1	1992	2016	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0029118	Opportunistic Infections	group	C01	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C0029172	Oral Submucous Fibrosis	disease	C07	Disease or Syndrome	0.31	1	2002	2006	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0029434	Osteogenesis Imperfecta	disease	C16;C17;C05	Disease or Syndrome; Congenital Abnormality	0.90	0.984	1985	2020	   1	  36	CTD_human;GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.70	1	1996	2017	   0	   0	CTD_human;GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0220679	Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified	disease	C16;C17;C15;C14	Disease or Syndrome	0.30	1	2000	2000	   1	   0	ORPHANET
     1277	COL1A1	0.43	0.808	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.40	0.929	2011	2019	   4	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0263628	Tumoral calcinosis	disease	C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0268345	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE	disease	C16;C18;C17;C15;C14	Disease or Syndrome	0.31	1	1991	1997	   2	   0	ORPHANET
     1277	COL1A1	0.43	0.808	C0268358	Osteogenesis imperfecta, dominant perinatal lethal	disease	C16;C17;C05	Disease or Syndrome; Congenital Abnormality	0.89	1	1986	2019	  38	  61	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1277	COL1A1	0.43	0.808	C0268362	Osteogenesis imperfecta type III (disorder)	disease	C16;C17;C05	Disease or Syndrome	0.99	1	1989	2018	  17	  31	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1277	COL1A1	0.43	0.808	C0268363	Osteogenesis imperfecta type IV (disorder)	disease		Disease or Syndrome; Congenital Abnormality	0.97	1	1989	2018	  12	  33	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1277	COL1A1	0.43	0.808	C0340643	Dissection of aorta	disease	C14	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0392784	Dermatofibrosarcoma Protuberans	disease	C04	Neoplastic Process	0.40	0.964	1997	2019	   0	   0	ORPHANET
     1277	COL1A1	0.43	0.808	C0521174	Microcalcification	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C1458140	Bleeding tendency	phenotype	C15	Pathologic Function	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C1619692	Nephrogenic Fibrosing Dermopathy	disease	C23;C17	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.31	1	2010	2018	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C1846545	Autoimmune Lymphoproliferative Syndrome Type 2B	disease	C16;C20;C15	Disease or Syndrome	0.31	1	1991	2017	   1	   0	GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C4277533	Dissection, Blood Vessel	phenotype	C14	Pathologic Function	0.30	1	1996	1996	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C4551623	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1	disease	C16;C17;C15;C14	Disease or Syndrome	0.60	1	1991	2016	   4	  11	CTD_human;GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C4552122	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1	disease		Disease or Syndrome	0.50	1	1991	2007	   4	   1	GENOMICS_ENGLAND;UNIPROT
     1277	COL1A1	0.43	0.808	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.40				   0	   1	GENOMICS_ENGLAND
     1278	COL1A2	0.486	0.846	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0013720	Ehlers-Danlos Syndrome	disease	C16;C17;C15;C14	Disease or Syndrome	0.40	1	1987	2020	   0	   0	GENOMICS_ENGLAND
     1278	COL1A2	0.486	0.846	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0018824	Heart valve disease	group	C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.31	1	2005	2016	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	1993	2014	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0023931	Lobstein Disease	disease	C16;C17;C05	Disease or Syndrome	0.89	1	1982	2019	   6	  64	ORPHANET;UNIPROT
     1278	COL1A2	0.486	0.846	C0029172	Oral Submucous Fibrosis	disease	C07	Disease or Syndrome	0.32	1	1995	2006	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.31	1	2006	2009	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0029434	Osteogenesis Imperfecta	disease	C16;C17;C05	Disease or Syndrome; Congenital Abnormality	0.70	0.977	1980	2020	   0	  15	GENOMICS_ENGLAND
     1278	COL1A2	0.486	0.846	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.67	1	1985	2018	   0	   0	CTD_human;GENOMICS_ENGLAND
     1278	COL1A2	0.486	0.846	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0036421	Systemic Scleroderma	disease	C17	Disease or Syndrome	0.40	1	1987	2014	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.34	1	1987	2019	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0268345	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE	disease	C16;C18;C17;C15;C14	Disease or Syndrome	0.39	1	1987	2000	   2	   0	ORPHANET
     1278	COL1A2	0.486	0.846	C0268358	Osteogenesis imperfecta, dominant perinatal lethal	disease	C16;C17;C05	Disease or Syndrome; Congenital Abnormality	0.66	1	1985	2011	  16	  29	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1278	COL1A2	0.486	0.846	C0268362	Osteogenesis imperfecta type III (disorder)	disease	C16;C17;C05	Disease or Syndrome	0.95	1	1991	2018	  16	  34	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1278	COL1A2	0.486	0.846	C0268363	Osteogenesis imperfecta type IV (disorder)	disease		Disease or Syndrome; Congenital Abnormality	0.80	1	1985	2015	  11	  26	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1278	COL1A2	0.486	0.846	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
     1278	COL1A2	0.486	0.846	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C1857034	Ehlers-Danlos syndrome, cardiac valvular form	disease	C16;C17;C15;C14	Disease or Syndrome	0.60	1	2004	2011	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1278	COL1A2	0.486	0.846	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C4303789	Ehlers-Danlos syndrome cardiac valvular type	disease	C16;C17;C15;C14	Disease or Syndrome	0.40	1	2006	2006	   1	   3	GENOMICS_ENGLAND
     1278	COL1A2	0.486	0.846	C4551623	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1	disease	C16;C17;C15;C14	Disease or Syndrome	0.40	1	2006	2006	   1	   4	GENOMICS_ENGLAND
     1278	COL1A2	0.486	0.846	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1280	COL2A1	0.444	0.846	C0003864	Arthritis	disease	C05	Disease or Syndrome	0.31	1	2007	2016	   3	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0003865	Arthritis, Adjuvant-Induced	disease	C05	Experimental Model of Disease	0.30	1	2005	2018	   9	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.35	0.857	1993	2018	   2	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0005974	Bone Resorption	phenotype	C05	Organ or Tissue Function	0.30	1	2017	2017	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0007302	Cartilage Diseases	group	C17;C05	Disease or Syndrome	0.32	1	1995	2017	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0008479	Chondrosarcoma	disease	C04	Neoplastic Process	0.33	1	2013	2015	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.64	1	1991	2011	   2	   0	CTD_human;GENOMICS_ENGLAND
     1280	COL2A1	0.444	0.846	C0013366	Dyschondroplasias	group	C16;C05	Congenital Abnormality	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0013604	Edema	phenotype	C23	Pathologic Function	0.40	1	2014	2018	   4	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30	1	2008	2008	   1	   0	GENOMICS_ENGLAND
     1280	COL2A1	0.444	0.846	C0015814	Femur Head Necrosis	disease	C23;C05	Disease or Syndrome	0.50	1	2010	2010	   0	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0018784	Sensorineural Hearing Loss (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.42	1	2004	2008	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0020507	Hyperplasia	phenotype	C23	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2013	2017	   2	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0023234	Legg-Calve-Perthes Disease	disease	C05	Disease or Syndrome	0.74	1	2007	2014	   3	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0025237	Melnick-Needles Syndrome	disease	C16;C05	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0026760	Multiple Epiphyseal Dysplasia	disease	C16;C05	Congenital Abnormality	0.41	1	1993	1993	   1	   1	CTD_human
     1280	COL2A1	0.444	0.846	C0027092	Myopia	disease	C11	Disease or Syndrome	0.42	1	2007	2012	   1	   1	CTD_human
     1280	COL2A1	0.444	0.846	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.50	0.941	1993	2020	   2	   1	CTD_human
     1280	COL2A1	0.444	0.846	C0029422	Osteochondrodysplasias	group	C16;C05	Disease or Syndrome	0.44	1	1993	2017	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0035305	Retinal Detachment	disease	C11	Disease or Syndrome	0.48	1	1993	2018	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0036391	Schwartz-Jampel Syndrome	disease	C16;C05	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0038015	Spondyloepiphyseal Dysplasia	disease	C16;C05	Disease or Syndrome	0.50	1	1989	2019	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0039103	Synovitis	disease	C05	Disease or Syndrome	0.31	1	2005	2014	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0041834	Erythema	phenotype	C23;C17	Disease or Syndrome	0.30	1	2014	2017	   2	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0085700	Chondromalacia	disease	C17;C05	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0086543	Cataract	disease	C11	Acquired Abnormality	0.41	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	1997	2005	   2	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0151603	Anasarca	phenotype	C23	Pathologic Function	0.30	1	2014	2018	   4	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0162323	Polyarthritis	disease	C05	Disease or Syndrome	0.30	1	2007	2016	   3	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0220685	Achondrogenesis type 2	disease	C16;C05	Congenital Abnormality	1.00	1	1988	2012	  13	  12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C0265279	Kniest dysplasia	disease	C16;C17;C05;C08;C19;C07	Disease or Syndrome	0.80	1	1989	2017	   9	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C0339546	Retinal Pigment Epithelial Detachment	disease	C11	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	1997	2004	   2	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0410480	Avascular Necrosis of Femur Head	phenotype	C23;C05	Disease or Syndrome	0.65	1	2005	2018	   1	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1280	COL2A1	0.444	0.846	C0410574	Synovial Hypertrophy	disease	C05	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0432214	Namaqualand hip dysplasia	disease	C16;C05	Disease or Syndrome	0.70	1	1990	2012	   5	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C0432221	Spondylometaphyseal dysplasia, 'corner fracture' type	disease	C23;C16;C05;C26	Disease or Syndrome	0.30	1	2007	2007	   1	   0	ORPHANET
     1280	COL2A1	0.444	0.846	C0432272	Van Buchem disease	disease	C16;C05	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0524595	Aseptic Necrosis of Femur Head	phenotype	C23;C05	Pathologic Function	0.30				   0	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0542428	Hypochondrogenesis	disease	C16;C05	Congenital Abnormality	0.66	1	1988	2003	   1	   3	ORPHANET
     1280	COL2A1	0.444	0.846	C0700635	Strudwick syndrome	disease	C16;C05	Disease or Syndrome	0.73	1	1989	2017	   5	   8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C0796173	Spondyloperipheral dysplasia short ulna	disease	C16;C05	Disease or Syndrome	0.75	1	1989	2013	   4	   8	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1280	COL2A1	0.444	0.846	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.40				   0	   0	GENOMICS_ENGLAND
     1280	COL2A1	0.444	0.846	C0971858	Arthritis, Collagen-Induced	disease	C05	Experimental Model of Disease	0.30	1	2005	2018	   9	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0993582	Arthritis, Experimental	disease	C05	Experimental Model of Disease	0.30	1	2005	2018	   9	   0	CTD_human
     1280	COL2A1	0.444	0.846	C1262477	Weight decreased	phenotype	C23	Finding	0.30	1	2015	2018	   2	   0	CTD_human
     1280	COL2A1	0.444	0.846	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C1691779	Sensory hearing loss	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C1835437	Platyspondylic Lethal Skeletal Dysplasia, Torrance Type	disease	C16;C05	Disease or Syndrome	0.73	1	1989	2016	   6	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C1836080	Stickler Syndrome, Type I, Nonsyndromic Ocular	disease	C16;C11	Disease or Syndrome	0.71	1	1989	2018	   8	   9	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1280	COL2A1	0.444	0.846	C1836081	RHEGMATOGENOUS RETINAL DETACHMENT, AUTOSOMAL DOMINANT	disease	C16;C11	Disease or Syndrome	0.41	1	2003	2005	   1	   2	ORPHANET
     1280	COL2A1	0.444	0.846	C1836683	Czech dysplasia, metatarsal type	disease	C16;C05	Congenital Abnormality	0.73	1	1993	2016	   6	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C1837218	Cleft palate, isolated	disease	C16;C05;C07	Congenital Abnormality	0.44	1	2003	2011	   1	   1	CTD_human
     1280	COL2A1	0.444	0.846	C1840452	Hyaloideoretinal degeneration of Wagner	disease	C11	Disease or Syndrome	0.36	1	1993	2003	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C1851536	Epiphyseal Dysplasia, Multiple, with Myopia and Conductive Deafness	disease	C23;C16;C11;C05;C10;C09	Disease or Syndrome	0.70	1	1998	2012	   3	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C1852989	Vitreoretinopathy with Phalangeal Epiphyseal Dysplasia	disease	C16;C11;C05	Disease or Syndrome	0.40	1	2008	2012	   2	   1	GENOMICS_ENGLAND
     1280	COL2A1	0.444	0.846	C1855310	Megaepiphyseal dwarfism	disease	C16;C05;C19	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C1861481	Stickler syndrome, type 3	disease	C17;C05	Disease or Syndrome	0.30	1	2005	2011	   2	   0	ORPHANET
     1280	COL2A1	0.444	0.846	C1866688	Spondylometaphyseal dysplasia, Algerian type	disease	C16;C05	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     1280	COL2A1	0.444	0.846	C2020284	Stickler syndrome, type 1	disease	C23;C11;C17;C05;C10;C09	Disease or Syndrome	0.80	0.968	1987	2019	   6	  23	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C2745959	Spondyloepiphyseal dysplasia, congenita	disease	C16;C05	Congenital Abnormality	1.00	0.981	1989	2020	  12	  14	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C3541456	Spondyloepiphyseal Dysplasia Tarda, X-Linked	disease	C16;C05	Congenital Abnormality	0.31	1	1993	1994	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C4225273	SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	disease		Disease or Syndrome	0.71	1	1991	2016	   5	   5	CLINGEN;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C4302548	Dysspondyloenchondromatosis	disease	C05	Disease or Syndrome	0.32	1	2011	2015	   2	   0	ORPHANET
     1280	COL2A1	0.444	0.846	C4479260	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2	disease		Disease or Syndrome	0.30	1	2005	2005	   1	   0	ORPHANET
     1280	COL2A1	0.444	0.846	C4520892	Otospondylomegaepiphyseal dysplasia	disease	C16;C05;C19	Disease or Syndrome	0.61	1	2005	2012	   2	   1	CTD_human;GENOMICS_ENGLAND
     1280	COL2A1	0.444	0.846	C4551479	Schwartz-Jampel Syndrome, Type 1	disease	C16;C05	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C4551562	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 1	disease	C23;C05	Disease or Syndrome	0.70	1	1989	2012	   4	   6	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1281	COL3A1	0.477	0.808	C0003504	Aortic Valve Insufficiency	disease	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0005398	Cholestasis, Extrahepatic	disease	C06	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2016	2016	   0	   2	UNIPROT
     1281	COL3A1	0.477	0.808	C0013720	Ehlers-Danlos Syndrome	disease	C16;C17;C15;C14	Disease or Syndrome	0.40	1	1986	2020	   0	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0020456	Hyperglycemia	disease	C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0020459	Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.41	1	2001	2017	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.31	1	2010	2017	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.31	1	1989	2008	   5	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0023891	Liver Cirrhosis, Alcoholic	disease	C23;C06;C25	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2002	2014	   2	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.31	1	2001	2008	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0027719	Nephrosclerosis	disease	C13;C12	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.32	1	2013	2018	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.31	1	1995	2014	   1	   0	GENOMICS_ENGLAND
     1281	COL3A1	0.477	0.808	C0041956	Ureteral obstruction	phenotype	C13;C12	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2001	2001	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0162871	Aortic Aneurysm, Abdominal	disease	C14	Disease or Syndrome	0.31	1	1990	2015	   2	   0	ORPHANET
     1281	COL3A1	0.477	0.808	C0238288	Muscular Dystrophy, Facioscapulohumeral	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0238590	Acrogeria	disease	C23;C16;C18;C17	Disease or Syndrome	0.32	1	1996	2004	   1	   0	ORPHANET
     1281	COL3A1	0.477	0.808	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	1989	2006	   5	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0268338	Ehlers-Danlos Syndrome, Type IV	disease	C16;C17;C15;C14	Disease or Syndrome	1.00	1	1980	2019	  43	 390	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1281	COL3A1	0.477	0.808	C0338586	Vertebral Artery Dissection	disease	C10;C14;C26	Disease or Syndrome	0.30	1	1995	1995	   1	   0	GENOMICS_ENGLAND
     1281	COL3A1	0.477	0.808	C0406584	Acrogeria, gottron type	disease	C16;C18	Disease or Syndrome	0.30	1	2000	2000	   1	   0	ORPHANET
     1281	COL3A1	0.477	0.808	C0553692	Brain hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	1995	1995	   1	   0	GENOMICS_ENGLAND
     1281	COL3A1	0.477	0.808	C0553980	Endomyocardial Fibrosis	phenotype	C14	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0948008	Ischemic stroke	disease	C10;C14	Disease or Syndrome	0.30	1	1995	1995	   1	   0	GENOMICS_ENGLAND
     1281	COL3A1	0.477	0.808	C1257963	Endogenous Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C1257964	Exogenous Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C1257965	Compensatory Hyperinsulinemia	disease	C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.31	1	2008	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C1853365	AORTIC ANEURYSM, FAMILIAL ABDOMINAL 1	disease	C14	Disease or Syndrome	0.30	1	1990	1999	   2	   0	ORPHANET
     1281	COL3A1	0.477	0.808	C1855520	Hyperglycemia, Postprandial	phenotype	C18	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C1862932	ANEURYSM, INTRACRANIAL BERRY, 1 (disorder)	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
     1281	COL3A1	0.477	0.808	C2697932	Loeys-Dietz Syndrome	disease	C16;C05;C14	Disease or Syndrome	0.41	1	1990	2016	   2	   1	GENOMICS_ENGLAND
     1281	COL3A1	0.477	0.808	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.60	1	1988	2015	  10	   4	CLINGEN;GENOMICS_ENGLAND
     1281	COL3A1	0.477	0.808	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0002878	Anemia, Hemolytic	disease	C15	Disease or Syndrome	0.42	1	2013	2016	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0002879	Anemia, Hemolytic, Acquired	disease	C15	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0002889	Anemia, Microangiopathic	disease	C15	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0009691	Congenital cataract	disease	C23;C16;C13;C11;C10	Congenital Abnormality	0.32	1	2014	2019	   0	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.31	1	2009	2016	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0015393	Eye Abnormalities	group	C16;C11	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0017667	Nodular glomerulosclerosis	disease	C13;C12;C19	Disease or Syndrome	0.30	1	2009	2016	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0017668	Focal glomerulosclerosis	disease	C13;C12	Disease or Syndrome	0.30	1	2005	2009	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0018965	Hematuria	phenotype	C23;C13;C12	Disease or Syndrome	0.42	1	2007	2010	   3	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0026848	Myopathy	group	C05;C10	Disease or Syndrome	0.37	1	2007	2020	   1	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0027726	Nephrotic Syndrome	group	C13;C12	Disease or Syndrome	0.31	1	1992	2019	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.40	1	2007	2007	   1	   1	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.50	1	2006	2020	   1	   1	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0086432	Hyalinosis, Segmental Glomerular	disease	C13;C12	Disease or Syndrome	0.30	1	2005	2009	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0149931	Migraine Disorders	group	C10	Disease or Syndrome	0.40	1	2007	2007	   1	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0221021	Microangiopathic hemolytic anemia	disease	C15	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0265221	Walker-Warburg congenital muscular dystrophy	disease	C16;C11;C10	Disease or Syndrome	0.52	1	2011	2015	   1	   0	ORPHANET
     1282	COL4A1	0.484	0.731	C0265341	Rieger syndrome	disease	C16;C11	Disease or Syndrome	0.30	1	2007	2010	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0266484	Schizencephaly	disease	C16;C10	Congenital Abnormality	0.75	1	2013	2019	   2	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1282	COL4A1	0.484	0.731	C0266548	Axenfeld anomaly (disorder)	disease	C16;C11	Congenital Abnormality	0.51	1	2007	2010	   3	   0	CTD_human;GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0270612	Leukoencephalopathy	group	C10	Disease or Syndrome	0.48	0.889	2007	2019	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0302892	Congenital porencephaly	disease	C16;C05;C10	Congenital Abnormality	0.60	1	1977	2020	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0338656	Impaired cognition	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0424605	Developmental delay (disorder)	phenotype	F03	Mental or Behavioral Dysfunction	0.32	1	2007	2017	   1	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0497327	Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.31	1	2007	2016	   1	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.42	1	2007	2017	   1	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C1135196	Heart Failure, Diastolic	disease	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C1280768	Axenfeld syndrome	disease	C16;C11	Disease or Syndrome	0.30	1	2007	2010	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C1843512	BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE	disease		Disease or Syndrome	0.82	1	2005	2013	   4	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1282	COL4A1	0.484	0.731	C1858991	Childhood Ataxia with Central Nervous System Hypomyelinization	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C1860475	Retinal vascular tortuosity	phenotype		Finding	0.40	1	2007	2010	   3	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C1867327	RETINAL ARTERIES, TORTUOSITY OF	phenotype		Finding	0.70	1	2014	2014	   1	   1	CTD_human;ORPHANET;UNIPROT
     1282	COL4A1	0.484	0.731	C1867983	PORENCEPHALY, FAMILIAL	disease	C16;C05;C10	Disease or Syndrome	0.83	1	1977	2016	   2	   1	CTD_human;ORPHANET
     1282	COL4A1	0.484	0.731	C2673195	Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps	disease	C23;C05;C10;C14	Disease or Syndrome	0.77	0.909	2007	2019	   6	  17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1282	COL4A1	0.484	0.731	C2675650	Brain Small Vessel Disease With Axenfeld-Rieger Anomaly	disease		Disease or Syndrome	0.30	1	2006	2007	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C2678503	AXENFELD-RIEGER SYNDROME, TYPE 3	disease	C16;C11	Disease or Syndrome	0.30	1	2007	2010	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C2733158	Cerebral Small Vessel Diseases	group	C10;C14	Disease or Syndrome	0.40	1	2007	2020	   1	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C2930808	Familial vascular leukoencephalopathy	disease	C23;C16;C10;C14	Disease or Syndrome	0.50	1	2005	2013	   1	   0	ORPHANET
     1282	COL4A1	0.484	0.731	C2931870	Familial schizencephaly	disease	C16;C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	ORPHANET
     1282	COL4A1	0.484	0.731	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.40				   0	   0	CTD_human
     1282	COL4A1	0.484	0.731	C3281105	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO	disease		Finding	0.60	1	2007	2012	   2	   2	GENOMICS_ENGLAND;UNIPROT
     1282	COL4A1	0.484	0.731	C3495488	Axenfeld-Rieger syndrome	disease	C16;C11	Disease or Syndrome	0.30	1	2007	2010	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C3698507	Post-traumatic Porencephaly	phenotype	C16;C05;C10	Acquired Abnormality	0.50	1	1977	2013	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C3714873	Axenfeld-Rieger Syndrome, Type 1	disease	C16;C11	Disease or Syndrome	0.30	1	2007	2010	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C4013035	BRAIN SMALL VESSEL DISEASE WITH OR WITHOUT OCULAR ANOMALIES	disease		Disease or Syndrome	0.40	1	2006	2018	   1	   2	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C4082173	Porencephaly	disease	C16;C05;C10	Disease or Syndrome	0.40	1	1977	2020	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C4082301	Developmental Porencephaly	disease	C16;C05;C10	Congenital Abnormality	0.30	1	1977	2013	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C4551998	Porencephaly, Type 1, Autosomal Dominant	disease	C16;C05;C10	Disease or Syndrome	0.90	1	1977	2018	  18	  15	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1282	COL4A1	0.484	0.731	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1284	COL4A2	0.563	0.654	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1284	COL4A2	0.563	0.654	C0027726	Nephrotic Syndrome	group	C13;C12	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
     1284	COL4A2	0.563	0.654	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1284	COL4A2	0.563	0.654	C0302892	Congenital porencephaly	disease	C16;C05;C10	Congenital Abnormality	0.36	0.833	2012	2016	   0	   0	CTD_human
     1284	COL4A2	0.563	0.654	C1867983	PORENCEPHALY, FAMILIAL	disease	C16;C05;C10	Disease or Syndrome	0.51	1	2012	2012	   0	   0	CTD_human;ORPHANET
     1284	COL4A2	0.563	0.654	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30				   0	   0	CTD_human
     1284	COL4A2	0.563	0.654	C3280970	PORENCEPHALY 2	disease		Disease or Syndrome	0.60	1	2012	2018	   4	   4	GENOMICS_ENGLAND;UNIPROT
     1284	COL4A2	0.563	0.654	C3281105	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO	disease		Finding	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
     1284	COL4A2	0.563	0.654	C3698507	Post-traumatic Porencephaly	phenotype	C16;C05;C10	Acquired Abnormality	0.30				   0	   0	CTD_human
     1284	COL4A2	0.563	0.654	C4082173	Porencephaly	disease	C16;C05;C10	Disease or Syndrome	0.56	0.857	2012	2016	   1	   0	CTD_human;GENOMICS_ENGLAND
     1284	COL4A2	0.563	0.654	C4082301	Developmental Porencephaly	disease	C16;C05;C10	Congenital Abnormality	0.30				   0	   0	CTD_human
     1284	COL4A2	0.563	0.654	C4551998	Porencephaly, Type 1, Autosomal Dominant	disease	C16;C05;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1285	COL4A3	0.552	0.692	C0027706	Hereditary nephritis	disease	C16;C13;C17;C12	Disease or Syndrome	0.39	1	1989	2018	   1	   0	CTD_human
     1285	COL4A3	0.552	0.692	C0241908	Hematuria, Benign Familial	disease	C23;C13;C12	Disease or Syndrome	0.80	1	1996	2019	   3	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1285	COL4A3	0.552	0.692	C0268731	Renal glomerular disease	group	C23;C13;C12	Disease or Syndrome	0.32	1	2007	2017	   0	   0	GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C0403440	Thin basement membrane disease	disease	C23;C13;C12	Disease or Syndrome	0.60	1	2001	2018	   0	   0	CTD_human;GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C0848548	hypertensive nephropathy	disease	C13;C12;C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C1567741	Alport Syndrome	disease	C16;C13;C17;C12	Disease or Syndrome	0.70	0.982	1986	2020	   2	   0	CTD_human;GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C1567742	Alport Syndrome, X-Linked	disease	C16;C13;C17;C12	Disease or Syndrome	0.60	1	1994	2019	   2	   0	CTD_human;GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C1567743	Alport Syndrome, Autosomal Dominant	disease	C16;C13;C17;C12	Disease or Syndrome	0.53	1	1997	2019	   2	   0	CTD_human;GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C1567744	Alport Syndrome, Autosomal Recessive	disease	C16;C13;C17;C12	Disease or Syndrome	0.80	1	1994	2017	   2	   0	CTD_human;GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C1868672	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	disease	C13;C12	Disease or Syndrome	0.30	1	2015	2015	   1	   0	ORPHANET
     1285	COL4A3	0.552	0.692	C2931253	Alport syndrome, dominant type	disease	C16;C13;C17;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
     1285	COL4A3	0.552	0.692	C2931254	Alport syndrome, recessive type	disease	C16;C13;C17;C12	Disease or Syndrome	0.50	1	1996	2014	   0	   0	CTD_human
     1285	COL4A3	0.552	0.692	C2931861	Hemorrhagic hereditary nephritis	disease	C16;C13;C17;C12	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1285	COL4A3	0.552	0.692	C4521256	Glomerulopathy Assessment	phenotype		Diagnostic Procedure	0.30				   0	   0	GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C4746547	ALPORT SYNDROME 3, AUTOSOMAL DOMINANT	disease		Disease or Syndrome	0.60	1	1997	2019	   5	   0	GENOMICS_ENGLAND;UNIPROT
     1285	COL4A3	0.552	0.692	C4746745	ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.80	1	1994	2017	   5	   3	GENOMICS_ENGLAND;UNIPROT
     1286	COL4A4	0.644	0.5	C0241908	Hematuria, Benign Familial	disease	C23;C13;C12	Disease or Syndrome	0.80	1	1982	2018	   4	   9	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1286	COL4A4	0.644	0.5	C0268731	Renal glomerular disease	group	C23;C13;C12	Disease or Syndrome	0.31	1	2011	2011	   0	   0	GENOMICS_ENGLAND
     1286	COL4A4	0.644	0.5	C0403440	Thin basement membrane disease	disease	C23;C13;C12	Disease or Syndrome	0.60	1	2001	2019	   0	   0	CTD_human;GENOMICS_ENGLAND
     1286	COL4A4	0.644	0.5	C0848548	hypertensive nephropathy	disease	C13;C12;C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1286	COL4A4	0.644	0.5	C1567741	Alport Syndrome	disease	C16;C13;C17;C12	Disease or Syndrome	0.40	1	1995	2020	   1	   0	GENOMICS_ENGLAND
     1286	COL4A4	0.644	0.5	C1567742	Alport Syndrome, X-Linked	disease	C16;C13;C17;C12	Disease or Syndrome	0.40	1	2001	2019	   1	   0	GENOMICS_ENGLAND
     1286	COL4A4	0.644	0.5	C1567743	Alport Syndrome, Autosomal Dominant	disease	C16;C13;C17;C12	Disease or Syndrome	0.53	1	1997	2018	   5	   0	GENOMICS_ENGLAND;ORPHANET
     1286	COL4A4	0.644	0.5	C1567744	Alport Syndrome, Autosomal Recessive	disease	C16;C13;C17;C12	Disease or Syndrome	0.60	1	1997	2019	   1	   0	GENOMICS_ENGLAND
     1286	COL4A4	0.644	0.5	C2931253	Alport syndrome, dominant type	disease	C16;C13;C17;C12	Disease or Syndrome	0.30	1	1997	2009	   4	   0	ORPHANET
     1286	COL4A4	0.644	0.5	C2931254	Alport syndrome, recessive type	disease	C16;C13;C17;C12	Disease or Syndrome	0.50	1	2011	2014	   0	   0	CTD_human
     1286	COL4A4	0.644	0.5	C4521256	Glomerulopathy Assessment	phenotype		Diagnostic Procedure	0.30				   0	   0	GENOMICS_ENGLAND
     1286	COL4A4	0.644	0.5	C4746745	ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.80	1	1994	2017	   4	  62	GENOMICS_ENGLAND;UNIPROT
     1287	COL4A5	0.553	0.654	C0017668	Focal glomerulosclerosis	disease	C13;C12	Disease or Syndrome	0.31	1	2017	2019	   1	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C0018965	Hematuria	phenotype	C23;C13;C12	Disease or Syndrome	0.48	1	2001	2019	   1	   3	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.40	1	2017	2017	   1	   4	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C0086533	Leiomyoma, Epithelioid	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1287	COL4A5	0.553	0.654	C0241908	Hematuria, Benign Familial	disease	C23;C13;C12	Disease or Syndrome	0.34	1	2003	2014	   1	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C0268731	Renal glomerular disease	group	C23;C13;C12	Disease or Syndrome	0.44	1	2011	2018	   0	   1	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.41	1	1995	1997	   1	   1	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C1567741	Alport Syndrome	disease	C16;C13;C17;C12	Disease or Syndrome	0.70	0.977	1990	2020	  12	 307	CLINGEN;GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C1567742	Alport Syndrome, X-Linked	disease	C16;C13;C17;C12	Disease or Syndrome	0.60	0.96	1992	2020	   1	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C1567743	Alport Syndrome, Autosomal Dominant	disease	C16;C13;C17;C12	Disease or Syndrome	0.30	1	2003	2003	   1	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C1567744	Alport Syndrome, Autosomal Recessive	disease	C16;C13;C17;C12	Disease or Syndrome	0.31	1	2003	2005	   1	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C1839884	Leiomyomatosis, esophageal and vulval, with nephropathy	disease	C16;C04;C13;C17;C12	Disease or Syndrome	0.32	1	1992	2013	   1	   0	ORPHANET
     1287	COL4A5	0.553	0.654	C4049702	Focal Segmental Glomerulosclerosis, Not Otherwise Specified	disease	C13;C12	Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C4521256	Glomerulopathy Assessment	phenotype		Diagnostic Procedure	0.30				   0	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C4746986	ALPORT SYNDROME 1, X-LINKED	disease		Disease or Syndrome	0.90	1	1991	2017	  24	 450	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1288	COL4A6	0.686	0.423	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1288	COL4A6	0.686	0.423	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1288	COL4A6	0.686	0.423	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     1288	COL4A6	0.686	0.423	C0086533	Leiomyoma, Epithelioid	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1288	COL4A6	0.686	0.423	C1839884	Leiomyomatosis, esophageal and vulval, with nephropathy	disease	C16;C04;C13;C17;C12	Disease or Syndrome	0.51	1	1998	2013	   2	   0	GENOMICS_ENGLAND;ORPHANET
     1288	COL4A6	0.686	0.423	C3806737	DEAFNESS, X-LINKED 6	disease		Disease or Syndrome	0.70	1	1998	2015	   3	   1	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1288	COL4A6	0.686	0.423	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1288	COL4A6	0.686	0.423	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0005779	Blood Coagulation Disorders	group	C15	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1289	COL5A1	0.536	0.769	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0220679	Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified	disease	C16;C17;C15;C14	Disease or Syndrome	0.30	1	2005	2012	   2	   0	ORPHANET
     1289	COL5A1	0.536	0.769	C0268335	Ehlers-Danlos syndrome type 1	disease	C16;C17;C15;C14	Disease or Syndrome	0.73	1	1996	2010	   3	   0	CTD_human;GENOMICS_ENGLAND
     1289	COL5A1	0.536	0.769	C0268336	Ehlers-Danlos syndrome type 2	disease	C16;C17;C15;C14	Disease or Syndrome	0.53	1	1995	1998	   2	   0	CTD_human;GENOMICS_ENGLAND
     1289	COL5A1	0.536	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C1458140	Bleeding tendency	phenotype	C15	Pathologic Function	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1289	COL5A1	0.536	0.769	C1846545	Autoimmune Lymphoproliferative Syndrome Type 2B	disease	C16;C20;C15	Disease or Syndrome	0.30	1	1997	1997	   1	   0	GENOMICS_ENGLAND
     1289	COL5A1	0.536	0.769	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C4225429	Ehlers-Danlos syndrome classic type	disease	C16;C17;C15;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1289	COL5A1	0.536	0.769	C4552122	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1	disease		Disease or Syndrome	0.60	1	1993	2018	   7	  38	GENOMICS_ENGLAND;UNIPROT
     1289	COL5A1	0.536	0.769	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.40				   0	   1	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1290	COL5A2	0.568	0.731	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1290	COL5A2	0.568	0.731	C0005779	Blood Coagulation Disorders	group	C15	Disease or Syndrome	0.30	1	1998	1998	   1	   0	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1290	COL5A2	0.568	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1290	COL5A2	0.568	0.731	C0220679	Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified	disease	C16;C17;C15;C14	Disease or Syndrome	0.30	1	2005	2012	   2	   0	ORPHANET
     1290	COL5A2	0.568	0.731	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1290	COL5A2	0.568	0.731	C0268335	Ehlers-Danlos syndrome type 1	disease	C16;C17;C15;C14	Disease or Syndrome	0.50	1	1998	2015	   1	   0	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C0268336	Ehlers-Danlos syndrome type 2	disease	C16;C17;C15;C14	Disease or Syndrome	0.31	1	1998	1998	   1	   0	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C1458140	Bleeding tendency	phenotype	C15	Pathologic Function	0.30	1	1998	1998	   1	   0	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C1846545	Autoimmune Lymphoproliferative Syndrome Type 2B	disease	C16;C20;C15	Disease or Syndrome	0.30	1	1998	1998	   1	   0	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C3151201	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	disease		Disease or Syndrome	0.30	1	2017	2018	   2	   0	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1290	COL5A2	0.568	0.731	C4225429	Ehlers-Danlos syndrome classic type	disease	C16;C17;C15;C14	Disease or Syndrome	0.30	1	1998	1998	   1	   0	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C4538407	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2	disease		Disease or Syndrome	0.60	1	1993	2016	   4	  11	GENOMICS_ENGLAND;UNIPROT
     1290	COL5A2	0.568	0.731	C4552122	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1	disease		Disease or Syndrome	0.40	1	1998	2018	   3	   3	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1290	COL5A2	0.568	0.731	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.40				   0	   2	GENOMICS_ENGLAND
     1291	COL6A1	0.587	0.731	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C0026850	Muscular Dystrophy	disease	C16;C05;C10	Disease or Syndrome	0.48	1	2002	2019	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C0410179	Ullrich congenital muscular dystrophy 1	disease	C23;C16;C05;C10	Disease or Syndrome	0.80	0.96	2003	2018	   6	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1291	COL6A1	0.587	0.731	C1135196	Heart Failure, Diastolic	disease	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C1834674	BETHLEM MYOPATHY 1	disease	C16;C05;C10	Disease or Syndrome	1.00	1	1993	2019	   7	  33	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1291	COL6A1	0.587	0.731	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1292	COL6A2	0.599	0.692	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	1995	2014	   1	   0	CTD_human
     1292	COL6A2	0.599	0.692	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1292	COL6A2	0.599	0.692	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1292	COL6A2	0.599	0.692	C0410179	Ullrich congenital muscular dystrophy 1	disease	C23;C16;C05;C10	Disease or Syndrome	0.80	1	2001	2017	   5	  12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1292	COL6A2	0.599	0.692	C1611706	Myosclerosis	disease	C16	Disease or Syndrome	0.31	1	2008	2008	   1	   0	ORPHANET
     1292	COL6A2	0.599	0.692	C1834674	BETHLEM MYOPATHY 1	disease	C16;C05;C10	Disease or Syndrome	0.79	1	1993	2016	   5	  36	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1292	COL6A2	0.599	0.692	C1850671	Myosclerosis, Autosomal Recessive	disease	C05;C10	Disease or Syndrome	0.61	1	2001	2014	   1	   3	CTD_human;GENOMICS_ENGLAND
     1293	COL6A3	0.563	0.769	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1293	COL6A3	0.563	0.769	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1293	COL6A3	0.563	0.769	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.34	1	2016	2018	   0	   0	CTD_human
     1293	COL6A3	0.563	0.769	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     1293	COL6A3	0.563	0.769	C0393588	Dystonia, Paroxysmal	phenotype	C23;C10	Sign or Symptom	0.30				   0	   0	CTD_human
     1293	COL6A3	0.563	0.769	C0393610	Dystonia, Diurnal	phenotype	C23;C10	Sign or Symptom	0.30				   0	   0	CTD_human
     1293	COL6A3	0.563	0.769	C0410179	Ullrich congenital muscular dystrophy 1	disease	C23;C16;C05;C10	Disease or Syndrome	1.00	1	2002	2018	   4	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1293	COL6A3	0.563	0.769	C0751093	Dystonia, Limb	phenotype	C23;C10	Sign or Symptom	0.40				   0	   0	CTD_human
     1293	COL6A3	0.563	0.769	C1834674	BETHLEM MYOPATHY 1	disease	C16;C05;C10	Disease or Syndrome	0.80	1	1993	2018	   5	  37	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1293	COL6A3	0.563	0.769	C2930471	Bilateral Wilms Tumor	disease	C16;C04;C13;C12	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     1293	COL6A3	0.563	0.769	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1293	COL6A3	0.563	0.769	C4225336	DYSTONIA 27	disease		Disease or Syndrome	0.72	1	2002	2018	   2	   7	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1293	COL6A3	0.563	0.769	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.50	1	2008	2008	   1	   1	CTD_human;UNIPROT
     1294	COL7A1	0.545	0.808	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C0079136	Cockayne-Touraine Disease	disease	C16;C17	Disease or Syndrome	0.40	0.957	1991	2017	   0	   0	CTD_human
     1294	COL7A1	0.545	0.808	C0079294	Epidermolysis Bullosa Dystrophica	disease	C16;C17	Disease or Syndrome	0.90	1	1992	2019	   2	   9	CTD_human;GENOMICS_ENGLAND
     1294	COL7A1	0.545	0.808	C0079474	Hallopeau-Siemens Disease	disease	C16;C17	Disease or Syndrome	1.00	0.983	1993	2020	  16	  51	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1294	COL7A1	0.545	0.808	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2018	2018	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C0268371	Epidermolysis Bullosa With Congenital Localized Absence Of Skin And Deformity Of Nails	disease	C16;C17	Congenital Abnormality	0.60	1	2002	2013	   2	  10	CTD_human;GENOMICS_ENGLAND
     1294	COL7A1	0.545	0.808	C0432321	Epidermolysis bullosa, pretibial	disease	C16;C17	Congenital Abnormality	0.75	1	1995	2018	   3	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1294	COL7A1	0.545	0.808	C0432322	Dominant dystrophic epidermolysis bullosa, albopapular type (disorder)	disease	C16;C17	Congenital Abnormality	0.78	1	1989	2017	  18	  24	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1294	COL7A1	0.545	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C1275114	Epidermolysis Bullosa Pruriginosa	disease	C16;C17	Disease or Syndrome	0.80	0.933	1999	2018	   2	  10	CTD_human;ORPHANET;UNIPROT
     1294	COL7A1	0.545	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C1843477	Epidermolysis Bullosa Simplex Superficialis	disease	C16;C17	Disease or Syndrome	0.30	1	2002	2002	   1	   0	ORPHANET
     1294	COL7A1	0.545	0.808	C1843761	TOENAIL DYSTROPHY, ISOLATED	disease	C23;C17	Disease or Syndrome	0.60	1	2002	2002	   1	  13	CTD_human;UNIPROT
     1294	COL7A1	0.545	0.808	C1851573	Transient bullous dermolysis of the newborn	disease	C16;C17	Disease or Syndrome	0.73	1	1997	2013	   3	  13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1294	COL7A1	0.545	0.808	C2673611	Epidermolysis Bullosa Dystrophica, Autosomal Recessive, Localisata Variant	disease	C16;C17	Disease or Syndrome	0.60	1	1999	2009	   0	   1	ORPHANET
     1294	COL7A1	0.545	0.808	C2673612	Epidermolysis Bullosa Dystrophica Inversa, Autosomal Recessive	disease	C16;C17	Disease or Syndrome	0.60	1	1999	2009	   0	   4	ORPHANET
     1294	COL7A1	0.545	0.808	C4511056	Centripetalis recessive dystrophic epidermolysis bullosa	disease	C16;C17	Disease or Syndrome	0.30				   0	   0	ORPHANET
     1294	COL7A1	0.545	0.808	C4518087	Acral dystrophic epidermolysis bullosa	disease		Disease or Syndrome	0.30				   0	   0	ORPHANET
     1294	COL7A1	0.545	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1295	COL8A1	0.678	0.538	C0000768	Congenital Abnormality	group	C16	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     1295	COL8A1	0.678	0.538	C1135196	Heart Failure, Diastolic	disease	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1296	COL8A2	0.67	0.423	C0016781	Fuchs Endothelial Dystrophy	disease	C16;C11	Disease or Syndrome	0.60	0.938	2004	2018	   1	   0	ORPHANET
     1296	COL8A2	0.67	0.423	C0339284	Polymorphous corneal dystrophy	disease	C16;C11	Disease or Syndrome	0.34	1	2001	2019	   1	   0	ORPHANET
     1296	COL8A2	0.67	0.423	C1850959	Corneal dystrophy, Fuchs' endothelial, 1	disease	C16;C11	Disease or Syndrome	0.72	1	2001	2019	   2	   7	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1296	COL8A2	0.67	0.423	C1852795	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2	disease	C16;C11	Disease or Syndrome	0.70	1	2001	2001	   1	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1297	COL9A1	0.566	0.731	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.40	1	2011	2011	   1	   0	GENOMICS_ENGLAND
     1297	COL9A1	0.566	0.731	C0013366	Dyschondroplasias	group	C16;C05	Congenital Abnormality	0.30	1	2001	2006	   2	   0	CTD_human
     1297	COL9A1	0.566	0.731	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1297	COL9A1	0.566	0.731	C0018784	Sensorineural Hearing Loss (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.40	1	2006	2006	   1	   0	CTD_human
     1297	COL9A1	0.566	0.731	C0025237	Melnick-Needles Syndrome	disease	C16;C05	Disease or Syndrome	0.30	1	2001	2006	   2	   0	CTD_human
     1297	COL9A1	0.566	0.731	C0026760	Multiple Epiphyseal Dysplasia	disease	C16;C05	Congenital Abnormality	0.70	1	2001	2019	   3	   0	CTD_human;GENOMICS_ENGLAND
     1297	COL9A1	0.566	0.731	C0027092	Myopia	disease	C11	Disease or Syndrome	0.40	1	2006	2006	   1	   0	CTD_human
     1297	COL9A1	0.566	0.731	C0029422	Osteochondrodysplasias	group	C16;C05	Disease or Syndrome	0.31	1	2001	2006	   2	   0	CTD_human
     1297	COL9A1	0.566	0.731	C0035309	Retinal Diseases	group	C11	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1297	COL9A1	0.566	0.731	C0036391	Schwartz-Jampel Syndrome	disease	C16;C05	Disease or Syndrome	0.30	1	2001	2006	   2	   0	CTD_human
     1297	COL9A1	0.566	0.731	C0038015	Spondyloepiphyseal Dysplasia	disease	C16;C05	Disease or Syndrome	0.30	1	2001	2006	   2	   0	CTD_human
     1297	COL9A1	0.566	0.731	C0265253	Stickler syndrome (disorder)	disease	C23;C16;C11;C05	Disease or Syndrome	0.35	1	2005	2019	   4	   0	CLINGEN
     1297	COL9A1	0.566	0.731	C0432272	Van Buchem disease	disease	C16;C05	Disease or Syndrome	0.30	1	2001	2006	   2	   0	CTD_human
     1297	COL9A1	0.566	0.731	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
     1297	COL9A1	0.566	0.731	C1691779	Sensory hearing loss	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1297	COL9A1	0.566	0.731	C2675767	EPIPHYSEAL DYSPLASIA, MULTIPLE, 6	disease		Disease or Syndrome	0.50	1	2001	2006	   2	   0	CTD_human;GENOMICS_ENGLAND
     1297	COL9A1	0.566	0.731	C3279941	STICKLER SYNDROME, TYPE IV	disease		Disease or Syndrome	0.60	1	2001	2006	   2	   2	CTD_human;GENOMICS_ENGLAND
     1297	COL9A1	0.566	0.731	C3541456	Spondyloepiphyseal Dysplasia Tarda, X-Linked	disease	C16;C05	Congenital Abnormality	0.30	1	2001	2006	   2	   0	CTD_human
     1297	COL9A1	0.566	0.731	C4551479	Schwartz-Jampel Syndrome, Type 1	disease	C16;C05	Disease or Syndrome	0.30	1	2001	2006	   2	   0	CTD_human
     1297	COL9A1	0.566	0.731	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1298	COL9A2	0.572	0.769	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1298	COL9A2	0.572	0.769	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1298	COL9A2	0.572	0.769	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.40	1	2011	2011	   1	   0	GENOMICS_ENGLAND
     1298	COL9A2	0.572	0.769	C0009782	Connective Tissue Diseases	group	C17	Disease or Syndrome	0.31	1	2002	2011	   1	   0	GENOMICS_ENGLAND
     1298	COL9A2	0.572	0.769	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1298	COL9A2	0.572	0.769	C0026760	Multiple Epiphyseal Dysplasia	disease	C16;C05	Congenital Abnormality	0.40	1	1998	2010	   1	   0	GENOMICS_ENGLAND
     1298	COL9A2	0.572	0.769	C0158252	Intervertebral disc disorder	group	C23;C05	Disease or Syndrome	0.55	1	1999	2016	   3	   1	GENOMICS_ENGLAND;UNIPROT
     1298	COL9A2	0.572	0.769	C0265253	Stickler syndrome (disorder)	disease	C23;C16;C11;C05	Disease or Syndrome	0.42	1	2005	2017	   9	   1	CLINGEN
     1298	COL9A2	0.572	0.769	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
     1298	COL9A2	0.572	0.769	C1838429	Epiphyseal dysplasia, multiple, 2	disease	C16;C05	Disease or Syndrome	0.50	1	2002	2011	   3	   0	CTD_human;GENOMICS_ENGLAND
     1298	COL9A2	0.572	0.769	C2020284	Stickler syndrome, type 1	disease	C23;C11;C17;C05;C10;C09	Disease or Syndrome	0.32	1	2011	2013	   1	   0	GENOMICS_ENGLAND
     1298	COL9A2	0.572	0.769	C3280342	STICKLER SYNDROME, TYPE V	disease		Disease or Syndrome	0.60	1	2002	2011	   3	   1	CTD_human;GENOMICS_ENGLAND
     1298	COL9A2	0.572	0.769	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1298	COL9A2	0.572	0.769	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1298	COL9A2	0.572	0.769	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1299	COL9A3	0.569	0.769	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.40				   0	   0	GENOMICS_ENGLAND
     1299	COL9A3	0.569	0.769	C0009782	Connective Tissue Diseases	group	C17	Disease or Syndrome	0.30	1	2005	2005	   1	   0	GENOMICS_ENGLAND
     1299	COL9A3	0.569	0.769	C0026760	Multiple Epiphyseal Dysplasia	disease	C16;C05	Congenital Abnormality	0.40	0.929	1999	2014	   1	   0	GENOMICS_ENGLAND
     1299	COL9A3	0.569	0.769	C0158252	Intervertebral disc disorder	group	C23;C05	Disease or Syndrome	0.55	0.8	2004	2018	   0	   0	CTD_human;GENOMICS_ENGLAND
     1299	COL9A3	0.569	0.769	C0221775	Lumbar disc disease	disease	C23;C05	Disease or Syndrome	0.33	0.667	2006	2018	   0	   0	CTD_human
     1299	COL9A3	0.569	0.769	C0265253	Stickler syndrome (disorder)	disease	C23;C16;C11;C05	Disease or Syndrome	0.33	1	2005	2019	   6	   0	CLINGEN
     1299	COL9A3	0.569	0.769	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
     1299	COL9A3	0.569	0.769	C1832998	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3	disease	C16;C05	Disease or Syndrome	0.70	1	1999	2014	   5	   6	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1299	COL9A3	0.569	0.769	C2020284	Stickler syndrome, type 1	disease	C23;C11;C17;C05;C10;C09	Disease or Syndrome	0.33	1	2014	2019	   1	   0	GENOMICS_ENGLAND
     1299	COL9A3	0.569	0.769	C3501899	Epiphyseal Dysplasia, Multiple, with Myopathy	disease	C16;C05;C10	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1300	COL10A1	0.619	0.5	C0265289	Metaphyseal chondrodysplasia Schmid type	disease	C16;C05	Disease or Syndrome	0.95	1	1994	2019	  10	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1300	COL10A1	0.619	0.5	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
     1301	COL11A1	0.495	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.31	1	2015	2015	   0	   1	UNIPROT
     1301	COL11A1	0.495	0.846	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.41	1	2003	2003	   0	   0	GENOMICS_ENGLAND
     1301	COL11A1	0.495	0.846	C0010093	Corpus Luteum Cyst	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1301	COL11A1	0.495	0.846	C0013366	Dyschondroplasias	group	C16;C05	Congenital Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
     1301	COL11A1	0.495	0.846	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1301	COL11A1	0.495	0.846	C0017605	Angle Closure Glaucoma	disease	C11	Disease or Syndrome	0.40	1	2012	2019	   2	   0	CTD_human
     1301	COL11A1	0.495	0.846	C0021818	Intervertebral Disk Displacement	disease	C23;C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1301	COL11A1	0.495	0.846	C0025237	Melnick-Needles Syndrome	disease	C16;C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1301	COL11A1	0.495	0.846	C0026760	Multiple Epiphyseal Dysplasia	disease	C16;C05	Congenital Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
     1301	COL11A1	0.495	0.846	C0029410	Osteoarthritis of hip	disease	C05	Disease or Syndrome	0.44	1	2014	2019	   1	   3	CTD_human
     1301	COL11A1	0.495	0.846	C0029422	Osteochondrodysplasias	group	C16;C05	Disease or Syndrome	0.31	1	2009	2014	   1	   0	CTD_human
     1301	COL11A1	0.495	0.846	C0029927	Ovarian Cysts	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1301	COL11A1	0.495	0.846	C0036391	Schwartz-Jampel Syndrome	disease	C16;C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1301	COL11A1	0.495	0.846	C0038015	Spondyloepiphyseal Dysplasia	disease	C16;C05	Disease or Syndrome	0.40	1	2009	2009	   1	   0	CTD_human
     1301	COL11A1	0.495	0.846	C0158252	Intervertebral disc disorder	group	C23;C05	Disease or Syndrome	0.51	1	1996	2014	   1	   0	CTD_human;GENOMICS_ENGLAND
     1301	COL11A1	0.495	0.846	C0221775	Lumbar disc disease	disease	C23;C05	Disease or Syndrome	0.31	1	2018	2018	   0	   0	CTD_human
     1301	COL11A1	0.495	0.846	C0265235	Marshall syndrome	disease	C23;C16;C11;C05;C10;C09	Disease or Syndrome	0.73	1	1996	2014	   3	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1301	COL11A1	0.495	0.846	C0265282	Fibrochondrogenesis	disease	C23;C16;C05;C19	Congenital Abnormality	0.63	1	2010	2013	   1	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1301	COL11A1	0.495	0.846	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
     1301	COL11A1	0.495	0.846	C0432272	Van Buchem disease	disease	C16;C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1301	COL11A1	0.495	0.846	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30	1	2007	2007	   1	   0	GENOMICS_ENGLAND
     1301	COL11A1	0.495	0.846	C1849792	Achromatopsia 3	disease	C23;C11;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
     1301	COL11A1	0.495	0.846	C1858084	STICKLER SYNDROME, TYPE II (disorder)	disease	C11;C17	Disease or Syndrome	0.98	1	1971	2020	   4	   9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1301	COL11A1	0.495	0.846	C2020284	Stickler syndrome, type 1	disease	C23;C11;C17;C05;C10;C09	Disease or Syndrome	0.60	1	1971	2017	   0	   0	GENOMICS_ENGLAND
     1301	COL11A1	0.495	0.846	C3151066	RETINITIS PIGMENTOSA 45	disease		Disease or Syndrome	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
     1301	COL11A1	0.495	0.846	C3278138	FIBROCHONDROGENESIS 1	disease		Disease or Syndrome	0.60	1	1996	2010	   2	   4	GENOMICS_ENGLAND;UNIPROT
     1301	COL11A1	0.495	0.846	C3541456	Spondyloepiphyseal Dysplasia Tarda, X-Linked	disease	C16;C05	Congenital Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
     1301	COL11A1	0.495	0.846	C4551479	Schwartz-Jampel Syndrome, Type 1	disease	C16;C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1301	COL11A1	0.495	0.846	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1302	COL11A2	0.435	0.846	C0007302	Cartilage Diseases	group	C17;C05	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1302	COL11A2	0.435	0.846	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.42	1	2003	2010	   0	   0	GENOMICS_ENGLAND
     1302	COL11A2	0.435	0.846	C0009782	Connective Tissue Diseases	group	C17	Disease or Syndrome	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
     1302	COL11A2	0.435	0.846	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1302	COL11A2	0.435	0.846	C0018784	Sensorineural Hearing Loss (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.41	1	2006	2007	   1	   1	CTD_human
     1302	COL11A2	0.435	0.846	C0085700	Chondromalacia	disease	C17;C05	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1302	COL11A2	0.435	0.846	C0206762	Limb Deformities, Congenital	group	C16;C05	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
     1302	COL11A2	0.435	0.846	C0265282	Fibrochondrogenesis	disease	C23;C16;C05;C19	Congenital Abnormality	0.51	1	2012	2012	   1	   0	CTD_human;ORPHANET
     1302	COL11A2	0.435	0.846	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
     1302	COL11A2	0.435	0.846	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30	1	2004	2004	   1	   0	GENOMICS_ENGLAND
     1302	COL11A2	0.435	0.846	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.32	1	1998	2012	   1	   0	GENOMICS_ENGLAND
     1302	COL11A2	0.435	0.846	C1691779	Sensory hearing loss	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1302	COL11A2	0.435	0.846	C1848488	Pierre Robin syndrome with fetal chondrodysplasia	disease	C16;C05;C07	Disease or Syndrome	0.82	1	1964	2015	  17	   1	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1302	COL11A2	0.435	0.846	C1855310	Megaepiphyseal dwarfism	disease	C16;C05;C19	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1302	COL11A2	0.435	0.846	C1861481	Stickler syndrome, type 3	disease	C17;C05	Disease or Syndrome	0.60	1	2004	2004	   1	   4	GENOMICS_ENGLAND;ORPHANET
     1302	COL11A2	0.435	0.846	C1864746	Deafness, Autosomal Recessive 53	disease	C23;C10;C09	Disease or Syndrome	0.71	1	1964	2015	   4	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1302	COL11A2	0.435	0.846	C1866095	Deafness, Autosomal Dominant 13	disease	C23;C10;C09	Disease or Syndrome	0.93	1	1964	2016	   3	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1302	COL11A2	0.435	0.846	C3281128	FIBROCHONDROGENESIS 2	disease		Disease or Syndrome	0.30	1	1998	2012	   2	   0	GENOMICS_ENGLAND
     1302	COL11A2	0.435	0.846	C3711374	Nonsyndromic Deafness	disease	C23;C10;C09	Disease or Syndrome	0.40	1	1999	2015	   6	   1	CLINGEN
     1302	COL11A2	0.435	0.846	C4520892	Otospondylomegaepiphyseal dysplasia	disease	C16;C05;C19	Disease or Syndrome	1.00	1	1964	2015	  18	   4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1303	COL12A1	0.615	0.692	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1303	COL12A1	0.615	0.692	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1303	COL12A1	0.615	0.692	C0410179	Ullrich congenital muscular dystrophy 1	disease	C23;C16;C05;C10	Disease or Syndrome	0.50	1	2014	2014	   1	   0	CTD_human;ORPHANET
     1303	COL12A1	0.615	0.692	C1834674	BETHLEM MYOPATHY 1	disease	C16;C05;C10	Disease or Syndrome	0.61	1	2014	2018	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1303	COL12A1	0.615	0.692	C3280240	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	disease		Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
     1303	COL12A1	0.615	0.692	C4225313	BETHLEM MYOPATHY 2	disease		Disease or Syndrome	0.60	1	2014	2017	   3	   7	GENOMICS_ENGLAND;UNIPROT
     1303	COL12A1	0.615	0.692	C4225314	ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2	disease		Disease or Syndrome	0.40	1	2014	2017	   2	   8	GENOMICS_ENGLAND
     1305	COL13A1	0.608	0.654	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1305	COL13A1	0.608	0.654	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1305	COL13A1	0.608	0.654	C0751882	Myasthenic Syndromes, Congenital	disease	C16;C10	Disease or Syndrome	0.34	1	2017	2019	   0	   0	CTD_human
     1305	COL13A1	0.608	0.654	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	disease	C16;C10	Disease or Syndrome	0.50	1	2015	2015	   1	   0	CTD_human;ORPHANET
     1305	COL13A1	0.608	0.654	C0751884	Congenital Myasthenic Syndromes, Presynaptic	disease	C16;C10	Disease or Syndrome	0.50	1	2015	2015	   1	   0	CTD_human;ORPHANET
     1305	COL13A1	0.608	0.654	C0751885	Myasthenic Syndromes, Congenital, Slow Channel	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1305	COL13A1	0.608	0.654	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1305	COL13A1	0.608	0.654	C4225235	MYASTHENIC SYNDROME, CONGENITAL, 19	disease		Disease or Syndrome	0.60	1	2015	2017	   1	   3	GENOMICS_ENGLAND
     1305	COL13A1	0.608	0.654	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1306	COL15A1	0.682	0.577	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1306	COL15A1	0.682	0.577	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1306	COL15A1	0.682	0.577	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2016	2017	   1	   0	CTD_human
     1308	COL17A1	0.545	0.769	C0002452	Amelogenesis Imperfecta	disease	C16;C07	Congenital Abnormality	0.33	1	1996	2016	   1	   0	GENOMICS_ENGLAND
     1308	COL17A1	0.545	0.769	C0079301	Junctional Epidermolysis Bullosa	disease	C16;C17	Disease or Syndrome	0.50	0.976	1995	2018	   2	   1	GENOMICS_ENGLAND
     1308	COL17A1	0.545	0.769	C0268374	Adult junctional epidermolysis bullosa (disorder)	disease	C16;C17	Disease or Syndrome	0.70	1	1996	2014	   7	  13	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1308	COL17A1	0.545	0.769	C1852551	Epithelial Recurrent Erosion Dystrophy	disease	C16;C11	Disease or Syndrome	0.75	1	2003	2019	   2	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1308	COL17A1	0.545	0.769	C2608084	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder)	disease	C16;C17	Disease or Syndrome	0.40	1	2014	2014	   1	   2	CTD_human
     1308	COL17A1	0.545	0.769	C4304724	Late-onset junctional epidermolysis bullosa	disease	C16;C17	Disease or Syndrome	0.30				   0	   0	ORPHANET
     1310	COL19A1	0.89	0.154	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   2	UNIPROT
     1310	COL19A1	0.89	0.154	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1311	COMP	0.503	0.808	C0022410	Joint Instability	phenotype	C05	Finding	0.30	1	1999	1999	   1	   0	CTD_human
     1311	COMP	0.503	0.808	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.50	0.971	1995	2019	   1	   0	CTD_human
     1311	COMP	0.503	0.808	C0029410	Osteoarthritis of hip	disease	C05	Disease or Syndrome	0.44	1	2014	2019	   1	   0	CTD_human
     1311	COMP	0.503	0.808	C0086437	Joint laxity	phenotype	C05	Pathologic Function	0.40	1	1999	1999	   1	   0	CTD_human
     1311	COMP	0.503	0.808	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1311	COMP	0.503	0.808	C0410538	Pseudoachondroplasia	disease	C16;C05	Congenital Abnormality	1.00	0.974	1995	2019	  14	  15	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1311	COMP	0.503	0.808	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
     1311	COMP	0.503	0.808	C1838280	Epiphyseal dysplasia, multiple, 1	disease	C16;C05	Disease or Syndrome	0.74	1	1995	2016	  11	  13	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1311	COMP	0.503	0.808	C4275061	Multiple epiphyseal dysplasia type 1	disease	C16;C05	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1312	COMT	0.4	0.923	C0001723	Affective Disorders, Psychotic	group	F03	Mental or Behavioral Dysfunction	0.35	1	2007	2011	   5	   0	PSYGENET
     1312	COMT	0.4	0.923	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	1999	2019	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	0.875	1999	2018	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.43	1	2001	2016	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0004930	Behavior Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2003	2006	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0004936	Mental disorders	group	F03	Mental or Behavioral Dysfunction	0.40	1	1998	2019	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.70	1	1997	2019	   6	   0	CTD_human;PSYGENET
     1312	COMT	0.4	0.923	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.51	0.5	2002	2006	   3	   0	CTD_human;PSYGENET
     1312	COMT	0.4	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.825	1997	2019	   3	   0	CTD_human
     1312	COMT	0.4	0.923	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0009241	Cognition Disorders	group	F03	Mental or Behavioral Dysfunction	0.40	0.818	2006	2018	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.40	1	1983	2019	   5	   0	PSYGENET
     1312	COMT	0.4	0.923	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.50	1	1983	2019	   5	   0	PSYGENET
     1312	COMT	0.4	0.923	C0012236	DiGeorge Syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.60	0.929	1996	2008	   1	   0	CTD_human;ORPHANET
     1312	COMT	0.4	0.923	C0015934	Fetal Growth Retardation	phenotype	C23;C16;C13	Disease or Syndrome	0.42	1	2006	2018	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.31	1	2016	2020	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2002	2002	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	1	2005	2016	   3	   0	PSYGENET
     1312	COMT	0.4	0.923	C0025261	Memory Disorders	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0026858	Musculoskeletal Pain	phenotype	C23;C05	Finding	0.30	1	2014	2014	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0030193	Pain	phenotype	C23	Sign or Symptom	0.60	0.958	2003	2020	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0030319	Panic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	0.955	2002	2017	   0	   0	CTD_human
     1312	COMT	0.4	0.923	C0031511	Pheochromocytoma	disease	C04	Neoplastic Process	0.31	1	2012	2012	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.50	0.887	1984	2020	   4	   0	CTD_human
     1312	COMT	0.4	0.923	C0039494	Temporomandibular Joint Disorders	group	C05;C07	Disease or Syndrome	0.40	1	2007	2020	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0041671	Attention Deficit Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.40	1	1998	2019	   5	   0	PSYGENET
     1312	COMT	0.4	0.923	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	1999	2015	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0086133	Depressive Syndrome	disease	F03	Mental or Behavioral Dysfunction	0.31	1	1983	1983	   1	   0	PSYGENET
     1312	COMT	0.4	0.923	C0086769	Panic Attacks	disease	F03	Mental or Behavioral Dysfunction	0.30				   0	   0	CTD_human
     1312	COMT	0.4	0.923	C0178417	Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	PSYGENET
     1312	COMT	0.4	0.923	C0220704	Shprintzen syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.60	0.9	1996	2012	   1	   0	CTD_human;ORPHANET
     1312	COMT	0.4	0.923	C0233477	Dysphoric mood	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.32	1	2004	2006	   2	   0	PSYGENET
     1312	COMT	0.4	0.923	C0233794	Memory impairment	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.33	1	2007	2016	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0236733	Amphetamine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0236804	Amphetamine Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0236807	Amphetamine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2002	2012	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0376338	Diagnosis, Psychiatric	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.727	2005	2019	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0431406	Asymmetric crying face association	disease	C23;C10;C07	Disease or Syndrome	0.30				   0	   0	ORPHANET
     1312	COMT	0.4	0.923	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2016	2016	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.40	0.8	1982	2019	   5	   0	PSYGENET
     1312	COMT	0.4	0.923	C0525046	Schizophrenia Spectrum and Other Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.52	1	2008	2010	   3	   0	CTD_human;PSYGENET
     1312	COMT	0.4	0.923	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.825	1997	2019	   3	   0	CTD_human
     1312	COMT	0.4	0.923	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0751292	Age-Related Memory Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0751293	Memory Disorder, Semantic	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0751294	Memory Disorder, Spatial	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0751295	Memory Loss	phenotype	C23;C10;F01	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.50	1	1996	1996	   1	   0	CTD_human;ORPHANET
     1312	COMT	0.4	0.923	C1257877	Pheochromocytoma, Extra-Adrenal	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	1997	2005	   3	   0	CTD_human
     1312	COMT	0.4	0.923	C1263846	Attention deficit hyperactivity disorder	disease	F03	Mental or Behavioral Dysfunction	0.50	0.873	1996	2019	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2004	2020	   5	   0	PSYGENET
     1312	COMT	0.4	0.923	C1306067	Drug-induced paranoid state	disease		Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
     1312	COMT	0.4	0.923	C1321905	Minimal Brain Dysfunction	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.38	1	1997	2008	   3	   0	CTD_human
     1312	COMT	0.4	0.923	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	1991	2004	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C2750088	HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO	disease		Finding	0.30	1	2009	2009	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C2936346	22q11 Deletion Syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.36	1	2001	2011	   0	   0	ORPHANET
     1312	COMT	0.4	0.923	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C3160814	Cannabis use	disease		Mental or Behavioral Dysfunction	0.40	1	2005	2019	   2	   0	PSYGENET
     1312	COMT	0.4	0.923	C3266101	22q11 partial monosomy syndrome	disease		Disease or Syndrome	0.30				   0	   0	ORPHANET
     1312	COMT	0.4	0.923	C3888239	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	disease		Finding	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
     1312	COMT	0.4	0.923	C4046029	Mental Disorders, Severe	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
     1312	COMT	0.4	0.923	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	1997	2005	   3	   0	CTD_human
     1314	COPA	0.7	0.385	C0003864	Arthritis	disease	C05	Disease or Syndrome	0.43	1	2015	2020	   1	   0	CTD_human
     1314	COPA	0.7	0.385	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1314	COPA	0.7	0.385	C0162323	Polyarthritis	disease	C05	Disease or Syndrome	0.31	1	2015	2018	   1	   0	CTD_human
     1314	COPA	0.7	0.385	C0206061	Pneumonia, Interstitial	disease	C08	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1314	COPA	0.7	0.385	C0206062	Lung Diseases, Interstitial	group	C08	Disease or Syndrome	0.42	1	2015	2020	   1	   0	CTD_human
     1314	COPA	0.7	0.385	C3860213	Autoinflammatory disorder	disease		Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
     1314	COPA	0.7	0.385	C4225334	AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE	disease		Disease or Syndrome	0.71	1	2015	2017	   2	   5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1316	KLF6	0.501	0.846	C0007112	Adenocarcinoma of prostate	disease	C04;C12	Neoplastic Process	0.31	1	1996	1996	   0	   0	CGI
     1316	KLF6	0.501	0.846	C0017638	Glioma	disease	C04	Neoplastic Process	0.35	1	2000	2019	   0	   0	CGI
     1316	KLF6	0.501	0.846	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1316	KLF6	0.501	0.846	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.66	1	2005	2019	   0	   0	CGI;CTD_human
     1316	KLF6	0.501	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.40	1	2001	2013	   0	   0	CTD_human
     1316	KLF6	0.501	0.846	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.61	1	2005	2005	   0	   1	CGI;CTD_human
     1316	KLF6	0.501	0.846	C0153943	Benign neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
     1316	KLF6	0.501	0.846	C0154060	Carcinoma in situ of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
     1316	KLF6	0.501	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.50	0.857	2001	2018	   0	   0	CTD_human
     1316	KLF6	0.501	0.846	C0496905	Neoplasm of uncertain or unknown behavior of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
     1316	KLF6	0.501	0.846	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.36	1	2005	2019	   0	   0	CGI
     1316	KLF6	0.501	0.846	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0000768	Congenital Abnormality	group	C16	Congenital Abnormality	0.30	1	2001	2001	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0012684	Blastocyst Disintegration	phenotype	C23;C13	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0013937	Embryo Resorption	phenotype	C23;C13	Organism Function	0.30	1	2001	2001	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2009	2009	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2014	2014	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0677050	Manganese Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2012	2012	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0752350	Embryo Death	phenotype	C23;C13	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0752351	Embryo Loss	phenotype	C23;C13	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C1136082	Embryo Disintegration	phenotype	C23;C13	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
     1317	SLC31A1	0.612	0.577	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1326	MAP3K8	0.516	0.846	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1326	MAP3K8	0.516	0.846	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.33	1	2004	2016	   0	   0	CTD_human
     1326	MAP3K8	0.516	0.846	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1326	MAP3K8	0.516	0.846	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.33	1	2004	2013	   0	   0	CTD_human
     1327	COX4I1	0.691	0.5	C0751651	Mitochondrial Diseases	group	C18	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1329	COX5B	0.711	0.423	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1337	COX6A1	0.78	0.154	C4015029	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D	disease		Disease or Syndrome	0.90	1	2014	2014	   1	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1340	COX6B1	0.7	0.577	C0268237	Cytochrome-c Oxidase Deficiency	disease	C16;C18	Disease or Syndrome; Congenital Abnormality	0.70	1	2008	2016	   3	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1340	COX6B1	0.7	0.577	C0751651	Mitochondrial Diseases	group	C18	Disease or Syndrome	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     1349	COX7B	0.595	0.654	C0796070	MICROPHTHALMIA, SYNDROMIC 7	disease	C16;C11;C17	Disease or Syndrome; Congenital Abnormality	0.52	1	2012	2015	   1	   0	CTD_human;ORPHANET
     1349	COX7B	0.595	0.654	C3550921	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2	disease		Disease or Syndrome	0.60	1	1998	2016	   3	   3	CTD_human;GENOMICS_ENGLAND
     1350	COX7C	1	0.077	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1351	COX8A	0.4	0.846	C0001969	Alcoholic Intoxication	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	PSYGENET
     1351	COX8A	0.4	0.846	C0268237	Cytochrome-c Oxidase Deficiency	disease	C16;C18	Disease or Syndrome; Congenital Abnormality	0.75	1	1997	2016	   1	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1352	COX10	0.623	0.654	C0023264	Leigh Disease	disease	C16;C18;C10	Disease or Syndrome	0.61	1	1990	2015	   9	   0	CLINGEN;CTD_human;GENOMICS_ENGLAND
     1352	COX10	0.623	0.654	C0268237	Cytochrome-c Oxidase Deficiency	disease	C16;C18	Disease or Syndrome; Congenital Abnormality	0.94	1	1999	2016	   5	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1352	COX10	0.623	0.654	C0751267	Encephalopathy, Subacute Necrotizing, Infantile	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1352	COX10	0.623	0.654	C0751268	Encephalopathy, Subacute Necrotizing, Juvenile	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1352	COX10	0.623	0.654	C0751651	Mitochondrial Diseases	group	C18	Disease or Syndrome	0.32	1	2013	2017	   1	   0	GENOMICS_ENGLAND
     1352	COX10	0.623	0.654	C1838951	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1990	2015	   7	   0	CLINGEN
     1352	COX10	0.623	0.654	C1850597	Leigh Syndrome Due To Mitochondrial Complex II Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1990	2015	   7	   0	CLINGEN
     1352	COX10	0.623	0.654	C1850598	Leigh Syndrome due to Mitochondrial Complex III Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1990	2015	   7	   0	CLINGEN
     1352	COX10	0.623	0.654	C1850599	Leigh Syndrome due to Mitochondrial Complex IV Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.40	1	1990	2015	   7	   2	CLINGEN
     1352	COX10	0.623	0.654	C1850600	Leigh Syndrome due to Mitochondrial Complex V Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1990	2015	   7	   0	CLINGEN
     1352	COX10	0.623	0.654	C2931891	Necrotizing encephalopathy, infantile subacute, of Leigh	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1990	2015	   7	   0	CLINGEN
     1355	COX15	0.638	0.538	C0023264	Leigh Disease	disease	C16;C18;C10	Disease or Syndrome	0.74	1	2002	2016	   8	   0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1355	COX15	0.638	0.538	C0268237	Cytochrome-c Oxidase Deficiency	disease	C16;C18	Disease or Syndrome; Congenital Abnormality	0.33	1	2003	2005	   0	   0	GENOMICS_ENGLAND
     1355	COX15	0.638	0.538	C0751267	Encephalopathy, Subacute Necrotizing, Infantile	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1355	COX15	0.638	0.538	C0751268	Encephalopathy, Subacute Necrotizing, Juvenile	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1355	COX15	0.638	0.538	C0751651	Mitochondrial Diseases	group	C18	Disease or Syndrome	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     1355	COX15	0.638	0.538	C1838951	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2002	2015	   6	   0	CLINGEN
     1355	COX15	0.638	0.538	C1850597	Leigh Syndrome Due To Mitochondrial Complex II Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2002	2015	   6	   0	CLINGEN
     1355	COX15	0.638	0.538	C1850598	Leigh Syndrome due to Mitochondrial Complex III Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2002	2015	   6	   0	CLINGEN
     1355	COX15	0.638	0.538	C1850599	Leigh Syndrome due to Mitochondrial Complex IV Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.40	1	2002	2015	   6	   0	CLINGEN
     1355	COX15	0.638	0.538	C1850600	Leigh Syndrome due to Mitochondrial Complex V Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2002	2015	   6	   0	CLINGEN
     1355	COX15	0.638	0.538	C1858424	Cardioencephalomyopathy, Fatal Infantile, due to Cytochrome C Oxidase Deficiency	disease	C16;C18;C05;C10;C14	Disease or Syndrome	0.50	1	1990	2011	   2	   0	CTD_human;ORPHANET
     1355	COX15	0.638	0.538	C2931891	Necrotizing encephalopathy, infantile subacute, of Leigh	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2002	2015	   6	   0	CLINGEN
     1355	COX15	0.638	0.538	C3554534	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2	disease		Disease or Syndrome	0.60	1	2003	2016	   4	   0	GENOMICS_ENGLAND;UNIPROT
     1356	CP	0.466	0.846	C0001925	Albuminuria	phenotype	C23;C13;C12	Finding	0.30	1	2011	2011	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0003865	Arthritis, Adjuvant-Induced	disease	C05	Experimental Model of Disease	0.30	1	2009	2009	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.33	1	2002	2018	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0004134	Ataxia	phenotype	C23;C10	Sign or Symptom	0.40	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2002	2004	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0006111	Brain Diseases	group	C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.31	1	2013	2016	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2003	2013	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0011849	Diabetes Mellitus	group	C18;C19	Disease or Syndrome	0.46	1	1995	2017	   1	   2	CTD_human
     1356	CP	0.466	0.846	C0011854	Diabetes Mellitus, Insulin-Dependent	disease	C18;C20;C19	Disease or Syndrome	0.33	1	1996	2019	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0012715	Iron Metabolism Disorders	group	C18	Disease or Syndrome	0.53	1	1998	2006	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2017	2017	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0013384	Dyskinetic syndrome	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.31	1	1987	2006	   1	   0	GENOMICS_ENGLAND
     1356	CP	0.466	0.846	C0018995	Hemochromatosis	disease	C16;C18	Disease or Syndrome	0.32	1	2003	2007	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0019189	Hepatitis, Chronic	disease	C06	Disease or Syndrome	0.31	1	2010	2015	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0019202	Hepatolenticular Degeneration	disease	C16;C06;C18;C10	Disease or Syndrome	0.40	0.906	1987	2020	   3	   0	CTD_human
     1356	CP	0.466	0.846	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0022116	Ischemia	phenotype	C23	Pathologic Function	0.30	1	2005	2007	   2	   0	CTD_human
     1356	CP	0.466	0.846	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0022716	Menkes Kinky Hair Syndrome	disease	C16;C18;C17;C10	Disease or Syndrome	0.33	1	1981	2012	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.31	1	2014	2018	   2	   0	CTD_human
     1356	CP	0.466	0.846	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0030246	Pustulosis of Palms and Soles	disease	C17	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.40	0.938	2004	2020	   2	   0	CTD_human
     1356	CP	0.466	0.846	C0032914	Pre-Eclampsia	phenotype	C13	Pathologic Function	0.31	1	2008	2008	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0033860	Psoriasis	disease	C17	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0035304	Retinal Degeneration	phenotype	C11	Pathologic Function	0.40	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0085397	Pasteurellaceae Infections	group	C01	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0085584	Encephalopathies	group	C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0149519	Chronic Persistent Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0152115	Lingual-Facial-Buccal Dyskinesia	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0205734	Diabetes, Autoimmune	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0221169	Hemiballismus	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0232766	Asterixis	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.31	1	2014	2018	   2	   0	CTD_human
     1356	CP	0.466	0.846	C0240991	Ataxia, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0278161	Ataxia, Motor	phenotype	C23;C10	Finding	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0282193	Iron Overload	disease	C18	Disease or Syndrome	0.40	1	2000	2019	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0338630	Senile Paranoid Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0342302	Brittle diabetes	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0392514	Hereditary hemochromatosis	disease	C16;C18	Disease or Syndrome	0.32	1	2001	2007	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0427086	Involuntary Movements	phenotype	C23;C10	Sign or Symptom	0.31	1	2001	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0427190	Ataxia, Truncal	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0454606	Oral Dyskinesia	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0497327	Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.41	1	2003	2015	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0520463	Chronic active hepatitis	disease	C06	Disease or Syndrome	0.31	1	1980	2015	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0520966	Abnormal coordination	phenotype	C23;C10	Finding	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0524611	Cryptogenic Chronic Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0750937	Ataxia, Appendicular	phenotype	C23;C10	Finding	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0750940	Tremor, Rubral	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0751071	Familial Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0752196	Ballismus	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0878682	Ceruloplasmin deficiency	disease	C18;C10	Disease or Syndrome	0.90	1	1987	2019	   6	  51	CTD_human;GENOMICS_ENGLAND
     1356	CP	0.466	0.846	C0971858	Arthritis, Collagen-Induced	disease	C05	Experimental Model of Disease	0.30	1	2009	2009	   1	   0	CTD_human
     1356	CP	0.466	0.846	C0993582	Arthritis, Experimental	disease	C05	Experimental Model of Disease	0.30	1	2009	2009	   1	   0	CTD_human
     1356	CP	0.466	0.846	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1356	CP	0.466	0.846	C1527352	Hepatic Form of Wilson Disease	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	1994	2013	   3	   0	CTD_human
     1356	CP	0.466	0.846	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     1356	CP	0.466	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2000	2009	   1	   0	CTD_human
     1356	CP	0.466	0.846	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2017	2017	   1	   0	CTD_human
     1356	CP	0.466	0.846	C2931082	Familial apoceruloplasmin deficiency	disease	C18;C10	Disease or Syndrome	0.30	1	2003	2012	   3	   0	CTD_human
     1356	CP	0.466	0.846	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1356	CP	0.466	0.846	C3837958	Diabetes Mellitus, Ketosis-Prone	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1356	CP	0.466	0.846	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1356	CP	0.466	0.846	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1356	CP	0.466	0.846	C4554117	Diabetes Mellitus, Sudden-Onset	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1357	CPA1	0.65	0.577	C0149521	Pancreatitis, Chronic	disease	C06	Disease or Syndrome	0.63	1	2013	2017	   2	   0	CTD_human;GENOMICS_ENGLAND
     1357	CPA1	0.65	0.577	C0238339	Hereditary pancreatitis	disease	C06	Disease or Syndrome	0.51	1	2013	2019	   3	   0	GENOMICS_ENGLAND;ORPHANET
     1358	CPA2	0.861	0.192	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1358	CPA2	0.861	0.192	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     1358	CPA2	0.861	0.192	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     1358	CPA2	0.861	0.192	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2009	2009	   1	   0	CTD_human
     1361	CPB2	0.536	0.846	C0002453	Amenorrhea	phenotype	C23	Finding	0.30	1	2005	2005	   1	   0	CTD_human
     1361	CPB2	0.536	0.846	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1361	CPB2	0.536	0.846	C0032796	Postpartum Amenorrhea	phenotype	C23	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
     1363	CPE	0.584	0.692	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.33	1	2010	2013	   0	   1	UNIPROT
     1363	CPE	0.584	0.692	C0014130	Endocrine System Diseases	group	C19	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1363	CPE	0.584	0.692	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
     1363	CPE	0.584	0.692	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     1363	CPE	0.584	0.692	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.73	0.923	1991	2013	   2	   0	CTD_human;GENOMICS_ENGLAND
     1363	CPE	0.584	0.692	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     1363	CPE	0.584	0.692	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
     1364	CLDN4	0.514	0.692	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	2009	2019	   1	   0	CTD_human
     1364	CLDN4	0.514	0.692	C0021367	Mammary Ductal Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1364	CLDN4	0.514	0.692	C0027643	Neoplasm Recurrence, Local	phenotype	C23;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1364	CLDN4	0.514	0.692	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.31	1	2011	2011	   1	   0	CTD_human
     1364	CLDN4	0.514	0.692	C0035228	Respiratory Hypersensitivity	phenotype	C08;C20	Pathologic Function	0.30	1	2019	2019	   1	   0	CTD_human
     1364	CLDN4	0.514	0.692	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	2005	2019	   1	   0	CTD_human
     1364	CLDN4	0.514	0.692	C1134719	Invasive Ductal Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1364	CLDN4	0.514	0.692	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1364	CLDN4	0.514	0.692	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1364	CLDN4	0.514	0.692	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.32	1	2009	2012	   1	   0	CTD_human
     1364	CLDN4	0.514	0.692	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1365	CLDN3	0.558	0.615	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.31	1	2006	2012	   1	   0	CTD_human
     1365	CLDN3	0.558	0.615	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1365	CLDN3	0.558	0.615	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2006	2007	   1	   0	CTD_human
     1365	CLDN3	0.558	0.615	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.33	0.75	2001	2019	   1	   0	CTD_human
     1365	CLDN3	0.558	0.615	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1366	CLDN7	0.494	0.808	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2003	2007	   1	   0	CTD_human
     1366	CLDN7	0.494	0.808	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.33	1	2003	2019	   1	   0	CTD_human
     1366	CLDN7	0.494	0.808	C4721610	Carcinoma, Ovarian Epithelial	disease	C04;C13;C19	Neoplastic Process	0.34	1	2009	2016	   1	   0	CTD_human
     1368	CPM	0.682	0.538	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1368	CPM	0.682	0.538	C0037116	Silicosis	disease	C08;C24	Disease or Syndrome	0.31	1	2014	2019	   1	   0	CTD_human
     1368	CPM	0.682	0.538	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1369	CPN1	0.729	0.423	C0398782	Carboxypeptidase N Deficiency	disease	C16;C18	Disease or Syndrome	0.50	1	2003	2003	   1	   1	CTD_human;UNIPROT
     1371	CPOX	0.488	0.846	C0162531	Hereditary Coproporphyria	disease	C16;C06;C18;C17	Disease or Syndrome	1.00	0.938	1983	2019	  12	  10	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1371	CPOX	0.488	0.846	C0162566	Porphyria Cutanea Tarda	disease	C16;C06;C18;C17	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1373	CPS1	0.59	0.615	C0009421	Comatose	phenotype	C23;C10	Disease or Syndrome	0.40	1	1993	1993	   1	   0	CTD_human
     1373	CPS1	0.59	0.615	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
     1373	CPS1	0.59	0.615	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2005	2007	   1	   0	CTD_human
     1373	CPS1	0.59	0.615	C0031190	Persistent Fetal Circulation Syndrome	disease	C16;C08	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1373	CPS1	0.59	0.615	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1373	CPS1	0.59	0.615	C0220994	Hyperammonemia	phenotype	C23	Disease or Syndrome	0.50	0.957	1993	2019	   2	   0	CTD_human
     1373	CPS1	0.59	0.615	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1373	CPS1	0.59	0.615	C0376618	Endotoxemia	phenotype	C23;C01	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1373	CPS1	0.59	0.615	C0751753	Carbamoyl-Phosphate Synthase I Deficiency Disease	disease	C16;C18;C10	Disease or Syndrome	0.87	1	1986	2019	  13	   0	CLINGEN;CTD_human;ORPHANET
     1373	CPS1	0.59	0.615	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.31	1	2015	2015	   1	   0	CTD_human
     1373	CPS1	0.59	0.615	C0860634	Psychogenic coma	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.30	1	1993	1993	   1	   0	CTD_human
     1373	CPS1	0.59	0.615	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1373	CPS1	0.59	0.615	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1373	CPS1	0.59	0.615	C3714958	PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO	phenotype		Finding	0.60				   0	   3	CTD_human;GENOMICS_ENGLAND
     1373	CPS1	0.59	0.615	C4082171	Hyperammonemia Due to Carbamoyl Phosphate Synthetase 1 Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.71	1	1993	2018	  19	 112	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1373	CPS1	0.59	0.615	C4085580	Carbamoyl Phosphate Synthase 1 Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.31	1	1993	2007	   2	   0	CTD_human
     1373	CPS1	0.59	0.615	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1373	CPS1	0.59	0.615	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1374	CPT1A	0.555	0.808	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     1374	CPT1A	0.555	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.36	1	2011	2019	   1	   0	CTD_human
     1374	CPT1A	0.555	0.808	C0011849	Diabetes Mellitus	group	C18;C19	Disease or Syndrome	0.32	1	2009	2020	   1	   0	CTD_human
     1374	CPT1A	0.555	0.808	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     1374	CPT1A	0.555	0.808	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.56	1	2005	2019	   1	   0	CTD_human
     1374	CPT1A	0.555	0.808	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.31	1	2010	2014	   1	   0	CTD_human
     1374	CPT1A	0.555	0.808	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     1374	CPT1A	0.555	0.808	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.34	1	2015	2019	   1	   0	CTD_human
     1374	CPT1A	0.555	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.37	1	2007	2019	   1	   0	CTD_human
     1374	CPT1A	0.555	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1374	CPT1A	0.555	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2014	2018	   1	   0	CTD_human
     1374	CPT1A	0.555	0.808	C1829703	Carnitine palmitoyl transferase 1A deficiency	disease	C16;C18	Disease or Syndrome	0.90	1	1981	2016	  13	  55	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1374	CPT1A	0.555	0.808	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1374	CPT1A	0.555	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1375	CPT1B	0.653	0.538	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2004	2004	   1	   0	CTD_human
     1375	CPT1B	0.653	0.538	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.30	1	2004	2004	   1	   0	CTD_human
     1375	CPT1B	0.653	0.538	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2014	2014	   1	   0	CTD_human
     1375	CPT1B	0.653	0.538	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1375	CPT1B	0.653	0.538	C0027404	Narcolepsy	disease	C10;F03	Disease or Syndrome	0.36	1	2008	2016	   1	   0	CTD_human
     1375	CPT1B	0.653	0.538	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2004	2004	   1	   0	CTD_human
     1375	CPT1B	0.653	0.538	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1375	CPT1B	0.653	0.538	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1375	CPT1B	0.653	0.538	C0751362	Narcolepsy-Cataplexy Syndrome	disease	C10;F03	Disease or Syndrome	0.31	1	2008	2009	   1	   0	CTD_human
     1375	CPT1B	0.653	0.538	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
     1376	CPT2	0.542	0.769	C0006112	Brain Diseases, Metabolic	group	C18;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1376	CPT2	0.542	0.769	C0026848	Myopathy	group	C05;C10	Disease or Syndrome	0.44	1	1999	2018	   1	   0	CTD_human
     1376	CPT2	0.542	0.769	C0270984	Metabolic myopathy	group	C05;C10	Disease or Syndrome	0.32	1	1996	2020	   1	   0	GENOMICS_ENGLAND
     1376	CPT2	0.542	0.769	C0342790	Carnitine palmitoyl transferase 2 deficiency	disease	C16;C18	Disease or Syndrome	0.50	1	1989	2019	   8	  27	CLINGEN
     1376	CPT2	0.542	0.769	C0750968	Central Nervous System Metabolic Disorders	disease	C18;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1376	CPT2	0.542	0.769	C0751743	Metabolic Disorder, Central Nervous System, Acquired	disease	C18;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1376	CPT2	0.542	0.769	C0751744	Brain Diseases, Metabolic, Acquired	group	C18;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1376	CPT2	0.542	0.769	C1135773	Acquired Metabolic Diseases, Nervous System	group	C18;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1376	CPT2	0.542	0.769	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.32	1	2006	2019	   1	   0	GENOMICS_ENGLAND
     1376	CPT2	0.542	0.769	C1833508	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET	disease	C16;C18;C05;C10	Disease or Syndrome	0.70	1	1992	2015	  14	  36	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1376	CPT2	0.542	0.769	C1833511	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	disease	C16;C06;C18	Disease or Syndrome	0.71	1	1992	2016	   5	  54	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1376	CPT2	0.542	0.769	C1833518	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL	disease	C16;C18	Disease or Syndrome	0.70	1	1998	2016	   3	  24	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1376	CPT2	0.542	0.769	C3280160	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4	phenotype		Finding	0.40				   0	   6	CTD_human
     1376	CPT2	0.542	0.769	C4706387	Acute necrotizing encephalopathy of childhood	disease		Disease or Syndrome	0.30	1	2011	2011	   1	   0	ORPHANET
     1378	CR1	0.533	0.808	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.50	0.971	2009	2019	   2	  10	CTD_human
     1378	CR1	0.533	0.808	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2011	   2	   0	CTD_human
     1378	CR1	0.533	0.808	C0024530	Malaria	disease	C01	Disease or Syndrome	0.40	0.929	2001	2019	   0	   0	CTD_human
     1378	CR1	0.533	0.808	C0024535	Malaria, Falciparum	disease	C01	Disease or Syndrome	0.36	0.875	1997	2013	   2	   0	CTD_human
     1378	CR1	0.533	0.808	C0234985	Mental deterioration	phenotype	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
     1378	CR1	0.533	0.808	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2009	2011	   2	   0	CTD_human
     1378	CR1	0.533	0.808	C0338656	Impaired cognition	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
     1378	CR1	0.533	0.808	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.35	1	2009	2018	   2	   0	CTD_human
     1378	CR1	0.533	0.808	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2011	   2	   0	CTD_human
     1378	CR1	0.533	0.808	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2011	   2	   0	CTD_human
     1378	CR1	0.533	0.808	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2009	2011	   2	   0	CTD_human
     1378	CR1	0.533	0.808	C1270972	Mild cognitive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2018	2019	   1	   0	CTD_human
     1380	CR2	0.556	0.654	C0009447	Common Variable Immunodeficiency	disease	C20	Disease or Syndrome	0.60	1	2009	2019	   1	   0	CTD_human;ORPHANET
     1380	CR2	0.556	0.654	C0024131	Lupus Vulgaris	disease	C01;C17	Disease or Syndrome	0.32	1	2007	2015	   1	   0	GENOMICS_ENGLAND
     1380	CR2	0.556	0.654	C0024138	Lupus Erythematosus, Discoid	disease	C17	Disease or Syndrome	0.32	1	2007	2015	   1	   0	GENOMICS_ENGLAND
     1380	CR2	0.556	0.654	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.69	1	2006	2020	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1380	CR2	0.556	0.654	C0086438	Hypogammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.33	1	1991	2015	   1	   0	GENOMICS_ENGLAND
     1380	CR2	0.556	0.654	C0239998	Recurrent infections	phenotype	C23;C01;C05	Finding	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1380	CR2	0.556	0.654	C0242380	Libman-Sacks Disease	disease	C17;C20	Disease or Syndrome	0.30				   0	   0	CTD_human
     1380	CR2	0.556	0.654	C0409974	Lupus Erythematosus	disease	C23;C17;C20	Disease or Syndrome	0.32	1	2007	2015	   1	   0	GENOMICS_ENGLAND
     1380	CR2	0.556	0.654	C2936664	Acquired Hypogammaglobulinemia	disease	C20	Disease or Syndrome	0.31	1	2012	2012	   0	   0	CTD_human
     1380	CR2	0.556	0.654	C2936665	Immunoglobulin Deficiency, Late-Onset	disease	C20	Disease or Syndrome	0.30				   0	   0	CTD_human
     1380	CR2	0.556	0.654	C3542922	IMMUNODEFICIENCY, COMMON VARIABLE, 7	disease		Disease or Syndrome	0.40	1	2015	2015	   1	   2	GENOMICS_ENGLAND
     1381	CRABP1	0.631	0.615	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.31	1	2005	2005	   1	   0	CTD_human
     1381	CRABP1	0.631	0.615	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     1381	CRABP1	0.631	0.615	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1381	CRABP1	0.631	0.615	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2007	2007	   1	   0	CTD_human
     1381	CRABP1	0.631	0.615	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.31	1	2005	2005	   1	   0	CTD_human
     1381	CRABP1	0.631	0.615	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1381	CRABP1	0.631	0.615	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1381	CRABP1	0.631	0.615	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1381	CRABP1	0.631	0.615	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1381	CRABP1	0.631	0.615	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1382	CRABP2	0.593	0.615	C0268583	Methylmalonic acidemia	phenotype	C16;C18	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1382	CRABP2	0.593	0.615	C1855119	Methylmalonic aciduria	disease	C16;C18	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1384	CRAT	0.656	0.577	C4693587	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8	disease		Disease or Syndrome	0.60	1	2018	2018	   1	   1	GENOMICS_ENGLAND;UNIPROT
     1385	CREB1	0.463	0.885	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2008	2014	   3	   0	PSYGENET
     1385	CREB1	0.463	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	0.667	2008	2016	   3	   0	PSYGENET
     1385	CREB1	0.463	0.885	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2001	2009	   3	   0	CTD_human
     1385	CREB1	0.463	0.885	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.40	1	2005	2019	   5	   0	PSYGENET
     1385	CREB1	0.463	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2002	2019	   5	   0	PSYGENET
     1385	CREB1	0.463	0.885	C0026552	Morphine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
     1385	CREB1	0.463	0.885	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1385	CREB1	0.463	0.885	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	1	1997	2019	   1	   0	CTD_human
     1385	CREB1	0.463	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.37	0.667	1999	2019	   3	   0	PSYGENET
     1385	CREB1	0.463	0.885	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     1385	CREB1	0.463	0.885	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.40	0.8	2000	2017	   5	   0	PSYGENET
     1385	CREB1	0.463	0.885	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1385	CREB1	0.463	0.885	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.31	1	2009	2019	   1	   0	CTD_human
     1385	CREB1	0.463	0.885	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.31	1	2010	2018	   1	   0	CTD_human
     1385	CREB1	0.463	0.885	C0206651	Clear Cell Sarcoma of Soft Tissue	disease	C04	Neoplastic Process	0.36	1	2006	2018	   1	   0	ORPHANET
     1385	CREB1	0.463	0.885	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2001	2009	   3	   0	CTD_human
     1385	CREB1	0.463	0.885	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.40	0.8	2002	2014	   5	   0	PSYGENET
     1385	CREB1	0.463	0.885	C0600272	Morphine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
     1385	CREB1	0.463	0.885	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.51	1	2001	2009	   4	   0	CTD_human;PSYGENET
     1385	CREB1	0.463	0.885	C1266127	Histiocytoma, Angiomatoid Fibrous	disease	C04	Neoplastic Process	0.40	1	2007	2019	   0	   0	CTD_human
     1385	CREB1	0.463	0.885	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	0.8	2000	2018	   5	   0	PSYGENET
     1386	ATF2	0.551	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.37	0.857	2002	2016	   0	   0	UNIPROT
     1386	ATF2	0.551	0.808	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.37	1	2000	2019	   1	   0	CTD_human
     1386	ATF2	0.551	0.808	C0027651	Neoplasms	group	C04	Neoplastic Process	0.40	1	1991	2018	   1	   0	CTD_human
     1386	ATF2	0.551	0.808	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1386	ATF2	0.551	0.808	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.32	1	2011	2019	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.32	1	2011	2019	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.33	1	2001	2016	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C0007138	Carcinoma, Transitional Cell	disease	C04	Neoplastic Process	0.32	1	2011	2017	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.40	1	2013	2016	   1	   2	CTD_human
     1387	CREBBP	0.428	0.808	C0011573	Endogenous depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
     1387	CREBBP	0.428	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.60	1	1996	2019	   0	   0	CGI
     1387	CREBBP	0.428	0.808	C0024301	Lymphoma, Follicular	disease	C04;C20;C15	Neoplastic Process	0.39	1	2011	2019	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CGI
     1387	CREBBP	0.428	0.808	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2004	2015	   2	   0	CTD_human
     1387	CREBBP	0.428	0.808	C0035934	Rubinstein-Taybi Syndrome	disease	C16;C05;C10	Disease or Syndrome	0.90	0.988	1997	2019	   6	  86	CLINGEN;CTD_human
     1387	CREBBP	0.428	0.808	C0036920	Sezary Syndrome	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.39	1	2011	2019	   0	   0	CGI
     1387	CREBBP	0.428	0.808	C0079745	Lymphoma, Large-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C0079758	Lymphoma, Mixed-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C0079765	Lymphoma, Small Cleaved-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.33	1	2012	2019	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.33	1	2016	2018	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C0268731	Renal glomerular disease	group	C23;C13;C12	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1387	CREBBP	0.428	0.808	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.34	1	2004	2018	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	1	2003	2019	   2	   0	CTD_human
     1387	CREBBP	0.428	0.808	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C1956130	Lymphoma, Follicular, Grade 1	disease	C04;C20;C15	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C1956131	Lymphoma, Follicular, Grade 3	disease	C04;C20;C15	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C1956132	Lymphoma, Follicular, Grade 2	disease	C04;C20;C15	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1387	CREBBP	0.428	0.808	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.35	1	2000	2018	   0	   0	CGI
     1387	CREBBP	0.428	0.808	C4511003	Acute myeloid leukemia with t(8;16)(p11;p13) translocation	disease		Neoplastic Process	0.30	1	2008	2013	   2	   0	ORPHANET
     1387	CREBBP	0.428	0.808	C4521256	Glomerulopathy Assessment	phenotype		Diagnostic Procedure	0.30				   0	   0	GENOMICS_ENGLAND
     1387	CREBBP	0.428	0.808	C4551859	RUBINSTEIN-TAYBI SYNDROME 1	disease	C16;C05;C10	Disease or Syndrome	0.70	1	1997	2016	  12	  37	CLINGEN;GENOMICS_ENGLAND;UNIPROT
     1387	CREBBP	0.428	0.808	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1390	CREM	0.575	0.692	C0011875	Diabetic Angiopathies	disease	C19;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1390	CREM	0.575	0.692	C0020564	Hypertrophy	phenotype	C23	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
     1390	CREM	0.575	0.692	C0025945	Microangiopathy, Diabetic	disease	C19;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1390	CREM	0.575	0.692	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1390	CREM	0.575	0.692	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1390	CREM	0.575	0.692	C0162820	Dermatitis, Allergic Contact	disease	C17;C20	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1390	CREM	0.575	0.692	C0263454	Chloracne	disease	C17	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1390	CREM	0.575	0.692	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1390	CREM	0.575	0.692	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1390	CREM	0.575	0.692	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1390	CREM	0.575	0.692	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.39	1	2004	2018	   5	   0	PSYGENET
     1392	CRH	0.439	0.808	C0002170	Alopecia	disease	C23;C17	Disease or Syndrome	0.31	1	2001	2011	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.39	0.9	1995	2019	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0003123	Anorexia	disease	C23	Disease or Syndrome	0.56	1	1999	2019	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.40	1	1994	2020	  11	   0	CTD_human
     1392	CRH	0.439	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	0.667	1998	2014	   3	   0	PSYGENET
     1392	CRH	0.439	0.808	C0005899	Body Rocking	phenotype	F03	Individual Behavior	0.30	1	1991	1991	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0008031	Chest Pain	phenotype	C23	Sign or Symptom	0.30	1	1989	1989	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1995	2009	   5	   0	CTD_human
     1392	CRH	0.439	0.808	C0009241	Cognition Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0010481	Cushing Syndrome	disease	C19	Disease or Syndrome	0.60	1	1992	2019	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.60	1	1992	2019	   5	   0	PSYGENET
     1392	CRH	0.439	0.808	C0011573	Endogenous depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2002	2018	   2	   0	CTD_human
     1392	CRH	0.439	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.60	1	1992	2019	   7	   0	CTD_human;PSYGENET
     1392	CRH	0.439	0.808	C0013415	Dysthymic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2000	2000	   1	   0	PSYGENET
     1392	CRH	0.439	0.808	C0015967	Fever	phenotype	C23	Sign or Symptom	0.31	1	2002	2019	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0018672	Head Banging	phenotype	F03	Mental or Behavioral Dysfunction	0.30	1	1991	1991	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	1984	1992	   2	   0	CTD_human
     1392	CRH	0.439	0.808	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0025193	Melancholia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2002	2018	   2	   0	CTD_human
     1392	CRH	0.439	0.808	C0026650	Movement Disorders	group	C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0030193	Pain	phenotype	C23	Sign or Symptom	0.38	1	1997	2019	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0032001	Pituitary Apoplexy	disease	C10;C19;C14	Disease or Syndrome	0.30	1	2003	2003	   2	   0	CTD_human
     1392	CRH	0.439	0.808	C0033922	Psychomotor Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	1992	1992	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0034012	Delayed Puberty	phenotype	C19	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0035333	Retinitis	disease	C11	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2003	2019	   1	   0	PSYGENET
     1392	CRH	0.439	0.808	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.32	1	1991	2018	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0037769	West Syndrome	disease	C10	Disease or Syndrome	0.32	1	2001	2017	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0038273	Stereotypic Movement Disorder	phenotype	F03	Mental or Behavioral Dysfunction	0.30	1	1991	1991	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2004	2009	   2	   0	CTD_human
     1392	CRH	0.439	0.808	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.60	1	1992	2018	   7	   0	CTD_human;PSYGENET
     1392	CRH	0.439	0.808	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.50	1	2004	2010	   1	   0	PSYGENET
     1392	CRH	0.439	0.808	C0086133	Depressive Syndrome	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2002	2009	   2	   0	CTD_human
     1392	CRH	0.439	0.808	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2004	2009	   2	   0	CTD_human
     1392	CRH	0.439	0.808	C0086873	Pseudopelade	disease	C23;C17	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2004	2009	   2	   0	CTD_human
     1392	CRH	0.439	0.808	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0154874	Neuroretinitis	disease	C11	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0162311	Androgenetic Alopecia	disease	C23;C17	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0178417	Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.32	1	2000	2020	   1	   0	PSYGENET
     1392	CRH	0.439	0.808	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.50	1	1995	2009	   5	   0	CTD_human
     1392	CRH	0.439	0.808	C0263477	Female pattern alopecia (disorder)	phenotype	C23;C17	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0266487	Etat Marbre	disease	C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0282126	Depression, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2002	2009	   2	   0	CTD_human
     1392	CRH	0.439	0.808	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1994	2012	  11	   0	CTD_human
     1392	CRH	0.439	0.808	C0393698	Cryptogenic Infantile Spasms	disease	C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0393699	Symptomatic Infantile Spasms	disease	C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0424230	Motor retardation	phenotype	C23;C10;F01	Finding	0.30	1	1992	1992	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0428977	Bradycardia	phenotype	C23;C14	Finding	0.30	1	1984	1984	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.40	1	2001	2019	   5	   0	PSYGENET
     1392	CRH	0.439	0.808	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0546878	Nodding spasm	disease	C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0553558	Jackknife Seizures	disease	C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1995	2009	   5	   0	CTD_human
     1392	CRH	0.439	0.808	C0684276	Hypsarrhythmia	phenotype	C10	Finding	0.30	1	2001	2001	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0751456	Developmental Psychomotor Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	1992	1992	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C1262477	Weight decreased	phenotype	C23	Finding	0.30	1	1996	1996	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	1992	2018	   5	   0	PSYGENET
     1392	CRH	0.439	0.808	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1994	2012	  11	   0	CTD_human
     1392	CRH	0.439	0.808	C1527306	spasmus nutans	disease	C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C1527366	Salaam Seizures	disease	C10	Disease or Syndrome	0.31	1	2001	2017	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C3203733	Precordial Catch Syndrome	phenotype	C23	Disease or Syndrome	0.30	1	1989	1989	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C3696898	Autosomal Dominant Nocturnal Frontal Lobe Epilepsy	disease	C10	Disease or Syndrome	0.33	1	2005	2013	   1	   0	ORPHANET
     1392	CRH	0.439	0.808	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C4083212	Alopecia, Male Pattern	disease	C23;C17	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1392	CRH	0.439	0.808	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1991	2000	   6	   0	CTD_human
     1392	CRH	0.439	0.808	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1991	2000	   6	   0	CTD_human
     1393	CRHBP	0.659	0.5	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2008	2011	   3	   0	PSYGENET
     1393	CRHBP	0.659	0.5	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1393	CRHBP	0.659	0.5	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.52	1	1996	2010	   2	   0	PSYGENET
     1393	CRHBP	0.659	0.5	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	1996	2010	   3	   0	PSYGENET
     1393	CRHBP	0.659	0.5	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2003	2003	   1	   0	PSYGENET
     1393	CRHBP	0.659	0.5	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1393	CRHBP	0.659	0.5	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2007	2007	   2	   0	PSYGENET
     1393	CRHBP	0.659	0.5	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1393	CRHBP	0.659	0.5	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2003	2007	   1	   0	PSYGENET
     1393	CRHBP	0.659	0.5	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2017	2018	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	1	2005	2015	   5	   0	PSYGENET
     1394	CRHR1	0.517	0.769	C0003123	Anorexia	disease	C23	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.40	1	1997	2020	   2	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	0.5	2012	2013	   4	   0	PSYGENET
     1394	CRHR1	0.517	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.31	1	2015	2018	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.60	1	2004	2019	   5	   0	PSYGENET
     1394	CRHR1	0.517	0.769	C0011574	Involutional Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2004	2019	   5	   0	PSYGENET
     1394	CRHR1	0.517	0.769	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.33	1	2017	2018	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0029410	Osteoarthritis of hip	disease	C05	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0030201	Pain, Postoperative	phenotype	C23	Sign or Symptom	0.30	1	2017	2017	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2014	2015	   1	   0	PSYGENET
     1394	CRHR1	0.517	0.769	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2006	2016	   5	   0	PSYGENET
     1394	CRHR1	0.517	0.769	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0178417	Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
     1394	CRHR1	0.517	0.769	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.50	1	2003	2009	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0349204	Nonorganic psychosis	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2014	2015	   1	   0	PSYGENET
     1394	CRHR1	0.517	0.769	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1997	2012	   2	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2017	2017	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.36	1	2006	2019	   5	   0	PSYGENET
     1394	CRHR1	0.517	0.769	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2009	2017	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.31	1	2015	2018	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2017	2017	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2017	2017	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2017	2017	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2017	2017	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C0751217	Hyperkinesia, Generalized	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.60	1	2006	2019	   5	   0	CTD_human;PSYGENET
     1394	CRHR1	0.517	0.769	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1997	2012	   2	   0	CTD_human
     1394	CRHR1	0.517	0.769	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.32	1	2010	2018	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C1571983	Involutional paraphrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C1571984	Psychosis, Involutional	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2017	2017	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C3887506	Hyperkinesia	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1394	CRHR1	0.517	0.769	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1395	CRHR2	0.584	0.731	C0003123	Anorexia	disease	C23	Disease or Syndrome	0.54	1	1999	2019	   1	   0	CTD_human
     1395	CRHR2	0.584	0.731	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.33	1	2000	2019	   1	   0	CTD_human
     1395	CRHR2	0.584	0.731	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
     1395	CRHR2	0.584	0.731	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1395	CRHR2	0.584	0.731	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.52	1	2003	2019	   4	   0	PSYGENET
     1395	CRHR2	0.584	0.731	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2003	2019	   4	   0	PSYGENET
     1395	CRHR2	0.584	0.731	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.32	1	2000	2019	   1	   0	CTD_human
     1395	CRHR2	0.584	0.731	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
     1395	CRHR2	0.584	0.731	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1395	CRHR2	0.584	0.731	C0178417	Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     1395	CRHR2	0.584	0.731	C0233477	Dysphoric mood	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     1395	CRHR2	0.584	0.731	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1395	CRHR2	0.584	0.731	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2000	2000	   1	   0	CTD_human
     1395	CRHR2	0.584	0.731	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2002	2006	   3	   0	PSYGENET
     1395	CRHR2	0.584	0.731	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1395	CRHR2	0.584	0.731	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2000	2000	   1	   0	CTD_human
     1398	CRK	0.394	0.923	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.31	1	2005	2010	   1	   0	CTD_human
     1399	CRKL	0.553	0.769	C0012236	DiGeorge Syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.52	1	2001	2019	   1	   0	CTD_human
     1399	CRKL	0.553	0.769	C0220704	Shprintzen syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.50	1	2001	2006	   1	   0	CTD_human
     1399	CRKL	0.553	0.769	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1399	CRKL	0.553	0.769	C2678480	Chromosome 22q11.2 Deletion Syndrome, Distal	disease	C23;C16;C05;C19;C15;C14	Disease or Syndrome	0.30				   0	   0	ORPHANET
     1400	CRMP1	0.525	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
     1400	CRMP1	0.525	0.808	C3178803	Social Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     1401	CRP	0.299	0.962	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.40	1	2010	2019	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0003865	Arthritis, Adjuvant-Induced	disease	C05	Experimental Model of Disease	0.30	1	2009	2009	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.60	0.955	1989	2020	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.40	0.942	2000	2020	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.40	0.955	2000	2020	   2	   0	CTD_human
     1401	CRP	0.299	0.962	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.40	0.939	1999	2020	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0010346	Crohn Disease	disease	C06	Disease or Syndrome	0.40	0.989	2001	2020	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0011854	Diabetes Mellitus, Insulin-Dependent	disease	C18;C20;C19	Disease or Syndrome	0.40	1	2007	2019	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0011884	Diabetic Retinopathy	disease	C11;C19;C14	Disease or Syndrome	0.32	1	2009	2015	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.38	0.889	2002	2020	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.40	0.947	2005	2019	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.40	0.957	2005	2020	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0020503	Hyperparathyroidism, Secondary	disease	C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.60	0.944	2003	2020	   4	   0	CTD_human
     1401	CRP	0.299	0.962	C0020557	Hypertriglyceridemia	phenotype	C18	Disease or Syndrome	0.40	0.909	2002	2019	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.60	1	2001	2011	   3	   0	CTD_human
     1401	CRP	0.299	0.962	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.40	1	1998	2019	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0023281	Leishmaniasis	disease	C01;C17	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0023290	Leishmaniasis, Visceral	disease	C01	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.31	1	2006	2006	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.40	0.923	1987	2020	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0024530	Malaria	disease	C01	Disease or Syndrome	0.40	0.905	1996	2020	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0025289	Meningitis	disease	C10	Disease or Syndrome	0.36	1	2003	2019	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0025517	Metabolic Diseases	group	C18	Disease or Syndrome	0.40	0.909	2006	2020	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0027059	Myocarditis	disease	C14	Disease or Syndrome	0.35	0.833	2009	2019	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0027707	Nephritis, Interstitial	disease	C13;C12	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.60	0.98	2001	2020	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0030167	Pachymeningitis	disease	C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0030246	Pustulosis of Palms and Soles	disease	C17	Disease or Syndrome	0.31	1	2003	2019	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0031051	Pericementitis	disease	C07	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0031099	Periodontitis	disease	C07	Disease or Syndrome	0.40	0.941	2005	2019	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0033860	Psoriasis	disease	C17	Disease or Syndrome	0.40	0.875	2003	2020	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.667	2007	2020	   3	   0	PSYGENET
     1401	CRP	0.299	0.962	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0040053	Thrombosis	phenotype	C14	Pathologic Function	0.31	1	2006	2007	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0041349	Nephritis, Tubulointerstitial	disease	C13;C12	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2012	2020	   2	   0	PSYGENET
     1401	CRP	0.299	0.962	C0085397	Pasteurellaceae Infections	group	C01	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0087086	Thrombus	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.60	0.938	2000	2019	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0156147	Crohn's disease of large bowel	disease	C06	Disease or Syndrome	0.31	1	2001	2019	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0205734	Diabetes, Autoimmune	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.32	1	2005	2019	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	0.964	2006	2020	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0242380	Libman-Sacks Disease	disease	C17;C20	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0267380	Crohn's disease of the ileum	disease	C06	Disease or Syndrome	0.31	1	2001	2008	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0274861	Arsenic Poisoning, Inorganic	disease	C10;C25	Injury or Poisoning	0.30	1	2012	2012	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0274862	Nervous System, Organic Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2012	2012	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0311375	Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2012	2012	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0342302	Brittle diabetes	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0344315	Depressed mood	phenotype	F01	Mental or Behavioral Dysfunction	0.40	1	2009	2020	   2	   0	PSYGENET
     1401	CRP	0.299	0.962	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0524620	Metabolic Syndrome X	disease	C18	Disease or Syndrome	0.40	0.965	2003	2020	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0678202	Regional enteritis	disease	C06	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0751851	Arsenic Encephalopathy	disease	C10;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0751852	Arsenic Induced Polyneuropathy	disease	C10;C25	Injury or Poisoning	0.30	1	2012	2012	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.31	1	2015	2019	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0869523	Carditis	disease	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0948089	Acute Coronary Syndrome	disease	C14	Disease or Syndrome	0.40	1	2004	2020	   2	   0	CTD_human
     1401	CRP	0.299	0.962	C0949272	IIeocolitis	disease	C06	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0971858	Arthritis, Collagen-Induced	disease	C05	Experimental Model of Disease	0.30	1	2009	2009	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C0993582	Arthritis, Experimental	disease	C05	Experimental Model of Disease	0.30	1	2009	2009	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2012	2020	   2	   0	PSYGENET
     1401	CRP	0.299	0.962	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.40	0.947	1999	2020	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.958	1990	2019	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C3714514	Infection	group	C01	Pathologic Function	0.35	1	1988	2008	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C3837958	Diabetes Mellitus, Ketosis-Prone	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1401	CRP	0.299	0.962	C4554117	Diabetes Mellitus, Sudden-Onset	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1404	HAPLN1	0.663	0.577	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1404	HAPLN1	0.663	0.577	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.50	1	2011	2011	   1	   0	CTD_human;UNIPROT
     1404	HAPLN1	0.663	0.577	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1404	HAPLN1	0.663	0.577	C0013336	Dwarfism	disease	C16;C05;C19	Congenital Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
     1404	HAPLN1	0.663	0.577	C0206762	Limb Deformities, Congenital	group	C16;C05	Congenital Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
     1404	HAPLN1	0.663	0.577	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
     1406	CRX	0.565	0.692	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   1	UNIPROT
     1406	CRX	0.565	0.692	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.31	1	2019	2019	   0	   0	GENOMICS_ENGLAND
     1406	CRX	0.565	0.692	C0035304	Retinal Degeneration	phenotype	C11	Pathologic Function	0.30	1	1998	1998	   1	   0	CTD_human
     1406	CRX	0.565	0.692	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.80	1	1997	2018	   3	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1406	CRX	0.565	0.692	C0339527	Leber Congenital Amaurosis	disease	C11	Disease or Syndrome	0.80	0.955	1998	2019	   3	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1406	CRX	0.565	0.692	C3151192	LEBER CONGENITAL AMAUROSIS 7	disease		Disease or Syndrome	0.90	1	1998	2014	   5	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1406	CRX	0.565	0.692	C3489532	Cone-Rod Dystrophy 2	disease	C16;C11	Disease or Syndrome	0.80	1	1997	2019	   6	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1406	CRX	0.565	0.692	C3540662	Congenital Amaurosis of Retinal Origin	disease	C11	Disease or Syndrome	0.30	1	1998	1999	   2	   0	CTD_human
     1406	CRX	0.565	0.692	C4277690	Ciliopathies	disease	C16	Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
     1407	CRY1	0.585	0.769	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	0.667	2005	2012	   3	   0	PSYGENET
     1407	CRY1	0.585	0.769	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
     1407	CRY1	0.585	0.769	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2012	2017	   2	   0	PSYGENET
     1407	CRY1	0.585	0.769	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1407	CRY1	0.585	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1407	CRY1	0.585	0.769	C0085159	Seasonal Affective Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
     1407	CRY1	0.585	0.769	C0393770	Delayed Sleep Phase Syndrome	disease	C10;F03;C24	Disease or Syndrome	0.30				   0	   0	CTD_human
     1407	CRY1	0.585	0.769	C0494410	Nonorganic Sleep Wake Cycle Disorders	disease	C10;F03;C24	Mental or Behavioral Dysfunction	0.30				   0	   0	CTD_human
     1407	CRY1	0.585	0.769	C0751758	Advanced Sleep Phase Syndrome	disease	C10;F03;C24	Disease or Syndrome	0.30				   0	   0	CTD_human
     1407	CRY1	0.585	0.769	C0751759	Non-24 Hour Sleep-Wake Disorder	disease	C10;F03;C24	Mental or Behavioral Dysfunction	0.30				   0	   0	CTD_human
     1407	CRY1	0.585	0.769	C0751760	Shift-Work Sleep Disorder	disease	C10;F03;C24	Mental or Behavioral Dysfunction	0.30				   0	   0	CTD_human
     1407	CRY1	0.585	0.769	C0877792	Sleep Disorders, Circadian Rhythm	group	C10;F03;C24	Pathologic Function	0.30				   0	   0	CTD_human
     1408	CRY2	0.599	0.692	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2006	2012	   4	   0	PSYGENET
     1408	CRY2	0.599	0.692	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.32	1	2010	2012	   3	   0	PSYGENET
     1408	CRY2	0.599	0.692	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2010	2017	   4	   0	PSYGENET
     1408	CRY2	0.599	0.692	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.31	1	2006	2006	   1	   0	CTD_human
     1408	CRY2	0.599	0.692	C0085159	Seasonal Affective Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
     1409	CRYAA	0.653	0.385	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1409	CRYAA	0.653	0.385	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
     1409	CRYAA	0.653	0.385	C0009691	Congenital cataract	disease	C23;C16;C13;C11;C10	Congenital Abnormality	0.70	1	1996	2018	   0	   4	GENOMICS_ENGLAND
     1409	CRYAA	0.653	0.385	C0042164	Uveitis	disease	C11	Disease or Syndrome	0.30	1	2009	2011	   2	   0	CTD_human
     1409	CRYAA	0.653	0.385	C0086543	Cataract	disease	C11	Acquired Abnormality	0.50	1	1998	2017	   1	   0	CTD_human
     1409	CRYAA	0.653	0.385	C0266539	Congenital total cataract	disease	C16;C11	Congenital Abnormality	0.30	1	2006	2006	   1	   0	ORPHANET
     1409	CRYAA	0.653	0.385	C0392557	Nuclear cataract	disease	C11	Disease or Syndrome	0.52	1	2007	2014	   3	   0	GENOMICS_ENGLAND;ORPHANET
     1409	CRYAA	0.653	0.385	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
     1409	CRYAA	0.653	0.385	C1112705	Nuclear non-senile cataract	disease	C11	Disease or Syndrome	0.32	1	2007	2014	   3	   0	ORPHANET
     1409	CRYAA	0.653	0.385	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	1998	1998	   1	   0	CTD_human
     1409	CRYAA	0.653	0.385	C1855179	CATARACT, ANTERIOR POLAR	disease	C11	Disease or Syndrome	0.30	1	2011	2011	   1	   0	ORPHANET
     1409	CRYAA	0.653	0.385	C1858679	CATARACT, AUTOSOMAL DOMINANT	disease	C11	Disease or Syndrome	0.90	1	1996	2013	   8	   8	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1409	CRYAA	0.653	0.385	C1861829	Cataract microcornea syndrome	disease	C11	Disease or Syndrome	0.31	1	2006	2011	   3	   0	ORPHANET
     1409	CRYAA	0.653	0.385	C3888098	Cataract, Autosomal Recessive Congenital 1	disease	C11	Disease or Syndrome	0.50	1	1996	2009	   0	   0	GENOMICS_ENGLAND
     1410	CRYAB	0.515	0.731	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.31	1	2004	2008	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0040411	Tongue Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0086543	Cataract	disease	C11	Acquired Abnormality	0.50	1	1998	2020	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0153349	Malignant neoplasm of tongue	disease	C04;C07	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.31	1	2004	2011	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0270715	Degenerative Diseases, Central Nervous System	group	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0340427	Familial dilated cardiomyopathy	disease	C14	Disease or Syndrome	0.30	1	2006	2006	   2	   0	ORPHANET
     1410	CRYAB	0.515	0.731	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2007	2018	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0392557	Nuclear cataract	disease	C11	Disease or Syndrome	0.31	1	1998	2015	   3	   0	ORPHANET
     1410	CRYAB	0.515	0.731	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0524851	Neurodegenerative Disorders	group	C10	Disease or Syndrome	0.36	1	2005	2018	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0751733	Degenerative Diseases, Spinal Cord	group	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C0858617	Posterior subcapsular cataract	disease	C11	Disease or Syndrome	0.30	1	2006	2014	   2	   0	ORPHANET
     1410	CRYAB	0.515	0.731	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.50	0.929	2003	2019	   0	   2	GENOMICS_ENGLAND
     1410	CRYAB	0.515	0.731	C1112705	Nuclear non-senile cataract	disease	C11	Disease or Syndrome	0.31	1	1998	2015	   3	   0	ORPHANET
     1410	CRYAB	0.515	0.731	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	2001	2001	   1	   0	CTD_human
     1410	CRYAB	0.515	0.731	C1837317	Alpha-B Crystallinopathy	disease	C11;C05;C10;C14	Disease or Syndrome	0.90	1	1998	2012	   6	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1410	CRYAB	0.515	0.731	C1850191	Posterior polar cataract	phenotype		Finding	0.40				   0	   0	GENOMICS_ENGLAND
     1410	CRYAB	0.515	0.731	C2678065	Myofibrillar Myopathy	disease	C05;C10	Disease or Syndrome	0.48	1	2001	2019	   1	   3	GENOMICS_ENGLAND
     1410	CRYAB	0.515	0.731	C3151236	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	disease		Disease or Syndrome	0.70	1	2011	2011	   1	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1410	CRYAB	0.515	0.731	C3554649	CARDIOMYOPATHY, DILATED, 1II	disease		Disease or Syndrome	0.70	1	2006	2017	   2	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1410	CRYAB	0.515	0.731	C3808377	CATARACT 16, MULTIPLE TYPES	disease		Disease or Syndrome	0.80	1	2001	2013	   2	   4	CTD_human;GENOMICS_ENGLAND
     1411	CRYBA1	0.716	0.269	C0392557	Nuclear cataract	disease	C11	Disease or Syndrome	0.31	1	2011	2018	   2	   0	ORPHANET
     1411	CRYBA1	0.716	0.269	C0858617	Posterior subcapsular cataract	disease	C11	Disease or Syndrome	0.30	1	2010	2010	   1	   0	ORPHANET
     1411	CRYBA1	0.716	0.269	C1112705	Nuclear non-senile cataract	disease	C11	Disease or Syndrome	0.31	1	2011	2018	   2	   0	ORPHANET
     1411	CRYBA1	0.716	0.269	C1833229	Cataract, Congenital Zonular, with Sutural Opacities	disease	C11	Disease or Syndrome	0.80	1	1998	2015	   2	   4	CTD_human;GENOMICS_ENGLAND
     1411	CRYBA1	0.716	0.269	C1854021	Cataract, Central Saccular, With Sutural Opacities	disease	C11	Disease or Syndrome	0.30	1	1998	1998	   1	   0	ORPHANET
     1412	CRYBA2	0.839	0.192	C0392557	Nuclear cataract	disease	C11	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     1412	CRYBA2	0.839	0.192	C1112705	Nuclear non-senile cataract	disease	C11	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     1412	CRYBA2	0.839	0.192	C1855179	CATARACT, ANTERIOR POLAR	disease	C11	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     1412	CRYBA2	0.839	0.192	C4011454	CATARACT 42	disease		Disease or Syndrome	0.50	1	2013	2013	   1	   0	CTD_human;UNIPROT
     1413	CRYBA4	0.716	0.269	C1861829	Cataract microcornea syndrome	disease	C11	Disease or Syndrome	0.30	1	2010	2010	   1	   0	ORPHANET
     1413	CRYBA4	0.716	0.269	C3808012	CATARACT 23, MULTIPLE TYPES	disease		Disease or Syndrome	0.70	1	2006	2010	   2	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1414	CRYBB1	0.686	0.231	C0086543	Cataract	disease	C11	Acquired Abnormality	0.45	0.8	2002	2016	   1	   0	CTD_human
     1414	CRYBB1	0.686	0.231	C0158551	Embryonal nuclear cataract (disorder)	disease	C16;C11	Congenital Abnormality	0.42	1	2008	2016	   0	   0	GENOMICS_ENGLAND
     1414	CRYBB1	0.686	0.231	C0392557	Nuclear cataract	disease	C11	Disease or Syndrome	0.40	1	2007	2014	   3	   0	ORPHANET
     1414	CRYBB1	0.686	0.231	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1414	CRYBB1	0.686	0.231	C1112705	Nuclear non-senile cataract	disease	C11	Disease or Syndrome	0.40	1	2007	2014	   3	   0	ORPHANET
     1414	CRYBB1	0.686	0.231	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	2002	2002	   1	   0	CTD_human
     1414	CRYBB1	0.686	0.231	C1833118	Cataract, Pulverulent	disease	C16;C11	Disease or Syndrome	0.41	1	2002	2012	   3	   0	ORPHANET
     1414	CRYBB1	0.686	0.231	C1852438	CATARACT, COPPOCK-LIKE	disease	C11	Disease or Syndrome	0.32	1	2002	2012	   3	   0	ORPHANET
     1414	CRYBB1	0.686	0.231	C1861829	Cataract microcornea syndrome	disease	C11	Disease or Syndrome	0.33	1	2005	2016	   2	   0	ORPHANET
     1414	CRYBB1	0.686	0.231	C1969062	Cataract, Congenital Nuclear, Autosomal Recessive 3	disease	C16;C11	Disease or Syndrome	0.50				   0	   0	CTD_human;GENOMICS_ENGLAND
     1414	CRYBB1	0.686	0.231	C3888124	CATARACT 17, MULTIPLE TYPES	disease		Disease or Syndrome	0.60	1	2002	2017	   4	   3	GENOMICS_ENGLAND;UNIPROT
     1415	CRYBB2	0.623	0.462	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1415	CRYBB2	0.623	0.462	C0042164	Uveitis	disease	C11	Disease or Syndrome	0.30	1	2009	2011	   2	   0	CTD_human
     1415	CRYBB2	0.623	0.462	C0266539	Congenital total cataract	disease	C16;C11	Congenital Abnormality	0.30	1	2010	2010	   1	   0	ORPHANET
     1415	CRYBB2	0.623	0.462	C0344523	Cataract, congenital, cerulean type 1	disease	C11	Congenital Abnormality	0.63	1	1997	2019	   2	   0	CTD_human;ORPHANET
     1415	CRYBB2	0.623	0.462	C0392557	Nuclear cataract	disease	C11	Disease or Syndrome	0.31	1	2004	2014	   2	   0	ORPHANET
     1415	CRYBB2	0.623	0.462	C1112705	Nuclear non-senile cataract	disease	C11	Disease or Syndrome	0.31	1	2004	2014	   2	   0	ORPHANET
     1415	CRYBB2	0.623	0.462	C1832175	Cataract, Congenital, Cerulean Type, 2	disease	C11	Disease or Syndrome	0.80	1	1980	2017	   2	   5	CTD_human;GENOMICS_ENGLAND
     1415	CRYBB2	0.623	0.462	C1833118	Cataract, Pulverulent	disease	C16;C11	Disease or Syndrome	0.30	1	2000	2000	   1	   0	ORPHANET
     1415	CRYBB2	0.623	0.462	C1852438	CATARACT, COPPOCK-LIKE	disease	C11	Disease or Syndrome	0.61	1	2000	2000	   1	   0	GENOMICS_ENGLAND;ORPHANET
     1415	CRYBB2	0.623	0.462	C1854021	Cataract, Central Saccular, With Sutural Opacities	disease	C11	Disease or Syndrome	0.30	1	2001	2001	   1	   0	ORPHANET
     1415	CRYBB2	0.623	0.462	C1861829	Cataract microcornea syndrome	disease	C11	Disease or Syndrome	0.30	1	2011	2011	   1	   0	ORPHANET
     1415	CRYBB2	0.623	0.462	C4721890	CATARACT 2, MULTIPLE TYPES	disease		Disease or Syndrome	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
     1417	CRYBB3	0.769	0.269	C0158551	Embryonal nuclear cataract (disorder)	disease	C16;C11	Congenital Abnormality	0.40				   0	   0	GENOMICS_ENGLAND
     1417	CRYBB3	0.769	0.269	C0392557	Nuclear cataract	disease	C11	Disease or Syndrome	0.40	1	2005	2013	   2	   0	ORPHANET
     1417	CRYBB3	0.769	0.269	C1112705	Nuclear non-senile cataract	disease	C11	Disease or Syndrome	0.40	1	2005	2013	   2	   0	ORPHANET
     1417	CRYBB3	0.769	0.269	C1855179	CATARACT, ANTERIOR POLAR	disease	C11	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     1417	CRYBB3	0.769	0.269	C1857853	Cataract, Congenital Nuclear, Autosomal Recessive 2	disease	C16;C11	Disease or Syndrome	0.70	1	2005	2013	   2	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1419	CRYGB	0.78	0.269	C0266539	Congenital total cataract	disease	C16;C11	Congenital Abnormality	0.30	1	2012	2012	   1	   0	ORPHANET
     1419	CRYGB	0.78	0.269	C1855179	CATARACT, ANTERIOR POLAR	disease	C11	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
     1419	CRYGB	0.78	0.269	C3808800	CATARACT 39, MULTIPLE TYPES	disease		Disease or Syndrome	0.80	1	1984	2012	   1	   2	CTD_human;GENOMICS_ENGLAND
     1420	CRYGC	0.612	0.577	C0086543	Cataract	disease	C11	Acquired Abnormality	0.46	1	1999	2012	   2	   0	CTD_human
     1420	CRYGC	0.612	0.577	C0392557	Nuclear cataract	disease	C11	Disease or Syndrome	0.40	1	2008	2014	   2	   0	ORPHANET
     1420	CRYGC	0.612	0.577	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	2000	2002	   2	   0	CTD_human
     1420	CRYGC	0.612	0.577	C1112705	Nuclear non-senile cataract	disease	C11	Disease or Syndrome	0.40	1	2008	2014	   2	   0	ORPHANET
     1420	CRYGC	0.612	0.577	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	2000	2002	   2	   0	CTD_human
     1420	CRYGC	0.612	0.577	C1833118	Cataract, Pulverulent	disease	C16;C11	Disease or Syndrome	0.31	1	2000	2013	   2	   0	ORPHANET
     1420	CRYGC	0.612	0.577	C1852438	CATARACT, COPPOCK-LIKE	disease	C11	Disease or Syndrome	0.82	1	1999	2017	   2	   1	CTD_human;ORPHANET
     1420	CRYGC	0.612	0.577	C1858679	CATARACT, AUTOSOMAL DOMINANT	disease	C11	Disease or Syndrome	0.31	1	2000	2013	   1	   0	GENOMICS_ENGLAND
     1420	CRYGC	0.612	0.577	C1861829	Cataract microcornea syndrome	disease	C11	Disease or Syndrome	0.30	1	2009	2012	   2	   0	ORPHANET
     1420	CRYGC	0.612	0.577	C4721890	CATARACT 2, MULTIPLE TYPES	disease		Disease or Syndrome	0.80	1	1999	2014	   8	   6	GENOMICS_ENGLAND;UNIPROT
     1421	CRYGD	0.51	0.808	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2017	2017	   1	   0	CTD_human
     1421	CRYGD	0.51	0.808	C0086543	Cataract	disease	C11	Acquired Abnormality	0.70	0.96	1999	2019	   2	   0	CTD_human;GENOMICS_ENGLAND
     1421	CRYGD	0.51	0.808	C0344523	Cataract, congenital, cerulean type 1	disease	C11	Congenital Abnormality	0.30	1	2003	2003	   1	   0	ORPHANET
     1421	CRYGD	0.51	0.808	C0392557	Nuclear cataract	disease	C11	Disease or Syndrome	0.32	1	2006	2015	   3	   0	ORPHANET
     1421	CRYGD	0.51	0.808	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	1999	2018	   2	   0	CTD_human
     1421	CRYGD	0.51	0.808	C1112705	Nuclear non-senile cataract	disease	C11	Disease or Syndrome	0.32	1	2006	2015	   3	   0	ORPHANET
     1421	CRYGD	0.51	0.808	C1392104	Coralliform cataract	disease	C11	Congenital Abnormality	0.33	1	2004	2013	   2	   0	ORPHANET
     1421	CRYGD	0.51	0.808	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	1999	2018	   2	   0	CTD_human
     1421	CRYGD	0.51	0.808	C1833118	Cataract, Pulverulent	disease	C16;C11	Disease or Syndrome	0.30	1	2011	2011	   1	   0	ORPHANET
     1421	CRYGD	0.51	0.808	C1852438	CATARACT, COPPOCK-LIKE	disease	C11	Disease or Syndrome	0.50	1	2000	2011	   1	   0	ORPHANET
     1421	CRYGD	0.51	0.808	C1858679	CATARACT, AUTOSOMAL DOMINANT	disease	C11	Disease or Syndrome	0.31	1	1999	2010	   1	   0	GENOMICS_ENGLAND
     1421	CRYGD	0.51	0.808	C1861829	Cataract microcornea syndrome	disease	C11	Disease or Syndrome	0.30	1	2007	2007	   1	   0	ORPHANET
     1421	CRYGD	0.51	0.808	C3540850	CATARACT 4, MULTIPLE TYPES	disease		Disease or Syndrome	0.90	1	1999	2011	  11	   6	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1427	CRYGS	0.743	0.192	C0086543	Cataract	disease	C11	Acquired Abnormality	0.48	1	2005	2019	   1	   0	CTD_human
     1427	CRYGS	0.743	0.192	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.40	1	2005	2005	   1	   0	CTD_human
     1427	CRYGS	0.743	0.192	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	2005	2005	   1	   0	CTD_human
     1427	CRYGS	0.743	0.192	C1854021	Cataract, Central Saccular, With Sutural Opacities	disease	C11	Disease or Syndrome	0.30	1	2005	2008	   2	   0	ORPHANET
     1427	CRYGS	0.743	0.192	C3805410	CATARACT 20, MULTIPLE TYPES	disease		Disease or Syndrome	0.90	1	1983	2005	   1	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1428	CRYM	0.769	0.346	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.31	1	1997	2003	   1	   0	GENOMICS_ENGLAND
     1428	CRYM	0.769	0.346	C4084708	DEAFNESS, AUTOSOMAL DOMINANT 40	disease		Disease or Syndrome	0.70	1	1997	2016	   7	   2	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1431	CS	0.59	0.654	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1431	CS	0.59	0.654	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     1431	CS	0.59	0.654	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.32	1	1996	2018	   1	   0	CTD_human
     1431	CS	0.59	0.654	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.32	1	1996	2018	   1	   0	CTD_human
     1431	CS	0.59	0.654	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     1431	CS	0.59	0.654	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.31	0.5	2011	2017	   1	   0	CTD_human
     1431	CS	0.59	0.654	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1431	CS	0.59	0.654	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1431	CS	0.59	0.654	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     1431	CS	0.59	0.654	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     1431	CS	0.59	0.654	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2009	2009	   1	   0	CTD_human
     1431	CS	0.59	0.654	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1431	CS	0.59	0.654	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     1431	CS	0.59	0.654	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	1996	1996	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0005398	Cholestasis, Extrahepatic	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0008312	Primary biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2018	2018	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.35	1	2006	2017	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0023892	Biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.33	1	1999	2011	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.35	1	2003	2019	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
     1432	MAPK14	0.379	0.923	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2008	2017	   1	   0	PSYGENET
     1432	MAPK14	0.379	0.923	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0086132	Depressive Symptoms	phenotype	F01	Sign or Symptom	0.32	1	2011	2017	   1	   0	PSYGENET
     1432	MAPK14	0.379	0.923	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.33	1	2001	2018	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.38	1	2011	2019	   0	   0	UNIPROT
     1432	MAPK14	0.379	0.923	C0233477	Dysphoric mood	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	PSYGENET
     1432	MAPK14	0.379	0.923	C0238065	Secondary Biliary Cholangitis	disease	C23;C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	1	2007	2019	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2016	2016	   0	   0	UNIPROT
     1432	MAPK14	0.379	0.923	C0338715	Drug-induced depressive state	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
     1432	MAPK14	0.379	0.923	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.31	1	2007	2019	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.31	1	1999	2007	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C1306571	Hepatic Insufficiency	phenotype	C06	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     1432	MAPK14	0.379	0.923	C4551595	Biliary Cirrhosis, Primary, 1	disease	C23;C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1434	CSE1L	0.521	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.36	1	2012	2018	   0	   0	UNIPROT
     1435	CSF1	0.473	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1992	2019	   1	   0	CTD_human
     1435	CSF1	0.473	0.808	C0029401	Osteitis Deformans	disease	C05	Disease or Syndrome	0.34	1	2010	2012	   1	   0	CTD_human
     1435	CSF1	0.473	0.808	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.31	1	1989	2014	   1	   0	CTD_human
     1435	CSF1	0.473	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1991	2019	   1	   0	CTD_human
     1435	CSF1	0.473	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.31	1	1991	2006	   1	   0	CTD_human
     1435	CSF1	0.473	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.33	1	2002	2012	   1	   0	CTD_human
     1435	CSF1	0.473	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1436	CSF1R	0.448	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1999	2019	   1	   0	CTD_human
     1436	CSF1R	0.448	0.808	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.60	1	1992	2020	   1	   0	CGI;CTD_human
     1436	CSF1R	0.448	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.40	1	1988	2019	   1	   0	CTD_human
     1436	CSF1R	0.448	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1436	CSF1R	0.448	0.808	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	1992	1992	   1	   0	CTD_human
     1436	CSF1R	0.448	0.808	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	1	1992	2018	   1	   0	CTD_human
     1436	CSF1R	0.448	0.808	C0027651	Neoplasms	group	C04	Neoplastic Process	0.50	0.96	1987	2020	   1	   4	CTD_human
     1436	CSF1R	0.448	0.808	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.30	1	1992	1992	   1	   0	CTD_human
     1436	CSF1R	0.448	0.808	C0149782	Squamous cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30				   0	   0	UNIPROT
     1436	CSF1R	0.448	0.808	C0270612	Leukoencephalopathy	group	C10	Disease or Syndrome	0.50	1	2011	2020	   1	   0	CTD_human
     1436	CSF1R	0.448	0.808	C0376545	Hematologic Neoplasms	group	C04;C15	Neoplastic Process	0.40	1	1990	2009	   0	   5	CGI
     1436	CSF1R	0.448	0.808	C0497327	Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.33	1	2013	2019	   1	   0	GENOMICS_ENGLAND
     1436	CSF1R	0.448	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1991	2019	   1	   0	CTD_human
     1436	CSF1R	0.448	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1436	CSF1R	0.448	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2006	2009	   1	   0	CTD_human
     1436	CSF1R	0.448	0.808	C1858991	Childhood Ataxia with Central Nervous System Hypomyelinization	disease	C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1436	CSF1R	0.448	0.808	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	1992	1992	   1	   0	CTD_human
     1436	CSF1R	0.448	0.808	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.40	1	1990	2009	   0	   0	CGI
     1436	CSF1R	0.448	0.808	C3711381	Hereditary Diffuse Leukoencephalopathy with Spheroids	disease	C10	Disease or Syndrome	0.80	1	1989	2020	   3	  44	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1436	CSF1R	0.448	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0001824	Agranulocytosis	disease	C15	Disease or Syndrome	0.31	1	1992	2001	   2	   0	CTD_human
     1437	CSF2	0.33	0.962	C0002622	Amnesia	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.31	1	1996	2019	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0002871	Anemia	disease	C15	Disease or Syndrome	0.32	1	1993	2001	   2	   0	CTD_human
     1437	CSF2	0.33	0.962	C0002874	Aplastic Anemia	disease	C15	Disease or Syndrome	0.32	1	1995	2009	   2	   0	CTD_human
     1437	CSF2	0.33	0.962	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.40	1	1989	2019	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1989	2020	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0007097	Carcinoma	group	C04	Neoplastic Process	0.37	1	1993	2016	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.38	1	2000	2018	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	2004	2017	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0011999	Diastematomyelia	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	1994	1994	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0015423	Eyelid Diseases	group	C11	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0017181	Gastrointestinal Hemorrhage	phenotype	C23;C06	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.32	1	2001	2019	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.34	1	2001	2019	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0018932	Hematochezia	phenotype	C23;C06	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.31	1	2005	2013	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0023290	Leishmaniasis, Visceral	disease	C01	Disease or Syndrome	0.31	1	1995	2007	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.40	0.985	1985	2019	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.36	1	2001	2007	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0024302	Reticulosarcoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	1993	2001	   3	   0	CTD_human
     1437	CSF2	0.33	0.962	C0024304	Lymphoma, Mixed-Cell	disease	C04;C20;C15	Neoplastic Process	0.30	1	1993	2001	   3	   0	CTD_human
     1437	CSF2	0.33	0.962	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.31	1	1993	2001	   3	   0	CTD_human
     1437	CSF2	0.33	0.962	C0024306	Lymphoma, Undifferentiated	disease	C04;C20;C15	Neoplastic Process	0.30	1	1993	2001	   3	   0	CTD_human
     1437	CSF2	0.33	0.962	C0025202	melanoma	disease	C04	Neoplastic Process	0.40	1	1995	2019	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.32	1	1993	2006	   3	   0	CTD_human
     1437	CSF2	0.33	0.962	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0027794	Neural Tube Defects	group	C16;C10	Congenital Abnormality	0.31	1	2006	2017	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0027806	Neurenteric Cyst	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0027947	Neutropenia	disease	C15	Disease or Syndrome	0.37	0.889	1993	2017	   2	   0	CTD_human
     1437	CSF2	0.33	0.962	C0030193	Pain	phenotype	C23	Sign or Symptom	0.33	1	1996	2019	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0030246	Pustulosis of Palms and Soles	disease	C17	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.35	1	1996	2019	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0033860	Psoriasis	disease	C17	Disease or Syndrome	0.35	1	1995	2019	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.51	1	1998	2007	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.35	1	2007	2019	   1	   0	PSYGENET
     1437	CSF2	0.33	0.962	C0040034	Thrombocytopenia	phenotype	C15	Disease or Syndrome	0.31	1	1994	2020	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0040136	Thyroid Neoplasm	disease	C04;C19	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	1994	1994	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0042487	Venous Thrombosis	phenotype	C14	Pathologic Function	0.30	1	1994	1994	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0079740	High Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30	1	1993	2001	   3	   0	CTD_human
     1437	CSF2	0.33	0.962	C0079741	Lymphoma, Intermediate-Grade	disease	C04;C20;C15	Neoplastic Process	0.30	1	1993	2001	   3	   0	CTD_human
     1437	CSF2	0.33	0.962	C0079747	Low Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30	1	1993	2001	   3	   0	CTD_human
     1437	CSF2	0.33	0.962	C0079757	Diffuse Mixed-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	1993	2001	   3	   0	CTD_human
     1437	CSF2	0.33	0.962	C0079770	Lymphoma, Small Noncleaved-Cell	disease	C04;C20;C15	Neoplastic Process	0.30	1	1993	2001	   3	   0	CTD_human
     1437	CSF2	0.33	0.962	C0080218	Tethered Cord Syndrome	disease	C16;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0085090	Lymphoma, AIDS-Related	disease	C04;C20;C15	Neoplastic Process	0.30	1	1993	1993	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0149871	Deep Vein Thrombosis	disease	C14	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0151468	Thyroid Gland Follicular Adenoma	disease	C04;C19	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0151786	Muscle Weakness	phenotype	C23;C05;C10	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0152234	Iniencephaly	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0152426	Craniorachischisis	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0178416	Hypoplastic anemia	disease	C15	Disease or Syndrome	0.30	1	1998	2002	   2	   0	CTD_human
     1437	CSF2	0.33	0.962	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0205944	Sarcoma, Epithelioid	disease	C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0205945	Sarcoma, Spindle Cell	disease	C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0233750	Hysterical amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0233796	Temporary Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0236795	Dissociative Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0242594	Residual Cancer	phenotype	C23;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0242596	Neoplasm, Residual	phenotype	C23;C04	Neoplastic Process	0.31	1	1999	2004	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0262497	Global Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0266453	Exencephaly	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0333355	Inflammatory disease of mucous membrane	group	C06;C07	Pathologic Function	0.30	1	1994	1994	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0344479	Spinal Cord Myelodysplasia	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0349639	Juvenile Myelomonocytic Leukemia	disease	C04;C15	Neoplastic Process	0.40	1	1994	2017	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0543478	Residual Tumor	disease	C23;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.31	1	2005	2015	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1989	2020	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0702169	Acrania	disease	C16;C10	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0750906	Tactile Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0750907	Amnestic State	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C1261473	Sarcoma	group	C04	Neoplastic Process	0.33	1	1990	2014	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.35	1	2001	2018	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C2931245	Bone Marrow failure syndromes	disease		Disease or Syndrome	0.30	1	1990	1990	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.31	1	2011	2011	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C3714542	Lymphoma, Diffuse	disease	C04;C20;C15	Neoplastic Process	0.30	1	1993	2001	   3	   0	CTD_human
     1437	CSF2	0.33	0.962	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.31	1	1996	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C3808553	Bone marrow failure syndrome 1	disease		Disease or Syndrome	0.30	1	1990	1990	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C3810350	Bone marrow failure syndrome 2	disease		Disease or Syndrome	0.30	1	1990	1990	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1437	CSF2	0.33	0.962	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.30	1	1993	2001	   3	   0	CTD_human
     1438	CSF2RA	0.67	0.615	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	2013	2013	   1	   0	GENOMICS_ENGLAND
     1438	CSF2RA	0.67	0.615	C0034050	Pulmonary Alveolar Proteinosis	disease	C08	Disease or Syndrome	0.70	1	2008	2019	   3	   0	CTD_human;GENOMICS_ENGLAND
     1438	CSF2RA	0.67	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2007	2010	   2	   0	PSYGENET
     1438	CSF2RA	0.67	0.615	C2677877	Surfactant Metabolism Dysfunction, Pulmonary, 4	disease	C16;C08	Disease or Syndrome	0.70	1	2008	2014	   4	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1438	CSF2RA	0.67	0.615	C2931035	Pulmonary alveolar proteinosis, congenital	disease	C08	Disease or Syndrome	0.51	1	2008	2013	   2	   0	GENOMICS_ENGLAND;ORPHANET
     1439	CSF2RB	0.705	0.423	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
     1439	CSF2RB	0.705	0.423	C0034050	Pulmonary Alveolar Proteinosis	disease	C08	Disease or Syndrome	0.64	1	1995	2019	   2	   0	GENOMICS_ENGLAND
     1439	CSF2RB	0.705	0.423	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2008	2011	   3	   0	PSYGENET
     1439	CSF2RB	0.705	0.423	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
     1439	CSF2RB	0.705	0.423	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
     1439	CSF2RB	0.705	0.423	C2931035	Pulmonary alveolar proteinosis, congenital	disease	C08	Disease or Syndrome	0.30	1	2011	2011	   2	   0	ORPHANET
     1439	CSF2RB	0.705	0.423	C3280574	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5	disease		Disease or Syndrome	0.60	1	2004	2011	   2	   1	CTD_human;GENOMICS_ENGLAND
     1440	CSF3	0.377	0.885	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0001824	Agranulocytosis	disease	C15	Disease or Syndrome	0.36	1	1987	2019	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0002871	Anemia	disease	C15	Disease or Syndrome	0.38	1	1999	2019	   3	   0	CTD_human
     1440	CSF3	0.377	0.885	C0002874	Aplastic Anemia	disease	C15	Disease or Syndrome	0.37	1	1992	2017	   6	   0	CTD_human
     1440	CSF3	0.377	0.885	C0003862	Arthralgia	phenotype	C23;C05	Sign or Symptom	0.30	1	1995	1995	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.32	1	1994	2007	   2	   0	CTD_human
     1440	CSF3	0.377	0.885	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.33	1	1994	2007	   2	   0	CTD_human
     1440	CSF3	0.377	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1993	2019	   8	   0	CTD_human
     1440	CSF3	0.377	0.885	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	1996	1996	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.30	1	1998	1998	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.37	1	1993	2019	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0007138	Carcinoma, Transitional Cell	disease	C04	Neoplastic Process	0.30	1	1994	1994	   2	   0	CTD_human
     1440	CSF3	0.377	0.885	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0011573	Endogenous depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	1996	2017	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0011644	Scleroderma	disease	C17	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0011991	Diarrhea	phenotype	C23	Sign or Symptom	0.30	1	1995	1995	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	1993	2016	   2	   0	CTD_human
     1440	CSF3	0.377	0.885	C0014518	Toxic Epidermal Necrolysis	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	1993	1993	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0015967	Fever	phenotype	C23	Sign or Symptom	0.38	0.889	1998	2019	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2009	2010	   2	   0	CTD_human
     1440	CSF3	0.377	0.885	C0017178	Gastrointestinal Diseases	group	C06	Disease or Syndrome	0.31	1	2006	2016	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0018671	Head and Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	1993	1993	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0018675	Head Neoplasms	group	C04	Neoplastic Process	0.30	1	1993	1993	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0018681	Headache	phenotype	C23	Sign or Symptom	0.32	1	2000	2018	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.31	1	2004	2009	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.32	1	2003	2009	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0018923	Hemangiosarcoma	disease	C04	Neoplastic Process	0.30	1	1998	1998	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0019156	Hepatic Veno-Occlusive Disease	disease	C06;C14	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0019829	Hodgkin Disease	disease	C04;C20;C15	Neoplastic Process	0.32	1	1999	2018	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0020433	Hyperbilirubinemia	disease	C23	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0020564	Hypertrophy	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0021308	Infarction	phenotype	C23	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0023269	leiomyosarcoma	disease	C04	Neoplastic Process	0.30	1	1998	1998	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.40	0.97	1987	2020	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0023530	Leukopenia	disease	C15	Disease or Syndrome	0.40	0.947	1987	2020	   4	   0	CTD_human
     1440	CSF3	0.377	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.32	1	2009	2019	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.31	1	1996	2018	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0024302	Reticulosarcoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0024304	Lymphoma, Mixed-Cell	disease	C04;C20;C15	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.40	1	1995	2020	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0024306	Lymphoma, Undifferentiated	disease	C04;C20;C15	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0025193	Melancholia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0025202	melanoma	disease	C04	Neoplastic Process	0.33	0.6	1987	2015	   2	   0	CTD_human
     1440	CSF3	0.377	0.885	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.40	0.969	1993	2020	   2	   0	CTD_human
     1440	CSF3	0.377	0.885	C0026848	Myopathy	group	C05;C10	Disease or Syndrome	0.31	1	1995	2017	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	1994	1994	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0027533	Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	1993	1993	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	0.917	1995	2019	   2	   0	CTD_human
     1440	CSF3	0.377	0.885	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.31	1	2006	2018	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0027947	Neutropenia	disease	C15	Disease or Syndrome	0.40	0.949	1987	2020	  13	   0	CTD_human
     1440	CSF3	0.377	0.885	C0028838	Ocular Headache	phenotype	C23	Sign or Symptom	0.30	1	2000	2000	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0030193	Pain	phenotype	C23	Sign or Symptom	0.38	1	1995	2020	   3	   0	CTD_human
     1440	CSF3	0.377	0.885	C0030312	Pancytopenia	disease	C15	Disease or Syndrome	0.35	0.857	1997	2020	   2	   0	CTD_human
     1440	CSF3	0.377	0.885	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.31	1	2007	2019	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0034189	Pyemia	phenotype	C23;C01	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0036420	Localized scleroderma	disease	C17	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0036690	Septicemia	disease	C23;C01	Disease or Syndrome	0.40	1	2000	2020	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	1998	1998	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0037579	Soft Tissue Neoplasms	group	C04	Neoplastic Process	0.31	1	1995	2017	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0038160	Staphylococcal Infections	group	C01	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0038325	Stevens-Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0038362	Stomatitis	disease	C07	Disease or Syndrome	0.31	1	2002	2017	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0040034	Thrombocytopenia	phenotype	C15	Disease or Syndrome	0.36	1	1995	2020	   2	   0	CTD_human
     1440	CSF3	0.377	0.885	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	1993	2016	   2	   0	CTD_human
     1440	CSF3	0.377	0.885	C0042138	Uterine Neoplasms	group	C04;C13	Neoplastic Process	0.30	1	1998	1998	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0079731	B-Cell Lymphomas	group	C04;C20;C15	Neoplastic Process	0.32	1	2000	2017	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0079740	High Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0079741	Lymphoma, Intermediate-Grade	disease	C04;C20;C15	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0079747	Low Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0079757	Diffuse Mixed-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0079770	Lymphoma, Small Noncleaved-Cell	disease	C04;C20;C15	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0085090	Lymphoma, AIDS-Related	disease	C04;C20;C15	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0085183	Neoplasms, Second Primary	phenotype	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0086133	Depressive Syndrome	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2009	2009	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0086696	Neoplasms, Therapy-Associated	phenotype	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30	1	1997	1997	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0151786	Muscle Weakness	phenotype	C23;C05;C10	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0152266	Mixed Cellularity Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0152267	Hodgkin lymphoma, lymphocyte depletion	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0153567	Uterine Cancer	disease	C04;C13	Neoplastic Process	0.30	1	1998	1998	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0162296	Polyarthralgia	disease	C23;C05	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.31	1	2011	2019	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0178416	Hypoplastic anemia	disease	C15	Disease or Syndrome	0.30	1	1992	2006	   6	   0	CTD_human
     1440	CSF3	0.377	0.885	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.33	1	1996	2018	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	1996	1996	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.33	1	1996	2018	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	1996	1996	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0205815	Leiomyosarcoma, Epithelioid	disease	C04	Neoplastic Process	0.30	1	1998	1998	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0205816	Leiomyosarcoma, Myxoid	disease	C04	Neoplastic Process	0.30	1	1998	1998	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0220597	Adult Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2007	2018	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	1995	2000	   3	   0	CTD_human
     1440	CSF3	0.377	0.885	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	1995	2000	   3	   0	CTD_human
     1440	CSF3	0.377	0.885	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	1995	2000	   3	   0	CTD_human
     1440	CSF3	0.377	0.885	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	2003	2007	   2	   0	CTD_human
     1440	CSF3	0.377	0.885	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.40	1	2000	2020	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0263409	Linear Scleroderma	disease	C17	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.31	1	1993	2001	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0282126	Depression, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1996	1996	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0282609	Bone Marrow Neoplasms	group	C04;C15	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0333355	Inflammatory disease of mucous membrane	group	C06;C07	Pathologic Function	0.30	1	1995	2006	   2	   0	CTD_human
     1440	CSF3	0.377	0.885	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	1996	1996	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0423618	Throbbing Headache	phenotype	C23	Sign or Symptom	0.30	1	2000	2000	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0423623	Bilateral Headache	phenotype	C23	Sign or Symptom	0.30	1	2000	2000	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	1995	2000	   3	   0	CTD_human
     1440	CSF3	0.377	0.885	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	1995	2000	   3	   0	CTD_human
     1440	CSF3	0.377	0.885	C0474366	Generalized Headache	phenotype	C23	Sign or Symptom	0.30	1	2000	2000	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	1993	1993	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0559031	Functional Gastrointestinal Disorders	disease	C06	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1993	2019	   8	   0	CTD_human
     1440	CSF3	0.377	0.885	C0746787	Cancer of Neck	disease	C04	Neoplastic Process	0.30	1	1993	1993	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0751177	Cancer of Head	disease	C04	Neoplastic Process	0.30	1	1993	1993	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0751186	Orthostatic Headache	phenotype	C23	Sign or Symptom	0.30	1	2000	2000	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0751187	Periorbital Headache	phenotype	C23	Sign or Symptom	0.30	1	2000	2000	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0751189	Retro-Ocular Headache	phenotype	C23	Sign or Symptom	0.30	1	2000	2000	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0751190	Sharp Headache	phenotype	C23	Sign or Symptom	0.30	1	2000	2000	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0751192	Vertex Headache	phenotype	C23	Sign or Symptom	0.30	1	2000	2000	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	1995	2000	   3	   0	CTD_human
     1440	CSF3	0.377	0.885	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	1995	2000	   3	   0	CTD_human
     1440	CSF3	0.377	0.885	C0752255	Impairment, Light Touch Sensation	phenotype	C23;C10	Sign or Symptom	0.30	1	1995	1995	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0752256	Pain Sensation Diminished	phenotype	C23;C10	Sign or Symptom	0.30	1	1995	1995	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0752257	Pinprick Sensation Diminished	phenotype	C23;C10	Sign or Symptom	0.30	1	1995	1995	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0752258	Position Sense Disorders	phenotype	C23;C10	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0752260	Proprioceptive Disorders	phenotype	C23;C10	Sign or Symptom	0.30	1	1995	1995	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0752261	Thermal Sensation Disorders	phenotype	C23;C10	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0752262	Somatosensory Disorders	group	C23;C10	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0877578	Treatment related secondary malignancy	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0877781	Hemicrania	phenotype	C23	Sign or Symptom	0.30	1	2000	2000	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C0887900	Upper Aerodigestive Tract Neoplasms	group	C04	Neoplastic Process	0.30	1	1993	1993	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	1993	2006	   8	   0	CTD_human
     1440	CSF3	0.377	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C1266194	Lymphocyte Rich Classical Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C1274933	Drug-Induced Stevens Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C1318973	Staphylococcus aureus infection	disease	C01	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C1334968	Nodular Lymphocyte Predominant Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.32	1	1993	2018	   8	   0	CTD_human
     1440	CSF3	0.377	0.885	C1527383	Morphea	disease	C17	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C1565321	Cholera Infantum	disease	C06	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C1568868	Oral Mucositis	disease	C07	Disease or Syndrome	0.31	1	2002	2017	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.30	1	2009	2010	   2	   0	CTD_human
     1440	CSF3	0.377	0.885	C1719672	Severe Sepsis	disease	C23;C01	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	1994	1994	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C3658301	Mycoplasma-Induced Stevens-Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C3658302	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C3714542	Lymphoma, Diffuse	disease	C04;C20;C15	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.35	1	2008	2020	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	1993	2006	   8	   0	CTD_human
     1440	CSF3	0.377	0.885	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.31	1	1998	2019	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1440	CSF3	0.377	0.885	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.39	1	1996	2020	   1	   0	CTD_human
     1441	CSF3R	0.55	0.692	C0023418	leukemia	disease	C04	Neoplastic Process	0.40	1	2001	2018	   0	   0	CGI
     1441	CSF3R	0.55	0.692	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.50	0.98	1995	2019	   0	   1	CGI
     1441	CSF3R	0.55	0.692	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.44	1	1997	2016	   0	   2	CGI
     1441	CSF3R	0.55	0.692	C0023481	Chronic Neutrophilic Leukemia	disease	C15	Neoplastic Process	0.60	0.935	2013	2020	   1	   0	CGI;ORPHANET
     1441	CSF3R	0.55	0.692	C0023518	Leukocytosis	phenotype	C23;C15	Disease or Syndrome	0.32	1	2009	2018	   1	   0	CTD_human
     1441	CSF3R	0.55	0.692	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CGI
     1441	CSF3R	0.55	0.692	C0151857	Pleocytosis	disease	C23;C15	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1441	CSF3R	0.55	0.692	C0340970	Congenital neutropenia	disease	C16;C15	Congenital Abnormality	0.40	0.967	1994	2020	   2	   0	GENOMICS_ENGLAND
     1441	CSF3R	0.55	0.692	C0543669	Neutrophilia, Hereditary	disease	C15	Disease or Syndrome	0.83	1	1998	2014	   1	   1	ORPHANET;UNIPROT
     1441	CSF3R	0.55	0.692	C1292772	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	disease	C04;C15	Neoplastic Process	0.59	1	2013	2020	   1	   0	CGI;ORPHANET
     1441	CSF3R	0.55	0.692	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.40	1	1998	2019	   0	   0	CGI
     1441	CSF3R	0.55	0.692	C4310764	NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.70	1	2009	2015	   3	   7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1442	CSH1	0.566	0.808	C0175693	Russell-Silver syndrome	disease	C16;C05	Disease or Syndrome	0.33	1	1998	2003	   1	   0	CTD_human
     1445	CSK	0.606	0.692	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1445	CSK	0.606	0.692	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.32	1	2012	2015	   1	   0	CTD_human
     1445	CSK	0.606	0.692	C0242380	Libman-Sacks Disease	disease	C17;C20	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1445	CSK	0.606	0.692	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2006	2006	   1	   0	CTD_human
     1445	CSK	0.606	0.692	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1445	CSK	0.606	0.692	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1445	CSK	0.606	0.692	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1445	CSK	0.606	0.692	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1445	CSK	0.606	0.692	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1447	CSN2	0.641	0.538	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	1998	2005	   2	   0	CTD_human
     1447	CSN2	0.641	0.538	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	1998	2005	   2	   0	CTD_human
     1447	CSN2	0.641	0.538	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1998	2005	   2	   0	CTD_human
     1447	CSN2	0.641	0.538	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	1998	2005	   2	   0	CTD_human
     1447	CSN2	0.641	0.538	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	1998	2005	   2	   0	CTD_human
     1447	CSN2	0.641	0.538	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	1998	2005	   2	   0	CTD_human
     1447	CSN2	0.641	0.538	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	1998	2005	   2	   0	CTD_human
     1447	CSN2	0.641	0.538	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	1998	2005	   2	   0	CTD_human
     1448	CSN3	0.736	0.346	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1448	CSN3	0.736	0.346	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1448	CSN3	0.736	0.346	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     1448	CSN3	0.736	0.346	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1448	CSN3	0.736	0.346	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1448	CSN3	0.736	0.346	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1448	CSN3	0.736	0.346	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1448	CSN3	0.736	0.346	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     1452	CSNK1A1	0.686	0.385	C0023493	Adult T-Cell Lymphoma/Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1452	CSNK1A1	0.686	0.385	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
     1453	CSNK1D	0.65	0.615	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.34	1	2008	2018	   0	   0	UNIPROT
     1453	CSNK1D	0.65	0.615	C1858496	Advanced Sleep-Phase Syndrome, Familial	disease	C10;F03;C24	Disease or Syndrome	0.51	1	2005	2005	   1	   0	CTD_human;ORPHANET
     1453	CSNK1D	0.65	0.615	C3808874	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2	disease		Disease or Syndrome	0.60	1	2005	2015	   3	   2	GENOMICS_ENGLAND;UNIPROT
     1454	CSNK1E	0.619	0.615	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2003	2019	   5	   0	PSYGENET
     1454	CSNK1E	0.619	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2012	2012	   2	   0	PSYGENET
     1454	CSNK1E	0.619	0.615	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     1457	CSNK2A1	0.597	0.731	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1457	CSNK2A1	0.597	0.731	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1457	CSNK2A1	0.597	0.731	C0023493	Adult T-Cell Lymphoma/Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1457	CSNK2A1	0.597	0.731	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.31	1	2016	2019	   1	   0	GENOMICS_ENGLAND
     1457	CSNK2A1	0.597	0.731	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1457	CSNK2A1	0.597	0.731	C4310739	OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME	disease		Disease or Syndrome	0.72	1	2016	2020	   1	   9	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1459	CSNK2A2	0.644	0.577	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1459	CSNK2A2	0.644	0.577	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1459	CSNK2A2	0.644	0.577	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1460	CSNK2B	0.686	0.538	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1460	CSNK2B	0.686	0.538	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1460	CSNK2B	0.686	0.538	C0023493	Adult T-Cell Lymphoma/Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1460	CSNK2B	0.686	0.538	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1462	VCAN	0.497	0.808	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1462	VCAN	0.497	0.808	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1462	VCAN	0.497	0.808	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1462	VCAN	0.497	0.808	C0036095	Salivary Gland Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1462	VCAN	0.497	0.808	C0220636	Malignant neoplasm of salivary gland	disease	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1462	VCAN	0.497	0.808	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1462	VCAN	0.497	0.808	C1840452	Hyaloideoretinal degeneration of Wagner	disease	C11	Disease or Syndrome	0.70	0.938	1999	2018	   0	   0	CTD_human;GENOMICS_ENGLAND
     1462	VCAN	0.497	0.808	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1463	NCAN	0.67	0.5	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.68	1	2011	2019	   6	   2	CTD_human;PSYGENET
     1463	NCAN	0.67	0.5	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
     1463	NCAN	0.67	0.5	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1463	NCAN	0.67	0.5	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1463	NCAN	0.67	0.5	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
     1463	NCAN	0.67	0.5	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.35	1	2011	2015	   3	   0	PSYGENET
     1463	NCAN	0.67	0.5	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2019	   1	   0	CTD_human
     1464	CSPG4	0.599	0.615	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2015	2017	   1	   0	CTD_human
     1465	CSRP1	0.686	0.346	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
     1465	CSRP1	0.686	0.346	C0014173	Endometrial Hyperplasia	disease	C13	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1465	CSRP1	0.686	0.346	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1465	CSRP1	0.686	0.346	C0349578	Complex Endometrial Hyperplasia	disease	C13	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1465	CSRP1	0.686	0.346	C0349579	Atypical Endometrial Hyperplasia	disease	C13	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1465	CSRP1	0.686	0.346	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2007	2008	   1	   0	CTD_human
     1465	CSRP1	0.686	0.346	C0456483	Simple Endometrial Hyperplasia	disease	C13	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1465	CSRP1	0.686	0.346	C0746402	manic symptom	phenotype		Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     1468	SLC25A10	0.666	0.5	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1468	SLC25A10	0.666	0.5	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1468	SLC25A10	0.666	0.5	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2002	2002	   1	   0	CTD_human
     1468	SLC25A10	0.666	0.5	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1468	SLC25A10	0.666	0.5	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1468	SLC25A10	0.666	0.5	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1468	SLC25A10	0.666	0.5	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1468	SLC25A10	0.666	0.5	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1469	CST1	0.659	0.577	C0018621	Hay fever	disease	C08;C20;C09	Disease or Syndrome	0.32	1	2013	2017	   1	   0	CTD_human
     1469	CST1	0.659	0.577	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
     1469	CST1	0.659	0.577	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1469	CST1	0.659	0.577	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1469	CST1	0.659	0.577	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1469	CST1	0.659	0.577	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.40	0.935	1988	2019	   2	   0	CTD_human
     1471	CST3	0.436	0.808	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.40	0.96	2004	2019	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.35	1	1996	2019	   2	   0	CTD_human
     1471	CST3	0.436	0.808	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2017	2017	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.40	1	2006	2020	   2	   0	CTD_human
     1471	CST3	0.436	0.808	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.40	1	2011	2020	   2	   0	CTD_human
     1471	CST3	0.436	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.31	1	2005	2007	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0025286	Meningioma	disease	C04;C10	Neoplastic Process	0.32	1	2005	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0029172	Oral Submucous Fibrosis	disease	C07	Disease or Syndrome	0.31	1	2002	2006	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.50	1	1989	2020	   0	   0	GENOMICS_ENGLAND
     1471	CST3	0.436	0.808	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0205834	Meningiomas, Multiple	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0259785	Malignant Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0268393	Familial Cerebral Amyloid Angiopathy	disease	C16;C18;C10;C14	Disease or Syndrome	0.31	1	2008	2013	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.30	1	2007	2007	   2	   0	CTD_human
     1471	CST3	0.436	0.808	C0281784	Benign Meningioma	disease	C04;C10	Neoplastic Process	0.31	1	2005	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0334605	Meningothelial meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0334606	Fibrous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0334607	Psammomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0334608	Angiomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0334609	Hemangioblastic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0334610	Hemangiopericytic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0334611	Transitional Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0347515	Spinal Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0349604	Intracranial Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0431121	Clear Cell Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0457190	Xanthomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0494463	Alzheimer Disease, Late Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.37	0.778	2000	2009	   2	   0	CTD_human
     1471	CST3	0.436	0.808	C0497327	Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.46	1	1996	2019	   0	   0	GENOMICS_ENGLAND
     1471	CST3	0.436	0.808	C0546126	Acute Confusional Senile Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   2	   0	CTD_human
     1471	CST3	0.436	0.808	C0553692	Brain hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30				   0	   0	GENOMICS_ENGLAND
     1471	CST3	0.436	0.808	C0750900	Alzheimer's Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   2	   0	CTD_human
     1471	CST3	0.436	0.808	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.31	1	1993	2007	   2	   0	CTD_human
     1471	CST3	0.436	0.808	C0751303	Cerebral Convexity Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C0751304	Parasagittal Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C1334261	Intraorbital Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C1334271	Intraventricular Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C1335107	Olfactory Groove Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C1384406	Secretory meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C1384408	Microcystic meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C1510489	Cerebral Amyloid Angiopathy, Hereditary	disease	C16;C18;C10;C14	Disease or Syndrome	0.39	1	1983	2008	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C1527197	Angioblastic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C1527338	Hereditary Cerebral Amyloid Angiopathy, Icelandic Type	disease	C16;C18;C10;C14	Disease or Syndrome	0.77	1	1987	2013	   5	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1471	CST3	0.436	0.808	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2011	2017	   2	   0	CTD_human
     1471	CST3	0.436	0.808	C1565950	Posterior Fossa Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C1565951	Sphenoid Wing Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.31	1	2002	2017	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C1956349	Cerebral Amyloid Angiopathy, Genetic	disease	C16;C18;C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2011	2017	   2	   0	CTD_human
     1471	CST3	0.436	0.808	C2677774	Age-Related Macular Degeneration type 11	disease	C11	Disease or Syndrome	0.60	1	1989	2009	   3	   1	CTD_human;UNIPROT
     1471	CST3	0.436	0.808	C3163622	Papillary Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1471	CST3	0.436	0.808	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1472	CST4	0.743	0.462	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
     1474	CST6	0.612	0.615	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1997	2014	   1	   0	CTD_human
     1474	CST6	0.612	0.615	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1474	CST6	0.612	0.615	C0025202	melanoma	disease	C04	Neoplastic Process	0.31	1	2012	2017	   1	   0	CTD_human
     1474	CST6	0.612	0.615	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
     1474	CST6	0.612	0.615	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
     1474	CST6	0.612	0.615	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1997	2014	   1	   0	CTD_human
     1474	CST6	0.612	0.615	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1474	CST6	0.612	0.615	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.39	0.889	2004	2016	   1	   0	CTD_human
     1474	CST6	0.612	0.615	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1475	CSTA	0.592	0.731	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1475	CSTA	0.592	0.731	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.34	1	2005	2019	   1	   0	CTD_human
     1475	CSTA	0.592	0.731	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2010	2012	   2	   0	CTD_human
     1475	CSTA	0.592	0.731	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1475	CSTA	0.592	0.731	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1475	CSTA	0.592	0.731	C1838440	ICHTHYOSIS EXFOLIATIVA	disease	C16;C17	Disease or Syndrome	0.34	1	2011	2016	   1	   0	ORPHANET
     1475	CSTA	0.592	0.731	C1842797	Exfoliative Ichthyosis, Autosomal Recessive, Ichthyosis Bullosa of Siemens-like	disease	C16;C17	Disease or Syndrome	0.50				   0	   0	CTD_human;GENOMICS_ENGLAND
     1475	CSTA	0.592	0.731	C1853354	Peeling skin syndrome, acral type	disease	C17	Disease or Syndrome	0.31	1	2016	2016	   1	   0	ORPHANET
     1475	CSTA	0.592	0.731	C2931822	Nasopharyngeal carcinoma	disease	C04;C07;C09	Neoplastic Process	0.31	1	2010	2010	   1	   0	CTD_human
     1475	CSTA	0.592	0.731	C4225407	PEELING SKIN SYNDROME 4	disease		Disease or Syndrome	0.41	1	2011	2016	   2	   4	GENOMICS_ENGLAND
     1476	CSTB	0.53	0.692	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0025286	Meningioma	disease	C04;C10	Neoplastic Process	0.32	1	2005	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2010	2012	   2	   0	CTD_human
     1476	CSTB	0.53	0.692	C0205834	Meningiomas, Multiple	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0259785	Malignant Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0281784	Benign Meningioma	disease	C04;C10	Neoplastic Process	0.31	1	2005	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0334605	Meningothelial meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0334606	Fibrous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0334607	Psammomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0334608	Angiomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0334609	Hemangioblastic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0334610	Hemangiopericytic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0334611	Transitional Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0347515	Spinal Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0349604	Intracranial Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0431121	Clear Cell Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0457190	Xanthomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0751303	Cerebral Convexity Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0751304	Parasagittal Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C0751785	Unverricht-Lundborg Syndrome	disease	C16;C10	Disease or Syndrome	1.00	0.984	1994	2019	   7	  13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1476	CSTB	0.53	0.692	C1334261	Intraorbital Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C1334271	Intraventricular Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C1335107	Olfactory Groove Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C1384406	Secretory meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C1384408	Microcystic meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C1527197	Angioblastic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C1565950	Posterior Fossa Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C1565951	Sphenoid Wing Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.31	1	2003	2012	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C3163622	Papillary Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1476	CSTB	0.53	0.692	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     1482	NKX2-5	0.533	0.692	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.46	0.889	2006	2019	   3	   0	CTD_human
     1482	NKX2-5	0.533	0.692	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.31	1	2017	2017	   1	   0	CTD_human
     1482	NKX2-5	0.533	0.692	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2017	2017	   1	   0	CTD_human
     1482	NKX2-5	0.533	0.692	C0018816	Heart Septal Defects	group	C16;C14	Congenital Abnormality	0.42	0.5	2009	2019	   0	   0	GENOMICS_ENGLAND
     1482	NKX2-5	0.533	0.692	C0018818	Ventricular Septal Defects	group	C16;C14	Congenital Abnormality	0.49	1	2005	2017	   0	   0	CTD_human
     1482	NKX2-5	0.533	0.692	C0027126	Myotonic Dystrophy	disease	C16;C05;C10	Disease or Syndrome	0.31	1	2008	2008	   1	   0	CTD_human
     1482	NKX2-5	0.533	0.692	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.31	1	2009	2018	   1	   0	CTD_human
     1482	NKX2-5	0.533	0.692	C0039685	Tetralogy of Fallot	disease	C16;C14	Congenital Abnormality	0.96	0.909	1999	2018	   4	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1482	NKX2-5	0.533	0.692	C0085298	Sudden Cardiac Death	phenotype	C23;C14	Pathologic Function	0.30				   0	   0	GENOMICS_ENGLAND
     1482	NKX2-5	0.533	0.692	C0149630	Bicuspid aortic valve	disease	C14	Congenital Abnormality	0.42	1	2006	2016	   1	   0	ORPHANET
     1482	NKX2-5	0.533	0.692	C0152101	Hypoplastic Left Heart Syndrome	disease	C16;C14	Disease or Syndrome	0.81	1	2003	2017	   3	   0	CTD_human;ORPHANET
     1482	NKX2-5	0.533	0.692	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2010	2018	   3	   0	CTD_human
     1482	NKX2-5	0.533	0.692	C0266283	Ectopic thyroid tissue (disorder)	phenotype		Disease or Syndrome	0.40	1	2006	2006	   1	   0	ORPHANET
     1482	NKX2-5	0.533	0.692	C0344724	Ostium secundum atrial septal defect	disease	C16;C14	Congenital Abnormality	0.43	1	2003	2017	   2	   0	ORPHANET
     1482	NKX2-5	0.533	0.692	C0410226	Congenital Myotonic Dystrophy	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1482	NKX2-5	0.533	0.692	C0428791	Aortic valve calcification	disease	C18;C14	Disease or Syndrome	0.40	1	2014	2014	   1	   0	ORPHANET
     1482	NKX2-5	0.533	0.692	C0685889	Splenic Hypoplasia	disease	C16;C20	Congenital Abnormality	0.31	1	2012	2012	   1	   0	ORPHANET
     1482	NKX2-5	0.533	0.692	C0749420	Thyroid Agenesis	disease	C16;C19	Congenital Abnormality	0.40	1	2006	2006	   1	   0	ORPHANET
     1482	NKX2-5	0.533	0.692	C0751956	Acute Cerebrovascular Accidents	disease	C10;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1482	NKX2-5	0.533	0.692	C1260873	Aortic valve disorder	disease	C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	ORPHANET
     1482	NKX2-5	0.533	0.692	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
     1482	NKX2-5	0.533	0.692	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.33	1	2015	2017	   1	   0	CTD_human
     1482	NKX2-5	0.533	0.692	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	disease	C23;C14	Disease or Syndrome	0.30	1	2012	2013	   2	   0	ORPHANET
     1482	NKX2-5	0.533	0.692	C1857586	CONOTRUNCAL HEART MALFORMATIONS (disorder)	disease	C16;C14	Disease or Syndrome	0.60	1	2003	2012	   3	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1482	NKX2-5	0.533	0.692	C1879286	Hereditary bundle branch system defect	disease	C23;C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	ORPHANET
     1482	NKX2-5	0.533	0.692	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2010	2018	   3	   0	CTD_human
     1482	NKX2-5	0.533	0.692	C2673630	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5 (disorder)	disease	C16;C05;C19	Disease or Syndrome	0.60	1	2006	2006	   1	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1482	NKX2-5	0.533	0.692	C2931574	Chromosome 5, monosomy 5q35	disease	C23;C16;C10	Cell or Molecular Dysfunction	0.30	1	2007	2007	   1	   0	ORPHANET
     1482	NKX2-5	0.533	0.692	C2931689	Dystrophia myotonica 2	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1482	NKX2-5	0.533	0.692	C3276096	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	disease		Disease or Syndrome	0.80	1	1998	2017	   6	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1482	NKX2-5	0.533	0.692	C3280785	VENTRICULAR SEPTAL DEFECT 3	disease		Disease or Syndrome; Congenital Abnormality	0.50	1	2010	2011	   2	   0	GENOMICS_ENGLAND;UNIPROT
     1482	NKX2-5	0.533	0.692	C3280795	HYPOPLASTIC LEFT HEART SYNDROME 2	disease		Disease or Syndrome	0.50	1	2003	2005	   2	   0	GENOMICS_ENGLAND;UNIPROT
     1482	NKX2-5	0.533	0.692	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2010	2018	   3	   0	CTD_human
     1482	NKX2-5	0.533	0.692	C3502353	Atrial Septal Defect with Atrioventricular Conduction Defects	disease	C23;C16;C14	Disease or Syndrome	0.70	1	2008	2017	   2	   0	GENOMICS_ENGLAND;ORPHANET
     1482	NKX2-5	0.533	0.692	C3887892	Aortic Valve Disease 1	disease	C16;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	ORPHANET
     1482	NKX2-5	0.533	0.692	C4277690	Ciliopathies	disease	C16	Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
     1487	CTBP1	0.559	0.692	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2006	2006	   1	   0	CTD_human
     1487	CTBP1	0.559	0.692	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1487	CTBP1	0.559	0.692	C0796117	Pitt-Rogers-Danks Syndrome	disease	C16	Disease or Syndrome	0.30				   0	   0	CTD_human
     1487	CTBP1	0.559	0.692	C1956097	Wolf-Hirschhorn Syndrome	disease	C16	Disease or Syndrome	0.30				   0	   0	CTD_human
     1487	CTBP1	0.559	0.692	C4693578	HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME	disease		Disease or Syndrome	0.60	1	2016	2019	   3	   0	GENOMICS_ENGLAND;UNIPROT
     1488	CTBP2	0.638	0.615	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     1488	CTBP2	0.638	0.615	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
     1488	CTBP2	0.638	0.615	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1488	CTBP2	0.638	0.615	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.46	1	2008	2018	   1	   1	CTD_human
     1489	CTF1	0.636	0.423	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2008	2008	   2	   0	CTD_human
     1489	CTF1	0.636	0.423	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1489	CTF1	0.636	0.423	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	2001	2001	   1	   0	CTD_human
     1489	CTF1	0.636	0.423	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1489	CTF1	0.636	0.423	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1489	CTF1	0.636	0.423	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2013	2013	   1	   0	CTD_human
     1489	CTF1	0.636	0.423	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.33	1	2011	2018	   1	   0	CTD_human
     1489	CTF1	0.636	0.423	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1489	CTF1	0.636	0.423	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2008	2008	   2	   0	CTD_human
     1490	CCN2	0.399	0.846	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.32	1	2004	2011	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0003504	Aortic Valve Insufficiency	disease	C14	Disease or Syndrome	0.50	1	2009	2011	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.39	1	2006	2020	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0005398	Cholestasis, Extrahepatic	disease	C06	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0017668	Focal glomerulosclerosis	disease	C13;C12	Disease or Syndrome	0.31	1	2006	2011	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.40	1	2006	2019	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.50	1	2005	2019	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.36	0.857	2006	2019	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0021361	Female infertility	phenotype	C13	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0023485	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2007	2014	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.35	1	1999	2016	   3	   0	CTD_human
     1490	CCN2	0.399	0.846	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2010	2014	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.31	1	2010	2017	   2	   0	CTD_human
     1490	CCN2	0.399	0.846	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0033054	Prenatal Exposure Delayed Effects	disease	C13	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.70	0.963	2001	2019	   4	   0	CTD_human
     1490	CCN2	0.399	0.846	C0036421	Systemic Scleroderma	disease	C17	Disease or Syndrome	0.40	0.957	1995	2019	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0038279	Sterility, Postpartum	phenotype	C13	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0086432	Hyalinosis, Segmental Glomerular	disease	C13;C12	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0206138	CREST Syndrome	disease	C06;C18;C17;C14	Disease or Syndrome	0.30				   0	   0	ORPHANET
     1490	CCN2	0.399	0.846	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0235833	Congenital diaphragmatic hernia	disease	C23;C16	Congenital Abnormality	0.30	1	2010	2011	   2	   0	CTD_human
     1490	CCN2	0.399	0.846	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.40	0.966	1999	2019	   3	   0	CTD_human
     1490	CCN2	0.399	0.846	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.35	1	2000	2019	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0265699	Congenital hernia of foramen of Morgagni	disease	C23;C16	Congenital Abnormality	0.30	1	2010	2011	   2	   0	CTD_human
     1490	CCN2	0.399	0.846	C0265700	Congenital hernia of foramen of Bochdalek	disease	C23;C16	Congenital Abnormality	0.30	1	2010	2011	   2	   0	CTD_human
     1490	CCN2	0.399	0.846	C0341869	Subfertility, Female	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0524909	Hepatitis B, Chronic	disease	C06;C01	Disease or Syndrome	0.33	1	2007	2015	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C0748540	Scleroderma, Limited	disease	C17	Disease or Syndrome	0.30				   0	   0	ORPHANET
     1490	CCN2	0.399	0.846	C0917730	Female sterility	phenotype	C13	Finding	0.30	1	2011	2011	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C1258104	Diffuse Scleroderma	disease	C17	Disease or Syndrome	0.31	1	2011	2011	   0	   0	ORPHANET
     1490	CCN2	0.399	0.846	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
     1490	CCN2	0.399	0.846	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2004	2016	   4	   0	CTD_human
     1491	CTH	0.578	0.615	C0015934	Fetal Growth Retardation	phenotype	C23;C16;C13	Disease or Syndrome	0.31	1	2012	2017	   1	   0	CTD_human
     1491	CTH	0.578	0.615	C0025202	melanoma	disease	C04	Neoplastic Process	0.31	1	2015	2015	   1	   0	CTD_human
     1491	CTH	0.578	0.615	C0035320	Retinal Neovascularization	phenotype	C23;C11	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
     1491	CTH	0.578	0.615	C0220993	Cystathioninuria	phenotype	C16;C18	Disease or Syndrome	0.94	1	1986	2019	   8	   3	CLINGEN;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1491	CTH	0.578	0.615	C0268616	Gamma-cystathionase deficiency	disease	C16;C18	Disease or Syndrome	0.94	1	1986	2019	   6	   0	CLINGEN;CTD_human;ORPHANET
     1491	CTH	0.578	0.615	C3495552	Cystathionase Deficiency	disease	C16;C18	Disease or Syndrome	0.30	1	1986	2012	   6	   0	CLINGEN
     1491	CTH	0.578	0.615	C4017108	HOMOCYSTEINE, TOTAL PLASMA, ELEVATED	disease		Finding	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     1493	CTLA4	0.369	0.923	C0002171	Alopecia Areata	disease	C17	Disease or Syndrome	0.41	1	2010	2018	   1	   1	CTD_human
     1493	CTLA4	0.369	0.923	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.40	0.931	1998	2019	   2	   0	CTD_human
     1493	CTLA4	0.369	0.923	C0004368	Autoimmune state	phenotype		Pathologic Function	0.40	1	2014	2014	   1	   0	GENOMICS_ENGLAND
     1493	CTLA4	0.369	0.923	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2004	2011	   2	   0	PSYGENET
     1493	CTLA4	0.369	0.923	C0007570	Celiac Disease	disease	C06;C18	Disease or Syndrome	0.40	0.9	1981	2016	   0	   0	CTD_human
     1493	CTLA4	0.369	0.923	C0009447	Common Variable Immunodeficiency	disease	C20	Disease or Syndrome	0.35	0.833	2007	2015	   1	   0	GENOMICS_ENGLAND
     1493	CTLA4	0.369	0.923	C0018133	Graft-vs-Host Disease	disease	C20	Disease or Syndrome	0.36	1	2003	2018	   1	   0	CTD_human
     1493	CTLA4	0.369	0.923	C0018213	Graves Disease	disease	C11;C20;C19	Disease or Syndrome	0.40	0.906	1995	2020	   3	   0	CTD_human
     1493	CTLA4	0.369	0.923	C0021831	Intestinal Diseases	group	C06	Disease or Syndrome	0.31	0.5	2005	2014	   1	   0	GENOMICS_ENGLAND
     1493	CTLA4	0.369	0.923	C0023493	Adult T-Cell Lymphoma/Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1493	CTLA4	0.369	0.923	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.70	0.829	1998	2020	   1	   0	CTD_human;ORPHANET
     1493	CTLA4	0.369	0.923	C0025202	melanoma	disease	C04	Neoplastic Process	0.40	0.946	2008	2020	   1	   0	CTD_human
     1493	CTLA4	0.369	0.923	C0026948	Mycosis Fungoides	group	C04;C20;C15	Neoplastic Process	0.31	1	2006	2015	   1	   0	ORPHANET
     1493	CTLA4	0.369	0.923	C0029172	Oral Submucous Fibrosis	disease	C07	Disease or Syndrome	0.31	1	2004	2006	   1	   0	CTD_human
     1493	CTLA4	0.369	0.923	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2002	2015	   3	   0	PSYGENET
     1493	CTLA4	0.369	0.923	C0036920	Sezary Syndrome	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	ORPHANET
     1493	CTLA4	0.369	0.923	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	0.5	2001	2011	   2	   0	PSYGENET
     1493	CTLA4	0.369	0.923	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.43	1	2006	2018	   1	   0	CTD_human
     1493	CTLA4	0.369	0.923	C0086438	Hypogammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.33	1	2014	2019	   1	   0	GENOMICS_ENGLAND
     1493	CTLA4	0.369	0.923	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1493	CTLA4	0.369	0.923	C0242380	Libman-Sacks Disease	disease	C17;C20	Disease or Syndrome	0.30				   0	   0	CTD_human
     1493	CTLA4	0.369	0.923	C0376407	Granulomatous Slack Skin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1493	CTLA4	0.369	0.923	C0494261	Combined immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
     1493	CTLA4	0.369	0.923	C0497156	Lymphadenopathy	phenotype	C15	Disease or Syndrome	0.41	1	2014	2019	   1	   0	GENOMICS_ENGLAND
     1493	CTLA4	0.369	0.923	C0677607	Hashimoto Disease	disease	C19	Disease or Syndrome	0.50	0.955	1998	2019	   0	   0	CTD_human
     1493	CTLA4	0.369	0.923	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	0.5	2001	2011	   2	   0	PSYGENET
     1493	CTLA4	0.369	0.923	C1832392	DIABETES MELLITUS, INSULIN-DEPENDENT, 12	disease	C18;C20;C19	Disease or Syndrome	0.31	1	1999	1999	   0	   0	CTD_human
     1493	CTLA4	0.369	0.923	C1844666	Immune dysregulation	phenotype		Finding	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
     1493	CTLA4	0.369	0.923	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.33	1	2006	2010	   1	   0	CTD_human
     1493	CTLA4	0.369	0.923	C3495801	Granulomatosis with polyangiitis	disease	C08;C20;C14	Disease or Syndrome	0.36	1	2000	2012	   1	   0	ORPHANET
     1493	CTLA4	0.369	0.923	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1493	CTLA4	0.369	0.923	C4015214	CTLA4 Haploinsufficiency	disease	C20	Disease or Syndrome	0.75	1	2014	2019	   2	   5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1493	CTLA4	0.369	0.923	C4316788	Abnormality of the intestine	phenotype		Finding	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
     1493	CTLA4	0.369	0.923	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1493	CTLA4	0.369	0.923	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1493	CTLA4	0.369	0.923	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.41	1	2011	2011	   1	   0	CTD_human
     1493	CTLA4	0.369	0.923	C4728035	CTLA4 deficiency	disease		Disease or Syndrome	0.33	1	2014	2018	   1	   0	GENOMICS_ENGLAND
     1495	CTNNA1	0.584	0.538	C0009405	Hereditary Nonpolyposis Colorectal Neoplasms	group	C16;C06;C04;C18	Neoplastic Process	0.30				   0	   0	CLINGEN
     1495	CTNNA1	0.584	0.538	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.45	1	2007	2017	   1	  28	CTD_human
     1495	CTNNA1	0.584	0.538	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1495	CTNNA1	0.584	0.538	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
     1495	CTNNA1	0.584	0.538	C1112155	Hereditary non-polyposis colorectal cancer syndrome	disease		Congenital Abnormality	0.30				   0	   0	CLINGEN
     1495	CTNNA1	0.584	0.538	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.30				   0	   0	CLINGEN
     1495	CTNNA1	0.584	0.538	C1333991	Hereditary Non-Polyposis Colon Cancer Type 2	disease	C16;C04	Neoplastic Process	0.30				   0	   0	CLINGEN
     1495	CTNNA1	0.584	0.538	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.34	0.833	2013	2019	   3	   0	ORPHANET
     1495	CTNNA1	0.584	0.538	C1837029	Macular Dystrophy, Butterfly-Shaped Pigmentary, 2	disease	C11	Disease or Syndrome	0.80	1	2016	2016	   1	   4	CTD_human;UNIPROT
     1495	CTNNA1	0.584	0.538	C1868569	Patterned dystrophy of retinal pigment epithelium	disease	C11	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1495	CTNNA1	0.584	0.538	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1495	CTNNA1	0.584	0.538	C2713368	Hematopoetic Myelodysplasia	phenotype	C15	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
     1495	CTNNA1	0.584	0.538	C2936783	Colorectal cancer, hereditary nonpolyposis, type 1	disease	C16;C06;C04;C18	Neoplastic Process	0.30				   0	   0	CLINGEN
     1495	CTNNA1	0.584	0.538	C3179349	Gastrointestinal Stromal Sarcoma	disease	C06;C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
     1495	CTNNA1	0.584	0.538	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.33	1	2007	2014	   1	   0	CTD_human
     1495	CTNNA1	0.584	0.538	C4511237	Butterfly-shaped pigmentary macular dystrophy	disease		Disease or Syndrome	0.32	1	2016	2017	   1	   0	ORPHANET
     1496	CTNNA2	0.663	0.5	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.42	1	2014	2019	   1	   1	PSYGENET
     1496	CTNNA2	0.663	0.5	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1496	CTNNA2	0.663	0.5	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.41	1	2008	2018	   1	   1	PSYGENET
     1496	CTNNA2	0.663	0.5	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1496	CTNNA2	0.663	0.5	C0266463	Lissencephaly	disease	C16;C10	Congenital Abnormality	0.31	1	2018	2019	   1	   0	CTD_human
     1496	CTNNA2	0.663	0.5	C0266483	Pachygyria	disease	C16;C10	Congenital Abnormality	0.41	1	2018	2018	   1	   0	CTD_human
     1496	CTNNA2	0.663	0.5	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
     1496	CTNNA2	0.663	0.5	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1496	CTNNA2	0.663	0.5	C1879312	Agyria	disease	C16;C10	Congenital Abnormality	0.30	1	2018	2018	   1	   0	CTD_human
     1496	CTNNA2	0.663	0.5	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
     1496	CTNNA2	0.663	0.5	C4748540	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9	disease		Disease or Syndrome	0.40	1	2018	2018	   1	   3	GENOMICS_ENGLAND
     1497	CTNS	0.628	0.538	C0268626	Juvenile nephropathic cystinosis (disorder)	disease	C16;C18;C13;C12	Disease or Syndrome; Congenital Abnormality	0.71	1	1998	2017	   6	  13	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1497	CTNS	0.628	0.538	C2749685	CYSTINOSIS, ATYPICAL NEPHROPATHIC (disorder)	disease		Disease or Syndrome	0.40	1	1978	1978	   1	   2	GENOMICS_ENGLAND
     1497	CTNS	0.628	0.538	C2931013	Cystinosis, benign, nonnephropathic	disease	C16;C18	Disease or Syndrome	0.70	1	1998	2017	   4	  12	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1497	CTNS	0.628	0.538	C2931187	Nephropathic cystinosis	disease	C16;C18	Disease or Syndrome	1.00	0.98	1998	2019	  14	  54	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1497	CTNS	0.628	0.538	C4316899	Cystinosis	disease	C16;C18	Disease or Syndrome	0.50	0.956	1998	2019	   1	  25	CTD_human
     1499	CTNNB1	0.303	0.885	C0000772	Multiple congenital anomalies	group	C16	Congenital Abnormality	0.40	1	1991	2017	   1	   3	CTD_human
     1499	CTNNB1	0.303	0.885	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.40	0.969	1997	2019	   3	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0001430	Adenoma	group	C04	Neoplastic Process	0.40	0.959	1996	2019	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0001624	Adrenal Gland Neoplasms	group	C04;C19	Neoplastic Process	0.32	1	2010	2014	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.48	0.889	2002	2017	   0	   2	CGI
     1499	CTNNB1	0.303	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.976	1995	2020	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.978	1995	2020	   0	   0	CGI
     1499	CTNNB1	0.303	0.885	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.40	0.995	1997	2020	   9	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0007103	Malignant neoplasm of endometrium	disease	C04;C13	Neoplastic Process	0.40	1	1996	2019	   0	   0	CGI
     1499	CTNNB1	0.303	0.885	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.31	1	2003	2018	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0007528	Cecal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0007873	Uterine Cervical Neoplasm	disease	C04;C13	Neoplastic Process	0.41	1	2001	2016	   1	   4	CTD_human
     1499	CTNNB1	0.303	0.885	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.40	1	1998	2017	   9	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.70	0.983	1997	2020	   5	   3	CTD_human;UNIPROT
     1499	CTNNB1	0.303	0.885	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.70	0.985	1997	2019	   4	   6	CTD_human
     1499	CTNNB1	0.303	0.885	C0010276	Craniopharyngioma	disease	C04	Neoplastic Process	0.70	1	2004	2019	   1	   3	CTD_human;ORPHANET
     1499	CTNNB1	0.303	0.885	C0014518	Toxic Epidermal Necrolysis	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0018923	Hemangiosarcoma	disease	C04	Neoplastic Process	0.31	1	2003	2019	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2011	   3	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2011	   3	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0021841	Intestinal Neoplasms	group	C06;C04	Neoplastic Process	0.40	1	1999	2016	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.38	1	2008	2019	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.40	1	1998	2020	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2011	   3	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.40	1	2002	2019	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.80	0.979	1998	2020	   2	   9	CGI;CTD_human;UNIPROT
     1499	CTNNB1	0.303	0.885	C0025202	melanoma	disease	C04	Neoplastic Process	0.50	0.986	1996	2020	   0	  12	CGI
     1499	CTNNB1	0.303	0.885	C0026846	Muscular Atrophy	phenotype	C23;C10	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2013	2017	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	0.962	1996	2020	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	Neoplastic Process	0.40	0.909	2000	2019	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2002	2002	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0029925	Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.34	1	1998	2005	   0	   0	CGI
     1499	CTNNB1	0.303	0.885	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.37	1	2000	2018	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0031149	Peritoneal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.60	1	2002	2020	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0036095	Salivary Gland Neoplasms	group	C04;C07	Neoplastic Process	0.31	1	2018	2018	   0	   0	CGI
     1499	CTNNB1	0.303	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2010	2019	   2	   0	PSYGENET
     1499	CTNNB1	0.303	0.885	C0038325	Stevens-Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0079218	Fibromatosis, Aggressive	disease	C04	Neoplastic Process	0.70	0.974	1996	2019	   0	   0	CGI;ORPHANET
     1499	CTNNB1	0.303	0.885	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2011	   3	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.31	1	2009	2018	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.33	1	2009	2019	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.43	1	2001	2017	   0	  10	CGI
     1499	CTNNB1	0.303	0.885	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.50	1	2001	2019	   0	  10	CGI
     1499	CTNNB1	0.303	0.885	C0153437	Malignant neoplasm of cecum	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0153633	Malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.31	1	2009	2009	   0	   0	CGI
     1499	CTNNB1	0.303	0.885	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.35	1	2000	2018	   3	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2000	2005	   3	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2000	2005	   3	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2000	2005	   3	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2000	2005	   3	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.36	1	1999	2018	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.32	1	1999	2004	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.31	1	1999	2003	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	1999	2000	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	1999	2000	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	1999	2000	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0205833	Medullomyoblastoma	disease	C04	Neoplastic Process	0.30				   0	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0206624	Hepatoblastoma	disease	C04	Neoplastic Process	0.70	0.981	1999	2019	   1	   3	CGI;CTD_human
     1499	CTNNB1	0.303	0.885	C0206667	Adrenal Cortical Adenoma	disease	C04;C19	Neoplastic Process	0.39	1	2005	2012	   0	   0	CGI
     1499	CTNNB1	0.303	0.885	C0206669	Hepatocellular Adenoma	disease	C06;C04	Neoplastic Process	0.40	0.971	2002	2020	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0206686	Adrenocortical carcinoma	disease	C04;C19	Neoplastic Process	0.50	1	2005	2020	   1	   6	CTD_human
     1499	CTNNB1	0.303	0.885	C0206711	Pilomatrixoma	disease	C04	Neoplastic Process	0.80	1	1999	2019	   3	   8	CTD_human;ORPHANET;UNIPROT
     1499	CTNNB1	0.303	0.885	C0232347	No-Reflow Phenomenon	phenotype	C23	Finding	0.30	1	2007	2007	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2016	2017	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.50	0.917	2011	2019	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	0.984	1999	2019	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0262587	Parathyroid Adenoma	disease	C04;C19	Neoplastic Process	0.37	1	2002	2016	   0	   0	CGI
     1499	CTNNB1	0.303	0.885	C0270948	Neurogenic Muscular Atrophy	phenotype	C23;C10	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0278510	Childhood Medulloblastoma	disease	C04	Neoplastic Process	0.40	0.96	2000	2019	   0	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.44	1	2014	2018	   0	   8	CGI
     1499	CTNNB1	0.303	0.885	C0278875	Adult Craniopharyngioma	disease	C04	Neoplastic Process	0.34	1	2005	2019	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0278876	Adult Medulloblastoma	disease	C04	Neoplastic Process	0.40	0.96	2000	2019	   0	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0279606	Childhood Hepatocellular Carcinoma	disease	C06;C04	Neoplastic Process	0.33	1	1999	2017	   1	   0	ORPHANET
     1499	CTNNB1	0.303	0.885	C0279607	Adult Hepatocellular Carcinoma	disease	C06;C04	Neoplastic Process	0.33	1	1999	2017	   1	   0	ORPHANET
     1499	CTNNB1	0.303	0.885	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.50	0.976	1999	2019	   0	   1	CGI
     1499	CTNNB1	0.303	0.885	C0334634	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	disease	C04;C20;C15	Neoplastic Process	0.31	1	2008	2008	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0339539	Familial Exudative Vitreoretinopathy	disease		Congenital Abnormality	0.32	1	2017	2017	   1	   0	ORPHANET
     1499	CTNNB1	0.303	0.885	C0342649	Vascular calcification	phenotype	C18	Disease or Syndrome	0.34	1	2013	2019	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.40	1	1999	2019	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.35	1	2001	2018	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0346191	Carcinoma in situ of endometrium	disease	C04;C13	Neoplastic Process	0.30				   0	   0	CGI
     1499	CTNNB1	0.303	0.885	C0346627	Intestinal Cancer	disease	C06;C04	Neoplastic Process	0.33	1	1999	2016	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.40	0.976	2002	2020	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0346990	Carcinomatosis of peritoneal cavity	disease	C06;C04	Neoplastic Process	0.31	1	2010	2013	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.60	0.979	1998	2020	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2001	2001	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0431128	Papillary craniopharyngioma	disease	C04	Neoplastic Process	0.39	1	2002	2019	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0431129	Adamantinous Craniopharyngioma	disease	C04	Neoplastic Process	0.40	1	2002	2019	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0431350	Primary microcephaly	disease	C16;C05;C10	Congenital Abnormality	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     1499	CTNNB1	0.303	0.885	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.40	0.981	1996	2020	   0	   0	CGI
     1499	CTNNB1	0.303	0.885	C0496920	Neoplasm of uncertain or unknown behavior of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
     1499	CTNNB1	0.303	0.885	C0600519	Ventricular Remodeling	phenotype	C23	Organ or Tissue Function	0.30	1	2018	2018	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0600520	Left Ventricle Remodeling	phenotype	C23	Organ or Tissue Function	0.30	1	2018	2018	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.50	0.964	1995	2020	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0750887	Adrenal Cancer	disease	C04;C19	Neoplastic Process	0.31	1	2014	2018	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0751061	Craniopharyngioma, Child	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0751291	Desmoplastic Medulloblastoma	disease	C04	Neoplastic Process	0.30				   0	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0751958	Lymphoma, Lymphocytic, Intermediate	disease	C04;C20;C15	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.90	1	1999	2019	   1	   4	CGI;CTD_human
     1499	CTNNB1	0.303	0.885	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.90	1	1998	2019	   2	   2	CGI;CTD_human;UNIPROT
     1499	CTNNB1	0.303	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2002	2014	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C1274933	Drug-Induced Stevens Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C1275668	Melanotic medulloblastoma	disease	C04	Neoplastic Process	0.30				   0	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.32	1	2011	2018	   0	   0	CGI
     1499	CTNNB1	0.303	0.885	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.36	1	2003	2018	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	0.957	2000	2018	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C1535926	Neurodevelopmental Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2014	2017	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.38	1	2008	2019	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C1851402	Exudative vitreoretinopathy 1	disease	C16;C11	Disease or Syndrome	0.40	1	2017	2017	   1	   3	ORPHANET
     1499	CTNNB1	0.303	0.885	C1879526	Aberrant Crypt Foci	phenotype	C04	Finding	0.30	1	2000	2003	   3	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.80	0.982	1998	2020	   5	  16	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1499	CTNNB1	0.303	0.885	C2713615	Slow-Flow Phenomenon	phenotype	C23	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C2930471	Bilateral Wilms Tumor	disease	C16;C04;C13;C12	Disease or Syndrome	0.30	1	2011	2017	   2	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C3554449	MENTAL RETARDATION, AUTOSOMAL DOMINANT 19	disease		Disease or Syndrome	0.70	1	1989	2017	   6	  21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1499	CTNNB1	0.303	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C3658301	Mycoplasma-Induced Stevens-Johnson Syndrome	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C3658302	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	disease	C17;C20;C25;C07	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C4048328	cervical cancer	disease	C04;C13	Neoplastic Process	0.40	1	1997	2020	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1499	CTNNB1	0.303	0.885	C4539767	EXUDATIVE VITREORETINOPATHY 7	disease		Disease or Syndrome	0.60	1	2017	2017	   2	   3	GENOMICS_ENGLAND;UNIPROT
     1499	CTNNB1	0.303	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2002	2014	   2	   0	CTD_human
     1500	CTNND1	0.5	0.808	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
     1500	CTNND1	0.5	0.808	C1861536	Blepharo-cheilo-dontic syndrome	disease	C16;C11;C05;C07	Disease or Syndrome	0.31	1	2017	2017	   1	   0	ORPHANET
     1501	CTNND2	0.579	0.731	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1501	CTNND2	0.579	0.731	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2014	2015	   0	   0	UNIPROT
     1501	CTNND2	0.579	0.731	C0010314	Cri-du-Chat Syndrome	disease	C16;C10	Disease or Syndrome	0.35	1	2000	2019	   0	   0	ORPHANET
     1501	CTNND2	0.579	0.731	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1501	CTNND2	0.579	0.731	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2009	2014	   1	   0	PSYGENET
     1501	CTNND2	0.579	0.731	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
     1501	CTNND2	0.579	0.731	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1501	CTNND2	0.579	0.731	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
     1501	CTNND2	0.579	0.731	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1501	CTNND2	0.579	0.731	C1832841	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1	disease	C10	Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
     1501	CTNND2	0.579	0.731	C2931860	Monosomy 5p	disease	C16;C10	Cell or Molecular Dysfunction	0.30				   0	   0	ORPHANET
     1501	CTNND2	0.579	0.731	C3495676	Anorectal Malformations	group	C16;C06	Anatomical Abnormality	0.30	1	2013	2013	   1	   0	GENOMICS_ENGLAND
     1503	CTPS1	0.736	0.269	C4014617	IMMUNODEFICIENCY 24	disease		Disease or Syndrome	0.70	1	1998	2016	   2	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1503	CTPS1	0.736	0.269	C4706524	Severe combined immunodeficiency due to CTPS1 deficiency	disease		Disease or Syndrome	0.30	1	1998	1998	   1	   0	GENOMICS_ENGLAND
     1504	CTRB1	0.76	0.385	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1504	CTRB1	0.76	0.385	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     1504	CTRB1	0.76	0.385	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     1504	CTRB1	0.76	0.385	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2009	2009	   1	   0	CTD_human
     1506	CTRL	0.599	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2019	   1	   0	PSYGENET
     1508	CTSB	0.457	0.846	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1508	CTSB	0.457	0.846	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.40	1	1995	2018	   1	   0	CTD_human
     1508	CTSB	0.457	0.846	C0026848	Myopathy	group	C05;C10	Disease or Syndrome	0.30	1	1982	1982	   1	   0	CTD_human
     1508	CTSB	0.457	0.846	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2012	2012	   1	   0	CTD_human
     1508	CTSB	0.457	0.846	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2010	2010	   2	   0	CTD_human
     1508	CTSB	0.457	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1508	CTSB	0.457	0.846	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.30	1	1987	1987	   1	   0	CTD_human
     1508	CTSB	0.457	0.846	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2012	2012	   1	   0	CTD_human
     1508	CTSB	0.457	0.846	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1508	CTSB	0.457	0.846	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1508	CTSB	0.457	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.39	1	2000	2019	   1	   0	CTD_human
     1508	CTSB	0.457	0.846	C0406756	Keratolytic winter erythema	disease	C23;C16;C17	Disease or Syndrome; Congenital Abnormality	0.52	1	2012	2017	   1	   0	CTD_human;ORPHANET
     1508	CTSB	0.457	0.846	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1508	CTSB	0.457	0.846	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1508	CTSB	0.457	0.846	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1508	CTSB	0.457	0.846	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1508	CTSB	0.457	0.846	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.40	1	1995	2019	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.31	1	1995	2003	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1509	CTSD	0.478	0.846	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.31	1	1995	2009	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.34	1	1995	2019	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.31	1	2002	2019	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C1864669	NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCY	disease	C16;C18;C10	Disease or Syndrome	0.93	1	1995	2018	   4	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1509	CTSD	0.478	0.846	C1864670	Neuronal Ceroid Lipofuscinosis, Congenital	disease	C16;C18;C10	Disease or Syndrome	0.50	1	1995	2003	   0	   0	CTD_human
     1509	CTSD	0.478	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2012	2016	   1	   0	CTD_human
     1509	CTSD	0.478	0.846	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1510	CTSE	0.631	0.615	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
     1510	CTSE	0.631	0.615	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1510	CTSE	0.631	0.615	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1510	CTSE	0.631	0.615	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1510	CTSE	0.631	0.615	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1510	CTSE	0.631	0.615	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1510	CTSE	0.631	0.615	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1512	CTSH	0.626	0.654	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     1512	CTSH	0.626	0.654	C0011854	Diabetes Mellitus, Insulin-Dependent	disease	C18;C20;C19	Disease or Syndrome	0.43	1	2008	2015	   1	   2	CTD_human
     1512	CTSH	0.626	0.654	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1512	CTSH	0.626	0.654	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1512	CTSH	0.626	0.654	C0027404	Narcolepsy	disease	C10;F03	Disease or Syndrome	0.43	1	2013	2015	   1	   1	ORPHANET
     1512	CTSH	0.626	0.654	C0205734	Diabetes, Autoimmune	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1512	CTSH	0.626	0.654	C0342302	Brittle diabetes	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1512	CTSH	0.626	0.654	C0751362	Narcolepsy-Cataplexy Syndrome	disease	C10;F03	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     1512	CTSH	0.626	0.654	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1512	CTSH	0.626	0.654	C3837958	Diabetes Mellitus, Ketosis-Prone	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1512	CTSH	0.626	0.654	C4554117	Diabetes Mellitus, Sudden-Onset	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1513	CTSK	0.497	0.808	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.35	1	2014	2018	   1	   0	CTD_human
     1513	CTSK	0.497	0.808	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.39	1	2002	2019	   1	   0	CTD_human
     1513	CTSK	0.497	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2006	2009	   2	   0	PSYGENET
     1513	CTSK	0.497	0.808	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     1513	CTSK	0.497	0.808	C0238402	Pycnodysostosis	disease	C16;C18;C05	Disease or Syndrome	0.80	0.979	1996	2019	  11	  35	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1513	CTSK	0.497	0.808	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1513	CTSK	0.497	0.808	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
     1513	CTSK	0.497	0.808	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.35	1	2014	2018	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0025286	Meningioma	disease	C04;C10	Neoplastic Process	0.32	1	2005	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.30	1	1987	1987	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0205834	Meningiomas, Multiple	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0259785	Malignant Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0281784	Benign Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0334605	Meningothelial meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0334606	Fibrous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0334607	Psammomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0334608	Angiomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0334609	Hemangioblastic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0334610	Hemangiopericytic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0334611	Transitional Meningioma	disease	C04;C10	Neoplastic Process	0.31	0.5	2005	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0347515	Spinal Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0349604	Intracranial Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0431121	Clear Cell Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0457190	Xanthomatous Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0751303	Cerebral Convexity Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C0751304	Parasagittal Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C1334261	Intraorbital Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C1334271	Intraventricular Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C1335107	Olfactory Groove Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C1384406	Secretory meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C1384408	Microcystic meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C1527197	Angioblastic Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C1565950	Posterior Fossa Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C1565951	Sphenoid Wing Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1514	CTSL	0.488	0.846	C3163622	Papillary Meningioma	disease	C04;C10	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1520	CTSS	0.539	0.731	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1520	CTSS	0.539	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1520	CTSS	0.539	0.731	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1520	CTSS	0.539	0.731	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.35	1	2005	2019	   1	   0	CTD_human
     1520	CTSS	0.539	0.731	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     1522	CTSZ	0.647	0.577	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1522	CTSZ	0.647	0.577	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1522	CTSZ	0.647	0.577	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1522	CTSZ	0.647	0.577	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1523	CUX1	0.465	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.39	1	1998	2017	   0	   0	UNIPROT
     1523	CUX1	0.465	0.846	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.962	2004	2019	   0	   0	CGI
     1523	CUX1	0.465	0.846	C0007103	Malignant neoplasm of endometrium	disease	C04;C13	Neoplastic Process	0.30				   0	   0	CGI
     1523	CUX1	0.465	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2006	2013	   0	   1	UNIPROT
     1523	CUX1	0.465	0.846	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.33	0.667	1993	2019	   0	   0	CGI
     1523	CUX1	0.465	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	0.36	1	1993	2014	   0	   0	CGI
     1523	CUX1	0.465	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.32	0.667	2008	2013	   3	   0	PSYGENET
     1523	CUX1	0.465	0.846	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
     1523	CUX1	0.465	0.846	C0346191	Carcinoma in situ of endometrium	disease	C04;C13	Neoplastic Process	0.30				   0	   0	CGI
     1523	CUX1	0.465	0.846	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.30				   0	   0	CGI
     1523	CUX1	0.465	0.846	C0596263	Carcinogenesis	phenotype	C23;C04	Neoplastic Process	0.37	0.857	2002	2018	   1	   0	CTD_human
     1523	CUX1	0.465	0.846	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.35	0.667	2008	2017	   3	   0	PSYGENET
     1523	CUX1	0.465	0.846	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
     1523	CUX1	0.465	0.846	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.33	1	2015	2019	   0	   0	CGI
     1524	CX3CR1	0.457	0.885	C0010068	Coronary heart disease	disease	C14	Disease or Syndrome	0.40	1	2001	2016	   0	   0	CTD_human
     1524	CX3CR1	0.457	0.885	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.33	1	2001	2014	   0	   0	CTD_human
     1524	CX3CR1	0.457	0.885	C0035304	Retinal Degeneration	phenotype	C11	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1524	CX3CR1	0.457	0.885	C0263454	Chloracne	disease	C17	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1524	CX3CR1	0.457	0.885	C3151079	MACULAR DEGENERATION, AGE-RELATED, 12	disease		Disease or Syndrome	0.50	1	2007	2007	   0	   0	CTD_human
     1524	CX3CR1	0.457	0.885	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30				   0	   0	CTD_human
     1525	CXADR	0.454	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1528	CYB5A	0.601	0.654	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1528	CYB5A	0.601	0.654	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1528	CYB5A	0.601	0.654	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1528	CYB5A	0.601	0.654	C0268285	Adrenal hyperplasia, congenital, type 5	disease	C16;C18;C13;C12;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	ORPHANET
     1528	CYB5A	0.601	0.654	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1528	CYB5A	0.601	0.654	C0272087	Congenital Methemoglobinemia	disease	C15	Disease or Syndrome	0.32	1	1992	1994	   0	   0	ORPHANET
     1528	CYB5A	0.601	0.654	C2673427	METHEMOGLOBINEMIA TYPE IV	disease	C15	Disease or Syndrome	0.30				   0	   0	CTD_human
     1528	CYB5A	0.601	0.654	C4285231	METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA	disease		Disease or Syndrome	0.60	1	1994	2012	   3	   3	GENOMICS_ENGLAND;UNIPROT
     1534	CYB561	0.78	0.192	C4748569	ORTHOSTATIC HYPOTENSION 2	disease		Disease or Syndrome	0.40	1	2018	2018	   1	   2	UNIPROT
     1535	CYBA	0.52	0.769	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2002	2003	   2	   0	CTD_human
     1535	CYBA	0.52	0.769	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.40	1	2000	2019	   1	   0	CTD_human
     1535	CYBA	0.52	0.769	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2002	2013	   2	   0	CTD_human
     1535	CYBA	0.52	0.769	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.40	0.917	2003	2016	   1	   0	CTD_human
     1535	CYBA	0.52	0.769	C0018203	Chronic granulomatous disease	group	C16;C20;C15	Disease or Syndrome	0.50	1	1990	2019	   1	   1	CTD_human
     1535	CYBA	0.52	0.769	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.31	1	2005	2016	   1	   0	CTD_human
     1535	CYBA	0.52	0.769	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.40	1	2017	2017	   1	   1	CTD_human
     1535	CYBA	0.52	0.769	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.60	0.964	2002	2017	   3	   0	CTD_human
     1535	CYBA	0.52	0.769	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.55	1	2005	2016	   1	   0	CTD_human
     1535	CYBA	0.52	0.769	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1535	CYBA	0.52	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1535	CYBA	0.52	0.769	C0035078	Kidney Failure	disease	C13;C12	Disease or Syndrome	0.32	1	2010	2016	   1	   0	CTD_human
     1535	CYBA	0.52	0.769	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2002	2003	   2	   0	CTD_human
     1535	CYBA	0.52	0.769	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1535	CYBA	0.52	0.769	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1535	CYBA	0.52	0.769	C1565489	Renal Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1535	CYBA	0.52	0.769	C1844376	Granulomatous Disease, Chronic, X-Linked	disease	C16;C20;C15	Disease or Syndrome	0.31	1	1990	2017	   1	   0	CTD_human
     1535	CYBA	0.52	0.769	C1856255	Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Negative	disease	C16;C20;C15	Disease or Syndrome	0.70	1	1990	2016	  11	  15	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1535	CYBA	0.52	0.769	C3661525	Autosomal Recessive Chronic Granulomatous Disease	disease	C16;C20;C15	Disease or Syndrome	0.33	1	1990	2009	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2009	2009	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0011849	Diabetes Mellitus	group	C18;C19	Disease or Syndrome	0.36	1	2009	2019	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2001	2009	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0018203	Chronic granulomatous disease	group	C16;C20;C15	Disease or Syndrome	0.90	0.986	1987	2020	   2	   2	CTD_human;GENOMICS_ENGLAND
     1536	CYBB	0.452	0.885	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.37	1	2010	2019	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.37	1	2010	2019	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.60	0.812	2003	2020	   4	   0	CTD_human
     1536	CYBB	0.452	0.885	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.31	1	2010	2013	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.51	1	2005	2017	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0024138	Lupus Erythematosus, Discoid	disease	C17	Disease or Syndrome	0.43	1	2016	2019	   0	   0	GENOMICS_ENGLAND
     1536	CYBB	0.452	0.885	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.50	1	2006	2009	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2009	2009	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0393953	Anterior Cerebral Circulation Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0751952	Anterior Circulation Brain Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0751953	Brain Infarction, Posterior Circulation	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0751954	Venous Infarction, Brain	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C0751955	Brain Infarction	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C1844376	Granulomatous Disease, Chronic, X-Linked	disease	C16;C20;C15	Disease or Syndrome	0.80	0.991	1976	2020	  25	  71	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1536	CYBB	0.452	0.885	C1863999	Peroxisome Biogenesis Disorder, Complementation Group D	disease	C16;C18	Disease or Syndrome	0.40	1	1993	2020	   0	   0	GENOMICS_ENGLAND
     1536	CYBB	0.452	0.885	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1536	CYBB	0.452	0.885	C1970859	Atypical Mycobacteriosis, Familial, X-Linked 2	disease	C16;C01	Disease or Syndrome	0.70	1	2007	2011	   2	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1536	CYBB	0.452	0.885	C3661525	Autosomal Recessive Chronic Granulomatous Disease	disease	C16;C20;C15	Disease or Syndrome	0.31	1	2000	2019	   2	   0	CTD_human
     1537	CYC1	0.656	0.462	C1852372	MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)	disease	C18	Disease or Syndrome	0.30				   0	   0	CTD_human
     1537	CYC1	0.656	0.462	C3809553	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6	disease		Disease or Syndrome	0.60	1	2013	2013	   1	   2	GENOMICS_ENGLAND;UNIPROT
     1540	CYLD	0.498	0.846	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1540	CYLD	0.498	0.846	C0007873	Uterine Cervical Neoplasm	disease	C04;C13	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1540	CYLD	0.498	0.846	C0018671	Head and Neck Neoplasms	group	C04	Neoplastic Process	0.30				   0	   0	CGI
     1540	CYLD	0.498	0.846	C0023860	Listeriosis	disease	C01	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1540	CYLD	0.498	0.846	C0040100	Thymoma	disease	C04;C15	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1540	CYLD	0.498	0.846	C0205969	Thymic Carcinoma	disease	C04;C15	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1540	CYLD	0.498	0.846	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.30				   0	   0	CGI
     1540	CYLD	0.498	0.846	C1275122	Familial multiple trichoepitheliomata	disease	C16;C04;C17	Neoplastic Process	0.80	1	2003	2019	   5	   2	CTD_human;ORPHANET;UNIPROT
     1540	CYLD	0.498	0.846	C1305968	Eccrine dermal cylindroma	disease	C16;C04;C17	Neoplastic Process	0.40	0.941	2002	2020	   1	   0	CTD_human
     1540	CYLD	0.498	0.846	C1851526	Ancell-Spiegler cylindromas	phenotype	C16;C04;C17	Pathologic Function	0.40	1	2009	2009	   1	  19	ORPHANET
     1540	CYLD	0.498	0.846	C1857941	Brooke-Spiegler syndrome	disease	C16;C04;C17	Disease or Syndrome	0.80	0.938	2000	2019	  13	   7	CLINGEN;CTD_human;UNIPROT
     1540	CYLD	0.498	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.37	1	2006	2016	   1	   0	CTD_human
     1540	CYLD	0.498	0.846	C3887461	Head and Neck Carcinoma	disease	C04	Neoplastic Process	0.30				   0	   0	CGI
     1540	CYLD	0.498	0.846	C4048328	cervical cancer	disease	C04;C13	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2009	2016	   2	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2009	2016	   2	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2012	2012	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0003860	Arteritis	phenotype	C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0005612	Birth Weight	phenotype	C23	Organism Attribute	0.30	1	2016	2016	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.913	1989	2019	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0011609	Drug Eruptions	group	C17;C20;C25	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2000	2012	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0018552	Hamartoma	disease	C04	Neoplastic Process	0.31	1	2012	2012	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2017	2017	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.40	0.923	2002	2019	   2	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.40	1	2008	2019	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0022665	Kidney Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0023976	Long QT Syndrome	disease	C23;C16;C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0024117	Chronic Obstructive Airway Disease	disease	C08	Disease or Syndrome	0.37	1	2008	2019	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0028797	Occupational Diseases	group	C24	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.37	1	2001	2008	   2	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2012	2012	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0039239	Sinus Tachycardia	disease	C23;C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0085096	Peripheral Vascular Diseases	group	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0086132	Depressive Symptoms	phenotype	F01	Sign or Symptom	0.31	1	2006	2006	   1	   0	PSYGENET
     1543	CYP1A1	0.436	0.846	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0162820	Dermatitis, Allergic Contact	disease	C17;C20	Disease or Syndrome	0.30	1	2001	2009	   2	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0242706	Hyperoxia	phenotype	C23	Sign or Symptom	0.50	1	1993	2014	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0273115	Lung Injury	disease	C08;C26	Injury or Poisoning	0.30	1	2014	2015	   2	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.931	1998	2019	   2	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0406537	Morbilliform Drug Reaction	disease	C17;C20;C25	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0428977	Bradycardia	phenotype	C23;C14	Finding	0.30	1	2016	2016	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.918	1989	2019	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.31	1	2004	2011	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0848676	Subfertility, Male	phenotype	C12	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C0917731	Male sterility	phenotype	C12	Finding	0.30	1	2009	2009	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C1449861	Micronuclei, Chromosome-Defective	phenotype	C23	Cell Component	0.30	1	2013	2013	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C1449862	Micronuclei, Genotoxicant-Induced	phenotype	C23	Cell Component	0.30	1	2013	2013	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	2001	2019	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C1527303	Chronic Airflow Obstruction	disease	C08	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C1527304	Allergic Reaction	phenotype	C20	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.903	1990	2020	   1	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C2350344	Chronic Lung Injury	disease	C08;C26	Disease or Syndrome	0.30	1	2014	2015	   2	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2009	2016	   2	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.33	1	2004	2016	   2	   0	CTD_human
     1543	CYP1A1	0.436	0.846	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.33	1	2007	2012	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.895	1993	2014	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	2007	2011	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0011999	Diastematomyelia	disease	C16;C10	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	1999	1999	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0018273	Growth Disorders	group	C23	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2018	2018	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2011	   2	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2011	   2	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	1999	1999	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.32	1	1995	2016	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2011	   2	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0024117	Chronic Obstructive Airway Disease	disease	C08	Disease or Syndrome	0.33	1	2008	2010	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.32	1	2007	2018	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0025637	Methemoglobinemia	disease	C15	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0027794	Neural Tube Defects	group	C16;C10	Congenital Abnormality	0.31	1	2010	2010	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0027806	Neurenteric Cyst	disease	C16;C10	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2000	2018	   1	   0	PSYGENET
     1544	CYP1A2	0.494	0.923	C0037997	Splenic Diseases	group	C15	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0038002	Splenomegaly	phenotype	C23	Finding	0.30	1	1999	1999	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	1999	1999	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0080218	Tethered Cord Syndrome	disease	C16;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2011	   2	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2003	2003	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0152234	Iniencephaly	disease	C16;C10	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0152426	Craniorachischisis	disease	C16;C10	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0162566	Porphyria Cutanea Tarda	disease	C16;C06;C18;C17	Disease or Syndrome	0.36	0.833	2000	2012	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	0.88	1977	2018	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0266453	Exencephaly	disease	C16;C10	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0273115	Lung Injury	disease	C08;C26	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0333641	Atrophic	phenotype	C23	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0344479	Spinal Cord Myelodysplasia	disease	C16;C10	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0702169	Acrania	disease	C16;C10	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C0809983	Schizophrenia and related disorders	group	F03	Disease or Syndrome	0.31	1	2010	2010	   1	   0	PSYGENET
     1544	CYP1A2	0.494	0.923	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.31	1	2014	2018	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C1527303	Chronic Airflow Obstruction	disease	C08	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	1990	2019	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C2350344	Chronic Lung Injury	disease	C08;C26	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1544	CYP1A2	0.494	0.923	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0001430	Adenoma	group	C04	Neoplastic Process	0.31	1	2001	2007	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.875	1995	2019	   2	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.34	1	1998	2011	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.875	2005	2018	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2007	2010	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1545	CYP1B1	0.457	0.769	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.50	1	2008	2010	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2016	2016	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0020302	Hydrophthalmos	disease	C16;C11	Congenital Abnormality	0.50	1	1995	2019	   1	   0	ORPHANET
     1545	CYP1B1	0.457	0.769	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.34	1	2001	2017	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.35	1	2008	2019	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.36	1	2002	2017	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0086132	Depressive Symptoms	phenotype	F01	Sign or Symptom	0.31	1	2011	2011	   1	   0	PSYGENET
     1545	CYP1B1	0.457	0.769	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	0.964	1977	2018	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0271650	Impaired glucose tolerance	phenotype	C18	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0344559	Irido-corneo-trabecular dysgenesis (disorder)	disease	C16;C11	Congenital Abnormality	0.45	1	2001	2015	   3	   0	ORPHANET
     1545	CYP1B1	0.457	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.931	2002	2019	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.875	1995	2019	   2	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.35	1	2001	2015	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.36	1	2001	2015	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2005	2007	   2	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	1995	2009	   2	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C1533041	Primary congenital glaucoma	disease	C16;C11;C10	Disease or Syndrome	0.50	0.979	1995	2019	   2	   0	GENOMICS_ENGLAND
     1545	CYP1B1	0.457	0.769	C1832977	GLAUCOMA 3, PRIMARY INFANTILE, B	disease	C11	Disease or Syndrome	0.40				   0	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C1842028	GLAUCOMA 1, OPEN ANGLE, A	disease	C11	Disease or Syndrome	0.30	1	2002	2002	   1	   1	UNIPROT
     1545	CYP1B1	0.457	0.769	C1856439	GLAUCOMA 3, PRIMARY CONGENITAL, A	disease	C11	Disease or Syndrome; Congenital Abnormality	0.70	1	1997	2016	  22	  17	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1545	CYP1B1	0.457	0.769	C1862839	Anterior segment mesenchymal dysgenesis	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2012	2013	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1545	CYP1B1	0.457	0.769	C2981140	Glaucoma of childhood	disease	C11	Disease or Syndrome	0.45	1	1997	2017	   2	   5	ORPHANET
     1545	CYP1B1	0.457	0.769	C4310809	ANTERIOR SEGMENT DYSGENESIS 5	disease		Disease or Syndrome	0.40	1	1997	2002	   2	   2	GENOMICS_ENGLAND
     1545	CYP1B1	0.457	0.769	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2005	2007	   2	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.34	0.75	2002	2009	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0006111	Brain Diseases	group	C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.33	1	2002	2007	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	2002	2007	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0019163	Hepatitis B	disease	C06;C01	Disease or Syndrome	0.30	1	1997	1997	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0019196	Hepatitis C	disease	C06;C01	Disease or Syndrome	0.33	1	1997	2013	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0023897	Liver Diseases, Parasitic	group	C06;C01	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.34	1	1999	2015	   6	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2002	2011	   2	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0027439	Nasopharyngeal Neoplasms	group	C04;C07;C09	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0028043	Nicotine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	0.957	1999	2020	   5	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0029106	Opisthorchiasis	disease	C01	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0034067	Pulmonary Emphysema	disease	C08	Disease or Syndrome	0.31	1	2003	2003	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2002	2011	   2	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0040332	Tobacco Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.38	1	2000	2018	   5	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0085584	Encephalopathies	group	C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0206704	Carcinoma, Large Cell	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0221227	Centriacinar Emphysema	disease	C08	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2011	2011	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0238301	Cancer of Nasopharynx	disease	C04;C07;C09	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	0.868	1999	2018	   6	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0262584	Carcinoma, Small Cell	disease	C04	Neoplastic Process	0.31	1	2005	2007	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0264393	Panacinar Emphysema	disease	C08	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0277004	Opisthorchis felineus Infection	disease	C01	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0277005	Opisthorchis viverrini Infection	disease	C01	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.33	1	2001	2010	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0376384	Nicotine Use Disorder	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2004	2018	   5	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0750384	Coumarin Resistance	phenotype	C16;C18	Disease or Syndrome	0.30				   0	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2002	2011	   2	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C1861063	TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)	phenotype		Finding	0.30	1	2001	2010	   2	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C2350878	Focal Emphysema	disease	C08	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1548	CYP2A6	0.556	0.731	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1553	CYP2A13	0.695	0.462	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
     1553	CYP2A13	0.695	0.462	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
     1553	CYP2A13	0.695	0.462	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.32	1	2003	2013	   1	   0	CTD_human
     1555	CYP2B6	0.428	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2006	   2	   0	PSYGENET
     1555	CYP2B6	0.428	0.846	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2018	2018	   1	   0	CTD_human
     1555	CYP2B6	0.428	0.846	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.32	1	2004	2005	   1	   0	CTD_human
     1555	CYP2B6	0.428	0.846	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2007	2013	   1	   0	PSYGENET
     1555	CYP2B6	0.428	0.846	C0206726	gliosarcoma	disease	C04	Neoplastic Process	0.30	1	1998	2001	   2	   0	CTD_human
     1555	CYP2B6	0.428	0.846	C0349204	Nonorganic psychosis	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2007	2013	   1	   0	PSYGENET
     1555	CYP2B6	0.428	0.846	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.38	0.889	2007	2018	   1	   0	CTD_human
     1555	CYP2B6	0.428	0.846	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.31	1	2010	2018	   1	   0	CTD_human
     1555	CYP2B6	0.428	0.846	C1861063	TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)	phenotype		Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1555	CYP2B6	0.428	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.947	1983	2019	   1	   0	CTD_human
     1555	CYP2B6	0.428	0.846	C3281153	EFAVIRENZ, POOR METABOLISM OF	phenotype		Finding	0.30				   0	   0	CTD_human
     1555	CYP2B6	0.428	0.846	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1555	CYP2B6	0.428	0.846	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1555	CYP2B6	0.428	0.846	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.34	1	2014	2018	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.39	1	2010	2018	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.37	1	2001	2020	   4	   0	PSYGENET
     1557	CYP2C19	0.467	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.38	1	2001	2020	   4	   0	PSYGENET
     1557	CYP2C19	0.467	0.846	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2003	2018	   2	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.31	1	2004	2004	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2003	2011	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C0040053	Thrombosis	phenotype	C14	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.35	1	1996	2018	   5	   0	PSYGENET
     1557	CYP2C19	0.467	0.846	C0085215	Ovarian Failure, Premature	disease	C13;C19	Disease or Syndrome	0.31	1	2004	2004	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C0086367	Gonadotropin-Resistant Ovary Syndrome	disease	C13;C19	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C0087086	Thrombus	phenotype	C14	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	1999	2011	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.32	1	2003	2018	   2	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2003	2018	   2	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.36	1	1996	2020	   5	   0	PSYGENET
     1557	CYP2C19	0.467	0.846	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C1836023	Drug Metabolism, Poor, CYP2C19-Related	phenotype	C16;C18	Disease or Syndrome	0.30				   0	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C3494522	Hypergonadotropic Ovarian Failure, X-Linked	disease	C13;C19	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2003	2018	   2	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2003	2018	   2	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2003	2018	   2	   0	CTD_human
     1557	CYP2C19	0.467	0.846	C4552079	Premature Ovarian Failure 1	disease	C13;C19	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1558	CYP2C8	0.615	0.615	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2016	2016	   1	   0	CTD_human
     1558	CYP2C8	0.615	0.615	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.31	1	2008	2008	   1	   0	CTD_human
     1558	CYP2C8	0.615	0.615	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1558	CYP2C8	0.615	0.615	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1558	CYP2C8	0.615	0.615	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1558	CYP2C8	0.615	0.615	C0035410	Rhabdomyolysis	phenotype	C05	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
     1558	CYP2C8	0.615	0.615	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
     1558	CYP2C8	0.615	0.615	C1832733	Rhabdomyolysis, Cerivastatin-Induced	phenotype	C05	Pathologic Function	0.30	1	2010	2010	   1	   0	GENOMICS_ENGLAND
     1558	CYP2C8	0.615	0.615	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1558	CYP2C8	0.615	0.615	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.34	1	2017	2020	   1	   0	CTD_human
     1558	CYP2C8	0.615	0.615	C4693948	DRUG METABOLISM, ALTERED, CYP2C8-RELATED	disease		Disease or Syndrome	0.40	1	2015	2016	   2	   1	ORPHANET
     1558	CYP2C8	0.615	0.615	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.32	1	2014	2016	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.31	1	2006	2006	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0013182	Drug Allergy	group	C20;C25	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2001	2012	   3	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0019080	Hemorrhage	phenotype	C23	Pathologic Function	0.31	1	2008	2016	   5	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2004	2018	   3	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0027707	Nephritis, Interstitial	disease	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0030922	Peptic Ulcer Hemorrhage	phenotype	C23;C06	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0041349	Nephritis, Tubulointerstitial	disease	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.33	0.75	2003	2013	   4	   0	PSYGENET
     1559	CYP2C9	0.506	0.885	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2001	2012	   3	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0153633	Malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0496899	Benign neoplasm of brain, unspecified	disease	C04;C10	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0750384	Coumarin Resistance	phenotype	C16;C18	Disease or Syndrome	0.41	1	2016	2016	   0	   1	CTD_human
     1559	CYP2C9	0.506	0.885	C0750974	Brain Tumor, Primary	disease	C04;C10	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0750977	Recurrent Brain Neoplasm	disease	C04;C10	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0750979	Primary malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.32	1	2004	2018	   3	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2004	2018	   3	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	0.75	2003	2013	   4	   0	PSYGENET
     1559	CYP2C9	0.506	0.885	C1527390	Neoplasms, Intracranial	group	C04;C10	Neoplastic Process	0.31	1	2006	2016	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C2608079	WARFARIN SENSITIVITY (disorder)	phenotype	C16;C18	Disease or Syndrome	0.40	0.882	2005	2019	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2004	2018	   3	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2004	2018	   3	   0	CTD_human
     1559	CYP2C9	0.506	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2004	2018	   3	   0	CTD_human
     1562	CYP2C18	0.666	0.731	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1562	CYP2C18	0.666	0.731	C0206726	gliosarcoma	disease	C04	Neoplastic Process	0.30	1	1998	1998	   1	   0	CTD_human
     1562	CYP2C18	0.666	0.731	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0002395	Alzheimer's Disease	disease	C10;F03	Disease or Syndrome	0.40	0.909	1995	2019	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0004782	Basal Ganglia Diseases	group	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.94	1996	2020	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0009421	Comatose	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0011265	Presenile dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.32	0.667	1995	2008	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.40	0.8	1996	2020	   5	   0	PSYGENET
     1565	CYP2D6	0.437	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	0.8	1996	2020	   5	   0	PSYGENET
     1565	CYP2D6	0.437	0.885	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.34	1	2000	2018	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0013170	Drug habituation	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2013	2013	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0013222	Drug Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0014549	Tonic-Clonic Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0015371	Extrapyramidal Disorders	group	C10	Disease or Syndrome	0.31	1	2002	2005	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0016722	Frigidity	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2003	2007	   2	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0020594	Hypoactive Sexual Desire Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2003	2007	   2	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0026837	Muscle Rigidity	phenotype	C23;C05;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0027707	Nephritis, Interstitial	disease	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0028797	Occupational Diseases	group	C24	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0029231	Organic Mental Disorders, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0029261	Orgasmic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2003	2007	   2	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.40	0.879	1992	2019	   2	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0033054	Prenatal Exposure Delayed Effects	disease	C13	Injury or Poisoning	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0033953	Psychosexual Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2003	2007	   2	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.4	1994	2019	   5	   0	PSYGENET
     1565	CYP2D6	0.437	0.885	C0036902	Sexual Arousal Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2003	2007	   2	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0038580	Substance Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0038586	Substance Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0040822	Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0040827	Saturnine Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0041349	Nephritis, Tubulointerstitial	disease	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.38	1	2004	2018	   5	   0	PSYGENET
     1565	CYP2D6	0.437	0.885	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0149840	Senile Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0151564	Cogwheel Rigidity	phenotype	C23;C05;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0231519	Gegenhalten	phenotype	C23;C05;C10	Finding	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0233608	Catatonic Rigidity	phenotype	C23;C05;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0234370	Persistent Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0234371	Continuous Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0234372	Intermittent Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0234373	Fine Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0234374	Coarse Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0234375	Massive Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0234376	Action Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0234377	Passive Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0234378	Static Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0234379	Resting Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0234381	Darkness Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0235078	Tremor, Perioral	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0235081	Tremor, Limb	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     1565	CYP2D6	0.437	0.885	C0235082	Tremor, Muscle	phenotype